PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ellner, A				Ellner, A			Rethinking prescribing in the United States	BMJ-BRITISH MEDICAL JOURNAL			English	Article									BMJ Knowledge, London WC1H 9JR, England		Ellner, A (corresponding author), BMJ Knowledge, London WC1H 9JR, England.	aellner@bmjgroup.com						*AM COLL PHYS, 2001, AMB CAR FORM PHARM B; [Anonymous], 2002, WORLD HLTH REP 2002; Blumenthal D, 2000, DESCRIPTION ANAL VA; Goff V V, 2001, Issue Brief Natl Health Policy Forum, P1; Holmer AF, 2002, NEW ENGL J MED, V346, P526, DOI 10.1056/NEJM200202143460714; Horn SD, 1996, LANCET, V348, P619, DOI 10.1016/S0140-6736(05)64839-8; Ioannides-Demos LL, 2002, PHARMACOECONOMICS, V20, P577, DOI 10.2165/00019053-200220090-00002; KITCHMAN M, 2002, SENIORS PRESCRIPTION; *NIH CAR MAN FDN, 2000, PRESCR DRUGS MASS ME; *PROD COMM, 2001, INT PHARM PRIC DIFF; *REF DRUG PROGR CO, 2002, REP MIN HLTH PLANN; Rennie D, 2000, JAMA-J AM MED ASSOC, V283, P2158, DOI 10.1001/jama.283.16.2158; Rosenthal MB, 2002, NEW ENGL J MED, V346, P498, DOI 10.1056/NEJMsa012075; RossDegnan D, 1996, LANCET, V347, P1264, DOI 10.1016/S0140-6736(96)90782-5; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; Schneeweiss S, 2002, CAN MED ASSOC J, V166, P737; Steinbrook R, 2002, NEW ENGL J MED, V346, P790, DOI 10.1056/NEJM200203143461102; STUART B, 2000, REPORT PRESIDENT PRE; World Health Organization, WHO MOD LIST ESS MED	19	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2003	327	7428					1397	1400		10.1136/bmj.327.7428.1397	http://dx.doi.org/10.1136/bmj.327.7428.1397			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670892	Green Published			2022-12-24	WOS:000187417900030
J	Ausmees, N; Kuhn, JR; Jacobs-Wagner, C				Ausmees, N; Kuhn, JR; Jacobs-Wagner, C			The bacterial cytoskeleton: An intermediate filament-like function	CELL			English	Article							PENICILLIN-BINDING-PROTEINS; ACTIN-LIKE FILAMENTS; CELL-SHAPE; CHROMOSOMAL INSERTION; LINEAR MOTOR; COILED COILS; DIVISION; PREDICTION; PHOSPHORYLATION; SEGREGATION	Various cell shapes are encountered in the prokaryotic world, but how they are achieved is poorly understood. Intermediate filaments (IFs) of the eukaryotic cytoskeleton play an important role in cell shape in higher organisms. No such filaments have been found in prokaryotes. Here, we describe a bacterial equivalent to IF proteins, named crescentin, whose cytoskeletal function is required for the vibrioid and helical shapes of Caulobacter crescentus. Without crescentin, the cells adopt a straight-rod morphology. Crescentin has characteristic features of IF proteins including the ability to assemble into filaments in vitro without energy or cofactor requirements. In vivo, crescentin forms a helical structure that colocalizes with the inner cell curvatures beneath the cytoplasmic membrane. We propose that IF-like filaments of crescentin assemble into a helical structure, which by applying its geometry to the cell, generates a vibrioid or helical cell shape depending on the length of the cell.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Jacobs-Wagner, C (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	christine.jacobs-wagner@yale.edu		Jacobs-Wagner, Christine/0000-0003-0980-5334	NIGMS NIH HHS [GM26338, GM065835] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065835, R01GM026338] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Brown JH, 1996, PROTEINS, V26, P134; Carballido-Lopez R, 2003, DEV CELL, V4, P19, DOI 10.1016/S1534-5807(02)00403-3; CONCHELLO JA, 1996, 3 DIMENSIONAL MICROS, P199; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; DOMINGO A, 1992, P223; Dusenbery DB, 1998, J BACTERIOL, V180, P5978, DOI 10.1128/JB.180.22.5978-5983.1998; ELY B, 1991, METHOD ENZYMOL, V204, P372; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; Gindullis F, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-9; HENNING U, 1972, EUR J BIOCHEM, V26, P570, DOI 10.1111/j.1432-1033.1972.tb01800.x; Henriques AO, 1998, MOL MICROBIOL, V28, P235, DOI 10.1046/j.1365-2958.1998.00766.x; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; HUIATT TW, 1980, J BIOL CHEM, V255, P6981; IP W, 1985, J MOL BIOL, V183, P365, DOI 10.1016/0022-2836(85)90007-5; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Mayordomo I, 2002, BIOCHEM J, V365, P51, DOI 10.1042/BJ20020053; Mewes HW, 1998, NUCLEIC ACIDS RES, V26, P33, DOI 10.1093/nar/26.1.33; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Nelson DE, 2000, J BACTERIOL, V182, P1714, DOI 10.1128/JB.182.6.1714-1721.2000; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; RENNER W, 1981, J MOL BIOL, V149, P285, DOI 10.1016/0022-2836(81)90303-X; Roberts RC, 1996, J BACTERIOL, V178, P1829, DOI 10.1128/jb.178.7.1829-1841.1996; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; SHOHAYEB M, 1987, J GEN MICROBIOL, V133, P1733; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246; TAMAKI S, 1980, J BACTERIOL, V141, P52, DOI 10.1128/JB.141.1.52-57.1980; TOWNSEND R, 1980, J BACTERIOL, V142, P694, DOI 10.1128/JB.142.2.694-700.1980; Trachtenberg S, 2003, MOL MICROBIOL, V47, P671, DOI 10.1046/j.1365-2958.2003.t01-1-03200.x; Trachtenberg S, 2001, MOL MICROBIOL, V41, P827, DOI 10.1046/j.1365-2958.2001.02527.x; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; van Hemert MJ, 2003, J BIOL CHEM, V278, P15049, DOI 10.1074/jbc.M212495200; van Hemert MJ, 2002, P NATL ACAD SCI USA, V99, P5390, DOI 10.1073/pnas.072556099; Vollmer W, 2001, CURR OPIN MICROBIOL, V4, P625, DOI 10.1016/S1369-5274(01)00261-2; WACHI M, 1987, J BACTERIOL, V169, P4935, DOI 10.1128/jb.169.11.4935-4940.1987; Wortinger MA, 1998, MOL MICROBIOL, V29, P963, DOI 10.1046/j.1365-2958.1998.00959.x	52	272	279	1	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2003	115	6					705	713		10.1016/S0092-8674(03)00935-8	http://dx.doi.org/10.1016/S0092-8674(03)00935-8			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675535	Bronze			2022-12-24	WOS:000187366100010
J	Darwin, KH; Ehrt, S; Gutierrez-Ramos, JC; Weich, N; Nathan, CF				Darwin, KH; Ehrt, S; Gutierrez-Ramos, JC; Weich, N; Nathan, CF			The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide	SCIENCE			English	Article							20S PROTEASOME; SYNTHASE; DEGRADATION; INCREASES; PROTEINS; LUNG	The production of nitric oxide and other reactive nitrogen intermediates (RNI) by macrophages helps to control infection by Mycobacterium tuberculosis (Mtb). However, the protection is imperfect and infection persists. To identify genes that Mtb requires to resist RNI, we screened 10,100 Mtb transposon mutants for hypersusceptibility to acidified nitrite. We found 12 mutants with insertions in seven genes representing six pathways, including the repair of DNA (uvrB) and the synthesis of a flavin cofactor (fbiC). Five mutants had insertions in proteasome-associated genes. An Mtb mutant deficient in a presumptive proteasomal adenosine triphosphatase was attenuated in mice, and exposure to proteasomal protease inhibitors markedly sensitized wild-type Mtb to RNI. Thus, the mycobacterial proteasome serves as a defense against oxidative or nitrosative stress.	Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Millennium Pharmaceut, Cambridge, MA 02139 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Immunol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Mol Biol, New York, NY 10021 USA	Cornell University; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Cornell University; Cornell University	Nathan, CF (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.			Darwin, K Heran/0000-0002-5043-7548	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007621] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL61241] Funding Source: Medline; NIAID NIH HHS [T32 AI07621, AI055549] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Benaroudj N, 2000, NAT CELL BIOL, V2, P833, DOI 10.1038/35041081; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; De Mot R, 1999, TRENDS MICROBIOL, V7, P88, DOI 10.1016/S0966-842X(98)01432-2; Facchetti F, 1999, AM J PATHOL, V154, P145, DOI 10.1016/S0002-9440(10)65261-3; Grune T, 1998, J BIOL CHEM, V273, P10857, DOI 10.1074/jbc.273.18.10857; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Knipfer N, 1997, MOL MICROBIOL, V25, P375, DOI 10.1046/j.1365-2958.1997.4721837.x; Long R, 1999, ANTIMICROB AGENTS CH, V43, P403, DOI 10.1128/AAC.43.2.403; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Nagy I, 1998, J BACTERIOL, V180, P5448, DOI 10.1128/JB.180.20.5448-5453.1998; Nathan C, 2002, AM J RESP CRIT CARE, V166, P130, DOI 10.1164/rccm.2205016; NATHAN C, 2003, TUBERCULOSIS, P215; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schaible UE, 1998, J IMMUNOL, V160, P1290; SCHON T, 2002, THESIS LINKOPING U S; St John G, 2001, P NATL ACAD SCI USA, V98, P9901; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Wolf S, 1998, J MOL BIOL, V277, P13, DOI 10.1006/jmbi.1997.1589	22	406	423	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1963	1966		10.1126/science.1091176	http://dx.doi.org/10.1126/science.1091176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671303				2022-12-24	WOS:000187174000060
J	Davidson, BL				Davidson, BL			Hepatic diseases - Hitting the target with inhibitory RNAs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INTERFERENCE; MICE		Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Iowa	Davidson, BL (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.							McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828	2	12	13	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2003	349	24					2357	2359		10.1056/NEJMcibr031609	http://dx.doi.org/10.1056/NEJMcibr031609			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752AX	14668464				2022-12-24	WOS:000187125000014
J	Offit, PA; Peter, G				Offit, PA; Peter, G			The meningococcal vaccine - Public policy and individual choices	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							C CONJUGATE VACCINE; POLYSACCHARIDE VACCINES; COLLEGE-STUDENTS; GROUP-A; DISEASE; CHILDREN; IMMUNOGENICITY; PREVENTION; INFANTS; ANTIBODIES		Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Rhode Isl Hosp, Div Pediat Infect Dis, Providence, RI USA; Brown Med Sch, Dept Pediat, Providence, RI USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Offit, PA (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA.							Abramson JS, 2000, PEDIATRICS, V106, P1500, DOI 10.1542/peds.106.6.1500; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; ARTENSTEIN MS, 1970, NEW ENGL J MED, V282, P417, DOI 10.1056/NEJM197002192820803; Balmer P, 2002, J MED MICROBIOL, V51, P717, DOI 10.1099/0022-1317-51-9-717; Borrow R, 2001, J INFECT DIS, V184, P377, DOI 10.1086/322024; Campbell JD, 2002, J INFECT DIS, V186, P1848, DOI 10.1086/345763; *CDCP, 2002, ACT BACT COR SURV AB; Centers for Disease Control and Prevention (CDC), 1985, MMWR-MORBID MORTAL W, V34, P255; FINNE J, 1983, LANCET, V2, P355; GOLD R, 1979, J INFECT DIS, V140, P690, DOI 10.1093/infdis/140.5.690; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; GRIFFISS JM, 1982, INFECT IMMUN, V37, P205, DOI 10.1128/IAI.37.1.205-208.1982; KAYHTY H, 1980, J INFECT DIS, V142, P861, DOI 10.1093/infdis/142.6.861; Kirsch EA, 1996, PEDIATR INFECT DIS J, V15, P967, DOI 10.1097/00006454-199611000-00009; Lebel MH, 2001, JAMA-J AM MED ASSOC, V285, P1578, DOI 10.1001/jama.285.12.1578; MacLennan JM, 2000, JAMA-J AM MED ASSOC, V283, P2795, DOI 10.1001/jama.283.21.2795; Meningococcal disease and college students, 2000, MMWR RECOMM REP, V49, P13; PICKERING LK, 2003, 2003 RED BOOK, P389; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; REINGOLD AL, 1985, LANCET, V2, P114; RIEDO FX, 1995, PEDIATR INFECT DIS J, V14, P643, DOI 10.1097/00006454-199508000-00001; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Scott RD, 2002, AM J PREV MED, V23, P98, DOI 10.1016/S0749-3797(02)00462-2; WYLE FA, 1972, J INFECT DIS, V126, P514, DOI 10.1093/infdis/126.5.514; ZANGWILL KM, 1994, J INFECT DIS, V169, P847, DOI 10.1093/infdis/169.4.847	25	25	27	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2003	349	24					2353	2356		10.1056/NEJMsb035678	http://dx.doi.org/10.1056/NEJMsb035678			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752AX	14668463				2022-12-24	WOS:000187125000013
J	Vellai, T; Takacs-Vellai, K; Zhang, Y; Kovacs, AL; Orosz, L; Muller, F				Vellai, T; Takacs-Vellai, K; Zhang, Y; Kovacs, AL; Orosz, L; Muller, F			Genetics - Influence of TOR kinase on lifespan in C-elegans	NATURE			English	Editorial Material							CAENORHABDITIS-ELEGANS		Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; Eotvos Lorand Univ, Dept Gen Zool, H-1117 Budapest, Hungary; Eotvos Lorand Univ, Dept Genet, H-1117 Budapest, Hungary; Agr Biotechnol Ctr, H-2100 Godollo, Hungary	University of Fribourg; Eotvos Lorand University; Eotvos Lorand University	Vellai, T (corresponding author), Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland.	fritz.mueller@unifr.ch	Vellai, Tibor/AAG-2154-2020	Takacs-Vellai, Krisztina/0000-0002-4472-0363				Abraham RT, 2002, CELL, V111, P9, DOI 10.1016/S0092-8674(02)01009-7; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KENYON C, 1997, C ELEGANS, V2, P701; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Riddle DL, 1997, C ELEGANS, P739; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Tissenbaum HA, 1998, GENETICS, V148, P703	11	774	817	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					620	620		10.1038/426620a	http://dx.doi.org/10.1038/426620a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668850	Bronze, Green Published			2022-12-24	WOS:000187132800027
J	Lieberman, DA; Prindiville, S; Weiss, DG; Willett, W				Lieberman, DA; Prindiville, S; Weiss, DG; Willett, W		VA Cooperative Study Grp 380	Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLORECTAL-CANCER; PHYSICAL-ACTIVITY; LARGE-BOWEL; ASPIRIN USE; SCREENING SIGMOIDOSCOPY; SERUM-CHOLESTEROL; CIGARETTE-SMOKING; REDUCED RISK; VITAMIN-D; ADENOMA	Context Knowledge of risk factors for colorectal neoplasia could inform risk reduction strategies for asymptomatic individuals. Few studies have evaluated risk factors for advanced colorectal neoplasia in asymptomatic individuals, compared risk factors between persons with and without polyps, or included most purported risk factors in a multivariate analysis. Objective To determine risk factors associated with advanced colorectal neoplasia in a cohort of asymptomatic persons with complete colonoscopy. Design, Setting, and Participants Prospective, cross-sectional study of 3121 asymptomatic patients aged 50 to 75 years from 13 Veterans Affairs medical centers conducted between February 1994 and January 1997. All participants had complete colonoscopy to determine the prevalence of advanced neoplasia, defined as an adenoma that was 10 mm or more in diameter, a villous adenoma, an adenoma with high-grade dysplasia, or invasive cancer. Variables examined included history of first-degree relative with colorectal cancer, prior cholecystectomy, serum cholesterol level, physical activity, smoking, alcohol use, and dietary factors. Main Outcome Measures An age-adjusted analysis was performed for each variable to calculate the odds ratios (ORs) and 95% confidence intervals (CIS) associated with having advanced neoplasia compared with having no polyps. We developed a multivariate logistic regression model to identify the most informative risk factors. A secondary analysis examined risk factors for having hyperplastic polyps compared with having no polyps and compared with having advanced neoplasia. Results Three hundred twenty-nine participants had advanced neoplasia and 1441 had no polyps. In multivariate analyses, we found positive associations for history of a first-degree relative with colorectal cancer (OR, 1.66; 95% Cl, 1.16-2.35), current-smoking (OR, 1.85; 95% Cl, 1.33-2.58), and current moderate to heavy alcohol use (OR, 1.02; 95% Cl, 1.01 -1.03). Inverse associations were found for cereal fiber intake (OR, 0.95; 95% Cl, 0.91-0.99), vitamin D intake (OR, 0.94; 95% Cl, 0.90-0.99), and use of nonsteroidal anti-inflammatory drugs (NSAIDs) (OR, 0.66; 95% Cl, 0.48-0.91). In the univariate analysis, the inverse association was found with cereal fiber intake greater than 4.2 g/d, vitamin D intake greater than 645 IU/d, and daily use of NSAIDs. Marginal factors included physical activity, daily multivitamin use, and intake of calcium and fat derived from red meat. No association was found for body mass index, prior cholecystectomy, or serum cholesterol level. Three hundred ninety-one patients had hyperplastic polyps as the worst lesion found at colonoscopy. Risk variables were similar to those for patients with no polyps, except that past and current smoking were associated with an increased risk of hyperplastic polyps. Conclusions Our data endorse several important risk factors for advanced colonic neoplasia and provide a rationale for prudent risk reduction strategies. Further study is needed to determine if lifestyle changes can moderate the risk of colorectal cancer.	Dept Vet Affairs Med Ctr, Portland, OR USA; NCI, Bethesda, MD 20892 USA; Dept Vet Affairs Med Ctr, Perry Point, MD USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health	Lieberman, DA (corresponding author), Portland VA Med Ctr, Div Gastroenterol, P3-GI,POB 1034, Portland, OR 97207 USA.	lieberma@ohsu.edu			NCI NIH HHS [K07CA75159] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K07CA075159] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Alberts DS, 2000, NEW ENGL J MED, V342, P1156, DOI 10.1056/NEJM200004203421602; Bardou M, 2002, GUT, V50, P38, DOI 10.1136/gut.50.1.38; Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Bonithon-Kopp C, 2000, LANCET, V356, P1300, DOI 10.1016/S0140-6736(00)02813-0; CANNONALBRIGHT LA, 1988, NEW ENGL J MED, V319, P533, DOI 10.1056/NEJM198809013190902; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; GARLAND C, 1985, LANCET, V1, P307, DOI 10.1016/S0140-6736(85)91082-7; GARLAND CF, 1989, LANCET, V2, P1176, DOI 10.1016/s0140-6736(89)91789-3; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; GIOVANNUCCI E, 1995, JNCI-J NATL CANCER I, V87, P265, DOI 10.1093/jnci/87.4.265; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; GIOVANNUCCI E, 1993, GASTROENTEROLOGY, V105, P130, DOI 10.1016/0016-5085(93)90018-8; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; GIOVANNUCCI E, 1994, J NATL CANCER I, V86, P183, DOI 10.1093/jnci/86.3.183; GREENBERG ER, 1993, JNCI-J NATL CANCER I, V85, P912, DOI 10.1093/jnci/85.11.912; Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Jorgensen OD, 2002, GUT, V50, P29, DOI 10.1136/gut.50.1.29; KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857; KIKENDALL JW, 1989, GASTROENTEROLOGY, V97, P660, DOI 10.1016/0016-5085(89)90637-9; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lagergren J, 2001, GASTROENTEROLOGY, V121, P542, DOI 10.1053/gast.2001.27083; LEE IM, 1992, J NATL CANCER I, V84, P1326, DOI 10.1093/jnci/84.17.1326; LIEBERMAN DA, 1992, AM J GASTROENTEROL, V87, P1085; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MANNES GA, 1986, NEW ENGL J MED, V315, P1634, DOI 10.1056/NEJM198612253152602; Martinez ME, 1998, CANCER EPIDEM BIOMAR, V7, P163; MCFARLANE MJ, 1993, AM J GASTROENTEROL, V88, P1994; NEWCOMB PA, 1992, JNCI-J NATL CANCER I, V84, P1572, DOI 10.1093/jnci/84.20.1572; Niv Y, 2002, GUT, V50, P33, DOI 10.1136/gut.50.1.33; Pariente A, 1998, GASTROENTEROLOGY, V115, P7, DOI 10.1016/S0016-5085(98)70358-0; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; POTTER JD, 1996, PREVENTION EARLY DET, P23; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; ROSENBERG L, 1991, J NATL CANCER I, V83, P355, DOI 10.1093/jnci/83.5.355; SANDLER RS, 1993, GASTROENTEROLOGY, V104, P1445, DOI 10.1016/0016-5085(93)90354-F; Sandler RS, 1998, GASTROENTEROLOGY, V114, P441, DOI 10.1016/S0016-5085(98)70526-8; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; SHABAHANG M, 1994, CANCER RES, V54, P4057; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; STJOHN DJB, 1993, ANN INTERN MED, V118, P785, DOI 10.7326/0003-4819-118-10-199305150-00005; Sturmer T, 1998, ANN INTERN MED, V128, P713, DOI 10.7326/0003-4819-128-9-199805010-00003; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; TORNBERG SA, 1986, NEW ENGL J MED, V315, P1629, DOI 10.1056/NEJM198612253152601; Ulvik A, 2001, AM J MED GENET, V101, P246, DOI 10.1002/ajmg.1370; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Willett W., 2012, NUTR EPIDEMIOLOGY; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407	57	351	362	3	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2003	290	22					2959	2967		10.1001/jama.290.22.2959	http://dx.doi.org/10.1001/jama.290.22.2959			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751WH	14665657	Bronze			2022-12-24	WOS:000187112700027
J	Smith, GCS; Pell, JP; Dobbie, R				Smith, GCS; Pell, JP; Dobbie, R			Caesarean section and risk of unexplained stillbirth in subsequent pregnancy	LANCET			English	Article							PLACENTAL ABRUPTION; PERINATAL DEATH; ARTERY DOPPLER; DELIVERY; TERM; BIRTH; OUTCOMES; LABOR; MORTALITY; SCOTLAND	Background Caesarean section is associated with an increased risk of disorders of placentation in subsequent pregnancies, but effects on the rate of antepartum stillbirth are unknown. We aimed to establish whether previous caesarean delivery is associated with an increased risk of antepartum stillbirth. Methods We linked pregnancy discharge data from the Scottish Morbidity Record (1980-98) and the Scottish Stillbirth and Infant Death Enquiry (1985-98). We estimated the relative risk of antepartum stillbirth in second pregnancies using time-to-event analyses. Findings For 120 633 singleton second births, there were 68 antepartum stillbirths in 17 754 women previously delivered by caesarean section (2.39 per 10 000 women per week) and 244 in 102879 women previously delivered vaginally (1.44; p<0.001). Risk of unexplained stillbirth associated with previous caesarean delivery differed significantly with gestational age (p=0.04); the excess risk was apparent from 34 weeks (hazard ratio 2.23 [95% CI 1.48-3.36]). Risk was not attenuated by adjustment for maternal characteristics or outcome of the first pregnancy (2.74 [1.74-4.30]). The absolute risk of unexplained stillbirth at or after 39 weeks' gestation was 1.1 per 1000 women who had had a previous caesarean section and 0.5 per 1000 in those who had not. The difference was due mostly to an excess of unexplained stillbirths among women previously delivered by caesarean section. Interpretation Delivery by caesarean section in the first pregnancy could increase the risk of unexplained stillbirth in the second. In women with one previous caesarean delivery, the risk of unexplained antepartum stillbirth at or after 39 weeks' gestation is about double the risk of stillbirth or neonatal death from intrapartum uterine rupture.	Univ Cambridge, Dept Obstet & Gynaecol, Cambridge CB2 2SW, England; Greater Glasgow NHS Board, Dept Publ Hlth, Glasgow, Lanark, Scotland; Common Serv Agcy, Informat & Stat Div, Edinburgh, Midlothian, Scotland	University of Cambridge	Smith, GCS (corresponding author), Univ Cambridge, Dept Obstet & Gynaecol, Rosie Matern Hosp, Cambridge CB2 2SW, England.	gcss2@cam.ac.uk	Smith, Gordon/A-8070-2008	Smith, Gordon/0000-0003-2124-0997; Pell, Jill/0000-0002-8898-7035				ALFIREVIC Z, 1995, AM J OBSTET GYNECOL, V172, P1379, DOI 10.1016/0002-9378(95)90466-2; Ananth CV, 2001, AM J EPIDEMIOL, V153, P332, DOI 10.1093/aje/153.4.332; Campbell S., 1993, ULTRASOUND OBSTET GY, P1432; Castro LC, 2002, CURR OPIN OBSTET GYN, V14, P601, DOI 10.1097/00001703-200212000-00005; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; COLE SK, 1986, BRIT J OBSTET GYNAEC, V93, P1204, DOI 10.1111/j.1471-0528.1986.tb07853.x; COLE SK, 1980, PERINATAL AUDIT SURV, P39; FELDMAN GB, 1992, OBSTET GYNECOL, V79, P547; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; Hemminki E, 1996, AM J OBSTET GYNECOL, V174, P1569, DOI 10.1016/S0002-9378(96)70608-7; Hosmer D. W., 1999, APPL SURVIVAL ANAL; *INF STAT DIV NHS, 2000, SCOTT PER INF MORT M; Jensen H, 1999, ACTA OBSTET GYN SCAN, V78, P799, DOI 10.1034/j.1600-0412.1999.780911.x; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; Kingdom JCP, 1997, ULTRASOUND OBST GYN, V9, P271, DOI 10.1046/j.1469-0705.1997.09040271.x; Lees C, 2001, OBSTET GYNECOL, V98, P369, DOI 10.1016/S0029-7844(01)01474-0; Lieberman E, 1997, CURR PROB OBST GYN F, V20, P98; Lydon-Rochelle M, 2001, NEW ENGL J MED, V345, P3, DOI 10.1056/NEJM200107053450101; Lydon-Rochelle M, 2001, OBSTET GYNECOL, V97, P765, DOI 10.1016/S0029-7844(01)01121-8; MACARA LM, 1994, AM J OBSTET GYNECOL, V171, P71, DOI 10.1016/S0002-9378(94)70080-X; Maller RA., 1996, SURVIVAL ANAL LONG T; MCILWAINE GM, 1985, BRIT J OBSTET GYNAEC, V92, P9, DOI 10.1111/j.1471-0528.1985.tb01041.x; MCLOONE P, 1994, BRIT MED J, V309, P1465, DOI 10.1136/bmj.309.6967.1465; Moore T. R., 1999, MATERNAL FETAL MED, P964; MORRISON JJ, 1995, BRIT J OBSTET GYNAEC, V102, P101, DOI 10.1111/j.1471-0528.1995.tb09060.x; PARRISH KM, 1994, JAMA-J AM MED ASSOC, V271, P443, DOI 10.1001/jama.271.6.443; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Porreco RP, 1996, AM J OBSTET GYNECOL, V175, P369, DOI 10.1016/S0002-9378(96)70148-5; Rasmussen S, 1999, PAEDIATR PERINAT EP, V13, P9; Smith GCS, 2002, JAMA-J AM MED ASSOC, V287, P2684, DOI 10.1001/jama.287.20.2684; Smith GCS, 2001, AM J OBSTET GYNECOL, V184, P489, DOI 10.1067/mob.2001.109735; SOPER DE, 1993, CURR OPIN OBSTET GYN, V5, P517; THORPEBEESTON JG, 1992, BRIT MED J, V305, P746, DOI 10.1136/bmj.305.6856.746; YUDKIN PL, 1987, LANCET, V1, P1192	35	252	260	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1779	1784		10.1016/S0140-6736(03)14896-9	http://dx.doi.org/10.1016/S0140-6736(03)14896-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654315	Green Accepted			2022-12-24	WOS:000186872900008
J	Lee, SJ; Sekimoto, T; Yamashita, E; Nagoshi, E; Nakagawa, A; Imamoto, N; Yoshimura, M; Sakai, H; Chong, KT; Tsukihara, T; Yoneda, Y				Lee, SJ; Sekimoto, T; Yamashita, E; Nagoshi, E; Nakagawa, A; Imamoto, N; Yoshimura, M; Sakai, H; Chong, KT; Tsukihara, T; Yoneda, Y			The structure of importin-beta bound to SREBP-2: Nuclear import of a transcription factor	SCIENCE			English	Article							CLEAVAGE-ACTIVATING PROTEIN; ELEMENT-BINDING PROTEIN-2; 2.3 ANGSTROM RESOLUTION; NUCLEOCYTOPLASMIC TRANSPORT; LOCALIZATION SIGNAL; B/HLH/Z DOMAIN; IDENTIFICATION; RECOGNITION; ALPHA; MECHANISMS	The sterol regulatory element - binding protein 2 (SREBP-2), a nuclear transcription factor that is essential for cholesterol metabolism, enters the nucleus through a direct interaction of its helix-loop-helix leucine zipper domain with importin-beta. We show the crystal structure of importin-beta complexed with the active form of SREBP-2. Importin-beta uses characteristic long helices like a pair of chopsticks to interact with an SREBP-2 dimer. Importin-beta changes its conformation to reveal a pseudo-twofold symmetry on its surface structure so that it can accommodate a symmetric dimer molecule. Importin-beta may use a similar strategy to recognize other dimeric cargoes.	Osaka Univ, Grad Sch Frontier Biosci, Dept Frontier Biosci, Suita, Osaka 5650871, Japan; Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Tsukihara, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Dept Frontier Biosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Yamashita, Eiki/V-6758-2019; Nakagawa, Atsushi/M-5731-2019; Nakagawa, Atsushi/D-4329-2009; Imamoto, Naoko/A-7458-2015	Yamashita, Eiki/0000-0002-4278-0039; Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861; Imamoto, Naoko/0000-0002-2886-3022; Nagoshi, Emi/0000-0002-6365-4074; Yoshimura, Masato/0000-0002-7466-2192				Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chan CK, 1998, GENE THER, V5, P1204, DOI 10.1038/sj.gt.3300708; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Corbett AH, 1997, MICROBIOL MOL BIOL R, V61, P193, DOI 10.1128/.61.2.193-211.1997; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DANG CV, 1988, MOL CELL BIOL, V8, P4048, DOI 10.1128/MCB.8.10.4048; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; Fortelle E., 1997, METHOD ENZYMOL, P472; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; Lee SJ, 2000, J MOL BIOL, V302, P251, DOI 10.1006/jmbi.2000.4055; Luo X, 1996, MOL CELL BIOL, V16, P1367; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Moore JD, 1999, J CELL BIOL, V144, P213, DOI 10.1083/jcb.144.2.213; Nagoshi E, 1999, MOL BIOL CELL, V10, P2221, DOI 10.1091/mbc.10.7.2221; Nagoshi E, 2001, MOL CELL BIOL, V21, P2779, DOI 10.1128/MCB.21.8.2779-2789.2001; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Palmeri D, 1999, MOL CELL BIOL, V19, P1218; Parraga A, 1998, STRUCT FOLD DES, V6, P661, DOI 10.1016/S0969-2126(98)00067-7; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Saphire ACS, 1998, J BIOL CHEM, V273, P29764, DOI 10.1074/jbc.273.45.29764; Truant R, 1999, MOL CELL BIOL, V19, P1210; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5	33	167	176	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1571	1575		10.1126/science.1088372	http://dx.doi.org/10.1126/science.1088372			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645851				2022-12-24	WOS:000186802200046
J	Sheng, GJ; dos Reis, M; Stern, CD				Sheng, GJ; dos Reis, M; Stern, CD			Churchill, a zinc finger transcriptional activator, regulates the transition between gastrulation and neurulation	CELL			English	Article							SMAD-INTERACTING PROTEIN-1; PRIMITIVE STREAK; NEURAL INDUCTION; CHICK-EMBRYO; MORPHOGENETIC MOVEMENT; MESODERM INDUCTION; XENOPUS-BRACHYURY; CELL MOVEMENTS; FGF; EXPRESSION	Gastrulation generates mesoderm and endoderm from embryonic epiblast; soon after, the neural plate is established within the epiblast-both events require FGF signaling. We describe a zinc finger transcriptional activator, Churchill (ChCh), which acts as a switch between different roles of FGF. FGF induces ChCh slowly; this activates Smad-interacting-protein-1 (Sip1), which blocks further induction of the mesoderm markers brachyury and Tbx6L by FGF. ChCh is first expressed as cells stop migrating through the primitive streak, and we show that it regulates cell ingression. We propose a simple mechanism by which FGF sensitizes cells to BMP signals. These results reveal that neural induction requires cessation of mesoderm formation at the midline in addition to the decision between epidermis and neural plate.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England	University of London; University College London	Stern, CD (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	c.stern@ucl.ac.uk	Stern, Claudio/AAZ-7381-2021; Sheng, Guojun/G-8746-2013; Reis, Mario dos/B-4938-2009; Sheng, Guojun/I-4900-2015; Sheng, Guojun/G-4116-2014; Stern, Claudio D/C-6265-2008	Stern, Claudio/0000-0002-9907-889X; Reis, Mario dos/0000-0001-9514-3976; Stern, Claudio D/0000-0002-9907-889X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060156] Funding Source: NIH RePORTER; NIMH NIH HHS [5R01MH060156] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Bertocchini F, 2002, DEV CELL, V3, P735, DOI 10.1016/S1534-5807(02)00318-0; Cacheux V, 2001, HUM MOL GENET, V10, P1503, DOI 10.1093/hmg/10.14.1503; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; CHRISTIAN JL, 1992, EMBO J, V11, P33, DOI 10.1002/j.1460-2075.1992.tb05024.x; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Ciruna BG, 1997, DEVELOPMENT, V124, P2829; CORNELL RA, 1994, DEVELOPMENT, V120, P453; CORNELL RA, 1995, DEVELOPMENT, V121, P2429; Cox WG, 1995, DEVELOPMENT, V121, P4349; DIAS MS, 1990, ANAT RECORD, V228, P437, DOI 10.1002/ar.1092280410; Domingos PM, 2001, DEV BIOL, V239, P148, DOI 10.1006/dbio.2001.0431; Eisaki A, 2000, BIOCHEM BIOPH RES CO, V271, P151, DOI 10.1006/bbrc.2000.2545; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; GALLERA J, 1975, EXPERIENTIA, V31, P584, DOI 10.1007/BF01932472; GALLERA J, 1964, J EMBRYOL EXP MORPH, V12, P693; Gallera J., 1971, EXPERIENTIA, V26, P1953; GARCIAMARTINEZ V, 1993, J EXP ZOOL, V267, P431, DOI 10.1002/jez.1402670409; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HATADA Y, 1994, DEVELOPMENT, V120, P2879; HEMMATIBRIVANLO.A, 1989, DEVELOPMENT, V106, P611; Holowacz T, 1999, DEV BIOL, V205, P296, DOI 10.1006/dbio.1998.9108; Joubin K, 1999, CELL, V98, P559, DOI 10.1016/S0092-8674(00)80044-6; KIMELMAN D, 1992, DEVELOPMENT, V116, P1; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; Knezevic V, 1997, DEVELOPMENT, V124, P411; LABONNE C, 1994, DEVELOPMENT, V120, P463; Launay C, 1996, DEVELOPMENT, V122, P869; Lerchner W, 2000, DEVELOPMENT, V127, P2729; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Newton A, 2001, J BIOL CHEM, V276, P35794, DOI 10.1074/jbc.M106256200; NICOLET G., 1965, ACTA EMBRYOL MORPHOL EXP, V8, P213; Nicolet G, 1970, J Embryol Exp Morphol, V23, P70; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Papin C, 2002, MECH DEVELOP, V111, P37, DOI 10.1016/S0925-4773(01)00599-8; Paterno G D, 1989, Prog Growth Factor Res, V1, P79, DOI 10.1016/0955-2235(89)90002-1; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Postigo AA, 2003, EMBO J, V22, P2443, DOI 10.1093/emboj/cdg225; Psychoyos D, 1996, DEVELOPMENT, V122, P1523; ROSENQUIST GC, 1971, DEV BIOL, V26, P323, DOI 10.1016/0012-1606(71)90131-X; ROSENQUIST GC, 1972, J EXP ZOOL, V180, P95, DOI 10.1002/jez.1401800108; ROSENQUIST GLENN C., 1966, CARNEGIE INST WASH PUBL, V38, P71; Sasai Y, 1996, EMBO J, V15, P4547, DOI 10.1002/j.1460-2075.1996.tb00832.x; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; Stern CD, 1998, CURR TOP DEV BIOL, V36, P223; STERN CD, 1981, ANAT EMBRYOL, V163, P245, DOI 10.1007/BF00315703; STOREY KG, 1992, DEVELOPMENT, V114, P729; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Streit A, 1997, DEVELOPMENT, V124, P1191; Streit A, 1998, DEVELOPMENT, V125, P507; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Tada M, 2000, DEVELOPMENT, V127, P2227; Teakle GR, 1998, TRENDS BIOCHEM SCI, V23, P100, DOI 10.1016/S0968-0004(98)01174-8; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Van de Putte T, 2003, AM J HUM GENET, V72, P465, DOI 10.1086/346092; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Wakamatsu N, 2001, NAT GENET, V27, P369, DOI 10.1038/86860; Wilson SI, 2000, CURR BIOL, V10, P421, DOI 10.1016/S0960-9822(00)00431-0; Wilson V, 1997, DEV BIOL, V192, P45, DOI 10.1006/dbio.1997.8701; WILSON V, 1995, DEVELOPMENT, V121, P877; Yamada K, 2001, AM J HUM GENET, V69, P1178, DOI 10.1086/324343; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3	65	152	155	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 26	2003	115	5					603	613		10.1016/S0092-8674(03)00927-9	http://dx.doi.org/10.1016/S0092-8674(03)00927-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651851	Bronze			2022-12-24	WOS:000186885600010
J	Pauly, D; Alder, J; Bennett, E; Christensen, V; Tyedmers, P; Watson, R				Pauly, D; Alder, J; Bennett, E; Christensen, V; Tyedmers, P; Watson, R			The future for fisheries	SCIENCE			English	Article							MARINE; MANAGEMENT	Formal analyses of long-term global marine fisheries prospects have yet to be performed, because fisheries research focuses on local, species-specific management issues. Extrapolation of present trends implies expansion of bottom fisheries into deeper waters, serious impact on biodiversity, and declining global catches, the last possibly aggravated by fuel cost increases. Examination of four scenarios, covering various societal development choices, suggests that the negative trends now besetting fisheries can be turned around, and their supporting ecosystems rebuilt, at least partly.	Univ British Columbia, Fisheries Ctr, Sea Around Us Project, Vancouver, BC V6T 1Z4, Canada; Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; Dalhousie Univ, Sch Resource & Environm Studies, Halifax, NS B3H 3J5, Canada	University of British Columbia; University of Wisconsin System; University of Wisconsin Madison; Dalhousie University	Pauly, D (corresponding author), Univ British Columbia, Fisheries Ctr, Sea Around Us Project, Vancouver, BC V6T 1Z4, Canada.	d.pauly@fisheries.ubc.ca	Watson, Reg A/F-4850-2012; Tyedmers, Peter H/I-7490-2012; Pauly, Daniel Marc/AAY-2316-2021; Tyedmers, Peter/N-1334-2019; Bennett, Elena/A-9553-2008; Christensen, Villy/C-3945-2009	Watson, Reg A/0000-0001-7201-8865; Tyedmers, Peter H/0000-0002-5150-0756; Tyedmers, Peter/0000-0002-5150-0756; Bennett, Elena/0000-0003-3944-2925; Christensen, Villy/0000-0003-0688-2633; Pauly, Daniel/0000-0003-3756-4793				Bennett EM, 2003, FRONT ECOL ENVIRON, V1, P322, DOI 10.2307/3868093; Christensen V, 2003, FISH FISH, V4, P1, DOI 10.1046/j.1467-2979.2003.00103.x; Christensen V, 1998, J FISH BIOL, V53, P128, DOI 10.1006/jfbi.1998.0809; CHRISTENSEN V, IN PRESS B MAR SCI; Cury P, 2001, FISH FISH, V2, P162, DOI 10.1046/j.1467-2960.2001.00044.x; HEINBERG R, 2003, PARTYS OVER OIL WAR; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Macinko Seth, 2002, WHO OWNS AM FISHERIE; Morgan LE, 2003, SHIFTING GEARS ADDRE; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Okey TA, 2003, MAR POLICY, V27, P193, DOI 10.1016/S0308-597X(03)00002-2; Parrish RH, 1998, GLOBAL VERSUS LOCAL CHANGES IN UPWELLING SYSTEMS, P525; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; PAULY D, 2003, PERFECT OCEAN STATE; Pauly Daniel, 2000, P227; Peterson GD, 2003, CONSERV BIOL, V17, P358, DOI 10.1046/j.1523-1739.2003.01491.x; Pew Oceans Commission, 2003, AM LIV OC CHART COUR; Pitcher TJ, 2001, ECOL APPL, V11, P601; Pitcher TJ, 2002, FISH FISH, V3, P317, DOI 10.1046/j.1467-2979.2002.00093.x; POPE J, 1989, DANA-J FISH MAR RES, V8, P33; TYEDMERS P, 2003, IN PRESS ENCY ENERGY, V2; *UN ENV PROGR, 2002, GLOB ENV OUTL, V3; Watson R, 2001, NATURE, V414, P534, DOI 10.1038/35107050	26	333	347	1	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2003	302	5649					1359	1361		10.1126/science.1088667	http://dx.doi.org/10.1126/science.1088667			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631031				2022-12-24	WOS:000186683500041
J	Ziemelis, K				Ziemelis, K			Hydrocarbon reservoirs	NATURE			English	Editorial Material																			0	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2003	426	6964					317	317		10.1038/426317a	http://dx.doi.org/10.1038/426317a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628059	Bronze			2022-12-24	WOS:000186660800051
J	Bradshaw, HD; Schemske, DW				Bradshaw, HD; Schemske, DW			Allele substitution at a flower colour locus produces a pollinator shift in monkeyflowers	NATURE			English	Article							QUANTITATIVE TRAIT LOCI; REPRODUCTIVE ISOLATION; FLORAL TRAITS; MIMULUS; EVOLUTION; GENETICS; ADAPTATION	The role of major mutations in adaptive evolution has been debated for more than a century(1,2). The classical view is that adaptive mutations are nearly infinite in number with infinitesimally small phenotypic effect(3), but recent theory suggests otherwise(4). To provide empirical estimates of the magnitude of adaptive mutations in wild plants, we conducted field studies to determine the adaptive value of alternative alleles at a single locus, YELLOW UPPER5-7 (YUP). YUP controls the presence or absence of yellow carotenoid pigments in the petals of pink-flowered Mimulus lewisii, which is pollinated by bumblebees(5,8-10), and its red-flowered sister species(11) M. cardinalis, which is pollinated by hummingbirds(5,8-10). We bred near-isogenic lines (NILs) in which the YUP allele from each species was substituted into the other. M. cardinalis NILs with the M. lewisii YUP allele had dark pink flowers and received 74-fold more bee visits than the wild type, whereas M. lewisii NILs with the M. cardinalis yup allele had yellow-orange flowers and received 68-fold more hummingbird visits than the wild type. These results indicate that an adaptive shift in pollinator preference may be initiated by a single major mutation.	Univ Washington, Dept Biol, Seattle, WA 98195 USA; Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA	University of Washington; University of Washington Seattle; Michigan State University; Michigan State University	Bradshaw, HD (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.							Beardsley PM, 2003, EVOLUTION, V57, P1397, DOI 10.1111/j.0014-3820.2003.tb00347.x; BRADSHAW HD, 1995, NATURE, V376, P762, DOI 10.1038/376762a0; Bradshaw HD, 1998, GENETICS, V149, P367; Fisher R., 2005, TEACHING CHILDREN TH; Gillham NW, 2001, GENETICS, V159, P1383; GRANT V, 1994, P NATL ACAD SCI USA, V91, P10407, DOI 10.1073/pnas.91.22.10407; HIESEY WM, 1971, CARNEGIE I WASH PUBL, V628; Hodges SA, 2002, AM NAT, V159, pS51, DOI 10.1086/338372; Mauricio R, 2001, NAT REV GENET, V2, P370, DOI 10.1038/35072085; ORR HA, 1992, AM NAT, V140, P725, DOI 10.1086/285437; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.1111/j.1558-5646.1998.tb01823.x, 10.2307/2411226]; Ramsey J, 2003, EVOLUTION, V57, P1520, DOI 10.1111/j.0014-3820.2003.tb00360.x; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; VICKERY RK, 1995, GREAT BASIN NAT, V55, P177	14	543	568	6	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2003	426	6963					176	178		10.1038/nature02106	http://dx.doi.org/10.1038/nature02106			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614505				2022-12-24	WOS:000186517200042
J	Fuchizaki, U; Miyamori, H; Kitagawa, S; Kaneko, S; Kobayashi, K				Fuchizaki, U; Miyamori, H; Kitagawa, S; Kaneko, S; Kobayashi, K			Hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease)	LANCET			English	Editorial Material							RECEPTOR-LIKE KINASE-1; GENE		Keiju Med Ctr, Dept Internal Med, Nanao, Ishikawa 9268605, Japan; Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa 920, Japan	Kanazawa University	Fuchizaki, U (corresponding author), Keiju Med Ctr, Dept Internal Med, 94 Tomioka Cho, Nanao, Ishikawa 9268605, Japan.							Bliss Michael, 2007, WILLIAM OSLER LIFE M; Cushing H., 1925, LIFE W OSLER; GIBBS DD, 1986, J ROY SOC MED, V79, P742; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Haitjema T, 1996, ARCH INTERN MED, V156, P714, DOI 10.1001/archinte.156.7.714; Hall LA, 2001, MED HIST, V45, P523, DOI 10.1017/S002572730006840X; Hanes FA, 1909, B JOHNS HOPKINS HOSP, V20, P63; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Osler W, 1901, B JOHNS HOPKINS HOSP, V12, P333; Rendu Henri, 1844, JAMA-J AM MED ASSOC, V197, P583; RENDU HJ, 1896, GAZ HOPITAUX, P1322; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; Weber FP, 1907, LANCET, V2, P160	15	63	66	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 1	2003	362	9394					1490	1494		10.1016/S0140-6736(03)14696-X	http://dx.doi.org/10.1016/S0140-6736(03)14696-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739PX	14602446				2022-12-24	WOS:000186356600027
J	Hsieh, JJD; Cheng, EHY; Korsmeyer, SJ				Hsieh, JJD; Cheng, EHY; Korsmeyer, SJ			Taspase1: A threonine aspartase required for cleavage of MLL and proper HOX gene expression	CELL			English	Article							DROSOPHILA-TRITHORAX; CHROMOSOMAL TRANSLOCATIONS; PROTEOLYTIC CLEAVAGE; MAMMALIAN TRITHORAX; BITHORAX COMPLEX; HOMEOBOX GENES; PROTEIN; LEUKEMIA; MECHANISM; ACTIVATION	The Mixed-Lineage Leukemia gene (MLL/HRX/ALL1) encodes a large nuclear protein homologous to Drosophila trithorax that is required for the maintenance of HOX gene expression. MLL is cleaved at two conserved sites generating N320 and C180 fragments, which heterodimerize to stabilize the complex and confer its subnuclear destination. Here, we purify and clone the protease responsible for cleaving MLL. We entitle it Taspase1 as it initiates a class of endopeptidases that utilize an N-terminal threonine as the active site nucleophile to proteolyze polypeptide substrates following aspartate. Taspase1 proenzyme is intramolecularly proteolyzed generating an active 28 kDa alpha/22 kDa beta heterodimer. RNAi-mediated knockdown of Taspase1 results in the appearance of unprocessed MLL and the loss of proper HOX gene expression. Taspase1 coevolved with MLL/trithorax as Arthropoda and Chordata emerged from Metazoa suggesting that Taspase1 originated to regulate complex segmental body plans in higher organisms.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Korsmeyer, SJ (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, 44 Binney St, Boston, MA 02115 USA.	stanley_korsmeyer@dfci.harvard.edu			NCI NIH HHS [CA102594, CA68484] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K01CA102594, P01CA068484] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; BREEN TR, 1993, DEVELOPMENT, V117, P119; Breen TR, 1999, GENETICS, V152, P319; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Buske C, 2000, INT J HEMATOL, V71, P301; Cillo C, 2001, J CELL PHYSIOL, V188, P161, DOI 10.1002/jcp.1115; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Dash A, 2001, BEST PRACT RES CL HA, V14, P49, DOI 10.1053/beha.2000.0115; DOMER PH, 1993, P NATL ACAD SCI USA, V90, P7884, DOI 10.1073/pnas.90.16.7884; Downing J R, 1996, Cancer Treat Res, V84, P73; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; FIAR K, 2001, MOL CELL BIOL, V21, P3589; Forster A, 2003, CANCER CELL, V3, P449, DOI 10.1016/S1535-6108(03)00106-5; FURIE B, 1992, NEW ENGL J MED, V326, P800; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Guan CD, 1996, J BIOL CHEM, V271, P1732, DOI 10.1074/jbc.271.3.1732; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; KUZIN B, 1994, GENE DEV, V8, P2478, DOI 10.1101/gad.8.20.2478; Liu Y, 1998, J BIOL CHEM, V273, P9688, DOI 10.1074/jbc.273.16.9688; MAZO AM, 1990, P NATL ACAD SCI USA, V87, P2112, DOI 10.1073/pnas.87.6.2112; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; ODAKE S, 1991, BIOCHEMISTRY-US, V30, P2217, DOI 10.1021/bi00222a027; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; SEDKOV Y, 1994, DEVELOPMENT, V120, P1907; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; THIRMAN MJ, 1993, NEW ENGL J MED, V329, P909, DOI 10.1056/NEJM199309233291302; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tikkanen R, 1996, EMBO J, V15, P2954, DOI 10.1002/j.1460-2075.1996.tb00658.x; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; WILSON AC, 1995, GENE DEV, V9, P2445, DOI 10.1101/gad.9.20.2445; Xia ZB, 2003, P NATL ACAD SCI USA, V100, P8342, DOI 10.1073/pnas.1436338100; Xu QA, 1999, CELL, V98, P651, DOI 10.1016/S0092-8674(00)80052-5; Ye YH, 2000, SEMIN CELL DEV BIOL, V11, P211, DOI 10.1006/scdb.2000.0167; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; ZELEZNIKLE NJ, 1994, P NATL ACAD SCI USA, V91, P10610, DOI 10.1073/pnas.91.22.10610	49	205	211	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2003	115	3					293	303		10.1016/S0092-8674(03)00816-X	http://dx.doi.org/10.1016/S0092-8674(03)00816-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	740RH	14636557	Bronze			2022-12-24	WOS:000186415000009
J	Vaux, DL; Silke, J				Vaux, DL; Silke, J			HtrA2/Omi, a sheep in wolf's clothing	CELL			English	Editorial Material							APOPTOSIS; PROTEASE; IDENTIFICATION; PROTEINS; BINDING		Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute	Vaux, DL (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Melbourne, Vic 3050, Australia.		Silke, John/B-7622-2008; Vaux, David L/C-7249-2013	Silke, John/0000-0002-7611-5774; Vaux, David L/0000-0003-2703-1651				Jin SK, 2003, GENE DEV, V17, P359, DOI 10.1101/gad.1047003; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Suzuki T, 2001, J BIOL CHEM, V276, P33181, DOI 10.1074/jbc.M103236200; Vaux DL, 2003, BIOCHEM BIOPH RES CO, V304, P499, DOI 10.1016/S0006-291X(03)00622-3; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Yang QH, 2003, GENE DEV, V17, P1487, DOI 10.1101/gad.1097903	8	36	40	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 31	2003	115	3					251	253		10.1016/S0092-8674(03)00851-1	http://dx.doi.org/10.1016/S0092-8674(03)00851-1			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	740RH	14636553	Bronze			2022-12-24	WOS:000186415000005
J	Dunlop, JA; Anderson, LI; Kerp, H; Hass, H				Dunlop, JA; Anderson, LI; Kerp, H; Hass, H			Preserved organs of Devonian harvestmen	NATURE			English	Article							ABERDEENSHIRE; SCOTLAND; OPILIONES; ARACHNIDA; SYSTEM; CHERTS; RHYNIE		Humboldt Univ, Museum Nat Kunde, Inst Systemat Zool, D-10115 Berlin, Germany; Natl Museums Scotland, Dept Geol & Zool, Edinburgh EH1 1JF, Midlothian, Scotland; Univ Munster, Forsch Stelle Palaobot, D-48143 Munster, Germany	Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Munster	Dunlop, JA (corresponding author), Humboldt Univ, Museum Nat Kunde, Inst Systemat Zool, D-10115 Berlin, Germany.		Dunlop, Jason A./AAC-8042-2019; Kerp, Hans/AAJ-1102-2020	Dunlop, Jason/0000-0002-0179-6640				Anderson LI, 2003, PALAEONTOLOGY, V46, P467, DOI 10.1111/1475-4983.00308; CLARIDGE MF, 1961, NATURE, V191, P1190, DOI 10.1038/1911190b0; Edgecombe GD, 1998, NATURE, V394, P172, DOI 10.1038/28156; Giribet G, 2002, CLADISTICS, V18, P5, DOI 10.1006/clad.2001.0185; Hofer AM, 2000, ARTHROPOD STRUCT DEV, V29, P13, DOI 10.1016/S1467-8039(00)00009-8; Martens J., 1981, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V105, P13; MARTENS J, 1976, Entomologica Germanica, V3, P51; Rice CM, 2002, J GEOL SOC LONDON, V159, P203, DOI 10.1144/0016-764900-181; TREWIN NH, 1994, T ROY SOC EDIN-EARTH, V84, P433	9	50	50	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2003	425	6961					916	916		10.1038/425916a	http://dx.doi.org/10.1038/425916a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14586459				2022-12-24	WOS:000186230600031
J	Okamoto, I; Otte, AP; Allis, CD; Reinberg, D; Heard, E				Okamoto, I; Otte, AP; Allis, CD; Reinberg, D; Heard, E			Epigenetic dynamics of imprinted X inactivation during early mouse development	SCIENCE			English	Article							CHROMOSOME INACTIVATION; XIST EXPRESSION; LINKED GENES; FEMALE MOUSE; HISTONE H3; PREIMPLANTATION EMBRYOS; CELL-DIFFERENTIATION; STEM-CELLS; IMPLANTATION; METHYLATION	The initiation of X-chromosome inactivation is thought to be tightly correlated with early differentiation events during mouse development. Here, we show that although initially active, the paternal X chromosome undergoes imprinted inactivation from the cleavage stages, well before cellular differentiation. A reversal of the inactive state, with a loss of epigenetic marks such as histone modi. cations and polycomb proteins, subsequently occurs in cells of the inner cell mass (ICM), which give rise to the embryo-proper in which random X inactivation is known to occur. This reveals the remarkable plasticity of the X-inactivation process during preimplantation development and underlines the importance of the ICM in global reprogramming of epigenetic marks in the early embryo.	Inst Curie, CNRS, UMR218, F-75005 Paris, France; Univ Amsterdam, BioCtr Amsterdam, Swammerdam Inst Life Sci, NL-1018 TV Amsterdam, Netherlands; Rockefeller Univ, New York, NY 10021 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Howard Hughes Med Inst, Dept Biochem,Div Nucleic Acids Enzymol, Piscataway, NJ 08854 USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); University of Amsterdam; Rockefeller University; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center	Heard, E (corresponding author), Inst Curie, CNRS, UMR218, 26 Rue Ulm, F-75005 Paris, France.	edith.heard@curie.fr	Heard, Edith/D-7197-2017	Heard, Edith/0000-0001-8052-7117; Reinberg, Danny/0000-0003-4288-2016				Chaumeil J, 2002, CYTOGENET GENOME RES, V99, P75, DOI 10.1159/000071577; CHAUMEIL J, UNPUB; Costanzi C, 2000, DEVELOPMENT, V127, P2283; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; EPSTEIN CJ, 1978, NATURE, V274, P500, DOI 10.1038/274500a0; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P11819, DOI 10.1073/pnas.1834207100; Hadjantonakis AK, 2001, GENESIS, V29, P133, DOI 10.1002/gene.1016; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; KRATZER PG, 1978, NATURE, V274, P503, DOI 10.1038/274503a0; LATHAM KE, 1995, DEV GENET, V17, P212, DOI 10.1002/dvg.1020170306; LEBON JM, 1995, GENET RES, V65, P223, DOI 10.1017/S0016672300033292; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; LYON MF, 1984, DIFFERENTIATION, V26, P63, DOI 10.1111/j.1432-0436.1984.tb01375.x; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Matsui J, 2001, HUM MOL GENET, V10, P1393, DOI 10.1093/hmg/10.13.1393; MONK M, 1981, J EMBRYOL EXP MORPH, V63, P75; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; Monk M, 2002, CYTOGENET GENOME RES, V99, P200, DOI 10.1159/000071594; MOORE T, 1995, DEV GENET, V17, P206, DOI 10.1002/dvg.1020170305; Nesterova TB, 2001, DEV BIOL, V235, P343, DOI 10.1006/dbio.2001.0295; Okamoto I, 2000, DEVELOPMENT, V127, P4137; Otte AP, 2003, CURR OPIN GENET DEV, V13, P448, DOI 10.1016/S0959-437X(03)00108-4; PAPAIOANNOU VE, 1981, GENET RES, V37, P183, DOI 10.1017/S0016672300020152; Patturajan M, 1998, MOL CELL BIOL, V18, P2406, DOI 10.1128/MCB.18.4.2406; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; RASTAN S, 1982, J EMBRYOL EXP MORPH, V71, P11; ROSSANT J, 1975, J EMBRYOL EXP MORPH, V33, P991; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; SINGERSAM J, 1992, P NATL ACAD SCI USA, V89, P10469, DOI 10.1073/pnas.89.21.10469; SUGAWARA O, 1985, CYTOGENET CELL GENET, V39, P210, DOI 10.1159/000132137; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; TAKAGI N, 1982, CHROMOSOMA, V85, P275, DOI 10.1007/BF00294971; TAKAGI N, 1974, EXP CELL RES, V86, P127, DOI 10.1016/0014-4827(74)90657-0; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Zuccotti M, 2002, MOL REPROD DEV, V61, P14, DOI 10.1002/mrd.1126	40	602	630	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2004	303	5658					644	649		10.1126/science.1092727	http://dx.doi.org/10.1126/science.1092727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768EN	14671313				2022-12-24	WOS:000188530800032
J	Asanuma, Y; Oeser, A; Shintani, AK; Turner, E; Olsen, N; Fazio, S; Linton, MF; Raggi, P; Stein, CM				Asanuma, Y; Oeser, A; Shintani, AK; Turner, E; Olsen, N; Fazio, S; Linton, MF; Raggi, P; Stein, CM			Premature coronary-artery atherosclerosis in systemic lupus erythematosus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BEAM COMPUTED-TOMOGRAPHY; RISK-FACTORS; MYOCARDIAL-INFARCTION; ACCELERATED ATHEROSCLEROSIS; DISEASE; CALCIUM; WOMEN; PREVALENCE; PREDICTION; PLAQUE	BACKGROUND: Premature coronary artery disease is a major cause of illness and death in patients with systemic lupus erythematosus, but little is known about the prevalence, extent, and causes of coronary-artery atherosclerosis. METHODS: We used electron-beam computed tomography to screen for the presence of coronary-artery calcification in 65 patients with systemic lupus erythematosus (mean [+/-SD] age, 40.3+/-11.6 years) and 69 control subjects (mean age, 42.7+/-12.6 years) with no history of coronary artery disease. When calcification was detected, the extent was measured by means of the Agatston score. The frequency of risk factors for coronary artery disease was compared in patients and controls, and the relation between the patients' clinical characteristics and the presence or absence of coronary-artery calcification was examined. RESULTS: The two groups were similar with respect to age, race, and sex. Coronary-artery calcification was more frequent in patients with lupus (20 of 65 patients) than in control subjects (6 of 69 subjects) (P=0.002). The mean calcification score was 68.9+/-244.2 in the patients and 8.8+/-41.8 (P<0.001) in controls. Levels of total, high-density lipoprotein, and low-density lipoprotein cholesterol were not elevated in patients with lupus, but levels of triglycerides (P=0.02) and homocysteine (P<0.001) were. Among patients with lupus, measures of disease activity were similar in those with and those without coronary-artery calcification, but those with calcification were more likely to be older (P<0.001) and male (P=0.008). CONCLUSIONS: In patients with systemic lupus erythematosus, the prevalence of coronary-artery atherosclerosis is elevated and the age at onset is reduced. Early detection of atherosclerosis may provide an opportunity for therapeutic intervention.	Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Div Gen Internal Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Div Rheumatol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Div Cardiovasc Med, Nashville, TN 37212 USA; Tulane Univ, Sch Med, Cardiol Sect, New Orleans, LA 70112 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Tulane University	Asanuma, Y (corresponding author), Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026657] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL04012] Funding Source: Medline; NIDDK NIH HHS [DK26657] Funding Source: Medline; NIGMS NIH HHS [GM5M01-RR00095] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABUSHAKRA M, 1995, J RHEUMATOL, V22, P1259; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Arad Y, 2000, J AM COLL CARDIOL, V36, P1253, DOI 10.1016/S0735-1097(00)00872-X; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bruce IN, 2000, J RHEUMATOL, V27, P2372; Budoff MJ, 2002, CIRCULATION, V105, P1791, DOI 10.1161/01.CIR.0000014483.43921.8C; BULKLEY BH, 1975, AM J MED, V58, P243, DOI 10.1016/0002-9343(75)90575-6; Callister TQ, 1998, NEW ENGL J MED, V339, P1972, DOI 10.1056/NEJM199812313392703; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Gladman DD, 1997, ARTHRITIS RHEUM-US, V40, P809, DOI 10.1002/art.1780400506; Jara LJ, 2003, CLIN REV ALLERG IMMU, V25, P79, DOI 10.1385/CRIAI:25:1:79; Keelan PC, 2001, CIRCULATION, V104, P412, DOI 10.1161/hc2901.093112; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Manzi S, 1999, ARTHRITIS RHEUM-US, V42, P51, DOI 10.1002/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Pearson TA, 2002, CIRCULATION, V105, P886, DOI 10.1161/hc0702.103727; PETRI M, 1992, AM J MED, V93, P513, DOI 10.1016/0002-9343(92)90578-Y; Petri M, 1996, LANCET, V348, P1120, DOI 10.1016/S0140-6736(96)03032-2; Raggi P, 2001, AM HEART J, V141, P375, DOI 10.1067/mhj.2001.113220; Raggi P, 2000, CIRCULATION, V101, P850, DOI 10.1161/01.CIR.101.8.850; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; RUBIN LA, 1985, Q J MED, V55, P87; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; RUMBERGER JA, 1995, CIRCULATION, V91, P1363, DOI 10.1161/01.CIR.91.5.1363; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Schmermund A, 2002, AM J CARDIOL, V90, P168, DOI 10.1016/S0002-9149(02)02445-1; Schmermund A, 1999, J AM COLL CARDIOL, V34, P777, DOI 10.1016/S0735-1097(99)00265-X; Svenungsson E, 2001, CIRCULATION, V104, P1887, DOI 10.1161/hc4101.097518; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; von der Thusen JH, 2003, PHARMACOL REV, V55, P133, DOI 10.1124/pr.55.1.5; Ward MM, 1999, ARTHRITIS RHEUM, V42, P338, DOI 10.1002/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U	34	627	647	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2003	349	25					2407	2415		10.1056/NEJMoa035611	http://dx.doi.org/10.1056/NEJMoa035611			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754PJ	14681506				2022-12-24	WOS:000187326200006
J	Humeau, Y; Shaban, H; Bissiere, S; Luthi, A				Humeau, Y; Shaban, H; Bissiere, S; Luthi, A			Presynaptic induction of heterosynaptic associative plasticity in the mammalian brain	NATURE			English	Article							LONG-TERM POTENTIATION; LATERAL AMYGDALA; SYNAPTIC TRANSMISSION; BASOLATERAL AMYGDALA; NMDA RECEPTORS; DEPRESSION; RAT; LOCALIZATION; CORTEX; MEMORY	The induction of associative synaptic plasticity in the mammalian central nervous system classically depends on coincident presynaptic and postsynaptic activity(1,2). According to this principle, associative homosynaptic long-term potentiation (LTP) of excitatory synaptic transmission can be induced only if synaptic release occurs during postsynaptic depolarization(1,2). In contrast, heterosynaptic plasticity in mammals is considered to rely on activity-independent, non-associative processes(3-8). Here we describe a novel mechanism underlying the induction of associative LTP in the lateral amygdala ( LA). Simultaneous activation of converging cortical and thalamic afferents specifically induced associative, N-methyl-D-aspartate (NMDA)-receptor-dependent LTP at cortical, but not at thalamic, inputs. Surprisingly, the induction of associative LTP at cortical inputs was completely independent of postsynaptic activity, including depolarization, postsynaptic NMDA receptor activation or an increase in postsynaptic Ca2+ concentration, and did not require network activity. LTP expression was mediated by a persistent increase in the presynaptic probability of release at cortical afferents. Our study shows the presynaptic induction and expression of heterosynaptic and associative synaptic plasticity on simultaneous activity of converging afferents. Our data indicate that input specificity of associative LTP can be determined exclusively by presynaptic properties.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel	Luthi, A (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.		Shaban, Hamdy/ABD-5617-2021; shaban, Hamdy/C-1939-2014	Shaban, Hamdy/0000-0003-3760-6113; shaban, Hamdy/0000-0003-3760-6113				ABRAHAM WC, 1991, BRAIN RES, V546, P336, DOI 10.1016/0006-8993(91)91498-P; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Doyere V, 2003, EUR J NEUROSCI, V17, P2703, DOI 10.1046/j.1460-9568.2003.02707.x; FARB CR, 1995, J COMP NEUROL, V362, P86, DOI 10.1002/cne.903620106; Farb CR, 1999, SYNAPSE, V33, P218, DOI 10.1002/(SICI)1098-2396(19990901)33:3<218::AID-SYN6>3.0.CO;2-1; GRACY KN, 1995, J COMP NEUROL, V362, P71, DOI 10.1002/cne.903620105; GUSTAFSSON B, 1990, SEMIN NEUROSCI, V2, P321; HESS G, 1987, NEUROSCI LETT, V77, P187, DOI 10.1016/0304-3940(87)90584-2; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Humeau Y, 2002, J NEUROSCI, V22, P7968; Lang EJ, 1997, J NEUROPHYSIOL, V77, P341, DOI 10.1152/jn.1997.77.1.341; Lang EJ, 1998, NEUROSCIENCE, V83, P877, DOI 10.1016/S0306-4522(97)00420-X; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McDonald AJ, 1996, NEUROSCIENCE, V75, P407, DOI 10.1016/0306-4522(96)00269-2; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0; Szinyei C, 2000, J NEUROSCI, V20, P8909; Tsukamoto M, 2003, J PHYSIOL-LONDON, V546, P665, DOI 10.1113/jphysiol.2002.033803; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Weisskopf MG, 1999, J NEUROSCI, V19, P10512	30	199	201	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					841	845		10.1038/nature02194	http://dx.doi.org/10.1038/nature02194			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685239				2022-12-24	WOS:000187342000059
J	Schiermeier, Q				Schiermeier, Q			Climate change - The long road from Kyoto	NATURE			English	News Item																		Christensen JH, 2003, NATURE, V421, P805, DOI 10.1038/421805a; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333	3	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2003	426	6968					756	756		10.1038/426756a	http://dx.doi.org/10.1038/426756a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685198	Bronze			2022-12-24	WOS:000187342000019
J	Hornekaer, L; Baurichter, A; Petrunin, VV; Field, D; Luntz, AC				Hornekaer, L; Baurichter, A; Petrunin, VV; Field, D; Luntz, AC			Importance of surface morphology in interstellar H-2 formation	SCIENCE			English	Article							MOLECULAR-HYDROGEN FORMATION; VIBRATIONAL-RELAXATION	Detailed laboratory experiments on the formation of HD from atom recombination on amorphous solid water films show that this process is extremely efficient in a temperature range of 8 to 20 kelvin, temperatures relevant for H-2 formation on dust grain surfaces in the interstellar medium (ISM). The fate of the 4.5 electron volt recombination energy is highly dependent on film morphology. These results suggest that grain morphology, rather than the detailed chemical nature of the grain surface, is most important in determining the energy content of the H 2 as it is released from the grain into the ISM.	Univ So Denmark, Dept Phys, Esbjerg, Denmark; Univ Aarhus, Dept Phys & Astron, DK-8000 Aarhus C, Denmark	University of Southern Denmark; Aarhus University	Hornekaer, L (corresponding author), Univ So Denmark, Dept Phys, Esbjerg, Denmark.	hornekaer@fysik.sdu.dk	Hornekær, Liv/B-3043-2019	Hornekær, Liv/0000-0003-0828-3642				ANDERSSON S, 1989, PHYS REV B, V40, P8146, DOI 10.1103/PhysRevB.40.8146; BONN M, 1995, CHEM PHYS LETT, V233, P309, DOI 10.1016/0009-2614(94)01411-N; CHANG HC, 1990, J ELECTRON SPECTROSC, V54, P39, DOI 10.1016/0368-2048(90)80199-K; Collings MP, 2003, ASTROPHYS J, V583, P1058, DOI 10.1086/345389; Diekhoner L, 2001, J CHEM PHYS, V115, P3356, DOI 10.1063/1.1386810; DULEY WW, 1993, MON NOT R ASTRON SOC, V260, P37, DOI 10.1093/mnras/260.1.37; FLOWER DR, 1990, MON NOT R ASTRON SOC, V247, P500; Gibb EL, 2000, ASTROPHYS J, V536, P347, DOI 10.1086/308940; Greenberg JM, 2002, SURF SCI, V500, P793, DOI 10.1016/S0039-6028(01)01555-2; Gry C, 2002, ASTRON ASTROPHYS, V391, P675, DOI 10.1051/0004-6361:20020691; HOLLENBACH D, 1971, ASTROPHYS J, V163, P155, DOI 10.1086/150754; HORNEKAER L, UNPUB; JURA M, 1975, ASTROPHYS J, V197, P575, DOI 10.1086/153545; Katz N, 1999, ASTROPHYS J, V522, P305, DOI 10.1086/307642; Manico G, 2001, ASTROPHYS J, V548, pL253, DOI 10.1086/319116; Schnaiter M, 1999, ASTROPHYS J, V519, P687, DOI 10.1086/307396; Stevenson KP, 1999, SCIENCE, V283, P1505, DOI 10.1126/science.283.5407.1505; Takahashi J, 1999, ASTROPHYS J, V520, P724, DOI 10.1086/307461	18	143	143	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1943	1946		10.1126/science.1090820	http://dx.doi.org/10.1126/science.1090820			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671297				2022-12-24	WOS:000187174000054
J	Kanadia, RN; Johnstone, KA; Mankodi, A; Lungu, C; Thornton, CA; Esson, D; Timmers, AM; Hauswirth, WW; Swanson, MS				Kanadia, RN; Johnstone, KA; Mankodi, A; Lungu, C; Thornton, CA; Esson, D; Timmers, AM; Hauswirth, WW; Swanson, MS			A muscleblind knockout model for myotonic dystrophy	SCIENCE			English	Article							PRE-MESSENGER-RNA; TRINUCLEOTIDE REPEAT; SKELETAL-MUSCLE; NUCLEAR FOCI; IN-VIVO; TRANSCRIPTS; EXPANSION; PROTEIN; DROSOPHILA; MBNL	The neuromuscular disease myotonic dystrophy (DM) is caused by microsatellite repeat expansions at two different genomic loci. Mutant DM transcripts are retained in the nucleus together with the muscleblind (Mbnl) proteins, and these abnormal RNAs somehow interfere with pre-mRNA splicing regulation. Here, we show that disruption of the mouse Mbnl1 gene leads to muscle, eye, and RNA splicing abnormalities that are characteristic of DM disease. Our results support the hypothesis that manifestations of DM can result from sequestration of specific RNA binding proteins by a repetitive element expansion in a mutant RNA.	Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Powell Gene Therapy Ctr, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Rochester	Swanson, MS (corresponding author), Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Powell Gene Therapy Ctr, Gainesville, FL 32610 USA.	mswanson@ufl.edu		Swanson, Maurice/0000-0001-6245-5367; Mankodi, Ami/0000-0002-5131-7767	NIAMS NIH HHS [AR48143, R01 AR046799, AR46799, AR46806] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR048143, R01AR046799, R01AR046806] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Artero R, 1998, DEV BIOL, V195, P131, DOI 10.1006/dbio.1997.8833; Begemann G, 1997, DEVELOPMENT, V124, P4321; Berul CI, 1999, J CLIN INVEST, V103, pR1, DOI 10.1172/JCI5346; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fardaei M, 2001, NUCLEIC ACIDS RES, V29, P2766, DOI 10.1093/nar/29.13.2766; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Harper P.S., 1989, MYOTONIC DYSTROPHY; HO T, UNPUB; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; MANKODI A, IN PRESS ANN NEUROL; MANKODI A, UNPUB; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Ranum LPW, 2002, CURR OPIN GENET DEV, V12, P266, DOI 10.1016/S0959-437X(02)00297-6; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Wang J, 1997, GENE, V193, P105, DOI 10.1016/S0378-1119(97)00100-5; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	25	548	573	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1978	1980		10.1126/science.1088583	http://dx.doi.org/10.1126/science.1088583			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671308				2022-12-24	WOS:000187174000065
J	Girou, E; Brun-Buisson, C; Taille, S; Lemaire, F; Brochard, L				Girou, E; Brun-Buisson, C; Taille, S; Lemaire, F; Brochard, L			Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE RESPIRATORY-FAILURE; POSITIVE-PRESSURE VENTILATION; RANDOMIZED CONTROLLED-TRIAL; CONVENTIONAL MECHANICAL VENTILATION; OBSTRUCTIVE LUNG-DISEASE; FACE MASK; MULTICENTER; SURVIVAL; SUPPORT; THERAPY	Context Randomized controlled trials have shown that the use of noninvasive ventilation (NIV) reduces the need for endotracheal intubation and invasive mechanical ventilation and reduces complication rates and mortality in selected groups of patients. But whether these benefits translate to a clinical setting is unclear. Objective To evaluate longitudinally the routine implementation of NIV and its effect on patients admitted to the intensive care unit (ICU) with acute exacerbation of chronic obstructive pulmonary disease (COPD) or severe cardiogenic pulmonary edema (CPE). Design Retrospective, observational cohort study using prospectively collected data from January 1, 1994, through December 31, 2001. Setting A 26-bed medical intensive care unit (ICU) of a French university referral hospital. Participants A cohort of 479 consecutive patients ventilated for acute exacerbation of COPD or CPE. Main Outcome Measures The ICU mortality and incidence rates of ICU-acquired infections. Results A significant increase in NIV use and a concomitant decrease in mortality and ICU-acquired infection rates were observed over the study years. With adjustment for relevant covariates and propensity scores, NIV was identified as an independent factor linked with a reduced risk of death in the cohort (odds ratio [OR], 0.37; 95% confidence interval [CI], 0.18-0.78), whereas a high severity score on admission (OR, 1.05; 95% Cl, 1.01-1.10) and the occurrence of a nosocomial infection (OR, 3.08; 95% Cl, 1.62-5.84) were independently associated with death. Rates of ICU-acquired pneumonia decreased from 20% in 1994 to 8% in 2001 (P=.04). Conclusion Implementing routine use of NIV in critically ill patients with acute exacerbation of COPD or severe CPE was associated with improved survival and reduction of nosocomial infections.	Hop Henri Mondor, Assistance Publ Hop Paris, Unite Hyg & Prevent Infect, F-94010 Creteil, France; Hop Henri Mondor, Assistance Publ Hop Paris, Serv Reanimat Med, F-94010 Creteil, France; Hop Henri Mondor, Assistance Publ Hop Paris, INSERM, U492, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Brun-Buisson, C (corresponding author), Hop Henri Mondor, Unite Hyg & Prevent Infect, F-94010 Creteil, France.	emmanuelle.girou@hmn.ap-hop-paris.fr						Antonelli M, 2001, INTENS CARE MED, V27, P1718, DOI 10.1007/s00134-001-1114-4; Antonelli M, 1998, NEW ENGL J MED, V339, P429, DOI 10.1056/NEJM199808133390703; Antonelli M, 2000, JAMA-J AM MED ASSOC, V283, P235, DOI 10.1001/jama.283.2.235; Auriant I, 2001, AM J RESP CRIT CARE, V164, P1231, DOI 10.1164/ajrccm.164.7.2101089; Azoulay E, 2001, CRIT CARE MED, V29, P519, DOI 10.1097/00003246-200103000-00009; Barbe F, 1996, EUR RESPIR J, V9, P1240, DOI 10.1183/09031936.96.09061240; BERSTEN AD, 1991, NEW ENGL J MED, V325, P1825, DOI 10.1056/NEJM199112263252601; BOTT J, 1993, LANCET, V341, P1555, DOI 10.1016/0140-6736(93)90696-E; Brochard L, 2002, JAMA-J AM MED ASSOC, V288, P932, DOI 10.1001/jama.288.8.932; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; BROCHARD L, 1990, NEW ENGL J MED, V323, P1523, DOI 10.1056/NEJM199011293232204; Calverley PMA, 2001, EUR RESPIR J, V18, p60S, DOI 10.1183/09031936.01.00229801; Carlucci A, 2001, AM J RESP CRIT CARE, V163, P874, DOI 10.1164/ajrccm.163.4.2006027; Carlucci A, 2003, INTENS CARE MED, V29, P419, DOI 10.1007/s00134-002-1574-1; Celikel T, 1998, CHEST, V114, P1636, DOI 10.1378/chest.114.6.1636; CHEVROLET JC, 1991, CHEST, V100, P775, DOI 10.1378/chest.100.3.775; Confalonieri M, 1999, AM J RESP CRIT CARE, V160, P1585, DOI 10.1164/ajrccm.160.5.9903015; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Delclaux C, 2000, JAMA-J AM MED ASSOC, V284, P2352, DOI 10.1001/jama.284.18.2352; Ely JW, 1997, INFECT CONT HOSP EP, V18, P267; Evans T W, 2001, Intensive Care Med, V27, P166, DOI 10.1007/s001340000721; Fagon J Y, 1996, Semin Respir Infect, V11, P109; Fein A, 2000, Curr Opin Pulm Med, V6, P122; Girou E, 2000, JAMA-J AM MED ASSOC, V284, P2361, DOI 10.1001/jama.284.18.2361; Girou E, 1998, AM J RESP CRIT CARE, V157, P1151, DOI 10.1164/ajrccm.157.4.9701129; Gregoretti C, 2002, INTENS CARE MED, V28, P278, DOI 10.1007/s00134-002-1208-7; Hilbert G, 2001, NEW ENGL J MED, V344, P481, DOI 10.1056/NEJM200102153440703; Hill NS, 2002, INTENS CARE MED, V28, P227, DOI 10.1007/s00134-002-1228-3; Keenan SP, 2002, JAMA-J AM MED ASSOC, V287, P3238, DOI 10.1001/jama.287.24.3238; KRAMER N, 1995, AM J RESP CRIT CARE, V151, P1799, DOI 10.1164/ajrccm.151.6.7767523; LeGall JR, 1996, JAMA-J AM MED ASSOC, V276, P802, DOI 10.1001/jama.276.10.802; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lightowler JV, 2003, BMJ-BRIT MED J, V326, P185, DOI 10.1136/bmj.326.7382.185; Martin TJ, 2000, AM J RESP CRIT CARE, V161, P807, DOI 10.1164/ajrccm.161.3.9808143; Masip J, 2000, LANCET, V356, P2126, DOI 10.1016/S0140-6736(00)03492-9; Mehta S, 2001, AM J RESP CRIT CARE, V163, P540, DOI 10.1164/ajrccm.163.2.9906116; Nava S, 1997, CHEST, V111, P1631, DOI 10.1378/chest.111.6.1631; Nava S, 1998, ANN INTERN MED, V128, P721, DOI 10.7326/0003-4819-128-9-199805010-00004; Nourdine K, 1999, INTENS CARE MED, V25, P567, DOI 10.1007/s001340050904; Plant PK, 2000, LANCET, V355, P1931, DOI 10.1016/S0140-6736(00)02323-0; Radford MJ, 2001, JAMA-J AM MED ASSOC, V286, P1228, DOI 10.1001/jama.286.10.1228; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; SENEFF MG, 1995, JAMA-J AM MED ASSOC, V274, P1852, DOI 10.1001/jama.274.23.1852; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wood KA, 1998, CHEST, V113, P1339, DOI 10.1378/chest.113.5.1339	46	165	181	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2003	290	22					2985	2991		10.1001/jama.290.22.2985	http://dx.doi.org/10.1001/jama.290.22.2985			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751WH	14665660	Bronze			2022-12-24	WOS:000187112700030
J	Sokol, RJ; Delaney-Black, V; Nordstrom, B				Sokol, RJ; Delaney-Black, V; Nordstrom, B			Fetal alcohol spectrum disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRENATAL ALCOHOL; IN-UTERO; EXPOSURE; AGE; ATTENTION; CHILDREN; IDENTIFICATION; RECOGNITION; PREVALENCE; CHILDHOOD		Wayne State Univ, CS Mott Ctr Human Growth & Dev, Childrens Res Ctr, Detroit, MI 48201 USA; Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48201 USA; E Tennessee State Univ, Dept Family Med, Johnson City, TN USA	Wayne State University; Wayne State University; East Tennessee State University	Sokol, RJ (corresponding author), Wayne State Univ, CS Mott Ctr Human Growth & Dev, Childrens Res Ctr, 275 E Hancock, Detroit, MI 48201 USA.	rsokol@moose.med.wayne.edu						Abel EL, 1998, ALCOHOL CLIN EXP RES, V22, P979, DOI 10.1111/j.1530-0277.1998.tb03692.x; [Anonymous], 1981, FDA Drug Bull, V11, P9; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P261; Chang G, 1998, OBSTET GYNECOL, V91, P892, DOI 10.1016/S0029-7844(98)00088-X; Chang G, 2000, J SUBST ABUSE TREAT, V18, P365, DOI 10.1016/S0740-5472(99)00105-1; Coles CD, 2000, J STUD ALCOHOL, V61, P607, DOI 10.15288/jsa.2000.61.607; COLES CD, 1991, NEUROTOXICOL TERATOL, V13, P357, DOI 10.1016/0892-0362(91)90084-A; Connor PD, 2000, DEV NEUROPSYCHOL, V18, P331, DOI 10.1207/S1532694204Connor; Connor PD, 1999, ALCOHOL CLIN EXP RES, V23, P1395; Cook JD, 2003, CLIN BIOCHEM, V36, P9, DOI 10.1016/S0009-9120(02)00424-1; Ebrahim SH, 1998, OBSTET GYNECOL, V92, P187, DOI 10.1016/S0029-7844(98)00205-1; ERNHART CB, 1988, ALCOHOL CLIN EXP RES, V12, P506, DOI 10.1111/j.1530-0277.1988.tb00233.x; FRIED PA, 1992, NEUROTOXICOL TERATOL, V14, P299, DOI 10.1016/0892-0362(92)90036-A; Handmaker NS, 1999, J STUD ALCOHOL, V60, P285, DOI 10.15288/jsa.1999.60.285; Handmaker NS, 2001, ALCOHOL RES HEALTH, V25, P219; HANKIN JR, 1995, SEMIN PERINATOL, V19, P286, DOI 10.1016/S0146-0005(05)80043-6; HANKIN JR, 1993, ALCOHOL CLIN EXP RES, V17, P284, DOI 10.1111/j.1530-0277.1993.tb00764.x; Jacobson JL, 1996, ALCOHOL CLIN EXP RES, V20, P359, DOI 10.1111/j.1530-0277.1996.tb01653.x; JACOBSON SW, 1994, ALCOHOL CLIN EXP RES, V18, P1125, DOI 10.1111/j.1530-0277.1994.tb00092.x; JONES KL, 1973, LANCET, V2, P999; Kaskutas L. A., 1998, J HLTH ED, V28, P11; Klein J, 2002, NEW ENGL J MED, V347, P2086, DOI 10.1056/NEJM200212193472523; Korkman M, 2003, CHILD NEUROPSYCHOL, V9, P117, DOI 10.1076/chin.9.2.117.14503; LANDESMANDWYER S, 1981, NEUROBEH TOXICOL TER, V3, P187; Langbehn DR, 2001, COMPR PSYCHIAT, V42, P272, DOI 10.1053/comp.2001.24579; LARSSON G, 1983, ACTA OBSTET GYN SCAN, V62, P171, DOI 10.3109/00016348309155786; LITTLE BB, 1990, AM J DIS CHILD, V144, P1142, DOI 10.1001/archpedi.1990.02150340088030; Mattson SN, 1999, ALCOHOL CLIN EXP RES, V23, P1808, DOI 10.1111/j.1530-0277.1999.tb04077.x; May PA, 2001, ALCOHOL RES HEALTH, V25, P159; Miller W.R., 2013, MOTIVATIONAL INTERVI, V3rd ed.; Nevin Alexandra C, 2002, BMC Fam Pract, V3, P2, DOI 10.1186/1471-2296-3-2; O'Connor MJ, 2002, AM J DRUG ALCOHOL AB, V28, P745, DOI 10.1081/ADA-120015880; OLSON HC, 1992, DEV PSYCHOPATHOL, V4, P341, DOI 10.1017/S0954579400000821; Roebuck TM, 1999, ALCOHOL CLIN EXP RES, V23, P1070, DOI 10.1111/j.1530-0277.1999.tb04227.x; ROSETT HL, 1983, JAMA-J AM MED ASSOC, V249, P2029; Sampson PD, 1997, TERATOLOGY, V56, P317, DOI 10.1002/(SICI)1096-9926(199711)56:5<317::AID-TERA5>3.0.CO;2-U; SOKOL RJ, 1989, AM J OBSTET GYNECOL, V160, P863, DOI 10.1016/0002-9378(89)90302-5; Sood B, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.2.e34; Stoler JM, 1999, J PEDIATR-US, V135, P430, DOI 10.1016/S0022-3476(99)70164-2; Stratton K., 1996, FETAL ALCOHOL SYNDRO; STREISSGUTH AP, 1989, NEUROTOXICOL TERATOL, V11, P493, DOI 10.1016/0892-0362(89)90026-3; STREISSGUTH AP, 1990, ALCOHOL CLIN EXP RES, V14, P662, DOI 10.1111/j.1530-0277.1990.tb01224.x; STREISSGUTH AP, 1986, NEUROTOXICOL TERATOL, V8, P717; STREISSGUTH AP, 1984, CIBA F SYMP, V105, P176; STREISSGUTH AP, 1994, ALCOHOL CLIN EXP RES, V18, P202, DOI 10.1111/j.1530-0277.1994.tb00904.x; Yates WR, 1998, ALCOHOL CLIN EXP RES, V22, P914, DOI 10.1111/j.1530-0277.1998.tb03889.x; 1997, MMWR MORB MORTAL WKL, V46, P346; 2002, MMWR MORB MORTAL WKL, V51, P433	48	467	475	0	48	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2003	290	22					2996	2999		10.1001/jama.290.22.2996	http://dx.doi.org/10.1001/jama.290.22.2996			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	751WH	14665662				2022-12-24	WOS:000187112700032
J	Walker, A; Sirel, JM; Marsden, AK; Cobbe, SM; Pell, JP				Walker, A; Sirel, JM; Marsden, AK; Cobbe, SM; Pell, JP			Cost effectiveness and cost utility model of public place defibrillators in improving survival after prehospital cardiopulmonary arrest	BRITISH MEDICAL JOURNAL			English	Article							AMERICAN-HEART-ASSOCIATION; HOSPITAL CARDIAC-ARREST; ACCESS DEFIBRILLATION; PERINATAL-MORTALITY; TASK-FORCE; RISK; PROFESSIONALS; RESUSCITATION; STATEMENT; COHORT	Objective To determine the cost effectiveness and cost utility of locating defibrillators in all major airports, railway stations, and bus stations throughout Scotland. Design Economic modelling exercise with data from Heartstart (Scotland). Parameters used in economic model included direct costs derived for increased accident and emergency attendances, increased hospital bed days, purchase and maintenance of defibrillators, and training in their use; life years gained calculated from increased discharges from hospital and mean survival after discharge; utility (quality of life) obtained from published data. Sensitivity analyses tested the robustness of model. Future gains discounted at 1.5% a year and future costs at 6%. Setting Whole of Scotland. Subjects Records,of all prehospital cardiac arrests due to presumed heart disease that occurred in a major airport, railway, or bus station between May 1991 and March 1998 and were not witnessed by ambulance or medical staff. Main outcome measures Observed survival to hospital admission and observed survival to discharge. Predicted survival calculated by applying observed survival in patients attended by ambulance staff within three minutes to those who waited longer. Results The total discounted direct costs were pound18 325 a year. The cost per life year gained was pound29 625 ($49 625, (sic)43 151) and the cost per quality adjusted life year (QALY) gained was pound41 146 ($68 924, (sic)59 932). More widespread provision of public place defibrillators would increase these figures. Conclusions The cost per QALY calculated for public place defibrillators represents poorer value for money than some alternative strategies for improving survival after prehospital cardiopulmonary arrest, such as the use of other trained first responders. The figure exceeds the commonly discussed cut off levels for funding in the United Kingdom and United States of pound30 000 and $50 000 per QALY, respectively.	Greater Glasgow NHS Board, Glasgow G3 8YZ, Lanark, Scotland; Scottish Ambulance Serv Headquarters, Edinburgh EH10 5UU, Midlothian, Scotland; Univ Glasgow, Dept Med Cardiol, Glasgow G32 2ER, Lanark, Scotland; Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	Pell, JP (corresponding author), Greater Glasgow NHS Board, Glasgow G3 8YZ, Lanark, Scotland.			Pell, Jill/0000-0002-8898-7035				Banister J., 1987, CHINAS CHANGING POPU; Chu JH, 2001, POPUL DEV REV, V27, P259; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Gratton M, 1999, Prehosp Emerg Care, V3, P303, DOI 10.1080/10903129908958958; GROENEVELD P, 2001, JAMA-J AM MED ASSOC, V28, P1482; Hummel S, 1997, PHARMACOECONOMICS, V12, P182, DOI 10.2165/00019053-199712020-00008; *I POP STUD, 2000, ZHONG GUO REN KOU NI; *INF STAT DIV, 2001, SCOTT HLTH SERV COST; Kane R, 1999, BRIT MED J, V319, P992, DOI 10.1136/bmj.319.7215.992; Kulmala T, 2000, PAEDIATR PERINAT EP, V14, P219, DOI 10.1046/j.1365-3016.2000.00270.x; Kuntz KM, 1996, CIRCULATION, V94, P957, DOI 10.1161/01.CIR.94.5.957; Lee KH, 1996, CRIT CARE MED, V24, P2046, DOI 10.1097/00003246-199612000-00019; LI XT, 1995, ZHONG GUO FU YOU BAO, V10, P246; Liu Y, 2001, WORLD J MICROB BIOT, V17, P111, DOI 10.1023/A:1016625209839; MU L, 1995, ZHONG GUO CHU JI WEI, V9, P34; *NAT I CLIN EXC, 2000, GUID IMPL CARD DEF A; NETTEN A, 2002, UNIT COSTS HLTH SOCI; Nichol G, 1998, CIRCULATION, V97, P1309, DOI 10.1161/01.CIR.97.13.1309; Nichol G, 1998, CIRCULATION, V97, P1315, DOI 10.1161/01.CIR.97.13.1315; Nichol G, 1996, ANN EMERG MED, V27, P711, DOI 10.1016/S0196-0644(96)70188-9; Pell JP, 2002, BRIT MED J, V325, P515, DOI 10.1136/bmj.325.7363.515; Pell JP, 2001, BRIT MED J, V322, P1385, DOI 10.1136/bmj.322.7299.1385; Pickin DM, 1999, HEART, V82, P325, DOI 10.1136/hrt.82.3.325; RAYMOND EG, 1994, BRIT J OBSTET GYNAEC, V101, P301, DOI 10.1111/j.1471-0528.1994.tb13614.x; *SECR STAT HLTH, 1999, SAV LIV OUR HLTH NAT; Shah D, 2000, INT J GYNECOL OBSTET, V71, P209, DOI 10.1016/S0020-7292(00)00215-0; Shah NM, 2000, SOC SCI MED, V51, P539, DOI 10.1016/S0277-9536(99)00485-2; WEI YZ, 1992, GUI YANG YI XUE YUAN, V17, P42; WEISFELDT ML, 1995, CIRCULATION, V92, P2763, DOI 10.1161/01.CIR.92.9.2763; Woollard M, 2001, J PUBLIC HEALTH MED, V23, P98, DOI 10.1093/pubmed/23.2.98; XU BZ, 1995, PERINATAL MORTALITY; Yao J S, 1991, Zhonghua Fu Chan Ke Za Zhi, V26, P224; ZHANG J, 1991, INT J EPIDEMIOL, V20, P958, DOI 10.1093/ije/20.4.958; ZHU XL, 1996, XIN JIANG YI XUE YUA, V19, P83	34	27	28	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 6	2003	327	7427					1316	1319		10.1136/bmj.327.7427.1316	http://dx.doi.org/10.1136/bmj.327.7427.1316			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752DE	14656838	Green Published, Bronze			2022-12-24	WOS:000187131100016
J	Nolan, MF; Malleret, G; Lee, KH; Gibbs, E; Dudman, JT; Santoro, B; Yin, DQ; Thompson, RF; Siegelbaum, SA; Kandel, ER; Morozov, A				Nolan, MF; Malleret, G; Lee, KH; Gibbs, E; Dudman, JT; Santoro, B; Yin, DQ; Thompson, RF; Siegelbaum, SA; Kandel, ER; Morozov, A			The hyperpolarization-activated HCN1 channel is important for motor learning and neuronal integration by cerebellar Purkinje cells	CELL			English	Article							LONG-TERM DEPRESSION; MUTANT MICE; NUCLEAR NEURONS; BASKET CELLS; COORDINATION; INHIBITION; RESPONSES; PACEMAKER; CURRENTS; CORTEX	In contrast to our increasingly detailed understanding of how synaptic plasticity provides a cellular substrate for learning and memory, it is less clear how a neuron's voltage-gated ion channels interact with plastic changes in synaptic strength to influence behavior. We find, using generalized and regional knockout mice, that deletion of the HCN1 channel causes profound motor learning and memory deficits in swimming and rotarod tasks. In cerebellar Purkinje cells, which are a key component of the cerebellar circuit for learning of correctly timed movements, HCN1 mediates an inward current that stabilizes the integrative properties of Purkinje cells and ensures that their input-output function is independent of the previous history of their activity. We suggest that this nonsynaptic integrative function of HCN1 is required for accurate decoding of input patterns and thereby enables synaptic plasticity to appropriately influence the performance of motor activity.	Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, Dept Physiol, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, Dept Psychiat, New York, NY 10032 USA; Univ So Calif, Neurosci Program, Los Angeles, CA 90089 USA; NIMH, Unit Behav Genet, Bethesda, MD 20892 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Nolan, MF (corresponding author), Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA.		Nolan, Matthew/A-1356-2009	Nolan, Matthew/0000-0003-1062-6501; Santoro, Bina/0000-0002-4277-1992; Dudman, Joshua/0000-0002-4436-1057	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045923, R37MH045923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036658] Funding Source: NIH RePORTER; NIMH NIH HHS [MH045923] Funding Source: Medline; NINDS NIH HHS [NS36658] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ANDERSEN P, 1964, J NEUROPHYSIOL, V27, P1138, DOI 10.1152/jn.1964.27.6.1138; [Anonymous], [No title captured]; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; CREPEL F, 1986, J PHYSIOL-LONDON, V372, P1; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Dragatsis I, 2000, GENESIS, V26, P133, DOI 10.1002/(SICI)1526-968X(200002)26:2<133::AID-GENE10>3.0.CO;2-V; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; Fairbanks CA, 1997, J PHARMACOL EXP THER, V282, P1408; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; HESSLOW G, 1994, NEUROREPORT, V5, P649, DOI 10.1097/00001756-199401000-00030; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; LI SJ, 1993, BRAIN RES, V617, P87, DOI 10.1016/0006-8993(93)90617-V; Malleret G, 1999, J NEUROSCI, V19, P6157, DOI 10.1523/JNEUROSCI.19-14-06157.1999; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MCCORMICK DA, 1984, J NEUROSCI, V4, P2811; MCCORMICK DA, 1982, P NATL ACAD SCI-BIOL, V79, P2731, DOI 10.1073/pnas.79.8.2731; Medina JF, 2002, NAT REV NEUROSCI, V3, P122, DOI 10.1038/nrn728; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nam SC, 1997, J NEUROBIOL, V33, P18, DOI 10.1002/(SICI)1097-4695(199707)33:1<18::AID-NEU3>3.0.CO;2-G; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Paylor R, 1999, LEARN MEMORY, V6, P521, DOI 10.1101/lm.6.5.521; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Raman IM, 1999, J NEUROSCI, V19, P1663; Raymond JL, 1998, J NEUROSCI, V18, P9112; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Roth A, 2001, J PHYSIOL-LONDON, V535, P445, DOI 10.1111/j.1469-7793.2001.00445.x; Saitow F, 2000, J NEUROPHYSIOL, V84, P2026, DOI 10.1152/jn.2000.84.4.2026; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; Southan AP, 2000, J PHYSIOL-LONDON, V526, P91, DOI 10.1111/j.1469-7793.2000.t01-1-00091.x; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; Thach WT, 1998, NEUROBIOL LEARN MEM, V70, P177, DOI 10.1006/nlme.1998.3846; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; Williams SR, 2002, J PHYSIOL-LONDON, V539, P469, DOI 10.1113/jphysiol.2001.013136; YEO CH, 1985, EXP BRAIN RES, V60, P99, DOI 10.1007/BF00237023	45	245	251	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 26	2003	115	5					551	564		10.1016/S0092-8674(03)00884-5	http://dx.doi.org/10.1016/S0092-8674(03)00884-5			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651847	Bronze			2022-12-24	WOS:000186885600006
J	Wu, YW; Escobar, GJ; Grether, JK; Croen, LA; Greene, JD; Newman, TB				Wu, YW; Escobar, GJ; Grether, JK; Croen, LA; Greene, JD; Newman, TB			Chorioamnionitis and cerebral palsy in term and near-term infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AUSTRALIAN CASE-CONTROL; V-LEIDEN MUTATION; NEONATAL ENCEPHALOPATHY; NEWBORN ENCEPHALOPATHY; MATERNAL FEVER; BRAIN-DAMAGE; RISK-FACTORS; APGAR SCORE; CHILDREN; ANTECEDENTS	Context Half of all cases of cerebral palsy (CP) occur in term infants, for whom risk factors have not been clearly defined. Recent studies suggest a possible role of chorioamnionitis. Objective To determine whether clinical chorioamnionitis increases the risk of CP in term and near-term infants. Design, Setting, and Patients Case-control study nested within a cohort of 231582 singleton infants born at 36 or more weeks' gestation between January 1, 1991, and December 31,1998, in the Kaiser Permanente Medical Care Program, a managed care organization providing care for more than 3 million residents of northern California. Case patients were identified from electronic records and confirmed by chart review by a child neurologist, and comprised all children with moderate to severe spastic or. dyskinetic CP not due to postnatal brain injury or developmental abnormalities (n=109). Controls (n=218) were randomly selected from the study population. Main Outcome Measure Association between clinical chorioamnionitis and increased risk of CP in term and near-term infants. Results Most CP cases had hemiparesis (40%) or quadriparesis (38%); 87% had been diagnosed by a neurologist and 83% had undergone neuroimaging. Chorioamnionitis, considered present if a treating physician made a diagnosis of chorioamnionitis or endometritis clinically, was noted in 14% of cases and 4% of controls (odds ratio [OR], 3.8; 95% confidence interval [CI], 1.5-10.1; P=.001). Independent risk factors identified in multiple logistic regression included chorioamnionitis (OR, 4.1; 95% CI, 1.6-10.1), intrauterine growth restriction (OR, 4.0;95% CI, 1.3-12.0), maternal black ethnicity (OR, 3.6; 95% CI, 1.4-9.3), maternal age older than 25 years (OR, 2.6; 95% CI, 1.3-5.2), and nulliparity (OR, 1.8; 95% CI, 1.0-3.0). The population-attributable fraction of chorioamnionitis for CP is 11%. Conclusion Our data suggest that chorioamnionitis is an independent risk factor for CP among term and near-term infants.	Univ Calif San Francisco, Dept Neurol, Div Child Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Kaiser Permanente Div Res, Oakland, CA USA; Calif Dept Hlth Serv, Sacramento, CA 95814 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; California Department of Health Care Services	Wu, YW (corresponding author), Univ Calif San Francisco, Dept Neurol, Div Child Neurol, Box 0136,500 Parnassus Ave,MUE 411, San Francisco, CA 94143 USA.			Croen, Lisa/0000-0001-7849-9428	NINDS NIH HHS [5 K12 NSO1692] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K12NS001692] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 2003, NEON ENC CER PALS; Badawi N, 1998, DEV MED CHILD NEUROL, V40, P520; Badawi N, 1998, BMJ-BRIT MED J, V317, P1549, DOI 10.1136/bmj.317.7172.1549; Badawi N, 1998, BMJ-BRIT MED J, V317, P1554, DOI 10.1136/bmj.317.7172.1554; BLAIR E, 1993, DEV MED CHILD NEUROL, V35, P449; Bloomenthal D, 2002, AM J PERINAT, V19, P37, DOI 10.1055/s-2002-20172; Colver AF, 2000, ARCH DIS CHILD-FETAL, V83, pF7, DOI 10.1136/fn.83.1.F7; Cowan F, 2003, LANCET, V361, P736, DOI 10.1016/S0140-6736(03)12658-X; Dammann O, 1998, Semin Pediatr Neurol, V5, P190, DOI 10.1016/S1071-9091(98)80034-X; Dite GS, 1998, AUST NZ J OBSTET GYN, V38, P377, DOI 10.1111/j.1479-828X.1998.tb03091.x; EASTMAN NJ, 1955, AM J OBSTET GYNECOL, V69, P950, DOI 10.1016/0002-9378(55)90094-6; Eun BL, 2000, PEDIATR RES, V47, P73, DOI 10.1203/00006450-200001000-00014; Foster-Barber A, 2002, MENT RETARD DEV D R, V8, P20, DOI 10.1002/mrdd.10009; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Grether J K, 1992, Paediatr Perinat Epidemiol, V6, P339, DOI 10.1111/j.1365-3016.1992.tb00774.x; Grether JK, 2003, ARCH PEDIAT ADOL MED, V157, P26, DOI 10.1001/archpedi.157.1.26; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; Gugino, 1998, Prim Care Update Ob Gyns, V5, P148, DOI 10.1016/S1068-607X(98)00026-2; Hagberg B, 2001, ACTA PAEDIATR, V90, P271, DOI 10.1080/080352501300067532; Hagstrom JN, 1998, J PEDIATR-US, V133, P777, DOI 10.1016/S0022-3476(98)70150-7; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Humphreys P, 2000, CAN J NEUROL SCI, V27, P210; Kim Y, 1996, STROKE, V27, P2274, DOI 10.1161/01.STR.27.12.2274; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; KUBAN KCK, 1994, NEW ENGL J MED, V330, P188, DOI 10.1056/NEJM199401203300308; Lieberman E, 2000, PEDIATRICS, V105, P8, DOI 10.1542/peds.105.1.8; Lynch JK, 2002, PEDIATRICS, V109, P116, DOI 10.1542/peds.109.1.116; Lynch JK, 2001, J CHILD NEUROL, V16, P735, DOI 10.1177/088307380101601006; MARTIN D, 1994, EXP NEUROL, V130, P362, DOI 10.1006/exnr.1994.1215; MENKES JH, 1994, AM J NEURORADIOL, V15, P451; MINAMISAWA H, 1990, ANN NEUROL, V28, P26, DOI 10.1002/ana.410280107; Moster D, 2001, J PEDIATR-US, V138, P798, DOI 10.1067/mpd.2001.114694; MURPHY CC, 1993, J PEDIATR-US, V123, pS13, DOI 10.1016/S0022-3476(05)80892-3; MUTCH L, 1992, DEV MED CHILD NEUROL, V34, P547; NELSON KB, 1982, PEDIATRICS, V69, P529; NELSON KB, 1985, AM J DIS CHILD, V139, P1031, DOI 10.1001/archpedi.1985.02140120077032; Nelson KB, 1998, ANN NEUROL, V44, P665, DOI 10.1002/ana.410440413; NELSON KB, 1986, NEW ENGL J MED, V315, P81, DOI 10.1056/NEJM198607103150202; Nelson KB, 2002, MENT RETARD DEV D R, V8, P146, DOI 10.1002/mrdd.10037; Pasternak JF, 1998, PEDIATR NEUROL, V18, P391, DOI 10.1016/S0887-8994(98)00002-2; Perlman JN, 1999, CLIN PEDIATR, V38, P287, DOI 10.1177/000992289903800506; *PMIC, 1999, INT CLASS DIS 9 REV; Roland EP, 1998, ANN NEUROL, V44, P161, DOI 10.1002/ana.410440205; Russel P., 1979, AM J DIAG GYN OBSTET, V1, P127; Shalak LF, 2002, MENT RETARD DEV D R, V8, P14, DOI 10.1002/mrdd.10006; Smulian JC, 1999, OBSTET GYNECOL, V94, P1000, DOI 10.1016/S0029-7844(99)00416-0; *STAT CA DEP HLTH, 1976, INTR GROWTH NEON RIS; Suzuki J, 2002, BRAIN DEV-JPN, V24, P39, DOI 10.1016/S0387-7604(01)00395-3; Thorngren-Jerneck K, 2001, OBSTET GYNECOL, V98, P65, DOI 10.1016/S0029-7844(01)01370-9; Topp M, 2001, PAEDIATR PERINAT EP, V15, P271, DOI 10.1046/j.1365-3016.2001.00354.x; Uvebrant P, 1988, Acta Paediatr Scand Suppl, V345, P1; Walstab J, 2002, AUST NZ J OBSTET GYN, V42, P138, DOI 10.1111/j.0004-8666.2002.00138.x; Winter S, 2002, PEDIATRICS, V110, P1220, DOI 10.1542/peds.110.6.1220; Wu YW, 2000, JAMA-J AM MED ASSOC, V284, P1417, DOI 10.1001/jama.284.11.1417; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676; [No title captured]; 2000, STATA 7 REFERENCE MA	57	369	378	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2003	290	20					2677	2684		10.1001/jama.290.20.2677	http://dx.doi.org/10.1001/jama.290.20.2677			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	747CR	14645309				2022-12-24	WOS:000186788100019
J	Basu, AR; Petaev, MI; Poreda, RJ; Jacobsen, SB; Becker, L				Basu, AR; Petaev, MI; Poreda, RJ; Jacobsen, SB; Becker, L			Chondritic meteorite fragments associated with the Permian-Triassic boundary in Antarctica	SCIENCE			English	Article							GIGANTIC RELEASE; SIBERIAN TRAPS; BOLIDE IMPACT; CATASTROPHE; FULLERENES; EXTINCTION; SULFUR	Multiple chondritic meteorite fragments have been found in two sedimentary rock samples from an end-Permian bed at Graphite Peak in Antarctica. The Ni/Fe, Co/Ni, and P/Fe ratios in metal grains; the Fe/Mg and Mn/Fe ratios in olivine and pyroxene; and the chemistry of Fe-, Ni-, P-, and S-bearing oxide in the meteorite fragments are typical of CM-type chondritic meteorites. In one sample, the meteoritic fragments are accompanied by more abundant discrete metal grains, which are also found in an end-Permian bed at Meishan, southern China. We discuss the implications of this finding for a suggested global impact event at the Permian-Triassic boundary.	Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Univ Calif Santa Barbara, Dept Geol, Inst Crustal Studies, Santa Barbara, CA 93106 USA	University of Rochester; Harvard University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of California System; University of California Santa Barbara	Basu, AR (corresponding author), Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA.	abasu@earth.rochester.edu	Jacobsen, Stein/B-1759-2013; Jacobsen, Stein/ABA-1063-2021	Jacobsen, Stein/0000-0003-2164-0720				ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; BASU AR, 1995, SCIENCE, V269, P822, DOI 10.1126/science.269.5225.822; Becker L, 2001, SCIENCE, V291, P1530, DOI 10.1126/science.1057243; Becker L, 2000, P NATL ACAD SCI USA, V97, P2979, DOI 10.1073/pnas.050519397; BECKERLING W, 1995, PLANET SPACE SCI, V43, P435, DOI 10.1016/0032-0633(94)00175-Q; Bowring SA, 1998, SCIENCE, V280, P1039, DOI 10.1126/science.280.5366.1039; BREARLEY AJ, 1998, REV MINERAL, V36, P3; Brownlee DE, 1997, METEORIT PLANET SCI, V32, P157, DOI 10.1111/j.1945-5100.1997.tb01257.x; CAMPBELL IH, 1992, SCIENCE, V258, P1760, DOI 10.1126/science.258.5089.1760; ERWIN DH, 1993, GREATEST PALEOZOIC C; Farley KA, 2001, SCIENCE, V293, P2343; Hallam A., 1997, MASS EXTINCTIONS THE; Jessberger EK, 2001, ASTR AST LI, P253; Jin YG, 2000, SCIENCE, V289, P432, DOI 10.1126/science.289.5478.432; Kaiho K, 2001, GEOLOGY, V29, P815, DOI 10.1130/0091-7613(2001)029<0815:EPCBAB>2.0.CO;2; Koeberl C, 2002, GEOLOGY, V30, P855, DOI 10.1130/0091-7613(2002)030<0855:EPCBBI>2.0.CO;2; Krull ES, 2000, GEOL SOC AM BULL, V112, P1459, DOI 10.1130/0016-7606(2000)112<1459:CDPFPA>2.0.CO;2; KURAT G, 1994, GEOCHIM COSMOCHIM AC, V58, P3879, DOI 10.1016/0016-7037(94)90369-7; Kyte FT, 1998, NATURE, V396, P237, DOI 10.1038/24322; KYTE FT, 2002, LUNAR PLANETARY SCI, V31; Miono S, 1999, NUCL INSTRUM METH B, V150, P516, DOI 10.1016/S0168-583X(98)00917-3; Poreda RJ, 2003, ASTROBIOLOGY, V3, P75, DOI 10.1089/153110703321632435; RAUP DM, 1979, SCIENCE, V206, P217, DOI 10.1126/science.206.4415.217; RENNE PR, 1991, SCIENCE, V253, P176, DOI 10.1126/science.253.5016.176; RENNE PR, 1995, SCIENCE, V269, P1413, DOI 10.1126/science.269.5229.1413; RETALLACK GJ, 1995, SCIENCE, V267, P77, DOI 10.1126/science.267.5194.77; Retallack GJ, 1998, GEOLOGY, V26, P979, DOI 10.1130/0091-7613(1998)026<0979:SFEOIA>2.3.CO;2; Rietmeijer F. J. M., 1998, REV MINERAL, V36, P1; Schmitz B, 2003, SCIENCE, V300, P961, DOI 10.1126/science.1082182; Schmitz B, 2001, EARTH PLANET SC LETT, V194, P1, DOI 10.1016/S0012-821X(01)00559-3; Sheldon ND, 2002, GEOLOGY, V30, P919, DOI 10.1130/0091-7613(2002)030<0919:LOLIET>2.0.CO;2; Shukolyukov A, 1998, SCIENCE, V282, P927, DOI 10.1126/science.282.5390.927; SUN Y, 1984, 27 INT GEOL C	33	106	122	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2003	302	5649					1388	1392		10.1126/science.1090852	http://dx.doi.org/10.1126/science.1090852			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631038				2022-12-24	WOS:000186683500050
J	Garcia-Ruiz, JM; Hyde, ST; Carnerup, AM; Christy, AG; Van Kranendonk, MJ; Welham, NJ				Garcia-Ruiz, JM; Hyde, ST; Carnerup, AM; Christy, AG; Van Kranendonk, MJ; Welham, NJ			Self-assembled silica-carbonate structures and detection of ancient microfossils	SCIENCE			English	Article							EARTHS EARLIEST FOSSILS; ARRHENIUS EQUATION; WESTERN-AUSTRALIA; LIFE	We have synthesized inorganic micron-sized filaments, whose microstucture consists of silica-coated nanometer-sized carbonate crystals, arranged with strong orientational order. They exhibit noncrystallographic, curved, helical morphologies, reminiscent of biological forms. The. laments are similar to supposed cyanobacterial microfossils from the Precambrian Warrawoona chert formation in Western Australia, reputed to be the oldest terrestrial microfossils. Simple organic hydrocarbons, whose sources may also be abiotic and indeed inorganic, readily condense onto these. laments and subsequently polymerize under gentle heating to yield kerogenous products. Our results demonstrate that abiotic and morphologically complex microstructures that are identical to currently accepted biogenic materials can be synthesized inorganically.	Univ Granada, Fac Ciencias, Inst Andaluz Ciencias Tierra, CSIC, Granada 18002, Spain; Australian Natl Univ, Res Sch Phys Sci, Dept Appl Math, Canberra, ACT 0200, Australia; Geol Survey Western Australia, Perth, WA 6004, Australia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada; Australian National University; Geological Survey of Western Australia	Garcia-Ruiz, JM (corresponding author), Univ Granada, Fac Ciencias, Inst Andaluz Ciencias Tierra, CSIC, Campus Fuentenueva, Granada 18002, Spain.		García-Ruiz, Juan Manuel/U-1085-2019; Hyde, Stephen/F-9248-2010; Garcia-Ruiz, Juan Manuel/C-4389-2015; Van Kranendonk, Martin J/J-8755-2012; Christy, Andrew/C-3205-2013; Hyde, Stephen T/N-2928-2019	García-Ruiz, Juan Manuel/0000-0002-4743-8718; Hyde, Stephen/0000-0003-2003-9992; Garcia-Ruiz, Juan Manuel/0000-0002-4743-8718; Van Kranendonk, Martin J/0000-0002-0611-2703; Christy, Andrew/0000-0002-2203-1444; Hyde, Stephen T/0000-0003-2003-9992; Welham, Nicholas/0000-0002-4716-9837				AWRAMIK SM, 1983, PRECAMBRIAN RES, V20, P357, DOI 10.1016/0301-9268(83)90081-5; BAIRD T, 1992, MATER RES BULL, V27, P1031, DOI 10.1016/0025-5408(92)90241-Q; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; BUICK R, 1990, Palaios, V5, P441, DOI 10.2307/3514837; Cartwright JHE, 2002, J COLLOID INTERF SCI, V256, P351, DOI 10.1006/jcis.2002.8620; CLOUD P, 1979, PRECAMBRIAN RES, V9, P81, DOI 10.1016/0301-9268(79)90052-4; DEGENNES PG, 1993, PHYSICS LIQUID CRYST; GARCIA-RUIZ J.M., 2002, ASTROBIOLOGY, V2, P335; Garcia-Ruiz J. M., 2000, CARBONATE SEDIMENTAT, V67, P75; Garcia-Ruiz JM, 1998, GEOLOGY, V26, P843; GarciaRuiz JM, 1997, AN QUIM, V93, P1; Garrels R.M., 1965, SOLUTIONS MINERALS E; Hofmann BA, 2000, PLANET SPACE SCI, V48, P1077, DOI 10.1016/S0032-0633(00)00081-7; HUNT JM, 1991, AAPG BULL, V75, P795; Ko TH, 2000, POLYM COMPOSITE, V21, P745, DOI 10.1002/pc.10229; Lowenstam HA, 1989, BIOMINERALIZATION; McCollom TM, 2003, GEOCHIM COSMOCHIM AC, V67, P311, DOI 10.1016/S0016-7037(02)00945-6; Pasteris JD, 2002, NATURE, V420, P476, DOI 10.1038/420476b; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; Schopf JW, 2002, NATURE, V416, P73, DOI 10.1038/416073a; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; SCHOPF JW, 1983, EARTHS EARLIEST BIOS, pCH9; SVENSSON IL, 1986, J CHEM SOC FARAD T 1, V82, P3635, DOI 10.1039/f19868203635; THORPE RI, 1992, ARCHAEAN TERRAINS PR, V22, P395; Ueno Y, 2001, INT GEOL REV, V43, P196, DOI 10.1080/00206810109465008; VANKRANENDONK MJ, UNPUB; WOOD DA, 1988, AAPG BULL, V72, P115; Yang H, 1997, NATURE, V386, P692, DOI 10.1038/386692a0	28	336	346	1	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2003	302	5648					1194	1197		10.1126/science.1090163	http://dx.doi.org/10.1126/science.1090163			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14615534	Green Submitted			2022-12-24	WOS:000186544300049
J	Pizzari, T; Cornwallis, CK; Lovlie, H; Jakobsson, S; Birkhead, TR				Pizzari, T; Cornwallis, CK; Lovlie, H; Jakobsson, S; Birkhead, TR			Sophisticated sperm allocation in male fowl	NATURE			English	Article							GALLUS-GALLUS; COMPETITION; STRATEGIES; EJACULATE; BEHAVIOR; CHOICE; EXPENDITURE	When a female is sexually promiscuous, the ejaculates of different males compete for the fertilization of her eggs(1); the more sperm a male inseminates into a female, the more likely he is to fertilize her eggs(2). Because sperm production is limited and costly, theory predicts that males will strategically allocate sperm (1) according to female promiscuity(1,3-5), (2) saving some for copulations with new females(3,6,7), and (3) to females producing more and/or better offspring(3,8). Whether males allocate sperm in all of these ways is not known, particularly in birds where the collection of natural ejaculates only recently became possible. Here we demonstrate male sperm allocation of unprecedented sophistication in the fowl Gallus gallus. Males show status-dependent sperm investment in females according to the level of female promiscuity; they progressively reduce sperm investment in a particular female but, on encountering a new female, instantaneously increase their sperm investment; and they preferentially allocate sperm to females with large sexual ornaments signalling superior maternal investment. Our results indicate that female promiscuity leads to the evolution of sophisticated male sexual behaviour.	Swedish Univ Agr Sci, Dept Anim Environm & Hlth, SE-53223 Uppsala, Sweden; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Swedish University of Agricultural Sciences; University of Sheffield	Pizzari, T (corresponding author), Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England.	t.pizzari@leeds.ac.uk	Cornwallis, Charlie/A-6276-2012					Bakst M.R., 1997, TECHNIQUES SEMEN EVA; BIRKHEAD TR, 1988, NATURE, V334, P60, DOI 10.1038/334060a0; CLUTTONBROCK TH, 1979, ANIM BEHAV, V27, P211, DOI 10.1016/0003-3472(79)90141-6; DER G, 2001, HDB STAT ANAL USING; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Evans JP, 2003, BEHAV ECOL, V14, P268, DOI 10.1093/beheco/14.2.268; Fumihito A, 1996, P NATL ACAD SCI USA, V93, P6792, DOI 10.1073/pnas.93.13.6792; Hunter FM, 2000, P ROY SOC B-BIOL SCI, V267, P1541, DOI 10.1098/rspb.2000.1176; ISHIKAWA H, 1930, P WORLD POULT J C, P90; MARTIN PA, 1974, J REPROD FERTIL, V39, P251, DOI 10.1530/jrf.0.0390251; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; Parker J. E., 1942, MISS AGR EXP STATION, V347, P3; Pilastro A, 2002, P NATL ACAD SCI USA, V99, P9913, DOI 10.1073/pnas.152133499; PITNICK S, 1994, AM NAT, V143, P785, DOI 10.1086/285633; Pizzari T, 2000, NATURE, V405, P787, DOI 10.1038/35015558; Pizzari T, 2002, TRENDS ECOL EVOL, V17, P456, DOI 10.1016/S0169-5347(02)02591-0; Pizzari T, 2001, ANIM BEHAV, V61, P601, DOI 10.1006/anbe.2000.1620; Pizzari T, 2001, P ROY SOC B-BIOL SCI, V268, P181, DOI 10.1098/rspb.2000.1348; PIZZARI T, IN PRESS BEHAV ECOL; Reinhold K, 2002, J EVOLUTION BIOL, V15, P201, DOI 10.1046/j.1420-9101.2002.00390.x; Schutz KE, 2001, ETHOLOGY, V107, P753, DOI 10.1046/j.1439-0310.2001.00703.x; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Westneat DF, 1998, BEHAV ECOL SOCIOBIOL, V43, P161, DOI 10.1007/s002650050477; WILSON JR, 1963, J COMP PHYSIOL PSYCH, V56, P636, DOI 10.1037/h0042469; ZUK M, 1995, P ROY SOC B-BIOL SCI, V260, P205, DOI 10.1098/rspb.1995.0081	25	246	249	4	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2003	426	6962					70	74		10.1038/nature02004	http://dx.doi.org/10.1038/nature02004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603319	Green Accepted			2022-12-24	WOS:000186370800043
J	Li, SX; Chen, W; Srinivasan, SR; Bond, MG; Tang, R; Urbina, EM; Berenson, GS				Li, SX; Chen, W; Srinivasan, SR; Bond, MG; Tang, R; Urbina, EM; Berenson, GS			Childhood cardiovascular risk factors and carotid vascular changes in adulthood - The Bogalusa Heart Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTIMA-MEDIA THICKNESS; ARTERIAL-WALL THICKNESS; BLACK-WHITE DIFFERENCES; B-MODE ULTRASOUND; YOUNG-ADULTS; INSULIN-RESISTANCE; ATHEROSCLEROTIC LESIONS; ADIPOSE-TISSUE; SERUM-LIPOPROTEINS; CHOLESTEROL LEVELS	Context Carotid artery intima-media thickness (IMT) is associated with cardiovascular risk factors and is recognized as an important predictive measure of clinical coronary atherosclerosis events in middle-aged and elderly populations. However, information on the association of carotid IMT in young adults with different risk factors measured in childhood, adulthood, or as a cumulative burden of each of the risk factors measured serially from childhood to adulthood is limited. Objective To examine the association between carotid IMT in young adults and traditional cardiovascular risk factors measured since childhood. Design, Setting, and Participants A cohort study of 486 adults aged 25 to 37 years from a semirural black and white community in Bogalusa, La (71% white, 39% men), who had at least 3 measurements of traditional risk factors since childhood, conducted between September 1973 and December 1996. Main Outcome Measure Association of carotid IMT with risk factors, including systolic blood pressure, lipoprotein levels, and body mass index. Results Male vs female (0.757 mm Vs 0.719 mm) and black vs white (0.760 mm vs 0.723 mm) participants had increased carotid IMT (P<.001 for both). In multivariable analyses, significant predictors for being in top vs lower 3 quartiles of carotid IMT in young adults were childhood measures of low-density lipoprotein cholesterol (LDL-C) level (odds ratio [OR], 1.42, corresponding to 1-SD change specific for age, race, and sex; 95% confidence interval [CI], 1.14-1.78) and body mass index (BMI; OR, 1.25; 95% CI, 1.01-1.54); adulthood measures of LDL-C level (OR, 1.46; 95% CI, 1.16-1.82), high-density lipoprotein cholesterol (HDL-C) level (OR; 0.67; 95% CI, 0.51-0.88), and systolic blood pressure (OR, 1.36; 95% CI, 1.08-1.72); and long-term cumulative burden of LDL-C (OR, 1.58; 95% CI, 1.24-2.01) and HDL-C (OR, 0.75; 95% CI, 0.58-0.97) levels measured serially from childhood to adulthood. An increasing trend in carotid IMT across quartiles of LDL-C level measured in childhood was observed, with a mean value of 0.761 mm (95% CI, 0.743-0.780 mm) for those at the top quartile vs 0.724 mm (95% CI, 0.715-0.734 mm) for those in the lower 3 quartiles (P<.001). Conclusions Childhood measures of LDL-C level and BMI predict carotid IMT in young adults: The prevention implications of these findings remains to be explored.	Tulane Univ, Hlth Sci Ctr, Tulane Ctr Cardiovasc Hlth, New Orleans, LA 70112 USA; Tulane Univ, Hlth Sci Ctr, Dept Epidemiol, New Orleans, LA 70112 USA; Wake Forest Univ, Bowman Gray Sch Med, Div Vasc Ultrasound Res, Winston Salem, NC USA	Tulane University; Tulane University; Wake Forest University; Wake Forest Baptist Medical Center	Berenson, GS (corresponding author), Tulane Univ, Hlth Sci Ctr, Tulane Ctr Cardiovasc Hlth, 1440 Canal St,Suite 1829, New Orleans, LA 70112 USA.		Li, Shengxu/D-8915-2012		NHLBI NIH HHS [HL-38844] Funding Source: Medline; NIA NIH HHS [AG-16592] Funding Source: Medline; NICHD NIH HHS [HD-043820] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD043820] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL038844, R01HL038844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016592] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AKERBLOM HK, 1991, ANN MED, V23, P35, DOI 10.3109/07853899109147928; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Bao WH, 1996, ARCH INTERN MED, V156, P1315, DOI 10.1001/archinte.156.12.1315; Berenson G.S., 1986, CAUSATION CARDIOVASC; Berenson GS, 2002, AM J CARDIOL, V90, p3L, DOI 10.1016/S0002-9149(02)02953-3; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; BUCULO G, 1973, CLIN CHEM, V19, P476; BURKE GL, 1995, STROKE, V26, P386, DOI 10.1161/01.STR.26.3.386; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Chambless LE, 2002, AM J EPIDEMIOL, V155, P38, DOI 10.1093/aje/155.1.38; Chobanian AV, 1996, ARCH INTERN MED, V156, P1952, DOI 10.1001/archinte.156.17.1952; Crouse JR, 2002, CIRCULATION, V106, P2061, DOI 10.1161/01.CIR.0000033833.54884.34; DAgostino RB, 1996, STROKE, V27, P1744, DOI 10.1161/01.STR.27.10.1744; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; DONAHUE RP, 1989, ARTERIOSCLEROSIS, V9, P656, DOI 10.1161/01.ATV.9.5.656; Engeli S, 2000, HYPERTENSION, V35, P1270, DOI 10.1161/01.HYP.35.6.1270; Greenlund KJ, 1998, ANN EPIDEMIOL, V8, P22, DOI 10.1016/S1047-2797(97)00127-0; HEISS G, 1991, AM J EPIDEMIOL, V134, P250, DOI 10.1093/oxfordjournals.aje.a116078; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Hulthe J, 1997, STROKE, V28, P1189, DOI 10.1161/01.STR.28.6.1189; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; LAUER RM, 1988, PEDIATRICS, V82, P309; LAUER RM, 1980, CHILDHOOD PREVENTION; Lipid Research Clinics Program, 1974, DHEW PUBL; Mannami T, 2000, ARCH INTERN MED, V160, P2297, DOI 10.1001/archinte.160.15.2297; MANOLIO TA, 1995, J CLIN EPIDEMIOL, V48, P1141, DOI 10.1016/0895-4356(94)00240-Q; McGill HC, 1998, ARTERIOSCL THROM VAS, V18, P1108, DOI 10.1161/01.ATV.18.7.1108; McGill HC, 1997, ARTERIOSCL THROM VAS, V17, P95, DOI 10.1161/01.ATV.17.1.95; MORRISON JA, 1979, METABOLISM, V28, P241, DOI 10.1016/0026-0495(79)90070-2; Napoli C, 1999, LANCET, V354, P1234, DOI 10.1016/S0140-6736(99)02131-5; NEWMAN WP, 1986, NEW ENGL J MED, V314, P138, DOI 10.1056/NEJM198601163140302; O'Leary DH, 2002, AM J CARDIOL, V90, p18L, DOI 10.1016/S0002-9149(02)02957-0; PORKKA KVK, 1994, AM J EPIDEMIOL, V140, P1096, DOI 10.1093/oxfordjournals.aje.a117210; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Riley WA, 1991, J NEUROIMAGING, V1, P168, DOI DOI 10.1111/JON199114168; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SAS Institute Inc, 1997, SAS STAT SOFTW CHANG; SRINIVASAN SR, 1975, BIOCHIM BIOPHYS ACTA, V388, P58, DOI 10.1016/0005-2760(75)90062-4; SRINIVASAN SR, 1991, PREV MED, V20, P671, DOI 10.1016/0091-7435(91)90063-A; Srinivasan SR., 1983, CRC HDB ELECTROPHORE, P185; STARY HC, 1989, ARTERIOSCLEROSIS, V9, pI19; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; STOUT RW, 1987, LANCET, V1, P1077; Tang R, 2000, J HYPERTENS, V18, P197, DOI 10.1097/00004872-200018020-00010; Urbina EM, 2002, AM J CARDIOL, V90, P953, DOI 10.1016/S0002-9149(02)02660-7; Wilson PWF, 1997, NEW ENGL J MED, V337, P516, DOI 10.1056/NEJM199708213370802; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; 1995, AM J MED SCI S1, V310, pS1	49	715	748	0	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2003	290	17					2271	2276		10.1001/jama.290.17.2271	http://dx.doi.org/10.1001/jama.290.17.2271			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739PZ	14600185	Bronze			2022-12-24	WOS:000186356800021
J	Blutt, SE; Kirkwood, CD; Parreno, V; Warfield, KL; Ciarlet, M; Estes, MK; Bok, K; Bishop, RF; Conner, ME				Blutt, SE; Kirkwood, CD; Parreno, V; Warfield, KL; Ciarlet, M; Estes, MK; Bok, K; Bishop, RF; Conner, ME			Rotavirus antigenaemia and viraemia: a common event?	LANCET			English	Article							POLYMERASE-CHAIN-REACTION; CEREBROSPINAL-FLUID; REVERSE TRANSCRIPTION; LYMPHOID-TISSUES; GASTROENTERITIS; INFECTION; IMMUNODEFICIENCY; ENCEPHALOPATHY; CHILD; VP7	Background Rotavirus infection is thought to be confined to the intestine. Reports of rotavirus RNA in the cerebral spinal fluid and serum of children infected with rotavirus suggest the possibility that rotavirus escapes the intestine into the circulatory system. We assessed whether rotavirus antigen, RNA, or both, were present in serum samples from immunocompetent rotavirus-infected children and animals. Methods We obtained sera from immunocompetent mice, rats, rabbits, and calves 1-10 days after inoculation with rotavirus or matched vehicle. We obtained sera retrospectively from immunocompetent children diagnosed with rotavirus diarrhoea (n=33), healthy children (n=6) and adults (n=12), children convalescing from rotavirus (n=6), and children with non-rotavirus diarrhoea (n=11). Samples were analysed for the presence of rotavirus antigen or RNA by EIA or RT-PCR, respectively. Findings Rotavirus antigen was present in sera from rotavirus-infected animals, but not in sera from control animals. Infectious rotavirus or rotavirus RNA was detected in sera of mice and calves, respectively. Antigen was present in 22 of 33 serum samples from children with confirmed rotavirus infection but in none of 35 samples from controls. Detection of serum antigen was inversely related to the number of days between symptom onset and sample collection, and directly related to stool antigen concentration. Rotavirus RNA was detected by RT-PCR in three of six rotavirus-positive sera. Interpretation Rotavirus can escape the gastrointestinal tract in children, resulting in antigenaemia and possible viraemia. This finding is important for the understanding of the pathogenesis, immunology, and clinical manifestations of rotavirus infection.	Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Murdoch Childrens Res Inst,Enter Virus Res Grp, Melbourne, Vic, Australia; INTA, CICVyA, Inst Virol, Buenos Aires, DF, Argentina; INEI ANLIS, Dept Virol, Lab Gastroenteritis Virales, Buenos Aires, DF, Argentina; Vet Affairs Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Instituto Nacional de Tecnologia Agropecuaria (INTA); Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Conner, ME (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza, Houston, TX 77030 USA.		Conner, Margaret E./I-7230-2019	parreno, viviana/0000-0003-0385-5592	NIAID NIH HHS [F32-AI10604, R01 AI24998] Funding Source: Medline; NIDDK NIH HHS [DK56338] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI010604, R01AI024998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brown KA, 1998, MICROB PATHOGENESIS, V24, P327, DOI 10.1006/mpat.1997.0198; Conner Margaret E., 1997, P713; COULSON BS, 1987, J CLIN MICROBIOL, V25, P509, DOI 10.1128/JCM.25.3.509-515.1987; DHARAKUL T, 1988, CLIN EXP IMMUNOL, V74, P14; ESTES MK, 1997, FIELDS VIROLOGY, P1625; GILGER MA, 1992, J PEDIATR-US, V120, P912, DOI 10.1016/S0022-3476(05)81959-6; Goldwater PN, 2001, J PAEDIATR CHILD H, V37, P206, DOI 10.1046/j.1440-1754.2001.00596.x; GOUVEA V, 1994, J CLIN MICROBIOL, V32, P1338, DOI 10.1128/JCM.32.5.1338-1340.1994; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; Iturriza-Gomara M, 2002, J CLIN MICROBIOL, V40, P4797, DOI 10.1128/JCM.40.12.4797-4799.2002; KRAFT LM, 1958, YALE J BIOL MED, V31, P122; Limbos MAP, 1996, CLIN INFECT DIS, V22, P834, DOI 10.1093/clinids/22.5.834; Lynch M, 2001, CLIN INFECT DIS, V33, P932, DOI 10.1086/322650; MCCORMACK JG, 1982, J INFECTION, V4, P167, DOI 10.1016/S0163-4453(82)93777-X; Morrison C, 2001, HUM PATHOL, V32, P216, DOI 10.1053/hupa.2001.21565; Mossel EC, 2002, J VIROL, V76, P6502, DOI 10.1128/JVI.76.13.6502-6509.2002; Nigrovic LE, 2002, CLIN INFECT DIS, V34, P130, DOI 10.1086/323560; NISHIMURA S, 1993, BRAIN DEV-JPN, V15, P457, DOI 10.1016/0387-7604(93)90088-P; ONeal CM, 1997, J VIROL, V71, P8707, DOI 10.1128/JVI.71.11.8707-8717.1997; Pang XL, 1996, PEDIATR INFECT DIS J, V15, P543, DOI 10.1097/00006454-199606000-00015; SAULSBURY FT, 1980, J PEDIATR-US, V97, P61, DOI 10.1016/S0022-3476(80)80131-4; Takahashi S, 1999, EUR J PEDIATR, V158, P133, DOI 10.1007/s004310051033; USHIJIMA H, 1994, J CLIN MICROBIOL, V32, P2893, DOI 10.1128/JCM.32.12.2893-2897.1994; YOSHIDA A, 1995, PEDIATR INFECT DIS J, V14, P914	24	164	179	1	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 1	2003	362	9394					1445	1449		10.1016/S0140-6736(03)14687-9	http://dx.doi.org/10.1016/S0140-6736(03)14687-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739PX	14602437				2022-12-24	WOS:000186356600009
J	Mallucci, G; Dickinson, A; Linehan, J; Klohn, PC; Brandner, S; Collinge, J				Mallucci, G; Dickinson, A; Linehan, J; Klohn, PC; Brandner, S; Collinge, J			Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis	SCIENCE			English	Article							CREUTZFELDT-JAKOB-DISEASE; KNOCKOUT MICE; PROTEIN PRP; SCRAPIE; EXPRESSION; RESISTANT; STRAINS	The mechanisms involved in prion neurotoxicity are unclear, and therapies preventing accumulation of PrPSc, the disease-associated form of prion protein (PrP), do not significantly prolong survival in mice with central nervous system prion infection. We found that depleting endogenous neuronal PrPc in mice with established neuroinvasive prion infection reversed early spongiform change and prevented neuronal loss and progression to clinical disease. This occurred despite the accumulation of extraneuronal PrPSc to levels seen in terminally ill wild-type animals. Thus, the propagation of non-neuronal PrPSc is not pathogenic, but arresting the continued conversion of PrPc to PrPSc within neurons during scrapie infection prevents prion neurotoxicity.	MRC, Prion Unit, London WC1, England; Inst Neurol, Dept Neurodgenerat Dis, London WC1, England		Collinge, J (corresponding author), MRC, Prion Unit, Queen Sq, London WC1, England.		Brandner, Sebastian/J-4562-2014; Kloehn, Peter/AAS-3719-2021	Brandner, Sebastian/0000-0002-9821-0342; Mallucci, Giovanna/0000-0001-8504-1191	MRC [MC_U123160654] Funding Source: UKRI; Medical Research Council [MC_U123160654, MC_U132692719] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aguzzi A, 2001, NAT REV NEUROSCI, V2, P745, DOI 10.1038/35094590; Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Baker CA, 1999, J VIROL, V73, P5089, DOI 10.1128/JVI.73.6.5089-5097.1999; Baker CA, 2002, J VIROL, V76, P10905, DOI 10.1128/JVI.76.21.10905-10913.2002; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; COLLINGE J, 1995, LANCET, V346, P569, DOI 10.1016/S0140-6736(95)91405-6; Collins SJ, 2002, ANN NEUROL, V52, P503, DOI 10.1002/ana.10336; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Goelz MF, 1998, LAB ANIM SCI, V48, P34; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; JULIEN JP, 1988, GENE, V68, P307, DOI 10.1016/0378-1119(88)90033-9; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; MANSON JC, 1994, NEURODEGENERATION, V3, P331; MEDORI R, 1992, PRION DIS HUMANS ANI, pCH18; Priola SA, 2000, SCIENCE, V287, P1503, DOI 10.1126/science.287.5457.1503; Raeber AJ, 1997, EMBO J, V16, P6057, DOI 10.1093/emboj/16.20.6057; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Tagliavini F, 1997, SCIENCE, V276, P1119, DOI 10.1126/science.276.5315.1119; Tremblay P, 1998, P NATL ACAD SCI USA, V95, P12580, DOI 10.1073/pnas.95.21.12580	22	529	551	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2003	302	5646					871	874		10.1126/science.1090187	http://dx.doi.org/10.1126/science.1090187			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593181				2022-12-24	WOS:000186258000051
J	Coupland, RM				Coupland, RM			Incapacitating chemical weapons: a year after the Moscow theatre siege	LANCET			English	Editorial Material							FENTANYL; TOXICOLOGY		Int Comm Red Cross, Legal Div, CH-1202 Geneva, Switzerland		Coupland, RM (corresponding author), Int Comm Red Cross, Legal Div, CH-1202 Geneva, Switzerland.	rcoupland@icrc.org						Bartfield JM, 2003, ACAD EMERG MED, V10, P215, DOI 10.1111/j.1553-2712.2003.tb01993.x; Coupland RM, 1997, BRIT MED J, V315, P72, DOI 10.1136/bmj.315.7100.72; Enserink M, 2002, SCIENCE, V298, P1150, DOI 10.1126/science.298.5596.1150; *ICRC, 2003, 1 SPEC SESS C STAT P; Lakoski J. M., 2000, ADVANTAGES LIMITATIO; Mather LE, 1998, BRIT J CLIN PHARMACO, V46, P37, DOI 10.1046/j.1365-2125.1998.00035.x; *NAT RES COUNC COM, 2003, ASS NONL WEAP SCI TE; Schiermeier Q, 2002, NATURE, V420, P7, DOI 10.1038/420007a; Wax PM, 2003, ANN EMERG MED, V41, P700, DOI 10.1067/mem.2003.148; Wheelis M, 2003, ISSUES SCI TECHNOL, V19, P74; *WORLD MED ASS, 1996, WORLD MED ASS 48 GEN; WORSLEY MH, 1990, ANAESTHESIA, V45, P449, DOI 10.1111/j.1365-2044.1990.tb14331.x; 2002, BBC NEWS        1029	13	11	13	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2003	362	9393					1346	1346		10.1016/S0140-6736(03)14684-3	http://dx.doi.org/10.1016/S0140-6736(03)14684-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735YX	14585634				2022-12-24	WOS:000186143300006
J	Zhou, DP; Cantu, C; Sagiv, Y; Schrantz, N; Kulkarni, AB; Qi, XY; Mahuran, DJ; Morales, CR; Grabowski, GA; Benlagha, K; Savage, P; Bendelac, A; Teyton, L				Zhou, DP; Cantu, C; Sagiv, Y; Schrantz, N; Kulkarni, AB; Qi, XY; Mahuran, DJ; Morales, CR; Grabowski, GA; Benlagha, K; Savage, P; Bendelac, A; Teyton, L			Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins	SCIENCE			English	Article							ACTIVATOR PROTEIN; CYTOPLASMIC TAIL; T-CELLS; INTRACELLULAR TRAFFICKING; ALPHA-GALACTOSIDASE; NKT CELLS; MOLECULES; MOUSE; CD1B; SPECIFICITY	It is now established that CD1 molecules present lipid antigens to T cells, although it is not clear how the exchange of lipids between membrane compartments and the CD1 binding groove is assisted. We report that mice deficient in prosaposin, the precursor to a family of endosomal lipid transfer proteins (LTP), exhibit specific defects in CD1d-mediated antigen presentation and lack Valpha14 NKT cells. In vitro, saposins extracted monomeric lipids from membranes and from CD1, thereby promoting the loading as well as the editing of lipids on CD1. Transient complexes between CD1, lipid, and LTP suggested a "tug-of-war" model in which lipid exchange between CD1 and LTP is on the basis of their respective affinities for lipids. LTPs constitute a previously unknown link between lipid metabolism and immunity and are likely to exert a profound influence on the repertoire of self, tumor, and microbial lipid antigens.	Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; Univ Toronto, Dept Med & Pathobiol, Toronto, ON M5G 1X8, Canada; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	University of Chicago; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Cincinnati Children's Hospital Medical Center; University of Toronto; McGill University; Brigham Young University	Bendelac, A (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	abendela@bsd.uchicago.edu; lteyton@scripps.edu	Benlagha, Kamel/I-5035-2016; Benlagha, Kamel/GLQ-8342-2022; Morales, Carlos R./H-1055-2011; Zhou, Dapeng/A-6446-2019; Savage, Paul B/HGB-3414-2022; zhou, dapeng/GXG-9715-2022; Savage, Paul B/E-1448-2011	Zhou, Dapeng/0000-0003-1347-3811; Savage, Paul B/0000-0002-4642-6109; Savage, Paul B/0000-0002-4642-6109; benlagha, kamel/0000-0002-3251-9195	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050867, R37AI038339, R01AI038339, P01AI053725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000698] Funding Source: NIH RePORTER; Canadian Institutes of Health Research [10435] Funding Source: Medline; NIAID NIH HHS [R01 AI050867, R01 AI038339, AI50867, P01 AI053725, P01 AI53725, R37 AI038339, AI38339] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahn VE, 2003, P NATL ACAD SCI USA, V100, P38, DOI 10.1073/pnas.0136947100; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Briken V, 2002, EMBO J, V21, P825, DOI 10.1093/emboj/21.4.825; Cantu C, 2003, J IMMUNOL, V170, P4673, DOI 10.4049/jimmunol.170.9.4673; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Fujita N, 1996, HUM MOL GENET, V5, P711, DOI 10.1093/hmg/5.6.711; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; HARDING CV, 1991, CELL, V64, P393, DOI 10.1016/0092-8674(91)90647-H; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Kang SJ, 2002, EMBO J, V21, P1650, DOI 10.1093/emboj/21.7.1650; Kase R, 1996, FEBS LETT, V393, P74, DOI 10.1016/0014-5793(96)00863-0; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Moody DB, 2003, NAT REV IMMUNOL, V3, P11, DOI 10.1038/nri979; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; QI XY, 1994, J BIOL CHEM, V269, P16746; RUECKERT DG, 1990, CHEM PHYS LIPIDS, V56, P1, DOI 10.1016/0009-3084(90)90083-4; Sakai N, 1996, J NEUROCHEM, V66, P1118, DOI 10.1046/j.1471-4159.1996.66031118.x; Sandhoff K, 1998, ANN NY ACAD SCI, V845, P139, DOI 10.1111/j.1749-6632.1998.tb09667.x; Shamshiev A, 2000, IMMUNITY, V13, P255, DOI 10.1016/S1074-7613(00)00025-X; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4; Vogler C, 2001, PEDIATR RES, V49, P342, DOI 10.1203/00006450-200103000-00007; Wright CS, 2003, J MOL BIOL, V331, P951, DOI 10.1016/S0022-2836(03)00794-0; WU YY, 1994, J BIOL CHEM, V269, P16276; Zhao Q, 2000, J BIOL CHEM, V275, P24829, DOI 10.1074/jbc.M003497200	33	259	270	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2004	303	5657					523	527		10.1126/science.1092009	http://dx.doi.org/10.1126/science.1092009			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765XM	14684827	Green Accepted			2022-12-24	WOS:000188316400038
J	Mizuguchi, G; Shen, XT; Landry, J; Wu, WH; Sen, S; Wu, C				Mizuguchi, G; Shen, XT; Landry, J; Wu, WH; Sen, S; Wu, C			ATP-Driven exchange of histone H2AZ variant catalyzed by SWR1 chromatin remodeling complex	SCIENCE			English	Article							ACTIN-RELATED PROTEINS; NUCLEOSOME CORE PARTICLE; NUCLEAR ACTIN; SACCHAROMYCES-CEREVISIAE; RSC	The conserved histone variant H2AZ has an important role in the regulation of gene expression and the establishment of a buffer to the spread of silent heterochromatin. How histone variants such as H2AZ are incorporated into nucleosomes has been obscure. We have found that Swr1, a Swi2/Snf2-related adenosine triphosphatase, is the catalytic core of a multisubunit, histone-variant exchanger that efficiently replaces conventional histone H2A with histone H2AZ in nucleosome arrays. Swr1 is required for the deposition of histone H2AZ at specific chromosome locations in vivo, and Swr1 and H2AZ commonly regulate a subset of yeast genes. These findings de. ne a previously unknown role for the adenosine triphosphate - dependent chromatin remodeling machinery.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wu, C (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bldg 37,Room 6068, Bethesda, MD 20892 USA.	carlwu@helix.nih.gov	Sen, Subhojit/I-9033-2012	Sen, Subhojit/0000-0001-8457-915X; Shen, Xuetong/0000-0002-4267-5298	NATIONAL CANCER INSTITUTE [Z01BC005263, ZIABC005263] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; [Anonymous], COMMUNICATION; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Begley TJ, 2002, MOL CANCER RES, V1, P103; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Clarkson MJ, 1999, NATURE, V399, P694, DOI 10.1038/21436; Fazzio TG, 2003, MOL CELL, V12, P1333, DOI 10.1016/S1097-2765(03)00436-2; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Goodson HV, 2002, J CELL SCI, V115, P2619; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595; HATCH CL, 1983, SCIENCE, V221, P468, DOI 10.1126/science.6306766; Hsu JM, 2003, MOL CELL BIOL, V23, P3202, DOI 10.1128/MCB.23.9.3202-3215.2003; ISHIMI Y, 1991, J BIOL CHEM, V266, P7025; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Luger K, 1999, METHOD ENZYMOL, V304, P3; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; MIZUGUCHI G, UNPUB; NAKATANI Y, COMMUNICATION; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Richmond T. J., 2000, CHROMATIN STRUCTURE; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Smith MM, 2002, CURR OPIN CELL BIOL, V14, P279, DOI 10.1016/S0955-0674(02)00331-9; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Szerlong H, 2003, EMBO J, V22, P3175, DOI 10.1093/emboj/cdg296; van Holde KE., 1989, SPRINGER SERIES MOL; VANHOLDE KE, 1995, CHROMATIN STRUCTURE; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003	39	952	998	3	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2004	303	5656					343	348		10.1126/science.1090701	http://dx.doi.org/10.1126/science.1090701			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14645854	Green Published			2022-12-24	WOS:000188111800035
J	Wilson, RI; Turner, GC; Laurent, G				Wilson, RI; Turner, GC; Laurent, G			Transformation of olfactory representations in the Drosophila antennal lobe	SCIENCE			English	Article							PRESYNAPTIC INHIBITION; FLY BRAIN; NEURONS; MELANOGASTER; MECHANISMS; BULB; MAP; TRANSMISSION; GLOMERULI; REVEALS	Molecular genetics has revealed a precise stereotypy in the projection of primary olfactory sensory neurons onto secondary neurons. A major challenge is to understand how this mapping translates into odor responses in these second-order neurons. We investigated this question in Drosophila using whole-cell recordings in vivo. We observe that monomolecular odors generally elicit responses in large ensembles of antennal lobe neurons. Comparison of odor-evoked activity from afferents and postsynaptic neurons in the same glomerulus revealed that second-order neurons display broader tuning and more complex responses than their primary afferents. This indicates a major transformation of odor representations, implicating lateral interactions within the antennal lobe.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Laurent, G (corresponding author), CALTECH, Div Biol, 139-74, Pasadena, CA 91125 USA.		Laurent, Gilles/A-4583-2012; Wilson, Rachel/E-2227-2012	Laurent, Gilles/0000-0002-2296-114X; Wilson, Rachel/0000-0001-8573-9266; Turner, Glenn/0000-0002-5341-2784				Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; Christensen TA, 2002, CURR OPIN NEUROBIOL, V12, P393, DOI 10.1016/S0959-4388(02)00336-7; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Goldberg F, 1999, J PHYSIOL-LONDON, V514, P759, DOI 10.1111/j.1469-7793.1999.759ad.x; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; Korsching S, 2002, CURR OPIN NEUROBIOL, V12, P387, DOI 10.1016/S0959-4388(02)00348-3; Laissue PP, 1999, J COMP NEUROL, V405, P543; Laurent G, 1996, J NEUROSCI, V16, P3837; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Oertner TG, 2001, J NEUROPHYSIOL, V85, P439, DOI 10.1152/jn.2001.85.1.439; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; STOCKER RF, 1983, CELL TISSUE RES, V232, P237, DOI 10.1007/BF00213783; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wachowiak M, 1999, J NEUROSCI, V19, P8808, DOI 10.1523/JNEUROSCI.19-20-08808.1999; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	28	391	395	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2004	303	5656					366	370		10.1126/science.1090782	http://dx.doi.org/10.1126/science.1090782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14684826				2022-12-24	WOS:000188111800042
J	Hanley, JA; Turner, E; Bellera, C; Teltsch, D				Hanley, JA; Turner, E; Bellera, C; Teltsch, D			How long did their hearts go on? A Titanic study	BRITISH MEDICAL JOURNAL			English	Article							JAZZ MUSICIANS		McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; McGill Univ, Dept Math & Stat, Montreal, PQ H3A 1A2, Canada	McGill University; McGill University	Hanley, JA (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave W, Montreal, PQ H3A 1A2, Canada.			Bellera, Carine/0000-0001-7926-4671				[Anonymous], ENCY TITANICA; *NAT CTR HLTH STAT, 2002, NAT VITAL STAT REPOR, V51, P26; ROTHMAN KJ, 1992, AM J PUBLIC HEALTH, V82, P761, DOI 10.2105/AJPH.82.5.761; SPENCER FJ, 1991, AM J PUBLIC HEALTH, V81, P804, DOI 10.2105/AJPH.81.6.804-a; *U CA BERK M PLANC, HUM MORT DAT LIF TAB	5	0	0	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1457	1458		10.1136/bmj.327.7429.1457	http://dx.doi.org/10.1136/bmj.327.7429.1457			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	757LA	14684648	Green Published, Green Accepted			2022-12-24	WOS:000187562700019
J	Whitelaw, CA; Barbazuk, WB; Pertea, G; Chan, AP; Cheung, F; Lee, Y; Zheng, L; van Heeringen, S; Karamycheva, S; Bennetzen, JL; SanMiguel, P; Lakey, N; Bedell, J; Yuan, Y; Budiman, MA; Resnick, A; Van Aken, S; Utterback, T; Riedmuller, S; Williams, M; Feldblyum, T; Schubert, K; Beachy, R; Fraser, CM; Quackenbush, J				Whitelaw, CA; Barbazuk, WB; Pertea, G; Chan, AP; Cheung, F; Lee, Y; Zheng, L; van Heeringen, S; Karamycheva, S; Bennetzen, JL; SanMiguel, P; Lakey, N; Bedell, J; Yuan, Y; Budiman, MA; Resnick, A; Van Aken, S; Utterback, T; Riedmuller, S; Williams, M; Feldblyum, T; Schubert, K; Beachy, R; Fraser, CM; Quackenbush, J			Enrichment of gene-coding sequences in maize by genome filtration	SCIENCE			English	Article							DNA; ORGANIZATION; ELEMENTS	Approximately 80% of the maize genome comprises highly repetitive sequences interspersed with single-copy, gene-rich sequences, and standard genome sequencing strategies are not readily adaptable to this type of genome. Methodologies that enrich for genic sequences might more rapidly generate useful results from complex genomes. Equivalent numbers of clones from maize selected by techniques called methylation filtering and High C(0)t selection were sequenced to generate similar to 200,000 reads ( approximately 132 megabases), which were assembled into contigs. Combination of the two techniques resulted in a sixfold reduction in the effective genome size and a fourfold increase in the gene identification rate in comparison to a nonenriched library.	Inst Genom Res TIGR, Rockville, MD 20850 USA; Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; Univ Georgia, Dept Genet, Athens, GA 30602 USA; Purdue Univ, Purdue Genom Core Facil, W Lafayette, IN 47907 USA; Orion Genom, St Louis, MO 63108 USA; J Craig Venter Sci fdn Joint Technol Ctr, Rockville, MD 20850 USA	J. Craig Venter Institute; Donald Danforth Plant Science Center; University System of Georgia; University of Georgia; Purdue University System; Purdue University; Purdue University West Lafayette Campus; J. Craig Venter Institute	Barbazuk, WB (corresponding author), Inst Genom Res TIGR, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	BBarbazuk@danforthcenter.org; Johnq@tigr.org	Jones, Cathy/A-7135-2011; SanMiguel, Phillip J/I-2196-2015; van Heeringen, Simon/H-4937-2012; van Heeringen, Simon/Q-8530-2017; Whitelaw, Catherine Ann/AAD-3716-2021	Jones, Cathy/0000-0003-2844-2161; SanMiguel, Phillip J/0000-0002-3742-9527; van Heeringen, Simon/0000-0002-0411-3219; Chan, Agnes/0000-0003-2373-9580; Barbazuk, William/0000-0002-0909-4563; Quackenbush, John/0000-0002-2702-5879; Fraser, Claire/0000-0003-1462-2428				Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Bennetzen JL, 2002, GENETICA, V115, P29, DOI 10.1023/A:1016015913350; BENNETZEN JL, 1994, GENOME, V37, P565, DOI 10.1139/g94-081; BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529; BRITTEN RJ, 1976, P NATL ACAD SCI USA, V73, P415, DOI 10.1073/pnas.73.2.415; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; FREELING M, 1984, ANNU REV PLANT PHYS, V35, P277; GISH WR, 2003, WU BLAST 2 0; HAKE S, 1980, CHROMOSOMA, V79, P251, DOI 10.1007/BF00327318; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202. Article published online before March 2002, 10.1101/gr.229202]; LANDER E S, 1988, Genomics, V2, P231; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Rabinowicz PD, 1999, NAT GENET, V23, P305, DOI 10.1038/15479; SPRINGER PS, 1994, P NATL ACAD SCI USA, V91, P863, DOI 10.1073/pnas.91.3.863; YUAN Y, 2003, PLANT J, V33, P1	18	166	195	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2118	2120		10.1126/science.1090047	http://dx.doi.org/10.1126/science.1090047			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684821				2022-12-24	WOS:000187385200043
J	Head, JW; Mustard, JF; Kreslavsky, MA; Milliken, RE; Marchant, DR				Head, JW; Mustard, JF; Kreslavsky, MA; Milliken, RE; Marchant, DR			Recent ice ages on Mars	NATURE			English	Article							MIOCENE GLACIER ICE; SURFACE GROUND ICE; CHAOTIC OBLIQUITY; NEAR-SURFACE; CLIMATE; ANTARCTICA; DEPOSITS; WATER; HYDROGEN; ODYSSEY	A key pacemaker of ice ages on the Earth is climatic forcing due to variations in planetary orbital parameters. Recent Mars exploration has revealed dusty, water-ice-rich mantling deposits that are layered, metres thick and latitude dependent, occurring in both hemispheres from mid-latitudes to the poles. Here we show evidence that these deposits formed during a geologically recent ice age that occurred from about 2.1 to 0.4 Myr ago. The deposits were emplaced symmetrically down to latitudes of similar to30degrees equivalent to Saudi Arabia and the southern United States on the Earth - in response to the changing stability of water ice and dust during variations in obliquity ( the angle between Mars' pole of rotation and the ecliptic plane) reaching 30 - 35degrees. Mars is at present in an 'interglacial' period, and the ice-rich deposits are undergoing reworking, degradation and retreat in response to the current instability of near-surface ice. Unlike the Earth, martian ice ages are characterized by warmer polar climates and enhanced equatorward transport of atmospheric water and dust to produce widespread smooth deposits down to mid-latitudes.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Kharkov Natl Univ, Astron Inst, UA-61077 Kharkov, Ukraine; Boston Univ, Dept Earth Sci, Boston, MA 02215 USA	Brown University; Ministry of Education & Science of Ukraine; VN Karazin Kharkiv National University; Boston University	Head, JW (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.		Kreslavsky, Mikhail/J-3425-2013	Kreslavsky, Mikhail/0000-0002-1900-826X				Bockheim JG, 2002, S AFR J SCI, V98, P82; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; CABROL NA, 2002, LUNAR PLANET SCI, V33; Carr MH, 2001, J GEOPHYS RES-PLANET, V106, P23571, DOI 10.1029/2000JE001316; Christensen PR, 2003, NATURE, V422, P45, DOI 10.1038/nature01436; CHRISTIEBLICK N, 1982, ICARUS, V50, P408; Costard F, 2002, SCIENCE, V295, P110, DOI 10.1126/science.1064419; DIXON JC, 1992, BINGHAMPTON S GEOMOR, V22; Fanale F.P., 1992, MARS, P1135; FANALE FP, 1994, ICARUS, V111, P305, DOI 10.1006/icar.1994.1147; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; FELDMAN WC, 2003, 6 INT MARS C; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; Hecht MH, 2002, ICARUS, V156, P373, DOI 10.1006/icar.2001.6794; IMBRIE J, 1982, ICARUS, V50, P408, DOI 10.1016/0019-1035(82)90132-4; Imbrie J., 1986, ICE AGES SOLVING MYS; JAKOSKY BM, 1995, J GEOPHYS RES-PLANET, V100, P1579, DOI 10.1029/94JE02801; JAKOSKY BM, 1985, NATURE, V315, P559, DOI 10.1038/315559a0; Johnson JB, 2000, GEOPHYS RES LETT, V27, P2769, DOI 10.1029/1999GL011077; Kieffer H. H., 1992, MARS, P1180; Kolb EJ, 2001, ICARUS, V154, P22, DOI 10.1006/icar.2001.6676; KOSTAMA VP, 2003, LUNAR PLANET SCI, V34; Kreslavsky MA, 2000, J GEOPHYS RES-PLANET, V105, P26695, DOI 10.1029/2000JE001259; KRESLAVSKY MA, 2002, GEOPHYS RES LETT, V29; KRESLAVSKY MA, 2003, LUNAR PLANET SCI, V34; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; Laskar J, 2002, NATURE, V419, P375, DOI 10.1038/nature01066; Leovy C, 2001, NATURE, V412, P245, DOI 10.1038/35084192; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; MANGOLD M, 2002, LUNAR PLANET SCI, V33; Marchant DR, 2002, GEOL SOC AM BULL, V114, P718, DOI 10.1130/0016-7606(2002)114<0718:FOPGAS>2.0.CO;2; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; MELLON MT, 2003, LUNAR PLANET SCI, V34; MILLIKEN RE, 2003, J GEOPHYS RES, V108; MISCHNA MA, 2003, J GEOPHYS RES, V108; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; Mustard JF, 2001, NATURE, V412, P411, DOI 10.1038/35086515; RICHARDSON MI, 2003, LUNAR PLANET SCI, V34; RICHARDSON MI, 2002, J GEOPHYS RES, V107; Seibert NM, 2001, GEOPHYS RES LETT, V28, P899, DOI 10.1029/2000GL012093; Squyres S. W., 1992, MARS, P523; SUGDEN DE, 1995, NATURE, V376, P412, DOI 10.1038/376412a0; TANAKA KL, 1987, MISC INVEST SER US G; Thomas P., 1992, MARS, P767; TOKAR RL, 2002, GEOPHYS RES LETT, V29; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; Ward W. R., 1992, MARS, P298; Williams P, 1989, FROZEN EARTH; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	50	555	561	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					797	802		10.1038/nature02114	http://dx.doi.org/10.1038/nature02114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685228				2022-12-24	WOS:000187342000047
J	Goldman, AP; Cassidy, J; de Leval, M; Haynes, S; Brown, K; Whitmore, P; Cohen, G; Tsang, V; Elliott, M; Davison, A; Hamilton, L; Bolton, D; Wray, J; Hasan, A; Radley-Smith, R; Macrae, D; Smith, J				Goldman, AP; Cassidy, J; de Leval, M; Haynes, S; Brown, K; Whitmore, P; Cohen, G; Tsang, V; Elliott, M; Davison, A; Hamilton, L; Bolton, D; Wray, J; Hasan, A; Radley-Smith, R; Macrae, D; Smith, J			The waiting game: bridging to paediatric heart transplantation	LANCET			English	Article							MECHANICAL CIRCULATORY SUPPORT; VENTRICULAR ASSIST DEVICE; CLINICAL-EXPERIENCE; CHILDREN; CARDIOMYOPATHY; INFANTS; SYSTEM; VAD	Background Although mechanical circulatory support might not increase the number of adults surviving to transplantation, because of the shortage of donor organs, the situation might be different for children. Our aim was to assess the effect of mechanical assist devices to bridge children with end-stage cardiomyopathy to heart transplantation. Methods A 5-year retrospective review was undertaken with data from the UK paediatric transplant programme and from bridging to transplant done at two paediatric transplant centres in the UK. Findings Between Jan 1, 1998 and Dec 31, 2002, 22 children with end-stage cardiomyopathy, median age 5.7 years (range 1.2-17), were supported by a mechanical assist device as a bridge to first heart transplantation, with a 77% survival rate to hospital discharge. Nine were supported by a paracorporeal ventricular assist device, six received transplantation, five survived to discharge (55%), with one late death. 13 were supported by extra-corporeal membrane oxygenation, and 12 were transplanted and survived to discharge (92%) with one late death. With urgent listing, the median waiting time for a heart was 7.5 days (range 1.5-22 days). The correlation between the proportion of patients bridged to transplantation and the proportion of patients dying while on the transplant waiting list was r=-0.93, p=0.02. Interpretation Our findings lend support to the hypothesis that a national mechanical assist programme to bridge children to transplantation can minimise the number dying while on the heart transplant waiting list. In the context of urgent listing and a short waiting time, extra-corporeal membrane oxygenation seems to provide the safest form of support.	Great Ormond St Hosp Children, London WC1N 3JY, England; Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; Royal Brompton & Harefield NHS Trust, London SW3 6NP, England; Childrens Hosp & Reg Med Ctr, Ctr Heart, Seattle, WA 98115 USA	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Newcastle Freeman Hospital; Newcastle University - UK; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Seattle Children's Hospital	Goldman, AP (corresponding author), Great Ormond St Hosp Children, Great Ormond St, London WC1N 3JY, England.		Macrae, Duncan/AAC-9564-2020	Brown, Katherine/0000-0002-0729-4959; SixNajn, Takashi/0000-0001-7521-1126; Macrae, Duncan/0000-0002-7158-6585; Wray, Jo/0000-0002-4769-1211				Daily BB, 1996, ANN THORAC SURG, V61, P437, DOI 10.1016/0003-4975(95)00991-4; Deng MC, 2000, BRIT MED J, V321, P540, DOI 10.1136/bmj.321.7260.540; DUNCAN B, 2002, J THORAC CARDIOV SUR, V117, P529; Duncan BW, 2001, J THORAC CARDIOV SUR, V122, P440, DOI 10.1067/mtc.2001.115243; Frazier OH, 2002, CIRCULATION, V105, P2855, DOI 10.1161/01.CIR.0000018167.47314.AF; Hetzer R, 1998, ANN THORAC SURG, V66, P1498, DOI 10.1016/S0003-4975(98)00914-X; Holman WL, 2002, ANN THORAC SURG, V73, P1489, DOI 10.1016/S0003-4975(02)03502-6; Hosenpud JD, 2000, J HEART LUNG TRANSPL, V19, P909, DOI 10.1016/S1053-2498(00)00138-8; Ibrahim AE, 2000, ANN THORAC SURG, V69, P186, DOI 10.1016/S0003-4975(99)01194-7; Kirshbom PM, 2002, J THORAC CARDIOV SUR, V123, P130, DOI 10.1067/mtc.2002.118504; Konertz W, 1997, ANN THORAC SURG, V63, P1138, DOI 10.1016/S0003-4975(97)00063-5; Levi D, 2002, J HEART LUNG TRANSPL, V21, P760, DOI 10.1016/S1053-2498(02)00386-8; Nield LE, 2000, CARDIOL YOUNG, V10, P358; Reinhartz O, 2001, J HEART LUNG TRANSPL, V20, P439, DOI 10.1016/S1053-2498(00)00236-9; Reinhartz O, 2002, ASAIO J, V48, P455, DOI 10.1097/00002480-200209000-00002	15	72	75	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 13	2003	362	9400					1967	1970		10.1016/S0140-6736(03)15015-5	http://dx.doi.org/10.1016/S0140-6736(03)15015-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683656				2022-12-24	WOS:000187210700009
J	Ben-Shem, A; Frolow, F; Nelson, N				Ben-Shem, A; Frolow, F; Nelson, N			Crystal structure of plant photosystem I	NATURE			English	Article							LIGHT-HARVESTING COMPLEX; FAST-ELECTRON TRANSFER; CHLAMYDOMONAS-REINHARDTII; ARABIDOPSIS-THALIANA; ANGSTROM RESOLUTION; THYLAKOID MEMBRANES; CYTOCHROME C(6); IRON-DEFICIENCY; ENERGY-TRANSFER; ANTENNA RING	Oxygenic photosynthesis is the principal producer of both oxygen and organic matter on Earth. The conversion of sunlight into chemical energy is driven by two multisubunit membrane protein complexes named photosystem I and II. We determined the crystal structure of the complete photosystem I ( PSI) from a higher plant ( Pisum sativum var. alaska) to 4.4 Angstrom resolution. Its intricate structure shows 12 core subunits, 4 different light- harvesting membrane proteins ( LHCI) assembled in a half- moon shape on one side of the core, 45 transmembrane helices, 167 chlorophylls, 3 Fe - S clusters and 2 phylloquinones. About 20 chlorophylls are positioned in strategic locations in the cleft between LHCI and the core. This structure provides a framework for exploration not only of energy and electron transfer but also of the evolutionary forces that shaped the photosynthetic apparatus of terrestrial plants after the divergence of chloroplasts from marine cyanobacteria one billion years ago.	Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Nelson, N (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel.	nelson@post.tau.ac.il	Frolow, Felix/A-1760-2013	Nelson, Nathan/0000-0003-3588-7265; Ben-Shem, Adam/0000-0003-0297-8662				Bailey S, 2001, PLANTA, V213, P794, DOI 10.1007/s004250100556; Barber J, 2002, CURR OPIN STRUC BIOL, V12, P523, DOI 10.1016/S0959-440X(02)00357-3; Ben-Shem A, 2003, ACTA CRYSTALLOGR D, V59, P1824, DOI 10.1107/S0907444903016056; BENGIS C, 1977, J BIOL CHEM, V252, P4564; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; CHITNIS PR, 1991, J BIOL CHEM, V266, P20146; Chitnis PR, 2001, ANNU REV PLANT PHYS, V52, P593, DOI 10.1146/annurev.arplant.52.1.593; Cramer WA, 1996, ANNU REV PLANT PHYS, V47, P477, DOI 10.1146/annurev.arplant.47.1.477; Croce R, 1998, BIOCHEMISTRY-US, V37, P17355, DOI 10.1021/bi9813227; Croce R, 2002, BBA-BIOENERGETICS, V1556, P29, DOI 10.1016/S0005-2728(02)00304-3; Durnford DG, 1999, J MOL EVOL, V48, P59, DOI 10.1007/PL00006445; Ganeteg U, 2001, PLANT PHYSIOL, V127, P150, DOI 10.1104/pp.127.1.150; Herrmann RG, 1999, BIOSCIENCE REP, V19, P355, DOI 10.1023/A:1020251903707; Hippler M, 1998, P NATL ACAD SCI USA, V95, P7339, DOI 10.1073/pnas.95.13.7339; Hippler M, 1996, EMBO J, V15, P6374, DOI 10.1002/j.1460-2075.1996.tb01028.x; Ihalainen JA, 2002, BIOPHYS J, V83, P2190, DOI 10.1016/S0006-3495(02)73979-9; Jansson S, 1996, PLANT PHYSIOL, V112, P409, DOI 10.1104/pp.112.1.409; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jennings RC, 2003, BBA-BIOENERGETICS, V1557, P91, DOI 10.1016/S0005-2728(02)00399-7; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Junge W, 1999, P NATL ACAD SCI USA, V96, P4735, DOI 10.1073/pnas.96.9.4735; Kargul J, 2003, J BIOL CHEM, V278, P16135, DOI 10.1074/jbc.M300262200; Knoetzel H, 2002, FEBS LETT, V510, P145, DOI 10.1016/S0014-5793(01)03253-7; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; Melkozernov AN, 2003, BIOCHEMISTRY-US, V42, P3893, DOI 10.1021/bi026987u; Morosinotto T, 2002, J BIOL CHEM, V277, P36253, DOI 10.1074/jbc.M205062200; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Nelson N, 2002, PHOTOSYNTH RES, V73, P193, DOI 10.1023/A:1020403231100; Nield J, 2003, BIOCHEMISTRY-US, V42, P3180, DOI 10.1021/bi026933k; Raymond J, 2002, SCIENCE, V298, P1616, DOI 10.1126/science.1075558; Rivadossi A, 1999, PHOTOSYNTH RES, V60, P209, DOI 10.1023/A:1006236829711; Scheller HV, 2001, BBA-BIOENERGETICS, V1507, P41, DOI 10.1016/S0005-2728(01)00196-7; Schmid VHR, 2002, BIOCHEMISTRY-US, V41, P9126, DOI 10.1021/bi016042x; Schmid VHR, 2002, J BIOL CHEM, V277, P37307, DOI 10.1074/jbc.M205889200; Sommer F, 2002, J BIOL CHEM, V277, P6573, DOI 10.1074/jbc.M110633200; TRISSL HW, 1993, TRENDS BIOCHEM SCI, V18, P415, DOI 10.1016/0968-0004(93)90136-B; Xiong J, 2002, ANNU REV PLANT BIOL, V53, P503, DOI 10.1146/annurev.arplant.53.100301.135212; Xue YF, 1998, PROTEIN SCI, V7, P2099, DOI 10.1002/pro.5560071006	40	628	682	6	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					630	635		10.1038/nature02200	http://dx.doi.org/10.1038/nature02200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668855				2022-12-24	WOS:000187132800032
J	Moore, P; Clayton, J				Moore, P; Clayton, J			To affinity and beyond	NATURE			English	Article																			0	6	13	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					725	+		10.1038/426725a	http://dx.doi.org/10.1038/426725a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668881	Bronze			2022-12-24	WOS:000187132800058
J	Renault, L; Guibert, B; Cherfils, J				Renault, L; Guibert, B; Cherfils, J			Structural snapshots of the mechanism and inhibition of a guanine nucleotide exchange factor	NATURE			English	Article							ADP-RIBOSYLATION FACTOR-1; BREFELDIN-A; SEC7 DOMAIN; ARF; PROTEIN; BINDING; RAS; FAMILY; GDP; ACTIVATION	Small GTP-binding (G) proteins are activated by GDP/GTP nucleotide exchange stimulated by guanine nucleotide exchange factors ( GEFs). Nucleotide dissociation from small G protein - GEF complexes involves transient GDP-bound intermediates whose structures have never been described. In the case of Arf proteins, small G proteins that regulate membrane traffic in eukaryotic cells, such intermediates can be trapped either by the natural inhibitor brefeldin A or by charge reversal at the catalytic glutamate of the Sec7 domain of their GEFs. Here we report the crystal structures of these intermediates that show that membrane recruitment of Arf and nucleotide dissociation are separate reactions stimulated by Sec7. The reactions proceed through sequential rotations of the Arf.GDP core towards the Sec7 catalytic site, and are blocked by interfacial binding of brefeldin A and unproductive stabilization of GDP by charge reversal. The structural characteristics of the reaction and its modes of inhibition reveal unexplored ways in which to inhibit the activation of small G proteins.	CNRS, UPR 9063, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Cherfils, J (corresponding author), CNRS, UPR 9063, Lab Enzymol & Biochim Struct, Ave Terrasse, F-91198 Gif Sur Yvette, France.	cherfils@lebs.cnrs-gif.fr		RENAULT, Louis/0000-0003-1722-074X				AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Baumgartner F, 2001, MOL MICROBIOL, V41, P1151, DOI 10.1046/j.1365-2958.2001.02572.x; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Beraud-Dufour S, 1999, J BIOL CHEM, V274, P37629, DOI 10.1074/jbc.274.53.37629; Boettner B, 2002, GENE, V286, P155, DOI 10.1016/S0378-1119(02)00426-2; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; Cherfils J, 2001, FEBS LETT, V507, P280, DOI 10.1016/S0014-5793(01)02970-2; Choi Jai-Pil, 1996, EUROPEAN J POLITICAL, V12, P273, DOI DOI 10.1016/0176-2680(95)00017-8; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; Cox AD, 2002, CANCER BIOL THER, V1, P599, DOI 10.4161/cbt.306; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Goody RS, 2002, EUR BIOPHYS J BIOPHY, V31, P268, DOI 10.1007/s00249-002-0225-3; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Jackson C L, 2000, Subcell Biochem, V34, P233; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Mansour SJ, 1999, P NATL ACAD SCI USA, V96, P7968, DOI 10.1073/pnas.96.14.7968; Mayer G, 2001, P NATL ACAD SCI USA, V98, P4961, DOI 10.1073/pnas.091100698; McCormick F, 2000, CURR OPIN BIOTECH, V11, P593, DOI 10.1016/S0958-1669(00)00149-X; Menetrey J, 2000, NAT STRUCT BIOL, V7, P466; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; PASQUALATO S, IN PRESS ARF BOOK, pCH3; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Renault L, 2002, BIOCHEMISTRY-US, V41, P3605, DOI 10.1021/bi012123h; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Robineau S, 2000, P NATL ACAD SCI USA, V97, P9913, DOI 10.1073/pnas.170290597; Sata M, 1999, P NATL ACAD SCI USA, V96, P2752, DOI 10.1073/pnas.96.6.2752; Schmidt S, 2002, FEBS LETT, V523, P35, DOI 10.1016/S0014-5793(02)02928-9; TORII S, 1995, J BIOL CHEM, V270, P11574, DOI 10.1074/jbc.270.19.11574; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WEBER HP, 1971, HELV CHIM ACTA, V54, P2763, DOI 10.1002/hlca.19710540839; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Zhu JW, 2000, BIOORGAN MED CHEM, V8, P455, DOI 10.1016/S0968-0896(99)00297-7	45	245	252	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					525	530		10.1038/nature02197	http://dx.doi.org/10.1038/nature02197			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654833				2022-12-24	WOS:000186944300030
J	Beall, CM				Beall, CM			High-altitude adaptations	LANCET			English	Article									Case Western Reserve Univ, Dept Anthropol, Cleveland, OH 44106 USA	Case Western Reserve University	Beall, CM (corresponding author), Case Western Reserve Univ, Dept Anthropol, 238 Mather Mem Bldg,11220 Bellflower Rd, Cleveland, OH 44106 USA.			Beall, Cynthia/0000-0003-1462-8299				SEVERINGHAUS J, HIGH ALTITUDE MED BI	1	47	50	1	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S14	S15		10.1016/S0140-6736(03)15058-1	http://dx.doi.org/10.1016/S0140-6736(03)15058-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698112				2022-12-24	WOS:000187790200008
J	Thor, J				Thor, J			Realities of rodeo	LANCET			English	Article											Thor, J (corresponding author), 1200 N 36 St, Norfolk, NE 68701 USA.								0	4	4	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S52	S53		10.1016/S0140-6736(03)15077-5	http://dx.doi.org/10.1016/S0140-6736(03)15077-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698131				2022-12-24	WOS:000187790200027
J	Mills, EM; Banks, ML; Sprague, JE; Finkel, T				Mills, EM; Banks, ML; Sprague, JE; Finkel, T			Pharmacology: Uncoupling the agony from ecstasy - A mitochondrial protein may mediate a dangerous side-effect of some recreational drugs	NATURE			English	Editorial Material							MDMA		NHLBI, Cardiovasc Branch, NIH, Bethesda, MD 20892 USA; Ohio No Univ, Dept Pharmaceut & Biomed Sci, Ada, OH 45810 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Ohio Northern University	Mills, EM (corresponding author), NHLBI, Cardiovasc Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	j-sprague@onu.edu	Sprague, Jon/AAE-6346-2021; Banks, Matthew L/CAF-1091-2022; Banks, Matthew L/K-4429-2014	Banks, Matthew L/0000-0003-4949-5246; Banks, Matthew L/0000-0003-4949-5246	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005012, ZIAHL005012] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Dar KJ, 1996, INTENS CARE MED, V22, P995; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; GONG DW, 1997, J BIOL CHEM, V272; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; Landry MJ, 2002, J PSYCHOACTIVE DRUGS, V34, P163, DOI 10.1080/02791072.2002.10399950; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Sprague JE, 2003, J PHARMACOL EXP THER, V305, P159, DOI 10.1124/jpet.102.044982; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; 1964, NATURE, V204, P387; 2003, PSYCHOPHARMACOLOGY, V166, P202	11	117	118	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2003	426	6965					403	404		10.1038/426403a	http://dx.doi.org/10.1038/426403a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647371				2022-12-24	WOS:000186800800027
J	Salonen, JT				Salonen, JT			Liver damage and protective effect of high density lipoprotein cholesterol	BRITISH MEDICAL JOURNAL			English	Article									Univ Kuopio, Publ Hlth Res Inst, Dept Publ Hlth & Gen Practice, FIN-70211 Kuopio, Finland	University of Eastern Finland	Salonen, JT (corresponding author), Univ Kuopio, Publ Hlth Res Inst, Dept Publ Hlth & Gen Practice, Box 1627, FIN-70211 Kuopio, Finland.				NHLBI NIH HHS [HL 44199] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044199] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Liinamaa MJ, 1997, ARTERIOSCL THROM VAS, V17, P2940, DOI 10.1161/01.ATV.17.11.2940; Perova Natalia V., 1995, Annals of Epidemiology, V5, P179, DOI 10.1016/1047-2797(94)00104-2; SALONEN JT, 1991, CIRCULATION, V84, P129, DOI 10.1161/01.CIR.84.1.129; SALONEN JT, 1992, LANCET, V339, P883, DOI 10.1016/0140-6736(92)90926-T; *SOC CLIN CHEM CLI, 1976, SCAND J CLIN LAB INV, V36, P119	5	7	7	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 8	2003	327	7423					1082	1083		10.1136/bmj.327.7423.1082	http://dx.doi.org/10.1136/bmj.327.7423.1082			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742QW	14604929	Green Published, Bronze			2022-12-24	WOS:000186530400018
J	Inatani, M; Irie, F; Plump, AS; Tessier-Lavigne, M; Yamaguchi, Y				Inatani, M; Irie, F; Plump, AS; Tessier-Lavigne, M; Yamaguchi, Y			Mammalian brain morphogenesis and midline axon guidance require heparan sulfate	SCIENCE			English	Article							NERVOUS-SYSTEM; PROTEOGLYCANS; GENE; NEUROGENESIS; DISRUPTION; EXPRESSION; RECEPTOR; EXT1; MICE	Heparan sulfate (HS) is required for morphogen signaling during Drosophila pattern formation, but little is known about its physiological importance in mammalian development. To de. ne the developmental role of HS in mammalian species, we conditionally disrupted the HS-polymerizing enzyme EXT1 in the embryonic mouse brain. The EXT1-null brain exhibited patterning defects that are composites of those caused by mutations of multiple HS-binding morphogens. Furthermore, the EXT1-null brain displayed severe guidance errors in major commissural tracts, revealing a pivotal role of HS in midline axon guidance. These findings demonstrate that HS is essential for mammalian brain development.	Burnham Inst, La Jolla, CA 92037 USA; Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94035 USA	Sanford Burnham Prebys Medical Discovery Institute; Howard Hughes Medical Institute; Stanford University	Yamaguchi, Y (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033117] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD25938] Funding Source: Medline; NINDS NIH HHS [R01 NS33117] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baeg GH, 2000, CURR OPIN CELL BIOL, V12, P575, DOI 10.1016/S0955-0674(00)00134-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI13530; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; IRIE F, UNPUB; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lin X, 1998, BIOCHEM BIOPH RES CO, V248, P738, DOI 10.1006/bbrc.1998.9050; Liu AM, 2001, ANNU REV NEUROSCI, V24, P869, DOI 10.1146/annurev.neuro.24.1.869; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Yamaguchi Y, 2001, SEMIN CELL DEV BIOL, V12, P99, DOI 10.1006/scdb.2000.0238	19	332	340	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2003	302	5647					1044	1046		10.1126/science.1090497	http://dx.doi.org/10.1126/science.1090497			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605369				2022-12-24	WOS:000186396300048
J	Biteau, B; Labarre, J; Toledano, MB				Biteau, B; Labarre, J; Toledano, MB			ATP-dependent reduction of cysteine-sulphinic acid by S-cerevisiae sulphiredoxin	NATURE			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; OXIDATIVE STRESS; THIOREDOXIN PEROXIDASE; 2-CYS PEROXIREDOXIN; CRYSTAL-STRUCTURE; SULFENIC ACID; YEAST; IDENTIFICATION; CATALYSIS; SITE	Proteins contain thiol-bearing cysteine residues that are sensitive to oxidation, and this may interfere with biological function either as 'damage' or in the context of oxidant-dependent signal transduction. Cysteine thiols oxidized to sulphenic acid are generally unstable, either forming a disulphide with a nearby thiol or being further oxidized to a stable sulphinic acid(1,2). Cysteine - sulphenic acids and disulphides are known to be reduced by glutathione or thioredoxin in biological systems, but cysteine - sulphinic acid derivatives have been viewed as irreversible protein modifications. Here we identify a yeast protein of relative molecular mass M-r = 13,000, which we have named sulphiredoxin ( identified by the US spelling 'sulfiredoxin', in the Saccharomyces Genome Database), that is conserved in higher eukaryotes and reduces cysteine - sulphinic acid in the yeast peroxiredoxin Tsa1. Peroxiredoxins are ubiquitous thiol-containing antioxidants that reduce hydroperoxides(3-5) and control hydroperoxide-mediated signalling in mammals(6-8). The reduction reaction catalysed by sulphiredoxin requires ATP hydrolysis and magnesium, involving a conserved active-site cysteine residue which forms a transient disulphide linkage with Tsa1. We propose that reduction of cysteine - sulphinic acids by sulphiredoxin involves activation by phosphorylation followed by a thiol-mediated reduction step. Sulphiredoxin is important for the antioxidant function of peroxiredoxins, and is likely to be involved in the repair of proteins containing cysteine sulphinic acid modifications, and in signalling pathways involving protein oxidation.	CEA Saclay, DBJC, SBGM, Lab Stress Oxydants & Canc, F-91191 Gif Sur Yvette, France; CEA Saclay, DBJC, SBGM, Lab Physiogenom, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Toledano, MB (corresponding author), CEA Saclay, DBJC, SBGM, Lab Stress Oxydants & Canc, F-91191 Gif Sur Yvette, France.							CHAE HZ, 1994, J BIOL CHEM, V269, P27670; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; Claiborne A, 2001, ADV PROTEIN CHEM, V58, P215; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P13349, DOI 10.1021/bi9713658; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; FURUKAWA M, 1980, SYNTHESIS-STUTTGART, P937; Giles GI, 2002, BIOL CHEM, V383, P375, DOI 10.1515/BC.2002.042; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Jeong JS, 1999, BIOCHEMISTRY-US, V38, P776, DOI 10.1021/bi9817818; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; KICE JL, 1979, J ORG CHEM, V44, P1918, DOI 10.1021/jo01326a005; KICE JL, 1980, ADV PHYS ORG CHEM, V17, P65; Lee J, 1999, J BIOL CHEM, V274, P4537, DOI 10.1074/jbc.274.8.4537; Maillet I, 1996, J BIOL CHEM, V271, P10263, DOI 10.1074/jbc.271.17.10263; NOGUCHI Y, 1983, B CHEM SOC JPN, V56, P349, DOI 10.1246/bcsj.56.349; Park SG, 2000, J BIOL CHEM, V275, P5723, DOI 10.1074/jbc.275.8.5723; Poole LB, 2002, METHOD ENZYMOL, V348, P122, DOI 10.1016/S0076-6879(02)48632-6; Prouzet-Mauleon V, 2002, J BIOL CHEM, V277, P4823, DOI 10.1074/jbc.M109614200; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; SIKORSKI RS, 1989, GENETICS, V122, P19; Wong CM, 2002, J BIOL CHEM, V277, P5385, DOI 10.1074/jbc.M106846200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	30	745	781	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2003	425	6961					980	984		10.1038/nature02075	http://dx.doi.org/10.1038/nature02075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14586471				2022-12-24	WOS:000186230600046
J	Grakoui, A; Shoukry, NH; Woollard, DJ; Han, JH; Hanson, HL; Ghrayeb, J; Murthy, KK; Rice, CM; Walker, CM				Grakoui, A; Shoukry, NH; Woollard, DJ; Han, JH; Hanson, HL; Ghrayeb, J; Murthy, KK; Rice, CM; Walker, CM			HCV persistence and immune evasion in the absence of memory T cell help	SCIENCE			English	Article							HEPATITIS-C VIRUS; PROTECTIVE IMMUNITY; CD8-T-CELL MEMORY; VIRAL CLEARANCE; CD4-T-CELL HELP; INFECTION; RESPONSES; CHIMPANZEES; CD8(+); DETERMINANTS	Spontaneous resolution of hepatitis C virus (HCV) infection in humans usually affords long-term immunity to persistent viremia and associated liver diseases. Here, we report that memory CD4+ T cells are essential for this protection. Antibody-mediated depletion of CD4+ T cells before reinfection of two immune chimpanzees resulted in persistent, low-level viremia despite functional intrahepatic memory CD8+ T cell responses. Incomplete control of HCV replication by memory CD8+ T cells in the absence of adequate CD4+ T cell help was associated with emergence of viral escape mutations in class I major histocompatibility complex-restricted epitopes and failure to resolve HCV infection.	Cilumbus Childrens Res Inst, Ctr Vaccines & Immun, Columbus, OH 43205 USA; Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10021 USA; Centocor Inc, Malvern, PA 19355 USA; SW Fdn Biomed Res, Dept Virol & Immunol, San Antonio, TX 78227 USA; Ohio State Univ, Coll Med & Publ Hlth, Dept Pediat, Columbus, OH 43205 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Rockefeller University; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Texas Biomedical Research Institute; University System of Ohio; Ohio State University	Walker, CM (corresponding author), Cilumbus Childrens Res Inst, Ctr Vaccines & Immun, 700 Childrens Dr,W503, Columbus, OH 43205 USA.		Yang, Chen/G-1379-2010		NCI NIH HHS [CA57973, CA85883] Funding Source: Medline; NHLBI NIH HHS [N01 HB27091] Funding Source: Medline; NIAID NIH HHS [AI40034, AI48231] Funding Source: Medline; PHS HHS [A14736] Funding Source: Medline; DIVISION OF BLOOD DISEASES AND RESOURCES [N01HB027091] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA085883, R01CA057973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI048231] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); DIVISION OF BLOOD DISEASES AND RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Bassett SE, 2001, HEPATOLOGY, V33, P1479, DOI 10.1053/jhep.2001.24371; Chang KM, 1997, J CLIN INVEST, V100, P2376, DOI 10.1172/JCI119778; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Erickson AL, 2001, IMMUNITY, V15, P883, DOI 10.1016/S1074-7613(01)00245-X; FARCI P, 1992, SCIENCE, V258, P135, DOI 10.1126/science.1279801; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; JONKER M, 1993, CLIN EXP IMMUNOL, V93, P301, DOI 10.1111/j.1365-2249.1993.tb08176.x; Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Looney James E., 1992, Human Antibodies and Hybridomas, V3, P191; Major ME, 2002, J VIROL, V76, P6586, DOI 10.1128/JVI.76.13.6586-6595.2002; Mehta SH, 2002, LANCET, V359, P1478, DOI 10.1016/S0140-6736(02)08435-0; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; NOWAK MA, 1995, NATURE, V375, P606, DOI 10.1038/375606a0; PRINCE AM, 1992, J INFECT DIS, V165, P438, DOI 10.1093/infdis/165.3.438; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Thimme R, 2002, P NATL ACAD SCI USA, V99, P15661, DOI 10.1073/pnas.202608299; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; WALKER CM, UNPUB; Weiner AJ, 2001, J VIROL, V75, P7142, DOI 10.1128/JVI.75.15.7142-7148.2001	28	651	679	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					659	662		10.1126/science.1088774	http://dx.doi.org/10.1126/science.1088774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576438				2022-12-24	WOS:000186119900063
J	Kinoshita, T; Miura, A; Choi, YH; Kinoshita, Y; Cao, XF; Jacobsen, SE; Fischer, RL; Kakutani, T				Kinoshita, T; Miura, A; Choi, YH; Kinoshita, Y; Cao, XF; Jacobsen, SE; Fischer, RL; Kakutani, T			One-way control of FWA imprinting in Arabidopsis endosperm by DNA methylation	SCIENCE			English	Article							CYTOSINE METHYLTRANSFERASE; EPIGENETIC ALLELES; POLYCOMB GENE; THALIANA; GLYCOSYLASE; MAINTENANCE; MUTATIONS; MUTANTS; MEA; DRM	The Arabidopsis FWA gene was initially identified from late-flowering epigenetic mutants that show ectopic FWA expression associated with heritable hypomethylation of repeats around transcription starting sites. Here, we show that wild-type FWA displays imprinted (maternal origin-specific) expression in endosperm. The FWA imprint depends on the maintenance DNA methyltransferase MET1, as is the case in mammals. Unlike mammals, however, the FWA imprint is not established by allele-specific de novo methylation. It is established by maternal gametophyte-specific gene activation, which depends on a DNA glycosylase gene, DEMETER. Because endosperm does not contribute to the next generation, the activated FWA gene need not be silenced again. Double fertilization enables plants to use such "one-way" control of imprinting and DNA methylation in endosperm.	Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka 4118540, Japan; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; University of California System; University of California Berkeley; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kinoshita, T (corresponding author), Natl Inst Genet, Mishima, Shizuoka 4118540, Japan.	tekinosh@lab.nig.ac.jp; tkakutan@lab.nig.ac.jp			NIGMS NIH HHS [GM60398] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM060398, R01GM060398] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; BIRCHLER JA, 1993, ANNU REV GENET, V27, P181, DOI 10.1146/annurev.ge.27.120193.001145; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Cao XF, 2000, P NATL ACAD SCI USA, V97, P4979, DOI 10.1073/pnas.97.9.4979; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; FINNEGAN EJ, 1993, NUCLEIC ACIDS RES, V21, P2383, DOI 10.1093/nar/21.10.2383; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; HAIG D, 1991, PHILOS T ROY SOC B, V333, P1, DOI 10.1098/rstb.1991.0057; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Kakutani T, 1997, PLANT J, V12, P1447, DOI 10.1046/j.1365-313x.1997.12061447.x; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Kankel MW, 2003, GENETICS, V163, P1109; Kinoshita T, 1999, PLANT CELL, V11, P1945, DOI 10.1105/tpc.11.10.1945; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Luo M, 2000, P NATL ACAD SCI USA, V97, P10637, DOI 10.1073/pnas.170292997; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Stokes TL, 2002, GENE DEV, V16, P171, DOI 10.1101/gad.952102; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Xiao WY, 2003, DEV CELL, V5, P891, DOI 10.1016/S1534-5807(03)00361-7	24	427	464	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2004	303	5657					521	523		10.1126/science.1089835	http://dx.doi.org/10.1126/science.1089835			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765XM	14631047				2022-12-24	WOS:000188316400037
J	Kerr, D				Kerr, D			Of Struldbruggs, sugar, and gatekeepers: a tale of our times	BRITISH MEDICAL JOURNAL			English	Article							PEOPLE; CARE; RISK		Royal Bournemouth Hosp, Bournemouth Diabet & Endocrine Ctr, Bournemouth BH7 7DW, Dorset, England		Kerr, D (corresponding author), Royal Bournemouth Hosp, Bournemouth Diabet & Endocrine Ctr, Bournemouth BH7 7DW, Dorset, England.							Armitage M, 2002, CLIN MED, V2, P331, DOI 10.7861/clinmedicine.2-4-331; Basile JN, 2002, BMJ-BRIT MED J, V325, P917, DOI 10.1136/bmj.325.7370.917; Evans JMM, 2002, DIABETIC MED, V19, P685, DOI 10.1046/j.1464-5491.2002.00749.x; GRANKS P, 1992, NEW ENGL J MED, V327, P424; Gregg EW, 2002, BRIT MED J, V325, P916, DOI 10.1136/bmj.325.7370.916; GROVES JE, 1978, NEW ENGL J MED, V298, P883, DOI 10.1056/NEJM197804202981605; Hampton JR, 2002, AGE AGEING, V31, P3, DOI 10.1093/ageing/31.1.3; McGouran RCM, 2002, CLIN MED, V2, P43, DOI 10.7861/clinmedicine.2-1-43; Schwartz AV, 2002, DIABETES CARE, V25, P1749, DOI 10.2337/diacare.25.10.1749; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SWIFT J, GULLIVERS TRAVELS 3, pCH10; Trewby PN, 2002, CLIN MED, V2, P527, DOI 10.7861/clinmedicine.2-6-527; WILSON AN, 2002, DAILY TELEGRAPH 0127; Winocour PH, 2002, BMJ-BRIT MED J, V324, P1577, DOI 10.1136/bmj.324.7353.1577	14	1	1	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1451	1453		10.1136/bmj.327.7429.1451	http://dx.doi.org/10.1136/bmj.327.7429.1451			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684643	Green Published, Green Submitted			2022-12-24	WOS:000187562700014
J	Serizawa, S; Miyamichi, K; Nakatani, H; Suzuki, M; Saito, M; Yoshihara, Y; Sakano, H				Serizawa, S; Miyamichi, K; Nakatani, H; Suzuki, M; Saito, M; Yoshihara, Y; Sakano, H			Negative feedback regulation ensures the one receptor-one olfactory neuron rule in mouse	SCIENCE			English	Article							IMMUNOGLOBULIN HEAVY; ODORANT RECEPTORS; GENE-EXPRESSION; LIGHT-CHAIN; ORGANIZATION; PROJECTION	In the mouse olfactory system, each olfactory sensory neuron (OSN) expresses only one odorant receptor (OR) gene in a monoallelic and mutually exclusive manner. Such expression forms the genetic basis for OR-instructed axonal projection of OSNs to the olfactory bulb of the brain during development. Here, we identify an upstream cis-acting DNA region that activates the OR gene cluster in mouse and allows the expression of only one OR gene within the cluster. Deletion of the coding region of the expressed OR gene or a naturally occurring frame-shift mutation allows a second OR gene to be expressed. We propose that stochastic activation of only one OR gene within the cluster and negative feedback regulation by that OR gene product are necessary to ensure the one receptor - one neuron rule.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; Japan Sci & Technol Corp, CREST Programs, Kawaguchi, Saitama 3320012, Japan; Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto 8620976, Japan; RIKEN, Brain Sci Inst, Lab Neurobiol Synapse, Wako, Saitama 3510198, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Kumamoto University; RIKEN	Sakano, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.	sakano@mail.ecc.u-tokyo.ac.jp	Yoshihara, Yoshihiro/N-6481-2015; Miyamichi, Kazunari/AAO-3705-2021	Yoshihara, Yoshihiro/0000-0002-0319-7166; 				BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Ishii T, 2001, GENES CELLS, V6, P71, DOI 10.1046/j.1365-2443.2001.00398.x; Karasuyama H, 1996, ADV IMMUNOL, V63, P1, DOI 10.1016/S0065-2776(08)60853-6; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nakatani H, 2003, EUR J NEUROSCI, V18, P2425, DOI 10.1046/j.1460-9568.2003.02998.x; Pyrski M, 2001, J NEUROSCI, V21, P4637, DOI 10.1523/JNEUROSCI.21-13-04637.2001; Qasba P, 1998, J NEUROSCI, V18, P227; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schweighoffer E, 2003, IMMUNITY, V18, P523, DOI 10.1016/S1074-7613(03)00082-7; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; SERIZAWA S, UNPUB; SMITH AFA, REPEATMASKER; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	28	385	393	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2088	2094		10.1126/science.1089122	http://dx.doi.org/10.1126/science.1089122			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14593185				2022-12-24	WOS:000187385200034
J	Wechsler, A; Brafman, A; Shafir, M; Heverin, M; Gottlieb, H; Damari, G; Gozlan-Kelner, S; Spivak, I; Moshkin, O; Fridman, E; Becker, Y; Skaliter, R; Einat, P; Faerman, A; Bjorkhem, I; Feinstein, E				Wechsler, A; Brafman, A; Shafir, M; Heverin, M; Gottlieb, H; Damari, G; Gozlan-Kelner, S; Spivak, I; Moshkin, O; Fridman, E; Becker, Y; Skaliter, R; Einat, P; Faerman, A; Bjorkhem, I; Feinstein, E			Generation of viable cholesterol-free mice	SCIENCE			English	Article							MOUSE MODEL; STEROL		Quark Biotech Inc, Cleveland, OH 44106 USA; H3 30 Huddinge Univ Hosp, Karolinska Inst, Div Clin Chem, Dept Med Lab Sci & Technol, SE-14186 Huddinge, Sweden; Chaim Sheba Med Ctr, Sackler Sch Med, Dept Pathol, IL-52621 Tel Hashomer, Israel	Karolinska Institutet; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Feinstein, E (corresponding author), Quark Biotech Inc, 10265 Carnegie Ave, Cleveland, OH 44106 USA.	elenaf@qbi.co.il	Heverin, Maura B/J-4101-2012	Bjorkhem, Ingemar/0000-0002-0575-9425; Fridman, Eddie/0000-0002-0317-7085				Andersson H. C., 2000, Journal of Inherited Metabolic Disease, V23, P200; Chevy F, 2002, J LIPID RES, V43, P1192, DOI 10.1194/jlr.M200082-JLR200; Fitzky BU, 2001, J CLIN INVEST, V108, P905, DOI 10.1172/JCI200112103; FitzPatrick DR, 1998, AM J MED GENET, V75, P145, DOI 10.1002/(SICI)1096-8628(19980113)75:2<145::AID-AJMG5>3.0.CO;2-S; Herz J, 1999, J NUTR, V129, p473S, DOI 10.1093/jn/129.2.473S; ROTHBLAT GH, 1970, SCIENCE, V169, P880, DOI 10.1126/science.169.3948.880; Singh SK, 2003, REPROD TOXICOL, V17, P37, DOI 10.1016/S0890-6238(02)00075-8; Wassif CA, 2001, HUM MOL GENET, V10, P555, DOI 10.1093/hmg/10.6.555	8	145	148	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2087	2087		10.1126/science.1090776	http://dx.doi.org/10.1126/science.1090776			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684813				2022-12-24	WOS:000187385200033
J	Getahun, H; Lambein, F; Vanhoorne, M; Van der Stuyft, P				Getahun, H; Lambein, F; Vanhoorne, M; Van der Stuyft, P			Food-aid cereals to reduce neurolathyrism related to grass-pea preparations during famine	LANCET			English	Article							EPIDEMIC	Neurolathyrism is a spastic paraparesis that can be caused by excessive consumption of the drought-resistant grass pea (Lathyrus sativus). Devastating neurolathyrism epidemics have occurred during major famine crises in various parts of the world. We investigated in a case-control study the effects of food aid on risk of paralysis. Risk increased with consumption of boiled grass pea (adjusted odds ratio 2.78, 95% CI 1.09-7.13 with cereals; 5.22, 2.01-13.55 without cereal) and raw unripe green grass pea (1.96, 1-1.6-3.31; p=0.011), but not with the fermented pancake, unleavened bread, and gravy preparations. In a correlational study there was an inverse relation between the number of new cases and the amount of food-aid cereals distributed per person. During famine, cereals and nutritional information should reach people before they have grass pea as the only food.	S Gonder Hlth Dept, Debre Tabor, Amhara Regional, Ethiopia; Univ Ghent, Fac Med & Hlth Sci, Physiol Chem Lab, B-9000 Ghent, Belgium; Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; Univ Ghent, Inst Plant Biotechnol Dev Countries, B-9000 Ghent, Belgium; Inst Trop Med, Epidemiol Unit, B-2000 Antwerp, Belgium	Ghent University; Ghent University; Ghent University; Institute of Tropical Medicine (ITM)	Lambein, F (corresponding author), Josef Kluyskensstr 27, B-9000 Ghent, Belgium.	fernand.lambein@UGent.be	Getahun, Haileyesus/ABC-5181-2020					Getahun H, 2002, TROP MED INT HEALTH, V7, P118, DOI 10.1046/j.1365-3156.2002.00836.x; Getahun H, 1999, LANCET, V354, P306, DOI 10.1016/S0140-6736(99)02532-5; KUO YH, 1995, J SCI FOOD AGR, V69, P81, DOI 10.1002/jsfa.2740690113; Moszynski P, 2002, LANCET, V360, P1952, DOI 10.1016/S0140-6736(02)11949-0; *US AG INT DEV CHE, FAM EARL WARN SYST N	5	48	52	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1808	1810		10.1016/S0140-6736(03)14902-1	http://dx.doi.org/10.1016/S0140-6736(03)14902-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654321				2022-12-24	WOS:000186872900014
J	Keren, K; Berman, RS; Buchstab, E; Sivan, U; Braun, E				Keren, K; Berman, RS; Buchstab, E; Sivan, U; Braun, E			DNA-templated carbon nanotube field-effect transistor	SCIENCE			English	Article							ROOM-TEMPERATURE; SEPARATION; MOLECULES; RECOGNITION; CIRCUITS; LOGIC; WIRE	The combination of their electronic properties and dimensions makes carbon nanotubes ideal building blocks for molecular electronics. However, the advancement of carbon nanotube-based electronics requires assembly strategies that allow their precise localization and interconnection. Using a scheme based on recognition between molecular building blocks, we report the realization of a self-assembled carbon nanotube field-effect transistor operating at room temperature. A DNA scaffold molecule provides the address for precise localization of a semiconducting single-wall carbon nanotube as well as the template for the extended metallic wires contacting it.	Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; Technion Israel Inst Technol, Inst Solid State, IL-32000 Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology	Braun, E (corresponding author), Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel.	erez@physics.technion.ac.il		Keren, Kinneret/0000-0002-2962-6977				Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Avouris P, 2002, ACCOUNTS CHEM RES, V35, P1026, DOI 10.1021/ar010152e; Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; Bockrath M, 2002, NANO LETT, V2, P187, DOI 10.1021/nl0100724; Bradley K, 2003, NANO LETT, V3, P639, DOI 10.1021/nl025941j; Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826; Chattopadhyay D, 2003, J AM CHEM SOC, V125, P3370, DOI 10.1021/ja028599l; Cox MM, 2000, PROG NUCLEIC ACID RE, V63, P311, DOI 10.1016/S0079-6603(08)60726-6; Dieckmann GR, 2003, J AM CHEM SOC, V125, P1770, DOI 10.1021/ja029084x; Eichen Y, 1998, ACTA POLYM, V49, P663, DOI 10.1002/(SICI)1521-4044(199810)49:10/11<663::AID-APOL663>3.0.CO;2-4; Gomez-Navarro C, 2002, P NATL ACAD SCI USA, V99, P8484, DOI 10.1073/pnas.122610899; Heath JR, 2003, PHYS TODAY, V56, P43, DOI 10.1063/1.1583533; Javey A, 2002, NANO LETT, V2, P929, DOI [10.1021/nl025647r, 10.1021/n1025647r]; Keren K, 2002, SCIENCE, V297, P72, DOI 10.1126/science.1071247; Krupke R, 2003, SCIENCE, V301, P344, DOI 10.1126/science.1086534; Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Niemeyer CM, 2000, CURR OPIN CHEM BIOL, V4, P609, DOI 10.1016/S1367-5931(00)00140-X; Pantarotto D, 2003, J AM CHEM SOC, V125, P6160, DOI 10.1021/ja034342r; Postma HWC, 2001, SCIENCE, V293, P76, DOI 10.1126/science.1061797; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Shim M, 2002, NANO LETT, V2, P285, DOI 10.1021/nl015692j; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Williams KA, 2002, NATURE, V420, P761, DOI 10.1038/420761a; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877	27	671	701	6	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2003	302	5649					1380	1382		10.1126/science.1091022	http://dx.doi.org/10.1126/science.1091022			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631035				2022-12-24	WOS:000186683500047
J	Kelman, CW; Kortt, MA; Becker, NG; Li, Z; Mathews, JD; Guest, CS; Holman, CD				Kelman, CW; Kortt, MA; Becker, NG; Li, Z; Mathews, JD; Guest, CS; Holman, CD			Deep vein thrombosis and air travel: record linkage study	BRITISH MEDICAL JOURNAL			English	Article							VENOUS THROMBOSIS; PULMONARY-EMBOLISM; RISK; EVENTS	Objective To investigate the time relations between long haul air travel and venous thromboembolisin. Design Record linkage study using the case crossover approach. Setting Western Australia. Participants 5408 patients admitted to hospital with venous thromboembolism and matched with data for arrivals of international flights during 1981-99. Results ne risk of venous thromboembolism is increased for only two weeks after a long haul flight; 46 Australian citizens and 200 non-Australian citizens had an episode of venous thromboembolism during this so called hazard period. The relative risk during this period for Australian citizens was 4.17 (95% confidence interval, 2.94 to 5.40), with 76% of cases (n=35) attributable to the preceding flight. A "healthy traveller" effect was observed, particularly for Australian citizens. Conclusions The annual risk of venous thromboembolism is increased by 12% if one long haul flight is taken yearly. The average risk of death from flight related venous thromboembolisin is small compared with that from motor vehicle crashes and injuries at work. The individual risk of death from flight related venous thromboembolism for people with certain pre-existing medical conditions is, however, likely to be greater than the average risk of 1 per 2 million for passengers arriving from a flight. Airlines and health authorities should continue to advise passengers on how to minimise risk.	Commonwealth Dept Hlth & Ageing, Canberra, ACT 2601, Australia; Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia; Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia	Australian National University; University of Western Australia	Kelman, CW (corresponding author), Commonwealth Dept Hlth & Ageing, GPO Box 9848, Canberra, ACT 2601, Australia.		Holman, Cashel DJ/B-6173-2009	Kortt, Michael/0000-0002-3556-3001; Kelman, Chris/0000-0001-5126-8179				ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Ansell JE, 2001, NEW ENGL J MED, V345, P828, DOI 10.1056/NEJM200109133451110; *AUSTR BUR STAT, 1999, 1998 CAUS DEATH; *DEP TRANSP REG DE, 1999, ROAD FAT AUSTR 1998; Eekhoff EMW, 2000, THROMB HAEMOSTASIS, V83, P408, DOI 10.1055/s-0037-1613828; Ferrari E, 1999, CHEST, V115, P440, DOI 10.1378/chest.115.2.440; Gallus AS, 2001, MED J AUSTRALIA, V174, P264, DOI 10.5694/j.1326-5377.2001.tb143263.x; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; HOMANS J, 1954, NEW ENGL J MED, V250, P148, DOI 10.1056/NEJM195401282500404; *INT CIV AV ORG, 2000, 1999 AN REP COUNC IN; Kelman CW, 2002, AUST NZ J PUBL HEAL, V26, P251, DOI 10.1111/j.1467-842X.2002.tb00682.x; Kesteven PJL, 2001, AVIAT SPACE ENVIR MD, V72, P125; Kraaijenhagen RA, 2000, LANCET, V356, P1492, DOI 10.1016/S0140-6736(00)02878-6; Lapostolle F, 2001, NEW ENGL J MED, V345, P779, DOI 10.1056/NEJMoa010378; Levine M, 1996, NEW ENGL J MED, V334, P677, DOI 10.1056/NEJM199603143341101; LORD RSA, 2000, HAWAII MED J, V59, P155; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; MARSHALL RJ, 1993, STAT MED, V12, P2333, DOI 10.1002/sim.4780122409; *NAT TRANSP SAF BO, 2001, ACC FAT RAT 1982 200; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Scurr JH, 2001, LANCET, V357, P1485, DOI 10.1016/S0140-6736(00)04645-6	22	79	80	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 8	2003	327	7423					1072	1075		10.1136/bmj.327.7423.1072	http://dx.doi.org/10.1136/bmj.327.7423.1072			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742QW	14604926	Green Published, Bronze			2022-12-24	WOS:000186530400015
J	Gong, SC; Zheng, C; Doughty, ML; Losos, K; Didkovsky, N; Schambra, UB; Nowak, NJ; Joyner, A; Leblanc, G; Hatten, ME; Heintz, N				Gong, SC; Zheng, C; Doughty, ML; Losos, K; Didkovsky, N; Schambra, UB; Nowak, NJ; Joyner, A; Leblanc, G; Hatten, ME; Heintz, N			A gene expression atlas of the central nervous system based on bacterial artificial chromosomes	NATURE			English	Article							ESCHERICHIA-COLI; TRANSGENIC MICE; GOOSECOID-LIKE; NEURONS; RECEPTORS; CELL; SEMAPHORINS; STRIATUM; NEUROSCIENCE; MIGRATION	The mammalian central nervous system (CNS) contains a remarkable array of neural cells, each with a complex pattern of connections that together generate perceptions and higher brain functions. Here we describe a large-scale screen to create an atlas of CNS gene expression at the cellular level, and to provide a library of verified bacterial artificial chromosome (BAC) vectors and transgenic mouse lines that offer experimental access to CNS regions, cell classes and pathways. We illustrate the use of this atlas to derive novel insights into gene function in neural cells, and into principal steps of CNS development. The atlas, library of BAC vectors and BAC transgenic mice generated in this screen provide a rich resource that allows a broad array of investigations not previously available to the neuroscience community.	Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, GENSAT Project, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, Dev Neurobiol Lab, New York, NY 10021 USA; E Tennessee State Univ, Dept Anat & Cell Biol, Johnson City, TN 37614 USA; Roswell Pk Canc Inst, Buffalo, NY 14263 USA; NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med,Dev Genet Program, New York, NY 10016 USA; Howard Hughes Med Inst, New York, NY 10016 USA; Natl Inst Neurol Disorders & Stroke, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; East Tennessee State University; Roswell Park Cancer Institute; New York University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Heintz, N (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, 1230 York Ave,Box 260, New York, NY 10021 USA.	gensat@rockefeller.edu						Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; BAIRD DH, 1992, J NEUROSCI, V12, P619; Bernard V, 1999, J NEUROSCI, V19, P10237; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Chen H, 1998, NAT NEUROSCI, V1, P436, DOI 10.1038/2154; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; DERER P, 1990, NEUROSCIENCE, V36, P839, DOI 10.1016/0306-4522(90)90027-2; EDWARDS MA, 1986, J COMP NEUROL, V248, P395, DOI 10.1002/cne.902480308; EDWARDS MA, 1986, J COMP NEUROL, V248, P410, DOI 10.1002/cne.902480309; Emanuel B S, 2001, Adv Pediatr, V48, P39; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; GERFEN CR, 1988, BRAIN RES, V460, P161, DOI 10.1016/0006-8993(88)91217-6; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Gottlieb S, 1998, HUM MOL GENET, V7, P1497, DOI 10.1093/hmg/7.9.1497; Gottlieb S, 1997, AM J HUM GENET, V60, P1194; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; HERSCH SM, 1995, J NEUROSCI, V15, P5222; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LEMOINE C, 1995, J COMP NEUROL, V355, P418, DOI 10.1002/cne.903550308; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Meyer G, 1998, J COMP NEUROL, V397, P493; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; PAXINOS G, 2001, MOUSE BRAIN STEREOTA, V132; Ramon y Cajal S, 1911, HISTOLOGY NERVOUS SY; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; ROSS CA, 1989, P NATL ACAD SCI USA, V86, P2923, DOI 10.1073/pnas.86.8.2923; Rybalkin SD, 2002, CIRC RES, V90, P151, DOI 10.1161/hh0202.104108; SACHS GM, 1986, J COMP NEUROL, V246, P395, DOI 10.1002/cne.902460308; SACHS GM, 1984, J COMP NEUROL, V230, P155, DOI 10.1002/cne.902300202; Schambra UB, 1992, ATLAS PRENATAL MOUSE; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Valjakka A, 1998, BRAIN RES BULL, V47, P171, DOI 10.1016/S0361-9230(98)00006-9; Valverde F, 1998, GOLGI ATLAS OF THE POSTNATAL MOUSE BRAIN, P1; Walz A, 2002, J NEUROSCI, V22, P4025, DOI 10.1523/JNEUROSCI.22-10-04025.2002; Wang X, 2002, J NEUROSCI, V22, P9185; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001	46	1540	1564	2	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2003	425	6961					917	925		10.1038/nature02033	http://dx.doi.org/10.1038/nature02033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14586460				2022-12-24	WOS:000186230600032
J	Manke, IA; Lowery, DM; Nguyen, A; Yaffe, MB				Manke, IA; Lowery, DM; Nguyen, A; Yaffe, MB			BRCT repeats as phosphopeptide-binding modules involved in protein targeting	SCIENCE			English	Article							PEPTIDE LIBRARIES; DOMAIN; ATM; CHECKPOINT; 53BP1; CAFFEINE; PTIP	We used a proteomic approach to identify phosphopeptide-binding modules mediating signal transduction events in the DNA damage response pathway. Using a library of partially degenerate phosphopeptides, we identified tandem BRCT (BRCA1 carboxyl-terminal) domains in PTIP (Pax transactivation domain-interacting protein) and in BRCA1 as phosphoserine- or phosphothreonine-specific binding modules that recognize substrates phosphorylated by the kinases ATM (ataxia telangiectasia-mutated) and ATR (ataxia telangiectasia- and RAD3-related) in response to gamma-irradiation. PTIP tandem BRCT domains are responsible for phosphorylation-dependent protein localization into 53BP1- and phospho-H2AX (gamma-H2AX)-containing nuclear foci, a marker of DNA damage. These findings provide a molecular basis for BRCT domain function in the DNA damage response and may help to explain why the BRCA1 BRCT domain mutation Met(1775) --> Arg, which fails to bind phosphopeptides, predisposes women to breast and ovarian cancer.	MIT, Dept Biol, Ctr Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Yaffe, MB (corresponding author), MIT, Dept Biol, Ctr Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060594] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM60594] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Cho EA, 2003, MOL CELL BIOL, V23, P1666, DOI 10.1128/MCB.23.5.1666-1673.2003; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Huyton T, 2000, MUTAT RES-DNA REPAIR, V460, P319, DOI 10.1016/S0921-8777(00)00034-3; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Lechner MS, 2000, NUCLEIC ACIDS RES, V28, P2741, DOI 10.1093/nar/28.14.2741; MANKE IA, UNPUB; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Sarkaria JN, 1999, CANCER RES, V59, P4375; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Shimizu K, 2001, MOL CELL BIOL, V21, P3901, DOI 10.1128/MCB.21.12.3901-3912.2001; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Williams RS, 2003, J BIOL CHEM, V278, P2630, DOI 10.1074/jbc.M210019200; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Yaffe MB, 2002, NAT REV MOL CELL BIO, V3, P177, DOI 10.1038/nrm759; Yaffe MB, 2000, METHOD ENZYMOL, V328, P157, DOI 10.1016/S0076-6879(00)28397-3; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	22	528	538	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					636	639		10.1126/science.1088877	http://dx.doi.org/10.1126/science.1088877			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576432				2022-12-24	WOS:000186119900057
J	Makhnevych, T; Lusk, CP; Anderson, AM; Aitchison, JD; Wozniak, RW				Makhnevych, T; Lusk, CP; Anderson, AM; Aitchison, JD; Wozniak, RW			Cell cycle regulated transport controlled by alterations in the nuclear pore complex	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; NUCLEOPORIN NUP153; PROTEOMIC ANALYSIS; IMPORT RECEPTOR; PROTEIN; YEAST; RAN; LOCALIZATION; BINDING; PHOSPHORYLATION	Eukaryotic cells have developed mechanisms for regulating the nuclear transport of macromolecules that control various cellular events including movement through defined stages of the cell cycle. In yeast cells, where the nuclear envelope remains intact throughout the cell cycle, these transport regulatory mechanisms must also function during mitosis. We have uncovered a mechanism for regulating transport that is controlled by M phase specific molecular rearrangements in the nuclear pore complex (NPC). These changes allow a transport inhibitory nucleoporin, Nup53p, to bind the karyopherin Kap121p specifically during mitosis, slowing its movement through the NPC and inducing cargo release. Yeast strains that possess defects in the function of Kap121p or the fidelity of the inhibitory pathway are delayed in mitosis. We propose that fluctuations in Kap121p transport mediated by the NPC contribute to controlling the subcellular distribution of molecules that direct progression through mitosis.	Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada; Inst Syst Biol, Seattle, WA 98103 USA	University of Alberta; Institute for Systems Biology (ISB)	Aitchison, JD (corresponding author), Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada.	jaitchison@systemsbiology.org; rick.wozniak@ualberta.ca		Lusk, C. Patrick/0000-0003-4703-0533				AITCHISON JD, 1995, J CELL BIOL, V131, P1133, DOI 10.1083/jcb.131.5.1133; Allen NPC, 2001, J BIOL CHEM, V276, P29268, DOI 10.1074/jbc.M102629200; Asakawa K, 2002, GENETICS, V162, P1545; Basrai MA, 1996, MOL CELL BIOL, V16, P2838; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; DELORME E, 1989, APPL ENVIRON MICROB, V55, P2242, DOI 10.1128/AEM.55.9.2242-2246.1989; Dilworth DJ, 2001, J CELL BIOL, V153, P1465, DOI 10.1083/jcb.153.7.1465; Englmeier L, 1999, CURR BIOL, V9, P30, DOI 10.1016/S0960-9822(99)80044-X; Favreau C, 1996, BIOCHEMISTRY-US, V35, P8035, DOI 10.1021/bi9600660; FELDHERR CM, 1994, EXP CELL RES, V215, P206, DOI 10.1006/excr.1994.1333; FELDHERR CM, 1993, EXP CELL RES, V205, P179, DOI 10.1006/excr.1993.1073; Fontoura BMA, 2000, J BIOL CHEM, V275, P31289, DOI 10.1074/jbc.M004651200; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gilchrist D, 2002, J BIOL CHEM, V277, P18161, DOI 10.1074/jbc.M112306200; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; Iouk T, 2002, J CELL BIOL, V159, P807, DOI 10.1083/jcb.200205068; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Jaquenoud M, 2002, EMBO J, V21, P6515, DOI 10.1093/emboj/cdf634; Jensen S, 2002, CELL CYCLE, V1, P300, DOI 10.4161/cc.1.5.142; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; Kehlenbach RH, 2000, J BIOL CHEM, V275, P17848, DOI 10.1074/jbc.M001455200; Kose S, 1997, J CELL BIOL, V139, P841, DOI 10.1083/jcb.139.4.841; Lee DCY, 1999, J BIOL CHEM, V274, P29031, DOI 10.1074/jbc.274.41.29031; Leslie DM, 2002, MOL CELL BIOL, V22, P2544, DOI 10.1128/MCB.22.8.2544-2555.2002; Lusk CP, 2002, J CELL BIOL, V159, P267, DOI 10.1083/jcb.200203079; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Madison DL, 2002, J BIOL CHEM, V277, P38755, DOI 10.1074/jbc.M207512200; Marelli M, 1998, J CELL BIOL, V143, P1813, DOI 10.1083/jcb.143.7.1813; Marelli M, 2001, J CELL BIOL, V153, P709, DOI 10.1083/jcb.153.4.709; Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982; NEHRBASS U, 1993, EUR J CELL BIOL, V62, P1; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Pyhtila B, 2003, J BIOL CHEM, V278, P42699, DOI 10.1074/jbc.M307135200; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 1999, CURR BIOL, V9, P47, DOI 10.1016/S0960-9822(99)80046-3; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Rout MP, 2001, J BIOL CHEM, V276, P16593, DOI 10.1074/jbc.R100015200; Schwoebel ED, 2002, J CELL BIOL, V157, P963, DOI 10.1083/jcb.200111077; Seedorf M, 1997, P NATL ACAD SCI USA, V94, P8590, DOI 10.1073/pnas.94.16.8590; Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31; Shah S, 1998, CURR BIOL, V8, P1376, DOI 10.1016/S0960-9822(98)00018-9; Sherman F., 1983, METHODS YEAST GENETI; Shou WY, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-4; Shulga N, 1996, J CELL BIOL, V135, P329, DOI 10.1083/jcb.135.2.329; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Ullman KS, 1999, MOL BIOL CELL, V10, P649, DOI 10.1091/mbc.10.3.649; Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yuste-Rojas M, 2000, MOL GEN GENET, V263, P60, DOI 10.1007/PL00008676; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039	57	122	128	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2003	115	7					813	823		10.1016/S0092-8674(03)00986-3	http://dx.doi.org/10.1016/S0092-8674(03)00986-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	758RV	14697200	Bronze			2022-12-24	WOS:000187664700006
J	Mitchell, AA				Mitchell, AA			Systematic identification of drugs that cause birth defects - A new opportunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACID; PREGNANCY		Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA	Boston University	Mitchell, AA (corresponding author), Boston Univ, Slone Epidemiol Ctr, 1010 Commonwealth Ave, Boston, MA 02215 USA.			Mitchell, Allen/0000-0003-0950-6799				Chambers CD, 2001, TERATOLOGY, V64, P252, DOI 10.1002/tera.1071; Hernandez-Diaz S, 2001, NEW ENGL J MED, V344, P934; Hernandez-Diaz S, 2000, NEW ENGL J MED, V343, P1608, DOI 10.1056/NEJM200011303432204; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; LENZ W, 1962, LANCET, V1, P45; MITCHELL AA, 1981, JAMA-J AM MED ASSOC, V245, P2311; MITCHELL AA, 2001, PHARMACOEPIDEM DR S, V10, pS341; MITCHELL AA, 2000, PHARMACOEPIDEM DR S, P595; ROBERT E, 1982, LANCET, V2, P937, DOI 10.1016/s0140-6736(82)90908-4; ROSA FW, 1991, NEW ENGL J MED, V324, P674, DOI 10.1056/NEJM199103073241006; Slone D, 1977, EPIDEMIOLOGICAL EVAL, P59; Werler MM, 2002, AM J EPIDEMIOL, V155, P26, DOI 10.1093/aje/155.1.26; Wilson JG, 1973, ENV BIRTH DEFECTS, P146; Yoon PW, 2001, PUBLIC HEALTH REP, V116, P32, DOI 10.1093/phr/116.S1.32	14	88	96	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2003	349	26					2556	2559		10.1056/NEJMsb031395	http://dx.doi.org/10.1056/NEJMsb031395			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757BT	14695418				2022-12-24	WOS:000187529500014
J	Abbott, A				Abbott, A			Membrane proteins - Channel voyager makes waves	NATURE			English	News Item							DEPENDENT K+ CHANNEL; X-RAY-STRUCTURE; POTASSIUM CHANNEL; MOLECULAR-BASIS; SELECTIVITY; CONDUCTION											Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	8	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					755	755		10.1038/426755a	http://dx.doi.org/10.1038/426755a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685197	Bronze			2022-12-24	WOS:000187342000018
J	Parker, AR; Welch, VL; Driver, D; Martini, N				Parker, AR; Welch, VL; Driver, D; Martini, N			Structural colour - Opal analogue discovered in a weevil	NATURE			English	Editorial Material									Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Parker, AR (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	andrew.parker@zoo.ox.ac.uk						Ajgaonkar M, 2002, J OPT SOC AM B, V19, P1391, DOI 10.1364/JOSAB.19.001391; Blackwell J., 1984, P257; Land M F, 1972, Prog Biophys Mol Biol, V24, P75, DOI 10.1016/0079-6107(72)90004-1; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Parker AR, 1998, J EXP BIOL, V201, P1307; Parker AR, 2000, J OPT A-PURE APPL OP, V2, pR15, DOI 10.1088/1464-4258/2/6/201; Parker AR, 2001, NATURE, V409, P36, DOI 10.1038/35051168; PHILIPSE AP, 1989, J MATER SCI LETT, V8, P1371, DOI 10.1007/BF00720190; Sanders J. V., 1971, MINERAL REC, V2, P261; SANDERS JV, 1964, NATURE, V204, P1151, DOI 10.1038/2041151a0; SCHULTZ T D, 1986, Bulletin of the Entomological Society of America, V32, P142	11	205	221	6	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2003	426	6968					786	787		10.1038/426786a	http://dx.doi.org/10.1038/426786a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685223				2022-12-24	WOS:000187342000042
J	Roman, MJ; Shanker, B; Davis, A; Lockshin, MD; Sammaritano, L; Simantov, R; Crow, MK; Schwartz, JE; Paget, SA; Devereux, RB; Salmon, JE				Roman, MJ; Shanker, B; Davis, A; Lockshin, MD; Sammaritano, L; Simantov, R; Crow, MK; Schwartz, JE; Paget, SA; Devereux, RB; Salmon, JE			Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY DISEASE; APPARENTLY HEALTHY-MEN; RISK-FACTORS; CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; FOLLOW-UP; CLASSIFICATION; EVENTS; PLASMA	BACKGROUND: Although systemic lupus erythematosus is associated with premature myocardial infarction, the prevalence of underlying atherosclerosis and its relation to traditional risk factors for cardiovascular disease and lupus-related factors have not been examined in a case-control study. METHODS: In 197 patients with lupus and 197 matched controls, we performed carotid ultrasonography, echocardiography, and an assessment for risk factors for cardiovascular disease. The patients were also evaluated with respect to their clinical and serologic features, inflammatory mediators, and disease treatment. RESULTS: The risk factors for cardiovascular disease were similar among patients and controls. Atherosclerosis (carotid plaque) was more prevalent among patients than the controls (37.1 percent vs. 15.2 percent, P<0.001). In multivariate analysis, only older age, the presence of systemic lupus erythematosus (odds ratio, 4.8; 95 percent confidence interval, 2.6 to 8.7), and a higher serum cholesterol level were independently related to the presence of plaque. As compared with patients without plaque, patients with plaque were older, had a longer duration of disease and more disease-related damage, and were less likely to have multiple autoantibodies or to have been treated with prednisone, cyclophosphamide, or hydroxychloroquine. In multivariate analyses including patients with lupus, independent predictors of plaque were a longer duration of disease, a higher damage-index score, a lower incidence of the use of cyclophosphamide, and the absence of anti-Smith antibodies. CONCLUSIONS: Atherosclerosis occurs prematurely in patients with systemic lupus erythematosus and is independent of traditional risk factors for cardiovascular disease. The clinical profile of patients with lupus and atherosclerosis suggests a role for disease-related factors in atherogenesis and underscores the need for trials of more focused and effective antiinflammatory therapy.	Cornell Univ, Weill Med Coll, Div Cardiol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Div Rheumatol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Div Hematol Oncol, New York, NY 10021 USA; Hosp Special Surg, New York, NY 10021 USA; SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA	Cornell University; Cornell University; Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Roman, MJ (corresponding author), Cornell Univ, Weill Med Coll, Div Cardiol, 525 E 68th St, New York, NY 10021 USA.		Crow, Mary/R-8480-2019	Schwartz, Joseph/0000-0002-8944-3566	NCRR NIH HHS [M10RR0047] Funding Source: Medline; NHLBI NIH HHS [HL 47540, P01 HL047540] Funding Source: Medline; NIAMS NIH HHS [AR 45591] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000047] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL047540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045591] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Asanuma Y, 2003, NEW ENGL J MED, V349, P2407, DOI 10.1056/NEJMoa035611; Belcaro G, 1996, ARTERIOSCL THROM VAS, V16, P851, DOI 10.1161/01.ATV.16.7.851; DEVEREUX RB, 1995, HYPERTENSION PATHOPH, V2, P1969; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; JOHNSON H, 1989, MEDICINE, V68, P141; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Manzi S, 1999, ARTHRITIS RHEUM-US, V42, P51, DOI 10.1002/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D; PETRI M, 1992, MEDICINE, V71, P291, DOI 10.1097/00005792-199209000-00004; PETRI M, 1994, AM J MED, V96, P254, DOI 10.1016/0002-9343(94)90151-1; PETRI M, 1992, AM J MED, V93, P513, DOI 10.1016/0002-9343(92)90578-Y; Petri M, 2002, ARTHRITIS RHEUM-US, V46, pS458; Petri M, 1996, LANCET, V348, P1120, DOI 10.1016/S0140-6736(96)03032-2; Petri M, 1998, ARTHRITIS RHEUM, V41, pS218; Ridker PM, 1997, NEW ENGL J MED, V337, P356; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Roman MJ, 1996, J AM COLL CARDIOL, V28, P1642; Roman MJ, 1996, J AM COLL CARDIOL, V28, P751, DOI 10.1016/0735-1097(96)00225-2; Roman MJ, 2001, AM J CARDIOL, V87, P663, DOI 10.1016/S0002-9149(00)01453-3; Salmon JE, 2001, CURR OPIN RHEUMATOL, V13, P341, DOI 10.1097/00002281-200109000-00001; SALONEN JT, 1993, CIRCULATION, V87, P56; Schnall PL, 1998, PSYCHOSOM MED, V60, P697, DOI 10.1097/00006842-199811000-00007; Schonbeck U, 2001, CIRCULATION, V104, P2266, DOI 10.1161/hc4401.099447; SIMANTOV R, 1995, J CLIN INVEST, V96, P2211, DOI 10.1172/JCI118276; Svenungsson E, 2001, CIRCULATION, V104, P1887, DOI 10.1161/hc4101.097518; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; UELAND PM, 1993, CLIN CHEM, V39, P1764; UROWITZ MB, 1976, AM J MED, V60, P221, DOI 10.1016/0002-9343(76)90431-9; Vaarala O, 2000, J INTERN MED, V247, P381, DOI 10.1046/j.1365-2796.2000.00657.x; Vakkalanka RK, 1999, ARTHRITIS RHEUM, V42, P871, DOI 10.1002/1529-0131(199905)42:5<871::AID-ANR5>3.0.CO;2-J; Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F	33	1034	1103	1	19	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2003	349	25					2399	2406		10.1056/NEJMoa035471	http://dx.doi.org/10.1056/NEJMoa035471			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754PJ	14681505				2022-12-24	WOS:000187326200005
J	Thomson, KS; Sutton, M; Thomas, B				Thomson, KS; Sutton, M; Thomas, B			A larval Devonian lungfish	NATURE			English	Article								Perhaps the most enduring of puzzles in palaeontology has been the identity of Palaeospondylus gunni Traquair, a tiny (5-60-mm) vertebrate fossil from the Middle Devonian period (similar to385 Myr ago) of Scotland, first discovered in 1890 (refs 1 - 3). It is known principally from a single site (Achanarras Quarry, Caithness) where, paradoxically, it is extremely abundant, preserved in varved lacustrine deposits along with 13 other genera of fishes(4). Here we show that Palaeospondylus is the larval stage of a lungfish, most probably Dipterus valenciennesi Sedgwick and Murchison 1828 (ref. 5), and that development of the adult form requires a distinct metamorphosis. Palaeospondylus is the oldest known true larva of a vertebrate.	Univ Oxford, Museum Nat Hist, Oxford OX1 3PW, England	University of Oxford	Thomson, KS (corresponding author), Univ Oxford, Museum Nat Hist, Parks Rd, Oxford OX1 3PW, England.							Agassiz A., 1879, P AM ACAD ARTS SCI, V14, P65; FOREY P., 1981, B BRIT MUS NAT HIST, V35, P131; FOX HAROLD, 1965, J ZOOL PROC ZOOL SOC LONDON, V146, P470; Kerr JG, 1900, P CAMB PHILOS SOC, V10, P298; MOY-THOMAS J. A., 1940, PHIL TRANS ROY SOC LONDON SER B BIOL SCI, V230, P391, DOI 10.1098/rstb.1940.0004; Rayner D. H., 1963, Proceedings of the Yorkshire Geological Society, V34, P117; SEDGWICK A, 1828, T GEOL SOC LOND, V3, P125; SOLLAS WJ, 1903, PHILOS T ROY SOC LON, V196, P267; Sutton MD, 2002, P ROY SOC B-BIOL SCI, V269, P1195, DOI 10.1098/rspb.2002.1986; SUTTON MD, 2000, PALEONT ELECT, V4, DOI ARTN 2; THOMSON KEITH STEWART, 1965, PROC ZOOL SOC LONDON, V145, P207; THOMSON KS, 1992, AM SCI, V80, P216; Traquair R. H., 1890, Annals of Natural History, V(6), P479; TREWIN N H, 1986, Transactions of the Royal Society of Edinburgh Earth Sciences, V77, P21; J MORPHOL S	15	19	22	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					833	834		10.1038/nature02175	http://dx.doi.org/10.1038/nature02175			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685237				2022-12-24	WOS:000187342000056
J	Ye, KQ; Malinina, L; Patel, DJ				Ye, KQ; Malinina, L; Patel, DJ			Recognition of small interfering RNA by a viral suppressor of RNA silencing	NATURE			English	Article							DOUBLE-STRANDED-RNA; GENE; SYSTEM; PCR	RNA silencing (also known as RNA interference) is a conserved biological response to double-stranded RNA that regulates gene expression, and has evolved in plants as a defence against viruses(1-3). The response is mediated by small interfering RNAs (siRNAs), which guide the sequence-specific degradation of cognate messenger RNAs. As a counter-defence, many viruses encode proteins that specifically inhibit the silencing machinery(3,4). The p19 protein from the tombusvirus is such a viral suppressor of RNA silencing(5) and has been shown to bind specifically to siRNA(6). Here, we report the 1.85-Angstrom crystal structure of p19 bound to a 21-nucleotide siRNA, where the 19-basepair RNA duplex is cradled within the concave face of a continuous eight-stranded beta-sheet, formed across the p19 homodimer interface. Direct and water-mediated intermolecular contacts are restricted to the backbone phosphates and sugar 20-OH groups, consistent with sequence-independent p19-siRNA recognition. Two alpha-helical 'reading heads' project from opposite ends of the p19 homodimer and position pairs of tryptophans for stacking over the terminal base pairs, thereby measuring and bracketing both ends of the siRNA duplex. Our structure provides an illustration of siRNA sequestering by a viral protein.	Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA.	pateld@mskcc.org	Malinina, Lucy/B-8161-2013		NCI NIH HHS [P30 CA008748] Funding Source: Medline; NIAID NIH HHS [R01 AI068776] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068776] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Casimiro DR, 1997, STRUCTURE, V5, P1407, DOI 10.1016/S0969-2126(97)00291-8; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Li WX, 2001, CURR OPIN BIOTECH, V12, P150, DOI 10.1016/S0958-1669(00)00190-7; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8	24	320	336	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2003	426	6968					874	878		10.1038/nature02213	http://dx.doi.org/10.1038/nature02213			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14661029	Green Accepted			2022-12-24	WOS:000187342000067
J	Methe, BA; Nelson, KE; Eisen, JA; Paulsen, IT; Nelson, W; Heidelberg, JF; Wu, D; Wu, M; Ward, N; Beanan, MJ; Dodson, RJ; Madupu, R; Brinkac, LM; Daugherty, SC; DeBoy, RT; Durkin, AS; Gwinn, M; Kolonay, JF; Sullivan, SA; Haft, DH; Selengut, J; Davidsen, TM; Zafar, N; White, O; Tran, B; Romero, C; Forberger, HA; Weidman, J; Khouri, H; Feldblyum, TV; Utterback, TR; Van Aken, SE; Lovley, DR; Fraser, CM				Methe, BA; Nelson, KE; Eisen, JA; Paulsen, IT; Nelson, W; Heidelberg, JF; Wu, D; Wu, M; Ward, N; Beanan, MJ; Dodson, RJ; Madupu, R; Brinkac, LM; Daugherty, SC; DeBoy, RT; Durkin, AS; Gwinn, M; Kolonay, JF; Sullivan, SA; Haft, DH; Selengut, J; Davidsen, TM; Zafar, N; White, O; Tran, B; Romero, C; Forberger, HA; Weidman, J; Khouri, H; Feldblyum, TV; Utterback, TR; Van Aken, SE; Lovley, DR; Fraser, CM			Genome of Geobacter sulfurreducens: Metal reduction in subsurface environments	SCIENCE			English	Article							URANIUM-CONTAMINATED AQUIFER; MYXOCOCCUS-XANTHUS; OXYGEN; EXPRESSION; SEDIMENTS; SEQUENCE; PROTEIN	The complete genome sequence of Geobacter sulfurreducens, a delta-proteobacterium, reveals unsuspected capabilities, including evidence of aerobic metabolism, one-carbon and complex carbon metabolism, motility, and chemotactic behavior. These characteristics, coupled with the possession of many two-component sensors and many c-type cytochromes, reveal an ability to create alternative, redundant, electron transport networks and offer insights into the process of metal ion reduction in subsurface environments. As well as playing roles in the global cycling of metals and carbon, this organism clearly has the potential for use in bioremediation of radioactive metals and in the generation of electricity.	Inst Genom Res, Rockville, MD 20850 USA; Univ Massachusetts, Dept Microbiol, Amherst, MA 01002 USA	J. Craig Venter Institute; University of Massachusetts System; University of Massachusetts Amherst	Methe, BA (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.		Nelson, William C/E-9263-2016; Eisen, Jonathan A./H-2706-2019; Paulsen, Ian T/K-3832-2012	Nelson, William C/0000-0002-1873-3929; Eisen, Jonathan A./0000-0002-0159-2197; Paulsen, Ian T/0000-0001-9015-9418; Fraser, Claire/0000-0003-1462-2428; Wu, Martin/0000-0003-3093-4077; Heidelberg, John/0000-0003-0673-3224				Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; BLAUT M, 1994, ANTON LEEUW INT J G, V66, P187, DOI 10.1007/BF00871639; Bond DR, 2002, SCIENCE, V295, P483, DOI 10.1126/science.1066771; CACCAVO F, 1994, APPL ENVIRON MICROB, V60, P3752, DOI 10.1128/AEM.60.10.3752-3759.1994; Cypionka H, 2000, ANNU REV MICROBIOL, V54, P827, DOI 10.1146/annurev.micro.54.1.827; Dailey TA, 1998, J BIOL CHEM, V273, P13658, DOI 10.1074/jbc.273.22.13658; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; HEISE R, 1993, FEMS MICROBIOL LETT, V112, P261, DOI 10.1111/j.1574-6968.1993.tb06460.x; Holmes DE, 2002, APPL ENVIRON MICROB, V68, P2300, DOI 10.1128/AEM.68.5.2300-2306.2002; Jolley KA, 2000, MICROBIOL-UK, V146, P1061, DOI 10.1099/00221287-146-5-1061; Kirby JR, 2003, P NATL ACAD SCI USA, V100, P2008, DOI 10.1073/pnas.0330944100; LEHMANN M, 1995, J BIOL CHEM, V270, P14420, DOI 10.1074/jbc.270.24.14420; Lemos RS, 2001, FEBS LETT, V496, P40, DOI 10.1016/S0014-5793(01)02399-7; Lovley D.R., 1997, IRON RELATED TRANSIT, P187; LOVLEY DR, 2003, PROKARYOTES RELEASE; Schnarrenberger C, 2002, EUR J BIOCHEM, V269, P868, DOI 10.1046/j.0014-2956.2001.02722.x; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Thelwell C, 1998, P NATL ACAD SCI USA, V95, P10728, DOI 10.1073/pnas.95.18.10728; Tsujibo H, 2000, APPL ENVIRON MICROB, V66, P3778, DOI 10.1128/AEM.66.9.3778-3783.2000; WHITE DC, 2000, PHYSL BIOCH PROKARYO, V2	20	548	1011	21	304	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1967	1969		10.1126/science.1088727	http://dx.doi.org/10.1126/science.1088727			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671304				2022-12-24	WOS:000187174000061
J	Kolodgie, FD; Gold, HK; Burke, AP; Fowler, DR; Kruth, HS; Weber, DK; Farb, A; Guerrero, LJ; Hayase, M; Kutys, R; Narula, J; Finn, AV; Virmani, R				Kolodgie, FD; Gold, HK; Burke, AP; Fowler, DR; Kruth, HS; Weber, DK; Farb, A; Guerrero, LJ; Hayase, M; Kutys, R; Narula, J; Finn, AV; Virmani, R			Intraplaque hemorrhage and progression of coronary atheroma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RED-BLOOD-CELLS; LOW-DENSITY-LIPOPROTEIN; ATHEROSCLEROTIC LESIONS; PLAQUE MORPHOLOGY; CHOLESTEROL; ERYTHROCYTES; MEMBRANE; RECEPTOR; DISEASE; HYPERCHOLESTEROLEMIA	BACKGROUND: Intraplaque hemorrhage is common in advanced coronary atherosclerotic lesions. The relation between hemorrhage and the vulnerability of plaque to disruption may involve the accumulation of free cholesterol from erythrocyte membranes. METHODS: We stained multiple coronary lesions from 24 randomly selected patients who had died suddenly of coronary causes with an antibody against glycophorin A (a protein specific to erythrocytes that facilitates anion exchange) and Mallory's stain for iron (hemosiderin), markers of previous intraplaque hemorrhage. Coronary lesions were classified as lesions with pathologic intimal thickening, fibrous-cap atheromas with cores in an early or late stage of necrosis, or thin-cap fibrous atheromas (vulnerable plaques). The arterial response to plaque hemorrhage was further defined in a rabbit model of atherosclerosis. RESULTS: Only traces of glycophorin A and iron were found in lesions with pathologic intimal thickening or fibrous-cap atheromas with cores in an early stage of necrosis. In contrast, fibroatheromas with cores in a late stage of necrosis or thin caps had a marked increase in glycophorin A in regions of cholesterol clefts surrounded by iron deposits. Larger amounts of both glycophorin A and iron were associated with larger necrotic cores and greater macrophage infiltration. Rabbit lesions with induced intramural hemorrhage consistently showed cholesterol crystals with erythrocyte fragments, foam cells, and iron deposits. In contrast, control lesions from the same animals had a marked reduction in macrophages and lipid content. CONCLUSIONS: By contributing to the deposition of free cholesterol, macrophage infiltration, and enlargement of the necrotic core, the accumulation of erythrocyte membranes within an atherosclerotic plaque may represent a potent atherogenic stimulus. These factors may increase the risk of plaque destabilization.	Armed Forces Inst Pathol, Dept Cardiovasc Pathol, Washington, DC 20306 USA; Massachusetts Gen Hosp, Dept Internal Med, Cardiac Unit, Boston, MA 02114 USA; Univ Maryland, Dept Pathol, Baltimore, MD 21201 USA; NHLBI, Sect Expt Atherosclerosis, NIH, Bethesda, MD 20892 USA; Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	United States Department of Defense; Harvard University; Massachusetts General Hospital; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Drexel University	Virmani, R (corresponding author), Armed Forces Inst Pathol, Dept Cardiovasc Pathol, Bldg 54,Rm 2005,6825 16th St, Washington, DC 20306 USA.				NHLBI NIH HHS [R01 HL61799-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002832, Z01HL002832, R01HL061799] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arbustini E, 2002, HEART, V88, P177, DOI 10.1136/heart.88.2.177; Auffray I, 2001, BLOOD, V97, P2872, DOI 10.1182/blood.V97.9.2872; Balkan J, 2002, BIOSCI BIOTECH BIOCH, V66, P2701, DOI 10.1271/bbb.66.2701; BARGER AC, 1984, NEW ENGL J MED, V310, P175, DOI 10.1056/NEJM198401193100307; Bloch K., 1991, NEW COMPREHENSIVE BI, V20, P363; Burke AP, 2002, CIRCULATION, V105, P297, DOI 10.1161/hc0302.102610; Burke AP, 1999, JAMA-J AM MED ASSOC, V281, P921, DOI 10.1001/jama.281.10.921; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; COFFEY MD, 1995, J CLIN INVEST, V96, P1866, DOI 10.1172/JCI118232; DARBONNE WC, 1991, J CLIN INVEST, V88, P1362, DOI 10.1172/JCI115442; Felton CV, 1997, ARTERIOSCL THROM VAS, V17, P1337, DOI 10.1161/01.ATV.17.7.1337; Guyton JR, 1996, ARTERIOSCL THROM VAS, V16, P4, DOI 10.1161/01.ATV.16.1.4; Ishikawa K, 2001, CIRC RES, V88, P506, DOI 10.1161/01.RES.88.5.506; ITO N, 1990, HISTOCHEM J, V22, P113, DOI 10.1007/BF01885790; Kempaiah RK, 2002, MOL CELL BIOCHEM, V236, P155, DOI 10.1023/A:1016199000149; Kockx MM, 2003, ARTERIOSCL THROM VAS, V23, P440, DOI 10.1161/01.ATV.0000057807.28754.7F; Koeppen AH, 1995, J NEUROL SCI, V134, P102, DOI 10.1016/0022-510X(95)00215-N; Koter M, 2002, EUR J CLIN PHARMACOL, V58, P501, DOI 10.1007/s00228-002-0507-9; KRUTH HS, 1984, AM J PATHOL, V114, P201; LALONDE JMA, 1977, VIRCHOWS ARCH B, V25, P221; Leon ME, 2002, ARCH PATHOL LAB MED, V126, P217; Martinez M, 1996, THROMB RES, V83, P375, DOI 10.1016/0049-3848(96)00147-8; McCarthy MJ, 1999, J VASC SURG, V30, P261, DOI 10.1016/S0741-5214(99)70136-9; Mofidi R, 2001, BRIT J SURG, V88, P945, DOI 10.1046/j.0007-1323.2001.01823.x; NEOTE K, 1993, J BIOL CHEM, V268, P12247; PATTERSON JC, 1954, S ATH; SAMBRANO GR, 1994, P NATL ACAD SCI USA, V91, P3265, DOI 10.1073/pnas.91.8.3265; SCHICK BP, 1985, BIOCHIM BIOPHYS ACTA, V833, P281, DOI 10.1016/0005-2760(85)90200-0; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Tabas I, 2000, BBA-MOL CELL BIOL L, V1529, P164, DOI 10.1016/S1388-1981(00)00146-3; Tulenko TN, 1998, J LIPID RES, V39, P947; Virmani R, 1998, AM HEART J, V136, P937, DOI 10.1016/S0002-8703(98)70144-9; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Virmani R., 1987, ADULT CONGENITAL HEA, P77; VIRMANI R, 1996, ATLAS CARDIOVASCULAR, P103; Wartman WB, 1938, AM HEART J, V15, P459, DOI 10.1016/S0002-8703(38)90300-X; WARTMAN WB, 1949, AM J PATHOL, V25, P383; WINTERNITZ MC, 1938, BIOL ARTERIOSCLEROSI, P94; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; YUAN XM, 1995, ARTERIOSCL THROM VAS, V15, P1345, DOI 10.1161/01.ATV.15.9.1345	40	1043	1109	4	48	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2003	349	24					2316	2325		10.1056/NEJMoa035655	http://dx.doi.org/10.1056/NEJMoa035655			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752AX	14668457				2022-12-24	WOS:000187125000007
J	Sharp, D				Sharp, D			The West Nile season	LANCET			English	Editorial Material							VIRUS		Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, London NW1 7BY, England.							Buckley A, 2003, J GEN VIROL, V84, P2807, DOI 10.1099/vir.0.19341-0; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; *CDCP, 2003, W NIL ACT 2003 HUM C; Centers for Disease Control and Prevention, 2003, MMWR-MORBID MORTAL W, V52, P886; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969; Pletnev AG, 2003, VIROLOGY, V314, P190, DOI 10.1016/S0042-6822(03)00450-1	7	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1870	1870		10.1016/S0140-6736(03)14999-9	http://dx.doi.org/10.1016/S0140-6736(03)14999-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667740				2022-12-24	WOS:000187011600005
J	Bower, EA				Bower, EA			Use of amphetamines in the military environment	LANCET			English	Article									Naval Hosp Pensacola, Dept Internal Med, Pensacola, FL 32512 USA; USN, Med Corps, Washington, DC USA	United States Department of Defense; United States Navy	Bower, EA (corresponding author), Naval Hosp Pensacola, Dept Internal Med, 6000 W Highway 98, Pensacola, FL 32512 USA.								0	9	11	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S18	S19		10.1016/S0140-6736(03)15060-X	http://dx.doi.org/10.1016/S0140-6736(03)15060-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698114				2022-12-24	WOS:000187790200010
J	Pilmanis, AA				Pilmanis, AA			Physiological hazards of flight at high altitude	LANCET			English	Article									USAF, Res Lab, AFRL HEPR, Brooks AFB, TX 78235 USA	United States Department of Defense; United States Air Force	Pilmanis, AA (corresponding author), 309 Driftwind, San Antonio, TX 78239 USA.								0	7	7	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S16	S17		10.1016/S0140-6736(03)15059-3	http://dx.doi.org/10.1016/S0140-6736(03)15059-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698113	Bronze, Green Submitted			2022-12-24	WOS:000187790200009
J	Webb, P				Webb, P			Can famine relief meet health and hunger goals simultaneously?	LANCET			English	Article									UN, World Food Programme, I-00148 Rome, Italy; Tufts Univ, Friedman Sch Nutr Sci & Policy, Food Policy & Appl Nutr Programme, Boston, MA 02111 USA	Tufts University	Webb, P (corresponding author), UN, World Food Programme, Via GC Viola 68-70,Parco Medici, I-00148 Rome, Italy.		Webb, Patrick/P-3420-2017	Webb, Patrick/0000-0002-9857-3354				DEWAAL A, 2003, NEW VARIANT FAMINE H; Sen A, 1981, POVERTY FAMINES	2	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S40	S41		10.1016/S0140-6736(03)15071-4	http://dx.doi.org/10.1016/S0140-6736(03)15071-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698125				2022-12-24	WOS:000187790200021
J	Tanser, FC; Sharp, B; le Sueur, D				Tanser, FC; Sharp, B; le Sueur, D			Potential effect of climate change on malaria transmission in Africa	LANCET			English	Article							DISEASE; MODEL	Background Climate change is likely to affect transmission of vector-borne diseases such as malaria. We quantitatively estimated current malaria exposure and assessed the potential effect of projected climate scenarios on malaria transmission. Methods We produced a spatiotemporally validated (against 3791 parasite surveys) model of Plasmodium falciparum malaria transmission in Africa. Using different climate scenarios from the Hadley Centre global climate model (HAD CM3) climate experiments, we projected the potential effect of climate change on transmission patterns. Findings Our model showed sensitivity and specificity of 63% and 96%, respectively (within 1 month temporal accuracy), when compared with the parasite surveys. We estimate that on average there are 3.1 billion person-months of exposure (445 million people exposed) in Africa per year. The projected scenarios would estimate a 5-7% potential increase (mainly altitudinal) in malaria distribution with surprisingly little increase in the latitudinal extents of the disease by 2100. Of the overall potential increase (although transmission will decrease in some countries) of 16-28% in person-months of exposure (assuming a constant population), a large proportion will be seen in areas of existing transmission. Interpretation The effect of projected climate change indicates that a prolonged transmission season is as important as geographical expansion in correct assessment of the effect of changes in transmission patterns. Our model constitutes a valid baseline against which climate scenarios can be assessed and interventions planned.	MRC, Malaria Res Lead Programme, ZA-4067 Overport, South Africa; Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa	University of Kwazulu Natal	Tanser, FC (corresponding author), MRC, Malaria Res Lead Programme, ZA-4067 Overport, South Africa.	tanserf@mrc.ac.za	Tanser, Frank/ABE-8326-2021	Tanser, Frank/0000-0001-9797-0000				Akhtar R, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, P451; [Anonymous], 1999, WORLD HLTH REPORT 19; Barnett TP, 1999, J CLIMATE, V12, P511, DOI 10.1175/1520-0442(1999)012<0511:CONSAT>2.0.CO;2; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; DEICHMANN U, 1996, AFRICA POPULATION DA; Fisher R. W., 1996, FUTURE RES Q, V31, P43; Hammond A., 1996, WHICH WORLD; Hay SI, 1998, T ROY SOC TROP MED H, V92, P12, DOI 10.1016/S0035-9203(98)90936-1; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Hutchinson M. F., 1995, AFRICA TOPOGRAPHIC C; Johns TC, 2003, CLIM DYNAM, V20, P583, DOI 10.1007/s00382-002-0296-y; Kleinschmidt I, 2000, INT J EPIDEMIOL, V29, P355, DOI 10.1093/ije/29.2.355; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; MARA, 1998, ATL MAL RISK AFR 1 T; Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; Molineaux L, 1988, MALARIA PRINCIPLES P, P919; Nabarro DN, 1998, SCIENCE, V280, P2067, DOI 10.1126/science.280.5372.2067; Nakicenovic N., 2000, SPECIAL REPORT EMISS; ONORI E, 1980, B WORLD HEALTH ORGAN, V58, P91; Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a; Reiter P, 2000, EMERG INFECT DIS, V6, P1; Reiter P, 1998, LANCET, V351, P839, DOI 10.1016/S0140-6736(05)78979-0; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; SLOOFF R., 1961, Tropical and Geographical Medicine, V13, P67; Snow RW, 1998, T ROY SOC TROP MED H, V92, P601, DOI 10.1016/S0035-9203(98)90781-7; STUCKENBERG BR, 1969, ZOOL AFR, P145; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; World Health Organization, 1993, GLOB STRAT MAL CONTR	30	263	273	3	100	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1792	1798		10.1016/S0140-6736(03)14898-2	http://dx.doi.org/10.1016/S0140-6736(03)14898-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654317				2022-12-24	WOS:000186872900010
J	Huang, TT; Wuerzbrger-Davis, SM; Wu, ZH; Miyamoto, S				Huang, TT; Wuerzbrger-Davis, SM; Wu, ZH; Miyamoto, S			Sequential modification of NEMO/IKK gamma by SUMO-1 and ubiquitin mediates NF-kappa B activation by genotoxic stress	CELL			English	Article							NUCLEAR EXPORT SIGNAL; DNA-DAMAGE; TRANSCRIPTIONAL ACTIVATION; ECTODERMAL DYSPLASIA; IONIZING-RADIATION; GENE-EXPRESSION; IKK ACTIVATION; FAMILY-MEMBERS; KINASE COMPLEX; PORE COMPLEX	The transcription factor NF-kappaB is critical for setting the cellular sensitivities to apoptotic stimuli, including DNA damaging anticancer agents. Central to NF-kappaB signaling pathways is NEMO/IKKgamma, the regulatory subunit of the cytoplasmic IkappaB kinase (IKK) complex. While NF-kappaB activation by genotoxic stress provides an attractive paradigm for nuclear-to-cytoplasmic signaling pathways, the mechanism by which nuclear DNA damage modulates NEMO to activate cytoplasmic IKK remains unknown. Here, we show that genotoxic stress causes nuclear localization of IKK-unbound NEMO via site-specific SUMO-1 attachment. Surprisingly, this sumoylation step is ATM-independent, but nuclear localization allows subsequent ATM-dependent ubiquitylation of NEMO to ultimately activate IKK in the cytoplasm. Thus, genotoxic stress induces two independent signaling pathways, SUMO-1 modification and ATM activation, which work in concert to sequentially cause nuclear targeting and ubiquitylation of free NEMO to permit the NF-kappaB survival pathway. These SUMO and ubiquitin modification pathways may serve as anticancer drug targets.	Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA; Univ Wisconsin, Program Mol & Cellular Biol, Madison, WI 53706 USA; Univ Wisconsin, Program Canc Biol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Miyamoto, S (corresponding author), Univ Wisconsin, Dept Pharmacol, 301 SMI,1300 Univ Ave, Madison, WI 53706 USA.	smiyamot@wisc.edu			NATIONAL CANCER INSTITUTE [R01CA077474, R01CA081065] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA081065, R01-CA077474] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Criswell T, 2003, ONCOGENE, V22, P5813, DOI 10.1038/sj.onc.1206680; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; DEVARY Y, 1992, CELL, V71, P1081, DOI 10.1016/S0092-8674(05)80058-3; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang TT, 2000, J BIOL CHEM, V275, P9501, DOI 10.1074/jbc.275.13.9501; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Huang TT, 2001, MOL CELL BIOL, V21, P4737, DOI 10.1128/MCB.21.14.4737-4747.2001; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Hur GM, 2003, GENE DEV, V17, P873, DOI 10.1101/gad.1062403; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kurepa J, 2003, J BIOL CHEM, V278, P6862, DOI 10.1074/jbc.M209694200; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahanty SK, 1999, CELL, V98, P501, DOI 10.1016/S0092-8674(00)81978-9; Makris C, 2002, MOL CELL BIOL, V22, P6573, DOI 10.1128/MCB.22.18.6573-6581.2002; Malek S, 2001, J BIOL CHEM, V276, P45225, DOI 10.1074/jbc.M105865200; Mao Y, 2000, P NATL ACAD SCI USA, V97, P4046, DOI 10.1073/pnas.080536597; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Miyamoto S, 1998, MOL CELL BIOL, V18, P19, DOI 10.1128/MCB.18.1.19; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Rui HL, 2002, J BIOL CHEM, V277, P42981, DOI 10.1074/jbc.M208099200; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Smahi A, 2000, NATURE, V405, P466; Sun SC, 1999, ONCOGENE, V18, P6948, DOI 10.1038/sj.onc.1203220; Tam WF, 2001, J BIOL CHEM, V276, P7701, DOI 10.1074/jbc.C000916200; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weil R, 2003, IMMUNITY, V18, P13, DOI 10.1016/S1074-7613(02)00506-X; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	56	455	477	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 26	2003	115	5					565	576		10.1016/S0092-8674(03)00895-X	http://dx.doi.org/10.1016/S0092-8674(03)00895-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651848	Bronze			2022-12-24	WOS:000186885600007
J	Fliers, E; Sauerwein, HP; Romijn, JA; Reiss, P; van der Valk, M; Kalsbeek, A; Kreier, F; Buijs, RM				Fliers, E; Sauerwein, HP; Romijn, JA; Reiss, P; van der Valk, M; Kalsbeek, A; Kreier, F; Buijs, RM			HIV-associated adipose redistribution syndrome as a selective autonomic neuropathy	LANCET			English	Article							VIRUS-INFECTED PATIENTS; PROTEASE INHIBITORS; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; INSULIN-RESISTANCE; LIPODYSTROPHY; GLUTAMATE; INNERVATION; NUCLEUS; TISSUE	Abnormal body-fat distribution in HIV-1-associated adipose redistribution syndrome (HARS) remains unexplained at present. White adipose tissue is controlled by humoral factors and by neural regulation. Sympathetic innervation stimulates lipolysis, whereas parasympathetic innervation has an anabolic influence on white adipose tissue. Results of neuroanatomical studies showed a clear somatotopy with respect to autonomic control of white adipose tissue by both the sympathetic and parasympathetic branch, with separate sets of autonomic neurons innervating either the subcutaneous or the visceral fat compartment. Thus, the CNS is likely to be a key player in regulation of body-fat distribution. We propose that HARS is mediated by effects of antiretroviral treatment on the CNS and could indicate a change in autonomic balance resulting in redistribution of adipose tissue.	Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1100 DE Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Infect Dis Trop Med & AIDS, NL-1100 DE Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Int Antiviral Therapy Evaluat Ctr, NL-1100 DE Amsterdam, Netherlands; Netherlands Inst Brain Res, NL-1105 AZ Amsterdam, Netherlands; Leiden Univ, Med Ctr, Dept Endocrinol & Metab, NL-2300 RC Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Fliers, E (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, F5-168,POB 22700, NL-1100 DE Amsterdam, Netherlands.		van der valk, marc/AAQ-9026-2020; Kalsbeek, Andries/H-3076-2019; Kreier, Felix/C-3371-2008; Buijs, Rudolf/AAD-5707-2020	van der valk, marc/0000-0002-8290-6425; Kalsbeek, Andries/0000-0001-9606-8453; Fliers, Eric/0000-0001-8048-9050				Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; Bastard JP, 2002, LANCET, V359, P1026, DOI 10.1016/S0140-6736(02)08094-7; Buijs RM, 2001, J COMP NEUROL, V431, P405, DOI 10.1002/1096-9861(20010319)431:4<405::AID-CNE1079>3.0.CO;2-D; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Chen DL, 2002, J CLIN ENDOCR METAB, V87, P4845, DOI 10.1210/jc.2002-020794; Christeff N, 2002, EUR J CLIN INVEST, V32, P775, DOI 10.1046/j.1365-2362.2002.01068.x; Dawson R, 1997, AM J PHYSIOL-ENDOC M, V273, pE202, DOI 10.1152/ajpendo.1997.273.1.E202; Flier JS, 2000, J CLIN INVEST, V105, P859, DOI 10.1172/JCI9725; GRIPSHOVER B, 2003, P 10 C RETR OPP INF; Kreier F, 2002, J CLIN INVEST, V110, P1243, DOI 10.1172/JCI200215736; Ledru E, 2000, BLOOD, V95, P3191, DOI 10.1182/blood.V95.10.3191.010k10_3191_3198; Lo JC, 1998, LANCET, V351, P867, DOI 10.1016/S0140-6736(97)11443-X; Martinez E, 2001, LANCET, V357, P592, DOI 10.1016/S0140-6736(00)04056-3; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Morris MJ, 1998, REGUL PEPTIDES, V75-6, P441, DOI 10.1016/S0167-0115(98)00100-1; van der Valk M, 2002, J CLIN ENDOCR METAB, V87, P5066, DOI 10.1210/jc.2002-020892; van der Valk M, 2001, AIDS, V15, P847, DOI 10.1097/00002030-200105040-00005; Vesce S, 1997, FEBS LETT, V411, P107, DOI 10.1016/S0014-5793(97)00674-1; Wulff EA, 2000, DRUGS, V59, P1251, DOI 10.2165/00003495-200059060-00005; Wynn HE, 2002, CNS DRUGS, V16, P595, DOI 10.2165/00023210-200216090-00002; Yanovski JA, 1999, J CLIN ENDOCR METAB, V84, P1925, DOI 10.1210/jc.84.6.1925	21	43	46	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 22	2003	362	9397					1758	1760		10.1016/S0140-6736(03)14858-1	http://dx.doi.org/10.1016/S0140-6736(03)14858-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746VE	14643128				2022-12-24	WOS:000186767700027
J	Mah, TF; Pitts, B; Pellock, B; Walker, GC; Stewart, PS; O'Toole, GA				Mah, TF; Pitts, B; Pellock, B; Walker, GC; Stewart, PS; O'Toole, GA			A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance	NATURE			English	Article							MOLECULAR-WEIGHT; SUCCINOGLYCAN; PENETRATION; LIMITATION; EXPRESSION	Biofilms are surface-attached microbial communities with characteristic architecture and phenotypic and biochemical properties distinct from their free-swimming, planktonic counterparts(1). One of the best-known of these biofilm-specific properties is the development of antibiotic resistance that can be up to 1,000-fold greater than planktonic cells(2). We report a genetic determinant of this high-level resistance in the Gram-negative opportunistic pathogen, Pseudomonas aeruginosa. We have identified a mutant of P. aeruginosa that, while still capable of forming biofilms with the characteristic P. aeruginosa architecture, does not develop high-level biofilm-specific resistance to three different classes of antibiotics. The locus identified in our screen, ndvB, is required for the synthesis of periplasmic glucans. Our discovery that these periplasmic glucans interact physically with tobramycin suggests that these glucose polymers may prevent antibiotics from reaching their sites of action by sequestering these antimicrobial agents in the periplasm. Our results indicate that biofilms themselves are not simply a diffusion barrier to these antibiotics, but rather that bacteria within these microbial communities employ distinct mechanisms to resist the action of antimicrobial agents.	Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Hanover, NH 03755 USA; Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA; MIT, Dept Biol, Cambridge, MA 02412 USA	Dartmouth College; Montana State University System; Montana State University Bozeman; Massachusetts Institute of Technology (MIT)	O'Toole, GA (corresponding author), Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Hanover, NH 03755 USA.	georgeo@Dartmouth.edu		/0000-0001-7243-8261; Stewart, Philip/0000-0001-7773-8570				Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; Bhagwat AA, 1996, J BACTERIOL, V178, P4635, DOI 10.1128/jb.178.15.4635-4642.1996; Bloemberg GV, 1997, APPL ENVIRON MICROB, V63, P4543, DOI 10.1128/AEM.63.11.4543-4551.1997; BREEDVELD MW, 1994, MICROBIOL REV, V58, P145, DOI 10.1128/MMBR.58.2.145-161.1994; CAETANOANOLLES G, 1993, PCR METH APPL, V3, P85; Chen RJ, 2002, CAN J MICROBIOL, V48, P1008, DOI 10.1139/W02-099; Christensen BB, 1999, METHOD ENZYMOL, V310, P20; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Gonzalez JE, 1998, P NATL ACAD SCI USA, V95, P13477, DOI 10.1073/pnas.95.23.13477; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hoyle B D, 1991, Prog Drug Res, V37, P91; LOEWUS FA, 1952, ANAL CHEM, V24, P219, DOI 10.1021/ac60061a050; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; PARDEE AB, 1959, J MOL BIOL, V1, P165, DOI 10.1016/S0022-2836(59)80045-0; SIMON R, 1989, GENE, V80, P161, DOI 10.1016/0378-1119(89)90262-X; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; SZEJTLI J, 1990, CARBOHYD POLYM, V12, P375, DOI 10.1016/0144-8617(90)90088-A; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; Wang LX, 1999, J BACTERIOL, V181, P6788, DOI 10.1128/JB.181.21.6788-6796.1999; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627	24	799	864	6	228	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2003	426	6964					306	310		10.1038/nature02122	http://dx.doi.org/10.1038/nature02122			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628055	Green Published			2022-12-24	WOS:000186660800048
J	Mofenson, LM; Harris, DR; Moye, J; Bethel, J; Korelitz, J; Read, JS; Nugent, R; Meyer, W				Mofenson, LM; Harris, DR; Moye, J; Bethel, J; Korelitz, J; Read, JS; Nugent, R; Meyer, W		NICHD IVIG Clinical Trial Study Gr	Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1-infected children in resource-poor settings	LANCET			English	Article								Cheaper, simpler alternatives to CD4 lymphocyte count and HIV-1 RNA detection for assessing the prognosis of HIV-1 infection are needed for resource-poor settings. However, little is known about the predictive value of alternative assays, in particular in children. We assessed the prognostic value of total lymphocyte count, immune complex-dissociated p24 antigen, white blood cell count, packed-cell volume (haematocrit), and serum albumin for mortality in 376 HIV-1-infected, mainly African-American or Hispanic children enrolled during March, 1988 to January, 1991. In a Cox proportional hazards model, including all assay-alternatives to CD4 and RNA, total lymphocyte count (p<0.0001) and serum albumin (p=0.0107) independently predicted mortality. Further assessment of these markers is warranted in resource-poor settings.	NICHHD, Pediat Adolescent & Maternal AIDS Branch, NIH, Rockville, MD 20852 USA; WESTAT Corp, Rockville, MD 20850 USA; Quest Diagnost, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Westat	Mofenson, LM (corresponding author), NICHHD, Pediat Adolescent & Maternal AIDS Branch, NIH, 6100 Execut Blvd, Rockville, MD 20852 USA.	LM65D@nih.gov	Mofenson, Lynne/P-9631-2019	Mofenson, Lynne/0000-0002-2818-9808; moye, john/0000-0001-9976-8586	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD033162] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 1998, MMWR Recomm Rep, V47, P1; MOFENSON LM, 1991, NEW ENGL J MED, V325, P73, DOI 10.1056/NEJM199107113250201; Mofenson LM, 1997, J INFECT DIS, V175, P1029, DOI 10.1086/516441; Rabkin M, 2002, LANCET, V360, P1503, DOI 10.1016/S0140-6736(02)11478-4; Taha TE, 2000, AIDS, V14, P453, DOI 10.1097/00002030-200003100-00021	5	34	35	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2003	362	9396					1625	1627		10.1016/S0140-6736(03)14825-8	http://dx.doi.org/10.1016/S0140-6736(03)14825-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744MZ	14630444				2022-12-24	WOS:000186637400012
J	Ule, J; Jensen, KB; Ruggiu, M; Mele, A; Ule, A; Darnell, RB				Ule, J; Jensen, KB; Ruggiu, M; Mele, A; Ule, A; Darnell, RB			CLIP identifies Nova-regulated RNA networks in the brain	SCIENCE			English	Article							4 SPLICE VARIANTS; MESSENGER-RNAS; PROTEIN; BINDING; GEPHYRIN; RECEPTOR; DISEASE; CHANNELS; DOMAIN; MOUSE	Nova proteins are neuron-specific antigens targeted in paraneoplastic opsoclonus myoclonus ataxia (POMA), an autoimmune neurologic disease characterized by abnormal motor inhibition. Nova proteins regulate neuronal pre-messenger RNA splicing by directly binding to RNA. To identify Nova RNA targets, we developed a method to purify protein-RNA complexes from mouse brain with the use of ultraviolet cross-linking and immunoprecipitation (CLIP). Thirty-four transcripts were identified multiple times by Nova CLIP. Three-quarters of these encode proteins that function at the neuronal synapse, and one-third are involved in neuronal inhibition. Splicing targets confirmed in Nova(-/-) mice include c-Jun N-terminal kinase 2, neogenin, and gephyrin; the latter encodes a protein that clusters inhibitory gamma-aminobutyric acid and glycine receptors, two previously identified Nova splicing targets. Thus, CLIP reveals that Nova coordinately regulates a biologically coherent set of RNAs encoding multiple components of the inhibitory synapse, an observation that may relate to the cause of abnormal motor inhibition in POMA.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA; Univ Amsterdam, Ctr Res Expt Econ & Polit Decis Making, NL-1018 WB Amsterdam, Netherlands	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; University of Amsterdam	Darnell, RB (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.		Jensen, Kirk/AAL-5883-2020; Jensen, Kirk/B-4756-2008; Ule, Jernej/C-6315-2013; Darnell, Robert B/B-9022-2008	Jensen, Kirk/0000-0002-2084-1734; Jensen, Kirk/0000-0002-2084-1734; Ule, Jernej/0000-0002-2452-4277; Darnell, Robert B/0000-0002-5134-8088; Ruggiu, Matteo/0000-0002-6404-1210	NIMH NIH HHS [K01 MH64753] Funding Source: Medline; NINDS NIH HHS [NS40955, R01 NS34389] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH064753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034389, R01NS040955] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Billups D, 2000, J NEUROSCI, V20, P8643; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; Butler MH, 2000, NEURON, V26, P307, DOI 10.1016/S0896-6273(00)81165-4; Casanova E, 1996, NEUROREPORT, V7, P1320, DOI 10.1097/00001756-199605170-00021; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Dredge BK, 2003, MOL CELL BIOL, V23, P4687, DOI 10.1128/MCB.23.13.4687-4700.2003; Dredge BK, 2001, NAT REV NEUROSCI, V2, P43, DOI 10.1038/35049061; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; GAO FB, 1994, P NATL ACAD SCI USA, V91, P11207, DOI 10.1073/pnas.91.23.11207; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Keeling SL, 1997, ONCOGENE, V15, P691, DOI 10.1038/sj.onc.1201225; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Lerche H, 2001, AM J MED GENET, V106, P146, DOI 10.1002/ajmg.1582; LERNER MR, 1979, P NATL ACAD SCI USA, V76, P5495, DOI 10.1073/pnas.76.11.5495; LERNER MR, 1981, CELL, V25, P298, DOI 10.1016/0092-8674(81)90047-7; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Musunuru K, 2001, ANNU REV NEUROSCI, V24, P239, DOI 10.1146/annurev.neuro.24.1.239; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Ramming M, 2000, P NATL ACAD SCI USA, V97, P10266, DOI 10.1073/pnas.97.18.10266; RUGGIU M, UNPUB; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; ULE J, UNPUB; Villanueva A, 2001, EMBO J, V20, P5114, DOI 10.1093/emboj/20.18.5114; VONMUHLEN CA, 1995, SEMIN ARTHRITIS RHEU, V24, P323, DOI 10.1016/S0049-0172(95)80004-2; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25	33	791	818	2	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2003	302	5648					1212	1215		10.1126/science.1090095	http://dx.doi.org/10.1126/science.1090095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14615540				2022-12-24	WOS:000186544300055
J	Tovar, J; Leon-Avila, G; Sanchez, LB; Sutak, R; Tachezy, J; van der Giezen, M; Hernandez, M; Muller, M; Lucocq, JM				Tovar, J; Leon-Avila, G; Sanchez, LB; Sutak, R; Tachezy, J; van der Giezen, M; Hernandez, M; Muller, M; Lucocq, JM			Mitochondrial remnant organelles of Giardia function in iron-sulphur protein maturation	NATURE			English	Article							PARASITE ENTAMOEBA-HISTOLYTICA; TRICHOMONAS-VAGINALIS; LAMBLIA; HYDROGENOSOMES; INTESTINALIS; EUKARYOTES; GENE; GENOME; PHYLOGENY; EVOLUTION	Giardia intestinalis (syn. lamblia) is one of the most widespread intestinal protozoan pathogens worldwide, causing hundreds of thousands of cases of diarrhoea each year(1). Giardia is a member of the diplomonads, often described as an ancient protist group whose primitive nature is suggested by the lack of typical eukaryotic organelles (for example, mitochondria, peroxisomes), the presence of a poorly developed endomembrane system and by their early branching in a number of gene phylogenies(1,2). The discovery of nuclear genes of putative mitochondrial ancestry in Giardia(3-7) and the recent identification of mitochondrial remnant organelles in amitochondrial protists such as Entamoeba histolytica(8,9) and Trachipleistophora hominis(10) suggest that the eukaryotic amitochondrial state is not a primitive condition but is rather the result of reductive evolution. Using an in vitro protein reconstitution assay and specific antibodies against IscS and IscU-two mitochondrial marker proteins involved in iron sulphur cluster biosynthesis-here we demonstrate that Giardia contains mitochondrial remnant organelles (mitosomes) bounded by double membranes that function in iron-sulphur protein maturation. Our results indicate that Giardia is not primitively amitochondrial and that it has retained a functional organelle derived from the original mitochondrial endosymbiont.	Univ London, Royal Holloway, Sch Biol Sci, Egham TW20 0EX, Surrey, England; Rockefeller Univ, New York, NY 10021 USA; Charles Univ, Fac Sci, Dept Parasitol, CR-12844 Prague, Czech Republic; Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland	University of London; Royal Holloway University London; Rockefeller University; Charles University Prague; University of Dundee	Tovar, J (corresponding author), Univ London, Royal Holloway, Sch Biol Sci, Egham TW20 0EX, Surrey, England.		Tachezy, Jan/R-4945-2017; sutak, robert/R-4369-2017; van der Giezen, Mark/J-9550-2019	Tachezy, Jan/0000-0001-6976-8446; sutak, robert/0000-0001-5588-1683; van der Giezen, Mark/0000-0002-1033-1335; lucocq, john/0000-0002-5191-0093				Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Andersson JO, 2003, CURR BIOL, V13, P94, DOI 10.1016/S0960-9822(03)00003-4; Arisue N, 2002, PARASITOL INT, V51, P9, DOI 10.1016/S1383-5769(01)00093-9; Cochran W. G., 1977, SAMPLING TECHNIQUES; Doolittle WE, 1998, TRENDS GENET, V14, P307; Dyall SD, 2000, CURR OPIN MICROBIOL, V3, P404, DOI 10.1016/S1369-5274(00)00112-0; Embley TM, 2003, PHILOS T R SOC B, V358, P191, DOI 10.1098/rstb.2002.1190; Hashimoto T, 1998, P NATL ACAD SCI USA, V95, P6860, DOI 10.1073/pnas.95.12.6860; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; Lloyd D, 2002, MICROBIOL-SGM, V148, P1349, DOI 10.1099/00221287-148-5-1349; Lloyd D, 2002, TRENDS MICROBIOL, V10, P122, DOI 10.1016/S0966-842X(02)02306-5; Lloyd D, 2002, MICROBIOL-SGM, V148, P727, DOI 10.1099/00221287-148-3-727; Mai ZM, 1999, MOL CELL BIOL, V19, P2198; Martin W, 2001, BIOL CHEM, V382, P1521, DOI 10.1515/BC.2001.187; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; Morrison HG, 2001, MOL BIOL EVOL, V18, P530, DOI 10.1093/oxfordjournals.molbev.a003832; Muller M., 2003, MOL MED PARASITOLOGY, P125, DOI DOI 10.1016/B978-012473346-6/50008-9; Philippe H, 2000, P ROY SOC B-BIOL SCI, V267, P1213, DOI 10.1098/rspb.2000.1130; Prescott AR, 1997, EUR J CELL BIOL, V72, P238; RIORDAN CE, 2003, CURR GENET      0820; Roger AJ, 1998, P NATL ACAD SCI USA, V95, P229, DOI 10.1073/pnas.95.1.229; Sogin ML, 1998, INT J PARASITOL, V28, P11, DOI 10.1016/S0020-7519(97)00181-1; SOLTYS BJ, 1994, J PARASITOL, V80, P580, DOI 10.2307/3283195; Strong WB, 2000, MOL BIOCHEM PARASIT, V107, P1, DOI 10.1016/S0166-6851(99)00225-X; Tachezy J, 2001, MOL BIOL EVOL, V18, P1919, DOI 10.1093/oxfordjournals.molbev.a003732; Tokumoto U, 2002, J BIOCHEM, V131, P713, DOI 10.1093/oxfordjournals.jbchem.a003156; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tovar J, 1999, MOL MICROBIOL, V32, P1013, DOI 10.1046/j.1365-2958.1999.01414.x; Vidakovic MS, 1996, J BIOL CHEM, V271, P14734, DOI 10.1074/jbc.271.25.14734; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949	31	369	389	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2003	426	6963					172	176		10.1038/nature01945	http://dx.doi.org/10.1038/nature01945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614504				2022-12-24	WOS:000186517200041
J	Mantyselka, PT; Turunen, JHO; Ahonen, RS; Kumpusalo, EA				Mantyselka, PT; Turunen, JHO; Ahonen, RS; Kumpusalo, EA			Chronic pain and poor self-rated health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-BACK-PAIN; GENERAL-POPULATION; MUSCULOSKELETAL PAIN; DEPRESSIVE SYMPTOMS; PRIMARY-CARE; PREVALENCE; COMMUNITY; COMPLAINTS; IMPACT; ADULTS	Context Chronic pain is common in Western societies. Self-rated health is an important indicator of morbidity and mortality, but little is known about the relation between chronic pain and self-rated health in the general population. Objective To analyze the association between chronic pain and self-rated health. Design, Setting, and Population A questionnaire survey carried out during the spring of 2002 of an age- and sex-stratified population sample of 6500 individuals in Finland aged 15 to 74 years, with a response rate of 71% (N=4542) after exclusion of those with unobtainable data (n=38). Chronic pain was defined as pain with a duration of at least 3 months and was graded by frequency: (1) at most once a week; (2) several times a week; and (3) daily or continuously. On the basis of a 5-item questionnaire on self-rated health; individuals were classified as having good, moderate, or poor health. Multinominal logistic regression analysis was used to assess the determinants of health. Analysis included sex, age, education, working status, chronic diseases, and mood. Main Outcome Measures Perceived chronic pain graded by,frequency and self-rated health status. Results The prevalence of any chronic pain was 35.1%; that of daily chronic pain, 14.3%. The prevalence of moderate self-rated health was 26.6% and of poor health, 7.6%. For moderate self-rated health among individuals having chronic pain at most once a week compared with individuals having no chronic pain, the adjusted odds were 1.36 (95% confidence interval [CI], 1.05-1.76); several times a week, 2.41 (95% CI, 1.94-3.00); and daily, 3.69 (95% CI, 2.97-4.59). Odds for poor self-rated health were as follows: having chronic pain at most once a week, 1.16 (95% CI, 0.65-2.07); several times a week, 2.62 (95% CI, 1.76-3.90); and daily, 11.82 (95% CI, 8.67-16.10). Conclusion Chronic pain is independently related to low self-rated health in the general population.	Univ Kuopio, Dept Publ Hlth & Gen Practice, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, Unit Gen Practice, Kuopio, Finland; Univ Kuopio, Dept Social Pharm, FIN-70211 Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland	Mantyselka, PT (corresponding author), Univ Kuopio, Dept Publ Hlth & Gen Practice, POB 1627, FIN-70211 Kuopio, Finland.	pekka.mantyselka@uku.fi		Turunen, Juha/0000-0002-9913-1240				Andersson HI, 1999, SCAND J PRIM HEALTH, V17, P87, DOI 10.1080/028134399750002700; ARINEN S, 1998, HLTH USE HLTH SERVIC; Blyth FM, 2001, PAIN, V89, P127, DOI 10.1016/S0304-3959(00)00355-9; BRATTBERG G, 1989, PAIN, V37, P215, DOI 10.1016/0304-3959(89)90133-4; Buskila D, 2000, J RHEUMATOL, V27, P1521; Cott CA, 1999, J EPIDEMIOL COMMUN H, V53, P731, DOI 10.1136/jech.53.11.731; CROFT P, 1993, J RHEUMATOL, V20, P710; CROOK J, 1984, PAIN, V18, P299, DOI 10.1016/0304-3959(84)90824-8; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; Elliott AM, 2002, PAIN, V99, P299, DOI 10.1016/S0304-3959(02)00138-0; Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006; Frolund F, 1986, Scand J Prim Health Care, V4, P97; FRYMOYER JW, 1991, ORTHOP CLIN N AM, V22, P263; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; MAGNI G, 1990, PAIN, V43, P299, DOI 10.1016/0304-3959(90)90027-B; Mantyselka P, 2001, PAIN, V89, P175, DOI 10.1016/S0304-3959(00)00361-4; Mantyselka PT, 2002, EUR J PAIN, V6, P141, DOI 10.1053/eujp.2001.0311; Molarius A, 2002, J CLIN EPIDEMIOL, V55, P364, DOI 10.1016/S0895-4356(01)00491-7; *NAT AG MED SOC IN, 2002, FINN STAT MED 2001; Ohayon MM, 2003, ARCH GEN PSYCHIAT, V60, P39, DOI 10.1001/archpsyc.60.1.39; Reyes-Gibby CC, 2002, PAIN, V95, P75, DOI 10.1016/S0304-3959(01)00375-X; SALOKANGAS RKR, 1995, ACTA PSYCHIAT SCAND, V92, P10, DOI 10.1111/j.1600-0447.1995.tb09536.x; Salokangas RKR, 2002, J AFFECT DISORDERS, V68, P215, DOI 10.1016/S0165-0327(00)00315-3; Smith BH, 2001, FAM PRACT, V18, P292, DOI 10.1093/fampra/18.3.292; VANTULDER MW, 1995, PAIN, V62, P233, DOI 10.1016/0304-3959(94)00272-G; Verhaak PFM, 1998, PAIN, V77, P231, DOI 10.1016/S0304-3959(98)00117-1; WEBSTER BS, 1994, SPINE, V19, P1111, DOI 10.1097/00007632-199405001-00001; *WHO, REG OFF EUR COUNTR I	29	221	229	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2003	290	18					2435	2442		10.1001/jama.290.18.2435	http://dx.doi.org/10.1001/jama.290.18.2435			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742LH	14612480	Bronze			2022-12-24	WOS:000186518300030
J	Stewart, WF; Ricci, JA; Chee, E; Morganstein, D; Lipton, R				Stewart, WF; Ricci, JA; Chee, E; Morganstein, D; Lipton, R			Lost productive time and cost due to common pain conditions in the US workforce	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; UNITED-STATES; MUSCULOSKELETAL DISORDERS; BACK-PAIN; WORK LOSS; AMERICAN MIGRAINE; HEALTH LITERACY; ECONOMIC COST; DOUBLE-BLIND; IMPACT	Context Common pain conditions appear to have an adverse effect on work, but no comprehensive estimates exist on the amount of productive time lost in the US workforce due to pain. Objective To measure lost productive time (absence and:reduced performance due to common pain conditions) during a 2-week period. Design,and Setting Cross-sectional study using survey data from the American Productivity Audit (a telephone survey that uses the Work and Health Interview) of working adults between August 1, 2001, and July 30, 2002. Participants Random sample of 28902 working adults in the United States. Main Outcome Measures Lost productive time due to common pain conditions (arthritis, back, headache, and other musculoskeletal) expressed in hours per worker per week and calculated in US dollars. Results Thirteen percent of the total workforce experienced a loss in productive time during a 2-week period due to a common pain condition. Headache was the most common (5.4%) pain condition resulting in lost productive time. It was followed by back pain (3.2%), arthritis pain (2.0%), and other mosculoskeletal pain. (2.0%) Workers who experienced lost productive time from a pain condition lost a mean (SE) of 4.6 (0.09) h/wk. Workers who had a headache had a mean (SE) loss in productive time of 3.5 (0.1) h/wk. Workers who reported arthritis or back pain had mean (SE) lost productive times of 5.2 (0.25) h/wk. Other common pain conditions resulted in a mean (SE) loss in productive time of 5.5 (0.22) h/wk. Lost productive time from common pain conditions among active workers costs an estimated $61.2 billion per year. The majority (76.6%) of the lost productive time was explained by reduced performance while at work and not work absence. Conclusions Pain is an inordinately common and disabling condition in the US work-force. Most of the pain-related lost productive time occurs while employees are at work-force. Most of the pain-related lost productive time occurs while employees are at work and is in the form of reduced. performance.	Geisinger Hlth Syst, Ctr Hlth Res & Rural Advocacy, Danville, PA 17822 USA; AdvancePCS Ctr Work & Hlth, Hunt VAlley, MD USA; WESTAT Corp, Stat Grp, Rockville, MD 20850 USA; Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA	Geisinger Health System; Westat; Yeshiva University; Albert Einstein College of Medicine	Stewart, WF (corresponding author), Geisinger Hlth Syst, Ctr Hlth Res & Rural Advocacy, 100 N Acad Ave, Danville, PA 17822 USA.		Bannuru, Raveendhara/G-2601-2011	Bannuru, Raveendhara/0000-0002-8069-5783				Berger ML, 2001, J OCCUP ENVIRON MED, V43, P18, DOI 10.1097/00043764-200101000-00005; Brick J M, 1996, Stat Methods Med Res, V5, P215, DOI 10.1177/096228029600500302; *BUR LAB STAT BUR, CURR POP SURV; Cady RC, 1998, ARCH INTERN MED, V158, P1013, DOI 10.1001/archinte.158.9.1013; Clark RG, 2002, INT STAT REV, V70, P289, DOI 10.2307/1403911; Cockburn I M, 1999, Bus Health, V17, P49; Cole DC, 2001, OCCUP ENVIRON MED, V58, P728, DOI 10.1136/oem.58.11.728; Coyte PC, 1998, ARTHRIT CARE RES, V11, P315, DOI 10.1002/art.1790110503; Crystal-Peters J, 2000, AM J MANAG CARE, V6, P373; Cull RE, 1992, BRIT J EC, V2, P103; Dartigues JF, 1998, CEPHALALGIA, V18, P26, DOI 10.1177/0333102498018S2107; Dasbach EJ, 2000, CEPHALALGIA, V20, P830, DOI 10.1046/j.1468-2982.2000.00126.x; Fautrel B, 2002, CURR OPIN RHEUMATOL, V14, P121, DOI 10.1097/00002281-200203000-00008; Gazmararian JA, 1999, JAMA-J AM MED ASSOC, V281, P545, DOI 10.1001/jama.281.6.545; Gerth WC, 2001, PHARMACOECONOMICS, V19, P197, DOI 10.2165/00019053-200119020-00006; Greenberg P E, 1995, Bus Health, V13, P27; GREENBERG PE, 1993, J CLIN PSYCHIAT, V54, P405; GROVES RM, 1988, TELEPHONE SURVEY MET, P208; Guo HR, 1999, AM J PUBLIC HEALTH, V89, P1029, DOI 10.2105/AJPH.89.7.1029; Henke CJ, 2000, AM J GASTROENTEROL, V95, P788; HILDEBRANDT VH, 1995, ERGONOMICS, V38, P1283, DOI 10.1080/00140139508925188; Hu XH, 1999, ARCH INTERN MED, V159, P813, DOI 10.1001/archinte.159.8.813; KARASEK R, 1986, JOB CONTENT INSTRUME; Kessler RC, 2001, ANN ALLERG ASTHMA IM, V87, P289, DOI 10.1016/S1081-1206(10)62242-9; LEE P, 1994, QUAL LIFE RES, V3, pS85, DOI 10.1007/BF00433381; Lerner D, 2002, J CLIN EPIDEMIOL, V55, P197, DOI 10.1016/S0895-4356(01)00424-3; Lipton RB, 2001, HEADACHE, V41, P638, DOI 10.1046/j.1526-4610.2001.041007638.x; Lipton RB, 2000, NEUROLOGY, V55, P629, DOI 10.1212/WNL.55.5.629; McCunney RJ, 2001, J OCCUP ENVIRON MED, V43, P30, DOI 10.1097/00043764-200101000-00007; Merkesdal S, 2001, ARTHRITIS RHEUM-US, V44, P528, DOI 10.1002/1529-0131(200103)44:3<528::AID-ANR100>3.0.CO;2-U; Michel P, 1997, HEADACHE, V37, P71, DOI 10.1046/j.1526-4610.1997.3702071.x; Osterhaus J T, 1992, Pharmacoeconomics, V2, P67, DOI 10.2165/00019053-199202010-00008; Parker RM, 1999, JAMA-J AM MED ASSOC, V281, P552; RASMUSSEN BK, 1992, J EPIDEMIOL COMMUN H, V46, P443, DOI 10.1136/jech.46.4.443; RICCI JA, 2001, VALUE HEALTH, V4, P460, DOI DOI 10.1016/S1098-3015(11)71634-5; Rizzo JA, 1998, MED CARE, V36, P1471, DOI 10.1097/00005650-199810000-00006; Schulman EA, 2000, MAYO CLIN PROC, V75, P782, DOI 10.4065/75.8.782; Schwartz BS, 1997, J OCCUP ENVIRON MED, V39, P320, DOI 10.1097/00043764-199704000-00009; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1007/s11916-010-0146-2; Stang P, 2001, PHARMACOECONOMICS, V19, P231, DOI 10.2165/00019053-200119030-00002; STANG PE, 1993, HEADACHE, V33, P29, DOI 10.1111/j.1526-4610.1993.hed3301029.x; Stewart W, 2002, CNS DRUGS, V16, P5, DOI 10.2165/00023210-200216001-00002; Stewart WF, 2003, JAMA-J AM MED ASSOC, V289, P3135, DOI 10.1001/jama.289.23.3135; Stewart WF, 1996, CEPHALALGIA, V16, P231, DOI 10.1046/j.1468-2982.1996.1604231.x; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; STEWART WF, IN PRESS J OCCUP ENV; STEWART WF, IN PRESS U OCCUP ENV; *US OFF PERS MAN, 1999, FED CIV WORKF STAT O; Von Korff M, 1998, NEUROLOGY, V50, P1741, DOI 10.1212/WNL.50.6.1741; YELIN E, 1992, ARTHRITIS RHEUM, V35, P489, DOI 10.1002/art.1992.35.5.489; YELIN E, 1995, ARTHRITIS RHEUM, V38, P1351, DOI 10.1002/art.1780381002; Yelin EH, 1995, ARTHRIT CARE RES, V8, P311, DOI 10.1002/art.1790080417	52	1029	1047	1	56	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2003	290	18					2443	2454		10.1001/jama.290.18.2443	http://dx.doi.org/10.1001/jama.290.18.2443			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742LH	14612481	Bronze			2022-12-24	WOS:000186518300031
J	Ehlers, MD				Ehlers, MD			Eppendorf 2003 prize-winning essay - Ubiquitin and the deconstruction of synapses	SCIENCE			English	Editorial Material							POSTSYNAPTIC DENSITY; NMDA RECEPTOR; MODULATION; PROTEINS; FAMILY		Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	ehlers@neuro.duke.edu						Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Ehlers M.D., 2003, NAT NEUROSCI, V10, P10; GEINISMAN Y, 1991, BRAIN RES, V566, P77, DOI 10.1016/0006-8993(91)91683-R; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Meyer T, 2000, TRENDS CELL BIOL, V10, P238, DOI 10.1016/S0962-8924(00)01764-5; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	22	16	16	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2003	302	5646					800	801		10.1126/science.1092546	http://dx.doi.org/10.1126/science.1092546			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593160				2022-12-24	WOS:000186258000030
J	Martinowich, K; Hattori, D; Wu, H; Fouse, S; He, F; Hu, Y; Fan, GP; Sun, YE				Martinowich, K; Hattori, D; Wu, H; Fouse, S; He, F; Hu, Y; Fan, GP; Sun, YE			DNA methylation-related chromatin remodeling in activity-dependent Bdnf gene regulation	SCIENCE			English	Article							BINDING PROTEIN MECP2; TRANSCRIPTION FACTOR; HISTONE DEACETYLASE; CALCIUM REGULATION; RETT-SYNDROME; CNS NEURONS; EXPRESSION; LOCALIZATION; REGIONS	In conjunction with histone modi. cations, DNA methylation plays critical roles in gene silencing through chromatin remodeling. Changes in DNA methylation perturb neuronal function, and mutations in a methyl-CpG-binding protein, MeCP2, are associated with Rett syndrome. We report that increased synthesis of brain-derived neurotrophic factor (BDNF) in neurons after depolarization correlates with a decrease in CpG methylation within the regulatory region of the Bdnf gene. Moreover, increased Bdnf transcription involves dissociation of the MeCP2-histone deacetylase-mSin3A repression complex from its promoter. Our findings suggest that DNA methylation-related chromatin remodeling is important for activity-dependent gene regulation that may be critical for neural plasticity.	Univ Calif Los Angeles, ACCESS Program, Neurosci Interdept Program, Los Angeles, CA USA; Univ Calif Los Angeles, ACCESS Program, Dept Mol & Med Pharmacol, Los Angeles, CA USA; Univ Calif Los Angeles, ACCESS Program, Dept Psychiat & Behav Sci, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fan, GP (corresponding author), Univ Calif Los Angeles, ACCESS Program, Neurosci Interdept Program, Los Angeles, CA USA.	gfan@mednet.ucla.edu; ysun@mednet.ucla.edu	Wu, Hao/G-4145-2013; Martinowich, Keri/F-9841-2012	Wu, Hao/0000-0002-1256-6891; Martinowich, Keri/0000-0002-5237-0789; Fan, Guoping/0000-0001-5235-6410; Wu, Hao/0000-0003-4395-6929	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044405] Funding Source: NIH RePORTER; NINDS NIH HHS [NS44405] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chen WG, 2003, J NEUROSCI, V23, P2572; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; GOTO K, 1994, DIFFERENTIATION, V56, P39, DOI 10.1046/j.1432-0436.1994.56120039.x; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Herman H, 2003, NAT GENET, V34, P199, DOI 10.1038/ng1162; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Nan XS, 1996, MOL CELL BIOL, V16, P414; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	28	1073	1116	4	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2003	302	5646					890	893		10.1126/science.1090842	http://dx.doi.org/10.1126/science.1090842			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593184				2022-12-24	WOS:000186258000056
J	Artsimovitch, I; Chu, C; Lynch, AS; Landick, R				Artsimovitch, I; Chu, C; Lynch, AS; Landick, R			A new class of bacterial RNA polymerase inhibitor affects nucleotide addition	SCIENCE			English	Article							3.3 ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; TRANSCRIPTION; DNA; ELONGATION; COMPLEX; INITIATION; MECHANISM; MUTATIONS	RNA polymerase (RNAP) is the central enzyme of gene expression. Despite availability of crystal structures, details of its nucleotide addition cycle remain obscure. We describe bacterial RNAP inhibitors (the CBR703 series) whose properties illuminate this mechanism. These compounds inhibit known catalytic activities of RNAP (nucleotide addition, pyrophosphorolysis, and Gre-stimulated transcript cleavage) but not translocation of RNA or DNA when translocation is uncoupled from catalysis. CBR703-resistance substitutions occur on an outside surface of RNAP opposite its internal active site. We propose that CBR703 compounds inhibit nucleotide addition allosterically by hindering movements of active site structures that are linked to the CBR703 binding site through a bridge helix.	Cumbre Inc, Dallas, TX 75235 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Lynch, AS (corresponding author), Cumbre Inc, 1502 Viceroy Dr, Dallas, TX 75235 USA.	simon.lynch@cumbre.net; landick@bact.wisc.edu	Artsimovitch, Irina/L-3467-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038660, R29GM038660, R01GM038660] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38660] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIVAZASHVILI VA, 1982, MOL BIOL, V15, P711; Artsimovitch I, 2000, J BACTERIOL, V182, P6027, DOI 10.1128/JB.182.21.6027-6035.2000; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Artsimovitch I, 2003, J BIOL CHEM, V278, P12344, DOI 10.1074/jbc.M211214200; ARTSIMOVITCH I, UNPUB; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; CHAN CL, 1993, J MOL BIOL, V233, P25, DOI 10.1006/jmbi.1993.1482; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Darst SA, 2002, P NATL ACAD SCI USA, V99, P4296, DOI 10.1073/pnas.052054099; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Ederth J, 2002, J BIOL CHEM, V277, P37456, DOI 10.1074/jbc.M207038200; Epshtein V, 2002, MOL CELL, V10, P623, DOI 10.1016/S1097-2765(02)00640-8; FENG GH, 1994, J BIOL CHEM, V269, P22282; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; PALANGAT M, UNPUB; PAVCO PA, 1990, J BIOL CHEM, V265, P9960; Santangelo TJ, 2003, GENE DEV, V17, P1281, DOI 10.1101/gad.1082103; SEVERINOV K, 1995, J BIOL CHEM, V270, P23926, DOI 10.1074/jbc.270.41.23926; SMAGOWICZ WJ, 1978, NUCLEIC ACIDS RES, V5, P1919, DOI 10.1093/nar/5.6.1919; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; WRIGHT DJ, 1989, J BIOL CHEM, V264, P11816; Yuzenkova J, 2002, J BIOL CHEM, V277, P50867, DOI 10.1074/jbc.M209425200; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	27	81	84	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2003	302	5645					650	654		10.1126/science.1087526	http://dx.doi.org/10.1126/science.1087526			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	735MV	14576436				2022-12-24	WOS:000186119900061
J	Kisinza, WN; McCall, PJ; Mitani, H; Talbert, A; Fukunaga, M				Kisinza, WN; McCall, PJ; Mitani, H; Talbert, A; Fukunaga, M			A newly identified tick-borne Borrelia species and relapsing fever in Tanzania	LANCET			English	Article								Tick-borne relapsing fever caused by the spirochaete Borrelia duttonii is a common cause of serious illness in central Tanzania. Screening of Ornithodoros sp ticks from infested houses for the presence of B duttonii had detected a previously unidentified species of Borrelia. We investigated whether this species infected the human population in a central Tanzanian village, by use of blood slide examination and PCR. PCR was twice as sensitive in detection of infections, showing Borrelia sp in six (11%) of 54 children with fever, and in 13 (4%) of 307 otherwise healthy children. Genotyping Borrelia from 17 infections identified Borrelia duttonii and an unnamed species. Our findings show that the newly discovered species is a causal agent of tick-borne relapsing fever.	Univ Liverpool, Liverpool Sch Trop Med, Vector Res Grp, Liverpool L3 5QA, Merseyside, England; Natl Inst Med Res, Dar Es Salaam, Tanzania; Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Mol Microbiol Lab, Hiroshima, Japan; Mvumi Hosp, Dodoma, Tanzania	Liverpool School of Tropical Medicine; University of Liverpool; National Institute of Medical Research; Fukuyama University	McCall, PJ (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Res Grp, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.			McCall, Philip J/0000-0002-0007-3985				BARCLAY AJG, 1990, T ROY SOC TROP MED H, V84, P852, DOI 10.1016/0035-9203(90)90106-O; Dennis DT, 1998, ZOONOSES, P17; Fukunaga M, 2001, VECTOR-BORNE ZOONOT, V1, P331, DOI 10.1089/15303660160025949; Talbert A, 1998, T ROY SOC TROP MED H, V92, P251, DOI 10.1016/S0035-9203(98)90998-1; TRAPE JF, 1991, LANCET, V337, P473, DOI 10.1016/0140-6736(91)93404-W	5	38	40	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 18	2003	362	9392					1283	1284		10.1016/S0140-6736(03)14609-0	http://dx.doi.org/10.1016/S0140-6736(03)14609-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734CD	14575974				2022-12-24	WOS:000186036900013
J	Lund, E; Guttinger, S; Calado, A; Dahlberg, JE; Kutay, U				Lund, E; Guttinger, S; Calado, A; Dahlberg, JE; Kutay, U			Nuclear export of microRNA precursors	SCIENCE			English	Article							RNA-INTERFERENCE; TRANSPORT; DICER; MATURATION	MicroRNAs (miRNAs), which function as regulators of gene expression in eukaryotes, are processed from larger transcripts by sequential action of nuclear and cytoplasmic ribonuclease III-like endonucleases. We show that Exportin-5 (Exp5) mediates efficient nuclear export of short miRNA precursors (pre-miRNAs) and that its depletion by RNA interference results in reduced miRNA levels. Exp5 binds correctly processed pre-miRNAs directly and specifically, in a Ran guanosine triphosphate-dependent manner, but interacts only weakly with extended pre-miRNAs that yield incorrect miRNAs when processed by Dicer in vitro. Thus, Exp5 is key to miRNA biogenesis and may help coordinate nuclear and cytoplasmic processing steps.	Univ Wisconsin, Sch Med, Dept Biomol Chem, Madison, WI 53706 USA; Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland	University of Wisconsin System; University of Wisconsin Madison; Swiss Federal Institutes of Technology Domain; ETH Zurich	Dahlberg, JE (corresponding author), Univ Wisconsin, Sch Med, Dept Biomol Chem, Madison, WI 53706 USA.	dahlberg@wisc.edu; ulrike.kutay@bc.biol.ethz.ch	Calado, Ângelo Miguel Silva/Y-2296-2019	Calado, Ângelo Miguel Silva/0000-0003-0182-2615	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030220, R01GM030220] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-30220] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banerjee D, 2002, BIOESSAYS, V24, P119, DOI 10.1002/bies.10046; Bohnsack MT, 2002, EMBO J, V21, P6205, DOI 10.1093/emboj/cdf613; Bollman KM, 2003, DEVELOPMENT, V130, P1493, DOI 10.1242/dev.00362; Brownawell AM, 2002, J CELL BIOL, V156, P53, DOI 10.1083/jcb.200110082; Calado A, 2002, EMBO J, V21, P6216, DOI 10.1093/emboj/cdf620; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Grimm C, 1997, EMBO J, V16, P793, DOI 10.1093/emboj/16.4.793; Gwizdek C, 2003, J BIOL CHEM, V278, P5505, DOI 10.1074/jbc.C200668200; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kidner CA, 2003, TRENDS GENET, V19, P13, DOI 10.1016/S0168-9525(02)00011-2; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; LUND E, UNPUB; Moss EG, 2002, CURR BIOL, V12, pR688, DOI 10.1016/S0960-9822(02)01206-X; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; TERNS MP, 1992, MOL CELL BIOL, V12, P3032, DOI 10.1128/MCB.12.7.3032; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	29	1889	2080	4	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2004	303	5654					95	98		10.1126/science.1090599	http://dx.doi.org/10.1126/science.1090599			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YU	14631048				2022-12-24	WOS:000187710600042
J	Malone, CJ; Misner, L; Le Bot, N; Tsai, MC; Campbell, JM; Ahringer, J; White, JG				Malone, CJ; Misner, L; Le Bot, N; Tsai, MC; Campbell, JM; Ahringer, J; White, JG			The C-elegans hook protein, ZYG-12, mediates the essential attachment between the centrosome and nucleus	CELL			English	Article							LIGHT INTERMEDIATE CHAIN; CAENORHABDITIS-ELEGANS; CYTOPLASMIC DYNEIN; MITOTIC SPINDLE; MICROTUBULE ORGANIZATION; MEMBRANE-PROTEINS; GAMMA-TUBULIN; MIGRATION; DROSOPHILA; EMBRYOS	The centrosome and nucleus are intimately associated in most animal cells, yet the significance of this interaction is unknown. Mutations in the zyg-12 gene of Caenorhabditis elegans perturb the attachment of the centrosome to the nucleus, giving rise to aberrant spindles and ultimately, DNA segregation defects and lethality. These phenotypes indicate that the attachment is essential. ZYG-12 is a member of the Hook family of cytoskeletal linker proteins and localizes to both the nuclear envelope (via SUN-1) and centrosomes. ZYG-12 is able to bind the dynein subunit DLI-1 in a two-hybrid assay and is required for dynein localization to the nuclear envelope. Loss of dynein function causes a low percentage of defective centrosome/nuclei interactions in both Drosophila and Caenorhabditis elegans. We propose that dynein and ZYG-12 move the centrosomes toward the nucleus, followed by a ZYG-12/SUN-1-dependent anchorage.	Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; Univ Wisconsin, Dept Anat, Madison, WI 53706 USA; Wellcome CRC Inst, Cambridge CB2 1QR, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Malone, CJ (corresponding author), Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA.	cjmalone@facstaff.wisc.edu		Ahringer, Julie/0000-0002-7074-4051; Tsai, Miao-Chih/0000-0003-4471-4825; Le Bot, Nathalie/0000-0002-5258-2837	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052454] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM052454] Funding Source: Medline; Wellcome Trust [054523] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARONSON JF, 1971, J CELL BIOL, V51, P579, DOI 10.1083/jcb.51.2.579; BOMENS M, 1977, NATURE, V270, P80; BRENNER S, 1974, GENETICS, V77, P71; CHEN L, 1992, SCIENCE, V256, P240, DOI 10.1126/science.1314423; Doxsey S, 2002, MOL CELL, V10, P439, DOI 10.1016/S1097-2765(02)00654-8; Dreger M, 2001, P NATL ACAD SCI USA, V98, P11943, DOI 10.1073/pnas.211201898; FRASER AG, 2000, BRIT J SOC PSYCHOL 4, V408, P325; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gonzalez C, 1998, J CELL SCI, V111, P2697; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; HEDGECOCK EM, 1982, CELL, V30, P321, DOI 10.1016/0092-8674(82)90038-1; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; Jakubowski J, 1999, GENETICS, V153, P743; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Keating HH, 1998, J CELL SCI, V111, P3027; Kitagawa R, 1999, NAT CELL BIOL, V1, P514, DOI 10.1038/70309; Kramer H, 1999, GENETICS, V151, P675; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Lee KK, 2002, MOL BIOL CELL, V13, P892, DOI 10.1091/mbc.01-06-0294; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Malone CJ, 1999, DEVELOPMENT, V126, P3171; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; McDonald K, 1999, METH MOL B, V117, P77; NADEZHDINA ES, 1979, EUR J CELL BIOL, V19, P109; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; PERSSON B, 1994, J MOL BIOL, V237, P182, DOI 10.1006/jmbi.1994.1220; Praitis V, 2001, GENETICS, V157, P1217; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; RAFF JW, 1989, CELL, V57, P611, DOI 10.1016/0092-8674(89)90130-X; Raff JW, 1999, CURR BIOL, V9, pR708, DOI 10.1016/S0960-9822(99)80446-1; Reinsch S, 1997, CURR BIOL, V7, P211, DOI 10.1016/S0960-9822(97)70092-7; Reinsch S, 1998, J CELL SCI, V111, P2283; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Siomos MF, 2001, CURR BIOL, V11, P1825, DOI 10.1016/S0960-9822(01)00588-7; SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119; Starr DA, 2001, DEVELOPMENT, V128, P5039; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923; Walther P, 2002, J MICROSC-OXFORD, V208, P3, DOI 10.1046/j.1365-2818.2002.01064.x; WOOD WB, 1980, DEV BIOL, V74, P446, DOI 10.1016/0012-1606(80)90445-5; Yoder JH, 2001, MOL BIOL CELL, V12, P2921, DOI 10.1091/mbc.12.10.2921; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	52	308	325	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 26	2003	115	7					825	836		10.1016/S0092-8674(03)00985-1	http://dx.doi.org/10.1016/S0092-8674(03)00985-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	758RV	14697201	Bronze			2022-12-24	WOS:000187664700007
J	Johnston, RJ; Hobert, O				Johnston, RJ; Hobert, O			A microRNA controlling left/right neuronal asymmetry in Caenorhabditis elegans	NATURE			English	Article							CHEMOSENSORY NEURONS; NERVOUS-SYSTEM; EXPRESSION; RNAS; LIM-6	How left/right functional asymmetry is layered on top of an anatomically symmetrical nervous system is poorly understood. In the nematode Caenorhabditis elegans, two morphologically bilateral taste receptor neurons, ASE left (ASEL) and ASE right (ASER), display a left/right asymmetrical expression pattern of putative chemoreceptor genes that correlates with a diversification of chemosensory specificities(1,2). Here we show that a previously undefined microRNA termed lsy-6 controls this neuronal left/right asymmetry of chemosensory receptor expression. lsy-6 mutants that we retrieved from a genetic screen for defects in neuronal left/right asymmetry display a loss of the ASEL-specific chemoreceptor expression profile with a concomitant gain of the ASER-specific profile. Alsy-6 reporter gene construct is expressed in less than ten neurons including ASEL, but not ASER. lsy-6 exerts its effects on ASEL through repression of cog-1, an Nkx-type homeobox gene, which contains a lsy-6 complementary site in its 30 untranslated region and that has been shown to control ASE-specific chemoreceptor expression profiles(3). lsy-6 is the first microRNA to our knowledge with a role in neuronal patterning, providing new insights into left/right axis formation.	Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University	Hobert, O (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, 701 W 168th St, New York, NY 10032 USA.	or38@columbia.edu		Hobert, Oliver/0000-0002-7634-2854				Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Halpern ME, 2003, TRENDS NEUROSCI, V26, P308, DOI 10.1016/S0166-2236(03)00129-2; Hobert O, 2002, NAT REV NEUROSCI, V3, P629, DOI 10.1038/nrn897; Hobert O, 1999, DEVELOPMENT, V126, P1547; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Johnson SM, 2003, DEV BIOL, V259, P364, DOI 10.1016/S0012-1606(03)00202-1; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Palmer RE, 2002, DEV BIOL, V252, P202, DOI 10.1006/dbio.2002.0850; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Yost HJ, 1998, DEV GENET, V23, P159; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	22	583	663	0	29	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 18	2003	426	6968					845	849		10.1038/nature02255	http://dx.doi.org/10.1038/nature02255			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685240				2022-12-24	WOS:000187342000060
J	Rosegrant, MW; Cline, SA				Rosegrant, MW; Cline, SA			Global food security: Challenges and policies	SCIENCE			English	Article							AGRICULTURE; POVERTY; INDIA	Global food security will remain a worldwide concern for the next 50 years and beyond. Recently, crop yield has fallen in many areas because of declining investments in research and infrastructure, as well as increasing water scarcity. Climate change and HIV/AIDS are also crucial factors affecting food security in many regions. Although agroecological approaches offer some promise for improving yields, food security in developing countries could be substantially improved by increased investment and policy reforms.	Int Food Policy Res Inst, Washington, DC 20006 USA	CGIAR; International Food Policy Research Institute (IFPRI)	Rosegrant, MW (corresponding author), Int Food Policy Res Inst, 2033 K St NW, Washington, DC 20006 USA.		Zhong, Hong Lin/C-2633-2012					Adams R.M, 1999, CHOICES, V14, P22; Alston, 2000, 113 IFPRI; BARGHOUTI SM, 2001, SUSTAIN DEV INT, V1, P127; Boserup E., 1965, CONDITIONS AGR GROWT; Brown L. R., 1994, FULL HOUSE REASSESSI; Bruinsma J, 2003, WORLD AGR 2015 2030; BYERLEE D, 2000, ACCESSING MODERN SCI; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Ceccarelli Salvatore, 1996, P99; Clark Colin, 1970, STARVATION PLENTY; Croppenstedt A, 2000, ECON DEV CULT CHANGE, V48, P475, DOI 10.1086/452607; Downing ET, 1993, RENEWABLE ENERGY, V3, P491, DOI [10.1016/0960-1481(93)90115-W, DOI 10.1016/0960-1481(93)90115-W]; Ehrlich P.R., 1990, POPULATION EXPLOSION; Evans L., 1998, FEEDING 10 BILLION P; Fan SG, 2000, AM J AGR ECON, V82, P1038, DOI 10.1111/0002-9092.00101; Fan Shenggen, 2002, GROWTH INEQUALITY PO; *FOOD AGR POL RES, 2003, US WORLD AGR OUTL 20; GAIHA R, 1994, DESIGN POVERTY ALEVI; Haddad L., 2001, Journal of International Development, V13, P487, DOI 10.1002/jid.799; IFAD, 1995, STAT WORLD RUR POV P; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 IMP; Kassouf AL, 1996, ECON DEV CULT CHANGE, V44, P817, DOI 10.1086/452246; KOMEGAY J, 1996, PARTICIPATORY PLANT, P151; LIPTON M, 1998, SUCCESS ANTIPOVERTY; Malthus TR, 2003, ESSAY PRINCIPLE POPU; Meadows D. H., 1992, LIMITS CONFRONTING G; *ORG EC COOP DEV, 2003, AGR OUTL 2003 2008; OWEIS T, 1999, 7 INT WAT MAN I; Pretty J., 1999, ENVIRON DEV SUSTAIN, V1, P253, DOI DOI 10.1016/j.jaridenv.2014.01.016; PRETTY JN, 1995, WORLD DEV, V23, P1247, DOI 10.1016/0305-750X(95)00046-F; Rosegrant M.W., 2002, INT MODEL POLICY ANA; Rosegrant M.W., 2002, INT FOOD POLICY RES; Simon JL, 1998, ULTIMATE RESOURCE; SINGH RP, 1993, ECON POLIT WEEKLY, V28, pA9; *UN FAO, 2000, CROPS DROPS; *UN FAO, 2001, COMM WORLD FOOD SEC; *UNAIDS, 2003, JOINT UN PROGR HIV A; *USDA, 2003, WAOB20031 USDA; *W AFR RIC DEV ASS, CONS FORM RAP DISS N; Witcover J., 2001, GLOBAL FOOD PROJECTI; *WORLD BANK, 1990, POV WORLD DEV IND; World Bank, 1996, POV RED WORLD BANK P; *WORLD BANK GROUP, 2003, MILL DEV GOALS GOALS	43	503	537	13	289	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1917	1919		10.1126/science.1092958	http://dx.doi.org/10.1126/science.1092958			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752NL	14671289	Green Submitted			2022-12-24	WOS:000187174000044
J	Roszak, AW; Howard, TD; Southall, J; Gardiner, AT; Law, CJ; Isaacs, NW; Cogdell, RJ				Roszak, AW; Howard, TD; Southall, J; Gardiner, AT; Law, CJ; Isaacs, NW; Cogdell, RJ			Crystal structure of the RC-LH1 core complex from Rhodopseudomonas palustris	SCIENCE			English	Article							PHOTOSYNTHETIC REACTION-CENTER; LIGHT-HARVESTING COMPLEX; CYTOCHROME BC(1) COMPLEX; RHODOBACTER-SPHAEROIDES; PUFX PROTEIN; RHODOSPIRILLUM-RUBRUM; ALPHA-POLYPEPTIDE; RESOLUTION; CAPSULATUS; BACTERIA	The crystal structure at 4.8 angstrom resolution of the reaction center-light harvesting 1 (RC-LH1) core complex from Rhodopseudomonas palustris shows the reaction center surrounded by an oval LH1 complex that consists of 15 pairs of transmembrane helical alpha- and beta-apoproteins and their coordinated bacteriochlorophylls. Complete closure of the RC by the LH1 is prevented by a single transmembrane helix, out of register with the array of inner LH1 alpha-apoproteins. This break, located next to the binding site in the reaction center for the secondary electron acceptor ubiquinone (UQ(B)), may provide a portal through which UQ(B) can transfer electrons to cytochrome b/c(1).	Univ Glasgow, Inst Biomed & Life Sci, Dept Chem, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	Isaacs, NW (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Dept Chem, Glasgow G12 8QQ, Lanark, Scotland.		Gardiner, Alastair T/N-8385-2017; Law, Christopher/E-7174-2011	Southall, June/0000-0002-5496-1531				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; BARZ WP, 1995, BIOCHEMISTRY-US, V34, P15248, DOI 10.1021/bi00046a033; BARZ WP, 1995, BIOCHEMISTRY-US, V34, P15235, DOI 10.1021/bi00046a032; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cogdell RJ, 1999, J BACTERIOL, V181, P3869, DOI 10.1128/JB.181.13.3869-3879.1999; Cogdell RJ, 1996, PHOTOSYNTH RES, V48, P55, DOI 10.1007/BF00040996; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Frese RN, 2000, P NATL ACAD SCI USA, V97, P5197, DOI 10.1073/pnas.090083797; Fritzsch G, 2002, ACTA CRYSTALLOGR D, V58, P1660, DOI 10.1107/S0907444902014178; GALL A, 1994, THESIS U GLASGOW UK; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Jamieson SJ, 2002, EMBO J, V21, P3927, DOI 10.1093/emboj/cdf410; Jungas C, 1999, EMBO J, V18, P534, DOI 10.1093/emboj/18.3.534; KARRASCH S, 1995, EMBO J, V14, P631, DOI 10.1002/j.1460-2075.1995.tb07041.x; LILBURN TG, 1992, BIOCHIM BIOPHYS ACTA, V1100, P160; McAuley KE, 1999, P NATL ACAD SCI USA, V96, P14706, DOI 10.1073/pnas.96.26.14706; McAuley KE, 2000, BIOCHEMISTRY-US, V39, P15032, DOI 10.1021/bi000557r; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; MCGLYNN P, 1994, FEBS LETT, V349, P349, DOI 10.1016/0014-5793(94)00701-2; McGlynn P, 1996, J BIOL CHEM, V271, P3285, DOI 10.1074/jbc.271.6.3285; Moser CC, 2003, ADV PROTEIN CHEM, V63, P71; Papiz MZ, 2003, J MOL BIOL, V326, P1523, DOI 10.1016/S0022-2836(03)00024-X; Parkes-Loach PS, 2001, BIOCHEMISTRY-US, V40, P5593, DOI 10.1021/bi002580i; Recchia PA, 1998, BIOCHEMISTRY-US, V37, P11055, DOI 10.1021/bi980657l; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; Stowell MHB, 1997, SCIENCE, V276, P812, DOI 10.1126/science.276.5313.812; VANGRONDELLE R, 1994, BBA-BIOENERGETICS, V1187, P1, DOI 10.1016/0005-2728(94)90166-X; Walz T, 1998, J MOL BIOL, V282, P833, DOI 10.1006/jmbi.1998.2050; Walz T, 1997, J MOL BIOL, V265, P107, DOI 10.1006/jmbi.1996.0714	29	561	604	4	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1969	1972		10.1126/science.1088892	http://dx.doi.org/10.1126/science.1088892			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671305				2022-12-24	WOS:000187174000062
J	Gao, WT; Tamin, A; Soloff, A; D'Aiuto, L; Nwanegbo, E; Robbins, PD; Bellini, WJ; Barratt-Boyes, S; Gambotto, A				Gao, WT; Tamin, A; Soloff, A; D'Aiuto, L; Nwanegbo, E; Robbins, PD; Bellini, WJ; Barratt-Boyes, S; Gambotto, A			Effects of a SARS-associated coronavirus vaccine in monkeys	LANCET			English	Article							VIRUS	The causative agent of severe acute respiratory syndrome (SARS) has been identified as a new type of coronavirus. Here, we have investigated the ability of adenoviral delivery of codon-optimised SARS-CoV strain Urbani structural antigens spike protein S1 fragment, membrane protein, and nucleocapsid protein to induce virus-specific broad immunity in rhesus macaques. We immunised rhesus macaques intramuscularly with a combination of the three Ads-SARS-CoV vectors or a control vector and gave a booster vaccination on day 28. The vaccinated animals all had antibody responses against spike protein S1 fragment and T-cell responses against the nucleocapsid protein. All vaccinated animals showed strong neutralising antibody responses to SARS-CoV infection in vitro. These results show that an adenoviral-based vaccine can induce strong SARS-CoV-specific immune responses in the monkey, and hold promise for development of a protective vaccine against the SARS causal agent.	Univ Pittsburgh, Sch Med, Inst Mol Med, Dept Surg,Div Infect Dis, Pittsburgh, PA 15219 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA USA; Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Div Infect Dis, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gambotto, A (corresponding author), Univ Pittsburgh, Sch Med, Inst Mol Med, Dept Surg,Div Infect Dis, Suite 412,300 Technol Dr, Pittsburgh, PA 15219 USA.			Soloff, Adam/0000-0002-1467-8168; D'Aiuto, Leonardo/0000-0002-7102-2093; Barratt Boyes, Simon/0000-0002-8869-4945	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066949] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL066949, U01 HL66949-01S1] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anton IM, 1996, VIRUS RES, V46, P111, DOI 10.1016/S0168-1702(96)01390-1; BROWN K, IN PRESS J IMMUNOL; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; WEISS RC, 1981, COMP IMMUNOL MICROB, V4, P175, DOI 10.1016/0147-9571(81)90003-5	5	211	247	0	27	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1895	1896		10.1016/S0140-6736(03)14962-8	http://dx.doi.org/10.1016/S0140-6736(03)14962-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667748	Green Published, Bronze			2022-12-24	WOS:000187011600012
J	Caulford, P				Caulford, P			SARS: aftermath of an outbreak	LANCET			English	Article									Scarborough Gen Hosp, Family Med Serv, Scarborough, ON, Canada; Scarborough Gen Hosp, Community Serv, Scarborough, ON, Canada; Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada	Scarborough Hospital; Scarborough Hospital; University of Toronto	Caulford, P (corresponding author), Suite 207,3030 Lawrence Ave E, Scarborough, ON M1P 2T7, Canada.								0	2	2	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S2	S3		10.1016/S0140-6736(03)15052-0	http://dx.doi.org/10.1016/S0140-6736(03)15052-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698106	Green Published, Bronze			2022-12-24	WOS:000187790200002
J	Battin, TJ; Kaplan, LA; Newbold, JD; Hansen, CME				Battin, TJ; Kaplan, LA; Newbold, JD; Hansen, CME			Contributions of microbial biofilms to ecosystem processes in stream mesocosms	NATURE			English	Article							MASS-TRANSPORT; DEPOSITION; NITROGEN; SIZE	In many aquatic ecosystems, most microbes live in matrix-enclosed biofilms(1-3) and contribute substantially to energy flow and nutrient cycling. Little is known, however, about the coupling of structure and dynamics of these biofilms to ecosystem function(2). Here we show that microbial biofilms changed the physical and chemical microhabitat and contributed to ecosystem processes in 30-m-long stream mesocosms. Biofilm growth increased hydrodynamic transient storage-streamwater detained in quiescent zones, which is a major physical template for ecological processes in streams(4,5) - by 300% and the retention of suspended particles by 120%. In addition, by enhancing the relative uptake of organic molecules of lower bioavailability, the interplay of biofilm microarchitecture and mass transfer changed their downstream linkage. As living zones of transient storage, biofilms bring hydrodynamic retention and biochemical processing into close spatial proximity and influence biogeochemical processes and patterns in streams. Thus, biofilms are highly efficient and successful ecological communities that may also contribute to the influence that headwater streams have on rivers, estuaries and even oceans(6,7) through longitudinal linkages of local biogeochemical and hydrodynamic processes.	Univ Vienna, IECB, Dept Limnol, A-1090 Vienna, Austria; Stroud Water Res Ctr, Avondale, PA 19311 USA; Univ Innsbruck, Inst Limnol & Zool, A-6020 Innsbruck, Austria	University of Vienna; University of Innsbruck	Battin, TJ (corresponding author), Univ Vienna, IECB, Dept Limnol, Waehringer Guertel 18, A-1090 Vienna, Austria.	tomba@pflaphy.pph.univie.ac.at	BAttin, Tom/H-7971-2012					Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; Battin TJ, 2003, APPL ENVIRON MICROB, V69, P5443, DOI 10.1128/AEM.69.9.5443-5452.2003; Cheng XH, 2001, ANAL CHEM, V73, P458, DOI 10.1021/ac001059r; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; DRURY WJ, 1993, WATER RES, V27, P1119, DOI 10.1016/0043-1354(93)90003-Z; GANTZER CJ, 1988, WATER RES, V22, P709, DOI 10.1016/0043-1354(88)90182-0; Gomi T, 2002, BIOSCIENCE, V52, P905, DOI 10.1641/0006-3568(2002)052[0905:UPADLO]2.0.CO;2; Grady C.P.L., 2011, BIOL WASTEWATER TREA; Jones JB, 2000, STREAMS GROUND WATER; Kaplan L.A., 2003, AQUATIC ECOSYSTEMS I, P97; KIM BK, 1990, WATER RESOUR RES, V26, P505, DOI 10.1029/WR026i003p00505; KUGAPRASATHAM S, 1992, WATER RES, V26, P1629, DOI 10.1016/0043-1354(92)90162-W; Lawrence JR, 1998, J MICROBIOL METH, V32, P253, DOI 10.1016/S0167-7012(98)00027-X; Minshall GW, 2000, J N AM BENTHOL SOC, V19, P1, DOI 10.2307/1468278; MULHOLLAND PJ, 1994, OECOLOGIA, V98, P40, DOI 10.1007/BF00326088; NEWBOLD JD, 1981, CAN J FISH AQUAT SCI, V38, P860, DOI 10.1139/f81-114; Packman AI, 2000, WATER RESOUR RES, V36, P2351, DOI 10.1029/2000WR900059; Palmer RJ, 1997, TRENDS MICROBIOL, V5, P435, DOI 10.1016/S0966-842X(97)01142-6; Peterson BJ, 2001, SCIENCE, V292, P86, DOI 10.1126/science.1056874; Picioreanu C, 2000, BIOTECHNOL BIOENG, V68, P355, DOI 10.1002/(SICI)1097-0290(20000520)68:4<355::AID-BIT1>3.0.CO;2-A; RUNKLE RL, 1998, 984018 US GEOL SURV; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Thomas SA, 2001, LIMNOL OCEANOGR, V46, P1415, DOI 10.4319/lo.2001.46.6.1415; Yang XM, 2000, J MICROBIOL METH, V39, P109, DOI 10.1016/S0167-7012(99)00097-4	24	512	522	13	347	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2003	426	6965					439	442		10.1038/nature02152	http://dx.doi.org/10.1038/nature02152			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647381				2022-12-24	WOS:000186800800037
J	Michael, TP; Salome, PA; Yu, HJ; Spencer, TR; Sharp, EL; McPeek, MA; Alonso, JM; Ecker, JR; McClung, CR				Michael, TP; Salome, PA; Yu, HJ; Spencer, TR; Sharp, EL; McPeek, MA; Alonso, JM; Ecker, JR; McClung, CR			Enhanced fitness conferred by naturally occurring variation in the circadian clock	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; ABERRANT EXPRESSION; GENE; LIGHT; RHYTHMS; PACEMAKER; RESPONSES; PLANTS; TIME	Natural variation in clock parameters is necessary for the circadian clock to contribute to organismal fitness over a broad geographic range. Considerable variation is evident in the period, phase, and amplitude of 150 Arabidopsis accessions, and the period length is correlated with the day length at the latitude of origin, implying the adaptive significance of correctly regulated circadian timing. Quantitative trait loci analysis of recombinant inbred lines indicates that multiple loci interact to determine period, phase, and amplitude. The loss-of-function analysis of each member of the ARABIDOPSIS PSEUDO-RESPONSE REGULATOR family suggests that they are candidates for clock quantitative trait loci.	Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	Dartmouth College; Salk Institute	McClung, CR (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	mcclung@dartmouth.edu	Ecker, Joseph R/B-9144-2008; Alonso, Jose M/K-6826-2014; McPeek, Mark/AAE-2784-2022; Salome, Patrice/E-5702-2017	Ecker, Joseph R/0000-0001-5799-5895; Alonso, Jose M/0000-0001-7087-1571; McClung, C. Robertson/0000-0002-7875-3614; Michael, Todd/0000-0001-6272-2875				Beaver LM, 2002, P NATL ACAD SCI USA, V99, P2134, DOI 10.1073/pnas.032426699; Borevitz JO, 2002, GENETICS, V160, P683; CLARKE JH, 1995, MOL GEN GENET, V248, P278, DOI 10.1007/BF02191594; Costa R, 1998, CURR OPIN NEUROBIOL, V8, P659, DOI 10.1016/S0959-4388(98)80096-2; Daido H, 2002, J THEOR BIOL, V217, P425, DOI 10.1006/jtbi.2002.3050; DeCoursey PJ, 2000, J COMP PHYSIOL A, V186, P169, DOI 10.1007/s003590050017; Green RM, 1999, P NATL ACAD SCI USA, V96, P4176, DOI 10.1073/pnas.96.7.4176; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Li B, 1998, OECOLOGIA, V115, P293, DOI 10.1007/s004420050519; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Makino S, 2002, PLANT CELL PHYSIOL, V43, P58, DOI 10.1093/pcp/pcf005; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; Matsushika A, 2002, PLANT CELL PHYSIOL, V43, P833, DOI 10.1093/pcp/pcf118; MCCLUNG CR, 2002, ARABIDOPSIS BOOK, P1, DOI DOI 10.1199/TAB.0044; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Miyashita NT, 1999, GENETICS, V152, P1723; PITTENDRIGH CS, 1989, J BIOL RHYTHM, V4, P217; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Roden LC, 2002, P NATL ACAD SCI USA, V99, P13313, DOI 10.1073/pnas.192365599; Sato E, 2002, PLANT CELL PHYSIOL, V43, P1374, DOI 10.1093/pcp/pcf166; Sawyer LA, 1997, SCIENCE, V278, P2117, DOI 10.1126/science.278.5346.2117; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; Somers DE, 1998, DEVELOPMENT, V125, P485; Swarup K, 1999, PLANT J, V20, P67, DOI 10.1046/j.1365-313X.1999.00577.x; Weinig C, 2003, MOL ECOL, V12, P1153, DOI 10.1046/j.1365-294X.2003.01787.x; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	30	330	339	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2003	302	5647					1049	1053		10.1126/science.1082971	http://dx.doi.org/10.1126/science.1082971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605371				2022-12-24	WOS:000186396300050
J	Walvoord, MA; Phillips, FM; Stonestrom, DA; Evans, RD; Hartsough, PC; Newman, BD; Striegl, RG				Walvoord, MA; Phillips, FM; Stonestrom, DA; Evans, RD; Hartsough, PC; Newman, BD; Striegl, RG			A reservoir of nitrate beneath desert soils	SCIENCE			English	Article							TERRESTRIAL ECOSYSTEMS; GLOBAL PATTERNS; NITROGEN-CYCLE; WATER; IMPACTS; STATES	A large reservoir of bioavailable nitrogen (up to -10(4) kilograms of nitrogen per hectare, as nitrate) has been previously overlooked in studies of global nitrogen distribution. The reservoir has been accumulating in subsoil zones of arid regions throughout the Holocene. Consideration of the subsoil reservoir raises estimates of vadose-zone nitrogen inventories by 14 to 71% for warm deserts and arid shrublands worldwide and by 3 to 16% globally. Subsoil nitrate accumulation indicates long-term leaching from desert soils, impelling further evaluation of nutrient dynamics in xeric ecosystems. Evidence that subsoil accumulations are readily mobilized raises concern about groundwater contamination after land-use or climate change.	US Geol Survey, Lakewood, CO 80225 USA; New Mexico Inst Min & Technol, Dept Earth & Environm Sci, Socorro, NM 87801 USA; US Geol Survey, Menlo Pk, CA 94025 USA; Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; Univ Nevada, Grad Program Hydrol Sci, Reno, NV 89557 USA; Desert Res Inst, Reno, NV 89512 USA; Los Alamos Natl Lab, Div Earth & Environm Sci, Los Alamos, NM 87545 USA	United States Department of the Interior; United States Geological Survey; New Mexico Institute of Mining Technology; United States Department of the Interior; United States Geological Survey; Washington State University; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; United States Department of Energy (DOE); Los Alamos National Laboratory	Walvoord, MA (corresponding author), US Geol Survey, Lakewood, CO 80225 USA.	walvoord@usgs.gov	Walvoord, Michelle/AAQ-1137-2020; Stonestrom, David/E-9125-2011; Evans, Raymond D/A-8829-2010; Hartsough, Peter C./B-6104-2008	Walvoord, Michelle/0000-0003-4269-8366; Stonestrom, David/0000-0001-7883-3385; Evans, Raymond D/0000-0002-0446-2806; Hartsough, Peter/0000-0001-7888-8028				Ainsworth CC, 2000, VADOSE ZONE SCIENCE AND TECHNOLOGY SOLUTIONS, VOLS I AND II, P829; [Anonymous], [No title captured]; BORING LR, 1988, BIOGEOCHEMISTRY, V6, P119, DOI 10.1007/BF00003034; BOWDEN WB, 1986, BIOGEOCHEMISTRY, V2, P249, DOI 10.1007/BF02180161; BOYCE JS, 1976, FARM RANCH HOME Q, V22, P2; Canter LW., 1997, NITRATES GROUNDWATER; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; EVANS RD, 1994, OECOLOGIA, V99, P233, DOI 10.1007/BF00627735; EVANS RD, 1993, OECOLOGIA, V94, P314, DOI 10.1007/BF00317104; EVANS RML, UNPUB; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Gebauer RLE, 2000, ECOLOGY, V81, P1415, DOI 10.1890/0012-9658(2000)081[1415:WANUPF]2.0.CO;2; GUTIERREZ JR, 1987, ECOLOGY, V68, P2032, DOI 10.2307/1939894; Hartsough P, 2001, GEOPHYS RES LETT, V28, P2955, DOI 10.1029/2000GL011823; HESS JW, 1977, PUBLICATION U NEVADA, V32; Jobbagy EG, 2001, BIOGEOCHEMISTRY, V53, P51, DOI 10.1023/A:1010760720215; KLEIN JM, 1979, 7960 US GEOL SURV; LAJTHA K, 1987, BIOGEOCHEMISTRY, V4, P265, DOI 10.1007/BF02187370; McMahon P.B., 2003, WATER MOVEMENT THICK, DOI [10.3133/wri034171, DOI 10.3133/WRI034171]; NEWMAN B, UNPUB; Nolan BT, 2000, ENVIRON SCI TECHNOL, V34, P1156, DOI 10.1021/es9907663; PETERJOHN WT, 1990, BIOGEOCHEMISTRY, V10, P67; PHILLIPS FM, 1994, SOIL SCI SOC AM J, V58, P15, DOI 10.2136/sssaj1994.03615995005800010003x; POST WM, 1985, NATURE, V317, P613, DOI 10.1038/317613a0; RICE RC, 1989, GROUND WATER, V27, P813, DOI 10.1111/j.1745-6584.1989.tb01045.x; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; SCHMIDT S, UNPUB; Stonestrom D.A., 2003, 03104 US GEOL SURV; Van Devender T. R., 1987, N AM ADJACENT OCEANS, P323; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Walvoord MA, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000824; Walvoord MA, 2002, THESIS NEW MEXICO I; West NE, 1978, NITROGEN DESERT ECOS; ZINKE PJ, 1984, TM8857 ORNL	34	266	279	4	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2003	302	5647					1021	1024		10.1126/science.1086435	http://dx.doi.org/10.1126/science.1086435			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605364				2022-12-24	WOS:000186396300040
J	Lewis, BP; Shih, IH; Jones-Rhoades, MW; Bartel, DP; Burge, CB				Lewis, BP; Shih, IH; Jones-Rhoades, MW; Bartel, DP; Burge, CB			Prediction of mammalian microRNA targets	CELL			English	Article							C-ELEGANS; SMALL RNAS; IDENTIFICATION; COMPLEMENTARY; CONSERVATION; EXPRESSION; SEQUENCE; ENCODES; LIN-28; TIME	MicroRNAs (miRNAs) can play important gene regulatory roles in nematodes, insects, and plants by base-pairing to mRNAs to specify posttranscriptional repression of these messages. However, the mRNAs regulated by vertebrate miRNAs are all unknown. Here we predict more than 400 regulatory target genes for the conserved vertebrate miRNAs by identifying mRNAs with conserved pairing to the 5' region of the miRNA and evaluating the number and quality of these complementary sites. Rigorous tests using shuffled miRNA controls supported a majority of these predictions, with the fraction of false positives estimated at 31% for targets identified in human, mouse, and rat and 22% for targets identified in pufferfish as well as mammals. Eleven predicted targets (out of 15 tested) were supported experimentally using a HeLa cell reporter system. The predicted regulatory targets of mammalian miRNAs were enriched for genes involved in transcriptional regulation but also encompassed an unexpectedly broad range of other functions.	MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Bartel, DP (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dbartel@wi.mit.edu; cburge@mit.edu	Burge, Christopher B./AAH-2177-2020					Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Ashburner M, 2001, GENOME RES, V11, P1425; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; BARTEL DP, 2004, IN PESS CELL; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Dostie J, 2003, RNA, V9, P631; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Iseli C, 2002, GENOME RES, V12, P1068, DOI 10.1101/gr.62002; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; NUSSINOV R, 1981, J BIOL CHEM, V256, P8458; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1	44	3992	4342	4	389	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2003	115	7					787	798		10.1016/S0092-8674(03)01018-3	http://dx.doi.org/10.1016/S0092-8674(03)01018-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	758RV	14697198	Bronze			2022-12-24	WOS:000187664700004
J	Walther, DJ; Peter, JU; Winter, S; Holtje, M; Paulmann, N; Grohmann, M; Vowinckel, J; Alamo-Bethencourt, V; Wilhelm, CS; Ahnert-Hilger, G; Bader, M				Walther, DJ; Peter, JU; Winter, S; Holtje, M; Paulmann, N; Grohmann, M; Vowinckel, J; Alamo-Bethencourt, V; Wilhelm, CS; Ahnert-Hilger, G; Bader, M			Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release	CELL			English	Article							VON-WILLEBRAND-FACTOR; SEROTONIN REUPTAKE INHIBITORS; TISSUE-TRANSGLUTAMINASE; INDUCED ACTIVATION; THROMBUS FORMATION; ENDOTHELIAL-CELLS; SH-SY5Y CELLS; RHO GTPASES; RAT; 5-HYDROXYTRYPTAMINE	Serotonin is a neurotransmitter in the central nervous system. In the periphery, serotonin functions as a ubiquitous hormone involved in vasoconstriction and platelet function. Serotonin is synthesized independently in peripheral tissues and neurons by two different rate-limiting tryptophan hydroxylase (TPH) isoenzymes. Here, we show that mice selectively deficient in peripheral TPH and serotonin exhibit impaired hemostasis, resulting in a reduced risk of thrombosis and thromboembolism, although the ultrastructure of the platelets is not affected. While the aggregation of serotonin-deficient platelets in vitro is apparently normal, their adhesion in vivo is reduced due to a blunted secretion of adhesive alpha-granular proteins. In elucidating the mechanism further, we demonstrate that serotonin is transamidated to small GTPases by transglutaminases during activation and aggregation of platelets, rendering these GTPases constitutively active. Our data provides evidence for a receptor-independent signaling mechanism, termed herein as "serotonylation," which leads to alpha-granule exocytosis from platelets.	Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Humbolt Univ Berlin, Inst Anat, Charite, D-10117 Berlin, Germany; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Walther, DJ (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.		Bader, Michael/K-2124-2013	Holtje, Markus/0000-0003-3193-4140; Bader, Michael/0000-0003-4780-4164				Aktories K, 2000, BIOL CHEM, V381, P421, DOI 10.1515/BC.2000.054; Azim AC, 2000, BLOOD, V95, P959, DOI 10.1182/blood.V95.3.959.003k22_959_964; Azmitia EC, 2001, BRAIN RES BULL, V56, P413, DOI 10.1016/S0361-9230(01)00614-1; BARRADAS MA, 1983, BRIT J CLIN PHARMACO, V16, P459, DOI 10.1111/j.1365-2125.1983.tb02198.x; Bodie SL, 2001, BIOCHEM BIOPH RES CO, V287, P71, DOI 10.1006/bbrc.2001.5547; BUCZKO W, 1975, BRIT J PHARMACOL, V53, P563, DOI 10.1111/j.1476-5381.1975.tb07395.x; Case A, 2003, BIOCHEMISTRY-US, V42, P9466, DOI 10.1021/bi030084z; Citron BA, 2000, NEUROCHEM INT, V37, P337, DOI 10.1016/S0197-0186(00)00044-9; COHEN RA, 1983, SCIENCE, V221, P273, DOI 10.1126/science.6574604; Dale GL, 2002, NATURE, V415, P175, DOI 10.1038/415175a; DECLERCK F, 1984, AGENTS ACTIONS, V15, P627; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Eddahibi S, 2002, J LAB CLIN MED, V139, P194, DOI 10.1067/mlc.2002.122181; Eddahibi S, 2001, J CLIN INVEST, V108, P1141, DOI 10.1172/JCI12805; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; HOLLAND JM, 1976, P SOC EXP BIOL MED, V151, P32; Holtje M, 2003, J BIOL CHEM, V278, P15850, DOI 10.1074/jbc.M212816200; Jackson SP, 2003, J THROMB HAEMOST, V1, P1602, DOI 10.1046/j.1538-7836.2003.00267.x; Katayama T, 2000, CIRC RES, V86, P1031, DOI 10.1161/01.RES.86.10.1031; KILLAM AL, 1991, THROMB RES, V64, P331, DOI 10.1016/0049-3848(91)90004-G; Lee SK, 2000, J HISTOCHEM CYTOCHEM, V48, P1565, DOI 10.1177/002215540004801113; LESCH KP, 1993, J NEUROCHEM, V60, P2319, DOI 10.1111/j.1471-4159.1993.tb03522.x; Maayani S, 2001, PLATELETS, V12, P279, DOI 10.1080/09537100120071004; Maayani S, 2001, PLATELETS, V12, P359; Maggio N, 2001, BRAIN RES BULL, V56, P173, DOI 10.1016/S0361-9230(01)00649-9; Masuda M, 2000, EMBO J, V19, P521, DOI 10.1093/emboj/19.4.521; McNicol A, 1999, THROMB RES, V95, P1, DOI 10.1016/S0049-3848(99)00015-8; MELINO G, 1994, MOL CELL BIOL, V14, P6584, DOI 10.1128/MCB.14.10.6584; MOHAMMAD SF, 1975, AM J PATHOL, V79, P81; Ni HY, 2000, J CLIN INVEST, V106, P385, DOI 10.1172/JCI9896; Nishioka H, 2001, BIOCHEM BIOPH RES CO, V280, P970, DOI 10.1006/bbrc.2001.4237; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; PALMER DS, 1994, THROMB HAEMOSTASIS, V72, P132; PUSZKIN EG, 1985, J BIOL CHEM, V260, P6012; RAPPORT MM, 1948, SCIENCE, V108, P329, DOI 10.1126/science.108.2804.329; Schluter T, 1999, BIOCHEM PHARMACOL, V57, P1191, DOI 10.1016/S0006-2952(99)00011-8; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Schmidt G, 1999, J BIOL CHEM, V274, P31875, DOI 10.1074/jbc.274.45.31875; Schoenwaelder SM, 2002, J BIOL CHEM, V277, P14738, DOI 10.1074/jbc.M200661200; Serafeim A, 2002, BLOOD, V99, P2545, DOI 10.1182/blood.V99.7.2545; Serebruany VL, 2001, PHARMACOL RES, V43, P453, DOI 10.1006/phrs.2001.0817; Shirakawa R, 2000, J BIOL CHEM, V275, P33844, DOI 10.1074/jbc.M002834200; SIESS W, 1989, PHYSIOL REV, V69, P59; Singh US, 2003, J BIOL CHEM, V278, P391, DOI 10.1074/jbc.M206361200; Singh US, 2001, EMBO J, V20, P2413, DOI 10.1093/emboj/20.10.2413; Szasz R, 2002, BLOOD, V100, P2827, DOI 10.1182/blood-2002-02-0354; Tucholski J, 2001, NEUROSCIENCE, V102, P481, DOI 10.1016/S0306-4522(00)00482-6; Walther DJ, 1999, MOL BRAIN RES, V68, P55, DOI 10.1016/S0169-328X(99)00046-7; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197	51	348	357	3	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 26	2003	115	7					851	862		10.1016/S0092-8674(03)01014-6	http://dx.doi.org/10.1016/S0092-8674(03)01014-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	758RV	14697203	Bronze			2022-12-24	WOS:000187664700009
J	Palmer, LE; Rabinowicz, PD; O'Shaughnessy, AL; Balija, VS; Nascimento, LU; Dike, S; de la Bastide, M; Martienssen, RA; McCombie, WR				Palmer, LE; Rabinowicz, PD; O'Shaughnessy, AL; Balija, VS; Nascimento, LU; Dike, S; de la Bastide, M; Martienssen, RA; McCombie, WR			Maize genome sequencing by methylation filtrations	SCIENCE			English	Article							DNA METHYLATION; TRANSPOSABLE ELEMENTS; DRAFT SEQUENCE; GENE; RETROTRANSPOSONS; REGIONS; PLANTS	Gene enrichment strategies offer an alternative to sequencing large and repetitive genomes such as that of maize. We report the generation and analysis of nearly 100,000 undermethylated (or methylation filtration) maize sequences. Comparison with the rice genome reveals that methylation filtration results in a more comprehensive representation of maize genes than those that result from expressed sequence tags or transposon insertion sites sequences. About 7% of the repetitive DNA is unmethylated and thus selected in our libraries, but potentially active transposons and unmethylated organelle genomes can be identified. Reverse transcription polymerase chain reaction can be used to finish the maize transcriptome.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.org; mccombie@cshl.edu		McCombie, W. Richard/0000-0003-1899-0682	NATIONAL CANCER INSTITUTE [T32CA009311] Funding Source: NIH RePORTER; NCI NIH HHS [2 T32-CA09311-25] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ANTEQUERA F, 1988, EMBO J, V7, P2295, DOI 10.1002/j.1460-2075.1988.tb03072.x; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; BENNETT MD, 1995, ANN BOT-LONDON, V76, P113, DOI 10.1006/anbo.1995.1085; BENNETZEN JL, 1994, GENOME, V37, P565, DOI 10.1139/g94-081; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; CRESSE AD, 1995, GENETICS, V140, P315; Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; FLAVELL RB, 1994, P NATL ACAD SCI USA, V91, P3490, DOI 10.1073/pnas.91.9.3490; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; HAKE S, 1980, CHROMOSOMA, V79, P251, DOI 10.1007/BF00327318; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Lunde China F., 2003, Functional & Integrative Genomics, V3, P25; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Mao L, 2000, GENOME RES, V10, P982, DOI 10.1101/gr.10.7.982; Martienssen R, 1998, TRENDS GENET, V14, P263, DOI 10.1016/S0168-9525(98)01518-2; MAY BP, IN PRESS P NATL ACAD; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Morishige DT, 2002, PLANT PHYSIOL, V130, P1614, DOI 10.1104/pp.012567; Papa CM, 2001, PLANT CELL, V13, P1919, DOI 10.1105/tpc.13.8.1919; Rabinowicz PD, 1999, NAT GENET, V23, P305, DOI 10.1038/15479; Rabinowicz PD, 2003, GENOME RES, V13, P2658, DOI 10.1101/gr.1784803; Rabinowicz PD, 2003, CURR OPIN PLANT BIOL, V6, P150, DOI 10.1016/S1369-5266(03)00008-6; Raizada MN, 2001, PLANT CELL, V13, P1587, DOI 10.1105/tpc.13.7.1587; RALEIGH EA, 1988, NUCLEIC ACIDS RES, V16, P1563, DOI 10.1093/nar/16.4.1563; *RIC CHROM 10 SEQ, 2003, SCIENCE NEW YORK NY, V0300; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; WALBOT V, 1990, PLANT MOL BIOL, V15, P121, DOI 10.1007/BF00017729; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yuan YN, 2003, PLANT J, V34, P249, DOI 10.1046/j.1365-313X.2003.01716.x	33	173	192	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2115	2117		10.1126/science.1091265	http://dx.doi.org/10.1126/science.1091265			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684820				2022-12-24	WOS:000187385200042
J	Luo, ZX; Ji, Q; Wible, JR; Yuan, CX				Luo, ZX; Ji, Q; Wible, JR; Yuan, CX			An early Cretaceous tribosphenic mammal and metatherian evolution	SCIENCE			English	Article							EUTHERIAN MAMMALS; ORIGIN; MARSUPIALS; PHYLOGENY	Derived features of a new boreosphenidan mammal from the Lower Cretaceous Yixian Formation of China suggest that it has a closer relationship to metatherians (including extant marsupials) than to eutherians (including extant placentals). This fossil dates to 125 million years ago and extends the record of marsupial relatives with skeletal remains by 50 million years. It also has many foot structures known only from climbing and tree-living extant mammals, suggesting that early crown therians exploited diverse niches. New data from this fossil support the view that Asia was likely the center for the diversification of the earliest metatherians and eutherians during the Early Cretaceous.	Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA; Nanjing Univ, Dept Earth Sci, Nanjing 200017, Peoples R China; Chinese Acad Geol Sci, Beijing 100037, Peoples R China; China Univ Geosci, Beijing 100083, Peoples R China	Nanjing University; Chinese Academy of Geological Sciences; China University of Geosciences	Luo, ZX (corresponding author), Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA.	luoz@carnegiemuseums.org	Luo, Zhe-XI/AAU-2263-2021					Archibald JD, 2001, NATURE, V414, P62, DOI 10.1038/35102048; Argot C, 2002, J MORPHOL, V253, P76, DOI 10.1002/jmor.1114; Argot C, 2001, J MORPHOL, V247, P51, DOI 10.1002/1097-4687(200101)247:1<51::AID-JMOR1003>3.0.CO;2-#; Averianov A, 1999, ACTA PALAEONTOL POL, V44, P71; BEARD KC, 1992, PRIMATES THEIR RELAT, P63; Cifelli Richard L., 1997, Journal of Mammalian Evolution, V4, P241, DOI 10.1023/A:1027394430433; Cifelli RL, 1999, NATURE, V401, P363, DOI 10.1038/43861; Cifelli RL, 1996, NATURE, V379, P715, DOI 10.1038/379715a0; Clemens W.A., 1966, U CALIFORNIA PUBLICA, V62, P1; de Muizon Christian, 1998, Geodiversitas, V20, P19; deMuizon C, 1997, NATURE, V389, P486, DOI 10.1038/39029; Horovitz I, 2003, CLADISTICS, V19, P181, DOI 10.1016/S0748-3007(03)00045-8; Horovitz I, 2000, J VERTEBR PALEONTOL, V20, P547, DOI 10.1671/0272-4634(2000)020[0547:TTOUNE]2.0.CO;2; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; Hu YM, 2002, CHINESE SCI BULL, V47, P933, DOI 10.1360/02tb9209; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Ji Q, 1999, NATURE, V398, P326; Kielan-Jaworowska Z., 1979, Palaeontologia Polonica, V38, P5; Kielan-Jaworowska Z, 2001, ACTA PALAEONTOL POL, V46, P377; KIELAN-JAWOROWSKA Z, 1975, Palaeontologia Polonica, V33, P103; KIELANJAWOROWSK.Z, IN PRESS MAMMALS AGE; KIELANJAWOROWSKA Z, 1989, ZOOL SCR, V18, P347, DOI 10.1111/j.1463-6409.1989.tb00460.x; Lillegraven J.A., 1974, Annual Rev Ecol Syst, V5, P263, DOI 10.1146/annurev.es.05.110174.001403; LILLEGRAVEN JA, 1984, U TENN STUD GEOL, V8, P1; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; Marshall Larry G., 1995, Memoires du Museum National d'Histoire Naturelle, V165, P1; McKenna MC, 1997, CLASSIFICATION MAMMA; Novacek MJ, 1997, NATURE, V389, P483, DOI 10.1038/39020; Reig O.A., 1987, P1; Rich Thomas H., 1999, Records of the Queen Victoria Museum, V106, P1; Rougier G.W., 1993, THESIS U NACL BUENOS; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856; Sanchez-Villagra Marcelo R., 1997, Journal of Mammalian Evolution, V4, P119, DOI 10.1023/A:1027318213347; SIGOGNEAURUSSELL D, 1992, ZOOL SCR, V21, P205, DOI 10.1111/j.1463-6409.1992.tb00322.x; Springer Mark S., 1997, Journal of Mammalian Evolution, V4, P285, DOI 10.1023/A:1027378615412; Springer Mark S., 1997, P129; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Swofford D. L., 2000, PAUP PHYLOGENETIC AN; Szalay F.S., 1994, EVOLUTIONARY HIST MA; Szalay Frederick S., 2001, Geodiversitas, V23, P139; Szalay FS, 1996, J VERTEBR PALEONTOL, V16, P474, DOI 10.1080/02724634.1996.10011335; Tyndale-Biscoe CH., 1987, REPROD PHYSL MARSUPI; Wang YQ, 2001, SCIENCE, V294, P357, DOI 10.1126/science.1063830; Weil A, 2002, NATURE, V416, P798, DOI 10.1038/416798a; [No title captured]	46	296	333	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1934	1940		10.1126/science.1090718	http://dx.doi.org/10.1126/science.1090718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671295				2022-12-24	WOS:000187174000052
J	Malin, MC; Edgett, KS				Malin, MC; Edgett, KS			Evidence for persistent flow and aqueous sedimentation on early Mars	SCIENCE			English	Article							CHANNELS; WATER; MORPHOLOGY; SCALE	Landforms representative of sedimentary processes and environments that occurred early in martian history have been recognized in Mars Global Surveyor Mars Orbiter Camera and Mars Odyssey Thermal Emission Imaging System images. Evidence of distributary, channelized flow (in particular, flow that lasted long enough to foster meandering) and the resulting deposition of a fan-shaped apron of debris indicate persistent flow conditions and formation of at least some large intracrater layered sedimentary sequences within fluvial, and potentially lacustrine, environments.	Malin Space Sci Syst, San Diego, CA 92191 USA		Malin, MC (corresponding author), Malin Space Sci Syst, POB 910148, San Diego, CA 92191 USA.			Edgett, Kenneth/0000-0001-7197-5751				[Anonymous], 1983, GEOL SOC AM BULL, V94, P1035; Baker V.R., 1992, CHANNELS VALLEY NETW, P493; Baker VR, 2001, NATURE, V412, P228, DOI 10.1038/35084172; BLAIR TC, 1994, J SEDIMENT RES A, V64, P450; Cabrol NA, 2001, ICARUS, V149, P291, DOI 10.1006/icar.2000.6530; Carr M.H, 1996, WATER MARS; Carr MH, 2000, ICARUS, V146, P366, DOI 10.1006/icar.2000.6428; Christensen PR, 2003, SCIENCE, V300, P2056, DOI 10.1126/science.1080885; Galloway W.E., 1975, DELTAS MODELS EXPLOR, P87; KOMAR PD, 1979, ICARUS, V37, P156, DOI 10.1016/0019-1035(79)90123-4; MAIZELS J, 1990, PALAEOGEOGR PALAEOCL, V76, P241, DOI 10.1016/0031-0182(90)90115-N; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; MALIN MC, 1992, J GEOPHYS RES-PLANET, V97, P7699, DOI 10.1029/92JE00340; Miller RP, 1937, J GEOL, V45, P432, DOI 10.1086/624550; MILTON DJ, 1973, J GEOPHYS RES, V78, P4037, DOI 10.1029/JB078i020p04037; MILTON DJ, 1974, ICARUS, V23, P27; Nemec W., 1990, SPECIAL PUBLICATION, V10, P3; Ori GG, 2000, J GEOPHYS RES-PLANET, V105, P17629, DOI 10.1029/1999JE001219; SHARP RP, 1975, GEOL SOC AM BULL, V86, P593, DOI 10.1130/0016-7606(1975)86<593:COM>2.0.CO;2; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; WEIHAUPT JG, 1974, J GEOPHYS RES, V79, P2073, DOI 10.1029/JB079i014p02073; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]	23	351	358	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1931	1934		10.1126/science.1090544	http://dx.doi.org/10.1126/science.1090544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14615547				2022-12-24	WOS:000187174000051
J	Zhang, FX; Su, KH; Yang, XY; Bowe, DB; Paterson, AJ; Kudlow, JE				Zhang, FX; Su, KH; Yang, XY; Bowe, DB; Paterson, AJ; Kudlow, JE			O-GIcNAc modification is an endogenous inhibitor of the proteasome	CELL			English	Article							PANCREATIC BETA-CELLS; N-ACETYLGLUCOSAMINE; GLCNAC TRANSFERASE; CYTOSOLIC PROTEINS; TETRATRICOPEPTIDE REPEATS; DEPENDENT DEGRADATION; PROTEOLYTIC PATHWAY; GENE-TRANSCRIPTION; RESEARCH TOOLS; LINKED GLCNAC	The ubiquitin proteasome system classically selects its substrates for degradation by tagging them with ubiquitin. Here, we describe another means of controlling proteasome function in a global manner. The 26S proteasome can be inhibited by modification with the enzyme, O-GlcNAc transferase (OGT). This reversible modification of the proteasome inhibits the proteolysis of the transcription factor Sp1 and a hydrophobic peptide through inhibition of the ATPase activity of 26S proteasomes. The Rpt2 ATPase in the mammalian proteasome 19S cap is modified by O-GlcNAc in vitro and in vivo and as its modification increases, proteasome function decreases. This mechanism may couple proteasomes to the general metabolic state of the cell. The O-GlcNAc modification of proteasomes may allow the organism to respond to its metabolic needs by controlling the availability of amino acids and regulatory proteins.	Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; Univ Alabama, Dept Pharmacol, Birmingham, AL 35294 USA; Univ Alabama, Dept Med, Div Endocrinol Diabet & Metabolism, Birmingham, AL 35294 USA; Gene Express Lab, Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Salk Institute	Kudlow, JE (corresponding author), Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA.				NATIONAL CANCER INSTITUTE [R01CA095021] Funding Source: NIH RePORTER; NCI NIH HHS [CA095021] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adams J, 1999, CANCER RES, V59, P2615; Bajorek M, 2003, CURR BIOL, V13, P1140, DOI 10.1016/S0960-9822(03)00417-2; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen F, 2000, CELL GROWTH DIFFER, V11, P239; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; Donath MY, 1999, DIABETES, V48, P738, DOI 10.2337/diabetes.48.4.738; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2002, NAT MED, V8, P338, DOI 10.1038/nm0402-338; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Han I, 2000, BIOCHEM J, V350, P109, DOI 10.1042/0264-6021:3500109; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hideshima T, 2001, CANCER RES, V61, P3071; Hoffman L, 1996, J BIOL CHEM, V271, P32538, DOI 10.1074/jbc.271.51.32538; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; LECKER SH, 2002, J PHYSL, V545, P819; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820; Lopes UG, 1997, J BIOL CHEM, V272, P12893, DOI 10.1074/jbc.272.20.12893; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; MOSS B, 1991, SCIENCE, V252, P1662, DOI 10.1126/science.2047875; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Pasquini LA, 2000, J NEUROSCI RES, V59, P601, DOI 10.1002/(SICI)1097-4547(20000301)59:5<601::AID-JNR3>3.0.CO;2-1; Price SR, 1996, J CLIN INVEST, V98, P1703, DOI 10.1172/JCI118968; Qiu JH, 2000, J NEUROSCI, V20, P259, DOI 10.1523/JNEUROSCI.20-01-00259.2000; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; Roos MD, 1998, P ASSOC AM PHYSICIAN, V110, P422; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Russell SJ, 2001, CHEM BIOL, V8, P941, DOI 10.1016/S1074-5521(01)00060-6; Sayeski PP, 1996, J BIOL CHEM, V271, P15237, DOI 10.1074/jbc.271.25.15237; Su KH, 1999, J BIOL CHEM, V274, P15194, DOI 10.1074/jbc.274.21.15194; Su KH, 2000, BIOCHEM J, V348, P281, DOI 10.1042/0264-6021:3480281; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wells L, 2003, BIOCHEM BIOPH RES CO, V302, P435, DOI 10.1016/S0006-291X(03)00175-X; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; WING SS, 1993, AM J PHYSIOL, V264, P668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998	53	329	355	3	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 12	2003	115	6					715	725		10.1016/S0092-8674(03)00974-7	http://dx.doi.org/10.1016/S0092-8674(03)00974-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675536	Bronze			2022-12-24	WOS:000187366100011
J	McNab, BK				McNab, BK			Metabolism - Ecology shapes bird bioenergetics	NATURE			English	Editorial Material							ENERGY-EXPENDITURE; MAMMALS; ENERGETICS; BASAL; RATES		Univ Florida, Dept Zool, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	McNab, BK (corresponding author), Univ Florida, Dept Zool, Gainesville, FL 32611 USA.							BARTHOLOMEW GA, 1983, PHYSIOL ZOOL, V56, P370, DOI 10.1086/physzool.56.3.30152601; Beehler B.M., 1989, ACT 19 C INT ORN, P816, DOI 10.1515/9781400880713; FRITH CB, 1998, BRIDS PARADISE; GLAZIER DS, 1985, COMP BIOCHEM PHYS A, V80, P587, DOI 10.1016/0300-9629(85)90417-7; KOTEJA P, 1991, FUNCT ECOL, V5, P56, DOI 10.2307/2389555; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; MCNAB BK, 1980, AM NAT, V116, P106, DOI 10.1086/283614; McNab BK, 2001, AUK, V118, P916, DOI 10.1642/0004-8038(2001)118[0916:EOTABA]2.0.CO;2; McNab BK, 2000, COMP BIOCHEM PHYS A, V127, P309, DOI 10.1016/S1095-6433(00)00268-3; NAGY KA, 1994, AUST J ZOOL, V42, P43, DOI 10.1071/ZO9940043; NAGY KA, 1987, ECOL MONOGR, V57, P111, DOI 10.2307/1942620; Reynolds PS, 1996, AM NAT, V147, P735, DOI 10.1086/285877; Ricklefs RE, 1996, AM NAT, V147, P1047, DOI 10.1086/285892	13	38	39	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					620	621		10.1038/426620b	http://dx.doi.org/10.1038/426620b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668851				2022-12-24	WOS:000187132800028
J	Shaevitz, JW; Abbondanzieri, EA; Landick, R; Block, SM				Shaevitz, JW; Abbondanzieri, EA; Landick, R; Block, SM			Backtracking by single RNA polymerase molecules observed at near-base-pair resolution	NATURE			English	Article							ESCHERICHIA-COLI; TRANSCRIPT CLEAVAGE; ELONGATION; DNA; FIDELITY; FORCE; GREA; MECHANISM; COMPLEXES; ARREST	Escherichia coli RNA polymerase ( RNAP) synthesizes RNA with remarkable fidelity in vivo(1). Its low error rate may be achieved by means of a ' proofreading' mechanism comprised of two sequential events. The first event ( backtracking) involves a transcriptionally upstream motion of RNAP through several base pairs, which carries the 30 end of the nascent RNA transcript away from the enzyme active site. The second event ( endonucleolytic cleavage) occurs after a variable delay and results in the scission and release of the most recently incorporated ribonucleotides, freeing up the active site. Here, by combining ultrastable optical trapping apparatus with a novel two- bead assay to monitor transcriptional elongation with near- base- pair precision, we observed backtracking and recovery by single molecules of RNAP. Backtracking events (similar to 5 bp) occurred infrequently at locations throughout the DNA template and were associated with pauses lasting 20 s to > 30 min. Inosine triphosphate increased the frequency of backtracking pauses, whereas the accessory proteins GreA and GreB, which stimulate the cleavage of nascent RNA, decreased the duration of such pauses.	Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	Stanford University; Stanford University; Stanford University; University of Wisconsin System; University of Wisconsin Madison	Block, SM (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.				NIGMS NIH HHS [R01 GM057035] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057035] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOULELA F, 1985, NUCLEIC ACIDS RES, V13, P4811, DOI 10.1093/nar/13.13.4811; Adelman K, 2002, P NATL ACAD SCI USA, V99, P13538, DOI 10.1073/pnas.212358999; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; deCastro MJ, 2000, NAT CELL BIOL, V2, P724, DOI 10.1038/35036357; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; ERIE DA, 1992, ANNU REV BIOPH BIOM, V21, P379, DOI 10.1146/annurev.bb.21.060192.002115; FENG GH, 1994, J BIOL CHEM, V269, P22282; Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; Marr MT, 2000, MOL CELL, V6, P1275, DOI 10.1016/S1097-2765(00)00126-X; MARTIN FH, 1985, NUCLEIC ACIDS RES, V13, P8927, DOI 10.1093/nar/13.24.8927; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Nishiyama M, 2001, NAT CELL BIOL, V3, P425, DOI 10.1038/35070116; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Tornaletti S, 1999, J BIOL CHEM, V274, P24124, DOI 10.1074/jbc.274.34.24124; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; YIN H, 1994, BIOPHYS J, V67, P2468, DOI 10.1016/S0006-3495(94)80735-0	28	289	303	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					684	687		10.1038/nature02191	http://dx.doi.org/10.1038/nature02191			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14634670	Green Accepted			2022-12-24	WOS:000187132800047
J	Journet, L; Agrain, C; Broz, P; Cornelis, GR				Journet, L; Agrain, C; Broz, P; Cornelis, GR			The needle length of bacterial injectisomes is determined by a molecular ruler	SCIENCE			English	Article							FLAGELLAR HOOK LENGTH; III SECRETION SYSTEM; SALMONELLA-TYPHIMURIUM; SUBSTRATE-SPECIFICITY; SHIGELLA-FLEXNERI; YOP SECRETION; TAIL LENGTH; PROTEIN; COMPLEX; YSCP	Size determination represents a fundamental requirement for multicomponent biological structures. Some pathogenic bacteria possess a weapon derived from the flagellum. Like the flagellum, this type-III secretion apparatus, called the injectisome, has a transmembrane basal body, but the external component is a needle-like structure instead of a hook and a. lament. Here, we provide evidence that the length of this needle is determined by the size of a protein, YscP, acting as a molecular ruler.	Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Cornelis, GR (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.		Broz, Petr/AAC-7940-2019	Broz, Petr/0000-0002-2334-7790; Journet, Laure/0000-0002-5847-2962				ABULADZE NK, 1994, VIROLOGY, V199, P301, DOI 10.1006/viro.1994.1128; Aizawa S, 2001, FEMS MICROBIOL LETT, V202, P157, DOI 10.1111/j.1574-6968.2001.tb10797.x; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; COLLAZO CM, 1995, MOL MICROBIOL, V15, P25, DOI 10.1111/j.1365-2958.1995.tb02218.x; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; DUDA RL, 1986, VIROLOGY, V151, P296, DOI 10.1016/0042-6822(86)90051-6; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994; Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798; KATSURA I, 1987, NATURE, V327, P73, DOI 10.1038/327073a0; KATSURA I, 1984, CELL, V39, P691, DOI 10.1016/0092-8674(84)90476-8; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Magdalena J, 2002, J BACTERIOL, V184, P3433, DOI 10.1128/JB.184.13.3433-3441.2002; Makishima S, 2001, SCIENCE, V291, P2411, DOI 10.1126/science.1058366; Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000; Minamino T, 1999, MOL MICROBIOL, V34, P295, DOI 10.1046/j.1365-2958.1999.01597.x; Payne PL, 1999, J BACTERIOL, V181, P2852, DOI 10.1128/JB.181.9.2852-2862.1999; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Stainier I, 2000, MOL MICROBIOL, V37, P1005, DOI 10.1046/j.1365-2958.2000.02026.x; Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002	23	235	246	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1757	1760		10.1126/science.1091422	http://dx.doi.org/10.1126/science.1091422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657497				2022-12-24	WOS:000186970100046
J	Monje, ML; Toda, H; Palmer, TD				Monje, ML; Toda, H; Palmer, TD			Inflammatory blockade restores adult hippocampal neurogenesis	SCIENCE			English	Article							NEURAL STEM-CELLS; DENTATE GYRUS; RAT-BRAIN; RECEPTOR ACTIVATION; MAMMALIAN FOREBRAIN; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; EXPRESSION; INTERLEUKIN-6; DIFFERENTIATION	Cranial radiation therapy causes a progressive decline in cognitive function that is linked to impaired neurogenesis. Chronic inflammation accompanies radiation injury, suggesting that inflammatory processes may contribute to neural stem cell dysfunction. Here, we show that neuroinflammation alone inhibits neurogenesis and that inflammatory blockade with indomethacin, a common nonsteroidal anti-inflammatory drug, restores neurogenesis after endotoxin-induced inflammation and augments neurogenesis after cranial irradiation.	Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA	Stanford University	Palmer, TD (corresponding author), Stanford Univ, Dept Neurosurg, MSLS P309,Mail Code 5487,1201 Welche Rd, Stanford, CA 94305 USA.		Toda, Hiroki/C-6932-2016; Palmer, Theo/GSI-6635-2022	Toda, Hiroki/0000-0002-1596-4131; Palmer, Theo/0000-0002-6266-1862	NIMH NIH HHS [MH20016-05] Funding Source: Medline; NINDS NIH HHS [F30 NS04696701] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brew BJ, 1999, NEUROL CLIN, V17, P861, DOI 10.1016/S0733-8619(05)70170-5; Bu J, 2001, GLIA, V34, P296, DOI 10.1002/glia.1063; CALVO W, 1988, BRIT J RADIOL, V61, P1043, DOI 10.1259/0007-1285-61-731-1043; Cameron HA, 1998, CURR OPIN NEUROBIOL, V8, P677, DOI 10.1016/S0959-4388(98)80099-8; Cameron HA, 1998, NEUROSCIENCE, V82, P349; Castella P, 1999, J NEUROSCI RES, V56, P229, DOI 10.1002/(SICI)1097-4547(19990501)56:3<229::AID-JNR2>3.0.CO;2-Z; Chojnacki A, 2003, J NEUROSCI, V23, P1730; Dickson DW, 2001, CLIN GERIATR MED, V17, P209, DOI 10.1016/S0749-0690(05)70066-5; EKDAHL CT, 2003, P NATL ACAD SCI US; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gould E, 1997, J NEUROSCI, V17, P2492; Hodges H, 1998, BEHAV BRAIN RES, V91, P99, DOI 10.1016/S0166-4328(97)00108-3; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Luskin MB, 1998, J NEUROBIOL, V36, P221; Mackenzie IRA, 2000, NEUROLOGY, V55, P132, DOI 10.1212/WNL.55.1.132; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; MARKS JE, 1981, INT J RADIAT ONCOL, V7, P243, DOI 10.1016/0360-3016(81)90443-0; Marz P, 1999, GLIA, V26, P191, DOI 10.1002/(SICI)1098-1136(199905)26:3<191::AID-GLIA1>3.0.CO;2-#; Monje ML, 2003, CURR OPIN NEUROL, V16, P129, DOI 10.1097/00019052-200304000-00002; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Nakashima K, 2002, MOL NEUROBIOL, V25, P233; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199; REICHMAN HR, 1986, J NEUROSURG, V65, P233, DOI 10.3171/jns.1986.65.2.0233; Reyes TM, 1998, AM J PHYSIOL-REG I, V274, pR139, DOI 10.1152/ajpregu.1998.274.1.R139; ROGERS J, 1993, NEUROLOGY, V43, P1609, DOI 10.1212/WNL.43.8.1609; Shaw KN, 2001, BEHAV BRAIN RES, V124, P47, DOI 10.1016/S0166-4328(01)00232-7; SHELINE GE, 1980, INT J RADIAT ONCOL, V6, P1215, DOI 10.1016/0360-3016(80)90175-3; SHINTANI F, 1995, J NEUROSCI, V15, P1961, DOI 10.1523/JNEUROSCI.15-03-01961.1995; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Tanapat P, 1998, INT J DEV NEUROSCI, V16, P235, DOI 10.1016/S0736-5748(98)00029-X; Terrazzino S, 2002, J NEUROIMMUNOL, V124, P45, DOI 10.1016/S0165-5728(02)00013-9; Turrin NP, 2001, BRAIN RES BULL, V54, P443, DOI 10.1016/S0361-9230(01)00445-2; Valerio A, 2002, MOL CELL NEUROSCI, V21, P602, DOI 10.1006/mcne.2002.1208; Vallieres L, 1997, J NEUROCHEM, V69, P1668, DOI 10.1046/j.1471-4159.1997.69041668.x; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; Van Wagoner NJ, 1999, J NEUROIMMUNOL, V100, P124, DOI 10.1016/S0165-5728(99)00187-3; Watanabe D, 1996, EUR J NEUROSCI, V8, P1630, DOI 10.1111/j.1460-9568.1996.tb01307.x; Weaver JD, 2002, NEUROLOGY, V59, P371, DOI 10.1212/WNL.59.3.371; Wright LS, 2003, J NEUROCHEM, V86, P179, DOI 10.1046/j.1471-4159.2003.01826.x	51	1809	1882	4	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1760	1765		10.1126/science.1088417	http://dx.doi.org/10.1126/science.1088417			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14615545				2022-12-24	WOS:000186970100047
J	Hull, MC; Morris, CG; Pepine, CJ; Mendenhall, NP				Hull, MC; Morris, CG; Pepine, CJ; Mendenhall, NP			Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NASOPHARYNGEAL CARCINOMA; HEART-DISEASE; RADIOTHERAPY; IRRADIATION; STENOSIS; REGURGITATION; PERICARDITIS; MORTALITY; EFFUSION; RISK	Context The majority of patients with Hodgkin lymphoma are young and highly curable. This necessitates concern for prevention, diagnosis, and optimal management of potential treatment-related complications. Objective To identify and quantify the incidence of and factors contributing to long-term cardiac and vascular complications after radiation therapy for Hodgkin lymphoma. Design and Setting Retrospective study comparing patients treated from 1962 to 1998 at a university-based referral center with a matched general population. Patients Four hundred fifteen consecutive patients who fulfilled the inclusion criteria of a minimum 2-year follow-up (median, 11.2 years) and whose radiation fields included the heart or carotid or subclavian arteries. Main Outcome Measures Multivariable analyses of potential risk factors and observed-to-expected ratios for cardiac valve surgery, coronary artery bypass graft surgery, percutaneous coronary intervention, or both based on Surveillance, Epidemiology, and End Results (SEER) and National Hospital Discharge Survey (NHDS) data. Results Forty-two patients (10.4%) developed coronary artery disease at a median of 9 years after treatment, 30 patients (7.4%) developed carotid and/or subclavian artery disease at a median of 17 years after treatment, and 25 patients (6.2%) developed clinically significant valvular dysfunction at a median of 22 years. The most common valve lesion was aortic stenosis, which occurred in 14 valves. The observed-to-expected ratio for valve surgery was 8.42 (95% confidence interval [CI], 3.20-13.65) and the observed-to-expected ratio for coronary artery bypass graft surgery or percutaneous coronary intervention was 1.63 (95% Cl, 0.98-2.28). At least 1 cardiac risk factor was present in all patients who developed coronary artery disease. The only treatment-related factor associated with the development of coronary artery disease was utilization of a radiation technique that resulted in a higher total dose to a portion of the heart (relative risk, 7.8; 95% Cl, 1.1-53.2; P=.04). No specific treatment-related factor was associated with carotid or subclavian artery disease or valvular dysfunction., Freedom from any cardiovascular morbidity was 88% at 15 years and 84% at 20 years. Conclusions Among patients treated with radiation therapy for Hodgkin lymphoma, there are statistically higher than expected rates of valve surgery and coronary revascularization procedures over the next 10 to 20 years. Coronary vascular disease is associated with higher radiation doses and traditional coronary heart disease risk factors. Noncoronary vascular disease and clinically important valvular dysfunction are less well understood complications at 15 to 20 years after radiation, requiring surveillance and further study.	Univ Florida, Coll Med, Dept Radiat Oncol, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Dept Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Mendenhall, NP (corresponding author), 2000 SW Archer Rd, Gainesville, FL 32608 USA.							Achenbach S, 1998, NEW ENGL J MED, V339, P1964, DOI 10.1056/NEJM199812313392702; AHUJA A, 1995, NEUROSURGERY, V36, P399, DOI 10.1227/00006123-199502000-00023; BOIVIN JF, 1992, CANCER, V69, P1241; BYHARDT R, 1975, CANCER-AM CANCER SOC, V35, P795, DOI 10.1002/1097-0142(197503)35:3<795::AID-CNCR2820350335>3.0.CO;2-M; *CDCP NAT CTR HLTH, 2002, CDCP NAT CTR HLTH ST, V13; Cheng SWK, 2000, ARCH OTOLARYNGOL, V126, P517, DOI 10.1001/archotol.126.4.517; COHN KE, 1967, MEDICINE, V46, P281, DOI 10.1097/00005792-196705000-00003; CONOMY JP, 1975, CANCER, V36, P1702, DOI 10.1002/1097-0142(197511)36:5<1702::AID-CNCR2820360525>3.0.CO;2-V; COSSET JM, 1991, INT J RADIAT ONCOL, V21, P447, DOI 10.1016/0360-3016(91)90794-5; COX DR, 1972, J R STAT SOC B, V34, P187; Dubec JJ, 1998, BRIT J RADIOL, V71, P872, DOI 10.1259/bjr.71.848.9828801; ELERDING SC, 1981, ANN SURG, V194, P609, DOI 10.1097/00000658-198111000-00009; Fletcher G, 1980, TXB RADIOTHERAPY; Glanzmann C, 1998, RADIOTHER ONCOL, V46, P51, DOI 10.1016/S0167-8140(97)00125-4; GUSTAVSSON A, 1990, ANN ONCOL, V1, P355, DOI 10.1093/oxfordjournals.annonc.a057774; Hancock SL, 1999, HODGKIN'S DISEASE, P647; HENRYAMAR M, 1990, INT J RADIAT ONCOL, V19, P1155, DOI 10.1016/0360-3016(90)90221-5; Hoppe RT, 1997, ANN ONCOL, V8, P115, DOI 10.1023/A:1008238908676; Houdart E, 2001, STROKE, V32, P118, DOI 10.1161/01.STR.32.1.118; HUDSON BV, 1994, ANN ONCOL         S2, V5, P65; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim WY, 2001, NEW ENGL J MED, V345, P1863, DOI 10.1056/NEJMoa010866; King LJ, 1999, RADIOLOGY, V213, P167, DOI 10.1148/radiology.213.1.r99oc07167; King V, 1996, INT J RADIAT ONCOL, V36, P881, DOI 10.1016/S0360-3016(96)00295-7; KREUSER ED, 1993, BRIT J HAEMATOL, V84, P615, DOI 10.1111/j.1365-2141.1993.tb03136.x; Lam WMM, 2001, CANCER, V92, P2357, DOI 10.1002/1097-0142(20011101)92:9<2357::AID-CNCR1583>3.0.CO;2-K; Lee CKK, 2000, INT J RADIAT ONCOL, V48, P169, DOI 10.1016/S0360-3016(00)00647-7; Lund MB, 1996, HEART, V75, P591, DOI 10.1136/hrt.75.6.591; Mauch P M, 1995, Cancer J Sci Am, V1, P33; Mendenhall NP, 1999, INT J RADIAT ONCOL, V44, P551, DOI 10.1016/S0360-3016(99)00087-5; MENDENHALL NP, 2000, CLIN RAD ONCOLOGY, P1123; MORTON DL, 1973, CHEST, V64, P291, DOI 10.1378/chest.64.3.291; *NCI DCCPS SURV RE, 2002, SURV EP END RES SEER; PERRAULT DJ, 1985, J CLIN ONCOL, V3, P546, DOI 10.1200/JCO.1985.3.4.546; POHJOLASINTONEN S, 1987, CANCER-AM CANCER SOC, V60, P31, DOI 10.1002/1097-0142(19870701)60:1<31::AID-CNCR2820600107>3.0.CO;2-D; PRENTICE RT, 1965, LANCET, V2, P388; Reinders JG, 1999, RADIOTHER ONCOL, V51, P35, DOI 10.1016/S0167-8140(99)00026-2; Santoro A, 2000, J Neurosurg Sci, V44, P159; *SAS I INC, 1999, SAS ONL COMP PROGR V	39	421	446	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2003	290	21					2831	2837		10.1001/jama.290.21.2831	http://dx.doi.org/10.1001/jama.290.21.2831			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QP	14657067	Bronze			2022-12-24	WOS:000186872800025
J	Le Marchand, L; Seifried, A; Lum-Jones, A; Donlon, T; Wilkens, LR				Le Marchand, L; Seifried, A; Lum-Jones, A; Donlon, T; Wilkens, LR			Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SQUAMOUS-CELL CARCINOMA; D1 POLYMORPHISM; GENE POLYMORPHISM; INCREASED RISK; EXPRESSION; SURVIVAL; HAWAII; HEAD; AGE	Context Cyclin D1 (CCND1) is a key cell cycle regulatory, protein, the overexpression of which is often found in human tumors and is associated with cell proliferation and poor prognosis. A common adenine-to-guanine substitution polymorphism (A870G) in the CCND1 gene results in an altered messenger RNA transcript and a longer-life protein, which are preferentially encoded by the A allele. Objective To test the overall and stage-specific associations of the CCND1 870A allele with colorectal cancer. Design, Setting, and Participants A population-based case-control study conducted in the multiethnic population of Hawaii between January 1, 1994, and August 31,1998, which included 504 patients with incident colorectal cancer and 624 population-based participants of Japanese, white, or Native Hawaiian origin. Participation rates were 58% for cases and 52% for controls. Main Outcome Measurement Ethnicity, gene-dosage effects, and stage (regional/ distant) and subsite (colon vs rectal) of cancer. Results The odds ratio (OR) for the CCND1 870 GA and AA genotypes compared with the GG genotype was 1.2 (95% confidence interval [01, 0.9-1.7) and 1.5 (95% Cl, 1.0-2.1), respectively (P=.03 for gene-dosage effect). These risk estimates were significantly greater for patients diagnosed at a regional or distant stage (GA vs GG: OR, 1.7; 95% Cl, 1.1 -2.5 and AA vs GG: OR, 1.9; 95% Cl, 1.2-3.1; P=.008 for gene-dosage effect) compared with those estimates for patients diagnosed at an earlier stage (P=.048). In subset analyses, the association between the A allele and advanced colorectal cancer was statistically significant in white and Hawaiian participants but not in Japanese, and was stronger for rectal cancer. Conclusion The CCND1 870A allele may be Associated with colorectal cancer, and particularly with forms of the disease that result in severe morbidity and mortality.	Univ Hawaii, Canc Res Ctr Hawaii, Etiol Program, Honolulu, HI 96813 USA	Cancer Research Center of Hawaii; University of Hawaii System	Le Marchand, L (corresponding author), Univ Hawaii, Canc Res Ctr Hawaii, Etiol Program, 1236 Lauhala St,Suite 407, Honolulu, HI 96813 USA.				DIVISION OF CANCER PREVENTION AND CONTROL [N01CN055424] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA072520, R01CA060987] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CN55424, R01 CA60987, CA72520] Funding Source: Medline	DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arber N, 1997, CANCER RES, V57, P1569; Arber N, 1996, GASTROENTEROLOGY, V110, P669, DOI 10.1053/gast.1996.v110.pm8608874; Bala S, 2001, CANCER RES, V61, P6042; BETTICHER DC, 1995, ONCOGENE, V11, P1005; Holley SL, 2001, AM J PATHOL, V159, P1917, DOI 10.1016/S0002-9440(10)63038-6; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; Izzo JG, 2003, JNCI-J NATL CANCER I, V95, P198, DOI 10.1093/jnci/95.3.198; Kong SM, 2001, JNCI-J NATL CANCER I, V93, P1106, DOI 10.1093/jnci/93.14.1106; Kong SM, 2000, CANCER RES, V60, P249; Le Marchand L, 2002, JNCI-J NATL CANCER I, V94, P454, DOI 10.1093/jnci/94.6.454; Le Marchand L, 2001, CANCER EPIDEM BIOMAR, V10, P1259; Maohua Le, 2002, Smarandache Notions Journal, V13, P239; McKay JA, 2000, INT J CANCER, V88, P77, DOI 10.1002/1097-0215(20001001)88:1<77::AID-IJC12>3.0.CO;2-O; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; OYAMA N, 1986, 54 HAW STAT DEP HLTH; Pagano IS, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-5; Porter TR, 2002, ONCOGENE, V21, P1928, DOI 10.1038/sj.onc.1205245; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Wang LZ, 2002, CARCINOGENESIS, V23, P257, DOI 10.1093/carcin/23.2.257; WEGNER EL, 1982, CANCER, V49, P2208, DOI 10.1002/1097-0142(19820515)49:10<2208::AID-CNCR2820491038>3.0.CO;2-6; Zheng YX, 2001, CARCINOGENESIS, V22, P1195, DOI 10.1093/carcin/22.8.1195	21	80	81	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2003	290	21					2843	2848						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QP	14657069	Bronze			2022-12-24	WOS:000186872800027
J	Wehr, M; Zador, AM				Wehr, M; Zador, AM			Balanced inhibition underlies tuning and sharpens spike timing in auditory cortex	NATURE			English	Article							VISUAL CORTICAL-NEURONS; DIRECTION SELECTIVITY; RESPONSE PROPERTIES; RECEPTIVE-FIELDS; SIMPLE CELLS; IN-VIVO; CAT; INPUT; ORIENTATION; SENSITIVITY	Neurons in the primary auditory cortex are tuned to the intensity and specific frequencies of sounds, but the synaptic mechanisms underlying this tuning remain uncertain. Inhibition seems to have a functional role in the formation of cortical receptive fields, because stimuli often suppress similar or neighbouring responses(1-3), and pharmacological blockade of inhibition broadens tuning curves(4,5). Here we use whole-cell recordings in vivo to disentangle the roles of excitatory and inhibitory activity in the tone-evoked responses of single neurons in the auditory cortex. The excitatory and inhibitory receptive fields cover almost exactly the same areas, in contrast to the predictions of classical lateral inhibition models. Thus, although inhibition is typically as strong as excitation, it is not necessary to establish tuning, even in the receptive field surround. However, inhibition and excitation occurred in a precise and stereotyped temporal sequence: an initial barrage of excitatory input was rapidly quenched by inhibition, truncating the spiking response within a few (1-4) milliseconds. Balanced inhibition might thus serve to increase the temporal precision(6) and thereby reduce the randomness of cortical operation, rather than to increase noise as has been proposed previously(7).	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Zador, AM (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.			Zador, Anthony/0000-0002-8431-9136				Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BRUGGE JF, 1969, J NEUROPHYSIOL, V32, P1005, DOI 10.1152/jn.1969.32.6.1005; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chen QC, 2000, HEARING RES, V150, P161, DOI 10.1016/S0378-5955(00)00197-0; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Covey E, 1996, J NEUROSCI, V16, P3009; De Ribaupierre F, 1972, Brain Res, V48, P185, DOI 10.1016/0006-8993(72)90178-3; DeWeese MR, 2003, J NEUROSCI, V23, P7940; HARTLINE HK, 1956, J GEN PHYSIOL, V39, P651, DOI 10.1085/jgp.39.5.651; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; MITANI A, 1985, J COMP NEUROL, V235, P417, DOI 10.1002/cne.902350402; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Ojima H, 2002, CEREB CORTEX, V12, P1079, DOI 10.1093/cercor/12.10.1079; PHILLIPS DP, 1988, J NEUROPHYSIOL, V59, P1524, DOI 10.1152/jn.1988.59.5.1524; PHILLIPS DP, 1985, HEARING RES, V18, P87, DOI 10.1016/0378-5955(85)90112-1; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; SCHULTE F J, 1969, Neuropaediatrie, V1, P36, DOI 10.1055/s-0028-1091862; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHAMMA SA, 1985, HEARING RES, V19, P1, DOI 10.1016/0378-5955(85)90094-2; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Sutter ML, 1999, J NEUROPHYSIOL, V82, P2358, DOI 10.1152/jn.1999.82.5.2358; VOLKOV IO, 1992, EXP BRAIN RES, V91, P115; Wang JA, 2002, BRAIN RES, V944, P219, DOI 10.1016/S0006-8993(02)02926-8; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796	30	975	985	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2003	426	6965					442	446		10.1038/nature02116	http://dx.doi.org/10.1038/nature02116			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647382				2022-12-24	WOS:000186800800038
J	Lynch, M; Conery, JS				Lynch, M; Conery, JS			The origins of genome complexity	SCIENCE			English	Article							DUPLICATE GENES; INTRON; EVOLUTION; SIZE; RECOMBINATION; PRESERVATION; COMMUNITIES; DROSOPHILA; MUTATION; DENSITY	Complete genomic sequences from diverse phylogenetic lineages reveal notable increases in genome complexity from prokaryotes to multicellular eukaryotes. The changes include gradual increases in gene number, resulting from the retention of duplicate genes, and more abrupt increases in the abundance of spliceosomal introns and mobile genetic elements. We argue that many of these modi. cations emerged passively in response to the long-term population-size reductions that accompanied increases in organism size. According to this model, much of the restructuring of eukaryotic genomes was initiated by nonadaptive processes, and this in turn provided novel substrates for the secondary evolution of phenotypic complexity by natural selection. The enormous long-term effective population sizes of prokaryotes may impose a substantial barrier to the evolution of complex genomes and morphologies.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Univ Oregon, Dept Comp & Informat Sci, Eugene, OR 97403 USA	Indiana University System; Indiana University Bloomington; University of Oregon	Lynch, M (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.							Akashi H, 2001, CURR OPIN GENET DEV, V11, P660, DOI 10.1016/S0959-437X(00)00250-1; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Carvalho AB, 1999, NATURE, V401, P344, DOI 10.1038/43827; Charlesworth B., 1985, POPULATION GENETICS, P213; Comeron JM, 2000, GENETICS, V156, P1175; CRAIG NL, 2002, MOBILE DNA, V2; Denver DR, 2000, SCIENCE, V289, P2342, DOI 10.1126/science.289.5488.2342; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Drake JW, 1998, GENETICS, V148, P1667; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Force A, 1999, GENETICS, V151, P1531; Gillespie J. H., 1991, CAUSES MOL EVOLUTION; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; Kimura M, 1985, NEUTRAL THEORY MOL E; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Lynch M, 2001, GENETICS, V159, P1789; Lynch M, 2002, CURR OPIN GENET DEV, V12, P701, DOI 10.1016/S0959-437X(02)00360-X; Lynch M, 2002, P NATL ACAD SCI USA, V99, P6118, DOI 10.1073/pnas.092595699; Lynch Michael, 2003, Journal of Structural and Functional Genomics, V3, P35, DOI 10.1023/A:1022696612931; Mair G, 2000, RNA, V6, P163, DOI 10.1017/S135583820099229X; Nixon JEJ, 2002, P NATL ACAD SCI USA, V99, P3701, DOI 10.1073/pnas.042700299; Ohno S., 1970, EVOLUTION GENE DUPLI; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Petrov DA, 1998, MOL BIOL EVOL, V15, P293, DOI 10.1093/oxfordjournals.molbev.a025926; Schmid PE, 2000, SCIENCE, V289, P1557, DOI 10.1126/science.289.5484.1557; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; Vinogradov AE, 1999, J MOL EVOL, V49, P376, DOI 10.1007/PL00006561	30	1110	1133	6	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2003	302	5649					1401	1404		10.1126/science.1089370	http://dx.doi.org/10.1126/science.1089370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631042				2022-12-24	WOS:000186683500054
J	Ravizza, G; Peucker-Ehrenbrink, B				Ravizza, G; Peucker-Ehrenbrink, B			Chemostratigraphic evidence of Deccan volcanism from the marine osmium isotope record	SCIENCE			English	Article							GLOBAL CLIMATE; TRAPS; AGE; GEOCHEMISTRY; INFERENCES; DURATION; ROCKS	Continental flood basalt (CFB) volcanism is hypothesized to have played a causative role in global climate change and mass extinctions. Uncertainties associated with radiometric dating preclude a clear chronological assessment of the environmental consequences of CFB volcanism. Our results document a 25% decline in the marine Os-187/Os-188 record that predates the Cretaceous-Tertiary boundary (KTB) and coincides with late Maastrichtian warming. We argue that this decline provides a chemostratigraphic marker of Deccan volcanism and thus constitutes compelling evidence that the main environmental consequence of Deccan volcanism was a transient global warming event of 3degrees to 5degreesC that is fully resolved from the KTB mass extinction.	Univ Hawaii, Dept Geol & Geophys, Honolulu, HI 96822 USA; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	University of Hawaii System; Woods Hole Oceanographic Institution	Ravizza, G (corresponding author), Univ Hawaii, Dept Geol & Geophys, Honolulu, HI 96822 USA.	ravizza@hawaii.edu	Ravizza, Greg/J-5104-2013	Peucker-Ehrenbrink, Bernhard/0000-0002-3819-992X				Allegre CJ, 1999, EARTH PLANET SC LETT, V170, P197, DOI 10.1016/S0012-821X(99)00110-7; Banerjee AC, 2000, J GEOL SOC INDIA, V56, P625; Barrera E, 1999, GEOL S AM S, P245; CALDEIRA K, 1990, GEOPHYS RES LETT, V17, P1299, DOI 10.1029/GL017i009p01299; Cohen AS, 2002, GEOLOGY, V30, P267, DOI 10.1130/0091-7613(2002)030<0267:NGEFTO>2.0.CO;2; Courtillot V, 2000, EARTH PLANET SC LETT, V182, P137, DOI 10.1016/S0012-821X(00)00238-7; Courtillot VE, 2003, CR GEOSCI, V335, P113, DOI 10.1016/S1631-0713(03)00006-3; Dessert C, 2001, EARTH PLANET SC LETT, V188, P459, DOI 10.1016/S0012-821X(01)00317-X; Hassler DR, 2000, CHEM GEOL, V166, P1, DOI 10.1016/S0009-2541(99)00180-1; Hicks JF, 2002, GEOL S AM S, P35; Hofmann C, 2000, EARTH PLANET SC LETT, V180, P13, DOI 10.1016/S0012-821X(00)00159-X; KYTE FT, 1993, GEOCHIM COSMOCHIM AC, V57, P1719, DOI 10.1016/0016-7037(93)90109-A; Li LQ, 1999, MAR GEOL, V161, P171, DOI 10.1016/S0025-3227(99)00078-X; Li LQ, 1998, GEOLOGY, V26, P995, DOI 10.1130/0091-7613(1998)026<0995:ADSWAT>2.3.CO;2; Mahoney JJ, 2002, EARTH PLANET SC LETT, V203, P295, DOI 10.1016/S0012-821X(02)00840-3; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; Mukhopadhyay S, 2001, GEOCHIM COSMOCHIM AC, V65, P653, DOI 10.1016/S0016-7037(00)00555-X; Nordt L, 2002, GEOLOGY, V30, P703, DOI 10.1130/0091-7613(2002)030<0703:PBIEFI>2.0.CO;2; Olsson RK, 2001, J FORAMIN RES, V31, P275, DOI 10.2113/31.3.275; Pande K, 2002, P INDIAN AS-EARTH, V111, P115, DOI 10.1007/BF02981139; Pegram WJ, 1999, GEOCHIM COSMOCHIM AC, V63, P4053, DOI 10.1016/S0016-7037(99)00308-7; Peucker-Ehrenbrink B, 2000, TERRA NOVA, V12, P205, DOI 10.1046/j.1365-3121.2000.00295.x; Ravizza G, 2001, PALEOCEANOGRAPHY, V16, P155, DOI 10.1029/2000PA000541; SUGARMAN PJ, 1995, GEOL SOC AM BULL, V107, P19, DOI 10.1130/0016-7606(1995)107<0019:UCMSIB>2.3.CO;2; Taylor AS, 1999, CHEM GEOL, V161, P199, DOI 10.1016/S0009-2541(99)00087-X; Vonhof HB, 1997, GEOLOGY, V25, P347, DOI 10.1130/0091-7613(1997)025<0347:HRLMED>2.3.CO;2; WARNER TB, 1974, INITIAL REPORTS DEEP, V25, P395; Wignall PB, 2001, EARTH-SCI REV, V53, P1, DOI 10.1016/S0012-8252(00)00037-4; Wilf P, 2003, P NATL ACAD SCI USA, V100, P599, DOI 10.1073/pnas.0234701100; Zachos JC, 1986, PALEOCEANOGRAPHY, V1, P5, DOI 10.1029/PA001i001p00005	30	119	127	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2003	302	5649					1392	1395		10.1126/science.1089209	http://dx.doi.org/10.1126/science.1089209			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631039				2022-12-24	WOS:000186683500051
J	Lee, DS; Austin, PC; Rouleau, JL; Liu, PP; Naimark, D; Tu, JV				Lee, DS; Austin, PC; Rouleau, JL; Liu, PP; Naimark, D; Tu, JV			Predicting mortality among patients hospitalized for heart failure - Derivation and validation of a clinical model	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOGISTIC-REGRESSION ANALYSIS; ACUTE MYOCARDIAL-INFARCTION; CARDIAC-SURGERY; CARE; COMMUNITY; RULES; INDEX; PROGNOSIS; SURVIVAL; MULTICENTER	Context A predictive model of mortality in heart failure may be useful for clinicians to improve communication with and care of hospitalized patients. Objectives To identify predictors of mortality and to develop and to validate a model using information available at hospital presentation. Design, Setting, and Participants Retrospective study of 4031 community-based patients presenting with heart failure at multiple hospitals in Ontario, Canada (2624 patients in the derivation cohort from 1999-2001 and 1407 patients in the validation cohort from 1997-1999), who had been identitifed as part of the Enhanced Feedback for Effective Cardiac Treatment (EFFECT) study. Main Outcome Measures All-cause 30-day and 1-year mortality. Results The mortality rates for the derivation cohort and validation cohort, respectively, were 8.9% and 8.2% in hospital, 10.7% and 10.4% at 30 days, and 32.9% and 30.5% at 1 year. Multivariable predictors of mortality at both 30 days and 1 year included older age, lower systolic blood pressure, higher respiratory rate, higher urea nitrogen level (all P<.001), and hyponatremia (P<.01). Comorbid conditions associated with mortality included cerebrovascular disease (30-day mortality odds ratio [OR], 1.43; 95% confidence interval [CI], 1.03-1.98; P=.03), chronic obstructive pulmonary disease (OR, 1.66; 95 % CI, 1.22-2.27; P=.002), hepatic cirrhosis (OR, 3.22; 95% CI, 1.08-9.65; P=.04), dementia (OR, 2.54; 95% CI, 1.77-3.65; P<.001), and cancer (OR, 1.86; 95% CI, 1.28-2.70; P=.001). A risk index stratified the risk of death and identified low- and high-risk individuals. Patients with very low-risk scores (:560) had a mortality rate of 0.4% at 30 days and 7.8% at 1 year. Patients with very high-risk scores (>150) had a mortality rate of 59.0% at 30 days and 78.8% at 1 year. Patients with higher 1-year risk scores had reduced survival at all times up to 1 year (log-rank, P<.001). For the derivation cohort, the area under the receiver operating characteristic curve for the model was 0.80 for 30-day mortality and 0.77 for 1-year mortality. Predicted mortality rates in the validation cohort closely matched observed rates across the entire spectrum of risk. Conclusions Among community-based heart failure patients, factors identifiable Within hours of hospital presentation predicted mortality risk at 30 days and 1 year. The externally validated predictive index may assist clinicians in estimating heart failure mortality risk and in providing quantitative guidance for decision making in heart failure care.	Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Univ Toronto, Toronto Gen Hosp, Toronto, ON M5G 1L7, Canada; Toronto Gen Hosp, Univ Hlth Network, Div Cardiol, Dept Hlth Policy, Toronto, ON, Canada; Toronto Gen Hosp, Univ Hlth Network, Div Cardiol, Dept Management, Toronto, ON, Canada; Toronto Gen Hosp, Univ Hlth Network, Div Cardiol, Dept Evaluat Clin Epidemiol, Toronto, ON, Canada; Toronto Gen Hosp, Univ Hlth Network, Div Cardiol, Dept Publ Hlth Sci, Toronto, ON, Canada; Mt Sinai Hosp, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON M5G 1X5, Canada; Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Tu, JV (corresponding author), Inst Clin Evaluat Sci, Room G-106,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	tu@ices.on.ca		Naimark, David Malcolm Joseph/0000-0002-0621-0637; Tu, Jack/0000-0003-0111-722X; Lee, Douglas/0000-0001-7078-745X; Austin, Peter/0000-0003-3337-233X				Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; CAMPANA C, 1993, J HEART LUNG TRANSPL, V12, P756; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chin MH, 1997, AM J CARDIOL, V79, P1640, DOI 10.1016/S0002-9149(97)00214-2; Cleland JGF, 2002, LANCET, V360, P1631, DOI 10.1016/S0140-6736(02)11601-1; DALEY J, 1988, JAMA-J AM MED ASSOC, V260, P3617, DOI 10.1001/jama.260.24.3617; Efron B, 1998, INTRO BOOTSTRAP; Eichhorn Eric J., 2001, American Journal of Medicine, V110, p14S; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Fried Terri R, 2003, J Palliat Med, V6, P237, DOI 10.1089/109662103764978489; GOLDBERGER JJ, 1986, ARCH INTERN MED, V146, P489, DOI 10.1001/archinte.146.3.489; Graff L, 1999, ANN EMERG MED, V34, P429, DOI 10.1016/S0196-0644(99)80043-2; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hanratty B, 2002, BRIT MED J, V325, P581, DOI 10.1136/bmj.325.7364.581; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jong P, 2002, ARCH INTERN MED, V162, P1689, DOI 10.1001/archinte.162.15.1689; KEELER EB, 1990, JAMA-J AM MED ASSOC, V264, P1962, DOI 10.1001/jama.264.15.1962; KONSTAM M, 2001, 940612 AHCPR; Krumholz HM, 1999, CIRCULATION, V99, P2986, DOI 10.1161/01.CIR.99.23.2986; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Lee DS, 2003, CAN J CARDIOL, V19, P357; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; LEMESHOW S, 1993, JAMA-J AM MED ASSOC, V270, P2478, DOI 10.1001/jama.270.20.2478; MacIntyre K, 2000, CIRCULATION, V102, P1126, DOI 10.1161/01.CIR.102.10.1126; Masoudi FA, 2003, J AM COLL CARDIOL, V41, P217, DOI 10.1016/S0735-1097(02)02696-7; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Moons KGM, 2002, J CLIN EPIDEMIOL, V55, P1054, DOI 10.1016/S0895-4356(02)00453-5; Polanczyk CA, 1998, MED CARE, V36, P1489, DOI 10.1097/00005650-199810000-00007; Poses RM, 2000, ANN INTERN MED, V133, P10, DOI 10.7326/0003-4819-133-1-200007040-00003; Reilly BM, 2002, JAMA-J AM MED ASSOC, V288, P342, DOI 10.1001/jama.288.3.342; Rosenthal GE, 2000, HEALTH SERV RES, V34, P1449; Seamark DA, 2002, PALLIATIVE MED, V16, P495, DOI 10.1191/0269216302pm596oa; SELKER HP, 1994, MED CARE, V32, P1040, DOI 10.1097/00005650-199410000-00005; Senni M, 1999, J AM COLL CARDIOL, V33, P164, DOI 10.1016/S0735-1097(98)00523-3; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; Sharpe N, 1998, PROG CARDIOVASC DIS, V41, P73, DOI 10.1016/S0033-0620(98)80034-0; Southard P, 1989, J Emerg Nurs, V15, P393; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.3.CO;2-S; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3; Tu JV, 1997, J CLIN EPIDEMIOL, V50, P743, DOI 10.1016/S0895-4356(97)89028-2; TU JV, 1994, CAN MED ASSOC J, V151, P177; TU JV, 1995, CIRCULATION, V91, P677, DOI 10.1161/01.CIR.91.3.677; TU JV, 1999, CARDIOVASCULAR HLTH, P111; US Dept of Health and Human Services . International Classification of Diseases, 1988, INT CLASS DIS; VANHOUWELINGEN JC, 1990, STAT MED, V9, P1303, DOI 10.1002/sim.4780091109; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Wenrich MD, 2001, ARCH INTERN MED, V161, P868, DOI 10.1001/archinte.161.6.868; Zannad F, 1999, J AM COLL CARDIOL, V33, P734, DOI 10.1016/S0735-1097(98)00634-2	53	997	1052	1	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2003	290	19					2581	2587		10.1001/jama.290.19.2581	http://dx.doi.org/10.1001/jama.290.19.2581			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744DQ	14625335	Bronze			2022-12-24	WOS:000186613000028
J	Sedkov, Y; Cho, E; Petruk, S; Cherbas, L; Smith, ST; Jones, RS; Cherbas, P; Canaani, E; Jaynes, JB; Mazo, A				Sedkov, Y; Cho, E; Petruk, S; Cherbas, L; Smith, ST; Jones, RS; Cherbas, P; Canaani, E; Jaynes, JB; Mazo, A			Methylation at lysine 4 of histone H3 in ecdysone-dependent development of Drosophila	NATURE			English	Article							MORPHOGENETIC FURROW MOVEMENT; POLARITY GENE HEDGEHOG; RETINOID-X-RECEPTOR; NUCLEAR RECEPTOR; ULTRASPIRACLE; PROTEIN; EYE; ECR; PROGRESSION; ENCODES	Steroid hormones fulfil important functions in animal development. In Drosophila, ecdysone triggers moulting and metamorphosis through its effects on gene expression(1). Ecdysone works by binding to a nuclear receptor, EcR, which heterodimerizes with the retinoid X receptor homologue Ultraspiracle(2,3). Both partners are required for binding to ligand or DNA(4-6). Like most DNA-binding transcription factors, nuclear receptors activate or repress gene expression by recruiting co-regulators, some of which function as chromatin-modifying complexes(7,8). For example, p160 class coactivators associate with histone acetyltransferases and arginine histone methyltransferases(9). The Trithorax-related gene of Drosophila encodes the SET domain protein TRR. Here we report that TRR is a histone methyltransferases capable of trimethylating lysine 4 of histone H3 (H3-K4). trr acts upstream of hedgehog (hh) in progression of the morphogenetic furrow, and is required for retinal differentiation. Mutations in trr interact in eye development with EcR, and EcR and TRR can be co-immunoprecipitated on ecdysone treatment. TRR, EcR and trimethylated H3-K4 are detected at the ecdysone-inducible promoters of hh and BR-C in cultured cells, and H3-K4 trimethylation at these promoters is decreased in embryos lacking a functional copy of trr. We propose that TRR functions as a coactivator of EcR by altering the chromatin structure at ecdysone-responsive promoters.	Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Jefferson University; Indiana University System; Indiana University Bloomington; Southern Methodist University; Weizmann Institute of Science	Mazo, A (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA.			Jaynes, James/0000-0001-7943-794X	NIGMS NIH HHS [R01 GM050231-05A2, R01 GM050231] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050231] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Brennan CA, 1998, DEVELOPMENT, V125, P2653; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chanut F, 2000, GENETICS, V156, P1203; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Ghbeish N, 2002, MECH DEVELOP, V111, P89, DOI 10.1016/S0925-4773(01)00610-4; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6; Hu X, 2003, MOL ENDOCRINOL, V17, P716, DOI 10.1210/me.2002-0287; Katsani KR, 2001, GENE DEV, V15, P2197, DOI 10.1101/gad.201901; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; KUZIN B, 1994, GENE DEV, V8, P2478, DOI 10.1101/gad.8.20.2478; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; ORO AE, 1990, NATURE, V347, P298, DOI 10.1038/347298a0; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; RIDDIFORD LM, 1993, RECEPTOR, V3, P203; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sedkov Y, 1999, MECH DEVELOP, V82, P171, DOI 10.1016/S0925-4773(98)00246-9; SMITH ST, UNPUB NATURE CELL BI; Stallcup MR, 2001, ONCOGENE, V20, P3014, DOI 10.1038/sj.onc.1204325; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Treisman JE, 1997, GENE DEV, V11, P1949, DOI 10.1101/gad.11.15.1949; TREISMAN JE, 1995, DEVELOPMENT, V121, P3519; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zelhof AC, 1997, DEVELOPMENT, V124, P2499	29	126	136	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2003	426	6962					78	83		10.1038/nature02080	http://dx.doi.org/10.1038/nature02080			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603321	Green Accepted			2022-12-24	WOS:000186370800045
J	Orlova, M; Yueh, A; Leung, J; Goff, SP				Orlova, M; Yueh, A; Leung, J; Goff, SP			Reverse transcriptase of Moloney murine leukemia virus binds to eukarvotic release factor 1 to modulate suppression of translational termination	CELL			English	Article							STOP CODON RECOGNITION; PEPTIDYL-TRANSFER-RNA; POL FUSION PROTEIN; GENE AMBER CODON; MESSENGER-RNA; DNA-POLYMERASE; READ-THROUGH; FACTOR ERF1; PRECURSOR POLYPROTEINS; MUTATIONAL ANALYSIS	The pol (for polymerase) gene of the murine leukemia viruses (MuLVs) is expressed in the form of a large Gag-Pol precursor protein by the suppression of translational termination, or enhanced readthrough, of a UAG stop codon at the end of gag. A search for cellular proteins that interact with the reverse transcriptase of Moloney MuLV resulted in the identification of eRF1, the eukaryotic translation release factor 1. The proteins bound strongly in vitro, and the overexpression of eRF1 resulted in the RT-dependent incorporation of the protein into assembling virion particles. The overexpression of RT in trans enhanced the translational readthrough of a reporter construct containing the Gag-Pol boundary region. Noninteracting mutants of RT failed to synthesize adequate levels of Gag-Pol and could not replicate. These results suggest that RT enhances suppression of termination and that the interaction of RT with eRF1 is required for an appropriate level of translational readthrough.	Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Integrated Program Cell & Mol Biol, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Goff, SP (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Integrated Program Cell & Mol Biol, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	goff@cancercenter.columbia.edu	Goff, Stephen P/K-6337-2014; Yueh, Andrew/D-2079-2010	Goff, Stephen P/0000-0003-0693-5547; 	NATIONAL CANCER INSTITUTE [R37CA030488, R01CA030488] Funding Source: NIH RePORTER; NCI NIH HHS [CA30488] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alam SL, 1999, J MOL BIOL, V288, P837, DOI 10.1006/jmbi.1999.2713; Alderete JP, 2001, J VIROL, V75, P7188, DOI 10.1128/JVI.75.15.7188-7192.2001; ATKINS JF, 1990, CELL, V62, P413, DOI 10.1016/0092-8674(90)90007-2; Bacharach E, 2000, J VIROL, V74, P11027, DOI 10.1128/JVI.74.23.11027-11039.2000; BERTEAUX V, 1991, BIOCHIMIE, V73, P1291, DOI 10.1016/0300-9084(91)90091-E; Bertram G, 2000, RNA, V6, P1236, DOI 10.1017/S1355838200000777; BLAIN SW, 1993, J BIOL CHEM, V268, P23585; Carnes J, 2000, RNA, V6, P1468, DOI 10.1017/S1355838200001242; COLICELLI J, 1988, J MOL BIOL, V199, P47, DOI 10.1016/0022-2836(88)90378-6; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; DINMAN JD, 1992, J VIROL, V66, P3669, DOI 10.1128/JVI.66.6.3669-3676.1992; Drugeon G, 1997, NUCLEIC ACIDS RES, V25, P2254, DOI 10.1093/nar/25.12.2254; FELSENSTEIN KM, 1988, J VIROL, V62, P2179, DOI 10.1128/JVI.62.6.2179-2182.1988; FELSENSTEIN KM, 1992, J VIROL, V66, P6601, DOI 10.1128/JVI.66.11.6601-6608.1992; FENG YX, 1989, J VIROL, V63, P2870, DOI 10.1128/JVI.63.6.2870-2873.1989; FENG YX, 1989, J VIROL, V63, P2405, DOI 10.1128/JVI.63.5.2405-2410.1989; FENG YX, 1992, J VIROL, V66, P5127, DOI 10.1128/JVI.66.8.5127-5132.1992; FENG YX, 1990, P NATL ACAD SCI USA, V87, P8860, DOI 10.1073/pnas.87.22.8860; Frolova L, 1996, RNA, V2, P334; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; GESTELAND RF, 1992, SCIENCE, V257, P1640, DOI 10.1126/science.1529352; Grentzmann G, 1998, RNA, V4, P479; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; HATFIELD DL, 1992, ADV VIRUS RES, V41, P193, DOI 10.1016/S0065-3527(08)60037-8; HONIGMAN A, 1991, VIROLOGY, V183, P313, DOI 10.1016/0042-6822(91)90144-Z; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; JACKS T, 1990, CURR TOP MICROBIOL, V157, P93; JACKS T, 1985, SCIENCE, V230, P1237, DOI 10.1126/science.2416054; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; JAMJOOM GA, 1977, VIROLOGY, V78, P11, DOI 10.1016/0042-6822(77)90075-7; Janzen DM, 2002, MOL CELL BIOL, V22, P8562, DOI 10.1128/MCB.22.24.8562-8570.2002; JONES DS, 1989, NUCLEIC ACIDS RES, V17, P5933, DOI 10.1093/nar/17.15.5933; KARACOSTAS V, 1993, VIROLOGY, V193, P661, DOI 10.1006/viro.1993.1174; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; KUCHINO Y, 1987, P NATL ACAD SCI USA, V84, P2668, DOI 10.1073/pnas.84.9.2668; LeGoff X, 1997, MOL CELL BIOL, V17, P3164, DOI 10.1128/MCB.17.6.3164; Leung DW, 1989, TECHNIQUE, V1, P11; Levin J. G., 1993, REVERSE TRANSCRIPTAS, P5; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; MURPHY EC, 1978, VIROLOGY, V86, P329, DOI 10.1016/0042-6822(78)90074-0; MURPHY EC, 1978, J VIROL, V13, P359; PANET A, 1975, P NATL ACAD SCI USA, V72, P2535, DOI 10.1073/pnas.72.7.2535; PANET A, 1978, J VIROL, V26, P214, DOI 10.1128/JVI.26.2.214-220.1978; PANGANIBAN AT, 1988, J VIROL, V62, P3574, DOI 10.1128/JVI.62.10.3574-3580.1988; PHILIPSON L, 1978, CELL, V13, P189, DOI 10.1016/0092-8674(78)90149-6; Shehu-Xhilaga M, 2001, J VIROL, V75, P1834, DOI 10.1128/JVI.75.4.1834-1841.2001; SHINNICK TM, 1981, NATURE, V293, P543, DOI 10.1038/293543a0; SKALKA A, 1993, REVERSE TRANSCRIPTAS; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Stansfield I, 1996, MOL MICROBIOL, V20, P1135, DOI 10.1111/j.1365-2958.1996.tb02634.x; Tachedjian G, 2000, P NATL ACAD SCI USA, V97, P6334, DOI 10.1073/pnas.97.12.6334; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; TANESE N, 1988, P NATL ACAD SCI USA, V85, P1777, DOI 10.1073/pnas.85.6.1777; TELESNITSKY A, 1993, EMBO J, V12, P4433, DOI 10.1002/j.1460-2075.1993.tb06128.x; Telesnitsky A., 1997, P121; TENDAM EB, 1990, VIRUS GENES, V2, P121; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; WILLS NM, 1991, P NATL ACAD SCI USA, V88, P6991, DOI 10.1073/pnas.88.16.6991; YOSHINAKA Y, 1985, P NATL ACAD SCI USA, V82, P1618, DOI 10.1073/pnas.82.6.1618; YOSHINAKA Y, 1985, J VIROL, V55, P870, DOI 10.1128/JVI.55.3.870-873.1985; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	64	49	54	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2003	115	3					319	331		10.1016/S0092-8674(03)00805-5	http://dx.doi.org/10.1016/S0092-8674(03)00805-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	740RH	14636559	Bronze			2022-12-24	WOS:000186415000011
J	Ying, QL; Nichols, J; Chambers, I; Smith, A				Ying, QL; Nichols, J; Chambers, I; Smith, A			BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3	CELL			English	Article							BONE MORPHOGENETIC PROTEIN-4; SIGNAL-TRANSDUCTION; NEURAL FATE; ES CELLS; ACTIVATION; EXPRESSION; PATHWAY; NEUROGENESIS; RECEPTOR; LINE	The cytokine leukemia inhibitory factor (LIF) drives self-renewal of mouse embryonic stem (ES) cells by activating the transcription factor STAT3. In serum-free cultures, however, LIF is insufficient to block neural differentiation and maintain pluripotency. Here, we report that bone morphogenetic proteins (BMPs) act in combination with LIF to sustain self-renewal and preserve multilineage differentiation, chimera colonization, and germline transmission properties. ES cells can be propagated from single cells and derived de novo without serum or feeders using LIF plus BMP. The critical contribution of BMP is to induce expression of Id genes via the Smad pathway. Forced expression of Id liberates ES cells from BMP or serum dependence and allows self-renewal in LIF alone. Upon LIF withdrawal, Id-expressing ES cells differentiate but do not give rise to neural lineages. We conclude that blockade of lineage-specific transcription factors by Id proteins enables the self-renewal response to LIF/STAT3.	Univ Edinburgh, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland	University of Edinburgh	Ying, QL (corresponding author), Univ Edinburgh, Inst Stem Cell Res, Kings Bldg,W Mains Rd, Edinburgh EH9 3JQ, Midlothian, Scotland.	qilong.ying@ed.ac.uk; austin.smith@ed.ac.uk		Smith, Austin/0000-0002-3029-4682; Nichols, Jennifer/0000-0002-8650-1388; Chambers, Ian/0000-0003-2605-1597				Adelman CA, 2002, DEVELOPMENT, V129, P539; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Baonza A, 2000, DEVELOPMENT, V127, P2383; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Benezra R, 2001, TRENDS CARDIOVAS MED, V11, P237, DOI 10.1016/S1050-1738(01)00117-7; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Buehr M, 2003, PHILOS T R SOC B, V358, P1397, DOI 10.1098/rstb.2003.1327; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Burdon T, 1999, CELLS TISSUES ORGANS, V165, P131, DOI 10.1159/000016693; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Harland R, 2000, CURR OPIN GENET DEV, V10, P357, DOI 10.1016/S0959-437X(00)00096-4; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nakashima K, 1997, FEBS LETT, V401, P49, DOI 10.1016/S0014-5793(96)01430-5; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Nichols J, 2001, DEVELOPMENT, V128, P2333; Nishinakamura R, 1999, DEV BIOL, V216, P481, DOI 10.1006/dbio.1999.9518; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Norton JD, 2000, J CELL SCI, V113, P3897; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Smith A, 2001, COLD SPRING HARBOR M, P205; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; SUDA Y, 1987, J CELL PHYSIOL, V133, P197, DOI 10.1002/jcp.1041330127; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Ying QL, 2003, METHOD ENZYMOL, V365, P327	62	1579	1747	4	159	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2003	115	3					281	292		10.1016/S0092-8674(03)00847-X	http://dx.doi.org/10.1016/S0092-8674(03)00847-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	740RH	14636556	Bronze			2022-12-24	WOS:000186415000008
J	Talbot, L				Talbot, L			"Failed back surgery syndrome"	BRITISH MEDICAL JOURNAL			English	Article								An inappropriate diagnostic label may exacerbate the discomfort of patients who develop persistent and disabling symptoms after back surgery.										HELTHOFF KB, 1985, ORTHOP CLIN N AM, V16, P417; Porter RW, 1997, J ROY COLL SURG EDIN, V42, P376; RESNICK D, MEDCYCLOPAEDIA	3	27	31	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2003	327	7421					985	986		10.1136/bmj.327.7421.985	http://dx.doi.org/10.1136/bmj.327.7421.985			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	736AL	14576254	Green Published			2022-12-24	WOS:000186147800024
J	Ebralidze, A; Wang, Y; Petkova, V; Ebralidse, K; Junghans, RP				Ebralidze, A; Wang, Y; Petkova, V; Ebralidse, K; Junghans, RP			RNA leaching of transcription factors disrupts transcription in myotonic dystrophy	SCIENCE			English	Article							CUG-BINDING PROTEIN; CHLORIDE CHANNEL; MESSENGER-RNA; TRINUCLEOTIDE REPEAT; MUSCLE; GENE; EXPANSION; EXPRESSION; CLONING; DISEASE	Myotonic dystrophy type 1 (DM1) is caused by a CUG(n) expansion (n approximate to 50 to 5000) in the 3' untranslated region of the mRNA of the DM protein kinase gene. We show that mutant RNA binds and sequesters transcription factors (TFs), with up to 90% depletion of selected TFs from active chromatin. Diverse genes are consequently reduced in expression, including the ion transporter CIC-1, which has been implicated in myotonia. When TF specificity protein 1 (Sp1) was overexpressed in DM1-affected cells, low levels of messenger RNA for CIC-1 were restored to normal. Transcription factor leaching from chromatin by mutant RNA provides a potentially unifying pathomechanistic explanation for this disease.	Harvard Univ, Sch Med, Harvard Inst Human Genet, Biotherapeut Dev Lab, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Junghans, RP (corresponding author), Harvard Univ, Sch Med, Harvard Inst Human Genet, Biotherapeut Dev Lab, 4 Blackfan Circle, Boston, MA 02215 USA.							Bergmann E, 2001, TRENDS GENET, V17, P279, DOI 10.1016/S0168-9525(01)02280-6; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; EBRALIDZE A, UNPUB; Finsterer J, 2002, EUR J NEUROL, V9, P441, DOI 10.1046/j.1468-1331.2002.00453.x; Freiman RN, 2002, SCIENCE, V296, P2149, DOI 10.1126/science.1073845; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; Junghans RP, 2001, NEUROGENETICS, V3, P59, DOI 10.1007/s100480000103; Kimura T, 2000, NEUROSCI LETT, V295, P93, DOI 10.1016/S0304-3940(00)01598-6; Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2; LORENZ C, 1994, HUM MOL GENET, V3, P941, DOI 10.1093/hmg/3.6.941; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1911, DOI 10.1093/hmg/11.17.1911; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Michalowski S, 1999, NUCLEIC ACIDS RES, V27, P3534, DOI 10.1093/nar/27.17.3534; Nicolas M, 2001, J BIOL CHEM, V276, P22126, DOI 10.1074/jbc.M010740200; Ohshima K, 1996, J BIOL CHEM, V271, P16773, DOI 10.1074/jbc.271.28.16773; OTTEN AD, 1995, P NATL ACAD SCI USA, V92, P5465, DOI 10.1073/pnas.92.12.5465; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rajavel KS, 2001, MOL CELL BIOL, V21, P5512, DOI 10.1128/MCB.21.16.5512-5519.2001; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; VERMEULEN W, 1994, COLD SPRING HARB SYM, V59, P317, DOI 10.1101/SQB.1994.059.01.036	27	115	118	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2004	303	5656					383	387		10.1126/science.1088679	http://dx.doi.org/10.1126/science.1088679			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14657503				2022-12-24	WOS:000188111800047
J	Lawlor, DA; Smith, GD; Ebrahim, S				Lawlor, DA; Smith, GD; Ebrahim, S			Association of insulin resistance with depression: cross sectional findings from the British women's heart and health study	BRITISH MEDICAL JOURNAL			English	Article									Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol	Lawlor, DA (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.		Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Lawlor, Debbie A/0000-0002-6793-2262				*ER U ROTT, EUROQOL INSTRUMENT V; FRAYN K, 1995, J CLIN NUTR S, V62, pS250; Golomb BA, 2002, J CLIN EPIDEMIOL, V55, P767, DOI 10.1016/S0895-4356(02)00407-9; Lawlor DA, 2002, BRIT MED J, V325, P805, DOI 10.1136/bmj.325.7368.805; Lipsett D, 1973, LIFE SCI, V9, P215	5	86	90	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1383	1384		10.1136/bmj.327.7428.1383	http://dx.doi.org/10.1136/bmj.327.7428.1383			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670883	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000187417900022
J	Andersen, JS; Wilkinson, CJ; Mayor, T; Mortensen, P; Nigg, EA; Mann, M				Andersen, JS; Wilkinson, CJ; Mayor, T; Mortensen, P; Nigg, EA; Mann, M			Proteomic characterization of the human centrosome by protein correlation profiling	NATURE			English	Article							COMPONENT; CYCLE; GENE; IDENTIFICATION; DUPLICATION; ALMS1	The centrosome is the major microtubule-organizing centre of animal cells and through its influence on the cytoskeleton is involved in cell shape, polarity and motility. It also has a crucial function in cell division because it determines the poles of the mitotic spindle that segregates duplicated chromosomes between dividing cells(1-5). Despite the importance of this organelle to cell biology and more than 100 years of study, many aspects of its function remain enigmatic and its structure and composition are still largely unknown. We performed a mass-spectrometry-based proteomic analysis of human centrosomes in the interphase of the cell cycle by quantitatively profiling hundreds of proteins across several centrifugation fractions. True centrosomal proteins were revealed by both correlation with already known centrosomal proteins and in vivo localization. We identified and validated 23 novel components and identified 41 likely candidates as well as the vast majority of the known centrosomal proteins in a large background of nonspecific proteins. Protein correlation profiling permits the analysis of any multiprotein complex that can be enriched by fractionation but not purified to homogeneity.	Univ So Denmark, Dept Biochem & Mol Biol, Ctr Expt Bioinformat, DK-5230 Odense M, Denmark; Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany	University of Southern Denmark; Max Planck Society	Nigg, EA (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Ctr Expt Bioinformat, Campusvej 55, DK-5230 Odense M, Denmark.	nigg@biochem.mpg.de; mann@bmb.sdu.dk	Mann, Matthias/A-3454-2013; Andersen, Jens S/L-2100-2015	Mann, Matthias/0000-0003-1292-4799; Andersen, Jens S/0000-0002-6091-140X; Wilkinson, Christopher/0000-0002-7448-0938; nigg, erich/0000-0003-4835-5719				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Bornens M, 1999, METHOD CELL BIOL, V61, P13; Brown CR, 1996, J BIOL CHEM, V271, P824, DOI 10.1074/jbc.271.2.824; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Chang P, 2000, NAT CELL BIOL, V2, P30, DOI 10.1038/71350; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Collin GB, 2002, NAT GENET, V31, P74, DOI 10.1038/ng867; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Gascard P, 1998, BLOOD, V92, P4404, DOI 10.1182/blood.V92.11.4404.423k50_4404_4414; Gergely F, 2000, P NATL ACAD SCI USA, V97, P14352, DOI 10.1073/pnas.97.26.14352; Hearn T, 2002, NAT GENET, V31, P79, DOI 10.1038/ng874; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; KELLOGG DR, 1994, ANNU REV BIOCHEM, V63, P639, DOI 10.1146/annurev.bi.63.070194.003231; Kenedy AA, 2003, GENE, V303, P35, DOI 10.1016/S0378-1119(02)01141-1; Kilmartin JV, 2003, J CELL BIOL, V162, P1211, DOI 10.1083/jcb.200307064; KLOTZ C, 1990, J CELL BIOL, V110, P405, DOI 10.1083/jcb.110.2.405; Lamond AI, 1997, TRENDS CELL BIOL, V7, P139, DOI 10.1016/S0962-8924(97)01031-3; Lange BMH, 2000, EMBO J, V19, P1252, DOI 10.1093/emboj/19.6.1252; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; Nakagawa Y, 2001, MOL BIOL CELL, V12, P1687, DOI 10.1091/mbc.12.6.1687; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Ohta T, 2002, J CELL BIOL, V156, P87, DOI 10.1083/jcb.200108088; Pfannenschmid F, 2003, J CELL SCI, V116, P1449, DOI 10.1242/jcs.00337; Pietromonaco SF, 1996, BLOOD CELL MOL DIS, V22, P225, DOI 10.1006/bcmd.1996.0103; Popovici C, 1999, BLOOD, V93, P1381, DOI 10.1182/blood.V93.4.1381.404k30_1381_1389; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; Romio L, 2003, J AM SOC NEPHROL, V14, P680, DOI 10.1097/01.ASN.0000054497.48394.D2; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; Yang J, 2002, J CELL BIOL, V159, P431, DOI 10.1083/jcb.200207153	30	1010	1068	3	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					570	574		10.1038/nature02166	http://dx.doi.org/10.1038/nature02166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654843				2022-12-24	WOS:000186944300042
J	Saleska, SR; Miller, SD; Matross, DM; Goulden, ML; Wofsy, SC; da Rocha, HR; de Camargo, PB; Crill, P; Daube, BC; de Freitas, HC; Hutyra, L; Keller, M; Kirchhoff, V; Menton, M; Munger, JW; Pyle, EH; Rice, AH; Silva, H				Saleska, SR; Miller, SD; Matross, DM; Goulden, ML; Wofsy, SC; da Rocha, HR; de Camargo, PB; Crill, P; Daube, BC; de Freitas, HC; Hutyra, L; Keller, M; Kirchhoff, V; Menton, M; Munger, JW; Pyle, EH; Rice, AH; Silva, H			Carbon in amazon forests: Unexpected seasonal fluxes and disturbance-induced losses	SCIENCE			English	Article							TROPICAL FORESTS; RAIN-FOREST; EL-NINO; DIOXIDE UPTAKE; CLIMATE; DYNAMICS; STORAGE; TREE; CO2; VARIABILITY	The net ecosystem exchange of carbon dioxide was measured by eddy covariance methods for 3 years in two old-growth forest sites near Santarem, Brazil. Carbon was lost in the wet season and gained in the dry season, which was opposite to the seasonal cycles of both tree growth and model predictions. The 3-year average carbon loss was 1.3 (confidence interval: 0.0 to 2.0) megagrams of carbon per hectare per year. Biometric observations confirmed the net loss but imply that it is a transient effect of recent disturbance superimposed on long-term balance. Given that episodic disturbances are characteristic of old-growth forests, it is likely that carbon sequestration is lower than has been inferred from recent eddy covariance studies at undisturbed sites.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; Univ Sao Paulo, Dept Atmospher Sci, BR-05508900 Sao Paulo, Brazil; Univ Sao Paulo, Ctr Energia Nucl Agr, BR-13416000 Piracicaba, Brazil; Univ New Hampshire, Complex Syst Res Ctr, Durham, NH 03824 USA; US Forest Serv, USDA, Int Inst Trop Forestry, San Juan, PR 00926 USA; INPE, BR-12227010 Sao Paulo, Brazil	Harvard University; University of California System; University of California Irvine; Universidade de Sao Paulo; Universidade de Sao Paulo; University System Of New Hampshire; University of New Hampshire; United States Department of Agriculture (USDA); United States Forest Service; Instituto Nacional de Pesquisas Espaciais (INPE)	Saleska, SR (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	saleska@fas.harvard.edu	Goulden, Michael L/B-9934-2008; Crill, Patrick/ABC-1357-2021; Freitas, Helber Custódio/D-3293-2012; de Camargo, Plínio B./D-6635-2012; Mitchard, Edward T A/C-6346-2009; Saleska, Scott R/K-1733-2016; Silva, Hudson/D-1564-2013; Munger, J William/H-4502-2013; Keller, Michael/A-8976-2012	de Camargo, Plínio B./0000-0002-0696-3778; Mitchard, Edward T A/0000-0002-5690-4055; Saleska, Scott R/0000-0002-4974-3628; Munger, J William/0000-0002-1042-8452; Keller, Michael/0000-0002-0253-3359; Menton, Mary/0000-0002-9892-2657; Goulden, Michael/0000-0002-9379-3948; Crill, Patrick/0000-0003-1110-3059				Andreae MO, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000524; Araujo AC, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000676; Botta A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013607; Carswell FE, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000284; Clark DA, 2002, ECOL APPL, V12, P3, DOI 10.1890/1051-0761(2002)012[0003:ATFAIC]2.0.CO;2; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; DENNING AS, 1995, NATURE, V376, P240, DOI 10.1038/376240a0; GOULDEN ML, IN PRESS ECOL APPL; Grace J, 1996, GLOBAL CHANGE BIOL, V2, P209, DOI 10.1111/j.1365-2486.1996.tb00073.x; GRACE J, 1995, SCIENCE, V270, P778, DOI 10.1126/science.270.5237.778; Grace J, 2002, NATURE, V416, P594, DOI 10.1038/416594b; Gurney KR, 2002, NATURE, V415, P626, DOI 10.1038/415626a; Keeling RF, 2002, P NATL ACAD SCI USA, V99, P7848, DOI 10.1073/pnas.122154899; Keller M, 1996, SCIENCE, V273, P201, DOI 10.1126/science.273.5272.201; Korner C, 2003, SCIENCE, V300, P1242, DOI 10.1126/science.1084460; KRUIJT B, IN PRESS ECOL APPL; Lee XH, 1998, AGR FOREST METEOROL, V91, P39, DOI 10.1016/S0168-1923(98)00071-9; MAHLI Y, 1998, J GEOPHYS RES, V103, P31593, DOI DOI 10.1029/98JD02647; Malhi Y, 2002, J VEG SCI, V13, P439, DOI 10.1111/j.1654-1103.2002.tb02068.x; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; MARTENS C, IN PRESS GLOB CHANGE; McPhaden MJ, 1999, NATURE, V398, P559, DOI 10.1038/19193; MILLER SD, IN PRESS ECOL APPL; Moorcroft PR, 2001, ECOL MONOGR, V71, P557, DOI 10.1890/0012-9615(2001)071[0557:AMFSVD]2.0.CO;2; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0; Nepstad DC, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000360; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Phillips OL, 2002, ECOL APPL, V12, P576, DOI 10.1890/1051-0761(2002)012[0576:CIGOTF]2.0.CO;2; PHILLIPS OL, 1994, SCIENCE, V263, P954, DOI 10.1126/science.263.5149.954; Potter C, 2001, J GEOPHYS RES-ATMOS, V106, P10423, DOI 10.1029/2000JD900563; Prentice IC, 1998, NATURE, V396, P619, DOI 10.1038/25224; RICE AH, IN PRESS ECOL APPL; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; ROCHA HR, IN PRESS ECOL APPL; Ropelewski CF, 1989, J CLIMATE, V2, P268, DOI 10.1175/1520-0442(1989)002<0268:PPAWTH>2.0.CO;2; Sakai RK, 2001, J APPL METEOROL, V40, P2178, DOI 10.1175/1520-0450(2001)040<2178:IOLFCT>2.0.CO;2; Savage KE, 2001, GLOBAL BIOGEOCHEM CY, V15, P337, DOI 10.1029/1999GB001248; SCOTT RL, IN PRESS AGR FOR MET; Sheil D, 2003, TRENDS ECOL EVOL, V18, P18, DOI 10.1016/S0169-5347(02)00005-8; Telles EDC, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001953; Tian H, 2000, GLOBAL ECOL BIOGEOGR, V9, P315, DOI 10.1046/j.1365-2699.2000.00198.x; Tian HQ, 1998, NATURE, V396, P664, DOI 10.1038/25328; Trenberth KE, 1997, GEOPHYS RES LETT, V24, P3057, DOI 10.1029/97GL03092; Williamson GB, 2000, CONSERV BIOL, V14, P1538, DOI 10.1046/j.1523-1739.2000.99298.x	45	518	543	3	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1554	1557		10.1126/science.1091165	http://dx.doi.org/10.1126/science.1091165			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645845	Green Submitted			2022-12-24	WOS:000186802200040
J	Benkova, E; Michniewicz, M; Sauer, M; Teichmann, T; Seifertova, D; Jurgens, G; Friml, J				Benkova, E; Michniewicz, M; Sauer, M; Teichmann, T; Seifertova, D; Jurgens, G; Friml, J			Local, efflux-dependent auxin gradients as a common module for plant organ formation	CELL			English	Article							LATERAL ROOT INITIATION; GNOM ARF-GEF; ARABIDOPSIS-THALIANA; OVULE DEVELOPMENT; POLAR TRANSPORT; GENE; GRAVITROPISM; LOCALIZATION; ORGANIZATION; EXPRESSION	Plants, compared to animals, exhibit an amazing adaptability and plasticity in their development. This is largely dependent on the ability of plants to form new organs, such as lateral roots, leaves, and flowers during postembryonic development. Organ primordia develop from founder cell populations into organs by coordinated cell division and differentiation. Here, we show that organ formation in Arabidopsis involves dynamic gradients of the signaling molecule auxin with maxima at the primordia tips. These gradients are mediated by cellular efflux requiring asymmetrically localized PIN proteins, which represent a functionally redundant network for auxin distribution in both aerial and underground organs. PIN1 polar localization undergoes a dynamic rearrangement, which correlates with establishment of auxin gradients and primordiurn development. Our results suggest that PIN-dependent, local auxin gradients represent a common module for formation of all plant organs, regardless of their mature morphology or developmental origin.	Univ Tubingen, Zentrum Molekularbiol Pflanzen, D-72076 Tubingen, Germany; Max Planck Gesell, Max Delbruck Lab, D-50829 Cologne, Germany; ASCR, Inst Biophys, Brno, Czech Republic	Eberhard Karls University of Tubingen; Max Planck Society; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences	Benkova, E (corresponding author), Univ Tubingen, Zentrum Molekularbiol Pflanzen, Morgenstelle 1, D-72076 Tubingen, Germany.		Benkova, Eva/E-2910-2012; Sauer, Michael/G-3424-2011; Sauer, Michael/F-6519-2014; Friml, Jiri/D-9511-2012	Sauer, Michael/0000-0002-4014-9825; Friml, Jiri/0000-0002-8302-7596				Barlier I, 2000, P NATL ACAD SCI USA, V97, P14819, DOI 10.1073/pnas.260502697; BLAKELY LM, 1979, PLANT SCI LETT, V14, P79, DOI 10.1016/0304-4211(79)90158-5; Cadigan KM, 2002, SEMIN CELL DEV BIOL, V13, P83, DOI 10.1016/S1084-9521(02)00014-9; Caruso John L., 1995, P433; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Dubrovsky JG, 2000, PLANT PHYSIOL, V124, P1648, DOI 10.1104/pp.124.4.1648; Elliott RC, 1996, PLANT CELL, V8, P155, DOI 10.1105/tpc.8.2.155; Esau K., 1977, ANATOMY SEED PLANTS; FERREIRA PCG, 1994, PLANT CELL, V6, P1763, DOI 10.1105/tpc.6.12.1763; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2003, PLANT J, V34, P115, DOI 10.1046/j.1365-313X.2003.01705.x; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; FRIML J., 2003, PLANT BIOLOGY, V6, P7; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; GELDNER N, 2003, IN PRESS DEVELOPMENT; Gross-Hardt R, 2002, GENE DEV, V16, P1129, DOI 10.1101/gad.225202; Haseloff J, 1999, METHOD CELL BIOL, V58, P139; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; LASKOWSKI MJ, 1995, DEVELOPMENT, V121, P3303; Lomax Terri L., 1995, P509; Malamy JE, 1997, DEVELOPMENT, V124, P33; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Maves L, 1999, CURR TOP DEV BIOL, V43, P115; MAYER U, 1991, NATURE, V353, P402, DOI 10.1038/353402a0; MAYER U, 1993, DEVELOPMENT, V117, P149; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Nemhauser JL, 2000, DEVELOPMENT, V127, P3877; Oka M, 1999, PLANT CELL PHYSIOL, V40, P231, DOI 10.1093/oxfordjournals.pcp.a029532; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vroemen CW, 2003, PLANT CELL, V15, P1563, DOI 10.1105/tpc.012203	39	1843	1938	30	519	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 26	2003	115	5					591	602		10.1016/S0092-8674(03)00924-3	http://dx.doi.org/10.1016/S0092-8674(03)00924-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651850	Bronze			2022-12-24	WOS:000186885600009
J	Krause, AE; Frank, KA; Mason, DM; Ulanowicz, RE; Taylor, WW				Krause, AE; Frank, KA; Mason, DM; Ulanowicz, RE; Taylor, WW			Compartments revealed in food-web structure	NATURE			English	Article							STABILITY; DIVERSITY; ECOLOGY	Compartments(1) in food webs are subgroups of taxa in which many strong interactions occur within the subgroups and few weak interactions occur between the subgroups(2). Theoretically, compartments increase the stability in networks(1-5), such as food webs. Compartments have been difficult to detect in empirical food webs because of incompatible approaches(6-9) or insufficient methodological rigour(8,10,11). Here we show that a method for detecting compartments from the social networking science(12-14) identified significant compartments in three of five complex, empirical food webs. Detection of compartments was influenced by food web resolution, such as interactions with weights. Because the method identifies compartmental boundaries in which interactions are concentrated, it is compatible with the definition of compartments. The method is rigorous because it maximizes an explicit function, identifies the number of non-overlapping compartments, assigns membership to compartments, and tests the statistical significance of the results(12-14). A graphical presentation(14) reveals systemic relationships and taxa-specific positions as structured by compartments. From this graphic, we explore two scenarios of disturbance to develop a hypothesis for testing how compartmentalized interactions increase stability in food webs(15-17).	Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; Michigan State Univ, Dept Educ Psychol Counseling & Special Educ, E Lansing, MI 48824 USA; NOAA, Great Lakes Environm Res Lab, Ann Arbor, MI 48105 USA; Univ Maryland, Chesapeake Biol Lab, Solomons, MD 20688 USA	Michigan State University; Michigan State University; National Oceanic Atmospheric Admin (NOAA) - USA; University System of Maryland; University of Maryland Center for Environmental Science	Krause, AE (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	krausean@msu.edu	Mason, Doran/ABF-1415-2020; Ulanowicz, Robert E/G-1021-2013; Krause, Ann/GRT-0163-2022	frank, kenneth/0000-0002-6116-5509; Mason, Doran/0000-0002-6017-4243				Abarca-Arenas LG, 2002, ECOL MODEL, V149, P285, DOI 10.1016/S0304-3800(01)00474-4; Blau Peter M., 1977, INEQUALITY HETEROGEN; Dicks LV, 2002, J ANIM ECOL, V71, P32, DOI 10.1046/j.0021-8790.2001.00572.x; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Frank KA, 1996, SOC NETWORKS, V18, P93, DOI 10.1016/0378-8733(95)00257-X; FRANK KA, 1995, SOC NETWORKS, V17, P27, DOI 10.1016/0378-8733(94)00247-8; Frank KA, 1998, AM J SOCIOL, V104, P642, DOI 10.1086/210083; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; GOLDWASSER L, 1993, ECOLOGY, V74, P1216, DOI 10.2307/1940492; Grimm Volker, 1996, Senckenbergiana Maritima, V27, P215; Huxham M, 1996, OIKOS, V76, P284, DOI 10.2307/3546201; Johnson JC, 2001, J SOC STRUCTURE; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; May R. M., 1973, STABILITY COMPLEXITY; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McMahon SM, 2001, SCIENCE, V293, P1604, DOI 10.1126/science.1062026; MCNAUGHTON SJ, 1978, NATURE, V274, P251, DOI 10.1038/274251a0; MOORE JC, 1988, NATURE, V333, P261, DOI 10.1038/333261a0; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; PIMM SL, 1979, THEOR POPUL BIOL, V16, P144, DOI 10.1016/0040-5809(79)90010-8; PIMM SL, 1980, J ANIM ECOL, V49, P879, DOI 10.2307/4233; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; RAFFAELLI D, 1992, J ANIM ECOL, V61, P551, DOI 10.2307/5610; Raffaelli D, 2002, SCIENCE, V296, P1035, DOI 10.1126/science.1072080; Simmel G., 1950, SOCIOLOGY G SIMMEL; Simmel G., 1955, CONFLICT WEB GROUP A; SIMON HA, 1965, GEN SYST, V10, P63; Ulanowicz RE, 1999, J MARINE SYST, V19, P159, DOI 10.1016/S0924-7963(98)90017-3; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; YODIZ P, 1982, AM NAT, V120, P551	30	511	523	2	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2003	426	6964					282	285		10.1038/nature02115	http://dx.doi.org/10.1038/nature02115			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628050	Green Published			2022-12-24	WOS:000186660800042
J	McCrea, M; Guskiewicz, KM; Marshall, SW; Barr, W; Randolph, C; Cantu, RC; Onate, JA; Yang, JZ; Kelly, JP				McCrea, M; Guskiewicz, KM; Marshall, SW; Barr, W; Randolph, C; Cantu, RC; Onate, JA; Yang, JZ; Kelly, JP			Acute effects and recovery time following concussion in collegiate football players - The NCAA Concussion Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; LONGITUDINAL DATA-ANALYSIS; STANDARDIZED ASSESSMENT; POSTURAL STABILITY; AUSTRALIAN RULES; SPORTS; DEFICITS; SEVERITY	Context Lack of empirical data on recovery time following sport-related concussion hampers clinical decision making about return to play after injury. Objective To prospectively measure immediate effects and natural recovery course relating to symptoms, cognitive functioning, and postural stability following sport-related concussion. Design, Setting, and Participants Prospective cohort study of 1631 football players from 15 US colleges. All players underwent preseason baseline testing on concussion assessment measures in 1999, 2000, and 2001. Ninety-four players with concussion (based on American Academy of Neurology criteria) and 56 noninjured controls underwent assessment of symptoms, cognitive functioning, and postural stability immediately, 3 hours, and 1, 2, 3, 5, 7, and 90 days after injury. Main Outcome Measures Scores on the Graded Symptom Checklist (GSC), Standardized Assessment of Concussion (SAC), Balance Error Scoring System (BESS), and a neuropsychological test battery. Results No player with concussion was excluded from participation; 79 players with concussion (84%) completed the protocol through day 90. Players with concussion exhibited more severe symptoms (mean GSC score 20.93 [95% confidence interval (CI), 15.65-26.21] points higher than that of controls), cognitive impairment (mean SAC score 2.94 [95% CI, 1.50-4.38] points lower than that of controls), and balance problems (mean BESS score 5.81 [95% CI, -0.67 to 12.30] points higher than that of controls) immediately after concussion. On average, symptoms gradually resolved by day 7 (GSC mean difference, 0.33; 95% CI, -1.41 to 2.06), cognitive functioning improved to baseline levels within 5 to 7 days (day 7 SAC mean difference, -0.03; 95% CI, -1.33 to 1.26), and balance deficits dissipated within 3 to 5 days after injury (day 5 BESS mean difference, -0.31; 95% CI, -3.02 to 2.40). Mild impairments in cognitive processing and verbal memory evident on neuropsychological testing 2 days after concussion resolved by day 7. There were no significant differences in symptoms or functional impairments in the concussion and control groups 90 days after concussion. Conclusions Collegiate football players may require several days for recovery of symptoms, cognitive dysfunction, and postural instability after concussion. Further research is required to determine factors that predict variability in recovery time after concussion. Standardized measurement of postconcussive symptoms, cognitive functioning, and postural stability may enhance clinical management of athletes recovering from concussion.	Waukesha Mem Hosp, Ctr Neurosci, Waukesha, WI 53188 USA; Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; Univ N Carolina, Dept Orthoped, Chapel Hill, NC USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; NYU, Sch Med, Dept Neurol, New York, NY USA; Northwestern Univ, Feonberg Sch Med, Chicago Neurol Inst, Chicago, IL 60611 USA; Northwestern Univ, Feonberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; Loyola Univ, Sch Med, Dept Neurol, Maywood, IL 60153 USA; Emerson Hosp, Neurosurg Serv, Concord, MA USA; Boston Univ, Sargent Coll Hlth & Rehabil Sci, Athlet Training Program, Dept Rehabil Sci, Boston, MA 02215 USA	Medical College of Wisconsin; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; New York University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Loyola University Chicago; Boston University	McCrea, M (corresponding author), Waukesha Mem Hosp, Ctr Neurosci, 721 Amer Ave,Suite 501, Waukesha, WI 53188 USA.	michael.mccrea@phci.org	Yang, Jingzhen/N-4786-2014; Onate, James/E-3790-2011	Guskiewicz, Kevin/0000-0002-8682-2130; Marshall, Stephen/0000-0002-2664-9233; Barr, William/0000-0001-7711-7758				ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Aubry Mark, 2002, Phys Sportsmed, V30, P57, DOI 10.3810/psm.2002.02.176; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Benton AL, 1983, MULTILINGUAL APHASIA; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Colorado Medical Society, 1991, REP SPORTS MED COMM; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V32, P649, DOI 10.1016/0028-3932(94)90026-4; DICK R, 2003, NATL COLL ATHLETIC A; DIGGLE PJ, 1994, ANAL LONGITUDINAL DA, pCH11; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Giza CC, 2001, J ATHL TRAINING, V36, P228; Golden J.C., 1978, STROOP COLOR WORD TE; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead WC, 1985, HALSTEADREITAN NEURO; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Hovda DA, 1999, SPORTS-RELATED CONCUSSION, P12; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; MCCREA M, 2003, J INT NEUROPSYCH SOC, V9, P206; MCCREA M, IN PRESS CLIN J SPOR; McCrea M., 2000, STANDARDIZED ASSESSM; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; Smith A., 1991, SYMBOL DIGIT MODALIT; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Vastag B, 2002, JAMA-J AM MED ASSOC, V287, P437, DOI 10.1001/jama.287.4.437; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	58	1033	1038	2	207	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2003	290	19					2556	2563		10.1001/jama.290.19.2556	http://dx.doi.org/10.1001/jama.290.19.2556			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	744DQ	14625332				2022-12-24	WOS:000186613000025
J	Sandidge, JS				Sandidge, JS			Arachnology - Scavenging by brown recluse spiders	NATURE			English	Editorial Material							ARANEAE		Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA	University of Kansas	Sandidge, JS (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.							ATKINS JA, 1958, AM J TROP MED HYG, V7, P165, DOI 10.4269/ajtmh.1958.7.165; Gertsch W. J., 1983, B AM MUS NAT HIST, V175, P264; HITE JM, 1966, U ARKANSAS AGR EXP S, V711, P1; JACKSON RR, 1982, J ZOOL, V196, P255; KNOST SJ, 1975, AM MIDL NAT, V93, P239, DOI 10.2307/2424125; POLLARD SD, 1993, NAT HIST, V102, P58; SMITH RB, 1984, SCIENCE, V226, P1330, DOI 10.1126/science.226.4680.1330; VERTER R, 2002, J MED ENTOMOL, V39, P948	8	35	40	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2003	426	6962					30	30		10.1038/426030a	http://dx.doi.org/10.1038/426030a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603305				2022-12-24	WOS:000186370800029
J	Gibb, DM; Duong, T; Tookey, PA; Sharland, M; Tudor-Williams, G; Novelli, V; Butler, K; Riordan, A; Farrelly, L; Masters, J; Peckham, CS; Dunn, DT				Gibb, DM; Duong, T; Tookey, PA; Sharland, M; Tudor-Williams, G; Novelli, V; Butler, K; Riordan, A; Farrelly, L; Masters, J; Peckham, CS; Dunn, DT		NSHPC; CHIPS	Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTIRETROVIRAL THERAPY; HIV-INFECTION	Objective To describe changes in demographic factors, disease progression, hospital admissions, and use of antiretroviral therapy in children with HIV. Design Active surveillance through the national study of HIV in pregnancy and childhood (NSHPC and additional data from a subset of children in the collaborative HIV paediatric study (CHIPS). Setting United Kingdom and Ireland. Participants 944 children with perinatally acquired HIV-1 under clinical care. Main outcome measures Changes over time in progression to AIDS and death, hospital admission rates, and use of antiretroviral therapy. Results 944 children with perinatally acquired HIV were reported in the United Kingdom and Ireland by October 2002; 628 (67%) were black African, 205 (22%) were aged ! 10 years at last follow up, 193 (20%) are know to have died. The proportion of children presenting who were born abroad increased from 20% in 1994-5 to 60% during 2000-2. Mortality was stable before 1997 at 9.3 per 100 child years at risk but fell to 2.0 in 2001-2 (trend P < 0.001). Progression to AIDS)S also declined (P < 0.00 1). From 1997 onwards the proportion of children on three or four drug antiretroviral therapy increased. Hospital admission rates declined by 80%, but with more children in follow up the absolute number of admissions fell by only 26%. Conclusion In children with HIV infection, mortality, AIDS, and hospital admission rates have declined substantially since the introduction of three or four drug antiretroviral therapy in 1997. As infected children in the United Kingdom and Ireland are living longer, there is an increasing need to address their medical, social, and psychological needs as they enter adolescence and adult life.	MRC, Clin Trials Unit, London NW1 2DA, England; Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Univ London St Georges Hosp, Paediat Infect Dis Unit, London SW17 0QT, England; St Marys Hosp, Dept Paediat, London W2 1NY, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; Our Ladys Hosp Sick Children, Dublin 12, Ireland; Birmingham Heartlands Hosp, Birmingham B9 5SS, W Midlands, England	Medical Research Council Clinical Trials Unit; University of London; University College London; St Georges University London; Imperial College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Our Ladys Children Hospital Crumlin; Heart of England NHS Foundation Trust; University of Birmingham	Gibb, DM (corresponding author), MRC, Clin Trials Unit, London NW1 2DA, England.	D.Gibb@ctu.mrc.ac.uk	Tookey, Pat A/G-2732-2010; peckham, catherine s/I-6300-2013	Tookey, Pat A/0000-0001-6258-0387; Dunn, David/0000-0003-1836-4446; sharland, mike/0000-0001-8626-8291; Gibb, Diana/0000-0002-9738-5490				Aboulker JP, 2001, ARCH DIS CHILD, V84, P230, DOI 10.1136/adc.84.3.230; ADES AE, 1993, BRIT MED J, V306, P1296, DOI 10.1136/bmj.306.6888.1296; [Anonymous], 1994, Morbidity and Mortality Weekly Report, V43, P1; [Anonymous], GUIDELINES USE ANTIR; *BRIT HIV ASS, GUID TREATM HIV INF; CLAYTON C, 1993, STAT MODELS EPIDEMIO; Cliffe S, 2001, BRIT MED J, V323, P376, DOI 10.1136/bmj.323.7309.376; de Martino M, 2000, JAMA-J AM MED ASSOC, V284, P190, DOI 10.1001/jama.284.2.190; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Gortmaker SL, 2001, NEW ENGL J MED, V345, P1522, DOI 10.1056/NEJMoa011157; Kinghorn G, 2001, BMJ-BRIT MED J, V323, P243, DOI 10.1136/bmj.323.7307.243; Litalien C, 2003, PEDIATR INFECT DIS J, V22, P48, DOI 10.1097/00006454-200301000-00014; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9; Sharland M, 2002, HIV Med, V3, P215, DOI 10.1046/j.1468-1293.2002.00120.x; Tarwater PM, 2001, AM J EPIDEMIOL, V154, P675, DOI 10.1093/aje/154.7.675; *UNL AN SURV STEER, 2002, PREV HIV HEP INF UK; Williams AJ, 2001, AIDS, V15, P335, DOI 10.1097/00002030-200102160-00006; *WORK GROUP ANT TH, 2001, GUID US ANT AG PED H; *WORK GROUP ANT TH, MED MAN HIV INF CHIL; World Health Organization, 2002, SCAL ANT THER RES LT	22	164	171	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2003	327	7422					1019	1023		10.1136/bmj.327.7422.1019	http://dx.doi.org/10.1136/bmj.327.7422.1019			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738NE	14593035	Green Submitted, Green Published, Green Accepted, Bronze			2022-12-24	WOS:000186294100020
J	Singleton, AB; Farrer, M; Johnson, J; Singleton, A; Hague, S; Kachergus, J; Hulihan, M; Peuralinna, T; Dutra, A; Nussbaum, R; Lincoln, S; Crawley, A; Hanson, M; Maraganore, D; Adler, C; Cookson, MR; Muenter, M; Baptista, M; Miller, D; Blancato, J; Hardy, J; Gwinn-Hardy, K				Singleton, AB; Farrer, M; Johnson, J; Singleton, A; Hague, S; Kachergus, J; Hulihan, M; Peuralinna, T; Dutra, A; Nussbaum, R; Lincoln, S; Crawley, A; Hanson, M; Maraganore, D; Adler, C; Cookson, MR; Muenter, M; Baptista, M; Miller, D; Blancato, J; Hardy, J; Gwinn-Hardy, K			alpha-synuclein locus triplication causes Parkinson's disease	SCIENCE			English	Article									NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; NINDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; Mayo Clin, Genet Neurodgenerat Lab, Jacksonville, FL 32224 USA; Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA; Mayo Clin, Dept Neurol, Scottsdale, AZ 85259 USA; Georgetown Univ, Med Ctr, Washington, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix; Georgetown University	Singleton, AB (corresponding author), NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.		Resource Center, NINDS Human Genetics/AGF-2474-2022; Gwinn, Katrina A/C-2508-2009; Hardy, John/C-2451-2009; Cookson, Mark/AAW-2516-2021; Sander-Effron, Samuel/AAX-2231-2020; Singleton, Andrew B/C-3010-2009; Johnson, Janel/A-7136-2010	Hardy, John/0000-0002-3122-0423; Cookson, Mark/0000-0002-1058-3831; Farrer, Matthew/0000-0003-1159-5321; Gwinn, Katrina/0000-0002-8277-651X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002974, Z01NS003006, Z01NS002974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000957, ZIAAG000953, Z01AG000953, ZIAAG000957] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Farrer M, 1999, HUM MOL GENET, V8, P81, DOI 10.1093/hmg/8.1.81; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Muenter MD, 1998, ANN NEUROL, V43, P768, DOI 10.1002/ana.410430612; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324	5	3208	3295	5	291	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2003	302	5646					841	841		10.1126/science.1090278	http://dx.doi.org/10.1126/science.1090278			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593171	Green Submitted			2022-12-24	WOS:000186258000041
J	Nambu, Y; Sugai, M; Gonda, H; Lee, CG; Katakai, T; Agata, Y; Yokota, Y; Shimizu, A				Nambu, Y; Sugai, M; Gonda, H; Lee, CG; Katakai, T; Agata, Y; Yokota, Y; Shimizu, A			Transcription-coupled events associating with immunoglobulin switch region chromatin	SCIENCE			English	Article							RNA EDITING ENZYME; ANTIBODY DIVERSIFICATION; V(D)J RECOMBINATION; ACCESSIBILITY CONTROL; HISTONE ACETYLATION; DNA DEAMINATION; AID; MECHANISM; INTERLEUKIN-4; HYPERMUTATION	Class switch recombination (CSR) at the antibody immunoglobulin locus is regulated by germline transcription (GLT) - coupled modi. cations in the accessibility of the switch region, where CSR takes place. Here we show that histone acetylation of switch regions is linked to CSR but that histone acetylation cannot alone promote CSR or GLT. Activation-induced cytidine deaminase (AID) specifically associates with the CSR target chromatin in a GLT-coupled manner, which may occur potentially by means of physical interaction between AID and the transcription machinery. These data indicate an important role of GLT in the regulation of chromatin accessibility, strongly suggesting that the target of AID is chromatin DNA. Our results give insights on the role of AID and the regulatory mechanism of CSR.	Kyoto Univ, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ Hosp, Translat Res Ctr, Sakyo Ku, Kyoto 068507, Japan; Alton Ochsner Med Fdn & Ochsner Clin, Cellular Immunol Lab, New Orleans, LA 70121 USA; Fukui Med Univ, Dept Biochem, Fukui 9101193, Japan	Kyoto University; Kyoto University; Ochsner Health System; University of Fukui	Sugai, M (corresponding author), Kyoto Univ, Ctr Mol Biol & Genet, Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan.		Katakai, Tomoya/AAX-1434-2021	Nambu, Yukiko/0000-0001-6030-4530; Agata, Yasutoshi/0000-0001-9642-6994; Sugai, Manabu/0000-0003-1668-7647; Katakai, Tomoya/0000-0002-4290-7028				Agata Y, 2001, J EXP MED, V193, P873, DOI 10.1084/jem.193.7.873; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; GAUCHAT JF, 1992, INT IMMUNOL, V4, P397, DOI 10.1093/intimm/4.3.397; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hempel WM, 1998, ADV IMMUNOL, V69, P309, DOI 10.1016/S0065-2776(08)60610-0; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lee CG, 2001, J EXP MED, V194, P365, DOI 10.1084/jem.194.3.365; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Martin A, 2002, NAT REV IMMUNOL, V2, P605, DOI 10.1038/nri858; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; NAMBU Y, UNPUB; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Schlissel M S, 1997, Semin Immunol, V9, P161, DOI 10.1006/smim.1997.0066; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; SNAPPER CM, 1988, J EXP MED, V167, P183, DOI 10.1084/jem.167.1.183; Sugai M, 2003, NAT IMMUNOL, V4, P25, DOI 10.1038/ni874; Sugai M, 1998, NUCLEIC ACIDS RES, V26, P911, DOI 10.1093/nar/26.4.911; Tripathi R, 2002, J IMMUNOL, V168, P2316, DOI 10.4049/jimmunol.168.5.2316; van Ginkel FW, 1999, J IMMUNOL, V163, P1951; Ye SK, 2001, IMMUNITY, V15, P813, DOI 10.1016/S1074-7613(01)00230-8; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	28	212	215	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2137	2140		10.1126/science.1092481	http://dx.doi.org/10.1126/science.1092481			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684824				2022-12-24	WOS:000187385200049
J	Clyde, DE; Corado, MSG; Wu, XL; Pare, A; Papatsenko, D; Small, S				Clyde, DE; Corado, MSG; Wu, XL; Pare, A; Papatsenko, D; Small, S			A self-organizing system of repressor gradients establishes segmental complexity in Drosophila	NATURE			English	Article							PAIR-RULE STRIPES; BINDING-SITES; IN-VIVO; EMBRYO; GENE; EXPRESSION; MORPHOGEN; HUNCHBACK; KRUPPEL; ACTIVATORS	Gradients of regulatory factors are essential for establishing precise patterns of gene expression during development(1-3); however, it is not clear how patterning information in multiple gradients is integrated to generate complex body plans. Here we show that opposing gradients of two Drosophila transcriptional repressors, Hunchback (Hb) and Knirps (Kni), position several segments by differentially repressing two distinct regulatory regions (enhancers) of the pair-rule gene even-skipped (eve). Computational and in vivo analyses suggest that enhancer sensitivity to repression is controlled by the number and affinity of repressor-binding sites. Because the kni expression domain is positioned between two gradients of Hb, each enhancer directs expression of a pair of symmetrical stripes, one on each side of the kni domain. Thus, only two enhancers are required for the precise positioning of eight stripe borders (four stripes), or more than half of the whole eve pattern. Our results show that complex developmental expression patterns can be generated by simple repressor gradients. They also support the utility of computational analyses for defining and deciphering regulatory information contained in genomic DNA.	NYU, Dept Biol, New York, NY 10003 USA	New York University	Small, S (corresponding author), NYU, Dept Biol, New York, NY 10003 USA.		Papatsenko, Dmitri/G-7375-2016	Papatsenko, Dmitri/0000-0002-4390-5446				Andrioli LPM, 2002, DEVELOPMENT, V129, P4931; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Fujioka M, 1999, DEVELOPMENT, V126, P2527; GOTO T, 1989, CELL, V57, P413, DOI 10.1016/0092-8674(89)90916-1; Gray S, 1996, CURR OPIN CELL BIOL, V8, P358; HannaRose W, 1996, TRENDS GENET, V12, P229, DOI 10.1016/0168-9525(96)10022-6; HARDING K, 1989, EMBO J, V8, P1205, DOI 10.1002/j.1460-2075.1989.tb03493.x; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; HOU XS, 1996, CELL, V85, P290; HULSKAMP M, 1990, NATURE, V346, P577, DOI 10.1038/346577a0; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Kosman D, 1997, DEVELOPMENT, V124, P1343; KRAUT R, 1991, DEVELOPMENT, V111, P611; LANGELAND JA, 1994, DEVELOPMENT, V120, P2945; LAWRENCE PA, 1987, NATURE, V328, P440, DOI 10.1038/328440a0; Lifanov AP, 2003, GENOME RES, V13, P579, DOI 10.1101/gr.668403; Nambu PA, 1996, DEVELOPMENT, V122, P3467; Papatsenko DA, 2002, GENOME RES, V12, P470, DOI 10.1101/gr.212502. Article published online before print in February ; Small S, 2000, METHOD ENZYMOL, V326, P146; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; Small S, 1996, DEV BIOL, V175, P314, DOI 10.1006/dbio.1996.0117; STANOJEVIC D, 1989, NATURE, V341, P331, DOI 10.1038/341331a0; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8	31	145	150	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					849	853		10.1038/nature02189	http://dx.doi.org/10.1038/nature02189			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685241				2022-12-24	WOS:000187342000061
J	Arcury, TA; Quandt, SA				Arcury, TA; Quandt, SA			Pesticides at work and at home: exposure of migrant farmworkers	LANCET			English	Editorial Material									Wake Forest Univ, Bowman Gray Sch Med, Dept Family & Community Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Arcury, TA (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Family & Community Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008739] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01-ES08739] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BARR DB, 2003, ENV HLTH PERSPE 1104; *GOV ACC OFF, 2000, GAORCED0040; Lindell A. R., 2003, NATL PESTICIDE COMPE	3	33	39	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 13	2003	362	9400					2021	2021		10.1016/S0140-6736(03)15027-1	http://dx.doi.org/10.1016/S0140-6736(03)15027-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14686376				2022-12-24	WOS:000187210700029
J	Antia, R; Regoes, RR; Koella, JC; Bergstrom, CT				Antia, R; Regoes, RR; Koella, JC; Bergstrom, CT			The role of evolution in the emergence of infectious diseases	NATURE			English	Article							TRANSMISSION DYNAMICS; NIPAH VIRUS; MONKEYPOX; HEALTH; SARS; OUTBREAK	It is unclear when, where and how novel pathogens such as human immunodeficiency virus ( HIV), monkeypox and severe acute respiratory syndrome ( SARS) will cross the barriers that separate their natural reservoirs from human populations and ignite the epidemic spread of novel infectious diseases. New pathogens are believed to emerge from animal reservoirs when ecological changes increase the pathogen's opportunities to enter the human population(1) and to generate subsequent human- to-human transmission(2). Effective human- to- human transmission requires that the pathogen's basic reproductive number, R-0, should exceed one, where R-0 is the average number of secondary infections arising from one infected individual in a completely susceptible population(3). However, an increase in R-0, even when insufficient to generate an epidemic, nonetheless increases the number of subsequently infected individuals. Here we show that, as a consequence of this, the probability of pathogen evolution to R-0 > 1 and subsequent disease emergence can increase markedly.	Emory Univ, Dept Biol, Atlanta, GA 30322 USA; Univ Paris 06, Lab Parasitol Evolut, F-75252 Paris, France; Univ Washington, Dept Biol, Seattle, WA 98195 USA	Emory University; UDICE-French Research Universities; Sorbonne Universite; University of Washington; University of Washington Seattle	Antia, R (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	rantia@emory.edu	Regoes, Roland R/A-6538-2008; Bergstrom, Carl T./H-2299-2011	Regoes, Roland R/0000-0001-8319-5293; Bergstrom, Carl T./0000-0002-2070-385X				ANDERSON R M, 1991; Athreya KB, 1972, BRANCHING PROCESSES; Breman JG, 1998, NEW ENGL J MED, V339, P556, DOI 10.1056/NEJM199808203390811; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Cyranoski D, 2003, NATURE, V423, P467, DOI 10.1038/423467a; DEMETRIUS L, 1985, B MATH BIOL, V47, P239; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Elton C. S., 1958, ECOLOGY INVASIONS AN; Enserink M, 2000, SCIENCE, V289, P518, DOI 10.1126/science.289.5479.518; Enserink M, 1999, SCIENCE, V284, P407, DOI 10.1126/science.284.5413.407; Enserink M, 2003, SCIENCE, V300, P1351; FINE PEM, 1988, INT J EPIDEMIOL, V17, P643, DOI 10.1093/ije/17.3.643; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720; Holmes EC, 2001, BIOL REV, V76, P239, DOI 10.1017/S1464793101005668; Hutin YJF, 2001, EMERG INFECT DIS, V7, P434; KORNBERG H, 1987, QUANTITATIVE BIOL EC; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Lloyd AL, 1996, J THEOR BIOL, V179, P1, DOI 10.1006/jtbi.1996.0042; May RM, 2001, PHILOS T R SOC B, V356, P901, DOI 10.1098/rstb.2001.0866; MAY RM, 1990, PARASITOLOGY, V100, pS89, DOI 10.1017/S0031182000073042; Peeters M, 2002, EMERG INFECT DIS, V8, P451, DOI 10.3201/eid0805.010522; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; SCHRAG SJ, 1995, TRENDS ECOL EVOL, V10, P319, DOI 10.1016/S0169-5347(00)89118-1; Stivers DN, 1996, MATH BIOSCI, V137, P25, DOI 10.1016/S0025-5564(96)00066-1; WALLACE B, 1989, AM NAT, V133, P578, DOI 10.1086/284937; Wilke CO, 2003, GENETICS, V163, P467; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	29	347	351	8	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					658	661		10.1038/nature02104	http://dx.doi.org/10.1038/nature02104			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668863	Green Published, Green Submitted			2022-12-24	WOS:000187132800040
J	Downey, M				Downey, M			The importance of being earnest	LANCET			English	Article									Amer Obes Assoc, Washington, DC 20037 USA		Downey, M (corresponding author), Amer Obes Assoc, Suite 300,1250 24th St NW, Washington, DC 20037 USA.								0	2	2	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S42	S43		10.1016/S0140-6736(03)15072-6	http://dx.doi.org/10.1016/S0140-6736(03)15072-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698126				2022-12-24	WOS:000187790200022
J	Sakaguchi, N; Takahashi, T; Hata, H; Nomura, T; Tagami, T; Yamazaki, S; Sakihama, T; Matsurtani, T; Negishi, I; Nakatsuru, S; Sakaguchi, S				Sakaguchi, N; Takahashi, T; Hata, H; Nomura, T; Tagami, T; Yamazaki, S; Sakihama, T; Matsurtani, T; Negishi, I; Nakatsuru, S; Sakaguchi, S			Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice	NATURE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TCR-ZETA-CHAIN; RHEUMATOID-ARTHRITIS; TYROSINE KINASE; TRANSGENIC MICE; RECEPTOR; DISEASE; THYMOCYTES; ANTIGEN	Rheumatoid arthritis (RA), which afflicts about 1% of the world population, is a chronic systemic inflammatory disease of unknown aetiology that primarily affects the synovial membranes of multiple joints(1-3). Although CD4+ T cells seem to be the prime mediators of RA, it remains unclear how arthritogenic CD4(+) T cells are generated and activated(1-3). Given that highly self-reactive T-cell clones are deleted during normal T-cell development in the thymus, abnormality in T-cell selection has been suspected as one cause of autoimmune disease(4,5). Here we show that a spontaneous point mutation of the gene encoding an SH2 domain of ZAP-70, a key signal transduction molecule in T cells(6), causes chronic autoimmune arthritis in mice that resembles human RA in many aspects. Altered signal transduction from T-cell antigen receptor through the aberrant ZAP-70 changes the thresholds of T cells to thymic selection, leading to the positive selection of otherwise negatively selected autoimmune T cells. Thymic production of arthritogenic T cells due to a genetically determined selection shift of the T-cell repertoire towards high self-reactivity might also be crucial to the development of disease in a subset of patients with RA.	Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan; RIKEN, Immunopathol Lab, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan; Shionogi Inst Med Sci, Dept Immunol, Osaka 5660022, Japan; Gunma Univ Hosp, Dept Dermatol, Maebashi, Gumma 3718511, Japan	Kyoto University; RIKEN; Shionogi & Company Limited; Gunma University	Sakaguchi, S (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan.		Sakaguchi, Shimon/C-9535-2009; Tagami, Takashi/HGA-3038-2022	Tagami, Takashi/0000-0001-6953-1932				Atsumi T, 2002, J EXP MED, V196, P979, DOI 10.1084/jem.20020619; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Dayer JM, 1999, ARTHRITIS RES, V1, P17, DOI 10.1186/ar5; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Firestein G.S, 1997, TXB RHEUMATOLOGY, P851; Harris ED, 1997, RHEUMATOID ARTHRITIS; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Itoh M, 1999, J IMMUNOL, V162, P5317; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Nambiar MP, 2001, ARTHRITIS RHEUM, V44, P1336, DOI 10.1002/1529-0131(200106)44:6<1336::AID-ART226>3.0.CO;2-8; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Noraz N, 2000, J BIOL CHEM, V275, P15832, DOI 10.1074/jbc.M908568199; PALS ST, 1985, J IMMUNOL, V134, P1475; Rincon M, 2001, CURR OPIN IMMUNOL, V13, P339, DOI 10.1016/S0952-7915(00)00224-7; SAKAGUCHI S, 1990, J EXP MED, V172, P537, DOI 10.1084/jem.172.2.537; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Takeuchi T, 1998, INT IMMUNOL, V10, P911, DOI 10.1093/intimm/10.7.911; van Oers NSC, 2000, NAT IMMUNOL, V1, P322, DOI 10.1038/79774; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Wiest DL, 1997, IMMUNITY, V6, P663, DOI 10.1016/S1074-7613(00)80442-2; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	30	610	645	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2003	426	6965					454	460		10.1038/nature02119	http://dx.doi.org/10.1038/nature02119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647385				2022-12-24	WOS:000186800800041
J	Tekkis, PP; Poloniecki, JD; Thompson, MR; Stamatakis, JD				Tekkis, PP; Poloniecki, JD; Thompson, MR; Stamatakis, JD		Assoc Coloproctology Great Britain	Operative mortality in colorectal cancer: prospective national study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SURGICAL CARE; RISK; PERFORMANCE; RATES; SURGEONS; QUALITY; POSSUM	Objective To develop a mathematical model that will predict the probability of death after surgery for colorectal cancer. Design Descriptive study using routinely collected clinical data. Data source The database of the Association of Coloproctology of Great Britain and Ireland (ACPGBI), encompassing 8077 patients with a new diagnosis of colorectal cancer in 73 hospitals during a 12 month period. Statistical analysis A three level hierarchical logistic regression model was used to identify independent predictors of operative mortality. The model was developed on 60% of the patient population and its validity tested on the remaining 40%. Results Overall postoperative mortality was 7.5% (95% confidence interval 6.9% to 8.1%). Independent predictors of death were age, American Society of Anesthesiology (ASA) grade, Dukes's stage, urgency of the operation, and cancer excision. When tested the predictive model showed good discrimination (area under the receiver operating characteristic curve = (0.775) and calibration (comparison of observed with expected mortality across different procedures; Hosmer-Lemeshow statistic = 6.34, 8 df, P = 0.610). Conclusions Clinicians can predict postoperative death by using a simple numerical table derived from the statistical model of the ACPGBI. The model can be used in everyday practice for preoperative counselling of patients and their carers as a part of multidisciplinary care. It may also be used to compare the outcomes between multidisciplinary teams for colorectal cancer.	Prince Wales Hosp, Dept Surg, Bridgend CF31 1RQ, Wales; St Marks Hosp, Dept Surg, Harrow HA1 3UJ, Middx, England; Univ London St Georges Hosp, Dept Publ Hlth Sci, London SW17 0WT, England; Queen Alexandra Hosp, Dept Surg, Portsmouth, Hants, England	Imperial College London; St Georges University London; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital	Stamatakis, JD (corresponding author), Prince Wales Hosp, Dept Surg, Bridgend CF31 1RQ, Wales.	jeff.stamatakis@bromor-tr.wales.nhs.uk						Aylin P, 2001, LANCET, V358, P181, DOI 10.1016/S0140-6736(01)05404-6; Callum KG.AppendixA, 2000, NOW 2000 REPORT NATL, P125; Copeland G P, 1992, J R Coll Surg Edinb, V37, P145; COPELAND GP, 1991, BRIT J SURG, V78, P356; Daley J, 2001, ANNU REV MED, V52, P275, DOI 10.1146/annurev.med.52.1.275; Department of Health, HOSP EP STAT; DRIPPS RD, 1961, JAMA-J AM MED ASSOC, V178, P261, DOI 10.1001/jama.1961.03040420001001; Goldstein H, 1996, J ROY STAT SOC A STA, V159, P149, DOI 10.2307/2983475; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Holm T, 1997, BRIT J SURG, V84, P657, DOI 10.1046/j.1365-2168.1997.02745.x; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Khuri SF, 1997, J AM COLL SURGEONS, V185, P315, DOI 10.1016/S1072-7515(01)00938-3; Marshall EG, 1998, BRIT MED J, V316, P1701, DOI 10.1136/bmj.316.7146.1701; Sagar PM, 1996, DIS COLON RECTUM, V39, P654, DOI 10.1007/BF02056945; Spiegelhalter DJ, 2002, J R STAT SOC A STAT, V165, P191, DOI 10.1111/1467-985X.02021; Tekkis PP, 2000, DIS COLON RECTUM, V43, P1528, DOI 10.1007/BF02236732; Treasure T, 2002, THORAX, V57, P3, DOI 10.1136/thorax.57.1.3; TURNBULL RB, 1967, ANN SURG, V166, P420	20	195	202	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 22	2003	327	7425					1196	1199		10.1136/bmj.327.7425.1196	http://dx.doi.org/10.1136/bmj.327.7425.1196			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	747BB	14630754	Bronze, Green Published			2022-12-24	WOS:000186784300017
J	Wada, S; Oishi, M; Yamada, TK				Wada, S; Oishi, M; Yamada, TK			A newly discovered species of living baleen whale	NATURE			English	Article							MITOCHONDRIAL-DNA; FIN WHALE; SEQUENCES; REGION	In the late 1970s eight Balaenoptera specimens of unknown identity were caught in the lower latitudinal Indo-Pacific waters by Japanese research whaling vessels(1). The combination of the allozyme patterns and physical maturity of the eight specimens separated them from all acknowledged Balaenoptera species(2). In September 1998 we collected a medium-sized baleen whale carcass on a coastal island in the Sea of Japan. This specimen and the previously collected eight specimens resembled Balaenoptera physalus (fin whale) in external appearance but were much smaller. Comparison of external morphology, osteology and mitochondrial DNA data grouped the nine specimens as a single species but separated them from all known baleen whale species. Therefore, here we describe a new species of Balaenoptera, which is characterized by its unique cranial morphology, its small number of baleen plates, and by its distant molecular relationships with all of its congeners. Our analyses also separated Balaenoptera brydei (Bryde's whale)(3,4) and Balaenoptera edeni (Eden's whale)(5) into two distinct species, raising the number of known living Balaenoptera species to eight.	Natl Res Inst Fisheries Sci, Fisheries Res Agcy, Kanazawa Ku, Yokohama, Kanagawa 2368648, Japan; Iwate Prefectural Museum, Morioka, Iwate 0200102, Japan; Museum Nat Sci, Shinjuku Ku, Tokyo 1690073, Japan	Japan Fisheries Research & Education Agency (FRA)	Wada, S (corresponding author), Natl Res Inst Fisheries Sci, Fisheries Res Agcy, Kanazawa Ku, 2-12-4 Fukuura, Yokohama, Kanagawa 2368648, Japan.		Yamada, Tadasu K./C-3362-2008					ANDERSON J, 1978, ANATOMICAL ZOOLOGICA, V1, P551; Andrews R. C., 1918, Records of the Indian Museum, V15; [Anonymous], 1993, MEGA MOL EVOLUTIONAR; ARNASON U, 1993, J MOL EVOL, V37, P312; ARNASON U, 1993, MOL BIOL EVOL, V10, P960; ARNASON U, 1991, J MOL EVOL, V33, P556, DOI 10.1007/BF02102808; Arnold P., 1987, SCI REP WHALES RES I, V38, P1; BEST PB, 1985, SCI REP WHALES RES, V36, P1; BEST PB, 1977, REPORTS INT WHALING, V1, P10; HOELZEL AR, 1991, MOL BIOL EVOL, V8, P475; Junge G. C. A., 1950, Zool Verh Leiden 1950, VNo. 9, P1; Kato H., 2002, ENCY MARINE MAMMALS, P171; LeDuc Richard G., 2002, P100; LONNBERG EINAR, 1931, ARK ZOOL, V23B, P1; Mackintosh N. A., 1929, Discovery Reports Cambridge, V1, P257; MATTHEWS L. HARRISON, 1938, DISCOVERY REPTS [GOVT DEPENDENCIES FALKLAND ISLANDS], V17, P183; Ohsumi S., 1980, REPORT INT WHALING C, V30, P319; OLSEN O, 1913, P ZOOL SOC LOND, P1073; Omura H., 1981, SCI REP WHALES RES, V33, P1; OMURA H, 1966, WHALES DOLPHINS PORP, P70; Pilleri G., 1974, INVEST CETACEA, VV, P95; RICE DW, 1998, MAR MAMMAL SCI, V4, P67; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Soot-Eyen T., 1961, Norsk Hvalfangsttidende Sandefjord, V50, P323; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRUE FW, 1904, SMITHSONIAN CONTRIBU, V33, P1; WADA S, 1991, REPORTS INT WHALING, V13, P125	27	135	168	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2003	426	6964					278	281		10.1038/nature02103	http://dx.doi.org/10.1038/nature02103			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628049				2022-12-24	WOS:000186660800041
J	Feldmann, J; Callebaut, I; Raposo, G; Certain, S; Bacq, D; Dumont, C; Lambert, N; Ouachee-Chardin, M; Chedeville, G; Tamary, H; Minard-Colin, V; Vilmer, E; Blanche, S; Le Deist, F; Fischer, A; Saint Basile, GD				Feldmann, J; Callebaut, I; Raposo, G; Certain, S; Bacq, D; Dumont, C; Lambert, N; Ouachee-Chardin, M; Chedeville, G; Tamary, H; Minard-Colin, V; Vilmer, E; Blanche, S; Le Deist, F; Fischer, A; Saint Basile, GD			Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)	CELL			English	Article							CHEDIAK-HIGASHI-SYNDROME; MEMBRANE-FUSION; CRYSTAL-STRUCTURE; LYMPHOCYTES-T; DOMAIN; EXOCYTOSIS; UNC-13; CELLS; PROTEINS; SYNTAXIN	Secretion of cytolytic granules content at the immunological synapse is a highly regulated process essential for lymphocyte cytotoxicity. This process requires the rapid transfer of perforin containing lytic granules to the target cell interface, followed by their docking and fusion with the plasma membrane. Defective cytotoxicity characterizes a genetically heterogeneous condition named familial hemophagocytic lymphohistiocytosis (FHL), which can be associated with perforin deficiency. The locus of a perforin (+) FHL subtype (FHL3), observed in 10 patients, was mapped to 17q25. This region contains hMunc13-4, a member of the Munc13 family of proteins involved in vesicle priming function. HMunc13-4 mutations were shown to cause FHL3. HMunc13-4 deficiency results in defective cytolytic granule exocytosis, despite polarization of the secretory granules and docking with the plasma membrane. Expressed tagged hMunc13-4 localizes with cytotoxic granules at the immunological synapse. HMunc13-4 is therefore essential for the priming step of cytolytic granules secretion preceding vesicle membrane fusion.	Hop Necker Enfants Malad, INSERM U429, F-75743 Paris, France; Univ Paris 06, CNRS UMR7590, LMCP, F-75005 Paris, France; Univ Paris 07, CNRS UMR7590, LMCP, F-75005 Paris, France; Inst Curie, CNRS UMR 144, Paris, France; Ctr Natl Genotypage, F-91057 Evry, France; Hop Necker Enfants Malad, Unite Immunol Hematol, F-75015 Paris, France; Schneiders Children Med Ctr, Pediat Hematol Unit, IL-49202 Petah Tiqwa, Israel; Hop Robert Debre, Unite Immunohematol, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; CEA; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Saint Basile, GD (corresponding author), Hop Necker Enfants Malad, INSERM U429, F-75743 Paris, France.		; de Saint Basile, Genevieve/G-9731-2017	Raposo, graca/0000-0001-9590-1298; DOGNIAUX, Stephanie/0000-0003-3309-1204; de Saint Basile, Genevieve/0000-0002-1913-5269				Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; BAETZ K, 1995, J IMMUNOL, V154, P6122; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Betz A, 1997, J BIOL CHEM, V272, P2520; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; de Saint Basile G, 2001, CURR OPIN IMMUNOL, V13, P549, DOI 10.1016/S0952-7915(00)00257-0; Dufourcq-Lagelouse R, 1999, AM J HUM GENET, V64, P172, DOI 10.1086/302194; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; FORTIER AH, 1989, CELL IMMUNOL, V124, P64, DOI 10.1016/0008-8749(89)90112-3; GRIFFITHS GM, 1993, J CELL BIOL, V120, P885, DOI 10.1083/jcb.120.4.885; Haddad EK, 2001, J CELL BIOL, V152, P835, DOI 10.1083/jcb.152.4.835; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; KUPFER H, 1994, J EXP MED, V179, P1507, DOI 10.1084/jem.179.5.1507; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Nagle DL, 1996, NAT GENET, V14, P307, DOI 10.1038/ng1196-307; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Ohadi M, 1999, AM J HUM GENET, V64, P165, DOI 10.1086/302187; Orita S, 1997, J BIOL CHEM, V272, P16081, DOI 10.1074/jbc.272.26.16081; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; PETERS PJ, 1989, EUR J IMMUNOL, V19, P1469, DOI 10.1002/eji.1830190819; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROTHSTEIN TL, 1978, J IMMUNOL, V121, P1652; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sassa T, 1999, J NEUROSCI, V19, P4772; Shiratsuchi T, 1998, BIOCHEM BIOPH RES CO, V251, P158, DOI 10.1006/bbrc.1998.9408; Shresta S, 1998, CURR OPIN IMMUNOL, V10, P581, DOI 10.1016/S0952-7915(98)80227-6; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; Ubach J, 1999, NAT CELL BIOL, V1, P106, DOI 10.1038/10076; Vyas YM, 2002, IMMUNOL REV, V189, P161, DOI 10.1034/j.1600-065X.2002.18914.x; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	50	657	690	1	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 14	2003	115	4					461	473		10.1016/S0092-8674(03)00855-9	http://dx.doi.org/10.1016/S0092-8674(03)00855-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	744KB	14622600	Bronze			2022-12-24	WOS:000186627100012
J	Gstaiger, M; Luke, B; Hess, D; Oakeley, EJ; Wirbelauer, C; Blondel, M; Vigneron, M; Peter, M; Krek, W				Gstaiger, M; Luke, B; Hess, D; Oakeley, EJ; Wirbelauer, C; Blondel, M; Vigneron, M; Peter, M; Krek, W			Control of nutrient-sensitive transcription programs by the unconventional prefoldin URI	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CYTOSOLIC CHAPERONIN; UNFOLDED PROTEINS; AMINO-ACID; YEAST; EXPRESSION; STARVATION; CELLS; TOR; P45(SKP2)	Prefoldins (PFDs) are members of a recently identified, small-molecular weight protein family able to assemble into molecular chaperone complexes. Here we describe an unusually large member of this family, termed URI, that forms complexes with other small-molecular weight PFDs and with RPB5, a shared subunit of all three RNA polymerases. Functional analysis of the yeast and human orthologs of URI revealed that both are targets of nutrient signaling and participate in gene expression controlled by the TOR kinase. Thus, URI is a component of a signaling pathway that coordinates nutrient availability with gene expression.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; ETH Honggerberg, Inst Biochem, CH-8093 Zurich, Switzerland; Univ Strasbourg 1, Ecole Super Biotechnol Strasbourg, CNRS, UMR 7100, F-67412 Illkirch Graffenstaden, France	Friedrich Miescher Institute for Biomedical Research; Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Krek, W (corresponding author), ETH Honggerberg, Inst Cell Biol, CH-8093 Zurich, Switzerland.		Blondel, Marc/AAJ-9049-2020	Blondel, Marc/0000-0003-4897-2995; Peter, Matthias/0000-0002-2160-6824; Luke, Brian/0000-0002-1648-5511				Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Dorjsuren D, 1998, MOL CELL BIOL, V18, P7546, DOI 10.1128/MCB.18.12.7546; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kanemaki M, 1997, BIOCHEM BIOPH RES CO, V235, P64, DOI 10.1006/bbrc.1997.6729; KRON SJ, 1995, CURR OPIN CELL BIOL, V7, P845, DOI 10.1016/0955-0674(95)80069-7; Lisztwan J, 1998, EMBO J, V17, P368, DOI 10.1093/emboj/17.2.368; LUKE BT, UNPUB; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; MURAKAMI Y, 1995, NAT GENET, V10, P261, DOI 10.1038/ng0795-261; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; WIRBELAUER C, UNPUB; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X; WOYCHIK NA, 1990, GENE DEV, V4, P313, DOI 10.1101/gad.4.3.313	25	135	143	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2003	302	5648					1208	1212		10.1126/science.1088401	http://dx.doi.org/10.1126/science.1088401			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14615539				2022-12-24	WOS:000186544300054
J	Koechlin, E; Ody, C; Kouneiher, F				Koechlin, E; Ody, C; Kouneiher, F			The architecture of cognitive control in the human prefrontal cortex	SCIENCE			English	Article							WORKING-MEMORY; MAINTENANCE; MECHANISMS; BEHAVIOR; MOTOR; FMRI	The prefrontal cortex (PFC) subserves cognitive control: the ability to coordinate thoughts or actions in relation with internal goals. Its functional architecture, however, remains poorly understood. Using brain imaging in humans, we showed that the lateral PFC is organized as a cascade of executive processes from premotor to anterior PFC regions that control behavior according to stimuli, the present perceptual context, and the temporal episode in which stimuli occur, respectively. The results support an unified modular model of cognitive control that describes the overall functional organization of the human lateral PFC and has basic methodological and theoretical implications.	Univ Paris 06, INSERM, F-75005 Paris, France; Hop La Pitie Salpetriere, F-75013 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Koechlin, E (corresponding author), Univ Paris 06, INSERM, 9 Quai St Bernard, F-75005 Paris, France.	koechlin@ccr.jussieu.fr	Koechlin, Etienne/E-5061-2016; Koechlin, Etienne/AAF-5717-2021	Koechlin, Etienne/0000-0002-6514-9311; Koechlin, Etienne/0000-0002-6514-9311				Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 1996, PHILOS T ROY SOC B, V351, P1397, DOI 10.1098/rstb.1996.0123; BERLYNE DE, 1957, PSYCHOL REV, V64, P329, DOI 10.1037/h0041135; Buckner RL, 1998, P NATL ACAD SCI USA, V95, P891, DOI 10.1073/pnas.95.3.891; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Fechner GT, 1860, ELEMENTE PSYCHOPHYSI; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Friston K. J., 1993, Human Brain Mapping, V1, P69, DOI 10.1002/hbm.460010108; Furey ML, 1997, P NATL ACAD SCI USA, V94, P6512, DOI 10.1073/pnas.94.12.6512; Fuster J.M., 1989, PREFRONTAL CORTEX; Goldman-Rakic P. S., 1987, COMPR PHYSIOL, P373, DOI DOI 10.1002/CPHY.CP010509; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Koechlin E, 2002, NEURON, V35, P371, DOI 10.1016/S0896-6273(02)00742-0; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; McIntosh A. R., 1994, Human Brain Mapping, V2, P2; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nagahama Y, 2001, CEREB CORTEX, V11, P85, DOI 10.1093/cercor/11.1.85; Norwich KH, 1997, PERCEPT PSYCHOPHYS, V59, P929, DOI 10.3758/BF03205509; Pandya DN, 1996, RES PER NEUROSCI, P13; Passingham R. E., 1993, OXFORD PSYCHOL SERIE; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Shallice T, 1996, PHILOS T R SOC B, V351, P1405, DOI 10.1098/rstb.1996.0124; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Veltman DJ, 2003, NEUROIMAGE, V18, P247, DOI 10.1016/S1053-8119(02)00049-6; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033	30	1180	1186	2	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2003	302	5648					1181	1185		10.1126/science.1088545	http://dx.doi.org/10.1126/science.1088545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14615530				2022-12-24	WOS:000186544300045
J	Nystul, TG; Goldmark, JP; Padilla, PA; Roth, MB				Nystul, TG; Goldmark, JP; Padilla, PA; Roth, MB			Suspended animation in C-elegans requires the spindle checkpoint	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; OXYGEN DEPRIVATION; MECHANISMS; HYPOXIA; PROTEIN; ARREST; ANOXIA; VISUALIZATION; DIAPAUSE; ENCODES	In response to environmental signals such as anoxia, many organisms enter a state of suspended animation, an extreme form of quiescence in which microscopically visible movement ceases. We have identified a gene, san-1, that is required for suspended animation in Caenorhabditis elegans embryos. We show that san-1 functions as a spindle checkpoint component in C. elegans. During anoxia-induced suspended animation, embryos lacking functional SAN-1 or a second spindle checkpoint component, MDF-2, failed to arrest the cell cycle, exhibited chromosome missegregation, and showed reduced viability. These data provide a model for how a dynamic biological process is arrested in suspended animation.	Univ Washington, Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98109 USA; Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of North Texas System; University of North Texas Denton	Roth, MB (corresponding author), Univ Washington, Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.		Nystul, Todd/AAA-7344-2022	Nystul, Todd/0000-0002-6250-2394	NIGMS NIH HHS [T32 GM07270, GM48435] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, R01GM048435] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam HB, 2002, SURGERY, V132, P278, DOI 10.1067/msy.2002.125787; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Clegg JS, 1997, J EXP BIOL, V200, P467; Douglas RM, 2003, J APPL PHYSIOL, V94, P2068, DOI 10.1152/japplphysiol.01029.2002; FOE VE, 1985, J CELL BIOL, V100, P1623, DOI 10.1083/jcb.100.5.1623; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fukushige T, 1999, P NATL ACAD SCI USA, V96, P11883, DOI 10.1073/pnas.96.21.11883; Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Jackson DC, 2002, J PHYSIOL-LONDON, V543, P731, DOI 10.1113/jphysiol.2002.024729; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kitagawa R, 1999, NAT CELL BIOL, V1, P514, DOI 10.1038/70309; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; NYSTUL TG, UNPUB; Padilla PA, 2001, P NATL ACAD SCI USA, V98, P7331, DOI 10.1073/pnas.131213198; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; Podrabsky JE, 1999, J EXP BIOL, V202, P2567; Renfree MB, 2000, ANNU REV PHYSIOL, V62, P353, DOI 10.1146/annurev.physiol.62.1.353; Safar P, 2000, CRIT CARE MED, V28, pN214, DOI 10.1097/00003246-200011001-00012; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Storey KB, 2002, COMP BIOCHEM PHYS A, V133, P733, DOI 10.1016/S1095-6433(02)00206-4; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1	23	72	78	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2003	302	5647					1038	1041		10.1126/science.1089705	http://dx.doi.org/10.1126/science.1089705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605367				2022-12-24	WOS:000186396300046
J	Arantes-Oliveira, N; Berman, JR; Kenyon, C				Arantes-Oliveira, N; Berman, JR; Kenyon, C			Healthy animals with extreme longevity	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; SIGNALS; GENES		Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Mission Bay Genentech Hall,600 16th St,Room S312D, San Francisco, CA 94143 USA.			Kenyon, Cynthia/0000-0003-3446-2636	NIA NIH HHS [R0I AG20932] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG020932] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Gems D, 1998, GENETICS, V150, P129; HEKIMI S, COMMUNICATION; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; LARSEN PL, 1995, GENETICS, V139, P1567; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447	7	128	140	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					611	611		10.1126/science.1089169	http://dx.doi.org/10.1126/science.1089169			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576426				2022-12-24	WOS:000186119900049
J	Pereira, G; Schiebel, E				Pereira, G; Schiebel, E			Separase regulates INCENP-Aurora B anaphase spindle function through Cdc14	SCIENCE			English	Article							CENTROMERE PROTEIN; PHOSPHATASE CDC14; MITOTIC EXIT; CLEAVAGE; KINASE; LOCALIZATION; KINETOCHORE; MITOSIS; COHESIN; COMPLEX	The inner centromere-like protein ( INCENP) forms a complex with the evolutionarily conserved family of Aurora B kinases. The INCENP-Aurora complex helps coordinate chromosome segregation, spindle behavior, and cytokinesis during mitosis. INCENP-Aurora associates with kinetochores in metaphase and with spindle microtubules in anaphase, yet the trigger for this abrupt transfer is unknown. Here we show that the conserved phosphatase Cdc14 regulated the yeast INCENP-Aurora complex, Sli15-Ipl1. Cdc14 dephosphorylated Sli15 and thereby directed the complex to spindles. Activation of Cdc14 by separase was sufficient for Sli15 dephosphorylation and relocalization. Cdc14 not only regulates mitotic exit but also modulates spindle midzone assembly through Sli15-Ipl1.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England	University of Manchester; Paterson Institute for Cancer Research	Schiebel, E (corresponding author), Paterson Inst Canc Res, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	eschiebel@picr.man.ac.uk	Pereira, Gislene/D-4024-2014					Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Buvelot S, 2003, J CELL BIOL, V160, P329, DOI 10.1083/jcb.200209018; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Donaldson AD, 1996, J CELL BIOL, V132, P887, DOI 10.1083/jcb.132.5.887; Gruneberg U, 2002, J CELL BIOL, V158, P901, DOI 10.1083/jcb.200202054; Janke C, 2001, EMBO J, V20, P777, DOI 10.1093/emboj/20.4.777; Jin QW, 2000, J CELL SCI, V113, P1903; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Kang JS, 2001, J CELL BIOL, V155, P763, DOI 10.1083/jcb.200105029; Pereira G, 2002, J CELL BIOL, V157, P367, DOI 10.1083/jcb.200112085; PEREIRA G, UNPUB; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; Terada Y, 2001, CELL STRUCT FUNCT, V26, P653, DOI 10.1247/csf.26.653; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415	22	210	217	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2120	2124		10.1126/science.1091936	http://dx.doi.org/10.1126/science.1091936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14605209				2022-12-24	WOS:000187385200044
J	Jiang, GQ; Kennedy, MJ; Christie-Blick, N				Jiang, GQ; Kennedy, MJ; Christie-Blick, N			Stable isotopic evidence for methane seeps in Neoproterozoic postglacial cap carbonates	NATURE			English	Article							GAS HYDRATE; EXCURSIONS; DEPOSITS; PRECIPITATION; DISSOCIATION; RECORD	The Earth's most severe glaciations are thought to have occurred about 600 million years ago, in the late Neoproterozoic era(1,2). A puzzling feature of glacial deposits from this interval is that they are overlain by 1-5-m-thick 'cap carbonates' (particulate deepwater marine carbonate rocks) associated with a prominent negative carbon isotope excursion(3-8). Cap carbonates have been controversially ascribed to the aftermath of almost complete shutdown of the ocean ecosystems for millions of years during such ice ages - the 'snowball Earth' hypothesis(4,5). Conversely, it has also been suggested that these carbonate rocks were the result of destabilization of methane hydrates during deglaciation and concomitant flooding of continental shelves and interior basins(3). The most compelling criticism of the latter 'methane hydrate' hypothesis has been the apparent lack of extreme isotopic variation in cap carbonates inferred locally to be associated with methane seeps. Here we report carbon isotopic and petrographic data from a Neoproterozoic postglacial cap carbonate in south China that provide direct evidence for methane-influenced processes during deglaciation. This evidence lends strong support to the hypothesis that methane hydrate destabilization contributed to the enigmatic cap carbonate deposition and strongly negative carbon isotopic anomalies following Neoproterozoic ice ages. This explanation requires less extreme environmental disturbance than that implied by the snowball Earth hypothesis(4,5).	Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	University of California System; University of California Riverside; Columbia University; Columbia University	Jiang, GQ (corresponding author), Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA.	ganqing@mail.ucr.edu	Jiang, Ganqing/A-9557-2011; Jiang, Ganqing/GZM-7526-2022; Jiang, Ganqing/AAX-7756-2020	Jiang, Ganqing/0000-0002-6627-2848; Jiang, Ganqing/0000-0002-6627-2848; Kennedy, Martin/0000-0002-1330-6864				Aiello IW, 2001, GEOLOGY, V29, P1111, DOI 10.1130/0091-7613(2001)029<1111:AAOOCS>2.0.CO;2; Barfod GH, 2002, EARTH PLANET SC LETT, V201, P203, DOI 10.1016/S0012-821X(02)00687-8; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Cavagna S, 1999, SEDIMENT GEOL, V126, P253, DOI 10.1016/S0037-0738(99)00044-5; CROWELL JC, 1999, MEM GEOL SOC AM, V192; Dickens G., 2003, GEOL SOC AM SPEC PAP, V369, P11, DOI [10.1130/0-8137-2369-8.11, DOI 10.1130/0-8137-2369-8.11]; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Gautier D. L., 1984, AAPG BULL, V37, P111; Greinert J, 2002, EARTH PLANET SC LETT, V203, P165, DOI 10.1016/S0012-821X(02)00830-0; Grotzinger JP, 1995, PALAIOS, V10, P578, DOI 10.2307/3515096; Hesselbo SP, 2000, NATURE, V406, P392, DOI 10.1038/35019044; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Hoffman PF, 2002, GEOLOGY, V30, P286, DOI 10.1130/0091-7613(2002)030<0286:APCCAI>2.0.CO;2; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; IRWIN H, 1977, NATURE, V269, P209, DOI 10.1038/269209a0; James NP, 2001, CAN J EARTH SCI, V38, P1229, DOI 10.1139/e01-046; Katz ME, 1999, SCIENCE, V286, P1531, DOI 10.1126/science.286.5444.1531; Kauffman EG, 1996, GEOLOGY, V24, P799, DOI 10.1130/0091-7613(1996)024<0799:WVOMRF>2.3.CO;2; Kennedy MJ, 2001, GEOLOGY, V29, P1135, DOI 10.1130/0091-7613(2001)029<1135:CICONG>2.0.CO;2; Kennedy MJ, 1996, J SEDIMENT RES, V66, P1050, DOI 10.2110/jsr.66.1050; Kennedy MJ, 2001, GEOLOGY, V29, P443, DOI 10.1130/0091-7613(2001)029<0443:APCCAI>2.0.CO;2; Kvenvolden KA, 1998, GEOL SOC SPEC PUBL, V137, P9, DOI 10.1144/GSL.SP.1998.137.01.02; Peckmann J, 2002, SEDIMENTOLOGY, V49, P855, DOI 10.1046/j.1365-3091.2002.00474.x; Sohl LE, 1999, GEOL SOC AM BULL, V111, P1120, DOI 10.1130/0016-7606(1999)111<1120:PPRIMC>2.3.CO;2; Stakes DS, 1999, MAR GEOL, V159, P93, DOI 10.1016/S0025-3227(98)00200-X; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318	26	290	370	6	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2003	426	6968					822	826		10.1038/nature02201	http://dx.doi.org/10.1038/nature02201			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685234	Green Published			2022-12-24	WOS:000187342000053
J	Beaugrand, G; Brander, KM; Lindley, JA; Souissi, S; Reid, PC				Beaugrand, G; Brander, KM; Lindley, JA; Souissi, S; Reid, PC			Plankton effect on cod recruitment in the North Sea	NATURE			English	Article							MATCH MISMATCH HYPOTHESIS; LARVAL FISH; GADUS-MORHUA; ATLANTIC COD; DEPENDENT MORTALITY; GROWTH; VARIABILITY; ZOOPLANKTON; ABUNDANCE; SURVIVAL	The Atlantic cod ( Gadus morhua L.) has been overexploited in the North Sea since the late 1960s and great concern has been expressed about the decline in cod biomass and recruitment(1). Here we show that, in addition to the effects of overfishing(1), fluctuations in plankton have resulted in long- term changes in cod recruitment in the North Sea ( bottom- up control). Survival of larval cod is shown to depend on three key biological parameters of their prey: the mean size of prey, seasonal timing and abundance. We suggest a mechanism, involving the match/ mismatch hypothesis(2), by which variability in temperature affects larval cod survival and conclude that rising temperature since the mid- 1980s has modified the plankton ecosystem in a way that reduces the survival of young cod.	Univ Sci & Technol Lille, Stn Marine, CNRS, UMR ELICO 8013, F-62930 Wimereux, France; Sir Alister Hardy Fdn Ocean Sci, The Lab, Plymouth PL1 2PB, Devon, England; ICES, DK-1261 Copenhagen, Denmark	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille	Beaugrand, G (corresponding author), Univ Sci & Technol Lille, Stn Marine, CNRS, UMR ELICO 8013, BP 80, F-62930 Wimereux, France.		Souissi, Sami/C-5146-2018; Brander, Keith/AAN-6278-2021	Souissi, Sami/0000-0002-6720-0096; BEAUGRAND, GREGORY/0000-0002-0712-5223				Beaugrand G, 2003, GLOBAL CHANGE BIOL, V9, P801, DOI 10.1046/j.1365-2486.2003.00632.x; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; BOLLENS SM, 1992, J PLANKTON RES, V14, P1279, DOI 10.1093/plankt/14.9.1279; Brander K, 2000, OCEANOL ACTA, V23, P485, DOI 10.1016/S0399-1784(00)00133-X; Cook RM, 1997, NATURE, V385, P521, DOI 10.1038/385521a0; CUSHING DH, 1984, J CONSEIL, V41, P159; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; CUSHING DH, 1997, SCI RECR FISH POP; Gallego A, 1997, J FISH BIOL, V51, P121, DOI 10.1111/j.1095-8649.1997.tb06096.x; Gotceitas V, 1996, MAR ECOL PROG SER, V130, P29, DOI 10.3354/meps130029; *ICES COOP RES REP, 2001, WORKSH GAD STOCKS N; *ICES COOP RES REP, 2002, REP ICES ADV COMM FI; Letcher BH, 1996, CAN J FISH AQUAT SCI, V53, P787, DOI 10.1139/cjfas-53-4-787; Mauchline, 1998, BIOL CALANOID COPEPO; Mauchline J, 1969, Adv. mar. Biol., V7, P1; Munk P, 1997, J FISH BIOL, V51, P340, DOI 10.1111/j.1095-8649.1997.tb06107.x; Myers RA, 1996, MAR ECOL PROG SER, V138, P293, DOI 10.3354/meps138293; Otterlei E, 1999, CAN J FISH AQUAT SCI, V56, P2099, DOI 10.1139/cjfas-56-11-2099; PEPIN P, 1993, CAN J FISH AQUAT SCI, V50, P2166, DOI 10.1139/f93-242; PETERS H, 1983, BIOL IMPLICATION BOD; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Pope JG, 1996, ICES J MAR SCI, V53, P1157, DOI 10.1006/jmsc.1996.0141; Reid PC, 2001, FISH RES, V50, P163, DOI 10.1016/S0165-7836(00)00249-6; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Rothschild BJ, 1998, J PLANKTON RES, V20, P1721, DOI 10.1093/plankt/20.9.1721; Shepherd JG, 1999, ICES J MAR SCI, V56, P584, DOI 10.1006/jmsc.1999.0498; Swain DP, 2003, FISH RES, V59, P327, DOI 10.1016/S0165-7836(02)00027-9; THORISSON K, 1989, RAP PROCES, V191, P264; VAUTARD R, 1992, PHYSICA D, V58, P95, DOI 10.1016/0167-2789(92)90103-T; WARNER AJ, 1994, PROG OCEANOGR, V34, P237, DOI 10.1016/0079-6611(94)90011-6	30	901	928	7	358	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					661	664		10.1038/nature02164	http://dx.doi.org/10.1038/nature02164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668864				2022-12-24	WOS:000187132800041
J	Loewe, L; Textor, V; Scherer, S				Loewe, L; Textor, V; Scherer, S			High deleterious genomic mutation rate in stationary phase of Escherichia coli	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; ENVIRONMENTAL-STRESS; ADAPTIVE MUTATION; FITNESS; DNA; POPULATIONS; EVOLUTION; BACTERIA; RECOMBINATION; HYPERMUTATION	In natural habitats, bacteria spend most of their time in some form of growth arrest. Little is known about deleterious mutations in such stages, and consequently there is limited understanding of what evolutionary events occur. In a deleterious mutation accumulation experiment in prolonged stationary phase of Escherichia coli, about 0.03 slightly deleterious mutations were observed per genome per day. This is over an order of magnitude higher than extrapolations from fast-growing cells, but in line with inferences from observations in adaptive stationary phase mutation experiments. These findings may affect understanding of bacterial evolution and the emergence of bacterial pathogenicity.	Tech Univ Munich, Dept Biosci, Microbial Ecol Grp, D-85354 Freising Weihenstephan, Germany	Technical University of Munich	Loewe, L (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, Ashworth Labs, Kings Bldg,W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.		Scherer, Siegfried/I-1320-2013	Scherer, Siegfried/0000-0002-0394-9890				Andersson DI, 1996, P NATL ACAD SCI USA, V93, P906, DOI 10.1073/pnas.93.2.906; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Bull HJ, 2000, GENETICS, V156, P925; Bull HJ, 2000, GENETICS, V154, P1427; Bull HJ, 2001, P NATL ACAD SCI USA, V98, P8334, DOI 10.1073/pnas.151009798; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; Domingo E, 2000, VIROLOGY, V270, P251, DOI 10.1006/viro.2000.0320; Drake JW, 1998, GENETICS, V148, P1667; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Finkel SE, 2000, BACTERIAL STRESS RESPONSES, P231; Finkel SE, 1999, P NATL ACAD SCI USA, V96, P4023, DOI 10.1073/pnas.96.7.4023; Funchain P, 2000, GENETICS, V154, P959; Hacker J, 2003, SCIENCE, V301, P790, DOI 10.1126/science.1086802; Keightley PD, 1998, GENETICS, V150, P1283; Keightley PD, 1999, GENETICS, V153, P515; Kibota TT, 1996, NATURE, V381, P694, DOI 10.1038/381694a0; Kivisaar M, 2003, ENVIRON MICROBIOL, V5, P814, DOI 10.1046/j.1462-2920.2003.00488.x; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; MATIN A, 1989, ANNU REV MICROBIOL, V43, P293, DOI 10.1146/annurev.mi.43.100189.001453; Morita RY, 1997, BACTERIA OLIGOTROPHI; MUKAI T, 1964, GENETICS, V50, P1; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Rosche WA, 1999, P NATL ACAD SCI USA, V96, P6862, DOI 10.1073/pnas.96.12.6862; Rosenberg SM, 1998, GENETICS, V148, P1559; RYAN FJ, 1963, J GEN MICROBIOL, V30, P193, DOI 10.1099/00221287-30-2-193; RYAN FJ, 1961, Z VEREBUNGSL, V92, P38, DOI 10.1007/BF01854099; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Szafraniec K, 2001, P NATL ACAD SCI USA, V98, P1107, DOI 10.1073/pnas.021390798; Torkelson J, 1997, EMBO J, V16, P3303, DOI 10.1093/emboj/16.11.3303; Townsend JP, 2003, GENETICS, V164, P13; Yeiser B, 2002, P NATL ACAD SCI USA, V99, P8737, DOI 10.1073/pnas.092269199; Zeyl C, 2001, GENETICS, V157, P53	32	60	62	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1558	1560		10.1126/science.1087911	http://dx.doi.org/10.1126/science.1087911			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645846	Green Submitted			2022-12-24	WOS:000186802200041
J	Sowell, ER; Thompson, PM; Welcome, SE; Henkenius, AL; Toga, AW; Peterson, BS				Sowell, ER; Thompson, PM; Welcome, SE; Henkenius, AL; Toga, AW; Peterson, BS			Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder	LANCET			English	Article							FUNCTIONAL MAGNETIC-RESONANCE; CEREBRAL GLUCOSE-METABOLISM; DEFICIT/HYPERACTIVITY DISORDER; TOURETTE SYNDROME; BRAIN METABOLISM; BLOOD-FLOW; MRI; CORTEX; GIRLS; FMRI	Background Results of structural brain imaging studies of patients with attention-deficit hyperactivity disorder have shown subtle reductions in total brain volume and in volumes of the right frontal lobe and caudate nucleus. Although various conventional volumetric and voxel-based methods of image analysis have been used in these studies, regional brain size and grey-matter abnormalities have not yet been mapped over the entire cortical surface in patients with this disorder. We aimed to map these features in patients with attention-deficit hyperactivity disorder. Methods We used high-resolution MRI and surface-based, computational image analytic techniques to map regional brain size and grey-matter abnormalities at the cortical surface in a group of 27 children and adolescents with attention-deficit hyperactivity disorder and 46 controls, who were group-matched by age and sex. Findings Abnormal morphology was noted in the frontal cortices of patients with attention-deficit hyperactivity disorder, with reduced regional brain size localised mainly to inferior portions of dorsal prefrontal cortices bilaterally. Brain size was also reduced in anterior temporal cortices bilaterally. Prominent increases in grey matter were recorded in large portions of the posterior temporal and inferior parietal cortices bilaterally. Interpretation The frontal, temporal, and parietal regions are heteromodal association cortices that constitute a distributed neural system, which subserves attention and behavioural inhibition. We have identified region-specific anatomical abnormalities in cortical components of attentional systems, which may help better account for the symptoms of attention-deficit hyperactivity disorder.	Univ Calif Los Angeles, Dept Neurol, Lab Neuro Imaging, Los Angeles, CA 90095 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA	University of California System; University of California Los Angeles; Columbia University; New York State Psychiatry Institute	Sowell, ER (corresponding author), Univ Calif Los Angeles, Dept Neurol, Lab Neuro Imaging, 710 Westwood Plaza,Room 4-238, Los Angeles, CA 90095 USA.		Thompson, Paul M/C-4194-2018	Thompson, Paul M/0000-0002-4720-8867	NCRR NIH HHS [P41 RR13642] Funding Source: Medline; NIMH NIH HHS [K01 MH01733, MH01232, MH59239] Funding Source: Medline; NINDS NIH HHS [NS3753] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001232, R01MH059239, K01MH001733] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Psychological Association, 1994, DIAGN STAT MAN MENT, V4th; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P171, DOI 10.1016/S1388-2457(02)00362-0; Baumgardner TL, 1996, NEUROLOGY, V47, P477, DOI 10.1212/WNL.47.2.477; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Castellanos FX, 2001, ARCH GEN PSYCHIAT, V58, P289, DOI 10.1001/archpsyc.58.3.289; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Castellanos FX, 1996, ARCH GEN PSYCHIAT, V53, P607; DUPAUL GJ, 1991, J CLIN CHILD PSYCHOL, V20, P245, DOI 10.1207/s15374424jccp2003_3; Ernst M, 1997, J AM ACAD CHILD PSY, V36, P1399, DOI 10.1097/00004583-199710000-00022; ERNST M, 1994, J AM ACAD CHILD PSY, V33, P858, DOI 10.1097/00004583-199407000-00012; Evans AC, 1996, AUTOMATIC 3D REGIONA; Filipek PA, 1997, NEUROLOGY, V48, P589, DOI 10.1212/WNL.48.3.589; FUSTER JM, 1997, PREFRONTAL CORTEX; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Goldman LS, 1998, JAMA-J AM MED ASSOC, V279, P1100, DOI 10.1001/jama.279.14.1100; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; KANDEL ER, 1991, PRINCIPLES NEURAL SC, P440; Langleben DD, 2001, NUCL MED COMMUN, V22, P1333, DOI 10.1097/00006231-200112000-00009; MacDonald D, 1994, P SOC PHOTO-OPT INS, V2359, P160; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Overmeyer S, 2001, PSYCHOL MED, V31, P1425, DOI 10.1017/S0033291701004706; Peterson BS, 2000, ARCH GEN PSYCHIAT, V57, P364, DOI 10.1001/archpsyc.57.4.364; Peterson BS, 1999, BIOL PSYCHIAT, V45, P1237, DOI 10.1016/S0006-3223(99)00056-6; Peterson BS, 1998, ARCH GEN PSYCHIAT, V55, P326, DOI 10.1001/archpsyc.55.4.326; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; Schweitzer JB, 2000, AM J PSYCHIAT, V157, P278, DOI 10.1176/appi.ajp.157.2.278; Semrud-Clikeman M, 2000, J AM ACAD CHILD PSY, V39, P477, DOI 10.1097/00004583-200004000-00017; Solanto MV, 2002, BEHAV BRAIN RES, V130, P65, DOI 10.1016/S0166-4328(01)00431-4; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sowell ER, 2002, CEREB CORTEX, V12, P17, DOI 10.1093/cercor/12.1.17; Spalletta G, 2001, J NEURAL TRANSM, V108, P1203, DOI 10.1007/s007020170010; Thompson Paul M, 2001, Inf Process Med Imaging, V2082, P488; THOMPSON PM, 2003, P 19 C MED RECH IPSE; Vaidya CJ, 1998, P NATL ACAD SCI USA, V95, P14494, DOI 10.1073/pnas.95.24.14494; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; ZAMETKIN AJ, 1993, ARCH GEN PSYCHIAT, V50, P333; ZAMETKIN AJ, 1990, NEW ENGL J MED, V323, P1361, DOI 10.1056/NEJM199011153232001	43	387	401	1	35	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 22	2003	362	9397					1699	1707		10.1016/S0140-6736(03)14842-8	http://dx.doi.org/10.1016/S0140-6736(03)14842-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	746VE	14643117				2022-12-24	WOS:000186767700007
J	Reinhardt, D; Pesce, ER; Stieger, P; Mandel, T; Baltensperger, K; Bennett, M; Traas, J; Friml, J; Kuhlemeier, C				Reinhardt, D; Pesce, ER; Stieger, P; Mandel, T; Baltensperger, K; Bennett, M; Traas, J; Friml, J; Kuhlemeier, C			Regulation of phyllotaxis by polar auxin transport	NATURE			English	Article							ARABIDOPSIS GENE MONOPTEROS; GNOM ARF-GEF; VASCULAR DEVELOPMENT; PATTERN-FORMATION; EMBRYOGENESIS; LOCALIZATION; MERISTEM; CARRIER; EMBRYO; PIN1	The regular arrangement of leaves around a plant's stem, called phyllotaxis, has for centuries attracted the attention of philosophers, mathematicians and natural scientists; however, to date, studies of phyllotaxis have been largely theoretical. Leaves and flowers are formed from the shoot apical meristem, triggered by the plant hormone auxin. Auxin is transported through plant tissues by specific cellular influx and efflux carrier proteins. Here we show that proteins involved in auxin transport regulate phyllotaxis. Our data indicate that auxin is transported upwards into the meristem through the epidermis and the outermost meristem cell layer. Existing leaf primordia act as sinks, redistributing auxin and creating its heterogeneous distribution in the meristem. Auxin accumulation occurs only at certain minimal distances from existing primordia, defining the position of future primordia. This model for phyllotaxis accounts for its reiterative nature, as well as its regularity and stability.	Univ Bern, Inst Plant Physiol, CH-3013 Bern, Switzerland; Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany; INRA, Biol Cellulaire Lab, F-78026 Versailles, France; Univ Nottingham, Sch Biosci, Nottingham NG7 2RD, England; Univ Bern, Inst Pharmacol, CH-3010 Bern, Switzerland	University of Bern; Eberhard Karls University of Tubingen; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Nottingham; University of Bern	Kuhlemeier, C (corresponding author), Univ Bern, Inst Plant Physiol, Altenbergrain 21, CH-3013 Bern, Switzerland.		Friml, Jiri/D-9511-2012; Traas, Jan/AAZ-7004-2020; Reinhardt, Didier/M-8508-2014; Bennett, Malcolm/G-4004-2010	Friml, Jiri/0000-0002-8302-7596; Traas, Jan/0000-0001-5107-1472; Reinhardt, Didier/0000-0003-3495-6783; Bennett, Malcolm/0000-0003-0475-390X				Aida M, 2002, DEVELOPMENT, V129, P3965; Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Benjamins R, 2001, DEVELOPMENT, V128, P4057; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; BENNETT SRM, 1995, PLANT J, V8, P505, DOI 10.1046/j.1365-313X.1995.8040505.x; Christensen SK, 2000, CELL, V100, P469, DOI 10.1016/S0092-8674(00)80682-0; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Fleming AJ, 1997, SCIENCE, V276, P1415, DOI 10.1126/science.276.5317.1415; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, PLANT MOL BIOL, V49, P273, DOI 10.1023/A:1015248926412; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Green PB, 1996, SEMIN CELL DEV BIOL, V7, P903, DOI 10.1006/scdb.1996.0110; Hadfi K, 1998, DEVELOPMENT, V125, P879; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Jean R., 1994, PHYLLOTAXIS SYSTEMAT; Jurgens G, 2001, EMBO J, V20, P3609, DOI 10.1093/emboj/20.14.3609; Kuhlemeier C, 2001, TRENDS PLANT SCI, V6, P187, DOI 10.1016/S1360-1385(01)01894-5; LIU CM, 1993, PLANT CELL, V5, P621, DOI 10.1105/tpc.5.6.621; Lomax Terri L., 1995, P509; Lynn K, 1999, DEVELOPMENT, V126, P469; Mattsson J, 2003, PLANT PHYSIOL, V131, P1327, DOI 10.1104/pp.013623; Meinhardt H., 1984, Positional controls in plant development, P1; MITCHISON GJ, 1977, SCIENCE, V196, P270, DOI 10.1126/science.196.4287.270; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Parry G, 2001, J PLANT GROWTH REGUL, V20, P217, DOI 10.1007/s003440010030; Przemeck GKH, 1996, PLANTA, V200, P229, DOI 10.1007/BF00208313; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; REINHARDT D, 2002, MERISTEMATIC TISSUES, P172; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; SACHS T, 1981, ADV BOT RES, V9, P151, DOI 10.1016/S0065-2296(08)60351-1; Schoute JC., 1913, RECL TRAV BOT EERL, V10, P153; Schwabe W. W., 1984, Positional controls in plant development, P403; SNOW M, 1962, PHILOS T ROY SOC B, V244, P483, DOI 10.1098/rstb.1962.0003; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Stieger PA, 2002, PLANT J, V32, P509, DOI 10.1046/j.1365-313X.2002.01448.x; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Vernoux T, 2000, DEVELOPMENT, V127, P5157; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N	43	1078	1144	12	247	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2003	426	6964					255	260		10.1038/nature02081	http://dx.doi.org/10.1038/nature02081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628043				2022-12-24	WOS:000186660800035
J	Tootle, TL; Silver, SJ; Davies, EL; Newman, V; Latek, RR; Mills, IA; Selengut, JD; Parlikar, BEW; Rebay, I				Tootle, TL; Silver, SJ; Davies, EL; Newman, V; Latek, RR; Mills, IA; Selengut, JD; Parlikar, BEW; Rebay, I			The transcription factor Eyes absent is a protein tyrosine phosphatase	NATURE			English	Article							P-TYPE ATPASE; SIGNALING PATHWAY; DROSOPHILA; PHOSPHORYLATION; SUPERFAMILY; REVEALS; COMPLEX; DOMAIN; EYA; PERVANADATE	Post-translational modifications provide sensitive and flexible mechanisms to dynamically modulate protein function in response to specific signalling inputs(1). In the case of transcription factors, changes in phosphorylation state can influence protein stability, conformation, subcellular localization, cofactor interactions, transactivation potential and transcriptional output(1). Here we show that the evolutionarily conserved transcription factor Eyes absent (Eya)(2,3) belongs to the phosphatase subgroup of the haloacid dehalogenase (HAD) superfamily(4,5), and propose a function for it as a non-thiol-based protein tyrosine phosphatase. Experiments performed in cultured Drosophila cells and in vitro indicate that Eyes absent has intrinsic protein tyrosine phosphatase activity and can autocatalytically dephosphorylate itself. Confirming the biological significance of this function, mutations that disrupt the phosphatase active site severely compromise the ability of Eyes absent to promote eye specification and development in Drosophila. Given the functional importance of phosphorylation-dependent modulation of transcription factor activity, this evidence for a nuclear transcriptional coactivator with intrinsic phosphatase activity suggests an unanticipated method of fine-tuning transcriptional regulation.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Inst Genom Res, Rockville, MD 20850 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); J. Craig Venter Institute	Rebay, I (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Tootle, Tina/AAE-1220-2019	Tootle, Tina/0000-0002-1515-9538				Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Bonini NM, 1997, DEVELOPMENT, V124, P4819; Bui QT, 2000, GENETICS, V155, P709; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698; Cohen J, 1997, BIOCHEM J, V327, P391, DOI 10.1042/bj3270391; Collet JF, 1999, J BIOL CHEM, V274, P33985, DOI 10.1074/jbc.274.48.33985; Collet JF, 1998, TRENDS BIOCHEM SCI, V23, P284, DOI 10.1016/S0968-0004(98)01252-3; Hsiao FC, 2001, DEV CELL, V1, P51, DOI 10.1016/S1534-5807(01)00011-9; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Ikeda K, 2002, MOL CELL BIOL, V22, P6759, DOI 10.1128/MCB.22.19.6759-6766.2002; IMBERT V, 1994, BIOCHEM J, V297, P163, DOI 10.1042/bj2970163; Kim SS, 2002, STRUCTURE, V10, P787, DOI 10.1016/S0969-2126(02)00769-4; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Ridder IS, 1999, BIOCHEM J, V339, P223, DOI 10.1042/0264-6021:3390223; Ruff SJ, 1997, J BIOL CHEM, V272, P1263, DOI 10.1074/jbc.272.2.1263; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Selengut JD, 2001, BIOCHEMISTRY-US, V40, P12704, DOI 10.1021/bi011405e; Selengut JD, 2000, BIOCHEMISTRY-US, V39, P8315, DOI 10.1021/bi0005052; Silver SJ, 2003, MOL CELL BIOL, V23, P5989, DOI 10.1128/MCB.23.17.5989-5999.2003; Thaller MC, 1998, PROTEIN SCI, V7, P1647, DOI 10.1002/pro.5560070722; Tootle TL, 2003, DEVELOPMENT, V130, P845, DOI 10.1242/dev.00312; Treisman JE, 1999, BIOESSAYS, V21, P843, DOI 10.1002/(SICI)1521-1878(199910)21:10<843::AID-BIES6>3.3.CO;2-A; Wawersik S, 2000, HUM MOL GENET, V9, P917, DOI 10.1093/hmg/9.6.917	28	202	213	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2003	426	6964					299	302		10.1038/nature02097	http://dx.doi.org/10.1038/nature02097			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628053				2022-12-24	WOS:000186660800046
J	Neuman, KC; Abbondanzieri, EA; Landick, R; Gelles, J; Block, SM				Neuman, KC; Abbondanzieri, EA; Landick, R; Gelles, J; Block, SM			Ubiquitous transcriptional pausing is independent of RNA polymerase backtracking	CELL			English	Article							ESCHERICHIA-COLI; SINGLE-MOLECULE; CHAIN ELONGATION; STRUCTURAL BASIS; DNA-POLYMERASE; II ELONGATION; TERMINATION; MECHANISM; COMPLEX; ARREST	RNA polymerase (RNAP) transcribes DNA discontinuously, with periods of rapid nucleotide addition punctuated by frequent pauses. We investigated the mechanism of transcription by measuring the effect of both hindering and assisting forces on the translocation of single Escherichia coli transcription elongation complexes, using an optical trapping apparatus that allows for the detection of pauses as short as one second. We found that the vast majority of pauses are brief (1-6 s at 21degreesC, 1 mM NTPs), and that the probability of pausing at any particular position on a DNA template is low and fairly constant. Neither the probability nor the duration of these ubiquitous pauses was affected by hindering or assisting loads, establishing that they do not result from the backtracking of RNAP along the DNA template. We propose instead that they are caused by a structural rearrangement within the enzyme.	Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Stanford University; Stanford University; University of Wisconsin System; University of Wisconsin Madison; Brandeis University	Block, SM (corresponding author), Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA.	sblock@stanford.edu	Neuman, Keir C./F-7400-2011	Neuman, Keir C./0000-0002-0863-5671	NIGMS NIH HHS [R01 GM057035-08] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057035] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adelman K, 2002, P NATL ACAD SCI USA, V99, P13538, DOI 10.1073/pnas.212358999; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; CHAMBERLIN MJ, 1994, HARVEY LECT, V88, P1992; Chan CL, 1997, J MOL BIOL, V268, P37, DOI 10.1006/jmbi.1997.0934; CHAN CL, 1994, TRANSCRIPTION MECHAN, P297; Darst SA, 2002, P NATL ACAD SCI USA, V99, P4296, DOI 10.1073/pnas.052054099; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; Erie DA, 2002, BBA-GENE STRUCT EXPR, V1577, P224, DOI 10.1016/S0167-4781(02)00454-2; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; ERIE DA, 1992, ANNU REV BIOPH BIOM, V21, P379, DOI 10.1146/annurev.bb.21.060192.002115; Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799; Foster JE, 2001, CELL, V106, P243, DOI 10.1016/S0092-8674(01)00420-2; Fu JH, 1999, CELL, V98, P799, DOI 10.1016/S0092-8674(00)81514-7; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Holmes SF, 2003, J BIOL CHEM, V278, P35597, DOI 10.1074/jbc.M304496200; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; KASSAVETIS GA, 1981, J BIOL CHEM, V256, P2777; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Landick R, 1997, CELL, V88, P741, DOI 10.1016/S0092-8674(00)81919-4; Landick R, 2001, CELL, V105, P567, DOI 10.1016/S0092-8674(01)00381-6; LANDICK R, 1985, P NATL ACAD SCI USA, V82, P4663, DOI 10.1073/pnas.82.14.4663; LANDICK R, 1987, ESCHERICHIA COLI SAL, P1276; LEVIN JR, 1987, J MOL BIOL, V196, P61, DOI 10.1016/0022-2836(87)90511-0; Lyakhov DL, 1998, J MOL BIOL, V280, P201, DOI 10.1006/jmbi.1998.1854; Maier B, 2000, P NATL ACAD SCI USA, V97, P12002, DOI 10.1073/pnas.97.22.12002; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; Marr MT, 2000, MOL CELL, V6, P1275, DOI 10.1016/S1097-2765(00)00126-X; MATSUZAKI H, 1994, J MOL BIOL, V235, P1173, DOI 10.1006/jmbi.1994.1072; MCDOWELL JC, 1994, SCIENCE, V266, P822, DOI 10.1126/science.7526463; Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Press WH., 1992, NUMERICAL RECIPES C; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; REISBIG RR, 1981, BIOCHEMISTRY-US, V20, P1907, DOI 10.1021/bi00510a029; Richardson J. P., 1996, ESCHERICHIA COLI SAL, P822; Roberts JW, 1998, COLD SPRING HARB SYM, V63, P319, DOI 10.1101/sqb.1998.63.319; Santangelo TJ, 2003, GENE DEV, V17, P1281, DOI 10.1101/gad.1082103; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; Sokal Robert R., 1969, BIOMETRY; THEISSEN G, 1990, ANAL BIOCHEM, V189, P254, DOI 10.1016/0003-2697(90)90117-R; Tinoco I, 2002, BIOPHYS CHEM, V101, P513, DOI 10.1016/S0301-4622(02)00177-1; Toulme F, 1999, EMBO J, V18, P5052, DOI 10.1093/emboj/18.18.5052; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; WANG DG, 1995, CELL, V81, P341, DOI 10.1016/0092-8674(95)90387-9; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; Weisberg RA, 1999, J BACTERIOL, V181, P359, DOI 10.1128/JB.181.2.359-367.1999; WINKLER ME, 1981, BIOCHEMISTRY-US, V20, P3738, DOI 10.1021/bi00516a011; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; XUE QF, 1995, NATURE, V373, P681, DOI 10.1038/373681a0; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653; Yin H, 1999, P NATL ACAD SCI USA, V96, P13124, DOI 10.1073/pnas.96.23.13124; YIN H, 1994, BIOPHYS J, V67, P2468, DOI 10.1016/S0006-3495(94)80735-0; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhuang XW, 2002, SCIENCE, V296, P1473, DOI 10.1126/science.1069013; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	64	258	265	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2003	115	4					437	447		10.1016/S0092-8674(03)00845-6	http://dx.doi.org/10.1016/S0092-8674(03)00845-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	744KB	14622598	Bronze			2022-12-24	WOS:000186627100010
J	Kitano, H				Kitano, H			Cancer robustness - Tumour tactics	NATURE			English	Editorial Material							SYSTEMS		Sony Comp Sci Labs Inc, Shinagawa Ku, Tokyo 1410022, Japan	Sony Corporation	Kitano, H (corresponding author), Sony Comp Sci Labs Inc, Shinagawa Ku, 3-14-13 Higashi Gotanda, Tokyo 1410022, Japan.							Carlson JM, 2000, PHYS REV LETT, V84, P2529, DOI 10.1103/PhysRevLett.84.2529; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537	3	107	114	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2003	426	6963					125	125		10.1038/426125a	http://dx.doi.org/10.1038/426125a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614483	Bronze			2022-12-24	WOS:000186517200021
J	Waren, A; Bengtson, S; Goffredi, SK; Van Dover, CL				Waren, A; Bengtson, S; Goffredi, SK; Van Dover, CL			A hot-vent gastropod with iron sulfide dermal sclerites	SCIENCE			English	Article							OCEAN		Swedish Museum Nat Hist, SE-10405 Stockholm, Sweden; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA	Swedish Museum of Natural History; Monterey Bay Aquarium Research Institute; William & Mary	Waren, A (corresponding author), Swedish Museum Nat Hist, Box 50007, SE-10405 Stockholm, Sweden.			Bengtson, Stefan/0000-0003-0206-5791; Van Dover, Cindy/0000-0001-9845-8391				Elderfield H, 1996, ANNU REV EARTH PL SC, V24, P191, DOI 10.1146/annurev.earth.24.1.191; Ip YK, 1997, J COMP PHYSIOL B, V167, P213, DOI 10.1007/s003600050067; Lowenstam HA, 1989, BIOMINERALIZATION; Van Dover CL, 2001, SCIENCE, V294, P818, DOI 10.1126/science.1064574; Waren A, 2001, VELIGER, V44, P116; YI Q, 1989, FOSSILS STRATA, V24, P1; Zbinden M, 2003, DEEP-SEA RES PT I, V50, P269, DOI 10.1016/S0967-0637(02)00161-9	7	82	87	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2003	302	5647					1007	1007		10.1126/science.1087696	http://dx.doi.org/10.1126/science.1087696			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605361				2022-12-24	WOS:000186396300036
J	Muller, W; Fricke, H; Halliday, AN; McCulloch, MT; Wartho, JA				Muller, W; Fricke, H; Halliday, AN; McCulloch, MT; Wartho, JA			Origin and migration of the Alpine Iceman	SCIENCE			English	Article							ISOTOPES; CLIMATE; VALLEY	The Alpine Iceman provides a unique window into the Neolithic-Copper Age of Europe. We compared the radiogenic (strontium and lead) and stable (oxygen and carbon) isotope composition of the Iceman's teeth and bones, as well as Ar-40/Ar-39 mica ages from his intestine, to local geology and hydrology, and we inferred his habitat and range from childhood to adult life. The Iceman's origin can be restricted to a few valleys within similar to60 kilometers south(east) of the discovery site. His migration during adulthood is indicated by contrasting isotopic compositions of enamel, bones, and intestinal content. This demonstrates that the Alpine valleys of central Europe were permanently inhabited during the terminal Neolithic.	Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Colorado Coll, Dept Geol, Colorado Springs, CO 80903 USA; ETH, Dept Earth Sci, CH-8092 Zurich, Switzerland; Curtin Univ Technol, Dept Appl Geol, Perth, WA 6845, Australia	Australian National University; Colorado College; Swiss Federal Institutes of Technology Domain; ETH Zurich; Curtin University	Muller, W (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia.	wolfgang.mueller@anu.edu.au	McCulloch, Malcolm T/C-3651-2009; Wartho, Jo-Anne/B-5169-2016	McCulloch, Malcolm T/0000-0003-1538-1558; Muller, Wolfgang/0000-0001-5368-8011				Bereuter TL, 1997, CHEM-EUR J, V3, P1032, DOI 10.1002/chem.19970030708; Budd P, 2001, ROY SOC CH, P311, DOI 10.1039/9781847551696-00311; DICKSON JH, 1996, P R SOC LONDON B, V263; FLECKINGER A, 1999, FASCINATION NEOLITHI; GABER O, 1999, GLETSCHERMUMIE KUPFE, V1, P39; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; Hoogewerff J, 2001, J ARCHAEOL SCI, V28, P983, DOI 10.1006/jasc.2001.0659; HORN P, COMMUNICATION; Humer G., 1995, NIEDERSCHLAGSISOTOPE, V52; Kralik C, 1996, MAN IN ICE, V3, P283; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; Longinelli A, 2003, J HYDROL, V270, P75; McDermott F, 1999, QUATERNARY SCI REV, V18, P1021, DOI 10.1016/S0277-3791(98)00107-3; Oeggl K, 2000, MAN IN ICE, V4, P163; Oeggl K, 2000, MAN IN ICE, V4, P89; PATE FD, 1994, J ARCHAEOL METHOD TH, V1, P161, DOI DOI 10.1007/BF02231415; PRINOTHFORNWAGNER R, 1994, NUCL INSTRUM METH B, V92, P282, DOI 10.1016/0168-583X(94)96020-8; ROZANSKI K, 1993, CLIMATE CHANGE CONTI; SEIDLER H, 1992, SCIENCE, V258, P455, DOI 10.1126/science.1411539; Sillen A, 1998, GEOCHIM COSMOCHIM AC, V62, P2463, DOI 10.1016/S0016-7037(98)00182-3; Spindler K., 1994, MAN ICE PRESERVED BO; Spotl C, 2002, J SEDIMENT RES, V72, P793, DOI 10.1306/041102720793; THOMAS MG, 2001, IC 2001 BOZ BOLZ IT; Thoni M, 1999, SCHWEIZ MINER PETROG, V79, P209; VANWAES HJM, 2001, KINDERZAHNMEDIZIN FA, V17; WINIGER J, 1998, BR ARCHAEOL REP INT, V701, P246	26	165	167	3	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2003	302	5646					862	866		10.1126/science.1089837	http://dx.doi.org/10.1126/science.1089837			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593178				2022-12-24	WOS:000186258000048
J	Hoang, QQ; Sicheri, F; Howard, AJ; Yang, DSC				Hoang, QQ; Sicheri, F; Howard, AJ; Yang, DSC			Bone recognition mechanism of porcine osteocalcin from crystal structure	NATURE			English	Article							GAMMA-CARBOXYGLUTAMIC ACID; PROTEIN	Osteocalcin is the most abundant noncollagenous protein in bone(1), and its concentration in serum is closely linked to bone metabolism and serves as a biological marker for the clinical assessment of bone disease(2). Although its precise mechanism of action is unclear, osteocalcin influences bone mineralization(3,4), in part through its ability to bind with high affinity to the mineral component of bone, hydroxyapatite(5). In addition to binding to hydroxyapatite, osteocalcin functions in cell signalling and the recruitment of osteoclasts(6) and osteoblasts(7), which have active roles in bone resorption and deposition, respectively. Here we present the X-ray crystal structure of porcine osteocalcin at 2.0 Angstrom resolution, which reveals a negatively charged protein surface that coordinates five calcium ions in a spatial orientation that is complementary to calcium ions in a hydroxyapatite crystal lattice. On the basis of our findings, we propose a model of osteocalcin binding to hydroxyapatite and draw parallels with other proteins that engage crystal lattices.	McMaster Univ, Fac Hlth Sci, Dept Biochem, Hamilton, ON L8N 3Z5, Canada; Microstar Biotech Inc, Flamborough, ON L9H 7H9, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; IIT, Dept Biol Chem & Phys Sci, Chicago, IL 60616 USA	McMaster University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Illinois Institute of Technology	Yang, DSC (corresponding author), McMaster Univ, Fac Hlth Sci, Dept Biochem, Hamilton, ON L8N 3Z5, Canada.	yang@mcmaster.ca	ID, IMCACAT/D-5867-2014; Sicheri, Frank/F-8856-2013					ATKINSON RA, 1995, EUR J BIOCHEM, V232, P515, DOI 10.1111/j.1432-1033.1995.515zz.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bodine PVN, 1999, BONE, V25, P535, DOI 10.1016/S8756-3282(99)00213-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calvo MS, 1996, ENDOCR REV, V17, P333, DOI 10.1210/er.17.4.333; CHENU C, 1994, J CELL BIOL, V127, P1149, DOI 10.1083/jcb.127.4.1149; COLOMBO G, 1993, J BONE MINER RES, V8, P733; Davies PL, 2002, PHILOS T R SOC B, V357, P927, DOI 10.1098/rstb.2002.1081; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dowd TL, 2003, BIOCHEMISTRY-US, V42, P7769, DOI 10.1021/bi034470s; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Eppell SJ, 2001, J ORTHOPAED RES, V19, P1027, DOI 10.1016/S0736-0266(01)00034-1; HAUSCHKA PV, 1978, DEV BIOL, V65, P426, DOI 10.1016/0012-1606(78)90038-6; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; HOHM L, 1993, J MOL BIOL, V233, P123; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0; Klein C., 1999, MANUAL MINERALOGY, V21st; Laue TM, 1992, BIOCH POLYM SCI; MUNDY GR, 1983, CALCIFIED TISSUE INT, V35, P164, DOI 10.1007/BF02405025; ONUMA K, 1995, J CRYST GROWTH, V154, P118, DOI 10.1016/0022-0248(95)00201-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PASTOUREAU P, 1993, J BONE MINER RES, V8, P1417; POSER JW, 1979, J BIOL CHEM, V254, P431; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Yang DSC, 1998, BIOPHYS J, V74, P2142, DOI 10.1016/S0006-3495(98)77923-8; Ziv V, 1996, BONE, V18, P417, DOI 10.1016/8756-3282(96)00049-X	30	406	420	5	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2003	425	6961					977	980		10.1038/nature02079	http://dx.doi.org/10.1038/nature02079			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14586470				2022-12-24	WOS:000186230600045
J	Hanczyc, MM; Fujikawa, SM; Szostak, JW				Hanczyc, MM; Fujikawa, SM; Szostak, JW			Experimental models of primitive cellular compartments: Encapsulation, growth, and division	SCIENCE			English	Article							MURCHISON CARBONACEOUS CHONDRITE; LARGE UNILAMELLAR VESICLES; FATTY-ACID MEMBRANES; MONTMORILLONITE CATALYSIS; SIZE DISTRIBUTION; EXTRUSION; SURFACE; RNA; POLYMERIZATION; COMPONENTS	The clay montmorillonite is known to catalyze the polymerization of RNA from activated ribonucleotides. Here we report that montmorillonite accelerates the spontaneous conversion of fatty acid micelles into vesicles. Clay particles often become encapsulated in these vesicles, thus providing a pathway for the prebiotic encapsulation of catalytically active surfaces within membrane vesicles. In addition, RNA adsorbed to clay can be encapsulated within vesicles. Once formed, such vesicles can grow by incorporating fatty acid supplied as micelles and can divide without dilution of their contents by extrusion through small pores. These processes mediate vesicle replication through cycles of growth and division. The formation, growth, and division of the earliest cells may have occurred in response to similar interactions with mineral particles and inputs of material and energy.	Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.			Hanczyc, Martin/0000-0002-5453-2139	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Apel CL, 2002, BBA-BIOMEMBRANES, V1559, P1, DOI 10.1016/S0005-2736(01)00400-X; Aranda-Espinoza H, 1999, SCIENCE, V285, P394, DOI 10.1126/science.285.5426.394; Berclaz N, 2001, J PHYS CHEM B, V105, P1056, DOI 10.1021/jp001298i; Blochliger E, 1998, J PHYS CHEM B, V102, P10383, DOI 10.1021/jp981234w; CLERC SG, 1994, BIOPHYS J, V67, P475, DOI 10.1016/S0006-3495(94)80503-X; DEAMER DW, 1985, NATURE, V317, P792, DOI 10.1038/317792a0; DEAMER DW, 1989, ORIGINS LIFE EVOL B, V19, P21, DOI 10.1007/BF01808285; Dworkin JP, 2001, P NATL ACAD SCI USA, V98, P815, DOI 10.1073/pnas.98.3.815; Ertem G, 1997, J AM CHEM SOC, V119, P7197, DOI 10.1021/ja970422h; FERRIS JP, 1993, J AM CHEM SOC, V115, P12270, DOI 10.1021/ja00079a006; FERRIS JP, 1992, SCIENCE, V257, P1387, DOI 10.1126/science.1529338; Franchi M, 2003, ORIGINS LIFE EVOL B, V33, P1, DOI 10.1023/A:1023982008714; Frisken BJ, 2000, LANGMUIR, V16, P928, DOI 10.1021/la9905113; GEBICKI JM, 1973, NATURE, V243, P232, DOI 10.1038/243232a0; GEBICKI JM, 1976, CHEM PHYS LIPIDS, V16, P142, DOI 10.1016/0009-3084(76)90006-2; HAINES TH, 1983, P NATL ACAD SCI-BIOL, V80, P160, DOI 10.1073/pnas.80.1.160; HARGREAVES WR, 1978, BIOCHEMISTRY-US, V17, P3759, DOI 10.1021/bi00611a014; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Hunter DG, 1998, BIOPHYS J, V74, P2996, DOI 10.1016/S0006-3495(98)78006-3; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Korgel BA, 1998, BIOPHYS J, V74, P3264, DOI 10.1016/S0006-3495(98)78033-6; Malinin VS, 2001, BIOCHEMISTRY-US, V40, P8292, DOI 10.1021/bi010570r; MAYER L, 1986, BIOCHIM BIOPHYS ACTA, V858, P61; McCollom TM, 1999, ORIGINS LIFE EVOL B, V29, P153, DOI 10.1023/A:1006592502746; Monnard PA, 2002, ASTROBIOLOGY, V2, P139, DOI 10.1089/15311070260192237; MUI BLS, 1995, BIOPHYS J, V69, P930, DOI 10.1016/S0006-3495(95)79967-2; NAYER R, 1989, BIOCHIM BIOPHYS ACTA, V986, P200; Ramos L, 1999, SCIENCE, V286, P2325, DOI 10.1126/science.286.5448.2325; Rushdi AI, 2001, ORIGINS LIFE EVOL B, V31, P103, DOI 10.1023/A:1006702503954; SMITH R, 1973, P NATL ACAD SCI USA, V70, P289, DOI 10.1073/pnas.70.2.289; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Traikia M, 2002, BIOPHYS J, V83, P1443, DOI 10.1016/S0006-3495(02)73915-5; WALDE P, 1994, J AM CHEM SOC, V116, P11649, DOI 10.1021/ja00105a004	34	576	593	11	215	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					618	622		10.1126/science.1089904	http://dx.doi.org/10.1126/science.1089904			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576428	Green Accepted			2022-12-24	WOS:000186119900051
J	King, MC; Marks, JH; Mandell, JB				King, MC; Marks, JH; Mandell, JB		New York Breast Canc Study Grp	Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2	SCIENCE			English	Article							ASHKENAZI JEWISH CARRIERS; FAMILY-HISTORY; PENETRANCE; WOMEN; PREVALENCE; FREQUENCY; SERIES; OOPHORECTOMY; INDIVIDUALS; MASTECTOMY	Risks of breast and ovarian cancer were determined for Ashkenazi Jewish women with inherited mutations in the tumor suppressor genes BRCA1 and BRCA2. We selected 1008 index cases, regardless of family history of cancer, and carried out molecular analysis across entire families. The lifetime risk of breast cancer among female mutation carriers was 82%, similar to risks in families with many cases. Risks appear to be increasing with time: Breast cancer risk by age 50 among mutation carriers born before 1940 was 24%, but among those born after 1940 it was 67%. Lifetime risks of ovarian cancer were 54% for BRCA1 and 23% for BRCA2 mutation carriers. Physical exercise and lack of obesity in adolescence were associated with significantly delayed breast cancer onset.	Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Sarah Lawrence Coll, Grad Program Human Genet, Bronxville, NY 10708 USA; Albert Einstein Coll Med, Montefiore Med Ctr, Bronx, NY USA; Beth Israel Med Ctr, New York, NY 10003 USA; Columbia Univ, Columbia Presbyterian Med Ctr, New York, NY 10027 USA; Englewood Hosp & Med Ctr, Englewood, NJ 07631 USA; Greenwich Hosp, Yale Canc Ctr, Greenwich, CT 06830 USA; Hackensack Univ, Med Ctr, Hackensack, NJ 07601 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; NYU, Med Ctr, New York, NY 10016 USA; N Shore Univ Hosp, Manhasset, NY 11030 USA; Stamford Hosp, Bennett Canc Ctr, Stamford, CT 06902 USA; Strang Canc Prevent Ctr, New York, NY USA; Univ Washington, Seattle, WA 98195 USA; White Plains Hosp Ctr, White Plains, NY 10601 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Sarah Lawrence College; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Columbia University; NewYork-Presbyterian Hospital; Englewood Hospital & Medical Center; Hackensack University Medical Center; Memorial Sloan Kettering Cancer Center; New York University; Northwell Health; North Shore University Hospital; Stamford Hospital; University of Washington; University of Washington Seattle	King, MC (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.			Walsh, Tom/0000-0002-8875-0310; Norton, Larry/0000-0003-3701-9250; Robson, Mark/0000-0002-3109-1692; King, Mary-Claire/0000-0001-9426-1743				Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Begg CB, 2002, J NATL CANCER I, V94, P1221; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; Carpenter CL, 2003, INT J CANCER, V106, P96, DOI 10.1002/ijc.11186; Colditz GA, 1996, J NATL CANCER I, V88, P365, DOI 10.1093/jnci/88.6.365; Fodor FH, 1998, AM J HUM GENET, V63, P45, DOI 10.1086/301903; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Foulkes WD, 2002, J MED GENET, V39, P407, DOI 10.1136/jmg.39.6.407; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Hartmann LC, 2001, JNCI-J NATL CANCER I, V93, P1633, DOI 10.1093/jnci/93.21.1633; Hopper JL, 1999, CANCER EPIDEM BIOMAR, V8, P741; Kalbfleisch JD, 1980, STAT ANAL FAILURE TI; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; LevyLahad E, 1997, AM J HUM GENET, V60, P1059; Meijers-Heijboer H, 2001, NEW ENGL J MED, V345, P159, DOI 10.1056/NEJM200107193450301; Narod SA, 2002, NAT REV CANCER, V2, P113, DOI 10.1038/nrc726; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Ries LA, 2002, SEER CANC STAT REV 1; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Satagopan JM, 2002, CLIN CANCER RES, V8, P3776; Satagopan JM, 2001, CANCER EPIDEM BIOMAR, V10, P467; Scheuer L, 2002, J CLIN ONCOL, V20, P1260, DOI 10.1200/JCO.2002.20.5.1260; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Thorlacius S, 1998, LANCET, V352, P1337, DOI 10.1016/S0140-6736(98)03300-5; Warner E, 1999, J NATL CANCER I, V91, P1241, DOI 10.1093/jnci/91.14.1241	27	1590	1648	2	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					643	646		10.1126/science.1088759	http://dx.doi.org/10.1126/science.1088759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576434				2022-12-24	WOS:000186119900059
J	Chitnis, V; Chitnis, S; Patil, S; Chitnis, D				Chitnis, V; Chitnis, S; Patil, S; Chitnis, D			Solar disinfection of infectious biomedical waste: a new approach for developing countries	LANCET			English	Article							DRINKING-WATER	Poor developing countries cannot afford expensive technologies such as incineration for management of infectious biomedical waste. We assessed solar heating as an alternative technology. We immersed simulated infectious waste with added challenge bacteria in water in a box-type solar cooker, which was left in the sun for 6 h. In 24 sets of observations, the amount of viable bacteria was reduced by about 7 log. We also tested infectious medical waste with a heavy load of bacteria (10(8)-10(9)/g) from our hospital's burn U nit for solar heat disinfection in 20 experiments. Our results showed a similar 7 log reduction in the amount of viable bacteria. Solar heating thus seems to be a cheap method to disinfect infectious medical waste in less economically developed countries.	Choithram Hosp & Res Ctr, Dept Microbiol, Indore 452001, Madhya Pradesh, India; Devi Ahilya Vishwavidyalaya, Sch Life Sci, Dept Microbiol, Indore, Madhya Pradesh, India	Devi Ahilya University	Chitnis, V (corresponding author), Choithram Hosp & Res Ctr, Dept Microbiol & Immunol, Indore 452001, Madhya Pradesh, India.							Conroy RM, 1996, LANCET, V348, P1695, DOI 10.1016/S0140-6736(96)02309-4; GRAHAM W, 1983, TOPLEY WILSONS PRINC, P70; Reed RH, 2000, LETT APPL MICROBIOL, V30, P432, DOI [10.1046/j.1472-765x.2000.00741.x, 10.1046/j.1472-765X.2000.00741.x]; Rijal GK, 2001, WATER SCI TECHNOL, V43, P155, DOI 10.2166/wst.2001.0728; *UNICEF REG OFF MI, 1984, SOL DIS DRINK WAT OR	5	10	10	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 18	2003	362	9392					1285	1286		10.1016/S0140-6736(03)14610-7	http://dx.doi.org/10.1016/S0140-6736(03)14610-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734CD	14575975				2022-12-24	WOS:000186036900014
J	Si, K; Lindquist, S; Kandel, ER				Si, K; Lindquist, S; Kandel, ER			A neuronal isoform of the Aplysia CPEB has prion-like properties	CELL			English	Article							CHAPERONE PROTEIN HSP104; YEAST SUP35 PROTEIN; CYTOPLASMIC POLYADENYLATION; SACCHAROMYCES-CEREVISIAE; OOCYTE MATURATION; MESSENGER-RNA; URE3 PRION; PSI+ PRION; IN-VITRO; PROPAGATION	Prion proteins have the unusual capacity to fold into two functionally distinct conformations, one of which is self-perpetuating. When yeast prion proteins switch state, they produce heritable phenotypes. We report prion-like properties in a neuronal member of the CPEB family (cytoplasmic polyadenylation element binding protein), which regulates mRNA translation. Compared to other CPEB family members, the neuronal protein has an N-terminal extension that shares characteristics of yeast prion-determinants: a high glutamine content and predicted conformational flexibility. When fused to a reporter protein in yeast, this region confers upon it the epigenetic changes in state that characterize yeast prions. Full-length CPEB undergoes similar changes, but surprisingly it is the dominant, self-perpetuating prion-like form that has the greatest capacity to stimulate translation of CPEB-regulated mRNA. We hypothesize that conversion of CPEB to a prion-like state in stimulated synapses helps to maintain long-term synaptic changes associated with memory storage.	New York State Psychiat Inst & Hosp, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; New York State Psychiatry Institute; New York State Psychiatry Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Si, K (corresponding author), New York State Psychiat Inst & Hosp, Coll Phys & Surg, Howard Hughes Med Inst, 722 W 168th St, New York, NY 10032 USA.	ks560@columbia.edu; erk5@columbia.edu						CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; Crist CG, 2003, GENES CELLS, V8, P603, DOI 10.1046/j.1365-2443.2003.00661.x; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Dichtl B, 2002, EMBO J, V21, P4125, DOI 10.1093/emboj/cdf390; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Hake LE, 1998, MOL CELL BIOL, V18, P685, DOI 10.1128/MCB.18.2.685; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; Lindquist S, 1997, CELL, V89, P495, DOI 10.1016/S0092-8674(00)80231-7; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Roberts BT, 2003, GENE DEV, V17, P2083, DOI 10.1101/gad.1115803; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Stumpf G, 1996, SCIENCE, V274, P1517, DOI 10.1126/science.274.5292.1517; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Tuite MF, 2000, CELL, V100, P289, DOI 10.1016/S0092-8674(00)80663-7; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 1996, CURR TOP MICROBIOL, V207, P147	38	435	448	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2003	115	7					879	891		10.1016/S0092-8674(03)01020-1	http://dx.doi.org/10.1016/S0092-8674(03)01020-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	758RV	14697205	Bronze			2022-12-24	WOS:000187664700011
J	Meyers, CD; Carr, MC; Park, S; Brunzell, JD				Meyers, CD; Carr, MC; Park, S; Brunzell, JD			Varying cost and free nicotinic acid content in over-the-counter niacin preparations for dyslipidemia	ANNALS OF INTERNAL MEDICINE			English	Article							SUSTAINED-RELEASE NIACIN; FULMINANT HEPATIC-FAILURE; CORONARY-ARTERY-DISEASE; LIPOPROTEIN LP(A); SERUM-CHOLESTEROL; MESO-INOSITOL; EFFICACY; SAFETY; THERAPY; NIASPAN	Background: Nicotinic acid is an effective treatment for dyslipidemia, but the content of over-the-counter niacin is not federally regulated. As a result, patients may use preparations of over-the-counter niacin that do not contain free nicotinic acid. Objective: To characterize the types, costs, and free nicotinic acid content of over-the-counter niacin preparations and to review literature on the use of over-the-counter niacin for dyslipidemia. Data Sources: Commonly used over-the-counter niacin preparations (500-mg tablets or capsules) from the 3 categories of immediate-release, sustained-release, and no-flush were purchased at health food stores and pharmacies and from Internet-based vitamin companies. Pertinent literature on the use of over-the-counter niacin was obtained by. searching PubMed. Measurements: For each preparation studied, the monthly cost of therapy (at 2000 mg/d) and the free nicotinic acid content (quantified by high-performance liquid chromatography) were reported. Data Synthesis: On average, immediate-release niacin preparations cost $7.10 per month, sustained-release preparations cost $9.75 per month, and no-flush preparations cost $21.70 per month. The average content of free nicotinic acid was 520.4 mg for immediate-release niacin, 502.6 mg for sustained-release niacin, and 0 for no-flush niacin. Conclusions: No-flush preparations of over-the-counter niacin contain no free nicotinic acid and should not be used to treat dyslipidemia. Over-the-counter sustained-release niacin contains free nicotinic acid, but some brands are hepatotoxic. Immediate-release niacin contains free nicotinic acid and is the least expensive form of over-the-counter niacin.	Univ Washington, Sch Med, Seattle, WA USA	University of Washington; University of Washington Seattle	Meyers, CD (corresponding author), Vet Affairs Med Ctr, 5901 E 7th St 11-111I, Long Beach, CA 90822 USA.	daniel.meyers@med.va.gov			NCRR NIH HHS [K23 RR16067] Funding Source: Medline; NHLBI NIH HHS [HL30086] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016067] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030086] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABOUELENEIN AM, 1983, NUTR REP INT, V28, P899; AGUSTI R, 1978, REV INVEST CLIN, V30, P327; ALDERMAN JD, 1989, AM J CARDIOL, V64, P725, DOI 10.1016/0002-9149(89)90754-6; ALTSCHUL R, 1955, ARCH BIOCHEM BIOPHYS, V54, P558, DOI 10.1016/0003-9861(55)90070-9; Altschul R, 1964, NIACIN VASCULAR DISO; [Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; Aronov DM, 1996, ARCH FAM MED, V5, P567, DOI 10.1001/archfami.5.10.567; Azen SP, 1996, CIRCULATION, V93, P34, DOI 10.1161/01.CIR.93.1.34; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; BROWN G, 1990, NEW ENGL J MED, V323, P1289, DOI 10.1056/NEJM199011083231901; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; Capuzzi D M, 2000, Curr Atheroscler Rep, V2, P64, DOI 10.1007/s11883-000-0096-y; Capuzzi DM, 1998, AM J CARDIOL, V82, p74U, DOI 10.1016/S0002-9149(98)00731-0; CARLSON LA, 1989, J INTERN MED, V226, P271, DOI 10.1111/j.1365-2796.1989.tb01393.x; CARLSON LA, 1968, ACTA MED SCAND, V183, P423; Chojnowska-Jezierska J, 1998, INT J CLIN PHARM TH, V36, P326; Cohn G, 2001, Curr Cardiol Rep, V3, P416; DALTON TA, 1992, AM J MED, V93, P102, DOI 10.1016/0002-9343(92)90689-9; Elam MB, 2000, JAMA-J AM MED ASSOC, V284, P1263, DOI 10.1001/jama.284.10.1263; ETCHASON JA, 1991, MAYO CLIN PROC, V66, P23, DOI 10.1016/S0025-6196(12)61171-9; FISCHER DJ, 1991, WESTERN J MED, V155, P410; GAUT ZN, 1971, METABOLISM, V20, P1031, DOI 10.1016/0026-0495(71)90026-6; GIBBONS LW, 1995, AM J MED, V99, P378, DOI 10.1016/S0002-9343(99)80185-5; GRAY DR, 1994, ANN INTERN MED, V121, P252, DOI 10.7326/0003-4819-121-4-199408150-00003; Grundy SM, 2002, ARCH INTERN MED, V162, P1568, DOI 10.1001/archinte.162.14.1568; GURAKAR A, 1985, ATHEROSCLEROSIS, V57, P293, DOI 10.1016/0021-9150(85)90041-3; HARTHON J G, 1964, Arzneimittelforschung, V14, P1170; HARTHON L, 1979, ARZNEIMITTEL-FORSCH, V29-2, P1859; HENKIN Y, 1991, AM J MED, V91, P239, DOI 10.1016/0002-9343(91)90122-E; *I MED US STAND CO, 2000, PAN FOL OTH B VIT CH; KAHN SE, 1989, DIABETES, V38, P562, DOI 10.2337/diabetes.38.5.562; KEENAN JM, 1991, ARCH INTERN MED, V151, P1424, DOI 10.1001/archinte.151.7.1424; Knopp RH, 1998, METABOLISM, V47, P1097, DOI 10.1016/S0026-0495(98)90284-0; KNOPP RH, 1985, METABOLISM, V34, P642, DOI 10.1016/0026-0495(85)90092-7; KRUSE W, 1979, EUR J CLIN PHARMACOL, V16, P11, DOI 10.1007/BF00644960; MCKENNEY JM, 1994, JAMA-J AM MED ASSOC, V271, P672, DOI 10.1001/jama.271.9.672; MIYAUCHI Y, 1993, INT J VITAM NUTR RES, V63, P145; MULLIN GE, 1989, ANN INTERN MED, V111, P253, DOI 10.7326/0003-4819-111-3-253; PARSONS WB, 1961, ARCH INTERN MED, V107, P653, DOI 10.1001/archinte.1961.03620050019003; RADER JI, 1992, AM J MED, V92, P77, DOI 10.1016/0002-9343(92)90018-7; SHEPHERD J, 1979, J CLIN INVEST, V63, P858, DOI 10.1172/JCI109385; SIFTON DW, 2002, DRUG TOPICS RED BOOK; SOMMER H, 1965, ARZNEI-FORSCHUNG, V15, P1337; Spies TD, 1938, J AMER MED ASSOC, V110, P622, DOI 10.1001/jama.1938.02790090004002; SVEDMYR N, 1969, CLIN PHARMACOL THER, V10, P559; WAHLBERG G, 1990, J INTERN MED, V228, P151, DOI 10.1111/j.1365-2796.1990.tb00209.x; Ziliotto G R, 1977, Arch Sci Med (Torino), V134, P359; 1998, ALTERN MED REV, V3, P222	48	46	54	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2003	139	12					996	1002		10.7326/0003-4819-139-12-200312160-00009	http://dx.doi.org/10.7326/0003-4819-139-12-200312160-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	756AG	14678919				2022-12-24	WOS:000187443200005
J	Dimitrov, DS				Dimitrov, DS			The secret life of ACE2 as a receptor for the SARS virus	CELL			English	Editorial Material							FUNCTIONAL-CHARACTERIZATION; CORONAVIRUS	The membrane-associated carboxypeptidase angiotensin-converting enzyme 2 (ACE2) is an essential regulator of heart function. Now, Li at al. identify and characterize an unexpected second function of ACE2 as a partner of the SARS-CoV spike glycoprotein in mediating virus entry and cell fusion.	NIH, NCI Frederick, CCR, LECB,Human Immunovirol & Computat Biol Grp, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Dimitrov, DS (corresponding author), NIH, NCI Frederick, CCR, LECB,Human Immunovirol & Computat Biol Grp, Ft Detrick, MD 21702 USA.							Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Breslin JJ, 2003, J VIROL, V77, P4435, DOI 10.1128/JVI.77.7.4435-4438.2003; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Xiao XD, 2003, BIOCHEM BIOPH RES CO, V312, P1159, DOI 10.1016/j.bbrc.2003.11.054; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0	8	101	107	1	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 12	2003	115	6					652	653		10.1016/S0092-8674(03)00976-0	http://dx.doi.org/10.1016/S0092-8674(03)00976-0			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675530	Green Published, Bronze			2022-12-24	WOS:000187366100005
J	Mas, P; Kim, WY; Somers, DE; Kay, SA				Mas, P; Kim, WY; Somers, DE; Kay, SA			Targeted degradation of TOC1 by ZTL modulates circadian function in Arabidopsis thaliana	NATURE			English	Article							CLOCK; PROTEIN; PERIOD; RHYTHMS; DOMAINS; OXYGEN; SLIMB; LIGHT; TIME; SCF	The underlying mechanism of circadian rhythmicity appears to be conserved among organisms, and is based on negative transcriptional feedback loops forming a cellular oscillator ( or 'clock')(1,2). Circadian changes in protein stability, phosphorylation and subcellular localization also contribute to the generation and maintenance of this clock(1,2). In plants, several genes have been shown to be closely associated with the circadian system(3,4). However, the molecular mechanisms proposed to regulate the plant clock are mostly based on regulation at the transcriptional level(3,4). Here we provide genetic and molecular evidence for a role of ZEITLUPE (ZTL)(5-7) in the targeted degradation of TIMING OF CAB EXPRESSION 1 (TOC1)(8,9) in Arabidopsis thaliana (thale cress). The physical interaction of TOC1 with ZTL is abolished by the ztl-1 mutation, resulting in constitutive levels of TOC1 protein expression. The dark-dependent degradation of TOC1 protein requires functional ZTL, and is prevented by inhibiting the proteosome pathway. Our results show that the TOC1 - ZTL interaction is important in the control of TOC1 protein stability, and is probably responsible for the regulation of circadian period by the clock.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Ohio State Univ, Dept Plant Biol, Ctr Plant Biotechnol, Columbus, OH 43210 USA	Scripps Research Institute; University System of Ohio; Ohio State University	Kay, SA (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevek@scripps.edu	Somers, David E/A-9209-2010; Mas, Paloma/B-8215-2016; Kay, Steve A/F-6025-2011	Mas, Paloma/0000-0002-3780-8041; Kay, Steve A/0000-0002-0402-2878				Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Cheng P, 2003, P NATL ACAD SCI USA, V100, P5938, DOI 10.1073/pnas.1031791100; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Jarillo JA, 2001, NATURE, V410, P487, DOI 10.1038/35068589; Kim WY, 2003, P NATL ACAD SCI USA, V100, P4933, DOI 10.1073/pnas.0736949100; Kiyosue T, 2000, PLANT J, V23, P807, DOI 10.1046/j.1365-313x.2000.00850.x; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Makino S, 2002, PLANT CELL PHYSIOL, V43, P58, DOI 10.1093/pcp/pcf005; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; Mas P, 2000, NATURE, V408, P207, DOI 10.1038/35041583; McClung CR, 2001, ANNU REV PLANT PHYS, V52, P139, DOI 10.1146/annurev.arplant.52.1.139; MILLAR AJ, 1995, SCIENCE, V267, P1163, DOI 10.1126/science.7855596; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Risseeuw EP, 2003, PLANT J, V34, P753, DOI 10.1046/j.1365-313X.2003.01768.x; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Schultz TF, 2001, PLANT CELL, V13, P2659, DOI 10.1105/tpc.13.12.2659; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 1998, DEVELOPMENT, V125, P485; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yanovsky MJ, 2001, CURR OPIN PLANT BIOL, V4, P429, DOI 10.1016/S1369-5266(00)00196-5; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	30	407	444	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					567	570		10.1038/nature02163	http://dx.doi.org/10.1038/nature02163			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654842				2022-12-24	WOS:000186944300041
J	Brindle, P; Emberson, J; Lampe, F; Walker, M; Whincup, P; Fahey, T; Ebrahim, S				Brindle, P; Emberson, J; Lampe, F; Walker, M; Whincup, P; Fahey, T; Ebrahim, S			Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INDIVIDUAL PATIENT DATA; ISCHEMIC-HEART-DISEASE; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; FOLLOW-UP; POPULATION; VALIDATION; RECOMMENDATIONS; STATEMENT; TRENDS	Objective To establish the predictive accuracy of the Framingham risk score for coronary heart disease in a representative British population. Design Prospective cohort study. Setting 24 towns in the United Kingdom. Participants 6643 British men aged 40-59 years and free from cardiovascular disease at entry into the British regional heart study. Main outcome measures Comparison of observed 10 year coronary heart disease mortality and event rates with predicted rates for each individual, using the relevant Framingham risk equation. Results Of 6643 men, 2.8% (95% confidence interval 2.4% to 3.2%) died from coronary heart disease compared with 4.1% predicted (relative overestimation 47%, P<0.0001). A fatal or non-fatal coronary heart disease event occurred in 10.2% (9.5% to 10.9%) of the men compared with 16.0% predicted (relative overestimation 57%, P<0.0001). These relative degrees of overestimation were similar at all levels of coronary heart disease risk, so that overestimation of absolute risk was greatest for those at highest risk. A simple adjustment provided an improved level of accuracy. In a "high risk score" approach, most cases occur in the low risk group. In this case, 84% of the deaths from coronary heart disease and non-fatal events occurred in the 93% of men classified at low risk (<30% in 10 years) by the Framingham score. Conclusion Guidelines for the primary prevention of coronary heart disease advocate offering preventive measures to individuals at high risk. Currently recommended risk scoring methods derived from the Framingham study significantly overestimate the absolute coronary risk assigned to individuals in the United Kingdom.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England; St George Hosp, Sch Med, Dept Community Hlth Sci, London SW17 0RE, England; Univ Dundee, Tayside Ctr Gen Practice, Dundee DD2 4AD, Scotland	University of Bristol; University of London; University College London; UCL Medical School; St Georges University London; University of Dundee	Brindle, P (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	peter.brindle@bristol.ac.uk	Fahey, Tom/C-9367-2012; Lampe, Fiona/I-5826-2019	Fahey, Tom/0000-0002-5896-5783; Lampe, Fiona/0000-0001-6851-5471; Whincup, Peter/0000-0002-5589-4107; Emberson, Jonathan/0000-0001-7792-9422				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Brindle P, 2002, BRIT MED J, V325, P56, DOI 10.1136/bmj.325.7355.56; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Fodor JG, 2000, CAN MED ASSOC J, V162, P1441; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; Gueyffier F, 1997, ANN INTERN MED, V126, P761, DOI 10.7326/0003-4819-126-10-199705150-00002; Haq IU, 1999, HEART, V81, P40, DOI 10.1136/hrt.81.1.40; Hense H, 2003, EUR HEART J, V3, P1; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; Jackson R, 2000, BMJ-BRIT MED J, V320, P709, DOI 10.1136/bmj.320.7236.709; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; LAURIER D, 1994, J CLIN EPIDEMIOL, V47, P1353, DOI 10.1016/0895-4356(94)90079-5; Lawlor DA, 2001, BRIT MED J, V323, P541, DOI 10.1136/bmj.323.7312.541; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; MANTEL N, 1959, J NATL CANCER I, V22, P719; Menotti A, 2000, EUR HEART J, V21, P365, DOI 10.1053/euhj.1999.1864; Packard CJ, 1998, CIRCULATION, V97, P1440; PETERSON S, 2002, CHRISTIAN SCI M 0328, P1; Pocock SJ, 2001, BMJ-BRIT MED J, V323, P75, DOI 10.1136/bmj.323.7304.75; Ramachandran S, 2000, BRIT MED J, V320, P676, DOI 10.1136/bmj.320.7236.676; SHAPER AG, 1981, BRIT MED J, V283, P179, DOI 10.1136/bmj.283.6285.179; SHAPER AG, 1984, BRIT HEART J, V51, P595, DOI 10.1136/hrt.51.6.595; Thomsen TF, 2002, INT J EPIDEMIOL, V31, P817, DOI 10.1093/ije/31.4.817; Vanderpump MPJ, 1996, THYROID, V6, P155; Walker M, 2000, J PUBLIC HEALTH MED, V22, P479, DOI 10.1093/pubmed/22.4.479; Wallis EJ, 2000, BMJ-BRIT MED J, V320, P671, DOI 10.1136/bmj.320.7236.671; Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X; Wood D, 1998, HEART, V80, pS1	32	324	346	2	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2003	327	7426					1267	1270A		10.1136/bmj.327.7426.1267	http://dx.doi.org/10.1136/bmj.327.7426.1267			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749VD	14644971	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000186948800020
J	Wang, XC; Wu, YC; Fadok, VA; Lee, MC; Gengyo-Ando, K; Cheng, LC; Ledwich, D; Hsu, PK; Chen, JY; Chou, BK; Henson, P; Mitani, S; Xue, D				Wang, XC; Wu, YC; Fadok, VA; Lee, MC; Gengyo-Ando, K; Cheng, LC; Ledwich, D; Hsu, PK; Chen, JY; Chou, BK; Henson, P; Mitani, S; Xue, D			Cell corpse engulfment mediated by C-elegans phosphatidylserine receptor through CED-5 and CED-12	SCIENCE			English	Article							CRKII/DOCK180/RAC PATHWAY; APOPTOTIC CELLS; GENERAL FEATURE; PHAGOCYTOSIS; CLEARANCE; MIGRATION; EXPOSURE; MACROPHAGES; ASYMMETRY	During apoptosis, phosphatidylserine, which is normally restricted to the inner lea. et of the plasma membrane, is exposed on the surface of apoptotic cells and has been suggested to act as an "eat-me" signal to trigger phagocytosis. It is unclear how phagocytes recognize phosphatidylserine. Recently, a putative phosphatidylserine receptor (PSR) was identified and proposed to mediate recognition of phosphatidylserine and phagocytosis. We report that psr-1, the Caenorhabditis elegans homolog of PSR, is important for cell corpse engulfment. In vitro PSR-1 binds preferentially phosphatidylserine or cells with exposed phosphatidylserine. In C. elegans, PSR-1 acts in the same cell corpse engulfment pathway mediated by intracellular signaling molecules CED-2 ( homologous to the human CrkII protein), CED-5 (DOCK180), CED-10 (Rac GTPase), and CED-12 (ELMO), possibly through direct interaction with CED-5 and CED-12. Our findings suggest that PSR-1 is likely an upstream receptor for the signaling pathway containing CED-2, CED-5, CED-10, and CED-12 proteins and plays an important role in recognizing phosphatidylserine during phagocytosis.	Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10617, Taiwan; Natl Jewish Med & Res Ctr, Dept Pediat, Cell Biol Program, Denver, CO 80206 USA; Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan	University of Colorado System; University of Colorado Boulder; National Taiwan University; National Jewish Health; Tokyo Women's Medical University	Wu, YC (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	yichun@ntu.edu.tw; ding.xue@colorado.edu	Gengyo-Ando, Keiko/AAC-4504-2019; Wu, Yi-Chun/F-7934-2012; Gengyo-Ando, Keiko/B-2753-2012	Wu, Yi-Chun/0000-0002-8621-4098; XUE, DING/0000-0002-8429-8136				Ashman RF, 1995, IMMUNOL LETT, V48, P159, DOI 10.1016/0165-2478(95)02471-9; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; CHENG L, UNPUB; ELLIS RE, 1991, GENETICS, V129, P79; FADOK V, UNPUB; FADOK VA, 1992, J IMMUNOL, V149, P4029; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Krahling S, 1999, CELL DEATH DIFFER, V6, P183, DOI 10.1038/sj.cdd.4400473; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Nakano T, 1997, J BIOL CHEM, V272, P29411, DOI 10.1074/jbc.272.47.29411; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Shiratsuchi A, 1998, BIOCHEM BIOPH RES CO, V246, P549, DOI 10.1006/bbrc.1998.8663; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; vandenEijnde SM, 1997, CYTOMETRY, V29, P313, DOI 10.1002/(SICI)1097-0320(19971201)29:4<313::AID-CYTO8>3.0.CO;2-A; VandenEijnde SM, 1997, CELL DEATH DIFFER, V4, P311, DOI 10.1038/sj.cdd.4400241; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; WANG X, UNPUB; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	28	157	174	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1563	1566		10.1126/science.1087641	http://dx.doi.org/10.1126/science.1087641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645848	Green Published			2022-12-24	WOS:000186802200043
J	Barrenas, ML; Bratthall, A; Dahlgren, J				Barrenas, ML; Bratthall, A; Dahlgren, J			The thrifty phenotype hypothesis and hearing problems	BRITISH MEDICAL JOURNAL			English	Article							GROWTH; EAR		Univ Gothenburg, Inst Hlth Woman & Child, Dept Pediat, Goteborg Pediat Growth Res Ctr, S-41685 Gothenburg, Sweden	University of Gothenburg	Barrenas, ML (corresponding author), Univ Gothenburg, Inst Hlth Woman & Child, Dept Pediat, Goteborg Pediat Growth Res Ctr, S-41685 Gothenburg, Sweden.		Dahlgren, Jovanna/J-8558-2015	Andersson Barrenas, Marie-Louise/0000-0002-7051-1178				Barrenas ML, 2000, HEARING RES, V144, P21, DOI 10.1016/S0378-5955(00)00040-X; BJORNTORP P, 1995, METABOLISM S2, V44, pS38; Camarero G, 2001, J NEUROSCI, V21, P7630, DOI 10.1523/JNEUROSCI.21-19-07630.2001; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241	5	18	19	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 22	2003	327	7425					1199	1200		10.1136/bmj.327.7425.1199	http://dx.doi.org/10.1136/bmj.327.7425.1199			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	747BB	14630755	Green Published, Bronze			2022-12-24	WOS:000186784300018
J	Chen, CC; Lamping, KG; Nuno, DW; Barresi, R; Prouty, SJ; Lavoie, JL; Cribbs, LL; England, SK; Sigmund, CD; Weiss, RM; Williamson, RA; Hill, JA; Campbell, KP				Chen, CC; Lamping, KG; Nuno, DW; Barresi, R; Prouty, SJ; Lavoie, JL; Cribbs, LL; England, SK; Sigmund, CD; Weiss, RM; Williamson, RA; Hill, JA; Campbell, KP			Abnormal coronary function in mice deficient in alpha(1H) T-type Ca2+ channels	SCIENCE			English	Article							CALCIUM CHANNELS; VENTRICULAR MYOCYTES; SINOATRIAL NODE; SMOOTH-MUSCLE; GENE FAMILY; EXPRESSION; CURRENTS; ALPHA-1H; CELLS; SUBUNIT	Calcium ion (Ca2+) influx through voltage-gated Ca2+ channels is important for the regulation of vascular tone. Activation of L-type Ca2+ channels initiates muscle contraction; however, the role of T-type Ca2+ channels (T-channels) is not clear. We show that mice deficient in the alpha(1H) T-type Ca2+ channel (alpha(1) 3.2-null) have constitutively constricted coronary arterioles and focal myocardial fibrosis. Coronary arteries isolated from alpha(1) 3.2-null arteries showed normal contractile responses, but reduced relaxation in response to acetylcholine and nitroprusside. Furthermore, acute blockade of T-channels with Ni2+ prevented relaxation of wild-type coronary arteries. Thus, Ca2+ influx through alpha(1H) T-type Ca2+ channels is essential for normal relaxation of coronary arteries.	Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; Vet Adm Med Ctr, Iowa City, IA 52242 USA; Loyola Univ, Med Ctr, Cardiovasc Inst, Maywood, IL 60153 USA; Univ Texas, SW Med Ctr, Div Cardiol, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Loyola University Chicago; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Campbell, KP (corresponding author), Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA.		Barresi, Rita/AAB-9569-2022; Lavoie, Julie/F-2288-2013; Chen, Chien-Chang/D-2023-2015; Sigmund, Curt D./W-1611-2019	Barresi, Rita/0000-0001-7351-959X; Lavoie, Julie/0000-0001-6316-2769; Chen, Chien-Chang/0000-0001-8850-4278; Sigmund, Curt D./0000-0002-1453-0921; Campbell, Kevin/0000-0003-2066-5889				Bijlenga P, 2000, P NATL ACAD SCI USA, V97, P7627, DOI 10.1073/pnas.97.13.7627; Bohn G, 2000, FEBS LETT, V481, P73, DOI 10.1016/S0014-5793(00)01979-7; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Guo W, 1998, J MOL CELL CARDIOL, V30, P1095, DOI 10.1006/jmcc.1998.0675; Gustafsson F, 2001, AM J PHYSIOL-HEART C, V280, pH582, DOI 10.1152/ajpheart.2001.280.2.H582; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916; Hansen PB, 2001, CIRC RES, V89, P630, DOI 10.1161/hh1901.097126; Kuga T, 1996, CIRC RES, V79, P14, DOI 10.1161/01.RES.79.1.14; Lamping KG, 2000, AM J PHYSIOL-HEART C, V279, pH1906, DOI 10.1152/ajpheart.2000.279.4.H1906; Lee JH, 1999, J NEUROSCI, V19, P1912; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; Martinez ML, 1999, J MOL CELL CARDIOL, V31, P1617, DOI 10.1006/jmcc.1999.0998; Namkung Y, 2001, J CLIN INVEST, V108, P1015, DOI 10.1172/JCI200113310; NELSON MT, 1995, AM J PHYSIOL, V268, P799; NUSS HB, 1993, CIRC RES, V73, P777, DOI 10.1161/01.RES.73.4.777; Perez-Reyes E, 1998, J BIOENERG BIOMEMBR, V30, P313, DOI 10.1023/A:1021981420839; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Schrier AD, 2001, AM J PHYSIOL-CELL PH, V280, pC265, DOI 10.1152/ajpcell.2001.280.2.C265; SEN L, 1994, CIRC RES, V75, P149, DOI 10.1161/01.RES.75.1.149; Son WY, 2002, DEV GROWTH DIFFER, V44, P181, DOI 10.1046/j.1440-169X.2002.00633.x; Talley EM, 1999, J NEUROSCI, V19, P1895	24	270	282	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2003	302	5649					1416	1418		10.1126/science.1089268	http://dx.doi.org/10.1126/science.1089268			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631046				2022-12-24	WOS:000186683500058
J	Wood, E; Hogg, RS; Yip, B; Harrigan, PR; O'Shaughnessy, MV; Montaner, JSG				Wood, E; Hogg, RS; Yip, B; Harrigan, PR; O'Shaughnessy, MV; Montaner, JSG			Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4(+) cell count is 0.200 to 0.350 X 10(9) cells/L	ANNALS OF INTERNAL MEDICINE			English	Article							SOCIETY-USA PANEL; BASE-LINE; UPDATED RECOMMENDATIONS; DISEASE PROGRESSION; VIRAL LOAD; AIDS; TOXICITY; TRIAL; RNA	Background: The safety of delaying highly active antiretroviral therapy (HAART) in HIV-infected patients is uncertain when the CD4(+) cell count declines below 0.350 x 10(9) cells/L. Objective: To evaluate the effect of baseline CD4(+) cell count and adherence to HAART on survival rates. Design: Prospective observational study. Setting: Province-wide Canadian HlV/AIDS treatment program. Patients: 1422 HIV-infected persons initiating HAART between 1 August 1996 and 31 July 2000 and followed through 31 March 2002. Measurements: Patients were stratified by baseline CD4+ cell count and adherence level. Cumulative mortality rates were evaluated by using Kaplan-Meier methods and Cox regression-estimated adjusted relative hazards. Results: Kaplan-Meier analyses showed no survival benefit of starting HAART at a CD4(+) count of 0.200 x 10(9) cells/L or greater among adherent patients. Adjusted analysis showed that compared with adherent patients who initiated HAART at a CD4+ cell count of 0.350 x 10(9) cells/L or greater, nonadherent patients who initiated HAART when the CD4+ cell count was 0.200 to 0.349 x 109 cells/L had statistically elevated mortality rates (adjusted relative hazard, 2.56 [95% Cl, 1.36 to 4.84]; P = 0.004). However, compared with adherent patients who initiated HAART at a CD4(+) cell count of 0.350 x 109 cells/L or greater, adherent patients who initiated HAART when the CD4(+) cell count was 0.200 to 0.349 x 10(9) cells/L had statistically similar mortality rates (adjusted relative hazard, 0.82 [Cl, 0.45 to 1.49]; P > 0.2). Conclusions: Delaying HAART until the CD4(+) cell count falls to 0.200 x 10(9) cells/L does not increase the mortality rate in HIV-infected patients with good medication adherence. Mortality rates increase if HAART is initiated below 0.200 x 10(9) cells/L. Also, nonadherent patients have higher mortality rates than adherent patients with similar CD4(+) cell counts. Above a CD4(+) cell count of 0.200 x 10(9) cells/L, medication adherence is the critical determinant of survival, not the CD4(+) cell count at which HAART is begun.	Univ British Columbia, St Pauls Hosp, AIDS Res Program, Vancouver, BC V6Z 1Y6, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan	Montaner, JSG (corresponding author), Univ British Columbia, St Pauls Hosp, AIDS Res Program, 667-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	jmontaner@hivnet.ubc.ca	Hogg, Robert S/B-2783-2012	Hogg, Robert S/0000-0003-3463-5488				Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Carpenter CCJ, 1997, JAMA-J AM MED ASSOC, V277, P1962, DOI 10.1001/jama.277.24.1962; Cote HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035; COX DR, 1972, J R STAT SOC B, V34, P187; Dybul M, 2002, ANN INTERN MED, V137, P381, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00001; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; FERRER E, 2003, 10 C RETR OPP INF BO; Gifford AL, 2000, J ACQ IMMUN DEF SYND, V23, P386; Grant LA, 2001, AIDS, V15, P2101, DOI 10.1097/00002030-200111090-00005; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Heath KV, 2001, AIDS, V15, P231, DOI 10.1097/00002030-200101260-00013; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Lane HC, 2003, ANN INTERN MED, V138, P680, DOI 10.7326/0003-4819-138-8-200304150-00018; Liu HH, 2001, ANN INTERN MED, V134, P968, DOI 10.7326/0003-4819-134-10-200105150-00011; Low-Beer S, 2000, J ACQ IMMUN DEF SYND, V23, P360; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; PALELLA F, 2002, 9 C RETR OPP INF SEA; Palepu A, 2001, AIDS, V15, P423, DOI 10.1097/00002030-200102160-00021; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Phair JP, 2002, AIDS, V16, P2455, DOI 10.1097/00002030-200212060-00011; Schackman BR, 2002, ARCH INTERN MED, V162, P2478, DOI 10.1001/archinte.162.21.2478; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; STERLING T, 2003, 10 C RETR OPP INF BO; Sterling TR, 2003, CLIN INFECT DIS, V36, P812, DOI 10.1086/367934; Sterling TR, 2001, AIDS, V15, P2251, DOI 10.1097/00002030-200111230-00006; Strathdee SA, 1998, JAMA-J AM MED ASSOC, V280, P547, DOI 10.1001/jama.280.6.547; *US PUBL HLTH SERV, GUID US ANT AG HIV I; Wood E, 2003, AIDS, V17, P711, DOI 10.1097/00002030-200303280-00009; WOOD E, 2003, IN PRESS J INFECT DI; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222; 2001, HIV MED, V2, P276	33	303	306	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2003	139	10					810	816		10.7326/0003-4819-139-10-200311180-00008	http://dx.doi.org/10.7326/0003-4819-139-10-200311180-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744ZV	14623618				2022-12-24	WOS:000186663500004
J	Herzig, S; Hedrick, S; Morantte, I; Koo, SH; Galimi, F; Montminy, M				Herzig, S; Hedrick, S; Morantte, I; Koo, SH; Galimi, F; Montminy, M			CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-gamma	NATURE			English	Article							GENE-EXPRESSION; RESPONSIVE ACTIVATOR; PROMOTER ANALYSIS; PROTEIN; GLUCONEOGENESIS; REVEALS; LIVER; HES-1	Fasting triggers a series of hormonal cues that promote energy balance by inducing glucose output and lipid breakdown in the liver(1). In response to pancreatic glucagon and adrenal cortisol, the cAMP-responsive transcription factor CREB activates gluconeogenic and fatty acid oxidation programmes by stimulating expression of the nuclear hormone receptor coactivator PGC-1 (refs 2-5). In parallel, fasting also suppresses lipid storage and synthesis ( lipogenic) pathways(1), but the underlying mechanism is unknown. Here we show that mice deficient in CREB activity have a fatty liver phenotype and display elevated expression of the nuclear hormone receptor PPAR-gamma, a key regulator of lipogenic genes(6,7). CREB inhibits hepatic PPAR-gamma expression in the fasted state by stimulating the expression of the Hairy Enhancer of Split (HES-1) gene, a transcriptional repressor that is shown here to be a mediator of fasting lipid metabolism in vivo. The coordinate induction of PGC-1 and repression of PPAR-gamma by CREB during fasting provides a molecular rationale for the antagonism between insulin and counter-regulatory hormones, and indicates a potential role for CREB antagonists as therapeutic agents in enhancing insulin sensitivity in the liver.	Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	Montminy, M (corresponding author), Salk Inst Biol Studies, Peptide Biol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu	Koo, Seung-Hoi/E-2763-2015; Galimi, Francesco/J-4238-2012	Koo, Seung-Hoi/0000-0001-8769-2879; Herzig, Stephan/0000-0003-3950-3652				Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Horton JD, 1999, CURR OPIN LIPIDOL, V10, P143, DOI 10.1097/00041433-199904000-00008; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Koo SH, 2000, J BIOL CHEM, V275, P5200, DOI 10.1074/jbc.275.7.5200; Lee Y, 2001, J BIOL CHEM, V276, P5629, DOI 10.1074/jbc.M008553200; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Nakajima T, 1997, GENE DEV, V11, P738, DOI 10.1101/gad.11.6.738; ORELLANA SA, 1992, P NATL ACAD SCI USA, V89, P4726, DOI 10.1073/pnas.89.10.4726; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200	27	234	250	0	31	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 13	2003	426	6963					190	193		10.1038/nature02110	http://dx.doi.org/10.1038/nature02110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614508				2022-12-24	WOS:000186517200046
J	Swingler, GH; Volmink, J; Ioannidis, JPA				Swingler, GH; Volmink, J; Ioannidis, JPA			Number of published systematic reviews and global burden of disease: database analysis	BRITISH MEDICAL JOURNAL			English	Article									Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin Trials & Evidence Based Med Unit, GR-45110 Ioannina, Greece; Univ Cape Town, Red Cross Childrens Hosp, Sch Child & Adolescent Hlth, ZA-7700 Rondebosch, South Africa; Univ Cape Town, Fac Hlth Sci, ZA-7925 Cape Town, South Africa	University of Ioannina; University of Cape Town; University of Cape Town	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin Trials & Evidence Based Med Unit, GR-45110 Ioannina, Greece.		Ioannidis, John P. A./G-9836-2011					Alderson P, 2000, BRIT MED J, V320, P376, DOI 10.1136/bmj.320.7231.376; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; Isaakidis P, 2002, BRIT MED J, V324, P702, DOI 10.1136/bmj.324.7339.702; Mulrow CD, 1997, ANN INTERN MED, V126, P389, DOI 10.7326/0003-4819-126-5-199703010-00008	5	75	79	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 8	2003	327	7423					1083	1084		10.1136/bmj.327.7423.1083	http://dx.doi.org/10.1136/bmj.327.7423.1083			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742QW	14604930	Green Published, Bronze			2022-12-24	WOS:000186530400019
J	Raitakari, OT; Juonala, M; Kahonen, M; Taittonen, L; Laitinen, T; Maki-Torkko, N; Jarvisalo, MJ; Uhari, M; Jokinen, E; Ronnemaa, T; Akerblom, HK; Viikari, JSA				Raitakari, OT; Juonala, M; Kahonen, M; Taittonen, L; Laitinen, T; Maki-Torkko, N; Jarvisalo, MJ; Uhari, M; Jokinen, E; Ronnemaa, T; Akerblom, HK; Viikari, JSA			Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood - The Cardiovascular Risk in Young Finns Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; WALL THICKNESS; PRECLINICAL ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; SERUM-CHOLESTEROL; FOLLOW-UP; CHILDREN; MEN; ASSOCIATION	Context Exposure to cardiovascular risk factors during childhood and adolescence may be associated with the development of atherosclerosis later in life. Objective To study the relationship between cardiovascular risk factors measured in childhood and adolescence and common carotid artery intima-media thickness (IMT), a marker of preclinical atherosclerosis, measured in adulthood. Design, Setting, and Participants Population-based, prospective cohort study conducted at 5 centers in Finland among 2229 white adults aged 24 to 39 years who were examined in childhood and adolescence at ages 3 to 18 years in 1980 and reexamined 21 years later, between September 2001 and January 2002. Main Outcome Measures Association between cardiovascular risk variables (levels of low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], and triglycerides; LDL-C/HDL-C ratio; systolic and diastolic blood pressure; body mass index; smoking) measured in childhood and adulthood and common carotid artery IMT measured in adulthood. Results In multivariable models adjusted for age and sex, IMT in adulthood was significantly associated with childhood LDL-C levels (P=.001), systolic blood pressure (P<.001), body mass index (P=.007), and smoking (P=.02), and with adult systolic blood pressure (P<.001), body mass index (P<.001), and smoking (P=.004). The number of risk factors measured in 12- to 18-year-old adolescents, including high levels (ie, extreme age- and sex-specific 80th percentile) of LDL-C, systolic blood pressure, body mass index, and cigarette smoking, were directly related to carotid IMT measured in young adults at ages 33 through 39 years (P<.001 for both men and women), and remained significant after adjustment for contemporaneous risk variables. The number of risk factors measured at ages 3 to 9 years demonstrated a weak direct relationship with carotid IMT at ages 24 to 30 years in men (P=.02) but not in women (P=.63). Conclusions Risk factor profile assessed in 12- to 18-year-old adolescents predicts adult common carotid artery IMT independently of contemporaneous risk factors. These findings suggest that exposure to cardiovascular risk factors early in life may induce changes in arteries that contribute to the development of atherosclerosis.	Univ Turku, Turku PET Ctr, FIN-20500 Turku, Finland; Univ Turku, Dept Clin Physiol, FIN-20500 Turku, Finland; Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, FIN-20500 Turku, Finland; Univ Turku, Dept Med, FIN-20500 Turku, Finland; Univ Tampere, Dept Clin Physiol, FIN-33101 Tampere, Finland; Univ Oulu, Dept Paediat, Oulu, Finland; Univ Kuopio, Dept Clin Physiol, FIN-70211 Kuopio, Finland; Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland	University of Turku; University of Turku; University of Turku; University of Turku; Tampere University; University of Oulu; University of Eastern Finland; University of Helsinki	Raitakari, OT (corresponding author), Univ Turku, Turku PET Ctr, POB 52, FIN-20500 Turku, Finland.	olli.raitakari@utu.fi	Raitakari, Olli/AAQ-7389-2021	Juonala, Markus/0000-0001-9498-364X; Kahonen, Mika/0000-0002-4510-7341				AKERBLOM HK, 1985, ACTA PAEDIATR SCAND, P49; Allan PL, 1997, STROKE, V28, P348, DOI 10.1161/01.STR.28.2.348; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; BURKE GL, 1995, STROKE, V26, P386, DOI 10.1161/01.STR.26.3.386; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; CRAVEN TE, 1990, CIRCULATION, V82, P1230, DOI 10.1161/01.CIR.82.4.1230; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gaziano JM, 1998, NEW ENGL J MED, V338, P1690, DOI 10.1056/NEJM199806043382310; HAAPANEN A, 1989, CIRCULATION, V80, P10, DOI 10.1161/01.CIR.80.1.10; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Jarvisalo MJ, 2001, CIRCULATION, V104, P2943, DOI 10.1161/hc4901.100522; Kanters SDJM, 1997, STROKE, V28, P665, DOI 10.1161/01.STR.28.3.665; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; LAPINLEIMU H, 1995, LANCET, V345, P471, DOI 10.1016/S0140-6736(95)90580-4; MAHONEY LT, 1991, ANN NY ACAD SCI, V623, P120, DOI 10.1111/j.1749-6632.1991.tb43723.x; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; McGill HC, 2000, ARTERIOSCL THROM VAS, V20, P836, DOI 10.1161/01.ATV.20.3.836; MCGILL HC, 1990, JAMA-J AM MED ASSOC, V264, P3018; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; O'Leary DH, 2002, AM J CARDIOL, V90, p18L, DOI 10.1016/S0002-9149(02)02957-0; Obarzanek E, 2001, PEDIATRICS, V107, P256, DOI 10.1542/peds.107.2.256; PAUCIULLO P, 1994, ARTERIOSCLER THROMB, V14, P1075, DOI 10.1161/01.ATV.14.7.1075; POLI A, 1988, ATHEROSCLEROSIS, V70, P253, DOI 10.1016/0021-9150(88)90176-1; Porkka KVK, 1997, AM J EPIDEMIOL, V146, P64, DOI 10.1093/oxfordjournals.aje.a009192; PORKKA KVK, 1994, AM J EPIDEMIOL, V140, P1096, DOI 10.1093/oxfordjournals.aje.a117210; SALONEN JT, 1991, ARTERIOSCLER THROMB, V11, P1245, DOI 10.1161/01.ATV.11.5.1245; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Tonstad S, 1996, ARTERIOSCL THROM VAS, V16, P984, DOI 10.1161/01.ATV.16.8.984; VIIKARI J, 1991, ANN MED, V23, P53, DOI 10.3109/07853899109147931; WEBBER LS, 1991, AM J EPIDEMIOL, V133, P884, DOI 10.1093/oxfordjournals.aje.a115968	32	1277	1317	0	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2003	290	17					2277	2283		10.1001/jama.290.17.2277	http://dx.doi.org/10.1001/jama.290.17.2277			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739PZ	14600186	Bronze			2022-12-24	WOS:000186356800022
J	Yagi, H; Furutani, Y; Hamada, H; Sasaki, T; Asakawa, S; Minoshima, S; Ichida, F; Joo, K; Kimura, M; Imamura, S; Kamatani, N; Momma, K; Takao, A; Nakazawa, M; Shimizu, N; Matsuoka, R				Yagi, H; Furutani, Y; Hamada, H; Sasaki, T; Asakawa, S; Minoshima, S; Ichida, F; Joo, K; Kimura, M; Imamura, S; Kamatani, N; Momma, K; Takao, A; Nakazawa, M; Shimizu, N; Matsuoka, R			Role of TBX1 in human del22q11.2 syndrome	LANCET			English	Article							T-BOX GENE; DELETION; DEFECTS; MUTANT; FGF8; ARCH	Background Del22q11.2 syndrome is the most frequent known chromosomal microdeletion syndrome, with an incidence of 1 in 4000-5000 livebirths. It is characterised by a 3-Mb deletion on chromosome 22q11.2, cardiac abnormalities, T-cell deficits, cleft palate facial anomalies, and hypocalcaemia. At least 30 genes have been mapped to the deleted region. However, the association of these genes with the cause of this syndrome is not clearly understood. Methods To test for the chromosomal deletion at 22q11.2, we did fluorescence in-situ hybridisation analysis with ten probes on 22q11.2 in 235 unrelated patients with clinically diagnosed del22q11.2 syndrome. To investigate mutations in the coding sequence of TBX1, we also did genetic analysis in 13 patients from ten families who have the 22q11.2 syndrome phenotype but no detectable deletion of 22q11.2. Findings 96% (225 of 235) of patients had a defined 1.5-3-Mb deletion at 22q11.2. We identified three mutations of TBX1 in two unrelated patients without the 22q11.2 deletion-one with sporadic conotruncal anomaly face syndrome/velocardiofacial syndrome and one with sporadic DiGeorge's syndrome-and in three patients from a family with conotruncal anomaly face syndrome/velocardiofacial syndrome. We did not record these three mutations in 555 healthy controls (1110 chromosomes; p<0.0001). Interpretation Our results suggest that the TBX1 mutation is responsible for five major phenotypes in del22q11.2 syndrome. Therefore, we conclude that TBX1 is a major genetic determinant of the del22q11.2 syndrome.	Tokyo Womens Med Univ, Grad Sch Med, Inst Adv Biomed Engn & Sci, Div Genom Med,Shinjuku Ku, Tokyo, Japan; Tokyo Womens Med Univ, Heart Inst Japan, Shinjuku Ku, Tokyo, Japan; Chiba Univ, Grad Sch Med, Dept Paediat, Chiba, Japan; Keio Univ, Sch Med, Dept Mol Biol, Tokyo, Japan; Toyama Med & Pharmaceut Univ, Dept Paediat, Toyama, Japan; Kyushu Welf Pens Hosp, Dept Paediat, Fukuoka, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University; Chiba University; Keio University; University of Toyama	Matsuoka, R (corresponding author), Tokyo Womens Med Univ, Grad Sch Med, Inst Adv Biomed Engn & Sci, Div Genom Med,Shinjuku Ku, 8-1 Kawada Cho, Tokyo, Japan.	rumiko@imcir.twmu.ac.jp	Sasaki, Takashi/AAD-1461-2019	Sasaki, Takashi/0000-0002-6275-046X; Yagi, Hisato/0000-0003-1460-4043				Abu-Issa R, 2002, DEVELOPMENT, V129, P4613; Asakawa S, 1997, GENE, V191, P69, DOI 10.1016/S0378-1119(97)00044-9; BURN J, 1995, DEVELOPMENTAL MECHANISMS OF HEART DISEASE, P559; Conti E, 2003, EUR J HUM GENET, V11, P349, DOI 10.1038/sj.ejhg.5200956; FIREMAN P, 1965, J PEDIATR-US, V67, P907; Frank DU, 2002, DEVELOPMENT, V129, P4591; Gong W, 2001, J Med Genet, V38, pE45, DOI 10.1136/jmg.38.12.e45; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kinouchi A, 1976, SHONIKA PEDIAT JPN, V17, P84; Lindsay EA, 2001, NAT REV GENET, V2, P858, DOI 10.1038/35098574; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; MATSUOKA R, 1994, AM J MED GENET, V53, P285, DOI 10.1002/ajmg.1320530314; Matsuoka R, 1998, HUM GENET, V103, P70, DOI 10.1007/s004390050786; Matsuoka R, 2000, ETIOLOGY MORPHOGENES, P341; McQuade L, 1999, AM J MED GENET, V86, P27, DOI 10.1002/(SICI)1096-8628(19990903)86:1<27::AID-AJMG6>3.0.CO;2-7; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Packham EA, 2003, HUM MOL GENET, V12, pR37, DOI 10.1093/hmg/ddg077; Papaioannou VE, 1998, BIOESSAYS, V20, P9, DOI 10.1002/(SICI)1521-1878(199801)20:1<9::AID-BIES4>3.0.CO;2-Q; Paxton C, 2002, GENE, V283, P117, DOI 10.1016/S0378-1119(01)00878-2; Scambler PJ, 2000, HUM MOL GENET, V9, P2421, DOI 10.1093/hmg/9.16.2421; SHPRINTZEN RJ, 1994, J MED GENET, V31, P423, DOI 10.1136/jmg.31.5.423-b; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; Tada M, 2001, DEV GROWTH DIFFER, V43, P1; TAKAO A, 1980, ETIOLOGY MORPHOGENES, P253; Vitelli F, 2002, DEVELOPMENT, V129, P4605; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903; Yamagishi H, 1998, AM J MED GENET, V78, P319, DOI 10.1002/(SICI)1096-8628(19980724)78:4<319::AID-AJMG3>3.0.CO;2-G; Yamagishi Hiroyuki, 2002, Keio Journal of Medicine, V51, P77; YOSHIDA MC, 1986, JPN J CANCER RES, V77, P1059	30	572	609	0	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2003	362	9393					1366	1373		10.1016/S0140-6736(03)14632-6	http://dx.doi.org/10.1016/S0140-6736(03)14632-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735YX	14585638				2022-12-24	WOS:000186143300010
J	Randak, C; Welsh, MJ				Randak, C; Welsh, MJ			An intrinsic adenylate kinase activity regulates gating of the ABC transporter CFTR	CELL			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; ATP-BINDING-CASSETTE; RECOMBINANT POLYPEPTIDE MODEL; CYSTIC-FIBROSIS; CRYSTAL-STRUCTURE; CHLORIDE CHANNELS; DOMAIN; SITE; MECHANISM; HYDROLYSIS	Cystic fibrosis transmembrane conductance regulator (CFTR) is an anion channel in the ATP binding cassette (ABC) transporter family. Like other ABC transporters, it can hydrolyze ATP. Yet while ATP hydrolysis influences channel gating, it has long seemed puzzling that CFTR would require this reaction because anions flow passively through CFTR. Moreover, no other ion channel is known to require the large energy of ATP hydrolysis to gate. We found that CFTR also has adenylate kinase activity (ATP + AMP reversible arrow ADP + ADP) that regulates gating. When functioning as an adenylate kinase, CFTR showed positive cooperativity for ATP suggesting its two nucleotide binding domains may dimerize. Thus, channel activity could be regulated by two different enzymatic reactions, ATPase and adenylate kinase, that share a common ATP binding site in the second nucleotide binding domain. At physiologic nucleotide concentrations, adenylate kinase activity, rather than ATPase activity may control gating, and therefore involve little energy consumption.	Univ Iowa, Howard Hughes Med Inst, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Dept Phys & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Howard Hughes Med Inst, Dept Internal Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu		Welsh, Michael/0000-0002-1646-6206; Randak, Christoph/0000-0003-3264-4137	NHLBI NIH HHS [HL29851-21, HL1234-05] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL029851, R01HL029851] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERTY RA, 1992, BIOCHEMISTRY-US, V31, P10610, DOI 10.1021/bi00158a025; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Aleksandrov L, 2001, J BIOL CHEM, V276, P12918, DOI 10.1074/jbc.M100515200; AMES GF, 1992, ADV ENZYMOL RAMB, V65, P1; ANDERSON MP, 1992, SCIENCE, V257, P1701, DOI 10.1126/science.1382316; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Berger AL, 2002, J BIOL CHEM, V277, P2125, DOI 10.1074/jbc.M109539200; BISHOP L, 1989, P NATL ACAD SCI USA, V86, P6953, DOI 10.1073/pnas.86.18.6953; BOZZI A, 1994, BIOCHEM MOL BIOL INT, V32, P95; BYEON IJL, 1995, BIOCHEMISTRY-US, V34, P3172, DOI 10.1021/bi00010a006; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; Cotten JF, 1998, J BIOL CHEM, V273, P31873, DOI 10.1074/jbc.273.48.31873; Dassa E., 2003, ABC PROTEINS BACTERI, P3; DAVIDSON AL, 1990, J BIOL CHEM, V265, P4254; Davidson AL, 1996, J BIOL CHEM, V271, P4858; DIEDERICHS K, 1990, BIOCHEMISTRY-US, V29, P8138, DOI 10.1021/bi00487a022; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; FELDHAUS P, 1975, EUR J BIOCHEM, V57, P197, DOI 10.1111/j.1432-1033.1975.tb02291.x; Fetsch EE, 2002, P NATL ACAD SCI USA, V99, P9685, DOI 10.1073/pnas.152204499; FONT B, 1980, BIOCHIM BIOPHYS ACTA, V611, P299, DOI 10.1016/0005-2744(80)90065-0; Fontanella L, 1999, ANAL BIOCHEM, V269, P353, DOI 10.1006/abio.1999.4042; Frederich M, 2002, J BIOL CHEM, V277, P1928, DOI 10.1074/jbc.M107128200; Gadsby D. C., 1999, PHYSIOL REV, V79, pS77; Gaudet R, 2001, EMBO J, V20, P4964, DOI 10.1093/emboj/20.17.4964; GUNDERSON KL, 1995, CELL, V82, P231, DOI 10.1016/0092-8674(95)90310-0; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Hanrahan JW, 2003, ABC PROTEINS BACTERI, P589; HIGGINS CF, 1986, NATURE, V323, P448, DOI 10.1038/323448a0; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Ikuma M, 2000, P NATL ACAD SCI USA, V97, P8675, DOI 10.1073/pnas.140220597; Ishihara H, 1997, AM J PHYSIOL-CELL PH, V273, pC1278, DOI 10.1152/ajpcell.1997.273.4.C1278; ITO Y, 1980, EUR J BIOCHEM, V105, P85, DOI 10.1111/j.1432-1033.1980.tb04477.x; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Kosloff M, 2003, J MOL BIOL, V331, P1157, DOI 10.1016/S0022-2836(03)00847-7; Levitzki A, 1976, Curr Top Cell Regul, V10, P1; LIENHARD GE, 1973, J BIOL CHEM, V248, P1121; Liu CE, 1997, J BIOL CHEM, V272, P21883, DOI 10.1074/jbc.272.35.21883; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; MALAISSE WJ, 1987, BIOCHIM BIOPHYS ACTA, V927, P190, DOI 10.1016/0167-4889(87)90134-0; MENENDEZ M, 1985, BIOPHYS CHEM, V21, P249, DOI 10.1016/0301-4622(85)80012-0; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; OKAJIMA T, 1993, J BIOCHEM-TOKYO, V114, P627, DOI 10.1093/oxfordjournals.jbchem.a124228; Olson LK, 1996, J BIOL CHEM, V271, P16544, DOI 10.1074/jbc.271.28.16544; OSBORNE L, 1992, HUM GENET, V89, P653, DOI 10.1007/BF00221957; Ostedgaard LS, 2002, P NATL ACAD SCI USA, V99, P3093, DOI 10.1073/pnas.261714599; Pucar D, 2002, AM J PHYSIOL-HEART C, V283, pH776, DOI 10.1152/ajpheart.00116.2002; Ramjeesingh M, 1999, BIOCHEMISTRY-US, V38, P1463, DOI 10.1021/bi982243y; Randak C, 1997, FEBS LETT, V410, P180, DOI 10.1016/S0014-5793(97)00574-7; Randak C, 1999, BIOCHEM J, V340, P227, DOI 10.1042/0264-6021:3400227; Randak C, 1996, FEBS LETT, V398, P97, DOI 10.1016/S0014-5793(96)01217-3; RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schneider E, 1998, FEMS MICROBIOL REV, V22, P1; SCHULTZ BD, 1995, J GEN PHYSIOL, V105, P329, DOI 10.1085/jgp.105.3.329; SHEPPARD DN, 1995, EMBO J, V14, P876, DOI 10.1002/j.1460-2075.1995.tb07069.x; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Smith CA, 1996, BIOPHYS J, V70, P1590, DOI 10.1016/S0006-3495(96)79745-X; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Szabo K, 1999, J BIOL CHEM, V274, P12209, DOI 10.1074/jbc.274.18.12209; Szellas T, 2003, FEBS LETT, V535, P141, DOI 10.1016/S0014-5793(02)03892-9; TRAVIS SM, 1993, J BIOL CHEM, V268, P15336; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vonrhein C, 1998, J MOL BIOL, V282, P167, DOI 10.1006/jmbi.1998.2003; Yan HG, 1999, ADV ENZYMOL RAMB, V73, P103, DOI 10.1002/9780470123195.ch4; Yuan YR, 2001, J BIOL CHEM, V276, P32313, DOI 10.1074/jbc.M100758200; ZELEZNIKAR RJ, 1995, J BIOL CHEM, V270, P7311, DOI 10.1074/jbc.270.13.7311; Zeltwanger S, 1999, J GEN PHYSIOL, V113, P541, DOI 10.1085/jgp.113.4.541	75	50	52	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2003	115	7					837	850		10.1016/S0092-8674(03)00983-8	http://dx.doi.org/10.1016/S0092-8674(03)00983-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	758RV	14697202	Bronze			2022-12-24	WOS:000187664700008
J	Vargason, JM; Szittya, G; Burgyan, J; Hall, TMT				Vargason, JM; Szittya, G; Burgyan, J; Hall, TMT			Size selective recognition of siRNA by an RNA silencing suppressor	CELL			English	Article							BUSHY-STUNT-VIRUS; SHORT INTERFERING RNA; NICOTIANA-BENTHAMIANA; VIRAL SUPPRESSOR; PROTEIN; PLANTS; DNA; EXPRESSION; INDUCTION; SYSTEM	RNA silencing in plants likely exists as a defense mechanism against molecular parasites such as RNA viruses, retrotransposons, and transgenes. As a result, many plant viruses have adapted mechanisms to evade and suppress gene silencing. Tombusviruses express a 19 kDa protein (p19), which has been shown to suppress RNA silencing in vivo and bind silencing-generated and synthetic small interfering RNAs (siRNAs) in vitro. Here we report the 2.5 Angstrom crystal structure of p19 from the Carnation Italian ringspot virus (CIRV) bound to a 21 nt siRNA and demonstrate in biochemical and in vivo assays that CIRV p19 protein acts as a molecular caliper to specifically select siRNAs based on the length of the duplex region of the RNA.	NIEHS, Lab Struct Biol, NIH, Res Triangle Pk, NC 27709 USA; Plant Biol Inst, Agr Biotechnol Ctr, Godollo, Hungary	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Hall, TMT (corresponding author), NIEHS, Lab Struct Biol, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.		Szittya, Gyorgy/M-9199-2019; Hall, Traci/F-5849-2019; Burgyan, Jozsef/C-7511-2012; Szittya, Gyorgy/A-2905-2012	Szittya, Gyorgy/0000-0003-2040-2851; Hall, Traci/0000-0001-6166-3009; Szittya, Gyorgy/0000-0003-2040-2851	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050165, Z01ES050165] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Baulcombe D, 2002, TRENDS MICROBIOL, V10, P306, DOI 10.1016/S0966-842X(02)02387-9; Baulcombe D, 2002, CURR BIOL, V12, pR82, DOI 10.1016/S0960-9822(02)00665-6; Baulcombe DC, 1999, CURR OPIN PLANT BIOL, V2, P109, DOI 10.1016/S1369-5266(99)80022-3; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Brunger A. T., 1992, NATURE, V355, P472; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgyan J, 1996, J GEN VIROL, V77, P1967, DOI 10.1099/0022-1317-77-8-1967; Chu M, 2000, VIROLOGY, V266, P79, DOI 10.1006/viro.1999.0071; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; DALMAY T, 1993, VIROLOGY, V194, P697, DOI 10.1006/viro.1993.1310; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano WL, 2002, PYMOL USERS MANUAL; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hull R., 2002, MATTHEWS PLANT VIROL; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jung J, 2001, PROTEIN SCI, V10, P1881, DOI 10.1110/ps.05801; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2001, CURR OPIN BIOTECH, V12, P150, DOI 10.1016/S0958-1669(00)00190-7; LIN S, 1972, J MOL BIOL, V72, P671, DOI 10.1016/0022-2836(72)90184-2; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luscombe NM, 1997, NUCLEIC ACIDS RES, V25, P4940, DOI 10.1093/nar/25.24.4940; Mallory AC, 2002, P NATL ACAD SCI USA, V99, P15228, DOI 10.1073/pnas.232434999; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nikulin A, 2003, NAT STRUCT BIOL, V10, P104, DOI 10.1038/nsb886; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papp I, 2003, PLANT PHYSIOL, V132, P1382, DOI 10.1104/pp.103.021980; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Provost P, 2002, P NATL ACAD SCI USA, V99, P16648, DOI 10.1073/pnas.212633199; Qiu WP, 2002, MOL PLANT MICROBE IN, V15, P269, DOI 10.1094/MPMI.2002.15.3.269; Qu F, 2002, MOL PLANT MICROBE IN, V15, P193, DOI 10.1094/MPMI.2002.15.3.193; SCHOLTHOF HB, 1995, PLANT CELL, V7, P1157, DOI 10.1105/tpc.7.8.1157; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; Szittya G, 2002, PLANT CELL, V14, P359, DOI 10.1105/tpc.010366; Szittya G, 2003, EMBO J, V22, P633, DOI 10.1093/emboj/cdg74; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Voinnet O, 2002, CURR OPIN PLANT BIOL, V5, P444, DOI 10.1016/S1369-5266(02)00291-1; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Waterhouse PM, 1999, TRENDS PLANT SCI, V4, P452, DOI 10.1016/S1360-1385(99)01493-4; WEEKS KM, 1992, BIOCHEMISTRY-US, V31, P10281, DOI 10.1021/bi00157a015; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	66	427	464	2	44	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 26	2003	115	7					799	811		10.1016/S0092-8674(03)00984-X	http://dx.doi.org/10.1016/S0092-8674(03)00984-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	758RV	14697199	Green Submitted, Bronze			2022-12-24	WOS:000187664700005
J	Stone, A				Stone, A			Audit of soap usage by a primary care team	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Canna Surg, Cardiff CF11 9EE, S Glam, Wales		Stone, A (corresponding author), Canna Surg, Cardiff CF11 9EE, S Glam, Wales.	alan_stone@btinternet.com						Cohen HA, 1998, INFECTION, V26, P49, DOI 10.1007/BF02768754; Cookson B, 1999, BRIT MED J, V318, P686; LARSON EL, 1995, AM J INFECT CONTROL, V23, P251, DOI 10.1016/0196-6553(95)90070-5; Rotter ML, 1997, HYG MED, V22, P332, DOI DOI 10.1136/BMJ.319.7208.518	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 20	2003	327	7429					1453	1454		10.1136/bmj.327.7429.1453	http://dx.doi.org/10.1136/bmj.327.7429.1453			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684644	Green Published			2022-12-24	WOS:000187562700015
J	Unger, DL				Unger, DL			One should never forget about heredity	LANCET			English	Editorial Material									Diplomate Amer Board Allergy & Immunol, Thousand Oaks, CA 91362 USA		Unger, DL (corresponding author), Diplomate Amer Board Allergy & Immunol, 1459 Thousand Oaks Blvd, Thousand Oaks, CA 91362 USA.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1934	1934		10.1016/S0140-6736(03)14969-0	http://dx.doi.org/10.1016/S0140-6736(03)14969-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667755				2022-12-24	WOS:000187011600029
J	Siveter, DJ; Sutton, MD; Briggs, DEG; Siveter, DJ				Siveter, DJ; Sutton, MD; Briggs, DEG; Siveter, DJ			An ostracode crustacean with soft parts from the lower silurian	SCIENCE			English	Article							FUNCTIONAL-MORPHOLOGY; HEREFORDSHIRE; ARTHROPOD; ENGLAND; MYODOCOPES; APPENDAGES	An exceptionally well-preserved ostracode from the Silurian of Herefordshire, United Kingdom, provides a rare view of the fossilized soft-part anatomy of this important group of living crustaceans and confirms that Ostracoda were extant in the Paleozoic. The fossil has striking similarity to the extant myodocopid family Cylindroleberididae, to which it is assigned, and demonstrates remarkable evolutionary stasis over 425 million years. The fossil is identified as a male on the basis of its copulatory organ.	Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; Univ Museum Nat Hist, Geol Collect, Oxford OX1 3PW, England	University of Leicester; University of Oxford; Yale University; University of Oxford	Siveter, DJ (corresponding author), Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England.	djs@leicester.ac.uk	Sutton, Mark/A-4189-2010					Briggs DEG, 1996, NATURE, V382, P248, DOI 10.1038/382248a0; Gabbott SE, 2003, LETHAIA, V36, P151, DOI 10.1080/00241160310004620; HIRUTA S, 1979, J FS HOKKAIDO U, V22, P9; Horne DJ, 2002, GEOPH MONOG SERIES, V131, P5; Hou XG, 1996, PHILOS T ROY SOC B, V351, P1131; KORNICKER LS, 1981, SMITHSON CONTRIB ZOO, V319, P1548; Muller K. J, 1979, P 7 INT S OSTR BEOGR, P5; Orr PJ, 2000, J GEOL SOC LONDON, V157, P173, DOI 10.1144/jgs.157.1.173; Parker AR, 1997, J MAR BIOL ASSOC UK, V77, P1223, DOI 10.1017/S002531540003873X; Parker AR, 1997, J CRUSTACEAN BIOL, V17, P632, DOI 10.2307/1549366; Siveter D.J., 1991, Journal of Micropalaeontology, V10, P151; SIVETER D. J, 1989, NATL MUSEUM WALES GE, V9, P252; SIVETER DJ, 1990, T ROY SOC EDIN-EARTH, V81, P45, DOI 10.1017/S0263593300005125; Smith RJ, 2000, PALAEONTOLOGY, V43, P63, DOI 10.1111/1475-4983.00119; Sutton MD, 2002, P ROY SOC B-BIOL SCI, V269, P1195, DOI 10.1098/rspb.2002.1986; Sutton MD, 2001, P ROY SOC B-BIOL SCI, V268, P2355, DOI 10.1098/rspb.2001.1788; Sutton MD, 2001, NATURE, V410, P461, DOI 10.1038/35068549; SUTTON MD, 2001, PALEONTOL ELECT, V4; Vannier J, 1998, MAR BIOL, V132, P391, DOI 10.1007/s002270050406; Vannier J, 1996, J CRUSTACEAN BIOL, V16, P453, DOI 10.2307/1548735; Walossek Dieter, 1993, Fossils and Strata, V32, P1; Yamaguchi S, 2003, MAR BIOL, V143, P23, DOI 10.1007/s00227-003-1062-3	22	106	115	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1749	1751		10.1126/science.1091376	http://dx.doi.org/10.1126/science.1091376			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657495				2022-12-24	WOS:000186970100043
J	Ariyo, AA; Thach, C; Tracy, R				Ariyo, AA; Thach, C; Tracy, R		Cardiovascular Hlth Study Investig	Lp(a) lipoprotein, vascular disease, and mortality in the elderly	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; INDEPENDENT RISK-FACTOR; ELEVATED LIPOPROTEIN(A); ATHEROTHROMBOTIC DISEASE; CEREBROVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CEREBRAL INFARCTION; MEN; WOMEN; JAPANESE	Background: As compared with what is known about predictors of vascular events in middle-aged persons, less is known about these events in the elderly. Lp(a) lipoprotein, which plays an important part in atherothrombogenesis, has been associated with an increased risk of vascular disease. We investigated this relation among older U.S. adults. Methods: In a prospective study of 5888 community-dwelling older adults (65 years of age or older) in the United States, 2375 women and 1597 men who were free of vascular disease provided base-line serum samples for analysis for levels of Lp(a) lipoprotein. These 3972 subjects were followed for a median of 7.4 years to evaluate the development of stroke and to track deaths from vascular causes and all causes. The men and women were divided into quintile groups according to the Lp(a) lipoprotein level at base line. Results: Using Cox proportional-hazards models, we determined the risk associated with each quintile level of Lp(a) lipoprotein, with the lowest quintile serving as the reference group. As compared with those in the lowest quintile, men in the highest quintile had three times the unadjusted risk of stroke (relative risk, 3.00; 95 percent confidence interval, 1.59 to 5.65), almost three times the risk of death associated with vascular events (relative risk, 2.54; 95 percent confidence interval, 1.59 to 4.08), and nearly twice the risk of death from all causes (relative risk, 1.76; 95 percent confidence interval, 1.31 to 2.36). Adjustment for age; sex; the levels of total cholesterol, low-density lipoprotein cholesterol, and triglycerides; carotid-wall thickness; smoking status; the presence or absence of diabetes and systolic and diastolic hypertension; body-mass index; and other traditional risk factors had little effect on the final assessments. Similar analyses for women, which also included adjustment for estrogen use or nonuse, revealed no such relation. Conclusions: Among older adults in the United States, an elevated level of Lp(a) lipoprotein is an independent predictor of stroke, death from vascular disease, and death from any cause in men but not in women. These data support the use of Lp(a) lipoprotein levels in predicting the risk of these events in older men.	HeartMasters, Ctr Cardiovasc Dis Prevent & Intervent, Dallas, TX 75212 USA; Johns Hopkins Univ Hosp, Div Cardiol, Baltimore, MD 21287 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Vermont, Dept Pathol, Burlington, VT 05405 USA	Johns Hopkins University; Johns Hopkins Medicine; University of Washington; University of Washington Seattle; University of Vermont	Ariyo, AA (corresponding author), HeartMasters, Ctr Cardiovasc Dis Prevent & Intervent, 2411 Poinciana Pl, Dallas, TX 75212 USA.				DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC015103] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-850079-85086, N01-HC-15103] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ariyo A, 1998, J Cardiovasc Risk, V5, P273, DOI 10.1097/00043798-199808000-00010; Assmann G, 1996, AM J CARDIOL, V77, P1179, DOI 10.1016/S0002-9149(96)00159-2; Bostom AG, 1996, JAMA-J AM MED ASSOC, V276, P544, DOI 10.1001/jama.276.7.544; BOSTOM AG, 1994, CIRCULATION, V90, P1688, DOI 10.1161/01.CIR.90.4.1688; CAMBILLAU M, 1992, ARTERIOSCLER THROMB, V12, P1346, DOI 10.1161/01.ATV.12.11.1346; Cantin B, 1998, J AM COLL CARDIOL, V31, P519, DOI 10.1016/S0735-1097(97)00528-7; COLEMAN MP, 1992, ATHEROSCLEROSIS, V92, P177, DOI 10.1016/0021-9150(92)90276-M; COX DR, 1972, J R STAT SOC B, V34, P187; Craig WY, 1998, CLIN CHEM, V44, P2301; Dahlen GH, 1998, J INTERN MED, V244, P425; Dangas G, 1998, J AM COLL CARDIOL, V32, P2035, DOI 10.1016/S0735-1097(98)00469-0; *DEP HLTH HHS, 1980, DHHS PUBL PHS; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; GAUBATZ JW, 1983, J BIOL CHEM, V258, P4582; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Kalbfleisch JD, 1980, STAT ANAL FAILURE TI; KANNEL WB, 1986, CORONARY HEART DISEA, P60; Kario K, 1996, ARTERIOSCL THROM VAS, V16, P734, DOI 10.1161/01.ATV.16.6.734; KARIO K, 1994, AM J CARDIOL, V73, P1187, DOI 10.1016/0002-9149(94)90179-1; Klausen IC, 1997, ATHEROSCLEROSIS, V132, P77, DOI 10.1016/S0021-9150(97)00071-3; LOSCALZO J, 1990, ARTERIOSCLEROSIS, V10, P672, DOI 10.1161/01.ATV.10.5.672; *MATHS, 1998, S PLUS WIND SYST REL; Nguyen TT, 1997, CIRCULATION, V96, P1390, DOI 10.1161/01.CIR.96.5.1390; RIDKER PM, 1993, JAMA-J AM MED ASSOC, V270, P2195, DOI 10.1001/jama.270.18.2195; RIDKER PM, 1995, JAMA-J AM MED ASSOC, V273, P1269, DOI 10.1001/jama.273.16.1269; *SAS I, 1996, SAS WIND SYST REL 6; SCHAEFER EJ, 1994, JAMA-J AM MED ASSOC, V271, P999, DOI 10.1001/jama.271.13.999; Schlaich MP, 1998, J AM COLL CARDIOL, V31, P359, DOI 10.1016/S0735-1097(97)00497-X; SHINTANI S, 1993, STROKE, V24, P965, DOI 10.1161/01.STR.24.7.965; SPENCER G, 1989, CURRENT POPULATI P25, V1018; Sunayama S, 1996, CIRCULATION, V94, P1263, DOI 10.1161/01.CIR.94.6.1263; Tell G S, 1993, Ann Epidemiol, V3, P358, DOI 10.1016/1047-2797(93)90062-9; Wild SH, 1997, ARTERIOSCL THROM VAS, V17, P239, DOI 10.1161/01.ATV.17.2.239; Wild SH, 1997, ARTERIOSCL THROM VAS, V17, P1010, DOI 10.1161/01.ATV.17.5.1010; WONG WLT, 1990, CLIN CHEM, V36, P192; ZENKER G, 1986, STROKE, V17, P942, DOI 10.1161/01.STR.17.5.942	36	181	194	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2003	349	22					2108	2115		10.1056/NEJMoa001066	http://dx.doi.org/10.1056/NEJMoa001066			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746ZV	14645638				2022-12-24	WOS:000186779700005
J	Varma, JK; Greene, KD; Reller, ME; DeLong, SM; Trottier, J; Nowicki, SF; DiOrio, M; Koch, EM; Bannerman, TL; York, ST; Lambert-Fair, MA; Wells, JG; Mead, PS				Varma, JK; Greene, KD; Reller, ME; DeLong, SM; Trottier, J; Nowicki, SF; DiOrio, M; Koch, EM; Bannerman, TL; York, ST; Lambert-Fair, MA; Wells, JG; Mead, PS			An outbreak of Escherichia coli O157 infection following exposure to a contaminated building	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DAIRY FARM FAMILIES; UNITED-STATES; RISK-FACTORS; SURVIVAL; CONTACT	Context Infection with Escherichia coli O157 causes an estimated 70000 diarrheal illnesses per year in the United States and can result in hemolytic-uremic syndrome and death. Environmental contamination with E coli O157 may be a public health problem. Objectives To determine risk factors for E coli O157 infection during an outbreak investigation at a county fair and to evaluate environmental contamination as a possible cause of the outbreak. Design, Setting, and Participants Case-control study of 23 patients (median age, 15 years) and 53 age-matched controls who had attended the Lorain County, Ohio, fair between August 20 and August 26, 2001. Case-patients had laboratory-confirmed E coli O157 infection, hemolytic-uremic syndrome, or bloody diarrhea within 7 days of attending the fair; controls attended the fair and did not have diarrhea. Main Outcome Measures Risk factors for infection and isolates of E coli O157 from environmental specimens. Results Six (26%) case-patients were hospitalized and 2 (9%) developed hemolyticuremic syndrome. Case-patients were more likely than controls to have visited building A (a multipurpose community facility on the fairgrounds; matched odds ratio [MOR], 21.4 [95% confidence interval {CI), 2.7-170.7]). Among visitors to building A, illness was independently associated with attending a dance in the building (MOR, 7.5; 95% CI, 1.4-41.2), handling sawdust from the floor (MOR, 4.6; 95% CI, 1.1-20.0), or eating and/or drinking in the building (MOR, 4.5; 95% CI, 1.2-16.6). Twenty-four (44%) of 54 specimens collected from building A 6 weeks after the fair grew Shiga toxin-producing E coli O157. Isolates from sawdust, the rafters, and other surfaces were identical by molecular fingerprinting to patient isolates. Sawdust specimens collected 42 weeks after the fair also grew the same E coli O157 strain. Conclusions Absence of evidence implicating specific food or beverage sources and the recovery of E coli O157 from the rafters suggest that airborne dispersion of bacteria contributed to the contamination. Because E coli O157 can survive in the environment for more than 10 months, humans may be at risk of infection long after an environment is initially contaminated.	Ctr Dis Control & Prevent, Food & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA USA; Ohio Dept Hlth, Elyria, OH USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Varma, JK (corresponding author), CDC HIV, TB Prevent & Control Sect, Box 68,Amer Embassy, APO, AP 96546 USA.		Bannerman, Tammy/E-2694-2011					Browning N.D., 2000, REV ADV MATER SCI, V1, P1; *CDCP, 2000, STAND MOL SUBT FOODB; *CDCP, 2000, FOODB DIS ACT SURV N, P19; Crampin M, 1999, EUR J CLIN MICROBIOL, V18, P286, DOI 10.1007/s100960050278; Crump JA, 2002, NEW ENGL J MED, V347, P555, DOI 10.1056/NEJMoa020524; CRUMP JA, IN PRESS EPIDEMIOL I; DOYLE MP, 1987, APPL ENVIRON MICROB, V53, P2394, DOI 10.1128/AEM.53.10.2394-2396.1987; Fields PI, 1997, J CLIN MICROBIOL, V35, P1066, DOI 10.1128/JCM.35.5.1066-1070.1997; Kudva IT, 1998, APPL ENVIRON MICROB, V64, P3166; Locking ME, 2001, EPIDEMIOL INFECT, V127, P215, DOI 10.1017/S0950268801006045; Mead PS, 1997, ARCH INTERN MED, V157, P204, DOI 10.1001/archinte.157.2.204; Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; O'Brien SJ, 2001, EMERG INFECT DIS, V7, P1049, DOI 10.3201/eid0706.010626; Ogden ID, 2002, LETT APPL MICROBIOL, V34, P100, DOI 10.1046/j.1472-765x.2002.01052.x; OLSVIK O, 1991, MOL CELL PROBE, V5, P429, DOI 10.1016/S0890-8508(05)80014-3; Rahn K, 1998, J INFECT DIS, V177, P1139, DOI 10.1086/517394; Reymond D, 1996, J CLIN MICROBIOL, V34, P2053, DOI 10.1128/JCM.34.9.2053-2057.1996; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; WELLS JG, 1999, 99 GEN M AM SOC MICR; Wilson JB, 1996, J INFECT DIS, V174, P1021, DOI 10.1093/infdis/174.5.1021; 2001, MMWR MORB MORTAL WKL, V50, P293	22	112	122	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2003	290	20					2709	2712		10.1001/jama.290.20.2709	http://dx.doi.org/10.1001/jama.290.20.2709			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	747CR	14645313	Bronze			2022-12-24	WOS:000186788100023
J	Pak, DTS; Sheng, M				Pak, DTS; Sheng, M			Targeted protein degradation and synapse remodeling by an inducible protein kinase	SCIENCE			English	Article							LONG-TERM POTENTIATION; POLO-LIKE KINASES; DENDRITIC SPINES; EXCITATORY SYNAPSES; PLASTICITY; ACTIN; UBIQUITIN; MITOSIS	Synaptic plasticity involves the reorganization of synapses at the protein and the morphological levels. Here, we report activity-dependent remodeling of synapses by serum-inducible kinase (SNK). SNK was induced in hippocampal neurons by synaptic activity and was targeted to dendritic spines. SNK bound to and phosphorylated spine-associated Rap guanosine triphosphatase activating protein (SPAR), a postsynaptic actin regulatory protein, leading to degradation of SPAR. Induction of SNK in hippocampal neurons eliminated SPAR protein, depleted postsynaptic density-95 and Bassoon clusters, and caused loss of mature dendritic spines. These results implicate SNK as a mediator of activity-dependent change in the molecular composition and morphology of synapses.	MIT, Howard Hughes Med Inst, Neurosci Res Ctr, RIKEN,Picower Ctr Learning & Memory, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN	Pak, DTS (corresponding author), MIT, Howard Hughes Med Inst, Neurosci Res Ctr, RIKEN,Picower Ctr Learning & Memory, Cambridge, MA 02139 USA.			Sheng, Morgan/0000-0002-8703-5366				BAILEY CH, 1989, J NEUROBIOL, V20, P356, DOI 10.1002/neu.480200508; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; El-Hussein AE, 2000, SCIENCE, V290, P1364; Feng Y, 2001, CELL GROWTH DIFFER, V12, P29; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Gao QS, 1999, MOL CELL BIOL, V19, P733; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Kim CH, 1999, J NEUROSCI, V19, P4314; Kotani S, 1998, MOL CELL, V1, P371, DOI 10.1016/S1097-2765(00)80037-4; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Matus A, 2000, HIPPOCAMPUS, V10, P555, DOI 10.1002/1098-1063(2000)10:5<555::AID-HIPO5>3.0.CO;2-Z; Murphey RK, 2002, NEURON, V36, P5, DOI 10.1016/S0896-6273(02)00943-1; Nedivi E, 1999, J NEUROBIOL, V41, P135, DOI 10.1002/(SICI)1097-4695(199910)41:1<135::AID-NEU17>3.0.CO;2-F; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; SIMMONS DL, 1992, MOL CELL BIOL, V12, P4164, DOI 10.1128/MCB.12.9.4164; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	28	233	244	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2003	302	5649					1368	1373		10.1126/science.1082475	http://dx.doi.org/10.1126/science.1082475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14576440				2022-12-24	WOS:000186683500044
J	Dacey, MJ				Dacey, MJ			Tragedy and response - The Rhode Island nightclub fire	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Kent Cty Hosp, Dept Crit Care Med, Warwick, RI 02886 USA		Dacey, MJ (corresponding author), Kent Cty Hosp, Dept Crit Care Med, Warwick, RI 02886 USA.								0	27	27	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2003	349	21					1990	1992		10.1056/NEJMp038179	http://dx.doi.org/10.1056/NEJMp038179			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744QE	14627783				2022-12-24	WOS:000186642900002
J	Friml, J; Vieten, A; Sauer, M; Weijers, D; Schwarz, H; Hamann, T; Offringa, R; Jurgens, G				Friml, J; Vieten, A; Sauer, M; Weijers, D; Schwarz, H; Hamann, T; Offringa, R; Jurgens, G			Efflux-dependent auxin gradients establish the apical-basal axis of Arabidopsis	NATURE			English	Article							GNOM ARF-GEF; PATTERN-FORMATION; MORPHOGEN GRADIENTS; POLAR TRANSPORT; PLANT; EMBRYO; GENE; CELLS; ROOT; EMBRYOGENESIS	Axis formation occurs in plants, as in animals, during early embryogenesis. However, the underlying mechanism is not known. Here we show that the first manifestation of the apical-basal axis in plants, the asymmetric division of the zygote, produces a basal cell that transports and an apical cell that responds to the signalling molecule auxin. This apical-basal auxin activity gradient triggers the specification of apical embryo structures and is actively maintained by a novel component of auxin efflux, PIN7, which is located apically in the basal cell. Later, the developmentally regulated reversal of PIN7 and onset of PIN1 polar localization reorganize the auxin gradient for specification of the basal root pole. An analysis of pin quadruple mutants identifies PIN-dependent transport as an essential part of the mechanism for embryo axis formation. Our results indicate how the establishment of cell polarity, polar auxin efflux and local auxin response result in apical-basal axis formation of the embryo, and thus determine the axiality of the adult plant.	Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany; Leiden Univ, Clusius Lab, Inst Biol, NL-2333 AL Leiden, Netherlands; Max Planck Inst Dev Biol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Leiden University; Leiden University - Excl LUMC; Max Planck Society	Friml, J (corresponding author), Univ Tubingen, Zentrum Mol Biol Pflanzen, Morgenstelle 3, D-72076 Tubingen, Germany.		Sauer, Michael/F-6519-2014; Weijers, Dolf/ABI-1332-2020; Weijers, Dolf/A-2076-2010; Friml, Jiri/D-9511-2012; Sauer, Michael/G-3424-2011	Sauer, Michael/0000-0002-4014-9825; Weijers, Dolf/0000-0003-4378-141X; Weijers, Dolf/0000-0003-4378-141X; Friml, Jiri/0000-0002-8302-7596; 				Braselton JP, 1996, BIOTECH HISTOCHEM, V71, P84, DOI 10.3109/10520299609117139; CARUSO JL, 1995, PLANT HORMONES PHYSL, P43; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Fischer-Iglesias C, 2001, PLANT J, V26, P115, DOI 10.1046/j.1365-313x.2001.01013.x; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, PLANT MOL BIOL, V49, P273, DOI 10.1023/A:1015248926412; Friml J, 2003, PLANT J, V34, P115, DOI 10.1046/j.1365-313X.2003.01705.x; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Hadfi K, 1998, DEVELOPMENT, V125, P879; Hamann T, 1999, DEVELOPMENT, V126, P1387; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Haseloff J, 1999, METHOD CELL BIOL, V58, P139; Jurgens G, 2001, EMBO J, V20, P3609, DOI 10.1093/emboj/20.14.3609; LIU CM, 1993, PLANT CELL, V5, P621, DOI 10.1105/tpc.5.6.621; Lyczak R, 2002, DEV CELL, V3, P157, DOI 10.1016/S1534-5807(02)00226-5; MAYER U, 1991, NATURE, V353, P402, DOI 10.1038/353402a0; MAYER U, 1993, DEVELOPMENT, V117, P149; Moctezuma E, 1999, ANN BOT-LONDON, V83, P235, DOI 10.1006/anbo.1998.0814; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; RAVEN JA, 1975, NEW PHYTOL, V74, P163, DOI 10.1111/j.1469-8137.1975.tb02602.x; Ribnicky DM, 2002, PLANTA, V214, P505, DOI 10.1007/s004250100639; RUBERY PH, 1974, PLANTA, V118, P101, DOI 10.1007/BF00388387; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; STJOHNSTON D, 1992, CELL, V68, P201; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Tabata T, 2001, NAT REV GENET, V2, P620, DOI 10.1038/35084577; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Weijers D, 2001, NATURE, V414, P709, DOI 10.1038/414709a; WEIJERS D, 2002, THESIS U LEIDEN; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5	39	1339	1423	15	348	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2003	426	6963					147	153		10.1038/nature02085	http://dx.doi.org/10.1038/nature02085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614497				2022-12-24	WOS:000186517200034
J	Lane, AA; Ley, TJ				Lane, AA; Ley, TJ			Neutrophil elastase cleaves PML-RAR alpha and is important for the development of acute promyelocytic leukemia in mice	CELL			English	Article							DIPEPTIDYL PEPTIDASE-I; RECURRING CHROMOSOMAL-ABNORMALITIES; TRANS-RETINOIC ACID; CATHEPSIN-G; PML/RAR-ALPHA; SERINE PROTEASES; FUSION PROTEIN; MOUSE MODEL; GRANZYME-B; CELL	The fusion protein PML-RARalpha, generated by the t(15;17)(q22;q11.2) translocation associated with acute promyelocytic leukemia (APL), initiates APL when expressed in the early myeloid compartment of transgenic mice. PML-RARalpha is cleaved in several positions by a neutral serine protease in a human myeloid cell line; purification revealed that the protease is neutrophil elastase (NE). Immunofluorescence localization studies suggested that the cleavage of PML-RARalpha must occur within the cell, and perhaps, within the nucleus. The functional importance of NE for APL development was assessed in NE deficient mice. Greater than 90% of bone marrow PML-RARalpha cleaving activity was lost in the absence of NE, and NE (but not Cathepsin G) deficient animals were protected from APL development. Primary mouse and human APL cells also contain NE-dependent PML-RARalpha cleaving activity. Since NE is maximally produced in promyelocytes, this protease may play a role in APL pathogenesis by facilitating the leukemogenic potential of PML-RARalpha.	Washington Univ, Sch Med, Siteman Canc Ctr, Dept Med,Div Oncol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Siteman Canc Ctr, Dept Genet,Div Oncol, St Louis, MO 63110 USA	Siteman Cancer Center; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Ley, TJ (corresponding author), Washington Univ, Sch Med, Siteman Canc Ctr, Dept Med,Div Oncol, St Louis, MO 63110 USA.	tley@im.wustl.edu		Lane, Andrew/0000-0001-7380-0226	NATIONAL CANCER INSTITUTE [R01CA083962] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007088] Funding Source: NIH RePORTER; NCI NIH HHS [CA83962] Funding Source: Medline; NHLBI NIH HHS [T32 HLO 7088] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Bird CH, 2001, MOL CELL BIOL, V21, P5396, DOI 10.1128/MCB.21.16.5396-5407.2001; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brown D, 1997, P NATL ACAD SCI USA, V94, P2551, DOI 10.1073/pnas.94.6.2551; CAMPBELL EJ, 1989, J IMMUNOL, V143, P2961; Early E, 1996, P NATL ACAD SCI USA, V93, P7900, DOI 10.1073/pnas.93.15.7900; Fanelli M, 1999, BLOOD, V93, P1477, DOI 10.1182/blood.V93.5.1477.405a33_1477_1481; Ferrucci PF, 1997, P NATL ACAD SCI USA, V94, P10901, DOI 10.1073/pnas.94.20.10901; FOURET P, 1989, J EXP MED, V169, P833, DOI 10.1084/jem.169.3.833; GALLAGHER RE, 1995, BLOOD, V86, P1540, DOI 10.1182/blood.V86.4.1540.bloodjournal8641540; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Grisolano JL, 1997, BLOOD, V89, P376, DOI 10.1182/blood.V89.2.376; He LZ, 1997, P NATL ACAD SCI USA, V94, P5302, DOI 10.1073/pnas.94.10.5302; Horwitz M, 2003, CURR OPIN HEMATOL, V10, P49, DOI 10.1097/00062752-200301000-00008; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Jans DA, 1998, J CELL SCI, V111, P2645; Jans DA, 1996, J BIOL CHEM, V271, P30781, DOI 10.1074/jbc.271.48.30781; Jing Y, 2003, ONCOGENE, V22, P4083, DOI 10.1038/sj.onc.1206568; Kelly LM, 2002, P NATL ACAD SCI USA, V99, P8283, DOI 10.1073/pnas.122233699; Kogan SC, 2001, J EXP MED, V193, P531, DOI 10.1084/jem.193.4.531; Le Beau MM, 2003, BLOOD, V102, P1072, DOI 10.1182/blood-2003-01-0155; Le Beau MM, 2002, BLOOD, V99, P2985, DOI 10.1182/blood.V99.8.2985; Le XF, 1996, J BIOL CHEM, V271, P130, DOI 10.1074/jbc.271.1.130; MacIvor DM, 1999, BLOOD, V94, P4282, DOI 10.1182/blood.V94.12.4282.424k45_4282_4293; Mcdonold SJF, 2001, BIOORG MED CHEM LETT, V11, P895, DOI 10.1016/S0960-894X(01)00078-6; MCGUIRE MJ, 1993, J BIOL CHEM, V268, P2458; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Minucci S, 2002, BLOOD, V100, P2989, DOI 10.1182/blood-2001-11-0089; OWEN CA, 1995, J CELL BIOL, V131, P775, DOI 10.1083/jcb.131.3.775; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Pollock JL, 2001, CURR OPIN HEMATOL, V8, P206, DOI 10.1097/00062752-200107000-00005; Sohal J, 2003, BLOOD, V101, P3188, DOI 10.1182/blood-2002-06-1800; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; Trapani JA, 1996, J BIOL CHEM, V271, P4127; TURHAN AG, 1995, BLOOD, V85, P2154, DOI 10.1182/blood.V85.8.2154.bloodjournal8582154; WELGUS HG, 1986, J CLIN INVEST, V77, P1675, DOI 10.1172/JCI112485; Westervelt P, 2003, BLOOD, V102, P1857, DOI 10.1182/blood-2002-12-3779; Westervelt P, 1999, BLOOD, V93, P2143, DOI 10.1182/blood.V93.7.2143.407a32_2143_2148; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807; ZIMMER M, 1992, P NATL ACAD SCI USA, V89, P8215, DOI 10.1073/pnas.89.17.8215; Zimonjic DB, 2000, P NATL ACAD SCI USA, V97, P13306, DOI 10.1073/pnas.97.24.13306	45	103	125	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2003	115	3					305	318		10.1016/S0092-8674(03)00852-3	http://dx.doi.org/10.1016/S0092-8674(03)00852-3			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	740RH	14636558	Bronze			2022-12-24	WOS:000186415000010
J	Pang, XH; Zhu, ZH; Xu, FJ; Guo, JY; Gong, XH; Liu, DL; Liu, ZJ; Chin, DP; Feikin, DR				Pang, XH; Zhu, ZH; Xu, FJ; Guo, JY; Gong, XH; Liu, DL; Liu, ZJ; Chin, DP; Feikin, DR			Evaluation of control measures implemented in the severe acute respiratory syndrome outbreak in Beijing, 2003	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SYNDROME SARS	Context Beijing, China, experienced the world's largest outbreak of severe acute respiratory syndrome (SARS) beginning in March 2003, with the outbreak resolving rapidly, within 6 weeks of its peak in late April. Little is known about the control measures implemented during this outbreak. Objective To describe and evaluate the measures undertaken to control the SARS outbreak. Design, Setting, and Participants Data were reviewed from standardized surveillance forms from SARS cases (2521 probable cases) and their close contacts observed in Beijing between March 5, 2003, and May 29, 2003. Procedures implemented by health authorities were investigated through review of official documents and discussions with public health officials.' Main Outcome Measures Timeline of major control measures; number of cases and quarantined close contacts and attack rates, with changes in infection control measures, management, and triage of suspected cases; and time lag between illness onset and hospitalization with information dissemination. Results Healthcare worker training in use of personal protective equipment and management of patients with SARS and establishing fever clinics and designated SARS wards in hospitals predated the steepest decline in cases. During the outbreak, 30178 persons were quarantined. Among 2195 quarantined close contacts in 5 districts, the attack rate was 6.3 % (95% confidence interval [CI], 5.3 % -7.3 %), with a range of 15.4% (95% Cl, 11.5%-19.2%) among spouses to 0.36% (95% CI, 0%-0.77%) among work and school contacts. The attack rate among quarantined household members increased with age from 5.0% (95 % Cl, 0% -10.5%) in children younger than 10 years to 27.6% (95% Cl, 18.2%-37.0%) in adults aged 60 to 69 years. Among almost 14 million people screened for fever at the airport, train stations, and roadside checkpoints, only 12 were found to have probable SARS. The national and municipal governments held 13 press conferences about SARS. The time lag between illness onset and hospitalization decreased from a median of 5 to 6 days on or before April 20, 2003, the day the outbreak was announced to the public, to 2 days after April 20 (P<.001). Conclusions The rapid resolution of the SARS outbreak was multifactorial, involving improvements in management and triage in hospitals and communities of patients with suspected SARS and the dissemination of information to health care workers and the public.	CDCP, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China; Beijing Municipal Hlth Bur, Beijing, Peoples R China; WHO, China Off, Beijing, Peoples R China	Centers for Disease Control & Prevention - USA; World Health Organization	Feikin, DR (corresponding author), CDCP, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, 1600 Clifton Rd,Mailstop C23, Atlanta, GA 30333 USA.	drf0@cdc.gov						Ashraf H, 2003, LANCET, V361, P2212, DOI 10.1016/S0140-6736(03)13790-7; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P462; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P680; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P405; Hsu LY, 2003, EMERG INFECT DIS, V9, P713; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; LIANG W, 2003, EMERG INFECT DIS; *MIN HLTH ED COMM, 2002, CHIN HLTH YB 2002, P514; PEIRIS JSM, LANCET; Twu SJ, 2003, EMERG INFECT DIS, V9, P718; *WHO, UPD 87 WHO CHANG LAS; *WHO, 2003, WKLY EPIDEMIOL REC, V78, P181; *WHO, 2003, WKLY EPIDEMIOL REC, V78, P137; World Health Organization, SUMM PROB SARS CAS O; [谢淑云 Xie Shuyun], 2003, [中华流行病学杂志, Chinese Journal of Epidemiology], V24, P449; SARS CASE DISTRIBUTI	17	156	165	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2003	290	24					3215	3221		10.1001/jama.290.24.3215	http://dx.doi.org/10.1001/jama.290.24.3215			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	756TR	14693874				2022-12-24	WOS:000187499300025
J	Benton, R; St Johnston, D				Benton, R; St Johnston, D			Drosophila PAR-1 and 14-3-3 inhibit Bazooka/PAR-3 to establish complementary cortical domains in polarized cells	CELL			English	Article							EPITHELIAL TIGHT JUNCTION; PROTEIN-KINASE-C; CAENORHABDITIS-ELEGANS; AXIS FORMATION; OOCYTE DIFFERENTIATION; LOCALIZATION; MAINTENANCE; NEUROBLASTS; TUMOR; STARDUST	PAR-1 kinases are required for polarity in diverse cell types, such as epithelial cells, where they localize laterally. PAR-1 activity is believed to be transduced by binding of 14-3-3 proteins to its phosphorylated substrates, but the relevant targets are unknown. We show that PAR-1 phosphorylates Bazooka/PAR-3 on two conserved serines to generate 14-3-3 binding sites. This inhibits formation of the Bazooka/PAR-6/ aPKC complex by blocking Bazooka oligomerization and binding to aPKC. In epithelia, this complex localizes apically and defines the apical membrane, whereas Bazooka lacking PAR-1 phosphorylation/14-3-3 binding sites forms ectopic lateral complexes. Lateral exclusion by PAR-1/14-3-3 cooperates with apical anchoring by Crumbs/Stardust to restrict Bazooka localization, and loss of both pathways disrupts epithelial polarity. PAR-1 also excludes Bazooka from the posterior of the oocyte, and disruption of this regulation causes anterior-posterior polarity defects. Thus, antagonism of Bazooka by PAR-1/14-3-3 may represent a general mechanism for establishing complementary cortical domains in polarized cells.	Univ Cambridge, Wellcome Trust Canc Res UK Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge	St Johnston, D (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Inst, Cambridge CB2 1QR, England.		St Johnston, Daniel/C-9568-2009	St Johnston, Daniel/0000-0001-5582-3301				Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Benton R, 2003, CURR BIOL, V13, P1330, DOI 10.1016/S0960-9822(03)00508-6; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Cox DN, 2001, CURR BIOL, V11, P75, DOI 10.1016/S0960-9822(01)00027-6; Cox DN, 2001, P NATL ACAD SCI USA, V98, P14475, DOI 10.1073/pnas.261565198; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Doerflinger H, 2003, DEVELOPMENT, V130, P3965, DOI 10.1242/dev.00616; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Goldstein B, 1996, DEVELOPMENT, V122, P1467; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; Hausser A, 1999, J BIOL CHEM, V274, P9258, DOI 10.1074/jbc.274.14.9258; Hirose T, 2002, J CELL SCI, V115, P2485; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; HURD TW, 2003, IN PRESS CURR BIOL; Huynh JR, 2001, DEVELOPMENT, V128, P1201; Huynh JR, 2001, CURR BIOL, V11, P901, DOI 10.1016/S0960-9822(01)00244-5; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; James P, 1996, GENETICS, V144, P1425; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lyczak R, 2002, DEV CELL, V3, P157, DOI 10.1016/S1534-5807(02)00226-5; Mizuno K, 2003, J BIOL CHEM, V278, P31240, DOI 10.1074/jbc.M303593200; Morton DG, 2002, DEV BIOL, V241, P47, DOI 10.1006/dbio.2001.0489; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nagai-Tamai Y, 2002, GENES CELLS, V7, P1161, DOI 10.1046/j.1365-2443.2002.00590.x; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Pielage J, 2003, DEV CELL, V5, P841, DOI 10.1016/S1534-5807(03)00358-7; Riechmann V, 2001, CURR OPIN GENET DEV, V11, P374, DOI 10.1016/S0959-437X(00)00207-0; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Rose LS, 1998, ANNU REV GENET, V32, P521, DOI 10.1146/annurev.genet.32.1.521; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Tomancak P, 2000, NAT CELL BIOL, V2, P458, DOI 10.1038/35017101; Vaccari T, 2002, CURR BIOL, V12, P1524, DOI 10.1016/S0960-9822(02)01079-5; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; XU T, 1993, DEVELOPMENT, V117, P1223; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4	53	319	320	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 12	2003	115	6					691	704		10.1016/S0092-8674(03)00938-3	http://dx.doi.org/10.1016/S0092-8674(03)00938-3			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675534	Bronze			2022-12-24	WOS:000187366100009
J	Gross, JD; Moerke, NJ; von der Haar, T; Lugovskoy, AA; Sachs, AB; McCarthy, JEG; Wagner, G				Gross, JD; Moerke, NJ; von der Haar, T; Lugovskoy, AA; Sachs, AB; McCarthy, JEG; Wagner, G			Ribosome loading onto the mRNA cap is driven by conformational coupling between eIF4G and eIF4E	CELL			English	Article							DEPENDENT TRANSLATION INITIATION; FACTOR 4G EIF4G; PROTEIN-SYNTHESIS; BINDING-PROTEIN; POLY(A)-BINDING PROTEIN; FACTOR EIF-4E; 4E BINDING; FACTOR 4F; YEAST; PHOSPHORYLATION	The eukaryotic initiation factor 4G (eIF4G) is the core of a multicomponent switch controlling gene expression at the level of translation initiation. It interacts with the small ribosomal subunit interacting protein eIF3, and the eIF4E/cap-mRNA complex in order to load the ribosome onto mRNA during cap-dependent translation. We describe the solution structure of the complex between yeast eIF4E/cap and eIF4G (393490). Binding triggers a coupled folding transition of eIF4G (393-490) and the eIF4E N terminus resulting in a molecular bracelet whereby eIF4G (393-490) forms a right-handed helical ring that wraps around the N terminus of eIF4E. Cofolding allosterically enhances association of eIF4E with the cap and is required for maintenance of optimal growth and polysome distributions in vivo. Our data explain how mRNA, eIF4E, and eIF4G exists as a stable mRNP that may facilitate multiple rounds of ribosomal loading during translation initiation, a key determinant in the overall rate of protein synthesis.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Grad Program Biol & Biomed Sci, Boston, MA 02115 USA; Univ Manchester, Inst Sci & Technol, Posttranscript Control Grp, Dept Biomol Sci, Manchester M60 1QD, Lancs, England; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Manchester; University of California System; University of California Berkeley	Wagner, G (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	gerhard_wagner@hms.harvard.edu		von der Haar, Tobias/0000-0002-6031-9254	NATIONAL CANCER INSTITUTE [R01CA068262] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER; NCI NIH HHS [CA68262] Funding Source: Medline; NCRR NIH HHS [RR00995] Funding Source: Medline; NIGMS NIH HHS [GM47467, P01 GM047467] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; ALTMANN M, 1987, MOL CELL BIOL, V7, P998, DOI 10.1128/MCB.7.3.998; Asano K, 2001, EMBO J, V20, P2326, DOI 10.1093/emboj/20.9.2326; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; BENNE R, 1976, P NATL ACAD SCI USA, V73, P3005, DOI 10.1073/pnas.73.9.3005; Berset C, 2003, RNA, V9, P871, DOI 10.1261/rna.5380903; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BRUNGER AT, 1996, X PLOR VERSION 3 851; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P1624, DOI 10.1021/bi00220a026; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; ETCHISON D, 1982, J BIOL CHEM, V257, P4806; Fletcher CM, 1998, BIOCHEMISTRY-US, V37, P9, DOI 10.1021/bi972494r; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Haghighat A, 1997, J BIOL CHEM, V272, P21677, DOI 10.1074/jbc.272.35.21677; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; He H, 2003, MOL CELL BIOL, V23, P5431, DOI 10.1128/MCB.23.15.5431-5445.2003; Hentze MW, 1997, SCIENCE, V275, P500, DOI 10.1126/science.275.5299.500; Hershey J. W. B., 2000, TRANSLATIONAL CONTRO; Hershey PEC, 1999, J BIOL CHEM, V274, P21297, DOI 10.1074/jbc.274.30.21297; IIZUKA N, 1994, MOL CELL BIOL, V14, P7322, DOI 10.1128/MCB.14.11.7322; Jacobson A, 1996, TRANSLATIONAL CONTRO; Karim MM, 2001, J BIOL CHEM, V276, P20750, DOI 10.1074/jbc.M011068200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE KAW, 1982, P NATL ACAD SCI-BIOL, V79, P3447, DOI 10.1073/pnas.79.11.3447; Luo YJ, 2001, J BIOL CHEM, V276, P43083, DOI 10.1074/jbc.M104970200; MADER S, 1995, MOL CELL BIOL, V15, P4990; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Ohlmann T, 1997, EMBO J, V16, P844, DOI 10.1093/emboj/16.4.844; OLIVEIRA CC, 1993, MOL MICROBIOL, V9, P521, DOI 10.1111/j.1365-2958.1993.tb01713.x; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pestova TV, 1996, MOL CELL BIOL, V16, P6870; Prevot D, 2003, BIOL CELL, V95, P141, DOI 10.1016/S0248-4900(03)00031-5; Ptushkina M, 1999, EMBO J, V18, P4068, DOI 10.1093/emboj/18.14.4068; Ptushkina M, 1998, EMBO J, V17, P4798, DOI 10.1093/emboj/17.16.4798; RAUGHT B, 2000, TRANSLATIONAL CONTRO; Richter JD, 2000, COLD SPRING HARBOR M, V39, P785; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Scheper GC, 2002, J BIOL CHEM, V277, P3303, DOI 10.1074/jbc.M103607200; SHA M, 1995, J BIOL CHEM, V270, P29904; Tarun SZ, 1997, MOL CELL BIOL, V17, P6876, DOI 10.1128/MCB.17.12.6876; Uchida N, 2002, J BIOL CHEM, V277, P50286, DOI 10.1074/jbc.M203029200; Vasilescu S, 1996, J BIOL CHEM, V271, P7030, DOI 10.1074/jbc.271.12.7030; von der Haar T, 2000, J BIOL CHEM, V275, P30551, DOI 10.1074/jbc.M004565200; von der Haar T, 2002, MOL MICROBIOL, V46, P531, DOI 10.1046/j.1365-2958.2002.03172.x; Wei CC, 1998, BIOCHEMISTRY-US, V37, P1910, DOI 10.1021/bi9724570; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7	56	269	273	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2003	115	6					739	750		10.1016/S0092-8674(03)00975-9	http://dx.doi.org/10.1016/S0092-8674(03)00975-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675538	Bronze			2022-12-24	WOS:000187366100013
J	McGuire, SE; Le, PT; Osborn, AJ; Matsumoto, K; Davis, RL				McGuire, SE; Le, PT; Osborn, AJ; Matsumoto, K; Davis, RL			Spatiotemporal rescue of memory dysfunction in Drosophila	SCIENCE			English	Article							MUSHROOM BODIES; ADENYLATE-CYCLASE; EXPRESSION; ACQUISITION; RUTABAGA; GENE	We have developed a method for temporal and regional gene expression targeting (TARGET) in Drosophila and show the simultaneous spatial and temporal rescue of a memory defect. The transient expression of the rutabaga-encoded adenylyl cyclase in the mushroom bodies of the adult brain was necessary and sufficient to rescue the rutabaga memory deficit, which rules out a developmental brain defect in the etiology of this deficit and demonstrates an acute role for rutabaga in memory formation in these neurons. The TARGET system offers general utility in simultaneously addressing issues of when and where gene products are required.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648602, Japan	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Nagoya University	Davis, RL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	rdavis@bcm.tmc.edu	Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019904] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM63929] Funding Source: Medline; NINDS NIH HHS [NS19904] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdel-Majid RM, 1998, NAT GENET, V19, P289, DOI 10.1038/980; Armstrong JD, 1998, LEARN MEMORY, V5, P102; BALLING A, 1987, J NEUROGENET, V4, P65, DOI 10.3109/01677068709102334; Barth M, 1997, LEARN MEMORY, V4, P219, DOI 10.1101/lm.4.2.219; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; BRAND AH, 1993, DEVELOPMENT, V118, P401; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; DUDAI Y, 1988, J COMP PHYSIOL A, V162, P101, DOI 10.1007/BF01342707; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; Hitier R, 1998, NEUROREPORT, V9, P2717, DOI 10.1097/00001756-199808240-00006; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Poser S, 2001, INT J DEV NEUROSCI, V19, P387, DOI 10.1016/S0736-5748(00)00094-0; Roman G, 2001, BIOESSAYS, V23, P571, DOI 10.1002/bies.1083; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; Welker E, 1996, SCIENCE, V271, P1864, DOI 10.1126/science.271.5257.1864; YANG MY, 1995, NEURON, V15, P45; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	19	918	932	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2003	302	5651					1765	1768		10.1126/science.1089035	http://dx.doi.org/10.1126/science.1089035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657498				2022-12-24	WOS:000186970100048
J	Zuber, MT				Zuber, MT			Planetary science - Learning to think like Martians	SCIENCE			English	Editorial Material							CARBON-DIOXIDE; BEHAVIOR; MARS/; TES		MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Zuber, MT (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.							BOYNTON WV, 2003, 3 INT C MARS POL SCI; FELDMAN WC, 2003, 3 INT C MARS POL SCI; Haberle R.M, 2003, 3 INT C MARS POL SCI; Kieffer HH, 2000, J GEOPHYS RES-PLANET, V105, P9653, DOI 10.1029/1999JE001136; KIEFFER HH, 2003, 3 INT C MARS POL SCI; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; LITVAK ML, 2003, 3 INT C MARS POL SCI; LONGHI J, 2003, 3 INT C MARS POL SCI; Malin MC, 2001, SCIENCE, V294, P2146, DOI 10.1126/science.1066416; Smith DE, 2001, SCIENCE, V294, P2141, DOI 10.1126/science.1066556; SMITH DE, 2003, 3 INT C MARS POL SCI; Titus TN, 2001, J GEOPHYS RES-PLANET, V106, P23181, DOI 10.1029/2000JE001284; ZUBER MT, 2003, 3 INT C MAR POL SCI; 2003, 3 INT C MARS POL SCI	14	8	8	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1694	1695		10.1126/science.1090517	http://dx.doi.org/10.1126/science.1090517			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657483				2022-12-24	WOS:000186970100030
J	Lorenz, K; Lohse, MJ; Quitterer, U				Lorenz, K; Lohse, MJ; Quitterer, U			Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2	NATURE			English	Article							ADRENERGIC-RECEPTOR KINASE; BETA-GAMMA-SUBUNITS; PHOSPHORYLATION; DESENSITIZATION; HETERODIMERS; SUPPRESSION; ACTIVATION; TERMINUS; BINDING	Feedback inhibition is a fundamental principle in signal transduction allowing rapid adaptation to different stimuli. In mammalian cells, the major feedback inhibitor for G-protein-coupled receptors (GPCR) is G-protein-coupled receptor kinase 2 (GRK-2), which phosphorylates activated receptors, uncouples them from G proteins and initiates their internalization(1,2). The functions of GRK-2 are indispensable and need to be tightly controlled(3). Dysregulation promotes disorders such as hypertension(4) or heart failure(5). In our search for a control mechanism for this vital kinase, here we show that the Raf kinase inhibitor protein(6-8) (RKIP) is a physiological inhibitor of GRK-2. After stimulation of GPCR, RKIP dissociates from its known target, Raf-1 (refs 6 - 8), to associate with GRK-2 and block its activity. This switch is triggered by protein kinase C (PKC)- dependent phosphorylation of the RKIP on serine 153. The data delineate a new principle in signal transduction: by activating PKC, the incoming receptor signal is enhanced both by removing an inhibitor from Raf-1 and by blocking receptor internalization. A physiological role for this mechanism is shown in cardiomyocytes in which the downregulation of RKIP restrains beta-adrenergic signalling and contractile activity.	Inst Pharmakol & Toxikol, D-97078 Wurzburg, Germany	University of Wurzburg	Quitterer, U (corresponding author), Inst Pharmakol & Toxikol, Versbacher Str 9, D-97078 Wurzburg, Germany.	toph029@rzbox.uni-wuerzburg.de	Lohse, Martin J/A-7160-2012; Lorenz, Kristina/F-3522-2016	Lohse, Martin J/0000-0002-0599-3510; Lorenz, Kristina/0000-0002-5747-2207				AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; Diviani D, 1996, J BIOL CHEM, V271, P5049; Dunigan CD, 2000, METH MOL B, V136, P329; Eichmann T, 2003, J BIOL CHEM, V278, P8052, DOI 10.1074/jbc.M204795200; Gros R, 1997, J CLIN INVEST, V99, P2087, DOI 10.1172/JCI119381; Hasuwa H, 2002, FEBS LETT, V532, P227, DOI 10.1016/S0014-5793(02)03680-3; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Krasel C, 2001, J BIOL CHEM, V276, P1911, DOI 10.1074/jbc.M008773200; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Ritter O, 2002, FASEB J, V16, P283, DOI 10.1096/fj.02-0321fje; Slupsky JR, 1999, CURR BIOL, V9, P971, DOI 10.1016/S0960-9822(99)80426-6; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; Wu JC, 2003, J CELL BIOCHEM, V88, P823, DOI 10.1002/jcb.10390; Yeung K, 2000, MOL CELL BIOL, V20, P3079, DOI 10.1128/MCB.20.9.3079-3085.2000; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yu QM, 1999, J NEUROCHEM, V73, P1222, DOI 10.1046/j.1471-4159.1999.0731222.x	27	284	326	1	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					574	579		10.1038/nature02158	http://dx.doi.org/10.1038/nature02158			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654844				2022-12-24	WOS:000186944300043
J	Poskanzer, KE; Marek, KW; Sweeney, ST; Davis, GW				Poskanzer, KE; Marek, KW; Sweeney, ST; Davis, GW			Synaptotagmin I is necessary for compensatory synaptic vesicle endocytosis in vivo	NATURE			English	Article							NEUROTRANSMITTER RELEASE; C2B DOMAIN; DROSOPHILA; MUTANTS; SYNAPSES; REGULATOR; BINDING; SENSOR	Neurotransmission requires a balance of synaptic vesicle exocytosis and endocytosis(1). Synaptotagmin I (Syt I) is widely regarded as the primary calcium sensor for synaptic vesicle exocytosis(2-6). Previous biochemical data suggest that Syt I may also function during synaptic vesicle endocytosis(7-16); however, ultrastructural analyses at synapses with impaired Syt I function have provided an indirect and conflicting view of the role of Syt I during synaptic vesicle endocytosis(3,8-10,14). Until now it has not been possible experimentally to separate the exocytic and endocytic functions of Syt I in vivo. Here, we test directly the role of Syt I during endocytosis in vivo. We use quantitative live imaging of a pH-sensitive green fluorescent protein fused to a synaptic vesicle protein (synapto-pHluorin) to measure the kinetics of endocytosis in sytI-null Drosophila. We then combine live imaging of the synapto-pHluorins with photoinactivation of Syt I, through fluorescein-assisted light inactivation, after normal Syt I-mediated vesicle exocytosis. By inactivating Syt I only during endocytosis, we demonstrate that Syt I is necessary for the endocytosis of synaptic vesicles that have undergone exocytosis using a functional Syt I protein.	Univ Calif San Francisco, Dept Biochem & Biophys, Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Program Neurosci, 513 Parnassus Ave, San Francisco, CA 94143 USA.			Sweeney, Sean/0000-0003-2673-9578				Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Fergestad T, 2001, J NEUROSCI, V21, P1218; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; FUKUDA M, 1995, P NATL ACAD SCI USA, V92, P10708, DOI 10.1073/pnas.92.23.10708; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Haucke V, 2000, EMBO J, V19, P6011, DOI 10.1093/emboj/19.22.6011; Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268; Jarousse N, 2001, J CELL BIOL, V154, P857, DOI 10.1083/jcb.200103040; Jarousse N, 2001, CURR OPIN CELL BIOL, V13, P461, DOI 10.1016/S0955-0674(00)00237-4; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Loewen CA, 2001, GENESIS, V31, P30, DOI 10.1002/gene.10002; Marek KW, 2002, NEURON, V36, P805, DOI 10.1016/S0896-6273(02)01068-1; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Reist NE, 1998, J NEUROSCI, V18, P7662; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; von Poser C, 2000, J BIOL CHEM, V275, P30916, DOI 10.1074/jbc.M005559200; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	30	201	209	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2003	426	6966					559	563		10.1038/nature02184	http://dx.doi.org/10.1038/nature02184			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14634669				2022-12-24	WOS:000186944300039
J	MacDonald, MP; Spalding, GC; Dholakia, K				MacDonald, MP; Spalding, GC; Dholakia, K			Microfluidic sorting in an optical lattice	NATURE			English	Article							SEPARATION; DNA; MACROMOLECULES; ARRAY; TRAP	The response of a microscopic dielectric object to an applied light field can profoundly affect its kinetic motion(1). A classic example of this is an optical trap, which can hold a particle in a tightly focused light beam(2). Optical fields can also be used to arrange, guide or deflect particles in appropriate light-field geometries(3,4). Here we demonstrate an optical sorter for microscopic particles that exploits the interaction of particles-biological or otherwise-with an extended, interlinked, dynamically reconfigurable, three-dimensional optical lattice. The strength of this interaction with the lattice sites depends on the optical polarizability of the particles, giving tunable selection criteria. We demonstrate both sorting by size (of protein microcapsule drug delivery agents) and sorting by refractive index (of other colloidal particle streams). The sorting efficiency of this method approaches 100%, with values of 96% or more observed even for concentrated solutions with throughputs exceeding those reported for fluorescence-activated cell sorting(5). This powerful, non-invasive technique is suited to sorting and fractionation within integrated ('lab-on-a-chip') microfluidic systems, and can be applied in colloidal, molecular and biological research.	Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; Illinois Wesleyan Univ, Dept Phys, Bloomington, IL 61702 USA	University of St Andrews; Illinois Wesleyan University	MacDonald, MP (corresponding author), Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.		Dholakia, Kishan/C-9873-2009; MacDonald, Michael P/F-5880-2011; Spalding, Gabriel C/C-8246-2009	MacDonald, Michael P/0000-0003-4415-5437; Spalding, Gabriel C/0000-0003-1126-3968; Dholakia, Kishan/0000-0001-6534-9009				ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Athanasopoulou A, 1996, INSTRUM SCI TECHNOL, V24, P79, DOI 10.1080/10739149608000470; BURNS MM, 1990, SCIENCE, V249, P749, DOI 10.1126/science.249.4970.749; Chou CF, 2002, BIOPHYS J, V83, P2170, DOI 10.1016/S0006-3495(02)73977-5; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Dholakia K, 2002, PHYS WORLD, V15, P31, DOI 10.1088/2058-7058/15/10/37; Duke TAJ, 1998, PHYS REV LETT, V80, P1552, DOI 10.1103/PhysRevLett.80.1552; Ertas D, 1998, PHYS REV LETT, V80, P1548, DOI 10.1103/PhysRevLett.80.1548; Fu AY, 1999, NAT BIOTECHNOL, V17, P1109, DOI 10.1038/15095; Galbraith DW, 1999, METHOD CELL BIOL, V58, P315; Greiner M, 2002, NATURE, V415, P39, DOI 10.1038/415039a; Han J, 2000, SCIENCE, V288, P1026, DOI 10.1126/science.288.5468.1026; IMASAKA T, 1995, ANAL CHEM, V67, P1763, DOI 10.1021/ac00107a003; Korda PT, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.128301; Korda PT, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.024504; MacDonald MP, 2002, SCIENCE, V296, P1101, DOI 10.1126/science.1069571; MACDONALD MP, UNPUB PHYS REV LETT; Marmottant P, 2003, NATURE, V423, P153, DOI 10.1038/nature01613; Nykypanchuk D, 2002, SCIENCE, V297, P987, DOI 10.1126/science.1073277; Tatarkova SA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.038101	20	1069	1110	10	394	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2003	426	6965					421	424		10.1038/nature02144	http://dx.doi.org/10.1038/nature02144			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647376				2022-12-24	WOS:000186800800032
J	Miyamoto, T; Hasuike, S; Yogev, L; Maduro, MR; Ishikawa, M; Westphal, H; Lamb, DJ				Miyamoto, T; Hasuike, S; Yogev, L; Maduro, MR; Ishikawa, M; Westphal, H; Lamb, DJ			Azoospermia in patients heterozygous for a mutation in SYCP3	LANCET			English	Article							SYNAPTONEMAL COMPLEX; PROTEIN; GENE; SCP3	Background Many cases of male infertility are diagnosed as idiopathic, reflecting poor understanding of the molecular defects underlying the abnormality. As more gene mutations causing male infertility in mice become known, there are improving prospects that knowledge about the genetic aetiology of human male infertility can be expanded. Sycp3 encodes a component of the synaptonemal complex. A null mutation of Sycp3 in mice causes azoospermia with meiotic arrest. We tested the hypothesis that mutation of the human testis-specific SYCP3 is associated with human nonobstructive azoospermia. Methods Human SYCP3 was isolated on the basis of homology between mouse Sycp3 cDNA and human genome sequences at the aminoacid level. Tissue-specific expression of SYCP3 was analysed by PCR of human cDNA. Samples of DNA from 19 azoospermic patients with maturation arrest and 75 normal fertile control men were screened for mutations in the SYCP3 gene by sequence analysis of the gene. The functional significance of the mutations found was analysed by a protein interaction study of the wild-type and truncated SYCP3 proteins. Findings We identified in two patients a 1 bp deletion (643delA) that results in a premature stop codon and truncation of the C-terminal, coiled-coil-forming region of the SYCP3 protein. The mutant protein showed greatly reduced interaction with the wild-type protein in vitro and interfered with SYCP3 fibre formation in cultured cells. Interpretation We suggest that SYCP3 has an essential meiotic function in human spermatogenesis that is compromised by the mutant protein via dominant negative interference.	Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA; NICHHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD 20892 USA; Asahikawa Med Coll, Dept Obstet & Gynecol, Asahikawa, Hokkaido 078, Japan; Lis Matern Hosp, Tel Aviv Sourasky Med Ctr, Inst Study Fertil, Tel Aviv, Israel; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Asahikawa Medical College; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Baylor College of Medicine	Lamb, DJ (corresponding author), Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA.	dlamb@www.urol.bcm.tmc.edu		Maduro, Maria Rosa/0000-0001-8988-6722	NICHD NIH HHS [P01HD36289] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD036289] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Botelho RJ, 2001, BBA-GENE STRUCT EXPR, V1518, P294, DOI 10.1016/S0167-4781(01)00171-3; DOBSON MJ, 1994, J CELL SCI, V107, P2749; Elliott DJ, 1997, P NATL ACAD SCI USA, V94, P3848, DOI 10.1073/pnas.94.8.3848; Heyting C, 1996, CURR OPIN CELL BIOL, V8, P389, DOI 10.1016/S0955-0674(96)80015-9; Martinez-Garay I, 2002, GENOMICS, V80, P259, DOI 10.1006/geno.2002.6834; Matzuk MM, 2002, NAT MED, V8, P41, DOI 10.1038/nm-fertilityS41; MEUWISSEN RLJ, 1992, EMBO J, V11, P5091, DOI 10.1002/j.1460-2075.1992.tb05616.x; Offenberg HH, 1998, NUCLEIC ACIDS RES, V26, P2572, DOI 10.1093/nar/26.11.2572; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; VONWETTSTEIN D, 1984, ANNU REV GENET, V18, P331, DOI 10.1146/annurev.ge.18.120184.001555; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Yuan L, 1998, J CELL BIOL, V142, P331, DOI 10.1083/jcb.142.2.331; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9	16	196	224	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2003	362	9397					1714	1719		10.1016/S0140-6736(03)14845-3	http://dx.doi.org/10.1016/S0140-6736(03)14845-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746VE	14643120				2022-12-24	WOS:000186767700010
J	Svenningsson, P; Tzavara, ET; Carruthers, R; Rachleff, I; Wattler, S; Nehls, M; McKinzie, DL; Fienberg, AA; Nomikos, GG; Greengard, P				Svenningsson, P; Tzavara, ET; Carruthers, R; Rachleff, I; Wattler, S; Nehls, M; McKinzie, DL; Fienberg, AA; Nomikos, GG; Greengard, P			Diverse psychotomimetics act through a common signaling pathway	SCIENCE			English	Article							CAMP-REGULATED PHOSPHOPROTEIN; SCHIZOPHRENIA; PHOSPHORYLATION; DARPP-32; MODELS; DRUG	Three distinct classes of drugs: dopaminergic agonists (such as D-amphetamine), serotonergic agonists (such as LSD), and glutamatergic antagonists (such as PCP) all induce psychotomimetic states in experimental animals that closely resemble schizophrenia symptoms in humans. Here we implicate a common signaling pathway in mediating these effects. In this pathway, dopamine- and an adenosine 3', 5'-monophosphate (cAMP)-regulated phosphoprotein of 32 kilodaltons (DARPP-32) is phosphorylated or dephosphorylated at three sites, in a pattern predicted to cause a synergistic inhibition of protein phosphatase-1 and concomitant regulation of its downstream effector proteins glycogen synthesis kinase-3 (GSK-3), cAMP response element-binding protein (CREB), and c-Fos. In mice with a genetic deletion of DARPP-32 or with point mutations in phosphorylation sites of DARPP-32, the effects of D-amphetamine, LSD, and PCP on two behavioral parameters-sensorimotor gating and repetitive movements-were strongly attenuated.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Eli Lilly & Co, Lilly Corp Ctr, Neurosci Discovery Res, Indianapolis, IN 46285 USA; Lexicon Genet Inc, The Woodlands, TX 77381 USA; Intracellular Therapies Inc, New York, NY 10032 USA	Rockefeller University; Eli Lilly; Lexicon Pharmaceuticals	Greengard, P (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10021 USA.		Svenningsson, Per JL/K-5210-2014		NIDA NIH HHS [DA10044] Funding Source: Medline; NIMH NIH HHS [MH40899] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH040899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abi-Dargham A, 1998, AM J PSYCHIAT, V155, P761; BERMAN KF, 1988, ARCH GEN PSYCHIAT, V45, P616; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Carlsson A, 2001, ANNU REV PHARMACOL, V41, P237, DOI 10.1146/annurev.pharmtox.41.1.237; DESDOUITS F, 1995, P NATL ACAD SCI USA, V92, P2682, DOI 10.1073/pnas.92.7.2682; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; GIRAULT JA, 1989, J BIOL CHEM, V264, P21748; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Jope RS, 2002, MOL PSYCHIATR, V7, pS35, DOI 10.1038/sj.mp.4001017; LIPSKA BK, 1994, NEUROPSYCHOPHARMACOL, V10, P199, DOI 10.1038/npp.1994.22; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; LUBY ED, 1959, ARCH NEURO PSYCHIATR, V81, P363, DOI 10.1001/archneurpsyc.1959.02340150095011; RIDLEY RM, 1994, PROG NEUROBIOL, V44, P221, DOI 10.1016/0301-0082(94)90039-6; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532; SHAW E, 1956, SCIENCE, V124, P121, DOI 10.1126/science.124.3212.121; SILBERSWEIG DA, 1995, NATURE, V378, P176, DOI 10.1038/378176a0; SNYDER SH, 1973, AM J PSYCHIAT, V130, P61, DOI 10.1176/ajp.130.1.61; SVENNINGSSON P, UNPUB; Vollenweider FX, 1998, PHARMACOPSYCHIATRY, V31, P92, DOI 10.1055/s-2007-979353	20	256	263	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2003	302	5649					1412	1415		10.1126/science.1089681	http://dx.doi.org/10.1126/science.1089681			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631045				2022-12-24	WOS:000186683500057
J	Li, X; Oghi, KA; Zhang, J; Krones, A; Bush, KT; Glass, CK; Nigam, SK; Aggarwal, AK; Maas, R; Rose, DW; Rosenfeld, MG				Li, X; Oghi, KA; Zhang, J; Krones, A; Bush, KT; Glass, CK; Nigam, SK; Aggarwal, AK; Maas, R; Rose, DW; Rosenfeld, MG			Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis	NATURE			English	Article							EYES-ABSENT GENE; MUSCLE PRECURSOR CELLS; KIDNEY DEVELOPMENT; DROSOPHILA DACHSHUND; NUCLEAR RECEPTORS; SKELETAL-MUSCLE; MULTIPLE STEPS; MYOGENIN GENE; MICE LACKING; EXPRESSION	The precise mechanistic relationship between gene activation and repression events is a central question in mammalian organogenesis, as exemplified by the evolutionarily conserved sine oculis ( Six), eyes absent (Eya) and dachshund ( Dach) network of genetically interacting proteins. Here, we report that Six1 is required for the development of murine kidney, muscle and inner ear, and that it exhibits synergistic genetic interactions with Eya factors. We demonstrate that the Eya family has a protein phosphatase function, and that its enzymatic activity is required for regulating genes encoding growth control and signalling molecules, modulating precursor cell proliferation. The phosphatase function of Eya switches the function of Six1-Dach from repression to activation, causing transcriptional activation through recruitment of co-activators. The gene-specific recruitment of a co-activator with intrinsic phosphatase activity provides a molecular mechanism for activation of specific gene targets, including those regulating precursor cell proliferation and survival in mammalian organogenesis.	Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Mt Sinai Sch Med, Dept Physiol & Biophys, Struct Biol Program, New York, NY 10029 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Genet, Boston, MA 02115 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Li, X (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, 9500 Gilman Dr,Room 345, La Jolla, CA 92093 USA.		Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592				Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Bonini NM, 1997, DEVELOPMENT, V124, P4819; Brohmann H, 2000, DEVELOPMENT, V127, P437; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5; Collet JF, 1999, J BIOL CHEM, V274, P33985, DOI 10.1074/jbc.274.48.33985; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Daston G, 1996, DEVELOPMENT, V122, P1017; Davies JA, 1998, CURR TOP DEV BIOL, V39, P245, DOI 10.1016/S0070-2153(08)60458-5; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Davis RJ, 1999, DEV GENES EVOL, V209, P526, DOI 10.1007/s004270050285; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; Dietrich S, 1999, DEVELOPMENT, V126, P1621; Glass CK, 2000, GENE DEV, V14, P121; Gross MK, 2000, DEVELOPMENT, V127, P413; Hammond KL, 1998, MECH DEVELOP, V74, P121, DOI 10.1016/S0925-4773(98)00071-9; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hausmann S, 2002, J BIOL CHEM, V277, P21213, DOI 10.1074/jbc.M202056200; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Ikeda K, 2002, MOL CELL BIOL, V22, P6759, DOI 10.1128/MCB.22.19.6759-6766.2002; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kobor MS, 1999, MOL CELL, V4, P55, DOI 10.1016/S1097-2765(00)80187-2; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Laclef C, 2003, DEVELOPMENT, V130, P2239, DOI 10.1242/dev.00440; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Li X, 2002, SCIENCE, V297, P1180; MARDON G, 1994, DEVELOPMENT, V120, P3473; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Oliver G, 1995, DEVELOPMENT, V121, P4045; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Pohl M, 2000, ANNU REV PHYSIOL, V62, P595, DOI 10.1146/annurev.physiol.62.1.595; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Schafer K, 1999, NAT GENET, V23, P213, DOI 10.1038/13843; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Shen WP, 1997, DEVELOPMENT, V124, P45; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Torres M, 1995, DEVELOPMENT, V121, P4057; Wang WR, 2002, J MOL BIOL, V319, P421, DOI 10.1016/S0022-2836(02)00324-8; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Xu PX, 1997, DEVELOPMENT, V124, P219; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Zhu CQC, 2002, DEVELOPMENT, V129, P2835	50	475	499	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2003	426	6964					247	254		10.1038/nature02083	http://dx.doi.org/10.1038/nature02083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628042				2022-12-24	WOS:000186660800034
J	McLeod, H; Ham, C; Kipping, R				McLeod, H; Ham, C; Kipping, R			Booking patients for hospital admissions: evaluation of a pilot programme for day cases	BRITISH MEDICAL JOURNAL			English	Article								Problem NHS patients requiring elective surgery usually have to wait before being treated and are usually told when a date becomes available. Design 18 month pilot programme to enable day case patients to book date of hospital admission at time of decision to operate. Background and setting 24 pilot sites in England with relatively short waiting times and some experience of booking appointments. Key measures for improvement Proportion of patients with booked or "to come in" date during and after pilot programme, proportion not attending for admission, and proportion waiting greater than or equal to6 months. Comparison of pilot sites with non-pilot sites. Strategies for change National Patients' Access Team established to help pilot sites enable patients to book admission dates. Provision of pound9.9m to pilot sites to employ project managers, purchase equipment, buy extra time from clinical and other staff, and invest in information and communications technology. Effects of change Proportion of patients with booked or "to come in" date increased from 51.1% to 72.7% between end of March 1999 and end of March 2000, and then fell to 66.2% by end of March 2001. Over the same periods, the proportion of patients waiting 6 months fell from 10.9% to 10.5% and then increased to 11.9%. The proportion of patients failing to attend fell from 5.7% to 3.1% between the first quarter of 1999 and the first quarter of 2000, and then increased to 4.0% in the first quarter of 2001. Pilot sites varied widely in performance during and after the pilot phase. Pilot sites had higher proportions of patients with booked or "to come in" date than non-pilot sites at end of each period. Lessons learnt Increasing the proportion of patients who book their date of hospital admission is possible, but there are difficulties in sustaining this. Several factors facilitated or hindered the implementation of booking, and the roll out of the programme across the NHS is seeking to incorporate these factors.	Univ Birmingham, Hlth Serv Management Ctr, Birmingham B15 2RT, W Midlands, England	University of Birmingham	McLeod, H (corresponding author), Univ Birmingham, Hlth Serv Management Ctr, Birmingham B15 2RT, W Midlands, England.			Kipping, Ruth/0000-0002-5446-8077; McLeod, Hugh/0000-0002-2266-7303				[Anonymous], IMPR EXP REF NEXT 3; Armitage P., 1987, STAT METHODS MED RES; BEECHAM L, 1991, BRIT MED J, V302, P929; COX AG, 1977, LANCET, V1, P301; Department of Health, 2002, IMPR EXP REF NEXT 3; DONNER A, 1987, STAT MED, V6, P43, DOI 10.1002/sim.4780060106; Fraser G, 1993, WAITING LISTS WAITIN; HAM C, 2002, CAPACITY CULTURE LEA; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; *S W REG HLTH AUTH, 1991, PROV HIGH QUAL SERV; *SECR STAT HLTH, 2000, NHS PLAN PLAN INV PL; YATES JM, 1998, BOOKING SYSTEMS SCOR	12	5	5	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 15	2003	327	7424					1147	+		10.1136/bmj.327.7424.1147	http://dx.doi.org/10.1136/bmj.327.7424.1147			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744HL	14615342	Green Published			2022-12-24	WOS:000186622100023
J	Campbell, BA; Campbell, DB; Chandler, JF; Hine, AA; Nolan, MC; Perillat, PJ				Campbell, BA; Campbell, DB; Chandler, JF; Hine, AA; Nolan, MC; Perillat, PJ			Radar imaging of the lunar poles - Long-wavelength measurements reveal a paucity of ice in the Moon's polar craters.	NATURE			English	Editorial Material									Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20013 USA; Cornell Univ, Ithaca, NY 14853 USA; Arecibo Observ, Arecibo, PR 00612 USA; Smithsonian Astrophys Observ, Cambridge, MA 02138 USA	Smithsonian Institution; Cornell University; National Aeronautics & Space Administration (NASA); Harvard University; Smithsonian Institution	Campbell, BA (corresponding author), Smithsonian Inst, Ctr Earth & Planetary Studies, Box 37012, Washington, DC 20013 USA.	campbellb@nasm.si.edu	Nolan, Michael C/H-4980-2012	Nolan, Michael C/0000-0001-8316-0680				Black GJ, 2001, ICARUS, V151, P167, DOI 10.1006/icar.2001.6616; BLACK GJ, 2002, LUNAR PLANET SCI C, V33; Bussey DB, 1999, GEOPHYS RES LETT, V26, P1187, DOI 10.1029/1999GL900213; Feldman WC, 2001, J GEOPHYS RES-PLANET, V106, P23231, DOI 10.1029/2000JE001444; HARMON JK, 1994, NATURE, V369, P213, DOI 10.1038/369213a0; Margot JL, 1999, SCIENCE, V284, P1658, DOI 10.1126/science.284.5420.1658; Nozette S, 1996, SCIENCE, V274, P1495, DOI 10.1126/science.274.5292.1495; Nozette S, 2001, J GEOPHYS RES-PLANET, V106, P23253, DOI 10.1029/2000JE001417; Stacy NJS, 1997, SCIENCE, V276, P1527, DOI 10.1126/science.276.5318.1527	9	38	40	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2003	426	6963					137	138		10.1038/426137a	http://dx.doi.org/10.1038/426137a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614491				2022-12-24	WOS:000186517200028
J	Choi, KW; Chau, TN; Tsang, O; Tso, E; Chiu, MC; Tong, WL; Lee, PO; Ng, TK; Ng, WF; Lee, KC; Lam, W; Yu, WC; Lai, JY; Lai, ST				Choi, KW; Chau, TN; Tsang, O; Tso, E; Chiu, MC; Tong, WL; Lee, PO; Ng, TK; Ng, WF; Lee, KC; Lam, W; Yu, WC; Lai, JY; Lai, ST		Princess Margaret Hosp Study Grp	Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong	ANNALS OF INTERNAL MEDICINE			English	Article							CORONAVIRUS; OUTBREAK; SARS; IDENTIFICATION	Background: severe acute respiratory syndrome (SARS) has become a global public health emergency. Objective: To evaluate the characteristics and outcomes of patients with SARS in Hong Kong and to identify predictors of mortality. Design: Retrospective cohort study. Setting: Quarantine hospital for patients with SARS in Hong Kong. Patients: 267 consecutive patients hospitalized from 26 February to 31 March 2003 for probable or confirmed SARS. Measurements: Clinical, laboratory, and radiographic measures; 3-month mortality rate. Results: According to our case definition, there were 227 cases of confirmed SARS and 40 cases of probable SARS. Common presenting symptoms were fever (99% of patients), chills (74%), malaise (63%), and myalgia (50%). Laboratory findings included lymphopenia (73%), thrombocytopenia (50%), hyponatremia (60%), and elevated levels of lactate dehydrogenase (47%) and C-reactive protein (75%). During hospitalization, incidence of diarrhea (53%), anemia (53%), and acute renal failure (6%) increased. Sixty-nine patients (26%) required intensive care because of respiratory failure. The 3-month mortality rate was 12% (95% Cl, 8% to 16%). Factors contributing to mortality were respiratory failure, acute renal failure, and nosocomial sepsis. On multivariate Cox regression, age older than 60 years (relative risk, 5.10 [Cl, 2.30 to 11.31]; P < 0.001) and lactate dehydrogenase level greater than 3.8 mu kat/L at presentation (relative risk, 2.20 [Cl, 1.03 to 4.71]; P = 0.04) were independent predictors of mortality. Conclusion: Because of the longer follow-up period in our cohort, the mortality rate in these patients is higher than rates reported in previous studies. Advanced age and high lactate dehydrogenase level at presentation predict mortality.	Princess Margaret Hosp, Dept Med & Geriatr, Kowloon, Hong Kong, Peoples R China		Lai, ST (corresponding author), Princess Margaret Hosp, Dept Med & Geriatr, Kowloon, Hong Kong, Peoples R China.	stpmh@netvigator.com						[Anonymous], 2003, UPD INT US CAS DEF S; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Cameron CE, 2001, CURR OPIN INFECT DIS, V14, P757, DOI 10.1097/00001432-200112000-00015; Chan-Yeung M, 2003, BRIT MED J, V326, P850, DOI 10.1136/bmj.326.7394.850; Cinatl J, 2003, LANCET, V361, P2045, DOI 10.1016/S0140-6736(03)13615-X; *DEP HLTH, 2003, AT PNEUM; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Rainer TH, 2003, BRIT MED J, V326, P1354, DOI 10.1136/bmj.326.7403.1354; So LKY, 2003, LANCET, V361, P1615, DOI 10.1016/S0140-6736(03)13265-5; Stohr K, 2003, LANCET, V361, P1730, DOI 10.1016/S0140-6736(03)13376-4; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; Wong RSM, 2003, BRIT MED J, V326, P1358, DOI 10.1136/bmj.326.7403.1358; World Health Organization, 2003, CAS DEF SURV SEV AC; ZUCKERFRANKLIN D, 1994, SEMIN HEMATOL, V31, P329	21	252	268	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2003	139	9					715	723		10.7326/0003-4819-139-9-200311040-00005	http://dx.doi.org/10.7326/0003-4819-139-9-200311040-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738XJ	14597455				2022-12-24	WOS:000186312900001
J	Ball, C; Kirkby, M; Williams, S				Ball, C; Kirkby, M; Williams, S			Effect of the critical care outreach team on patient survival to discharge from hospital and readmission to critical care: non-randomised population based study	BRITISH MEDICAL JOURNAL			English	Article							MEDICAL EMERGENCY TEAM; INTENSIVE-CARE; MORTALITY; ADMISSIONS; ARRESTS; DEATHS; UNITS	Objectives To determine the effect of the critical care outreach team on patient survival to discharge from hospital after discharge from critical care and readmission to critical care. Design Non-randomised population based study. Setting Tertiary referral teaching hospital with 1200 beds. Participants Patients discharged from the critical care unit after their first or only admission for two study periods, 26 February 2000 to 25 February 2001 and 26 February 2001 to 25 February 2002. Main outcome measures Survival to discharge from hospital after discharge from critical care and readmission to critical care. Results The introduction of a critical care outreach team increased survival to discharge from hospital after discharge from critical care by 6.8% (risk ratio 1.08). Readmission to critical care decreased by 6.4% (0.48). Conclusions The activity of the critical care outreach team seems to improve patient survival to discharge from hospital and may reduce the number of readmissions to critical care.	Royal Free Hampstead NHS Trust, Crit Care Unit, London NW3 2QG, England	University of London; University College London	Ball, C (corresponding author), Royal Free Hampstead NHS Trust, Crit Care Unit, London NW3 2QG, England.							Bristow PJ, 2000, MED J AUSTRALIA, V173, P236, DOI 10.5694/j.1326-5377.2000.tb125627.x; Buist MD, 2002, BRIT MED J, V324, P387, DOI 10.1136/bmj.324.7334.387; Cuthbertson BH, 2003, BRIT J ANAESTH, V90, P4, DOI 10.1093/bja/aeg004; DALY K, 2001, BRIT MED J, V322, P1; *DEP HLTH, 2001, COMPR CRIT CAR; Garrard C, 1998, BMJ-BRIT MED J, V316, P1841; Goldhill DR, 1999, ANAESTHESIA, V54, P853; Goldhill DR, 1996, INTENS CARE MED, V22, P415, DOI 10.1007/BF01712157; Goldhill DR, 2002, CURR ANAESTH CRIT CA, V13, P356, DOI DOI 10.1054/cacc.2003.0433; Hillman K, 2003, BRIT J ANAESTH, V90, P808, DOI 10.1093/bja/aeg573; *ICNARC, 1997, INT CAR NAT AUD RES; *INT CAR NAT AUD R, 1997, INT CAR NAT AUD RES; Leary T, 2003, ANAESTHESIA, V58, P328, DOI 10.1046/j.1365-2044.2003.03077.x; McGloin H, 1999, J ROY COLL PHYS LOND, V33, P255; McQuillan P, 1998, BMJ-BRIT MED J, V316, P1853; Metnitz PGH, 2003, INTENS CARE MED, V29, P241, DOI 10.1007/s00134-002-1584-z; Patel PA, 1999, INTENS CARE MED, V25, P977, DOI 10.1007/s001340050992; Rosenberg AL, 2000, CHEST, V118, P492, DOI 10.1378/chest.118.2.492; *SCOTT EX HLTH DEP, 2000, BETT CRIT CAR REP SH; Trivedi M, 2001, ANAESTHESIA, V56, P841, DOI 10.1046/j.1365-2044.2001.02174.x	20	174	177	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 1	2003	327	7422					1014	1016A		10.1136/bmj.327.7422.1014	http://dx.doi.org/10.1136/bmj.327.7422.1014			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738NE	14593033	Bronze, Green Published			2022-12-24	WOS:000186294100017
J	Burke, MD; Berger, EM; Schreiber, SL				Burke, MD; Berger, EM; Schreiber, SL			Generating diverse skeletons of small molecules combinatorially	SCIENCE			English	Article							FURAN COMPOUNDS; LIBRARY	Lack of efficient access to collections of synthetic compounds that have skeletal diversity is a key bottleneck in the small-molecule discovery process. We report a synthesis strategy that involves transforming substrates with different appendages that pre-encode skeletal information, named sigma elements, into products that have different skeletons with the use of common reaction conditions. With this approach, split-pool synthesis can be used to pre-encode skeletal diversity combinatorially and thereby generate such small molecules very efficiently. A split-pool synthesis of more than 1000 compounds produced overlapping, combinatorial matrices of molecular skeletons and appended building blocks in both enantiomeric and diastereomeric forms.	Harvard Univ, Inst Chem & Cell Biol, Howard Hughes Med Inst, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Schreiber, SL (corresponding author), Harvard Univ, Inst Chem & Cell Biol, Howard Hughes Med Inst, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	sls@slsiris.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080436] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM080436] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACHMATOWICZ O, 1971, TETRAHEDRON, V27, P1973, DOI 10.1016/S0040-4020(01)98229-8; Bach T, 1999, EUR J ORG CHEM, V1999, P2045; Blackwell HE, 2001, CHEM BIOL, V8, P1167, DOI 10.1016/S1074-5521(01)00085-0; Breinbauer R, 2002, ANGEW CHEM INT EDIT, V41, P2879; BUNIN BA, 1992, J AM CHEM SOC, V114, P10997, DOI 10.1021/ja00053a067; BURGESS K, 1994, J MED CHEM, V37, P2985, DOI 10.1021/jm00045a001; CLAUSONKAAS N, 1953, ACTA CHEM SCAND, V7, P845, DOI 10.3891/acta.chem.scand.07-0845; DEWITT SH, 1993, P NATL ACAD SCI USA, V90, P6909, DOI 10.1073/pnas.90.15.6909; Ding S, 2002, J AM CHEM SOC, V124, P1594, DOI 10.1021/ja0170302; Dolle RE, 2002, J COMB CHEM, V4, P369, DOI 10.1021/cc020039v; EVANS DA, 1981, J AM CHEM SOC, V103, P2127, DOI 10.1021/ja00398a058; Furka A, 1988, HIGHLIGHTS MODERN BI, P47; Harris JM, 2000, TETRAHEDRON LETT, V41, P183, DOI 10.1016/S0040-4039(99)02050-X; HOUGHTEN RA, 1991, NATURE, V354, P84, DOI 10.1038/354084a0; Kobayashi Y, 1998, J ORG CHEM, V63, P7505, DOI 10.1021/jo980942a; Kwon O, 2002, J AM CHEM SOC, V124, P13402, DOI 10.1021/ja028086e; LAM KS, 1991, NATURE, V354, P82, DOI 10.1038/354082a0; Lee DS, 2000, ORG LETT, V2, P709, DOI 10.1021/ol005574n; NESTLER HP, 1994, J ORG CHEM, V59, P4723, DOI 10.1021/jo00096a008; NEWTH FH, 1951, ADV CARBOHYD CHEM, V6, P83; Schreiber SL, 2003, CHEM ENG NEWS, V81, P51, DOI 10.1021/cen-v081n009.p051; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Tan DS, 1998, J AM CHEM SOC, V120, P8565, DOI 10.1021/ja981746o; Taniguchi T, 1998, TETRAHEDRON-ASYMMETR, V9, P1451, DOI 10.1016/S0957-4166(98)00117-7; Weber L, 2000, CURR OPIN CHEM BIOL, V4, P295, DOI 10.1016/S1367-5931(00)00092-2; [No title captured]	26	336	342	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2003	302	5645					613	618		10.1126/science.1089946	http://dx.doi.org/10.1126/science.1089946			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576427				2022-12-24	WOS:000186119900050
J	Mazel, CH; Cronin, TW; Caldwell, RL; Marshall, NJ				Mazel, CH; Cronin, TW; Caldwell, RL; Marshall, NJ			Fluorescent enhancement of signaling in a mantis shrimp	SCIENCE			English	Article									Phys Sci Inc, Andover, MA 01810 USA; Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Queensland, Vis Touch & Hearing Res Ctr, Brisbane, Qld 4072, Australia	Physical Sciences Inc.; University System of Maryland; University of Maryland Baltimore County; University of California System; University of California Berkeley; University of Queensland	Mazel, CH (corresponding author), Phys Sci Inc, 20 New England Business Ctr, Andover, MA 01810 USA.			Marshall, Justin/0000-0001-9006-6713				Arnold KE, 2002, SCIENCE, V295, P92, DOI 10.1126/science.295.5552.92; Cronin TW, 2000, PHILOS T ROY SOC B, V355, P1263, DOI 10.1098/rstb.2000.0680; Lythgoe J.N., 1979, ECOLOGY VISION; Mathger LM, 2001, J EXP BIOL, V204, P2103; Mazel CH, 2003, LIMNOL OCEANOGR, V48, P390, DOI 10.4319/lo.2003.48.1_part_2.0390	5	68	69	3	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2004	303	5654					51	51		10.1126/science.1089803	http://dx.doi.org/10.1126/science.1089803			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YU	14615546				2022-12-24	WOS:000187710600027
J	Gobert, V; Gottar, M; Matskevich, AA; Rutschmann, S; Royet, J; Belvin, M; Hoffmann, JA; Ferrandon, D				Gobert, V; Gottar, M; Matskevich, AA; Rutschmann, S; Royet, J; Belvin, M; Hoffmann, JA; Ferrandon, D			Dual activation of the Drosophila Toll pathway by two pattern recognition receptors	SCIENCE			English	Article							GRAM-NEGATIVE BACTERIA; GENOME-WIDE ANALYSIS; IMMUNE-RESPONSE; BINDING PROTEIN; SERINE-PROTEASE; HOST-DEFENSE; BOMBYX-MORI; BETA-1,3-GLUCAN; ANTIFUNGAL; MICROORGANISMS	The Toll-dependent defense against Gram-positive bacterial infections in Drosophila is mediated through the peptidoglycan recognition protein SA(PGRP-SA). A mutation termed osiris disrupts the Gram-negative binding protein 1 (GNBP1) gene and leads to compromised survival of mutant flies after Gram-positive infections, but not after fungal or Gram-negative bacterial challenge. Our results demonstrate that GNBP1 and PGRP-SA can jointly activate the Toll pathway. The potential for a combination of distinct proteins to mediate detection of infectious nonself in the fly will refine the concept of pattern recognition in insects.	CNRS, Inst Biol Mol & Cellulaire, Unite Propre Rech 9022, F-67084 Strasbourg, France; Exelixis Inc, San Francisco, CA 94083 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Exelixis, Inc.	Ferrandon, D (corresponding author), CNRS, Inst Biol Mol & Cellulaire, Unite Propre Rech 9022, 15 Rue Rene Descartes, F-67084 Strasbourg, France.			FERRANDON, Dominique/0000-0001-7680-7773; Rutschmann, Sophie/0000-0003-3932-1162				Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; GOBERT V, UNPUB; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; JANEWAY CA, 1989, COLD SH Q B, V54, P1; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; WEBER AN, 2003, NATURE IMMUNOL, V4, P494; YOSHIDA H, 1986, BIOCHEM BIOPH RES CO, V141, P1177, DOI 10.1016/S0006-291X(86)80168-1; Zhang R, 2003, J BIOL CHEM, V278, P42072, DOI 10.1074/jbc.M307475200	26	290	305	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2126	2130		10.1126/science.1085432	http://dx.doi.org/10.1126/science.1085432			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684822				2022-12-24	WOS:000187385200046
J	Johnson, JM; Castle, J; Garrett-Engele, P; Kan, ZY; Loerch, PM; Armour, CD; Santos, R; Schadt, EE; Stoughton, R; Shoemaker, DD				Johnson, JM; Castle, J; Garrett-Engele, P; Kan, ZY; Loerch, PM; Armour, CD; Santos, R; Schadt, EE; Stoughton, R; Shoemaker, DD			Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays	SCIENCE			English	Article							HUMAN GENES; TRANSCRIPTOME; EXPRESSION; DIVERSITY; BIOLOGY; ARRAYS	Alternative pre-messenger RNA (pre-mRNA) splicing plays important roles in development, physiology, and disease, and more than half of human genes are alternatively spliced. To understand the biological roles and regulation of alternative splicing across different tissues and stages of development, systematic methods are needed. Here, we demonstrate the use of microarrays to monitor splicing at every exon-exon junction in more than 10,000 multi-exon human genes in 52 tissues and cell lines. These genome-wide data provide experimental evidence and tissue distributions for thousands of known and novel alternative splicing events. Adding to previous studies, the results indicate that at least 74% of human multi-exon genes are alternatively spliced.	Merck & Co Inc, Rosetta Inpharmat LLC, Kirkland, WA 98034 USA	Merck & Company	Johnson, JM (corresponding author), Merck & Co Inc, Rosetta Inpharmat LLC, 115th Ave NE, Kirkland, WA 98034 USA.	jason_johnson@merck.com; shoemakd@stanfordalumni.org						Aboushadi N, 2000, BIOCHEMISTRY-US, V39, P237, DOI 10.1021/bi9916325; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Camargo AA, 2001, P NATL ACAD SCI USA, V98, P12103, DOI 10.1073/pnas.201182798; Castle J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r66; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Egan J.P., 1975, SIGNAL DETECTION THE; Hu GK, 2001, GENOME RES, V11, P1237, DOI 10.1101/gr.165501; Kan ZY, 2002, GENOME RES, V12, P1837, DOI 10.1101/gr.764102; KRAWCZAK M, 1992, HUM GENET, V90, P41; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Nussbaum RL, 1997, HUM GENET, V99, P145, DOI 10.1007/s004390050329; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; Wang H, 2003, BIOINFORMATICS, V19, pi315, DOI 10.1093/bioinformatics/btg1044; Yeakley JM, 2002, NAT BIOTECHNOL, V20, P353, DOI 10.1038/nbt0402-353; Zavolan M, 2003, GENOME RES, V13, P1290, DOI 10.1101/gr.1017303	20	1124	1208	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2141	2144		10.1126/science.1090100	http://dx.doi.org/10.1126/science.1090100			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684825				2022-12-24	WOS:000187385200050
J	Imperiale, TF; Wagner, DR; Lin, CY; Larkin, GN; Rogge, JD; Ransohoff, DF				Imperiale, TF; Wagner, DR; Lin, CY; Larkin, GN; Rogge, JD; Ransohoff, DF			Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer	ANNALS OF INTERNAL MEDICINE			English	Article							FLEXIBLE SIGMOIDOSCOPY; ASYMPTOMATIC ADULTS; SOCIETY GUIDELINES; COLONOSCOPY; ADENOMAS; RECOMMENDATIONS; PREVENTION; POLYPS; UPDATE	Background: Colonoscopic screening for colorectal cancer has been suggested because sigmoidoscopy misses nearly half of persons with advanced proximal neoplasia. Objective: To create a clinical index to stratify risk for advanced proximal neoplasia and to identify a subgroup with very low risk in which screening sigmoidoscopy alone might suffice. Design: Cross-sectional study. Setting: A company-based program of screening colonoscopy for colorectal cancer. Patients: Consecutive persons 50 years of age or older undergoing first-time screening colonoscopy between September 1995 and June 2001. Measurements: A clinical index with 3 variables was created from information on the first 1994 persons. Points were assigned to categories of age, sex, and distal findings. Risk for advanced proximal neoplasia (defined as an adenoma 1 cm or larger or one with villous histology, severe dysplasia, or cancer) was measured for each score. The index was tested on the next 1031 persons from the same screening program. Results: Of 1994 persons, 67 (3.4%) had advanced proximal neoplasia. A low-risk subgroup comprising 37% of the cohort had scores of 0 or 1 and a risk of 0.68% (95% CI, 0.22% to 1.57%). Among the validation group of 1031 persons, risk for advanced proximal neoplasia in the low-risk subgroup (comprising 47% of the cohort) was 0.4% (upper confidence limit of 1.49%). Application of this index detected 92% of persons with advanced proximal neoplasms and, if applied following screening sigmoidoscopy, could reduce the need for colonoscopy by 40%. The marginal benefit of colonoscopy among low-risk persons was small: To detect 7 additional persons with advanced proximal neoplasia, 1217 additional colonoscopies would be required. Conclusions: This clinical index stratifies the risk for advanced proximal neoplasia and identifies a subgroup at very low risk. If it is validated in other cohorts or groups, the index could be used to tailor endoscopic screening for colorectal cancer.	Regenstrief Inst Hlth Care, Indianapolis, IN 46202 USA; Univ N Carolina, Chapel Hill, NC USA; Eli Lilly & Co, Indianapolis, IN 46285 USA; Indianapolis Gastroenterol Res Fdn, Indianapolis, IN 46285 USA; Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; University of North Carolina; University of North Carolina Chapel Hill; Eli Lilly; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis	Imperiale, TF (corresponding author), Regenstrief Inst Hlth Care, 1050 Wishard Blvd, Indianapolis, IN 46202 USA.			Imperiale, Thomas/0000-0001-7586-1073	NIDDK NIH HHS [K24 DK 02756] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK002756] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ATKIN WS, 1993, LANCET, V341, P736, DOI 10.1016/0140-6736(93)90499-7; Atkin WS, 2000, JNCI-J NATL CANCER I, V92, P513, DOI 10.1093/jnci/92.7.513; Braitman LE, 1996, ANN INTERN MED, V125, P406, DOI 10.7326/0003-4819-125-5-199609010-00008; Byers T, 1997, CA-CANCER J CLIN, V47, P154, DOI 10.3322/canjclin.47.3.154; Detsky AS, 2001, NEW ENGL J MED, V345, P607, DOI 10.1056/NEJM200108233450809; Fletcher RH, 1999, GASTROENTEROLOGY, V117, P486, DOI 10.1053/gast.1999.0029900486; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRELL FE, 1985, CANCER TREAT REP, V69, P1071; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; KONISHI F, 1982, J CLIN PATHOL, V35, P830, DOI 10.1136/jcp.35.8.830; Levin Theodore R, 2002, Gastrointest Endosc Clin N Am, V12, P23, DOI 10.1016/S1052-5157(03)00055-2; Levin TR, 1999, JAMA-J AM MED ASSOC, V281, P1611, DOI 10.1001/jama.281.17.1611; Lewis JD, 1999, ANN INTERN MED, V130, P525, DOI 10.7326/0003-4819-130-6-199903160-00017; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; Podolsky DK, 2000, NEW ENGL J MED, V343, P207, DOI 10.1056/NEJM200007203430309; Ransohoff DF, 2002, NEW ENGL J MED, V346, P40, DOI 10.1056/NEJMcp010886; Read TE, 1997, NEW ENGL J MED, V336, P8, DOI 10.1056/NEJM199701023360102; Rex DK, 2001, GASTROINTEST ENDOSC, V54, P662, DOI 10.1067/mge.2001.117594; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; RUTTIMANN UE, 1994, CRIT CARE CLIN, V10, P19, DOI 10.1016/S0749-0704(18)30142-8; Schoen RE, 1998, GASTROENTEROLOGY, V115, P533, DOI 10.1016/S0016-5085(98)70132-5; SELBY JV, 1994, GASTROENTEROLOGY, V106, P1702, DOI 10.1016/0016-5085(94)90429-4; Sherrick RC, 2000, NEW ENGL J MED, V343, P1651; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4; Wallace MB, 1998, ANN INTERN MED, V129, P273, DOI 10.7326/0003-4819-129-4-199808150-00002; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; ZARCHY TM, 1994, GASTROENTEROLOGY, V106, P1501, DOI 10.1016/0016-5085(94)90403-0	29	132	139	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2003	139	12					959	965		10.7326/0003-4819-139-12-200312160-00005	http://dx.doi.org/10.7326/0003-4819-139-12-200312160-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	756AG	14678915				2022-12-24	WOS:000187443200001
J	Rigotti, NA				Rigotti, NA			Commentary: Putting the research into practice	BRITISH MEDICAL JOURNAL			English	Editorial Material							SMOKING CESSATION; PATCH; TRIAL		Harvard Univ, Sch Med, Tobacco Res & Treatment Ctr, Boston, MA 02114 USA	Harvard University; Harvard Medical School	Rigotti, NA (corresponding author), Harvard Univ, Sch Med, Tobacco Res & Treatment Ctr, Boston, MA 02114 USA.							Burke BL, 2003, J CONSULT CLIN PSYCH, V71, P843, DOI 10.1037/0022-006X.71.5.843; FIORE MC, 2000, TREATING TOBACCO USE; Hajek P, 1999, ARCH INTERN MED, V159, P2033, DOI 10.1001/archinte.159.17.2033; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Lancaster T, 2000, BRIT MED J, V321, P355, DOI 10.1136/bmj.321.7257.355; Rigotti NA, 2002, NEW ENGL J MED, V346, P506, DOI 10.1056/NEJMcp012279; US Department of Health and Human Services, 1990, DHHS PUBL; West R, 2000, THORAX, V55, P987, DOI 10.1136/thorax.55.12.987	8	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1395	1396		10.1136/bmj.327.7428.1395	http://dx.doi.org/10.1136/bmj.327.7428.1395			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670890	Green Published			2022-12-24	WOS:000187417900028
J	Ceci, M; Gaviraghi, C; Gorrini, C; Sala, LA; Offenhauser, N; Marchisio, PC; Biffo, S				Ceci, M; Gaviraghi, C; Gorrini, C; Sala, LA; Offenhauser, N; Marchisio, PC; Biffo, S			Release of eIF6 (p27(BBP)) from the 60S subunit allows 80S ribosome assembly	NATURE			English	Article							TRANSLATION INITIATION-FACTOR; PROTEIN-KINASE-C; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; CLONING; RACK1; RECEPTOR; HOMOLOG; BINDING; CELLS	The assembly of 80S ribosomes requires joining of the 40S and 60S subunits, which is triggered by the formation of an initiation complex on the 40S subunit(1). This event is rate-limiting for translation(2), and depends on external stimuli(3) and the status of the cell(4). Here we show that 60S subunits are activated by release of eIF6 (also termed p27(BBP))(5,6). In the cytoplasm, eIF6 is bound to free 60S but not to 80S. Furthermore, eIF6 interacts in the cytoplasm with RACK1(7), a receptor for activated protein kinase C (PKC). RACK1 is a major component of translating ribosomes, which harbour significant amounts of PKC. Loading 60S subunits with eIF6 caused a dose-dependent translational block and impairment of 80S formation, which were reversed by expression of RACK1 and stimulation of PKC in vivo and in vitro. PKC stimulation led to eIF6 phosphorylation, and mutation of a serine residue in the carboxy terminus of eIF6 impaired RACK1/PKC-mediated translational rescue. We propose that eIF6 release regulates subunit joining, and that RACK1 provides a physical and functional link between PKC signalling and ribosome activation.	DIBIT HSR, Mol Histol Unit, I-20132 Milan, Italy; Univ Vita Salute San Raffaele, Sch Med, I-20132 Milan, Italy; Firc Inst Mol Oncol, I-20100 Milan, Italy; Univ Eastern Piedmont Amedeo Avogadro, Dept Sci & Adv Technol, I-15100 Alessandria, Italy	Vita-Salute San Raffaele University; IFOM - FIRC Institute of Molecular Oncology; University of Eastern Piedmont Amedeo Avogadro	Biffo, S (corresponding author), DIBIT HSR, Mol Histol Unit, I-20132 Milan, Italy.	biffo.stefano@hsr.it		Offenhauser, Nina/0000-0002-3316-3047; biffo, stefano/0000-0002-3780-1050; Ceci, Marcello/0000-0002-5066-1590; Gorrini, Chiara/0000-0002-5239-6671				Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Biffo S, 1997, J BIOL CHEM, V272, P30314, DOI 10.1074/jbc.272.48.30314; Chantrel Y, 1998, GENETICS, V148, P559; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Groft CM, 2000, NAT STRUCT BIOL, V7, P1156; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Ho JHN, 2000, RNA, V6, P1625, DOI 10.1017/S1355838200001291; MOCHLYROSEN D, 1995, BIOCHEM SOC T, V23, P596, DOI 10.1042/bst0230596; Nadano D, 2000, JPN J CANCER RES, V91, P802, DOI 10.1111/j.1349-7006.2000.tb01017.x; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Peterson RT, 1998, CURR BIOL, V8, pR248, DOI 10.1016/S0960-9822(98)70152-6; Proud CG, 2001, BIOCHEM SOC T, V29, P541, DOI 10.1042/BST0290541; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Rhoads RE, 1999, J BIOL CHEM, V274, P30337, DOI 10.1074/jbc.274.43.30337; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Senger B, 2001, MOL CELL, V8, P1363, DOI 10.1016/S1097-2765(01)00403-8; Si K, 1997, P NATL ACAD SCI USA, V94, P14285, DOI 10.1073/pnas.94.26.14285; Si K, 1999, MOL CELL BIOL, V19, P1416; SPROTT SC, 1991, ANAL BIOCHEM, V194, P407, DOI 10.1016/0003-2697(91)90249-S; VALENZUELA DM, 1982, J BIOL CHEM, V257, P7712; Wood LC, 1999, J BIOL CHEM, V274, P11653, DOI 10.1074/jbc.274.17.11653	27	318	329	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					579	584		10.1038/nature02160	http://dx.doi.org/10.1038/nature02160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654845				2022-12-24	WOS:000186944300044
J	Wikramanayake, AH; Hong, M; Lee, PN; Pang, K; Byrum, CA; Bince, JM; Xu, RH; Martindale, MQ				Wikramanayake, AH; Hong, M; Lee, PN; Pang, K; Byrum, CA; Bince, JM; Xu, RH; Martindale, MQ			An ancient role for nuclear beta-catenin in the evolution of axial polarity and germ layer segregation	NATURE			English	Article							SIGNAL-TRANSDUCTION; XENOPUS EMBRYOS; CELL FATES; SPECIFICATION; ENDODERM; LOCALIZATION; HYPOTHESES; INDUCTION; LITHIUM	The human oncogene beta-catenin is a bifunctional protein with critical roles in both cell adhesion and transcriptional regulation in the Wnt pathway(1-3). Wnt/beta-catenin signalling has been implicated in developmental processes as diverse as elaboration of embryonic polarity(2-6), formation of germ layers(4-8), neural patterning, spindle orientation and gap junction communication(2), but the ancestral function of beta-catenin remains unclear. In many animal embryos, activation of beta-catenin signalling occurs in blastomeres that mark the site of gastrulation and endomesoderm formation(5-10), raising the possibility that asymmetric activation of beta-catenin signalling specified embryonic polarity and segregated germ layers in the common ancestor of bilaterally symmetrical animals. To test whether nuclear translocation of beta-catenin is involved in axial identity and/or germ layer formation in 'pre-bilaterians', we examined the in vivo distribution, stability and function of beta-catenin protein in embryos of the sea anemone Nematostella vectensis (Cnidaria, Anthozoa). Here we show that N. vectensis beta-catenin is differentially stabilized along the oral-aboral axis, translocated into nuclei in cells at the site of gastrulation and used to specify entoderm, indicating an evolutionarily ancient role for this protein in early pattern formation.	Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA; Univ Hawaii, Pacific Biomed Res Ctr, Kewalo Marine Lab, Honolulu, HI 96813 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System	Wikramanayake, AH (corresponding author), Univ Hawaii Manoa, Dept Zool, 2538 McCarthy Mall, Honolulu, HI 96822 USA.	athula@hawaii.edu; mqmartin@hawaii.edu		Byrum, Christine/0000-0002-6653-7922				Collins AG, 1998, P NATL ACAD SCI USA, V95, P15458, DOI 10.1073/pnas.95.26.15458; Ding YN, 2002, TRENDS BIOCHEM SCI, V27, P327, DOI 10.1016/S0968-0004(02)02137-0; FREEMAN G, 1982, DEV BIOL, V94, P142, DOI 10.1016/0012-1606(82)90077-X; Goldstein B, 1997, BIOESSAYS, V19, P105, DOI 10.1002/bies.950190205; HAND C, 1992, BIOL BULL, V182, P169, DOI 10.2307/1542110; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Imai K, 2000, DEVELOPMENT, V127, P3009; Kao KR, 1998, BIOL CELL, V90, P585, DOI 10.1016/S0248-4900(99)80016-1; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; KLYMKOWSKY MW, 1991, METHOD CELL BIOL, V36, P419; Knoll AH, 1999, SCIENCE, V284, P2129, DOI 10.1126/science.284.5423.2129; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Logan CY, 1999, DEVELOPMENT, V126, P345; Mao CA, 1996, DEVELOPMENT, V122, P1489; MCCREA PD, 1993, J CELL BIOL, V123, P477, DOI 10.1083/jcb.123.2.477; Medina M, 2001, P NATL ACAD SCI USA, V98, P9707, DOI 10.1073/pnas.171316998; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Miller JR, 1997, J CELL BIOL, V139, P229, DOI 10.1083/jcb.139.1.229; Miyawaki K, 2003, DEV GROWTH DIFFER, V45, P121; Montross WT, 2000, J CELL SCI, V113, P1759; Polakis P, 2000, GENE DEV, V14, P1837; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Schneider SQ, 2003, J EXP ZOOL PART B, V295B, P25, DOI 10.1002/jez.b.00006; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Weitzel HE, 2002, DEV BIOL, V247, P479; Wikramanayake AH, 1998, P NATL ACAD SCI USA, V95, P9343, DOI 10.1073/pnas.95.16.9343; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	30	238	243	1	25	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 27	2003	426	6965					446	450		10.1038/nature02113	http://dx.doi.org/10.1038/nature02113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647383				2022-12-24	WOS:000186800800039
J	Sijen, T; Plasterk, RHA				Sijen, T; Plasterk, RHA			Transposon silencing in the Caenorhabditis elegans germ line by natural RNAi	NATURE			English	Article							DOUBLE-STRANDED-RNA; C-ELEGANS; GENE; INTERFERENCE; HELICASE; HOMOLOG; RDE-1	Transposable elements are stretches of DNA that can move and multiply within the genome of an organism. The Caenorhabditis elegans genome contains multiple Tc1 transposons that jump in somatic cells, but are silenced in the germ line(1-3). Many mutants that have lost this silencing have also lost the ability to execute RNA interference (RNAi)(2,3), a process whereby genes are suppressed by exposure to homologous double-stranded RNA ( dsRNA). Here we show how RNAi causes transposon silencing in the nematode germ line. We find evidence for transposon-derived dsRNAs, in particular to the terminal inverted repeats, and show that these RNAs may derive from read-through transcription of entire transposable elements. Small interfering RNAs of Tc1 were detected. When a germline-expressed reporter gene is fused to a stretch of Tc1 sequence, this transgene is silenced in a manner dependent on functional mutator genes (mut-7, mut-16 and pk732). These results indicate that RNAi surveillance is triggered by fortuitous read-through transcription of dispersed Tc1 copies, which can form dsRNA as a result of 'snap-back' of the terminal inverted repeats. RNAi mediated by this dsRNA silences transposase gene expression.	Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Plasterk, RHA (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.knaw.nl						Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aroian RV, 1997, EMBO J, V16, P1541, DOI 10.1093/emboj/16.7.1541; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; EMMONS SW, 1983, CELL, V32, P55, DOI 10.1016/0092-8674(83)90496-8; English JJ, 1996, PLANT CELL, V8, P179, DOI 10.1105/tpc.8.2.179; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fischer SEJ, 2003, GENETICS, V164, P127; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Kelly WG, 1998, DEVELOPMENT, V125, P2451; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Praitis V, 2001, GENETICS, V157, P1217; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sijen T, 2001, CURR BIOL, V11, P436, DOI 10.1016/S0960-9822(01)00116-6; Sijen T, 1996, PLANT CELL, V8, P2277, DOI 10.1105/tpc.8.12.2277; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tijsterman M, 2002, SCIENCE, V295, P694, DOI 10.1126/science.1067534; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI 10.1016/s0960-9822(03)00539-6; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Vos JC, 1996, GENE DEV, V10, P755, DOI 10.1101/gad.10.6.755; Wilm T, 1999, GENE, V229, P31, DOI 10.1016/S0378-1119(99)00043-8; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	30	337	364	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2003	426	6964					310	314		10.1038/nature02107	http://dx.doi.org/10.1038/nature02107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628056				2022-12-24	WOS:000186660800049
J	Prahlad, V; Pilgrim, D; Goodwin, EB				Prahlad, V; Pilgrim, D; Goodwin, EB			Roles for mating and environment in C. elegans sex determination	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; NEMATODE	In Caenorhabditis elegans the two sexes, hermaphrodites and males, are thought to be irreversibly determined at fertilization by the ratio of X chromosomes to sets of autosomes: XX embryos develop as hermaphrodites and XO embryos as males. We show instead that both sex and genotype of C. elegans can be altered postembryonically and that this. exibility requires sexual reproduction. When grown in specific bacterial metabolites, some XX larvae generated by mating males and hermaphrodites develop as males and lose one X chromosome. However, XX larvae produced by hermaphrodite self-fertilization show no such changes. We propose that sexual reproduction increases developmental. exibility of progeny, allowing for better adaptation to changing environments.	Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; Univ Alberta, Ctr Biol Sci, CW 405, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	University of Wisconsin System; University of Wisconsin Madison; University of Alberta	Goodwin, EB (corresponding author), Univ Wisconsin, Dept Genet, 445 Henry Mall, Madison, WI 53706 USA.	goodwin@wisc.edu	; Pilgrim, David/A-2676-2014	Prahlad, Veena/0000-0002-0413-6074; Pilgrim, David/0000-0001-7820-7915	NIGMS NIH HHS [GM51836] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051836] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; BRENNER S, 1974, GENETICS, V77, P71; Butlin R, 2002, NAT REV GENET, V3, P311, DOI 10.1038/nrg749; Carmi I, 1998, NATURE, V396, P168, DOI 10.1038/24164; Chasnov JR, 2002, GENETICS, V160, P983; Delmotte F, 2002, MOL ECOL, V11, P711, DOI 10.1046/j.1365-294X.2002.01478.x; DONIACH T, 1986, GENETICS, V114, P53; Edgley ML, 2001, MOL GENET GENOMICS, V266, P385, DOI 10.1007/s004380100523; HODGKIN J, 1992, BIOESSAYS, V14, P253, DOI 10.1002/bies.950140409; KELLY WB, COMMUNICATION; Kelly WG, 2002, DEVELOPMENT, V129, P479; Lieb JD, 1996, SCIENCE, V274, P1732, DOI 10.1126/science.274.5293.1732; Maynard Smith J., 1978, EVOLUTION SEX; NELSON GA, 1978, DEV BIOL, V66, P386, DOI 10.1016/0012-1606(78)90247-6; PERRY MD, 1993, GENE DEV, V7, P216, DOI 10.1101/gad.7.2.216; Pigliucci M, 1998, CURR OPIN PLANT BIOL, V1, P87, DOI 10.1016/S1369-5266(98)80133-7; PRAHLAD V, UNPUB; Stewart AD, 2002, GENETICS, V160, P975; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; WARD S, 1979, DEV BIOL, V73, P304, DOI 10.1016/0012-1606(79)90069-1; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi	21	22	26	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2003	302	5647					1046	1049		10.1126/science.1087946	http://dx.doi.org/10.1126/science.1087946			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605370				2022-12-24	WOS:000186396300049
J	Chen, WG; Chang, Q; Lin, YX; Meissner, A; West, AE; Griffith, EC; Jaenisch, R; Greenberg, ME				Chen, WG; Chang, Q; Lin, YX; Meissner, A; West, AE; Griffith, EC; Jaenisch, R; Greenberg, ME			Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2	SCIENCE			English	Article							CPG-BINDING PROTEIN-2; RETT-SYNDROME; HISTONE DEACETYLASE; SIGNALING PATHWAY; MESSENGER-RNAS; EXPRESSION; MUTATIONS; NEURONS; CELLS; GENE	Mutations in MeCP2, which encodes a protein that has been proposed to function as a global transcriptional repressor, are the cause of Rett syndrome (RTT), an X-linked progressive neurological disorder. Although the selective inactivation of MeCP2 in neurons is sufficient to confer a Rett-like phenotype in mice, the specific functions of MeCP2 in postmitotic neurons are not known. We find that MeCP2 binds selectively to BDNF promoter III and functions to repress expression of the BDNF gene. Membrane depolarization triggers the calcium-dependent phosphorylation and release of MeCP2 from BDNF promoter III, thereby facilitating transcription. These studies indicate that MeCP2 plays a key role in the control of neuronal activity-dependent gene regulation and suggest that the deregulation of this process may underlie the pathology of RTT.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Greenberg, ME (corresponding author), Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.			Chen, Wen/0000-0003-0853-7526; Griffith, Eric/0000-0003-0428-3215; /0000-0002-7002-1275	NICHD NIH HHS [HD 18655] Funding Source: Medline; NINDS NIH HHS [NS28829] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028829, R01NS028829] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akbarian S, 2001, NEUROBIOL DIS, V8, P784, DOI 10.1006/nbdi.2001.0420; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen W., UNPUB; Chen WG, 2003, J NEUROSCI, V23, P2572; Drewell RA, 2002, NUCLEIC ACIDS RES, V30, P1139, DOI 10.1093/nar/30.5.1139; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GHOSH A, 1994, J NEUROBIOL, V25, P294, DOI 10.1002/neu.480250309; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GINTY DD, 1991, J BIOL CHEM, V266, P17454; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jung BP, 2003, J NEUROBIOL, V55, P86, DOI 10.1002/neu.10201; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shahbazian MD, 2001, CURR OPIN NEUROL, V14, P171, DOI 10.1097/00019052-200104000-00006; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tokuyama W, 2000, NAT NEUROSCI, V3, P1134, DOI 10.1038/80655; Traynor Jeff, 2002, BMC Med Genet, V3, P12, DOI 10.1186/1471-2350-3-12; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Van den Veyver IB, 2000, CURR OPIN GENET DEV, V10, P275, DOI 10.1016/S0959-437X(00)00083-6; Wan MM, 2001, HUM MOL GENET, V10, P1085, DOI 10.1093/hmg/10.10.1085; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298	37	945	988	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2003	302	5646					885	889		10.1126/science.1086446	http://dx.doi.org/10.1126/science.1086446			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593183				2022-12-24	WOS:000186258000055
J	Wernet, MF; Labhart, T; Baumann, F; Mazzoni, EO; Pichaud, F; Desplan, C				Wernet, MF; Labhart, T; Baumann, F; Mazzoni, EO; Pichaud, F; Desplan, C			Homothorax switches function of Drosophila photoreceptors from color to polarized light sensors	CELL			English	Article							MARGINAL OMMATIDIA; OPTIC LOBE; CELL FATES; EYE; RHODOPSIN; GENES; R7; ENCODES; PROTEIN; DIFFERENTIATION	Different classes of photoreceptors (PRs) allow animals to perceive various types of visual information. In the Drosophila eye, the outer PRs of each ommatidium are involved in motion detection while the inner PRs mediate color vision. In addition, flies use a specialized class of inner PRs in the "dorsal rim area" of the eye (DRA) to detect the e-vector of polarized light, allowing them to exploit skylight polarization for orientation. We show that homothorax is both necessary and sufficient for inner PRs to adopt the polarization-sensitive DRA fate instead of the color-sensitive default state. Homothorax increases rhabdomere size and uncouples R7-R8 communication to allow both cells to express the same opsin rather than different ones as required for color vision. Homothorax expression is induced by the iroquois complex and the wingless (wg) pathway. However, crucial wg pathway components are not required, suggesting that additional signals are involved.	NYU, Dept Biol, New York, NY 10003 USA; Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland	New York University; University of Zurich	Desplan, C (corresponding author), NYU, Dept Biol, 100 Washington Sq E, New York, NY 10003 USA.	cd38@nyu.edu		Pichaud, Franck/0000-0002-8393-716X; mazzoni, esteban/0000-0001-8994-681X; Desplan, Claude/0000-0002-6914-1413	NATIONAL EYE INSTITUTE [R01EY013010] Funding Source: NIH RePORTER; MRC [MC_U122673973] Funding Source: UKRI; Medical Research Council [MC_U122673973] Funding Source: Medline; NEI NIH HHS [R01 EY13010] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bessa J, 2002, GENE DEV, V16, P2415, DOI 10.1101/gad.1009002; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brennan CA, 2000, CELL MOL LIFE SCI, V57, P195, DOI 10.1007/PL00000684; CAMPOSORTEGA JA, 1979, ROUX ARCH DEV BIOL, V186, P27, DOI 10.1007/BF00848106; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; Chen CM, 1999, DEVELOPMENT, V126, P5441; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; Chou WH, 1999, DEVELOPMENT, V126, P607; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; FORTINI ME, 1991, CELL TISSUE RES, V265, P185, DOI 10.1007/BF00318153; FORTINI ME, 1990, GENE DEV, V4, P444, DOI 10.1101/gad.4.3.444; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; FRANCESCHINI N, 1971, KYBERNETIK, V8, P1, DOI 10.1007/BF00270828; Frankfort BJ, 2001, NEURON, V32, P403, DOI 10.1016/S0896-6273(01)00480-9; GAUL U, 1992, CELL, V68, P1007, DOI 10.1016/0092-8674(92)90073-L; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; HARDIE RC, 1984, J COMP PHYSIOL, V154, P157, DOI 10.1007/BF00604981; Huber A, 1997, FEBS LETT, V406, P6, DOI 10.1016/S0014-5793(97)00210-X; Kauffmann RC, 1996, GENE DEV, V10, P2167, DOI 10.1101/gad.10.17.2167; KIRSCHFE.K, 1968, KYBERNETIK, V5, P47, DOI 10.1007/BF00272694; KIRSCHFELD K, 1977, BIOPHYS STRUCT MECH, V3, P191, DOI 10.1007/BF00535818; Labhart T, 1999, MICROSC RES TECHNIQ, V47, P368, DOI 10.1002/(SICI)1097-0029(19991215)47:6<368::AID-JEMT2>3.0.CO;2-Q; Labhart T, 2000, NATURWISSENSCHAFTEN, V87, P133, DOI 10.1007/s001140050691; Labhart T, 2002, CURR OPIN NEUROBIOL, V12, P707, DOI 10.1016/S0959-4388(02)00384-7; LABHART T, 1988, NATURE, V331, P435, DOI 10.1038/331435a0; McNeill H, 1997, GENE DEV, V11, P1073, DOI 10.1101/gad.11.8.1073; MLODZIK M, 1990, CELL, V60, P211, DOI 10.1016/0092-8674(90)90737-Y; Mollereau B, 2000, MECH DEVELOP, V93, P151, DOI 10.1016/S0925-4773(00)00287-2; Mollereau B, 2001, NATURE, V412, P911, DOI 10.1038/35091076; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; MOSKOW JJ, 1995, MOL CELL BIOL, V15, P5434; Papatsenko D, 1997, DEVELOPMENT, V124, P1665; Pichaud F, 2001, DEVELOPMENT, V128, P815; Pichaud F, 2000, MECH DEVELOP, V96, P15, DOI 10.1016/S0925-4773(00)00372-5; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; ROSSEL S, 1986, NATURE, V323, P128, DOI 10.1038/323128a0; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9; TOMLINSON A, 2003, IN PRESS DEV CELL; TREISMAN JE, 1995, DEVELOPMENT, V121, P3519; VONPHILIPSBORN A, 1990, J COMP PHYSIOL A, V167, P737, DOI 10.1007/BF00189764; WADA S, 1974, Z MORPHOL TIERE, V77, P87, DOI 10.1007/BF00374212; WEHNER R, 1994, FORTS ZOOL, V39, P103; WOLF R, 1980, J COMP PHYSIOL, V139, P177, DOI 10.1007/BF00657080; WOLFF T, 2000, DROSOPHILA PROTOCOLS, P201; Wolff Tanya, 1993, P1277; WUNDERER H, 1982, INT J INSECT MORPHOL, V11, P25, DOI 10.1016/0020-7322(82)90035-6; XU T, 1993, DEVELOPMENT, V117, P1223; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	50	146	151	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2003	115	3					267	279		10.1016/S0092-8674(03)00848-1	http://dx.doi.org/10.1016/S0092-8674(03)00848-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	740RH	14636555	Bronze			2022-12-24	WOS:000186415000007
J	Martina, BEE; Haagmans, BL; Kuiken, T; Fouchier, RAM; Rimmelzwaan, GF; van Amerongen, G; Peiris, JSM; Lim, W; Osterhaus, ADME				Martina, BEE; Haagmans, BL; Kuiken, T; Fouchier, RAM; Rimmelzwaan, GF; van Amerongen, G; Peiris, JSM; Lim, W; Osterhaus, ADME			SARS virus infection of cats and ferrets	NATURE			English	Article							ACUTE RESPIRATORY SYNDROME; CORONAVIRUS		Erasmus Med Ctr, Inst Virol, NL-3015 GE Rotterdam, Netherlands; Queen Mary Hosp, Dept Pathol & Microbiol, Hong Kong, Hong Kong, Peoples R China; Govt Virus Unit, Kowloon, Hong Kong, Peoples R China	Erasmus University Rotterdam; Erasmus MC; University of Hong Kong	Martina, BEE (corresponding author), Erasmus Med Ctr, Inst Virol, NL-3015 GE Rotterdam, Netherlands.		Fouchier, Ron A/A-1911-2014; Haagmans, Bart/E-9791-2015	Fouchier, Ron A/0000-0001-8095-2869; Haagmans, Bart/0000-0001-6221-2015; Osterhaus, Albert/0000-0002-6074-1172				Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2	5	424	459	64	245	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2003	425	6961					915	915		10.1038/425915a	http://dx.doi.org/10.1038/425915a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14586458	Green Published, Bronze			2022-12-24	WOS:000186230600030
J	Klak, C; Reeves, G; Hedderson, T				Klak, C; Reeves, G; Hedderson, T			Unmatched tempo of evolution in Southern African semi-desert ice plants	NATURE			English	Article							DIVERSIFICATION RATES; AIZOACEAE	The Succulent Karoo is an arid region, situated along the west coast of southern Africa. Floristically this region is part of the Greater Cape Flora(1) and is considered one of the Earth's 25 biodiversity hotspots(2). Of about 5,000 species occurring in this region, more than 40% are endemic(3). Aizoaceae (ice plants) dominate the Succulent Karoo both in terms of species numbers (1,750 species in 127 genera) and density of coverage(3,4). Here we show that a well-supported clade within the Aizoaceae, representing 1,563 species almost exclusively endemic to southern Africa, has diversified very recently and very rapidly. The estimated age for this radiation lies between 3.8 and 8.7 million years (Myr) ago, yielding a per-lineage diversification rate of 0.77-1.75 per million years. Both the number of species involved and the tempo of evolution far surpass those of any previously postulated continental or island plant radiation(5-7). Diversification of the group is closely associated with the origin of several morphological features and one anatomical feature. Because species-poor clades lacking these features occur over a very similar distribution area, we propose that these characteristics are key innovations that facilitated this radiation.	Univ Cape Town, Dept Bot, Bolus Herbarium, ZA-7701 Rondebosch, South Africa; Natl Bot Inst Cape Town, Kirstenbosch Res Ctr, Leslie Hill Mol Systemat Lab, ZA-7735 Claremont, South Africa	University of Cape Town	Klak, C (corresponding author), Univ Cape Town, Dept Bot, Bolus Herbarium, ZA-7701 Rondebosch, South Africa.	klak@botzoo.uct.ac.za	Hedderson, Terry/AAD-8614-2021					Axelrod D. I., 1978, Biogeography and ecology of Southern Africa. Vol.1., P77; Baldwin BG, 1998, P NATL ACAD SCI USA, V95, P9402, DOI 10.1073/pnas.95.16.9402; ERIKSSON O, 1992, EVOLUTION, V46, P258, DOI [10.2307/2409820, 10.1111/j.1558-5646.1992.tb02000.x]; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Hendey QB., 1982, LANGEBAANWEG RECORD; HULBERT RC, 1993, PALEOBIOLOGY, V19, P216, DOI 10.1017/S0094837300015888; IHLENFELDT HD, 1994, ANNU REV ECOL SYST, V25, P521; JURGENS N, 1991, VEGETATIO, V97, P21; Jurgens N., 1986, MITT I ALLG BOT HAMB, V21, P129; Klak C, 2003, AM J BOT, V90, P1433, DOI 10.3732/ajb.90.10.1433; Landrum JV, 2001, PLANT SYST EVOL, V227, P49, DOI 10.1007/s006060170056; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Mauseth JD, 1995, J PLANT RES, V108, P517, DOI 10.1007/BF02344242; Mayhew PJ, 2002, P ROY SOC B-BIOL SCI, V269, P969, DOI 10.1098/rspb.2002.1957; McCune Amy R., 1997, P585; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Parolin P, 2001, FLORA, V196, P313; RAMBAUT A, 2000, TREEEDIT VERSION 1 0; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Richardson JE, 2001, NATURE, V412, P181, DOI 10.1038/35084067; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Schmiedel U, 1999, PLANT ECOL, V142, P57, DOI 10.1023/A:1009818210799; Scott L., 1997, P62; Scott L, 1995, QUATERNARY SCI REV, V14, P937, DOI 10.1016/0277-3791(95)00072-0; Swofford D.L., 1998, PAUP 4 0B2 PHYLOGENE; TANKARD AJ, 1978, J BIOGEOGR, V5, P319, DOI 10.2307/3038026; Ward J, 1990, MONOGRAPH TRANSVAAL, V7, P17; WARD JD, 1983, S AFR J SCI, V79, P175; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782	30	242	251	1	57	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 1	2004	427	6969					63	65		10.1038/nature02243	http://dx.doi.org/10.1038/nature02243			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YP	14702084	Green Submitted			2022-12-24	WOS:000187710000033
J	Arnold, P				Arnold, P			Why running is not for people	BRITISH MEDICAL JOURNAL			English	Article											Arnold, P (corresponding author), 202-170 Ocean St, Sydney, NSW 2027, Australia.							PORTER R, 2002, BLOOD GUTS SHORT HIS, P4	1	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1476	1476		10.1136/bmj.327.7429.1476	http://dx.doi.org/10.1136/bmj.327.7429.1476			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684658	Green Published			2022-12-24	WOS:000187562700029
J	Mercereau-Puijalon, O				Mercereau-Puijalon, O			Antimalarial activity of artemisinins: identification of a novel target?	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM; MALARIA; ERYTHROCYTES		Inst Pasteur, Unite Immunol Mol Parasites, CNRS, URA 2581, F-75724 Paris 15, France; Inst Pasteur Cambodge, Lab Epidemiol Mol, Phnom Penh, Cambodia	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia	Mercereau-Puijalon, O (corresponding author), Inst Pasteur, Unite Immunol Mol Parasites, CNRS, URA 2581, F-75724 Paris 15, France.	omp@pasteur.fr	Hua, QX/HGE-3640-2022; Mercereau-Puijalon, Odile/AAA-2242-2020					Alleva LM, 2001, MOL BIOCHEM PARASIT, V117, P121, DOI 10.1016/S0166-6851(01)00338-3; Bhisutthibhan J, 2001, ANTIMICROB AGENTS CH, V45, P2397, DOI 10.1128/AAC.45.8.2397-2399.2001; Dow GS, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-4; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; ELLIS DS, 1985, ANN TROP MED PARASIT, V79, P367, DOI 10.1080/00034983.1985.11811933; Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130; GU HM, 1984, T ROY SOC TROP MED H, V78, P265, DOI 10.1016/0035-9203(84)90296-7; Hotta CT, 2000, NAT CELL BIOL, V2, P466, DOI 10.1038/35017112; KIMURA M, 1993, J CELL SCI, V104, P1129; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Meshnick SR, 1996, MICROBIOL REV, V60, P301, DOI 10.1128/MMBR.60.2.301-315.1996; Olliaro PL, 2001, TRENDS PARASITOL, V17, P122, DOI 10.1016/S1471-4922(00)01838-9; Varotti FP, 2003, CELL CALCIUM, V33, P137, DOI 10.1016/S0143-4160(02)00224-5; Vyas N, 2002, ANTIMICROB AGENTS CH, V46, P105, DOI 10.1128/AAC.46.1.105-109.2002	14	13	14	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 20	2003	362	9401					2035	2036		10.1016/S0140-6736(03)15146-X	http://dx.doi.org/10.1016/S0140-6736(03)15146-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UJ	14697798				2022-12-24	WOS:000187429600003
J	Shann, F				Shann, F			Hypothermia for traumatic brain injury: how soon, how cold, and how long?	LANCET			English	Editorial Material							LOW INTRACRANIAL-PRESSURE; SEVERE HEAD-INJURY; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; CARDIAC-ARREST; HYPERTENSION		Royal Childrens Hosp, Intens Care Unit, Parkville, Vic 3052, Australia	Royal Children's Hospital Melbourne	Shann, F (corresponding author), Royal Childrens Hosp, Intens Care Unit, Flemington Rd, Parkville, Vic 3052, Australia.		Shann, Frank/C-9510-2011					Aibiki M, 2000, CRIT CARE MED, V28, P3902, DOI 10.1097/00003246-200012000-00029; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1992, J NEUROTRAUM, V9, pS487; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Colbourne F, 1998, STROKE, V29, P1967, DOI 10.1161/01.STR.29.9.1967; Colbourne F, 1997, MOL NEUROBIOL, V14, P171, DOI 10.1007/BF02740655; Colbourne F, 1999, J CEREBR BLOOD F MET, V19, P742, DOI 10.1097/00004647-199907000-00003; GADKARY CA, 2003, COCHRANE LIB; Gunn AJ, 2000, CURR OPIN PEDIATR, V12, P111, DOI 10.1097/00008480-200004000-00004; HIRAYAMA T, 1994, INTRACRANIAL PRESSUR, V9; Holzer M, 2002, NEW ENGL J MED, V346, P549; Iida K, 2003, J NEUROSURG, V98, P793, DOI 10.3171/jns.2003.98.4.0793; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; LEROUX PD, 1991, CHILD NERV SYST, V7, P34, DOI 10.1007/BF00263831; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MEISSNER W, 1998, CRITICAL CARE MED S1, V26, pA82; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; SCHUBERT A, 1995, J NEUROSURG ANESTH, V7, P139, DOI 10.1097/00008506-199504000-00021; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Yan Y, 2001, Chin J Traumatol, V4, P8; Zhang K, 2000, INNER MONGOLIA MED J, V32, P4	27	33	36	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 13	2003	362	9400					1950	1951		10.1016/S0140-6736(03)15083-0	http://dx.doi.org/10.1016/S0140-6736(03)15083-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683651				2022-12-24	WOS:000187210700004
J	Davies, AG; Pierce-Shimomura, JT; Kim, H; VanHoven, MK; Thiele, TR; Bonci, A; Bargmann, CI; McIntire, SL				Davies, AG; Pierce-Shimomura, JT; Kim, H; VanHoven, MK; Thiele, TR; Bonci, A; Bargmann, CI; McIntire, SL			A central role of the BK potassium channel in behavioral responses to ethanol in C-elegans	CELL			English	Article							CA2+-ACTIVATED K+ CHANNELS; CAENORHABDITIS-ELEGANS; SYNAPTIC-TRANSMISSION; LARGE-CONDUCTANCE; MULTIPLE ASPECTS; GENE; NEURONS; SENSITIVITY; SEROTONIN; CURRENTS	The activities of many neuronal proteins are modulated by ethanol, but the fundamental mechanisms underlying behavioral effects of ethanol remain unclear. To identify mechanisms responsible for intoxication, we screened for Caenorhabditis elegans mutants with altered behavioral responses to ethanol. We found that slo-1 mutants, which were previously recognized as having slightly uncoordinated movement, are highly resistant to ethanol in two behavioral assays. Numerous loss-of-function slo-1 alleles emerged from our screens, indicating that slo-1 has a central role in ethanol responses. slo-1 encodes the BK potassium channel. Electrophysiological analysis shows that ethanol activates the channel in vivo, which would inhibit neuronal activity. Moreover, behaviors of slo-1 gain-of-function mutants resemble those of ethanol-intoxicated animals. These results demonstrate that selective activation of BK channels is responsible for acute intoxicating effects of ethanol in C. elegans. BK channel activation may explain a variety of behavioral responses to ethanol in invertebrate and vertebrate systems.	Univ Calif San Francisco, Ernest Gallo Clin, Emeryville, CA 94608 USA; Univ Calif San Francisco, Res Ctr, Dept Neurol, Program Neurosci, Emeryville, CA 94608 USA; Univ Calif San Francisco, Res Ctr, Dept Neurol, Program Biomed Sci, Emeryville, CA 94608 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	McIntire, SL (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin, Emeryville, CA 94608 USA.	slm@itsa.ucsf.edu	Davies, Andrew G/AAY-3567-2020	VanHoven, Miri/0000-0001-7714-1555; Thiele, Tod/0000-0003-2628-8359; Bargmann, Cornelia/0000-0002-8484-0618; Kim, Hongkyun/0000-0002-4879-7122				ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Chu BS, 1998, MOL PHARMACOL, V54, P397, DOI 10.1124/mol.54.2.397; Diamond I, 1997, PHYSIOL REV, V77, P1, DOI 10.1152/physrev.1997.77.1.1; DIAMOND IF, 2002, DIS NERVOUS SYSTEM C, P1814; Dopico AM, 1996, MOL PHARMACOL, V49, P40; Dopico AM, 1999, J PHYSIOL-LONDON, V519, P101, DOI 10.1111/j.1469-7793.1999.0101o.x; Dopico AM, 1998, J PHARMACOL EXP THER, V284, P258; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gruss M, 2001, EUR J NEUROSCI, V14, P1246, DOI 10.1046/j.0953-816x.2001.01754.x; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; Hallam S, 2000, DEVELOPMENT, V127, P4239; Harris RA, 1999, ALCOHOL CLIN EXP RES, V23, P1563, DOI 10.1097/00000374-199910000-00001; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Jakab M, 1997, J MEMBRANE BIOL, V157, P237, DOI 10.1007/PL00005895; Jerng HH, 1999, J GEN PHYSIOL, V113, P641, DOI 10.1085/jgp.113.5.641; Jin YS, 1999, J NEUROSCI, V19, P539; Jospin M, 2002, J PHYSIOL-LONDON, V544, P373, DOI 10.1113/jphysiol.2002.022293; Lees-Miller JP, 2000, MOL PHARMACOL, V57, P367; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; MCCOBB DP, 1995, AM J PHYSIOL-HEART C, V269, pH767, DOI 10.1152/ajpheart.1995.269.3.H767; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; Mello C, 1995, METHOD CELL BIOL, V48, P451; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Nickell WT, 2002, J MEMBRANE BIOL, V189, P55, DOI 10.1007/s00232-002-1004-x; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Phillips TJ, 1998, NAT NEUROSCI, V1, P610, DOI 10.1038/2843; Rubinstein M, 1997, CELL, V90, P991, DOI 10.1016/S0092-8674(00)80365-7; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Schreiber M, 1999, NAT NEUROSCI, V2, P416, DOI 10.1038/8077; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Shioi G, 2001, GENETICS, V157, P1611; Spanagel R, 2002, J NEUROSCI, V22, P8676; Thiele TE, 1998, NATURE, V396, P366, DOI 10.1038/24614; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Walters FS, 2000, AM J PHYSIOL-CELL PH, V279, pC1107, DOI 10.1152/ajpcell.2000.279.4.C1107; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5	44	260	272	4	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2003	115	6					655	666		10.1016/S0092-8674(03)00979-6	http://dx.doi.org/10.1016/S0092-8674(03)00979-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675531	Bronze			2022-12-24	WOS:000187366100006
J	Li, MY; Brooks, CL; Wu-Baer, F; Chen, DL; Baer, R; Gu, W				Li, MY; Brooks, CL; Wu-Baer, F; Chen, DL; Baer, R; Gu, W			Mono-versus polyubiquitination: Differential control of p53 fate by Mdm2	SCIENCE			English	Article							UBIQUITIN-PROTEIN LIGASE; RING-FINGER DOMAIN; NUCLEAR EXPORT; MDM2-DEPENDENT UBIQUITINATION; DEGRADATION; STABILITY; PROMOTES	Although Mdm2-mediated ubiquitination is essential for both degradation and nuclear export of p53, the molecular basis for the differential effects of Mdm2 remains unknown. Here we show that low levels of Mdm2 activity induce monoubiquitination and nuclear export of p53, whereas high levels promote p53's polyubiquitination and nuclear degradation. A p53-ubiquitin fusion protein that mimics monoubiquitinated p53 was found to accumulate in the cytoplasm in an Mdm2-independent manner, indicating that monoubiquitination is critical for p53 trafficking. These results clarify the nature of ubiquitination-mediated p53 regulation and suggest that distinct mechanisms regulate p53 function in accordance with the levels of Mdm2 activity.	Columbia Univ Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University	Gu, W (corresponding author), Columbia Univ Coll Phys & Surg, Inst Canc Genet, 1150 St Nicholas Ave, New York, NY 10032 USA.			Brooks, Christopher/0000-0003-3487-6644				Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Blattner C, 2002, MOL CELL BIOL, V22, P6170, DOI 10.1128/MCB.22.17.6170-6182.2002; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Gu JJ, 2001, MOL CELL BIOL, V21, P8533, DOI 10.1128/MCB.21.24.8533-8546.2001; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li M., UNPUB; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Midgley CA, 2000, ONCOGENE, V19, P2312, DOI 10.1038/sj.onc.1203593; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X; Parant JM, 2003, HUM MUTAT, V21, P321, DOI 10.1002/humu.10186; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Shirangi TR, 2002, FASEB J, V16, P420, DOI 10.1096/fj.01-0617fje; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314; Yu ZK, 2000, ONCOGENE, V19, P5892, DOI 10.1038/sj.onc.1203980	31	608	621	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1972	1975		10.1126/science.1091362	http://dx.doi.org/10.1126/science.1091362			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671306				2022-12-24	WOS:000187174000063
J	Mascie-Taylor, CGN; Karim, E				Mascie-Taylor, CGN; Karim, E			The burden of chronic disease	SCIENCE			English	Article							HUMAN HOOKWORM INFECTIONS; PUBLIC-HEALTH IMPORTANCE; RESISTANCE; PYRANTEL; REGION	The shift from acute infectious and deficiency diseases to chronic noncommunicable diseases is not a simple transition but a complex and dynamic epidemiological process, with some diseases disappearing and others appearing or reemerging. The unabated pandemic of childhood and adulthood obesity and concomitant comorbidities are affecting both rich and poor nations, while infectious diseases remain an important public health problem, particularly in developing countries. More attention should be given to the high burden of disease associated with soil-transmitted helminths and schistosomiasis, which until recently was not considered a priority even though regular drug treatment is obtainable at relatively little cost. In developing countries, the pressing requirement is to provide an accessible and good quality health-care system, whereas industrialized countries have a major need for greater public health education and the promotion of healthy life-styles.	Univ Cambridge, Dept Biol Anthropol, Cambridge CB2 3DZ, England; Hlth & Life Sci Partnership, London EC1V 9HL, England	University of Cambridge	Mascie-Taylor, CGN (corresponding author), Univ Cambridge, Dept Biol Anthropol, Cambridge CB2 3DZ, England.	nmt1@cam.ac.uk						*CDCP, 2003, MMWR-MORBID MORTAL W, V52, P881; Chan MS, 1997, PARASITOL TODAY, V13, P438, DOI 10.1016/S0169-4758(97)01144-7; Cioli D, 2000, CURR OPIN INFECT DIS, V13, P659, DOI 10.1097/00001432-200012000-00014; COOPER E, 1991, T ROY SOC TROP MED H, V85, P168, DOI 10.1016/0035-9203(91)90009-N; Crompton DWT, 2000, PARASITOLOGY, V121, pS39, DOI 10.1017/S0031182000006454; Geerts S, 2001, TROP MED INT HEALTH, V6, P915, DOI 10.1046/j.1365-3156.2001.00774.x; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Guyatt H, 2002, WORLD CL PARASITES, V2, P75; Horton J, 2003, TRENDS PARASITOL, V19, P405, DOI 10.1016/S1471-4922(03)00171-5; MONTRESSOR A, 2002, HELMINTH CONTROL SCH; Murray C. J. L., 1996, GLOBAL BURDEN DIS; O'Lorcain P, 2000, PARASITOLOGY, V121, pS51, DOI 10.1017/S0031182000006442; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Reynoldson JA, 1997, ACTA TROP, V68, P301, DOI 10.1016/S0001-706X(97)00106-X; *RI DEP HLTH, OB CONTR PROGR; Sacko M, 1999, T ROY SOC TROP MED H, V93, P195, DOI 10.1016/S0035-9203(99)90306-1; SAVIOLI L, 2002, T R SOC TROP MED HYG, V86, P353; Smith RD, 2003, B WORLD HEALTH ORGAN, V81, P475; Stephenson LS, 2000, PARASITOLOGY, V121, pS23, DOI 10.1017/S0031182000006491; STOLL NR, 1947, J PARASITOL, V33, P1; United Nations Development Programme, HUM DEV REP; *WHO, HLTH ALL 21 CENT; Yokogawa M., 1985, Ascariasis and its public health significance, P265	23	73	81	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1921	1922		10.1126/science.1092488	http://dx.doi.org/10.1126/science.1092488			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671291				2022-12-24	WOS:000187174000046
J	Potuschak, T; Lechner, E; Parmentier, Y; Yanagisawa, S; Grava, S; Koncz, C; Genschik, P				Potuschak, T; Lechner, E; Parmentier, Y; Yanagisawa, S; Grava, S; Koncz, C; Genschik, P			EIN3-dependent regulation of plant ethylene hormone signaling by two Arabidopsis F box proteins: EBF1 and EBF2	CELL			English	Article							SCF UBIQUITIN-LIGASE; RESPONSE PATHWAY; AUX/IAA PROTEINS; AUXIN RESPONSE; DEGRADATION; TRANSDUCTION; THALIANA; ETHYLENE-INSENSITIVE3; IDENTIFICATION; PROTEOLYSIS	The plant hormone ethylene regulates a wide range of developmental processes and the response of plants to stress and pathogens. Genetic studies in Arabidopsis led to a partial elucidation of the mechanisms of ethylene action. Ethylene signal transduction initiates with ethylene binding at a family of ethylene receptors and terminates in a transcription cascade involving the EIN3/EIL and ERF families of plant-specific transcription factors. Here, we identify two Arabidopsis F box proteins called EBF1 and EBF2 that interact physically with EIN3/EIL transcription factors. EBF1 overexpression results in plants insensitive to ethylene. In contrast, plants carrying the ebf1 and ebf2 mutations display a constitutive ethylene response and accumulate the EIN3 protein in the absence of the hormone. Our work places EBF1 and EBF2 within the genetic framework of the ethylene-response pathway and supports a model in which ethylene action depends on EIN3 protein stabilization.	CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; Okayama Univ, Res Inst Bioresources, Kurashiki, Okayama 7100046, Japan; Max Planck Inst Zuchtungsforsch, D-50829 Cologne, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Okayama University; Max Planck Society	Genschik, P (corresponding author), CNRS, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.			GENSCHIK, Pascal/0000-0002-4107-5071; Potuschak, Thomas/0000-0002-2632-4981				Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Alonso JM, 2003, P NATL ACAD SCI USA, V100, P2992, DOI 10.1073/pnas.0438070100; [Anonymous], 2002, ARABIDOPSIS BOOK; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Farras R, 2001, EMBO J, V20, P2742, DOI 10.1093/emboj/20.11.2742; Ferrando A, 2000, PLANT J, V22, P553, DOI 10.1046/j.1365-313x.2000.00763.x; Frugis G, 2002, TRENDS CELL BIOL, V12, P308, DOI 10.1016/S0962-8924(02)02308-5; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Hellmann H, 2002, SCIENCE, V297, P793, DOI 10.1126/science.1072831; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hsiung YG, 2001, MOL CELL BIOL, V21, P2506, DOI 10.1128/MCB.21.7.2506-2520.2001; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Johnson PR, 1998, ANNU REV GENET, V32, P227, DOI 10.1146/annurev.genet.32.1.227; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; KIPREOS ET, 2000, IN PRESS GENOME BIOL; Lechner E, 2002, J BIOL CHEM, V277, P50069, DOI 10.1074/jbc.M204254200; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; Rios G, 2002, PLANT J, V32, P243, DOI 10.1046/j.1365-313X.2002.01416.x; ROMAN G, 1995, GENETICS, V139, P1393; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Shen WH, 2002, MOL BIOL CELL, V13, P1916, DOI 10.1091/mbc.E02-02-0077; Smalle J, 1997, P NATL ACAD SCI USA, V94, P2756, DOI 10.1073/pnas.94.6.2756; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Xiao WY, 2000, TRENDS PLANT SCI, V5, P454, DOI 10.1016/S1360-1385(00)01769-6; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Yanagisawa S, 2003, NATURE, V425, P521, DOI 10.1038/nature01984; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; ZUO J, 2002, PLANT J, V24, P265	41	517	575	8	115	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 12	2003	115	6					679	689		10.1016/S0092-8674(03)00968-1	http://dx.doi.org/10.1016/S0092-8674(03)00968-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675533	Bronze			2022-12-24	WOS:000187366100008
J	Tanaka, M; Vitek, CR; Pascual, FB; Bisgard, KM; Tate, JE; Murphy, TV				Tanaka, M; Vitek, CR; Pascual, FB; Bisgard, KM; Tate, JE; Murphy, TV			Trends in pertussis among infants in the United States, 1980-1999	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							YOUNG INFANTS; EPIDEMIOLOGIC FEATURES; CHANGING EPIDEMIOLOGY; NEONATAL PERTUSSIS; VACCINE; ADULTS; IMMUNIZATION; DIAGNOSIS; CHILDREN	Context Reported cases of pertussis among adolescents and adults have increased since the 1980s, despite increasingly high rates of vaccination among infants and children. However, severe pertussis morbidity and mortality occur primarily among infants. Objective To describe the trends and characteristics of reported cases of pertussis among infants younger than 12 months in the United States from 1980 to 1999. Design, Setting, and Participants Cases of pertussis in infants younger than 12 months in the United States reported to the National Notifiable Disease Surveillance System of the Centers for Disease Control and Prevention between 1980 and 1999, and detailed case data from the Supplementary Pertussis Surveillance System. Main Outcome Measures incidence and demographic and clinical characteristics of cases. Results The incidence of reported cases of pertussis among infants increased 49% in the 1990s compared with the incidence in the 1980s (19798 vs 12550 cases reported; 51.1 cases vs 34.2 cases per 100000 infant population, respectively), increases in the incidence of cases and the number of deaths among infants during the 1990s primarily were among those aged 4 months or younger, contrasting with a stable incidence of cases among infants aged 5 months or older. The proportion of cases confirmed by bacterial culture was higher in the 1990s than in the 1980s (50% and 33%, respectively); the proportion of hospitalized cases was unchanged (67% vs 68%, respectively). Receipt of fewer doses of vaccine was associated with hospitalization, when,cases were stratified by age in months. Conclusions The incidence of reported cases of pertussis among infants increased in the 1990s compared with the 1980s. The limited age group affected, the increased rate of bacteriologic confirmation, and the unchanged severity of illness suggest that an increase in infant pertussis has occurred apart from any change in reporting. Strategies are needed to prevent the morbidity and mortality from pertussis among infants too young to be fully vaccinated, according to the current recommended schedules of vaccination in the United States.	Ctr Dis Control & Prevent MS 61, Bacterial Vaccine Preventable Dis Branch, Epidemiol & Surveillance Div, Natl Immunizat Program, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of North Carolina; University of North Carolina Chapel Hill	Tanaka, M (corresponding author), Ctr Dis Control & Prevent MS 61, Bacterial Vaccine Preventable Dis Branch, Epidemiol & Surveillance Div, Natl Immunizat Program, 1600 Clifton Rd, Atlanta, GA 30333 USA.							Baron S, 1998, PEDIATR INFECT DIS J, V17, P412, DOI 10.1097/00006454-199805000-00013; BASS JW, 1989, PEDIATR INFECT DIS J, V8, P352, DOI 10.1097/00006454-198906000-00004; BEITER A, 1993, OBSTET GYNECOL, V82, P691; BISGARD K, 2002, MANUAL SURVEILLANCE; Bisgard Kristine M., 2001, Pediatric Research, V49, p110A; BROOKSALER F, 1967, AM J DIS CHILD, V114, P389, DOI 10.1001/archpedi.1967.02090250087005; *CDCP, 1992, MMWR-MORBID MORTAL W, V41, P11; *CDCP, NAT IMM PROGR IMM CO; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P73; Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P1; CHRISTIE CDC, 1989, AM J DIS CHILD, V143, P1199, DOI 10.1001/archpedi.1989.02150220097027; De Serres G, 2000, Can Commun Dis Rep, V26, P1; EDWARDS KM, 1993, JAMA-J AM MED ASSOC, V269, P53, DOI 10.1001/jama.269.1.53; FARIZO KM, 1992, CLIN INFECT DIS, V14, P708, DOI 10.1093/clinids/14.3.708; FEIGIN RD, 1992, TXB PEDIAT INFECT DI, P1208; FINE PEM, 1986, INT J EPIDEMIOL, V15, P237, DOI 10.1093/ije/15.2.237; GAN VN, 1990, AM J DIS CHILD, V144, P1130, DOI 10.1001/archpedi.1990.02150340076027; Grimprel E, 1999, LANCET, V354, P1699, DOI 10.1016/S0140-6736(99)01576-7; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; Halperin SA, 1999, CLIN INFECT DIS, V28, P1238, DOI 10.1086/514792; HEININGER U, 1992, EUR J PEDIATR, V151, P342, DOI 10.1007/BF02113254; Hoppe JE, 2000, PEDIATR INFECT DIS J, V19, P244, DOI 10.1097/00006454-200003000-00014; Izurieta HS, 1996, CLIN INFECT DIS, V22, P503, DOI 10.1093/clinids/22.3.503; Juretzko P, 2002, CLIN INFECT DIS, V35, P162, DOI 10.1086/341027; KAUFMAN S, 1960, AMA J DIS CHILD, V99, P417, DOI 10.1001/archpedi.1960.02070030419003; Keitel WA, 1999, CLIN INFECT DIS, V28, pS118, DOI 10.1086/515064; Muller FMC, 1997, J CLIN MICROBIOL, V35, P2435; *NAT BUR CENS, ANN TIM SER STAT POP; NELSON JD, 1978, AM J DIS CHILD, V132, P371, DOI 10.1001/archpedi.1978.02120290043006; ONORATO IM, 1992, JAMA-J AM MED ASSOC, V267, P2745, DOI 10.1001/jama.267.20.2745; Simpson DM, 2001, AM J PREV MED, V20, P6, DOI 10.1016/S0749-3797(01)00286-0; SOTOMAYOR J, 1985, AM J DIS CHILD, V139, P724, DOI 10.1001/archpedi.1985.02140090086039; SUTTER RW, 1992, JAMA-J AM MED ASSOC, V267, P386, DOI 10.1001/jama.267.3.386; Sweden Ad Hoc Group for the Study of Pertussis Vaccines, 1988, Lancet, Vi, P955; *US DHHS, 2000, HLTH PEOPL 2010, V1, pCH14; *US PHS, ANN REP SURG GEN PUB; *US PHS, 1953, REP INC SEL NOT DIS, P240; Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012; Wharton M, 1990, MMWR Recomm Rep, V39, P1; WHARTON M, 2002, MANUAL SURVEILLANCE	40	262	272	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2003	290	22					2968	2975		10.1001/jama.290.22.2968	http://dx.doi.org/10.1001/jama.290.22.2968			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751WH	14665658	Bronze			2022-12-24	WOS:000187112700028
J	Calsbeek, R; Smith, TB				Calsbeek, R; Smith, TB			Ocean currents mediate evolution in island lizards	NATURE			English	Article							LOCOMOTOR PERFORMANCE; ANOLIS; SPECIATION; RADIATIONS; MORPHOLOGY	Islands are considered to be natural laboratories in which to examine evolution because of the implicit assumption that limited gene flow allows tests of evolutionary processes in isolated replicates(1). Here we show that this well-accepted idea requires re-examination. Island inundation during hurricanes can have devastating effects on lizard populations in the Bahamas(2,3). After severe storms, islands may be recolonized by overwater dispersal of lizards from neighbouring islands(3). High levels of gene flow may homogenize genes responsible for divergence, and are widely viewed as a constraining force on evolution(4,5). Ultimately, the magnitude of gene flow determines the extent to which populations diverge from one another, and whether or not they eventually form new species(6,7). We show that patterns of gene flow among island populations of Anolis lizards are best explained by prevailing ocean currents, and that over-water dispersal has evolutionary consequences. Across islands, divergence in fitness-related morphology decreases with increasing gene flow(5). Results suggest that over-water dispersal after hurricanes constrains adaptive diversification in Anolis lizards, and that it may have an important but previously undocumented role in this classical example of adaptive radiation.	Univ Calif Los Angeles, Inst Environm, Ctr Trop Res, Los Angeles, CA 90065 USA	University of California System; University of California Los Angeles	Calsbeek, R (corresponding author), Univ Calif Los Angeles, Inst Environm, Ctr Trop Res, Los Angeles, CA 90065 USA.	calsbeek@ucla.edu		Calsbeek, Ryan/0000-0002-9236-4092				BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; Batchelet E., 1981, CIRCULAR STAT BIOL, V1st; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; CALSBEEK R, UNPUB AM NAT; CASGRAIN P, 2001, R PACKAGE MULTIVARIA; Endler J.A., 1977, Monographs in Population Biology, pi; Georges TM, 1996, NATURE, V379, P434, DOI 10.1038/379434a0; Irschick DJ, 1998, EVOLUTION, V52, P219, DOI 10.1111/j.1558-5646.1998.tb05155.x; Irschick DJ, 1997, ECOLOGY, V78, P2191, DOI 10.2307/2265955; Irschick DJ, 1996, BIOL J LINN SOC, V59, P21, DOI 10.1111/j.1095-8312.1996.tb01451.x; Jackman TR, 1999, SYST BIOL, V48, P254, DOI 10.1080/106351599260283; KINDER TH, 1985, MAR GEOL, V68, P25, DOI 10.1016/0025-3227(85)90004-0; Lee TN, 1996, J PHYS OCEANOGR, V26, P962, DOI 10.1175/1520-0485(1996)026<0962:MOOWBC>2.0.CO;2; LIGHTY RG, 1979, NATURE, V278, P281, DOI 10.1038/278281b0; LOSOS JB, 1990, ECOL MONOGR, V60, P369, DOI 10.2307/1943062; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; LOSOS JB, 1989, J EXP BIOL, V145, P23; LOSOS JB, 1990, EVOLUTION, V44, P1189, DOI 10.1111/j.1558-5646.1990.tb05225.x; Losos JB, 2000, EVOLUTION, V54, P301, DOI 10.1111/j.0014-3820.2000.tb00032.x; Mayr E., 1963, ANIMAL SPECIES EVOLU; Ogden R, 2002, P NATL ACAD SCI USA, V99, P13612, DOI 10.1073/pnas.212248499; RICE WR, 1993, EVOLUTION, V47, P1637, DOI 10.1111/j.1558-5646.1993.tb01257.x; Schluter D, 2000, ECOLOGY ADAPTIVE RAD; SCHOENER A, 1984, OECOLOGIA, V63, P289, DOI 10.1007/BF00390655; Schoener T.W., 1983, P491; Schoener TW, 2001, SCIENCE, V294, P1525, DOI 10.1126/science.1064396; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Smith TB, 1997, SCIENCE, V276, P1855, DOI 10.1126/science.276.5320.1855; Spiller DA, 1998, SCIENCE, V281, P695, DOI 10.1126/science.281.5377.695; Williams E.E., 1983, LIZARD ECOLOGY STUDI, P326, DOI DOI 10.4159/HARVARD.9780674183384.C18	30	109	112	0	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					552	555		10.1038/nature02143	http://dx.doi.org/10.1038/nature02143			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654839				2022-12-24	WOS:000186944300037
J	Conboy, IM; Conboy, MJ; Smythe, GM; Rando, TA				Conboy, IM; Conboy, MJ; Smythe, GM; Rando, TA			Notch-mediated restoration of regenerative potential to aged muscle	SCIENCE			English	Article							SKELETAL-MUSCLE; SATELLITE CELLS; DIFFERENTIATION; MYOGENESIS; NUMBERS; FIBERS	A hallmark of aging is diminished regenerative potential of tissues, but the mechanism of this decline is unknown. Analysis of injured muscle revealed that, with age, resident precursor cells ( satellite cells) had a markedly impaired propensity to proliferate and to produce myoblasts necessary for muscle regeneration. This was due to insufficient up-regulation of the Notch ligand Delta and, thus, diminished activation of Notch in aged, regenerating muscle. Inhibition of Notch impaired regeneration of young muscle, whereas forced activation of Notch restored regenerative potential to old muscle. Thus, Notch signaling is a key determinant of muscle regenerative potential that declines with age.	Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; VA Palo Alto Hlth Care Syst, GRECC, Palo Alto, CA 94304 USA; VA Palo Alto Hlth Care Syst, Serv Neurol, Palo Alto, CA 94304 USA	Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.			Smythe, Gayle/0000-0002-4967-209X; Rando, Thomas/0000-0001-5843-8564	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [F31NR005902] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS36409] Funding Source: Medline; NINR NIH HHS [NRSA-AG05902] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bockhold KJ, 1998, MUSCLE NERVE, V21, P173, DOI 10.1002/(SICI)1097-4598(199802)21:2<173::AID-MUS4>3.0.CO;2-8; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Cossu G, 1996, TRENDS GENET, V12, P218, DOI 10.1016/0168-9525(96)10025-1; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Goldring K, 2002, J PATHOL, V197, P457, DOI 10.1002/path.1157; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; Kojika S, 2001, EXP HEMATOL, V29, P1041, DOI 10.1016/S0301-472X(01)00676-2; Nnodim JO, 2000, MECH AGEING DEV, V112, P99, DOI 10.1016/S0047-6374(99)00076-7; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Partridge TA, 2002, GENE THER, V9, P752, DOI 10.1038/sj.gt.3301764; Roth SM, 2000, ANAT REC, V260, P351, DOI 10.1002/1097-0185(200012)260:4<350::AID-AR30>3.0.CO;2-6; SCHULTZ E, 1982, MECH AGEING DEV, V20, P377, DOI 10.1016/0047-6374(82)90105-1; Shawber C, 1996, DEVELOPMENT, V122, P3765; Welle S, 2002, CAN J APPL PHYSIOL, V27, P19, DOI 10.1139/h02-002; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653	21	777	815	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1575	1577		10.1126/science.1087573	http://dx.doi.org/10.1126/science.1087573			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645852				2022-12-24	WOS:000186802200047
J	Manel, N; Kim, FJ; Kinet, S; Taylor, N; Sitbon, M; Battini, JL				Manel, N; Kim, FJ; Kinet, S; Taylor, N; Sitbon, M; Battini, JL			The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV	CELL			English	Article							T-CELL LEUKEMIA; HAMSTER OVARY CELLS; VIRUS TYPE-I; SYNCYTIUM FORMATION; SURFACE EXPRESSION; HUMAN ERYTHROCYTES; BINDING-PROTEIN; LYMPHOCYTES; RETROVIRUS; ACTIVATION	The human T cell leukemia virus (HTLV) is associated with leukemia and neurological syndromes. The physiopathological effects of HTLV envelopes are unclear and the identity of the receptor, present on all vertebrate cell lines, has been elusive. We show that the receptor binding domains of both HTLV-1 and -2 envelope glycoproteins inhibit glucose transport by interacting with GLUT-1, the ubiquitous vertebrate glucose transporter. Receptor binding and HTLV envelope-driven infection are selectively inhibited when glucose transport or GLUT-1 expression are blocked by cytochalasin B or siRNAs, respectively. Furthermore, ectopic expression of GLUT-1, but not the related transporter GLUT-3, restores HTLV infection abrogated by either GLUT-1 siRNAs or interfering HTLV envelope glycoproteins. Therefore, GLUT-1 is a receptor for HTLV. Perturbations in glucose metabolism resulting from interactions of HTLV envelope glycoproteins with GLUT-1 are likely to contribute to HTLV-associated disorders.	Inst Genet Mol Montpellier, CNRS UMR 5535, IFR 122, F-34293 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Sitbon, M (corresponding author), Inst Genet Mol Montpellier, CNRS UMR 5535, IFR 122, F-34293 Montpellier 5, France.		Taylor, Naomi/H-4016-2014; Sitbon, Marc/A-6771-2010; Manel, Nicolas/E-2128-2011	Sitbon, Marc/0000-0003-3616-2338; Manel, Nicolas/0000-0002-1481-4430; Battini, Jean-Luc/0000-0002-5884-9934; kinet, sandrina/0000-0003-0699-108X				Akaoka H, 2001, VIRUS RES, V78, P57, DOI 10.1016/S0168-1702(01)00284-2; ASANO T, 1992, BIOCHEM J, V288, P189, DOI 10.1042/bj2880189; Battini JL, 1999, P NATL ACAD SCI USA, V96, P1385, DOI 10.1073/pnas.96.4.1385; BATTINI JL, 1995, J VIROL, V69, P713, DOI 10.1128/JVI.69.2.713-719.1995; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Cavrois M, 1996, ONCOGENE, V12, P2419; CHAKRABARTI R, 1994, J IMMUNOL, V152, P2660; Concha II, 1997, BLOOD, V89, P4190, DOI 10.1182/blood.V89.11.4190; Daenke S, 1999, J GEN VIROL, V80, P1429, DOI 10.1099/0022-1317-80-6-1429; Daenke S, 2000, J CELL SCI, V113, P37; DENESVRE C, 1995, J VIROL, V69, P4149, DOI 10.1128/JVI.69.7.4149-4157.1995; Denesvre C, 1996, J VIROL, V70, P4380, DOI 10.1128/JVI.70.7.4380-4386.1996; Derse D, 2003, SCIENCE, V299, P1670, DOI 10.1126/science.1083218; DEVIVO DC, 1991, NEW ENGL J MED, V325, P703, DOI 10.1056/NEJM199109053251006; Escher SA, 1999, HEREDITAS, V130, P95, DOI 10.1111/j.1601-5223.1999.00095.x; Feuer G, 1996, J VIROL, V70, P4038, DOI 10.1128/JVI.70.6.4038-4044.1996; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; GARCIA CK, 1994, CELL, V76, P865, DOI 10.1016/0092-8674(94)90361-1; GESSAIN A, 1985, LANCET, V2, P407; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hanon E, 2000, IMMUNITY, V13, P657, DOI 10.1016/S1074-7613(00)00065-0; HARRISON SA, 1990, J BIOL CHEM, V265, P5793; Hildreth JEK, 1997, J VIROL, V71, P1173, DOI 10.1128/JVI.71.2.1173-1180.1997; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jassal SR, 2001, J VIROL, V75, P8317, DOI 10.1128/JVI.75.17.8317-8328.2001; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; KASAHARA M, 1977, J BIOL CHEM, V252, P7384; KASINRERK W, 1992, J IMMUNOL, V149, P847; Kim FJ, 2000, J BIOL CHEM, V275, P23417, DOI 10.1074/jbc.C901002199; Kim FJ, 2003, J VIROL, V77, P963, DOI 10.1128/JVI.77.2.963-969.2003; KIM FJ, 2003, IN PRESS VIROLOGY; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Korgun ET, 2002, BLOOD CELL MOL DIS, V28, P152, DOI 10.1006/bcmd.2002.0504; Manel N, 2003, BLOOD, V101, P1913, DOI 10.1182/blood-2002-09-2681; MANTYCH G, 1991, BIOCHEM BIOPH RES CO, V180, P367, DOI 10.1016/S0006-291X(05)81302-6; MILLER DG, 1994, P NATL ACAD SCI USA, V91, P78, DOI 10.1073/pnas.91.1.78; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Nath MD, 2003, BLOOD, V101, P3085, DOI 10.1182/blood-2002-07-2277; OSAME M, 1986, LANCET, V1, P1031; Overbaugh J, 2001, MICROBIOL MOL BIOL R, V65, P371, DOI 10.1128/MMBR.65.3.371-389.2001; PICHARD L, 1990, DRUG METAB DISPOS, V18, P595; Pinon JD, 2003, J VIROL, V77, P9922, DOI 10.1128/JVI.77.18.9922-9930.2003; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Rodrigues P, 1999, J VIROL, V73, P3789, DOI 10.1128/JVI.73.5.3789-3799.1999; Rosenberg AR, 1998, J VIROL, V72, P7609, DOI 10.1128/JVI.72.9.7609-7614.1998; SIEGEL GJ, 1998, CIRCULATION ENERGY M, pCH5; Slattery JP, 1999, GENOME RES, V9, P525; Sutton RE, 1996, J VIROL, V70, P7322, DOI 10.1128/JVI.70.10.7322-7326.1996; Tailor CS, 2003, CURR TOP MICROBIOL, V281, P29; Trejo SR, 2000, VIROLOGY, V268, P41, DOI 10.1006/viro.2000.0143; VANZEIJL M, 1994, P NATL ACAD SCI USA, V91, P1168, DOI 10.1073/pnas.91.3.1168; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Yu Q, 2003, J EXP MED, V197, P475, DOI 10.1084/jem.20021765	56	299	319	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 14	2003	115	4					449	459		10.1016/S0092-8674(03)00881-X	http://dx.doi.org/10.1016/S0092-8674(03)00881-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	744KB	14622599	Bronze			2022-12-24	WOS:000186627100011
J	Zhao, GQ; Zhang, YF; Hoon, MA; Chandrashekar, J; Erlenbach, I; Ryba, NJP; Zuker, CS				Zhao, GQ; Zhang, YF; Hoon, MA; Chandrashekar, J; Erlenbach, I; Ryba, NJP; Zuker, CS			The receptors for mammalian sweet and umami taste	CELL			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; PHOSPHOLIPASE-C; GENE-EXPRESSION; CHORDA TYMPANI; BITTER TASTE; RESPONSES; CELLS; MICE; IDENTIFICATION; FAMILY	Sweet and umami (the taste of monosodium glutamate) are the main attractive taste modalities in humans. T1Rs are candidate mammalian taste receptors that combine to assemble two heteromeric G-protein-coupled receptor complexes: T1R1+3, an umami sensor, and T1R2+3, a sweet receptor. We now report the behavioral and physiological characterization of T1R1, T1R2, and T1R3 knockout mice. We demonstrate that sweet and umami taste are strictly dependent on T1R-receptors, and show that selective elimination of T1R-subunits differentially abolishes detection and perception of these two taste modalities. To examine the basis of sweet tastant recognition and coding, we engineered animals expressing either the human T1R2-receptor (hT1R2), or a modified opioid-receptor (RASSL) in sweet cells. Expression of hT1R2 in mice generates animals with humanized sweet taste preferences, while expression of RASSL drives strong attraction to a synthetic opiate, demonstrating that sweet cells trigger dedicated behavioral outputs, but their tastant selectivity is determined by the nature of the receptors.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ryba, NJP (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	nr13k@nih.gov; charles@flyeye.ucsd.edu		Ryba, Nicholas/0000-0002-2060-8393; Chandrashekar, jayaram/0000-0001-6412-0114	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000561] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Abaffy T, 2003, AM J PHYSIOL-CELL PH, V284, pC1420, DOI 10.1152/ajpcell.00556.2002; Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Bachmanov AA, 2000, J NUTR, V130, p935S, DOI 10.1093/jn/130.4.935S; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 1998, ANN NY ACAD SCI, V855, P398, DOI 10.1111/j.1749-6632.1998.tb10598.x; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Chaudhari N, 1996, J NEUROSCI, V16, P3817; Dahl M, 1997, BRAIN RES, V756, P22, DOI 10.1016/S0006-8993(97)00131-5; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Danilova V, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-5; Danilova V, 1998, J NEUROPHYSIOL, V80, P2102, DOI 10.1152/jn.1998.80.4.2102; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Gossen Manfred, 1994, Current Opinion in Biotechnology, V5, P516, DOI 10.1016/0958-1669(94)90067-1; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Kinnamon SC, 2000, NEURON, V25, P507, DOI 10.1016/S0896-6273(00)81054-5; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Margolskee RF, 2002, J BIOL CHEM, V277, P1, DOI 10.1074/jbc.R100054200; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Mody SM, 2000, MOL PHARMACOL, V57, P13; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Ninomiya Y, 1999, J NEUROPHYSIOL, V81, P3087, DOI 10.1152/jn.1999.81.6.3087; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Redfern CH, 1999, NAT BIOTECHNOL, V17, P165, DOI 10.1038/6165; Rossler P, 1998, EUR J CELL BIOL, V77, P253; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; SCHIFFMAN SS, 1981, PHARMACOL BIOCHEM BE, V15, P377, DOI 10.1016/0091-3057(81)90266-5; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; YOSHII K, 1986, BRAIN RES, V367, P45, DOI 10.1016/0006-8993(86)91577-5; ZACK DJ, 1991, NEURON, V6, P187, DOI 10.1016/0896-6273(91)90355-4; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	40	898	958	8	167	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2003	115	3					255	266		10.1016/S0092-8674(03)00844-4	http://dx.doi.org/10.1016/S0092-8674(03)00844-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	740RH	14636554	Bronze			2022-12-24	WOS:000186415000006
J	Liotta, LA; Ferrari, M; Petricoin, E				Liotta, LA; Ferrari, M; Petricoin, E			Written in blood	NATURE			English	Article									NCI, Bethesda, MD 20892 USA; Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Dept Internal Med, Columbus, OH 43210 USA; US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; Ohio State University; US Food & Drug Administration (FDA)	Liotta, LA (corresponding author), NCI, 10 Ctr Dr, Bethesda, MD 20892 USA.							Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Liu J, 2002, DIS MARKERS, V18, P175, DOI 10.1155/2002/874157; Mehta AI, 2003, DIS MARKERS, V19, P1; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Tirumalai RS, 2003, MOL CELL PROTEOMICS, V2, P1096, DOI 10.1074/mcp.M300031-MCP200	5	410	450	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2003	425	6961					905	905		10.1038/425905a	http://dx.doi.org/10.1038/425905a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14586448	Bronze, Green Published			2022-12-24	WOS:000186230600022
J	Nelson, KB				Nelson, KB			Can we prevent cerebral palsy?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CESAREAN-SECTION; BIRTH-WEIGHT; RISK-FACTORS; INFANTS; STROKE; INTRAPARTUM; DELIVERY; TRENDS		NINDS, Neuroepidemiol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Nelson, KB (corresponding author), NINDS, Neuroepidemiol Branch, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002863] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andrew M E, 2001, Hematology Am Soc Hematol Educ Program, P358; Clark SL, 2003, AM J OBSTET GYNECOL, V188, P628, DOI 10.1067/mob.2003.204; Golomb MR, 2001, ANN NEUROL, V50, P163, DOI 10.1002/ana.1078; GRANT A, 1989, LANCET, V2, P1233; Grether JK, 1998, JAMA-J AM MED ASSOC, V279, P118; Grether JK, 2003, ARCH PEDIAT ADOL MED, V157, P26, DOI 10.1001/archpedi.157.1.26; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Jackson N, 2001, BEST PRACT RES CL OB, V15, P49, DOI 10.1053/beog.2000.0148; Lanska DJ, 2000, STROKE, V31, P1274, DOI 10.1161/01.STR.31.6.1274; LILFORD RJ, 1990, BRIT J OBSTET GYNAEC, V97, P883, DOI 10.1111/j.1471-0528.1990.tb02442.x; Lynch JK, 2001, CURR OPIN PEDIATR, V13, P499, DOI 10.1097/00008480-200112000-00002; MacDorman MF, 2002, PEDIATRICS, V110, P1037, DOI 10.1542/peds.110.6.1037; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Mello MM, 2003, NEW ENGL J MED, V348, P2281, DOI 10.1056/NEJMp030064; Nelson KB, 1996, NEW ENGL J MED, V334, P613, DOI 10.1056/NEJM199603073341001; Nelson KB, 1998, AM J OBSTET GYNECOL, V179, P507, DOI 10.1016/S0002-9378(98)70387-4; PETTERSON B, 1993, BRIT MED J, V307, P1239, DOI 10.1136/bmj.307.6914.1239; Ros HS, 2002, AM J OBSTET GYNECOL, V186, P198, DOI 10.1067/mob.2002.119177; SHY KK, 1990, NEW ENGL J MED, V322, P588, DOI 10.1056/NEJM199003013220904; STANLEY F, 2000, CLIN DEV MED, V151; Surman G, 2003, DEV MED CHILD NEUROL, V45, P456, DOI 10.1017/S0012162203000859; THACKER SB, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000063; Walstab J, 2002, AUST NZ J OBSTET GYN, V42, P138, DOI 10.1111/j.0004-8666.2002.00138.x; Willoughby RE, 2002, CLIN PERINATOL, V29, P603, DOI 10.1016/S0095-5108(02)00058-1; Winter S, 2002, PEDIATRICS, V110, P1220, DOI 10.1542/peds.110.6.1220	25	131	137	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2003	349	18					1765	1769		10.1056/NEJMsb035364	http://dx.doi.org/10.1056/NEJMsb035364			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	737FJ	14585946				2022-12-24	WOS:000186219500013
J	Duyk, G				Duyk, G			Attrition and translation	SCIENCE			English	Article							DRUG DEVELOPMENT; UNITED-STATES	The recently published NIH Roadmap proposes that public-sector science should place increased emphasis on the development of new therapeutics and diagnostics based on the fruits of fundamental research. Such "translational research" activities, traditionally the province of the private sector, have long been compromised by high rates of attrition (failure during the course of preclinical or clinical development of therapeutics). Attrition has led to growing financial costs, as well as opportunity costs. The new focus offers a way to reverse these trends, especially if the scientific community can improve on its ability to reconcile molecular genetic research with integrative organ- and organism-based research.	Exelixis Inc, San Francisco, CA 94083 USA	Exelixis, Inc.	Duyk, G (corresponding author), Exelixis Inc, 170 Harbor Way, San Francisco, CA 94083 USA.							*BILL MEL GAT FDN, GLOB HLTH PROGR; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564; DiMasi JA, 2001, CLIN PHARMACOL THER, V69, P286, DOI 10.1067/mcp.2001.115132; DIMASI JA, 1991, CLIN PHARMACOL THER, V50, P471, DOI 10.1038/clpt.1991.172; DiMasi Joseph A., 1996, Am J Ther, V3, P647, DOI 10.1097/00045391-199609000-00008; Eisenberg RS, 2003, SCIENCE, V299, P1018, DOI 10.1126/science.1081790; FALK M, 2003, STATUS FUTURE INTEGR; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; KAITIN KI, 2003, TUFTS CTR STUDY DRUG, V5; *LEHM BROTH, 2001, FRUITS GEN DRUG PIP; Malakoff D, 2003, SCIENCE, V300, P1635; MCCLELLAN MB, 2003, COMMUNICATION   0609; MILNE CP, 2002, PHARMACOECONOMICS S3, V20; Wellcome Trust, 2003, SHAR DAT LARG SCAL B; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867	16	72	74	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					603	605		10.1126/science.1090521	http://dx.doi.org/10.1126/science.1090521			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576424				2022-12-24	WOS:000186119900047
J	Boyd, PA; Tondi, F; Hicks, NR; Chamberlain, PF				Boyd, PA; Tondi, F; Hicks, NR; Chamberlain, PF			Autopsy after termination of pregnancy for fetal anomaly: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							PRENATAL-DIAGNOSIS	Objective To study trends in termination of pregnancy for fetal anomaly over 10 years and to assess the contribution of autopsy to the final diagnosis and counselling after termination. Design Retrospective study with cases from a congenital anomaly register and a defined unselected population. Data sources Pregnancies resulting in termination for fetal anomaly identified from the Oxford congenital anomaly register. Details about the prenatal diagnosis and autopsy findings were retrieved from case notes. Results Of the 57 258 deliveries, 309 (0.5%) were terminated because of prenatally diagnosed abnormality. There Were 129/29 086 (0.4%) terminations for fetal anomaly carried out in 1991-5 and 180/28 172 (0.6%) in 1996-2000. The percentage of fetuses that underwent autopsy fell from 84% to 67%. Autopsy was performed in 132 cases identified by ultrasound scan, with no evidence for abnormal karyotype. In 95 (72%) the autopsy confirmed the suspected diagnosis and did not add important further information, two cases were not classified, and in 35 (27%) the autopsy added information that led to a refinement of the risk of recurrence (reduced in 17, increased in 18); in I I of these 18 cases it was increased to a one in four risk. Conclusions Though there has been an increase in the rate of terminations of pregnancy for fetal anomaly, there has been a decline in the autopsy rate. When a prenatal diagnosis was based on the results of a scan only, the addition of information from a autopsy by a specialist paediatric pathologist provided important information that changed the estimated risk of recurrence in 27% of cases and in 8% this was to a higher (one in four) risk.	Inst Hlth Sci, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England; Univ Florence, Fac Med & Chirurg, Dept Ginecol Perinatol & Riprod Umana, Florence, Italy; Univ Oxford, Dept Publ Hlth & Primary Care, Inst Hlth Sci, Oxford OX3 7LF, England; Oxford Radcliffe NHS Trust, Prenatal Diag Unit, Oxford OX3 9DU, England	University of Oxford; University of Florence; University of Oxford	Boyd, PA (corresponding author), Inst Hlth Sci, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England.	Patricia.boyd@orh.nhs.uk						Bauchner H, 2001, BMJ-BRIT MED J, V322, P309, DOI 10.1136/bmj.322.7282.309; Boyd PA, 1998, LANCET, V352, P1577, DOI 10.1016/S0140-6736(98)03202-4; Bricker L, 2000, HEALTH TECHNOL ASSES, V4, P1; Brodlie M, 2002, BRIT MED J, V324, P761, DOI 10.1136/bmj.324.7340.761; Gaffney G, 1998, PRENATAL DIAG, V18, P357, DOI 10.1002/(SICI)1097-0223(199804)18:4<357::AID-PD276>3.0.CO;2-0; Hunter M, 2001, BRIT MED J, V322, P255, DOI 10.1136/bmj.322.7281.255; Khong TY, 2002, BRIT MED J, V324, P749, DOI 10.1136/bmj.324.7340.749; Laussel-Riera A, 2000, ANN PATHOL, V20, P549; Morris JK, 1999, PRENATAL DIAG, V19, P142, DOI 10.1002/(SICI)1097-0223(199902)19:2<142::AID-PD486>3.3.CO;2-Z; *NAT PER EP UN, 2003, REP OXF CONG AN REG; Redfern Michael, 2001, ROYAL LIVERPOOL CHIL; *ROYAL COLL OBST G, 1997, ULTR SCANN FET ABN R; Wald NJ, 1998, HEALTH TECHNOL ASSES, V2, P1, DOI DOI 10.3310/HTA2010; 2002, BMJ, V325, P1121	14	115	116	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 17	2004	328	7432					137	140		10.1136/bmj.37939.570104.EE	http://dx.doi.org/10.1136/bmj.37939.570104.EE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	765CQ	14662522	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000188249900017
J	Chen, CZ; Li, L; Lodish, HF; Bartel, DP				Chen, CZ; Li, L; Lodish, HF; Bartel, DP			MicroRNAs modulate hematopoietic lineage differentiation	SCIENCE			English	Article							EXPRESSION; RNAS; IDENTIFICATION; CONSERVATION; SEQUENCE; ENCODES; DEATH; FAT	MicroRNAs (miRNAs) are an abundant class of similar to22-nucleotide regulatory RNAs found in plants and animals. Some miRNAs of plants, Caenorhabditis elegans, and Drosophila play important gene-regulatory roles during development by pairing to target mRNAs to specify posttranscriptional repression of these messages. We identify three miRNAs that are specifically expressed in hematopoietic cells and show that their expression is dynamically regulated during early hematopoiesis and lineage commitment. One of these miRNAs, miR-181, was preferentially expressed in the B-lymphoid cells of mouse bone marrow, and its ectopic expression in hematopoietic stem/progenitor cells led to an increased fraction of B-lineage cells in both tissue-culture differentiation assays and adult mice. Our results indicate that microRNAs are components of the molecular circuitry that controls mouse hematopoiesis and suggest that other microRNAs have similar regulatory roles during other facets of vertebrate development.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Lodish, HF (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lodish@wi.mit.edu; dbartel@wi.mit.edu	Li, Ling/A-2008-2010; Huang, H/E-9490-2010	Chen, Chang-Zheng/0000-0002-1620-242X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081612] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL081612, R01 HL081612-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; COLLINS LS, 1987, J IMMUNOL, V138, P1082; Dostie J, 2003, RNA, V9, P631; Enver T, 1998, CELL, V94, P9, DOI 10.1016/S0092-8674(00)81215-5; GAUWERKY CE, 1989, P NATL ACAD SCI USA, V86, P8867, DOI 10.1073/pnas.86.22.8867; HANTZOPOULOS PA, 1989, P NATL ACAD SCI USA, V86, P3519, DOI 10.1073/pnas.86.10.3519; Kawasaki H, 2003, NATURE, V423, P838, DOI 10.1038/nature01730; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503	27	2633	2946	3	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2004	303	5654					83	86		10.1126/science.1091903	http://dx.doi.org/10.1126/science.1091903			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YU	14657504	Green Submitted			2022-12-24	WOS:000187710600038
J	Aarts, M; Iihara, K; Wei, WL; Xiong, ZG; Arundine, M; Cerwinski, W; MacDonald, JF; Tymianski, M				Aarts, M; Iihara, K; Wei, WL; Xiong, ZG; Arundine, M; Cerwinski, W; MacDonald, JF; Tymianski, M			A key role for TRPM7 channels in anoxic neuronal death	CELL			English	Article							METHYL-D-ASPARTATE; CORTICAL CELL-CULTURE; CATION CHANNEL; CALCIUM NEUROTOXICITY; RECEPTOR ACTIVATION; RNA INTERFERENCE; CLINICAL-TRIALS; BRAIN INJURY; NITRIC-OXIDE; ACUTE STROKE	Excitotoxicity in brain ischemia triggers neuronal death and neurological disability, and yet these are not prevented by antiexcitotoxic therapy (AET) in humans. Here, we show that in neurons subjected to prolonged oxygen glucose deprivation (OGD), AET unmasks a dominant death mechanism perpetuated by a Ca2+-permeable nonselective cation conductance (I-OGD). I-OGD was activated by reactive oxygen/nitrogen species (ROS), and permitted neuronal Ca2+ overload and further ROS production despite AET. I-OGD currents corresponded to those evoked in HEK-293 cells expressing the nonselective cation conductance TRPM7. In cortical neurons, blocking I-OGD or suppressing TRPM7 expression blocked TRPM7 currents, anoxic Ca-45(2+) up-take, ROS production, and anoxic death. TRPM7 suppression eliminated the need for AET to rescue anoxic neurons and permitted the survival of neurons previously destined to die from prolonged anoxia. Thus, excitotoxicity is a subset of a greater overall anoxic cell death mechanism, in which TRPM7 channels play a key role.	Toronto Western Hosp, Res Inst, Toronto, ON M5T 2S8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Surg, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Tymianski, M (corresponding author), Toronto Western Hosp, Res Inst, Toronto, ON M5T 2S8, Canada.		Aarts, Michelle/C-5766-2008	Aarts, Michelle/0000-0002-9171-0571; Tymianski, Mike/0000-0002-6311-9565	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039060] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 39060] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Birmingham K, 2002, NAT MED, V8, P5, DOI 10.1038/nm0102-5a; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; CHOI DW, 1987, J NEUROSCI, V7, P357; Cullen BR, 2002, NAT IMMUNOL, V3, P597, DOI 10.1038/ni0702-597; Davis SM, 1997, LANCET, V349, P32, DOI 10.1016/S0140-6736(05)62166-6; DUGAN LL, 1995, J NEUROSCI, V15, P6377; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gao TM, 1998, NEUROSCIENCE, V87, P371, DOI 10.1016/S0306-4522(98)00150-X; GOLDBERG MP, 1987, J PHARMACOL EXP THER, V243, P784; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Golovina VA, 1997, SCIENCE, V275, P1643, DOI 10.1126/science.275.5306.1643; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Kerschbaum HH, 2003, BIOPHYS J, V84, P2293, DOI 10.1016/S0006-3495(03)75035-8; Kozak JA, 2003, BIOPHYS J, V84, P922, DOI 10.1016/S0006-3495(03)74909-1; Lees KR, 2000, LANCET, V355, P1949, DOI 10.1016/S0140-6736(00)02326-6; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sattler R, 1998, J NEUROCHEM, V71, P2349; Sattler R, 1997, J CEREBR BLOOD F MET, V17, P455, DOI 10.1097/00004647-199704000-00011; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Sensi SL, 1999, NEUROREPORT, V10, P1723, DOI 10.1097/00001756-199906030-00018; Sheline CT, 2002, NEUROBIOL DIS, V10, P41, DOI 10.1006/nbdi.2002.0497; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; WEISS JH, 1993, NEURON, V10, P43, DOI 10.1016/0896-6273(93)90240-R; Xiong ZG, 1997, P NATL ACAD SCI USA, V94, P7012, DOI 10.1073/pnas.94.13.7012; Ying WH, 2000, J CEREBR BLOOD F MET, V20, P359, DOI 10.1097/00004647-200002000-00018	43	615	649	3	70	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 26	2003	115	7					863	877		10.1016/S0092-8674(03)01017-1	http://dx.doi.org/10.1016/S0092-8674(03)01017-1			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	758RV	14697204	Bronze			2022-12-24	WOS:000187664700010
J	Berry, KL; Bulow, HE; Hall, DH; Hobert, O				Berry, KL; Bulow, HE; Hall, DH; Hobert, O			A C-elegans CLIC-like protein required for intracellular tube formation and maintenance	SCIENCE			English	Article							CHLORIDE-ION CHANNEL; SECRETORY-EXCRETORY SYSTEM; CAENORHABDITIS-ELEGANS; MOLECULAR-CLONING; ANION CHANNEL; CELL; NCC27; EXPRESSION; FAMILY; P64H1	The Caenorhabditis elegans excretory canal is composed of a single elongated and branched cell that is tunneled by an inner lumen of apical character. Loss of the exc-4 gene causes a cystic enlargement of this intracellular tube. exc-4 encodes a member of the chloride intracellular channel (CLIC) family of proteins. EXC-4 protein localizes to various tubular membranes in distinct cell types, including the lumenal membrane of the excretory tubes. A conserved 55 - amino acid domain enables EXC-4 translocation from the cytosol to the lumenal membrane. The tubular architecture of this membrane requires EXC-4 for both its formation and maintenance.	Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA; Yeshiva Univ Albert Einstein Coll Med, Ctr C Elegans Anat, Dept Neurosci, Bronx, NY 10461 USA	Columbia University; Yeshiva University; Albert Einstein College of Medicine	Hobert, O (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA.			Hobert, Oliver/0000-0002-7634-2854; Berry, Katherine/0000-0002-2311-0734	NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR012596] Funding Source: NIH RePORTER; NCRR NIH HHS [R24 RR012596] Funding Source: Medline; NIH HHS [R24 OD010943] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ashley RH, 2003, MOL MEMBR BIOL, V20, P1, DOI 10.1080/09687680210042746; Buechner M, 1999, DEV BIOL, V214, P227, DOI 10.1006/dbio.1999.9398; Buechner M, 2002, TRENDS CELL BIOL, V12, P479, DOI 10.1016/S0962-8924(02)02364-4; Cromer BA, 2002, EUR BIOPHYS J BIOPHY, V31, P356, DOI 10.1007/s00249-002-0219-1; Duncan RR, 1997, J BIOL CHEM, V272, P23880, DOI 10.1074/jbc.272.38.23880; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Harrop SJ, 2001, J BIOL CHEM, V276, P44993, DOI 10.1074/jbc.M107804200; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; LANDRY DW, 1989, SCIENCE, V244, P1469, DOI 10.1126/science.2472007; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6; NELSON FK, 1984, J EXP ZOOL, V231, P45, DOI 10.1002/jez.1402310107; NELSON FK, 1983, J ULTRA MOL STRUCT R, V82, P156; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nishizawa T, 2000, J BIOL CHEM, V275, P11164, DOI 10.1074/jbc.275.15.11164; Proutski I, 2002, BIOCHEM BIOPH RES CO, V297, P317, DOI 10.1016/S0006-291X(02)02199-X; Tonini R, 2000, FASEB J, V14, P1171, DOI 10.1096/fasebj.14.9.1171; Tulk BM, 2000, J BIOL CHEM, V275, P26986; Tulk BM, 2002, AM J PHYSIOL-CELL PH, V282, pC1103, DOI 10.1152/ajpcell.00402.2001; Valenzuela SM, 2000, J PHYSIOL-LONDON, V529, P541, DOI 10.1111/j.1469-7793.2000.00541.x; Valenzuela SM, 1997, J BIOL CHEM, V272, P12575, DOI 10.1074/jbc.272.19.12575; Warton K, 2002, J BIOL CHEM, V277, P26003, DOI 10.1074/jbc.M203666200	23	124	129	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2134	2137		10.1126/science.1087667	http://dx.doi.org/10.1126/science.1087667			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684823				2022-12-24	WOS:000187385200048
J	Paschen, SA; Waizenegger, T; Stan, T; Preuss, M; Cyrklaff, M; Hell, K; Rapaport, D; Neupert, W				Paschen, SA; Waizenegger, T; Stan, T; Preuss, M; Cyrklaff, M; Hell, K; Rapaport, D; Neupert, W			Evolutionary conservation of biogenesis of beta-barrel membrane proteins	NATURE			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; TOM COMPLEX; IMPORT PORE; CHANNEL; COMPONENT; MACHINERY; RECEPTORS; YEAST	The outer membranes of mitochondria and chloroplasts are distinguished by the presence of beta-barrel membrane proteins(1,2). The outer membrane of Gram-negative bacteria also harbours beta-barrel proteins(3). In mitochondria these proteins fulfil a variety of functions such as transport of small molecules (porin/VDAC), translocation of proteins (Tom40) and regulation of mitochondrial morphology (Mdm10)(4-7). These proteins are encoded by the nucleus, synthesized in the cytosol, targeted to mitochondria as chaperone-bound species, recognized by the translocase of the outer membrane, and then inserted into the outer membrane where they assemble into functional oligomers(8-11). Whereas some knowledge has been accumulated on the pathways of insertion of proteins that span cellular membranes with alpha-helical segments, very little is known about how beta-barrel proteins are integrated into lipid bilayers and assembled into oligomeric structures(12). Here we describe a protein complex that is essential for the topogenesis of mitochondrial outer membrane beta-barrel proteins (TOB). We present evidence that important elements of the topogenesis of beta-barrel membrane proteins have been conserved during the evolution of mitochondria from endosymbiotic bacterial ancestors(13).	Univ Munich, Adolf Butenandt Inst Physiol Chem, D-81377 Munich, Germany; Max Planck Inst Biochem, Abt Mol Strukturbiol, D-82152 Martinsried, Germany	University of Munich; Max Planck Society	Neupert, W (corresponding author), Univ Munich, Adolf Butenandt Inst Physiol Chem, Butenandtstr 5, D-81377 Munich, Germany.							Ahting U, 2001, J CELL BIOL, V153, P1151, DOI 10.1083/jcb.153.6.1151; Blachly-Dyson E, 2001, IUBMB LIFE, V52, P113; Brachat A, 2000, YEAST, V16, P241, DOI 10.1002/(SICI)1097-0061(200002)16:3<241::AID-YEA517>3.0.CO;2-T; De Carlo S, 2002, J STRUCT BIOL, V138, P216, DOI 10.1016/S1047-8477(02)00035-7; Ellis RJ, 1996, FOLD DES, V1, pR9, DOI 10.1016/S1359-0278(96)00004-1; Endo T, 2002, BBA-MOL CELL RES, V1592, P3, DOI 10.1016/S0167-4889(02)00259-8; Gabriel K, 2001, TRENDS BIOCHEM SCI, V26, P36, DOI 10.1016/S0968-0004(00)01684-4; Genevrois S, 2003, EMBO J, V22, P1780, DOI 10.1093/emboj/cdg174; GRATZER S, 1995, J CELL BIOL, V129, P25, DOI 10.1083/jcb.129.1.25; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hegerl R, 1996, J STRUCT BIOL, V116, P30, DOI 10.1006/jsbi.1996.0006; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; Lafontaine D, 1996, NUCLEIC ACIDS RES, V24, P3469, DOI 10.1093/nar/24.17.3469; Marcotte EM, 2000, P NATL ACAD SCI USA, V97, P12115, DOI 10.1073/pnas.220399497; Matouschek A, 2001, NAT STRUCT BIOL, V8, P284, DOI 10.1038/86140; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Paschen SA, 2001, IUBMB LIFE, V52, P101, DOI 10.1080/15216540152845894; Pavlov EV, 2001, J CELL BIOL, V155, P725, DOI 10.1083/jcb.200107057; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Popp B, 1996, J BIOL CHEM, V271, P13593, DOI 10.1074/jbc.271.23.13593; Rapaport D, 1999, J CELL BIOL, V146, P321, DOI 10.1083/jcb.146.2.321; Rapaport D, 2002, TRENDS BIOCHEM SCI, V27, P191, DOI 10.1016/S0968-0004(02)02065-0; Raussens V, 2003, ANAL BIOCHEM, V319, P114, DOI 10.1016/S0003-2697(03)00285-9; Schleiff E, 2003, PROTEIN SCI, V12, P748, DOI 10.1110/ps.0237503; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; SOGO LF, 1994, J CELL BIOL, V126, P1361, DOI 10.1083/jcb.126.6.1361; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753	29	334	347	5	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					862	866		10.1038/nature02208	http://dx.doi.org/10.1038/nature02208			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685243				2022-12-24	WOS:000187342000064
J	Adams, WM; Brockington, D; Dyson, J; Vira, B				Adams, WM; Brockington, D; Dyson, J; Vira, B			Managing tragedies: Understanding conflict over common pool resources	SCIENCE			English	Article							NONEQUILIBRIUM	Conflicts over the management of common pool resources are not simply material. They also depend on the perceptions of the protagonists. Policy to improve management often assumes that problems are self-evident, but in fact careful and transparent consideration of the ways different stakeholders understand management problems is essential to effective dialogue.	Univ Cambridge, Dept Geog, Cambridge CB2 3EN, England; Univ Oxford, Sch Geog & Environm, Oxford OX1 3TB, England	University of Cambridge; University of Oxford	Adams, WM (corresponding author), Univ Cambridge, Dept Geog, Downing Pl, Cambridge CB2 3EN, England.	wa12@cam.ac.uk	/ADO-3246-2022; Brockington, Dan/AAK-9065-2021	Brockington, Dan/0000-0001-5692-0154; DYSON, JANE/0000-0003-4868-3229				Agrawal A, 2001, WORLD DEV, V29, P1649, DOI 10.1016/S0305-750X(01)00063-8; Arnold J. E. M., 1997, FARMS TREES FARMERS; BEHNKE RH, 1993, RANGE ECOLOGY AT DISEQUILIBRIUM, P1; Bobbitt P., 1978, TRAGIC CHOICES; Brown K, 2001, ECOL ECON, V37, P417, DOI 10.1016/S0921-8009(00)00293-7; Dryzek J.S., 2017, POLITICS EARTH ENV D, V3rd, DOI 10.1093/hepl/9780199696000.001.0001; Edwards VM, 1998, J THEOR POLIT, V10, P347, DOI 10.1177/0951692898010003008; Illius AW, 1999, ECOL APPL, V9, P798, DOI 10.1890/1051-0761(1999)009[0798:OTRONC]2.0.CO;2; Leach G., 1988, WOODFUEL CRISIS PEOP; Leach M., 1996, The lie of the land: challenging received wisdom on the African environment., P1; Oakerson R. J., 1992, Making the commons work: theory, practice, and policy., P41; Oakerson Ronald, 1986, P C COMM PROP RES MA, P13; OSTROM E, 1990, GOVT COMMONS EVOLUTI; ROE EM, 1991, WORLD DEV, V19, P287, DOI 10.1016/0305-750X(91)90177-J; SINCLAIR ARE, 1985, CAN J ZOOL, V63, P987, DOI 10.1139/z85-147; Sullivan S, 2002, J BIOGEOGR, V29, P1595, DOI 10.1046/j.1365-2699.2002.00799.x; Thomson J. T., 1992, Making the commons work: theory, practice, and policy., P129; Wilson James, 2002, DRAMA COMMONS, P327; Wollenberg E., 2001, International Journal of Agricultural Resources, Governance and Ecology, V1, P199, DOI 10.1504/IJARGE.2001.000012	19	205	214	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1915	1916		10.1126/science.1087771	http://dx.doi.org/10.1126/science.1087771			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671288	Green Submitted			2022-12-24	WOS:000187174000043
J	Guo, HW; Ecker, JR				Guo, HW; Ecker, JR			Plant responses to ethylene gas are mediated by SCF (EBF1/EBF2)-dependent proteolysis of EIN3 transcription factor	CELL			English	Article							RECEPTOR GENE FAMILY; F-BOX SUBUNIT; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; PROTEIN-DEGRADATION; UBIQUITIN-LIGASE; PATHWAY; COMPLEX; MUTANT; KINASE	Plants use ethylene gas as a signal to regulate myriad developmental processes and stress responses. The Arabidopsis EIN3 protein is a key transcription factor mediating ethylene-regulated gene expression and morphological responses. Here, we report that EIN3 protein levels rapidly increase in response to ethylene and this response requires several ethylene-signaling pathway components including the ethylene receptors (ETR1 and EIN4), CTR1, EIN2, EIN5, and EIN6. In the absence of ethylene, EIN3 is quickly degraded through a ubiquitin/proteasome pathway mediated by two F box proteins, EBF1 and EBF2. Plants containing mutations in either gene show enhanced ethylene response by stabilizing EIN3, whereas efb1 efb2 double mutants show constitutive ethylene phenotypes. Plants over-expressing either F box gene display ethylene insensitivity and destabilization of EIN3 protein. These results reveal that a ubiquitin/proteasome pathway negatively regulates ethylene responses by targeting EIN3 for degradation, and pinpoint EIN3 regulation as the key step in the response to ethylene.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ecker@salk.edu	Ecker, Joseph R/B-9144-2008	Ecker, Joseph R/0000-0001-5799-5895	NIGMS NIH HHS [1F32GM66639] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM066639] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abeles F, 1992, ETHYLENE PLANT BIOL; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bechtold N, 1998, METH MOL B, V82, P259; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; ECKER JR, 1995, SCIENCE, V268, P667, DOI 10.1126/science.7732375; Frugis G, 2002, TRENDS CELL BIOL, V12, P308, DOI 10.1016/S0962-8924(02)02308-5; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Guo HW, 2001, SCIENCE, V291, P487, DOI 10.1126/science.291.5503.487; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; Hellmann H, 2002, SCIENCE, V297, P793, DOI 10.1126/science.1072831; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hua J, 1998, PLANT CELL, V10, P1321, DOI 10.1105/tpc.10.8.1321; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Larsen PB, 2001, PLANT PHYSIOL, V125, P1061, DOI 10.1104/pp.125.2.1061; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; LIN C, 1995, P NATL ACAD SCI USA, V92, P8423, DOI 10.1073/pnas.92.18.8423; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; Ouaked F, 2003, EMBO J, V22, P1282, DOI 10.1093/emboj/cdg131; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; ROMAN G, 1995, GENETICS, V139, P1393; Sakai H, 1998, P NATL ACAD SCI USA, V95, P5812, DOI 10.1073/pnas.95.10.5812; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Stepanova AN, 2000, CURR OPIN PLANT BIOL, V3, P353, DOI 10.1016/S1369-5266(00)00096-0; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Xiao WY, 2000, TRENDS PLANT SCI, V5, P454, DOI 10.1016/S1360-1385(00)01769-6; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	43	619	686	15	138	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2003	115	6					667	677		10.1016/S0092-8674(03)00969-3	http://dx.doi.org/10.1016/S0092-8674(03)00969-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675532	Bronze			2022-12-24	WOS:000187366100007
J	Opferman, JT; Letai, A; Beard, C; Sorcinelli, MD; Ong, CC; Korsmeyer, SJ				Opferman, JT; Letai, A; Beard, C; Sorcinelli, MD; Ong, CC; Korsmeyer, SJ			Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1	NATURE			English	Article							HEMATOPOIETIC-CELLS; DEFICIENT MICE; BCL-2 FAMILY; APOPTOSIS; DEATH; SURVIVAL; HOMEOSTASIS; LACKING; MEMBER; IL-7	Regulated apoptosis is essential for both the development and the subsequent maintenance of the immune system(1,2). Interleukins, including IL- 2, IL- 4, IL- 7 and IL- 15, heavily influence lymphocyte survival during the vulnerable stages of VDJ rearrangement and later in ensuring cellular homeostasis, but the genes specifically responsible for the development and maintenance of lymphocytes have not been identified(3 - 8). The antiapoptotic protein MCL- 1 is an attractive candidate, as it is highly regulated(9), appears to enhance short- term survival(10) and functions at an apical step in genotoxic deaths(11). However, Mcl- 1 deficiency results in peri- implantation lethality(12). Here we show that mice conditional for Mcl- 1 display a profound reduction in B and T lymphocytes when MCL- 1 is removed. Deletion of Mcl- 1 during early lymphocyte differentiation increased apoptosis and arrested the development at pro- B- cell and double- negative T- cell stages. Induced deletion of Mcl- 1 in peripheral B- and T- cell populations resulted in their rapid loss. Moreover, IL- 7 both induced and required MCL- 1 to mediate lymphocyte survival. Thus, MCL- 1, which selectively inhibits the proapoptotic protein BIM, is essential both early in lymphoid development and later on in the maintenance of mature lymphocytes.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst,Dept Pathol & Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Korsmeyer, SJ (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst,Dept Pathol & Med, Boston, MA 02115 USA.	stanley_korsmeyer@dfci.harvard.edu	Opferman, Joseph T/M-5331-2018	Opferman, Joseph T/0000-0002-1147-5621				Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; GODFREY DI, 1993, J IMMUNOL, V150, P4244; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee PD., 2001, J LIGHT MET, V1, P15; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Marsden VS, 2003, ANNU REV IMMUNOL, V21, P71, DOI 10.1146/annurev.immunol.21.120601.141029; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Rathmell JC, 1999, ANNU REV IMMUNOL, V17, P781, DOI 10.1146/annurev.immunol.17.1.781; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rinkenberger JL, 2000, GENE DEV, V14, P23; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Vella AT, 1998, P NATL ACAD SCI USA, V95, P3810, DOI 10.1073/pnas.95.7.3810; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yang T, 1996, J CELL PHYSIOL, V166, P523, DOI 10.1002/(SICI)1097-4652(199603)166:3<523::AID-JCP7>3.0.CO;2-R; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zhou P, 1997, BLOOD, V89, P630, DOI 10.1182/blood.V89.2.630	30	644	676	0	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					671	676		10.1038/nature02067	http://dx.doi.org/10.1038/nature02067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668867				2022-12-24	WOS:000187132800044
J	Curtis, JP; Wang, YF; Portnay, EL; Masoudi, FA; Havranek, EP; Krumholz, HM				Curtis, JP; Wang, YF; Portnay, EL; Masoudi, FA; Havranek, EP; Krumholz, HM			Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article									Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Dis, New Haven, CT 06520 USA; Denver Hlth Med Ctr, Div Cardiol, Denver, CO 80204 USA	Yale University; Denver Health Medical Center	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Dis, Room I-456 SHM,333 Cedar St,POB 208088, New Haven, CT 06520 USA.		, Harlan/AAI-2875-2020; Masoudi, Frederick/Q-7467-2019		NATIONAL INSTITUTE ON AGING [K08AG001011] Funding Source: NIH RePORTER; NIA NIH HHS [K08-AG01011] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		FitzGerald GA, 2003, LANCET, V361, P542, DOI 10.1016/S0140-6736(03)12560-3; FLEMING C, 1992, MED CARE, V30, P377, DOI 10.1097/00005650-199205000-00001; MacDonald TM, 2003, LANCET, V361, P573, DOI 10.1016/S0140-6736(03)12509-3; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; 2003, US TODAY        0213, pD1	5	62	63	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 6	2003	327	7427					1322	1323		10.1136/bmj.327.7427.1322	http://dx.doi.org/10.1136/bmj.327.7427.1322			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752DE	14656840	Green Published, Bronze			2022-12-24	WOS:000187131100018
J	von Kries, R; Ihme, N; Oberle, D; Lorani, A; Stark, R; Altenhofen, L; Niethard, FU				von Kries, R; Ihme, N; Oberle, D; Lorani, A; Stark, R; Altenhofen, L; Niethard, FU			Effect of ultrasound screening on the rate of first operative procedures for developmental hip dysplasia in Germany	LANCET			English	Article							CONGENITAL DISLOCATION; NEWBORN-INFANTS; DIAGNOSIS; INSTABILITY; ULTRASONOGRAPHY; CHILDREN; TRIAL; UK	Background Ultrasound screening for developmental hip dysplasia and early conservative treatment might prevent later hip operations. A national hip ultrasound-screening programme, undertaken during the first 6 weeks of life, was introduced across Germany in 1996 and was continued for 5 years. We assessed the rate of first operation on the hip during this programme. Methods A national active surveillance programme of initial operations for developmental hip dysplasia was started in 1997 and continued for 5 years. Screening participation was assessed by a random digit dialling telephone survey. Cases were children aged between 10 weeks and 5 years at first operation, who had had no underlying disease leading to developmental hip dysplasia. Completeness of case ascertainment was validated with a capture-recapture study in a representative subsample. Calculated incidences were compared with previously established rates. Findings About 90% of all children were screened. 147 cases in the first year, and between 81 and 105 for subsequent years were reported. Treatment included closed reductions 353 (66%), open reductions 61 (11%), and osteotomies 121 (23%). Developmental hip dysplasia was diagnosed by ultrasound before 6 weeks of age in 272 (55%) of cases, 64 (13%) were screened at the recommended time but had normal findings, 70 (14%) had delayed screening, and 89 (18%) were not screened. Capture-recapture estimates suggested that 52% of cases were reported. The corrected incidence for first operation was 0.26 per 1000 livebirths (95% CI 0.22-0.32). Interpretation Ultrasound screening seems to prevent many, but not all, operations for developmental hip dysplasia. Rates of timely screening (ie, before 6 weeks of age) and training of doctors in ultrasound screening need to be improved.	Univ Munich, Inst Social Paediat & Adolescent Med, Dept Paediat Epidemiol, D-81377 Munich, Germany; Univ Aachen, Dept Orthopaed, Aachen, Germany; Cent Res Inst Ambulatory Hlth Care Germany, Cologne, Germany	University of Munich; RWTH Aachen University	von Kries, R (corresponding author), Univ Munich, Inst Social Paediat & Adolescent Med, Dept Paediat Epidemiol, Heiglhofstr 63, D-81377 Munich, Germany.	AG.EPI@LRZ.uni-muenchen.de	Stark, Renée/B-6733-2013	Stark, Renée/0000-0002-6612-292X				Altenhofen L, 1996, DEUT ARZTEBLATT, V93, pA; Andersson JE, 2002, ACTA PAEDIATR, V91, P926, DOI 10.1080/080352502760148658; BARLOW TG, 1962, J BONE JOINT SURG BR, V44, P292, DOI 10.1302/0301-620X.44B2.292; Chan A, 1999, LANCET, V354, P1514, DOI 10.1016/S0140-6736(98)12469-8; Duppe H, 2002, J BONE JOINT SURG BR, V84B, P878, DOI 10.1302/0301-620X.84B6.12326; Eastwood DM, 2003, LANCET, V361, P595, DOI 10.1016/S0140-6736(03)12519-6; Elbourne D, 2002, LANCET, V360, P2009, DOI 10.1016/S0140-6736(02)12024-1; Godward S, 1998, LANCET, V351, P1149, DOI 10.1016/S0140-6736(97)10466-4; GRAF R, 1983, J PEDIATR ORTHOPED, V3, P354, DOI 10.1097/01241398-198307000-00015; Holen KJ, 2002, J BONE JOINT SURG BR, V84B, P886, DOI 10.1302/0301-620X.84B6.12093; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; KATTHAGEN BD, 1988, Z ORTHOP GRENZGEB, V126, P475, DOI 10.1055/s-2008-1044470; Laubereau B, 2001, MONATSSCHR KINDERH, V149, P367, DOI 10.1007/s001120050777; MARKS DS, 1994, J BONE JOINT SURG BR, V76B, P534, DOI 10.1302/0301-620X.76B4.8027134; Maxwell SL, 2002, BMJ-BRIT MED J, V324, P1031, DOI 10.1136/bmj.324.7344.1031; NIETHARD FU, 2000, DTSCH ARZTEBLATT, V97, P1593; Ortolani M., 1937, PEDIATRIA NAPOLI, V45, P129; Pauwels F, 1976, BIOMECHANICS NORMAL; ROSENDAHL K, 1992, ACTA PAEDIATR, V81, P177, DOI 10.1111/j.1651-2227.1992.tb12198.x; ROSENDAHL K, 1994, PEDIATRICS, V94, P47; von Kries R, 2001, MONATSSCHR KINDERH, V149, P1191, DOI 10.1007/s001120170044; VON ROSEN S, 1956, Acta Orthop Scand, V26, P136; WEIDTMAN V, 1984, HUFTGELENKSVERANDERU; *ZENTR, 1991, HINW DURCHF FRUH KIN	24	101	103	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2003	362	9399					1883	1887		10.1016/S0140-6736(03)14957-4	http://dx.doi.org/10.1016/S0140-6736(03)14957-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667743				2022-12-24	WOS:000187011600008
J	He, YH; Michaels, SD; Amasino, RM				He, YH; Michaels, SD; Amasino, RM			Regulation of flowering time by histone acetylation in Arabidopsis	SCIENCE			English	Article							POLYAMINE OXIDASE; LOCUS-C; GENE; THALIANA; ENCODES; PROTEIN; VERNALIZATION; REPRESSION; EXPRESSION; COMPLEXES	The Arabidopsis autonomous floral-promotion pathway promotes flowering independently of the photoperiod and vernalization pathways by repressing FLOWERING LOCUS C (FLC), a MADS-box transcription factor that blocks the transition from vegetative to reproductive development. Here, we report that FLOWERING LOCUS D (FLD), one of six genes in the autonomous pathway, encodes a plant homolog of a protein found in histone deacetylase complexes in mammals. Lesions in FLD result in hyperacetylation of histones in FLC chromatin, up-regulation of FLC expression, and extremely delayed flowering. Thus, the autonomous pathway regulates flowering in part by histone deacetylation. However, not all autonomous-pathway mutants exhibit FLC hyperacetylation, indicating that multiple means exist by which this pathway represses FLC expression.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Amasino, RM (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.		Michaels, Scott/D-5458-2009; HE, Yuehui/H-9795-2012; HE, Yuehui/Y-8792-2018	HE, Yuehui/0000-0003-3304-4555; HE, Yuehui/0000-0003-3304-4555; Michaels, Scott/0000-0001-5248-3487				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Aravind L, 2002, GENOME BIOL, V3; Binda C, 1999, STRUCTURE, V7, P265, DOI 10.1016/S0969-2126(99)80037-9; Chua YL, 2003, PLANT CELL, V15, P1468, DOI 10.1105/tpc.011825; Eimer S, 2002, EMBO J, V21, P5787, DOI 10.1093/emboj/cdf561; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef M, 1998, GENETICS, V148, P885; LEE I, 1994, PLANT CELL, V6, P75, DOI 10.1105/tpc.6.1.75; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Murray-Stewart T, 2002, BIOCHEM J, V368, P673, DOI 10.1042/BJ20021587; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sanda SL, 1996, PLANT PHYSIOL, V111, P641, DOI 10.1104/pp.111.2.641; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Sheldon CC, 2002, PLANT CELL, V14, P2527, DOI 10.1105/tpc.004564; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simpson GG, 1999, ANNU REV CELL DEV BI, V15, P519, DOI 10.1146/annurev.cellbio.15.1.519; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Tian L, 2001, P NATL ACAD SCI USA, V98, P200, DOI 10.1073/pnas.011347998	24	371	417	10	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1751	1754		10.1126/science.1091109	http://dx.doi.org/10.1126/science.1091109			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14593187				2022-12-24	WOS:000186970100044
J	Hall, C; Tharakan, P; Hallock, J; Cleveland, C; Jefferson, M				Hall, C; Tharakan, P; Hallock, J; Cleveland, C; Jefferson, M			Hydrocarbons and the evolution of human culture	NATURE			English	Editorial Material							LOWER 48 STATES; OIL PRODUCTION; ENERGY	Most of the progress in human culture has required the exploitation of energy resources. About 100 years ago, the major source of energy shifted from recent solar to fossil hydrocarbons, including liquid and gaseous petroleum. Technology has generally led to a greater use of hydrocarbon fuels for most human activities, making civilization vulnerable to decreases in supply. At this time our knowledge is not sufficient for us to choose between the different estimates of, for example, resources of conventional oil.	SUNY Coll Environm Sci & Forestry, Dept Environm, Syracuse, NY 13210 USA; SUNY Coll Environm Sci & Forestry, Dept Forest Biol, Syracuse, NY 13210 USA; SUNY Coll Environm Sci & Forestry, Grad Program Environm Sci, Syracuse, NY 13210 USA; Univ Montana, Flathead Lake Biol Stn, Polson, MT 59860 USA; Syracuse Univ, Maxwell Sch Citizenship & Publ Affairs, Syracuse, NY USA; Boston Univ, Ctr Energy & Environm Studies, Boston, MA 02215 USA; Boston Univ, Dept Geog, Boston, MA 02215 USA; Global Energy & Environm Consultants, Old Stables, Felmersham MK43 7HJ, Beds, England	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; University of Montana System; University of Montana; Syracuse University; Boston University; Boston University	Hall, C (corresponding author), SUNY Coll Environm Sci & Forestry, Dept Environm, Syracuse, NY 13210 USA.	chall@esf.edu; cutler@bu.edu; jeffers@dircon.co.uk						Campbell CJ, 1998, SCI AM, V278, P77; CLEVELAND CJ, 1984, SCIENCE, V225, P890, DOI 10.1126/science.225.4665.890; Cooper C., 1998, WALL STREET J   1012; *EN INF ADM, 2003, DOEEIA0484 US DEP EN; HAKES J, LONG TERM WORLD OIL; Hall C, 2001, BIOSCIENCE, V51, P663, DOI 10.1641/0006-3568(2001)051[0663:TNTRTN]2.0.CO;2; HALLOCK J, IN PRESS ENERGY; Hubbert M., 1962, ENERGY RESOURCES REP; *INT WORK GROUP, 2000, LBNL44029; KAUFMANN RK, 1991, RESOUR ENERG, V13, P111, DOI 10.1016/0165-0572(91)90022-U; Kaufmann RK, 2001, ENERG J, V22, P27; KAUFMANN RK, IN PRESS ENERGY J; Lynch M.C., 2002, Q REV EC FINANCE, V42, P373, DOI DOI 10.1016/S1062-9769(02)00126-6; Munasinghe M., 2002, INT J SUSTAIN DEV, V5, P125, DOI DOI 10.1504/IJSD.2002.002563; Sadorsky P, 1999, ENERG ECON, V21, P449, DOI 10.1016/S0140-9883(99)00020-1; Smulders S, 2003, RESOUR ENERGY ECON, V25, P59, DOI 10.1016/S0928-7655(02)00017-9; Tainter J., 1988, COLLAPSE COMPLEX SYS; Tharakan P.J, 2001, ENVIRON SCI POLICY, V4, P319, DOI [10.1016/S1462-9011(01)00036-3, DOI 10.1016/S1462-9011(01)00036-3]; Tissot B.P., 1979, GEOL J, V116, P243, DOI [10.1017/S0016756800043685, DOI 10.1017/S0016756800043685]; United States Geological Survey (USGS), 2003, WORLD PETR ASS 2000; *USGS, 2000, US DEP LONG TERM WOR	21	155	161	1	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 20	2003	426	6964					318	322		10.1038/nature02130	http://dx.doi.org/10.1038/nature02130			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628060				2022-12-24	WOS:000186660800052
J	Ira, G; Malkova, A; Liberi, G; Foiani, M; Haber, JE				Ira, G; Malkova, A; Liberi, G; Foiani, M; Haber, JE			Srs2 and Sgs1-Top3 suppress crossovers during double-strand break repair in yeast	CELL			English	Article							SYNDROME GENE-PRODUCT; SACCHAROMYCES-CEREVISIAE; MITOTIC RECOMBINATION; TOPOISOMERASE-III; CROSSING-OVER; HOMOLOGOUS RECOMBINATION; DNA HELICASE; FUNCTIONAL OVERLAP; HOLLIDAY JUNCTIONS; SGS1	Very few gene conversions in mitotic cells are associated with crossovers, suggesting that these events are regulated. This may be important for the maintenance of genetic stability. We have analyzed the relationship between homologous recombination and crossing-over in haploid budding yeast and identified factors involved in the regulation of crossover outcomes. Gene conversions unaccompanied by a crossover appear 30 min before conversions accompanied by exchange, indicating that there are two different repair mechanisms in mitotic cells. Crossovers are rare (5%), but deleting the BLM/WRN homolog, SGS1, or the SRS2 helicase increases crossovers 2- to 3-fold. Overexpressing SRS2 nearly eliminates crossovers, whereas overexpression of RAD51 in srs2Delta cells almost completely eliminates the noncrossover recombination pathway. We suggest Sgs1 and its associated topoisomerase Top3 remove double Holliday junction intermediates from a crossover-producing repair pathway, thereby reducing crossovers. Srs2 promotes the noncrossover synthesis-dependent strand-annealing (SDSA) pathway, apparently by regulating Rad51 binding during strand exchange.	Brandeis Univ, Rosentiel Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Ist FIRC Oncol Mol, I-20141 Milan, Italy; Univ Milan, Dipartimento Genet & Biol Microrganismi, I-20133 Milan, Italy	Brandeis University; Brandeis University; IFOM - FIRC Institute of Molecular Oncology; University of Milan	Haber, JE (corresponding author), Brandeis Univ, Rosentiel Ctr, Waltham, MA 02454 USA.	haber@brandeis.edu	Ira, Grzegorz/B-7912-2010; Foiani, Marco/M-8234-2014; LIBERI, GIORDANO/AAY-7273-2020	Foiani, Marco/0000-0003-4795-834X; LIBERI, GIORDANO/0000-0003-3160-2242; Haber, James/0000-0002-1878-0610	NIGMS NIH HHS [R01 GM020056, GM20056, R37 GM020056, R01 GM080600, R01 GM061766, GM61766] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061766, R37GM020056, R01GM020056, R01GM080600] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; AGUILERA A, 1988, GENETICS, V119, P779; Ajima J, 2002, MUTAT RES-FUND MOL M, V504, P157, DOI 10.1016/S0027-5107(02)00089-1; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Aylon Y, 2003, MOL CELL BIOL, V23, P1403, DOI 10.1128/MCB.23.4.1403-1417.2003; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Bennett RJ, 1999, J MOL BIOL, V289, P235, DOI 10.1006/jmbi.1999.2739; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Church G M, 1985, Prog Clin Biol Res, V177, P17; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; ESPOSITO MS, 1978, P NATL ACAD SCI USA, V75, P4436, DOI 10.1073/pnas.75.9.4436; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Frei C, 2000, GENE DEV, V14, P81; Fricke WM, 2001, J BIOL CHEM, V276, P8848, DOI 10.1074/jbc.M009719200; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Gangloff S, 1999, EMBO J, V18, P1701, DOI 10.1093/emboj/18.6.1701; Goss KH, 2002, SCIENCE, V297, P2051, DOI 10.1126/science.1074340; HASTINGS PJ, 1988, BIOESSAYS, V9, P61, DOI 10.1002/bies.950090206; Hickson ID, 2001, BIOCHEM SOC T, V29, P201, DOI 10.1042/0300-5127:0290201; Hu P, 2001, HUM MOL GENET, V10, P1287, DOI 10.1093/hmg/10.12.1287; Hunter N, 1997, GENE DEV, V11, P1573, DOI 10.1101/gad.11.12.1573; Ira G, 2002, MOL CELL BIOL, V22, P6384, DOI 10.1128/MCB.22.18.6384-6392.2002; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Kang LE, 2000, MOL CELL BIOL, V20, P9162, DOI 10.1128/MCB.20.24.9162-9172.2000; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Khazanehdari KA, 2000, CHROMOSOMA, V109, P94, DOI 10.1007/s004120050416; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Kwan KY, 2003, P NATL ACAD SCI USA, V100, P2526, DOI 10.1073/pnas.0437998100; Lee SK, 1999, SCIENCE, V286, P2339, DOI 10.1126/science.286.5448.2339; Liberi G, 2000, EMBO J, V19, P5027, DOI 10.1093/emboj/19.18.5027; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Malkova A, 2000, P NATL ACAD SCI USA, V97, P14500, DOI 10.1073/pnas.97.26.14500; Mankouri HW, 2002, NUCLEIC ACIDS RES, V30, P1103, DOI 10.1093/nar/30.5.1103; MCGILL C, 1989, CELL, V57, P459, DOI 10.1016/0092-8674(89)90921-5; MILNE GT, 1995, GENETICS, V139, P1189; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; NASMYTH KA, 1982, ANNU REV GENET, V16, P439, DOI 10.1146/annurev.ge.16.120182.002255; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paques F, 1997, MOL CELL BIOL, V17, P6765, DOI 10.1128/MCB.17.11.6765; Prado F, 2003, TRENDS GENET, V19, P428, DOI 10.1016/S0168-9525(03)00173-2; Prince PR, 2001, GENE DEV, V15, P933, DOI 10.1101/gad.877001; Rockmill B, 2003, CURR BIOL, V13, P1954, DOI 10.1016/j.cub.2003.10.059; RONG L, 1991, GENETICS, V127, P75; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Shao CS, 2001, NAT GENET, V28, P169, DOI 10.1038/88897; Shen JC, 2001, MECH AGEING DEV, V122, P921, DOI 10.1016/S0047-6374(01)00248-2; Shor E, 2002, GENETICS, V162, P647; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Stark JM, 2003, MOL CELL BIOL, V23, P733, DOI 10.1128/MCB.23.2.733-743.2003; Sugawara N, 2000, MOL CELL BIOL, V20, P5300, DOI 10.1128/MCB.20.14.5300-5309.2000; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; THALER DS, 1988, ANNU REV GENET, V22, P169, DOI 10.1146/annurev.ge.22.120188.001125; Tsubouchi H, 2000, MOL BIOL CELL, V11, P2221, DOI 10.1091/mbc.11.7.2221; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Virgin JB, 2001, GENETICS, V157, P63; Watt PM, 1996, GENETICS, V144, P935; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636	67	454	461	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2003	115	4					401	411		10.1016/S0092-8674(03)00886-9	http://dx.doi.org/10.1016/S0092-8674(03)00886-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	744KB	14622595	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000186627100007
J	Morillon, A; Karabetsou, N; O'Sullivan, J; Kent, N; Proudfoot, N; Mellor, J				Morillon, A; Karabetsou, N; O'Sullivan, J; Kent, N; Proudfoot, N; Mellor, J			Isw1 chromatin remodeling ATPase coordinates transcription elongation and termination by RNA polymerase II	CELL			English	Article							PRE-MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; IN-VIVO; PROCESSING FACTORS; GENE-EXPRESSION; CAPPING ENZYME; HISTONE H3; YEAST; COMPLEX; RECRUITMENT	We demonstrate that distinct forms of the yeast chromatin-remodeling enzyme lsw1p sequentially regulate each stage of the transcription cycle. The lsw1a complex (lswlp/loc3p) represses gene expression at initiation through specific positioning of a promoter proximal dinucleosome, whereas the lsw1b complex (lswlp/loc2p/loc4p) acts within coding regions to control the amount of RNA polymerase (RNAPII) released into productive elongation and to coordinate elongation with termination and pre-mRNA processing. These effects of lsw1b are controlled via phosphorylation of the heptad repeat carboxy-terminal domain (CTD) of RNAPII and methylation of the chromatin template. The transcription elongation factor Spt4p antagonizes lsw1p and overcomes the lsw1p dependent pausing of RNAPII at the onset of the elongation cycle. Overall these studies establish the central role played by lsw1p in the coordination of transcription.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Mellor, J (corresponding author), Univ Oxford, Dept Biochem, S Pk Rd, Oxford OX1 3QU, England.	jane.mellor@bioch.ox.ac.uk	Morillon, Antonin/M-4751-2017; O'Sullivan, Justin/HDO-1639-2022; Pillay, Nischalan/F-9536-2012; Kent, Nicholas/A-4503-2010	Morillon, Antonin/0000-0002-0575-5264; O'Sullivan, Justin/0000-0003-2927-450X; Kent, Nicholas/0000-0002-4114-1307; Proudfoot, Nicholas/0000-0001-8646-3222				Adams A, 1997, METHODS YEAST GENETI; Alen C, 2002, MOL CELL, V10, P1441, DOI 10.1016/S1097-2765(02)00778-5; ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; ARCHAMBAULT J, 1992, MOL CELL BIOL, V12, P4142, DOI 10.1128/MCB.12.9.4142; Badenhorst P, 2002, GENE DEV, V16, P3186, DOI 10.1101/gad.1032202; Barilla D, 2001, P NATL ACAD SCI USA, V98, P445, DOI 10.1073/pnas.021545298; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Cho EJ, 1998, GENE DEV, V12, P3482, DOI 10.1101/gad.12.22.3482; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; Corey LL, 2003, GENE DEV, V17, P1392, DOI 10.1101/gad.1071803; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Dower K, 2002, RNA, V8, P686, DOI 10.1017/S1355838202024068; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Hartzog GA, 2003, CURR OPIN GENET DEV, V13, P119, DOI 10.1016/S0959-437X(03)00024-8; Hartzog GA, 2002, BBA-GENE STRUCT EXPR, V1577, P276, DOI 10.1016/S0167-4781(02)00458-X; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Kent NA, 2001, GENE DEV, V15, P619, DOI 10.1101/gad.190301; Kikyo N, 2000, SCIENCE, V289, P2360, DOI 10.1126/science.289.5488.2360; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Kulish D, 2001, MOL CELL BIOL, V21, P4162, DOI 10.1128/MCB.21.13.4162-4168.2001; Kuras L, 2002, MOL CELL, V10, P69, DOI 10.1016/S1097-2765(02)00561-0; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Moreau JL, 2003, MOL CELL, V11, P1609, DOI 10.1016/S1097-2765(03)00184-9; Morillon A, 2003, SCIENCE, V300, P492, DOI 10.1126/science.1081379; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Rodriguez CR, 2000, MOL CELL BIOL, V20, P104, DOI 10.1128/MCB.20.1.104-112.2000; Rondon AG, 2003, EMBO J, V22, P612, DOI 10.1093/emboj/cdg047; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Schwartz BE, 2003, MOL CELL BIOL, V23, P6876, DOI 10.1128/MCB.23.19.6876-6886.2003; Shaw RJ, 2000, MOL CELL BIOL, V20, P7427, DOI 10.1128/MCB.20.20.7427-7437.2000; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Teng YM, 1997, J MOL BIOL, V267, P324, DOI 10.1006/jmbi.1996.0908; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Vary JC, 2003, MOL CELL BIOL, V23, P80, DOI 10.1128/MCB.23.1.80-91.2003; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503	57	140	145	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2003	115	4					425	435		10.1016/S0092-8674(03)00880-8	http://dx.doi.org/10.1016/S0092-8674(03)00880-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	744KB	14622597	Bronze			2022-12-24	WOS:000186627100009
J	Lu, D; Searles, MA; Klug, A				Lu, D; Searles, MA; Klug, A			Crystal structure of a zinc-finger - RNA complex reveals two modes of molecular recognition	NATURE			English	Article							TRANSCRIPTION FACTOR IIIA; 5S RNA; DNA RECOGNITION; BINDING; PROTEIN; OOCYTES; TFIIIA	Zinc-finger proteins of the classical Cys(2)His(2) type are the most frequently used class of transcription factor and account for about 3% of genes in the human genome(1,2). The zinc-finger motif was discovered(3) during biochemical studies on the transcription factor TFIIIA, which regulates the 5S ribosomal RNA genes of Xenopus laevis(4,5). Zinc-fingers mostly interact with DNA, but TFIIIA binds not only specifically to the promoter DNA, but also to 5S RNA itself(6-9). Increasing evidence indicates that zinc-fingers are more widely used to recognize RNA(10-13). There have been numerous structural studies on DNA binding(14), but none on RNA binding by zinc-finger proteins. Here we report the crystal structure of a three-finger complex with 61 bases of RNA, derived(15) from the central regions of the complete nine-finger TFIIIA - 5S RNA complex. The structure reveals two modes of zinc-finger binding, both of which differ from that in common use for DNA: first, the zinc-fingers interact with the backbone of a double helix; and second, the zinc-fingers specifically recognize individual bases positioned for access in otherwise intricately folded 'loop' regions of the RNA.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Klug, A (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	akl@mrc-lmb.cam.ac.uk						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; BOGENHAGEN DF, 1992, NUCLEIC ACIDS RES, V20, P2639, DOI 10.1093/nar/20.11.2639; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clamp M, 2003, NUCLEIC ACIDS RES, V31, P38, DOI 10.1093/nar/gkg083; CLEMENS KR, 1993, SCIENCE, V260, P530, DOI 10.1126/science.8475383; Correll CC, 1998, P NATL ACAD SCI USA, V95, P13436, DOI 10.1073/pnas.95.23.13436; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; ENGELKE DR, 1980, CELL, V19, P717, DOI 10.1016/S0092-8674(80)80048-1; Finerty PJ, 1997, J MOL BIOL, V271, P195, DOI 10.1006/jmbi.1997.1177; Friesen WJ, 1997, J BIOL CHEM, V272, P10994; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Ladomery M, 2003, J CELL SCI, V116, P1539, DOI 10.1242/jcs.00324; MCBRYANT SJ, 1995, J MOL BIOL, V248, P44, DOI 10.1006/jmbi.1995.0201; Mendez-Vidal C, 2002, NUCLEIC ACIDS RES, V30, P1991, DOI 10.1093/nar/30.9.1991; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Nagai K, 2001, BIOCHEM SOC T, V29, P15; Nolte RT, 1998, P NATL ACAD SCI USA, V95, P2938, DOI 10.1073/pnas.95.6.2938; PELHAM HRB, 1980, P NATL ACAD SCI-BIOL, V77, P4170, DOI 10.1073/pnas.77.7.4170; PICARD B, 1979, P NATL ACAD SCI USA, V76, P241, DOI 10.1073/pnas.76.1.241; SAKONJU S, 1982, CELL, V31, P395, DOI 10.1016/0092-8674(82)90133-7; Searles MA, 2000, J MOL BIOL, V301, P47, DOI 10.1006/jmbi.2000.3946; Setzer DR, 1996, RNA, V2, P1254; SHELDRICK GM, 1995, ACTA CRYSTALLOGR B, V51, P423, DOI 10.1107/S0108768195003661; THEUNISSEN O, 1992, CELL, V71, P679, DOI 10.1016/0092-8674(92)90601-8; Theunissen O, 1998, EUR J BIOCHEM, V258, P758, DOI 10.1046/j.1432-1327.1998.2580758.x; WIMBERLY B, 1993, BIOCHEMISTRY-US, V32, P1078, DOI 10.1021/bi00055a013; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183	30	149	154	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2003	426	6962					96	100		10.1038/nature02088	http://dx.doi.org/10.1038/nature02088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603324				2022-12-24	WOS:000186370800049
J	Rappuoli, R; Covacci, A				Rappuoli, R; Covacci, A			Reverse vaccinology and genomics	SCIENCE			English	Article							SEQUENCE	The genomic revolution has had a dramatic effect on our ability to find new vaccine targets and develop effective vaccines.	IRIS, Chiron Vaccines, I-53100 Siena, Italy	Novartis	Rappuoli, R (corresponding author), IRIS, Chiron Vaccines, I-53100 Siena, Italy.							FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Foster I, 1999, GRID: BLUEPRINT FOR A NEW COMPUTING INFRASTRUCTURE, P15; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; RAPPUOLI R, UNPUB; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; IN PRESS BIOTECHNOLO	9	75	86	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2003	302	5645					602	602		10.1126/science.1092329	http://dx.doi.org/10.1126/science.1092329			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576423				2022-12-24	WOS:000186119900046
J	Ota, S; Ueoka, H; Tanimoto, M				Ota, S; Ueoka, H; Tanimoto, M			Clinical picture - Retroperitoneal paraganglioma	LANCET			English	Editorial Material									Okayama Univ, Sch Med & Dent, Dept Internal Med 2, Okayama 7008558, Japan	Okayama University	Ota, S (corresponding author), Okayama Univ, Sch Med & Dent, Dept Internal Med 2, Okayama 7008558, Japan.								0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 18	2003	362	9392					1266	1266		10.1016/S0140-6736(03)14569-2	http://dx.doi.org/10.1016/S0140-6736(03)14569-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734CD	14575970				2022-12-24	WOS:000186036900009
J	Zhou, HL; Wertz, I; O'Rourke, K; Ultsch, M; Seshagiri, S; Eby, M; Xiao, W; Dixit, VM				Zhou, HL; Wertz, I; O'Rourke, K; Ultsch, M; Seshagiri, S; Eby, M; Xiao, W; Dixit, VM			Bcl10 activates the NF-kappa B pathway through ubiquitination of NEMO	NATURE			English	Article							CONJUGATING ENZYME COMPLEX; KINASE COMPLEX; MALT LYMPHOMA; IKK-GAMMA; GENE; CYLD	The NF-kappaB family of transcription factors is activated in response to many stimuli, including pro-inflammatory cytokines, environmental stresses and, in the case of B and T lymphocytes, by antigenic stimulation(1,2). Bcl10 is essential for NF-kappaB activation by T- and B-cell receptors. T and B lymphocytes from Bcl10-deficient mice fail to activate NF-kappaB in response to antigenreceptor stimulation and, as a consequence, are unable to proliferate(3). Bcl10 overexpression is sufficient to activate NF-kappaB, a process that requires the NF-kappaB essential modulator NEMO ( also known as IKK-gamma), which is the regulatory subunit of the IkappaB kinase complex(4). However, the cellular mechanism by which Bcl10 activates the NF-kappaB pathway remains unclear. Here we show that Bcl10 targets NEMO for lysine-63-linked ubiquitination. Notably, a mutant form of NEMO that cannot be ubiquitinated inhibited Bcl10-induced NF-kappaB activation. Paracaspase and a ubiquitin-conjugating enzyme (UBC13) were both required for Bcl10-induced NEMO ubiquitination and subsequent NF-kappaB activation. Furthermore, short interfering RNAs that reduced the expression of paracaspase and UBC13 abrogated the effects of Bcl10. Thus, the adaptor protein Bcl10 promotes activation of NF-kappaB transcription factors through paracaspase- and UBC13-dependent ubiquitination of NEMO.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; Univ Calif Davis, Sch Med, Dept Biol Chem, Davis, CA 95616 USA; Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California Davis; University of Saskatchewan	Dixit, VM (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; Seshagiri, Somasekar/0000-0003-4272-6443; Xiao, Wei/0000-0001-7568-0782				Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dixit V, 2002, CELL, V111, P615, DOI 10.1016/S0092-8674(02)01166-2; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Harhaj EW, 2000, ONCOGENE, V19, P1448, DOI 10.1038/sj.onc.1203445; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Karin M., 1999, SCI SIGNAL TRANSDUCT, V5, P1; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Makris C, 2002, MOL CELL BIOL, V22, P6573, DOI 10.1128/MCB.22.18.6573-6581.2002; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Ohi MD, 2003, NAT STRUCT BIOL, V10, P250, DOI 10.1038/nsb906; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Smahi A, 2000, NATURE, V405, P466; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767	28	430	461	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2004	427	6970					167	171		10.1038/nature02273	http://dx.doi.org/10.1038/nature02273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760YY	14695475				2022-12-24	WOS:000187863900038
J	Beaber, JW; Hochhut, B; Waldor, MK				Beaber, JW; Hochhut, B; Waldor, MK			SOS response promotes horizontal dissemination of antibiotic resistance genes	NATURE			English	Article							VIBRIO-CHOLERAE O139; INTEGRATING ELEMENTS; ESCHERICHIA-COLI; R391; PLASMIDS; SXT; DETERMINANTS	Mobile genetic elements have a crucial role in spreading antibiotic resistance genes among bacterial populations. Environmental and genetic factors that regulate conjugative transfer of antibiotic resistance genes in bacterial populations are largely unknown(1). Integrating conjugative elements (ICEs) are a diverse group of mobile elements that are transferred by means of cell-cell contact and integrate into the chromosome of the new host(2). SXT is a similar to100-kilobase ICE derived from Vibrio cholerae that encodes genes that confer resistance to chloramphenicol, sulphamethoxazole, trimethoprim and streptomycin(3). SXT-related elements were not detected in V. cholerae before 1993 but are now present in almost all clinical V. cholerae isolates from Asia(4). ICEs related to SXT are also present in several other bacterial species and encode a variety of antibiotic and heavy metal resistance genes(4-7). Here we show that SetR, an SXT encoded repressor, represses the expression of activators of SXT transfer. The 'SOS response' to DNA damage alleviates this repression, increasing the expression of genes necessary for SXT transfer and hence the frequency of transfer. SOS is induced by a variety of environmental factors and antibiotics, for example ciprofloxacin, and we show that ciprofloxacin induces SXT transfer as well. Thus, we present a mechanism by which therapeutic agents can promote the spread of antibiotic resistance genes.	Tufts Univ, Sch Med, Dept Microbiol, Boston, MA 02111 USA; Howard Hughes Med Inst, Boston, MA 02111 USA	Tufts University; Howard Hughes Medical Institute	Waldor, MK (corresponding author), Tufts Univ, Sch Med, Dept Microbiol, 136 Harrison Ave, Boston, MA 02111 USA.	matthew.waldor@tufts.edu		Waldor, Matthew/0000-0003-1843-7000				Ausubel FA, 1990, CURRENT PROTOCOLS MO; Beaber JW, 2002, J BACTERIOL, V184, P4259, DOI 10.1128/JB.184.15.4259-4269.2002; Beaber JW, 2002, CELL MOL LIFE SCI, V59, P2065, DOI 10.1007/s000180200006; Boltner D, 2002, J BACTERIOL, V184, P5158, DOI 10.1128/JB.184.18.5158-5169.2002; Burrus V, 2002, MOL MICROBIOL, V46, P601, DOI 10.1046/j.1365-2958.2002.03191.x; COETZEE JN, 1972, J GEN MICROBIOL, V72, P543, DOI 10.1099/00221287-72-3-543; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; GIMBLE FS, 1985, J BACTERIOL, V162, P147, DOI 10.1128/JB.162.1.147-154.1985; Hochhut B, 2001, ANTIMICROB AGENTS CH, V45, P2991, DOI 10.1128/AAC.45.11.2991-3000.2001; Hochhut B, 2001, J BACTERIOL, V183, P1124, DOI 10.1128/JB.183.4.1124-1132.2001; Little John W., 1996, P453; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Miller J.H., 1992, SHORT COURSE BACTERI, P150; PETERS SE, 1991, MOL GEN GENET, V228, P294, DOI 10.1007/BF00282479; PHILLIPS I, 1987, J ANTIMICROB CHEMOTH, V20, P631, DOI 10.1093/jac/20.5.631; Ptashne M., 1992, A GENETIC SWITCH; SCHNEIDER K, 1986, GENE, V42, P37, DOI 10.1016/0378-1119(86)90148-4; SINGER M, 1989, MICROBIOL REV, V53, P1; Waldor MK, 1996, J BACTERIOL, V178, P4157, DOI 10.1128/jb.178.14.4157-4165.1996; Walker GC., 1996, E COLI SALMONELLA CE, V2, P1400; Zatyka M, 1998, FEMS MICROBIOL REV, V21, P291, DOI 10.1111/j.1574-6976.1998.tb00355.x	21	674	750	23	350	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2004	427	6969					72	74		10.1038/nature02241	http://dx.doi.org/10.1038/nature02241			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YP	14688795				2022-12-24	WOS:000187710000036
J	Peres, CA; Baider, C; Zuidema, PA; Wadt, LHO; Kainer, KA; Gomes-Silva, DAP; Salomao, RP; Simoes, LL; Franciosi, ERN; Valverde, FC; Gribel, R; Shepard, GH; Kanashiro, M; Coventry, P; Yu, DW; Watkinson, AR; Freckleton, RP				Peres, CA; Baider, C; Zuidema, PA; Wadt, LHO; Kainer, KA; Gomes-Silva, DAP; Salomao, RP; Simoes, LL; Franciosi, ERN; Valverde, FC; Gribel, R; Shepard, GH; Kanashiro, M; Coventry, P; Yu, DW; Watkinson, AR; Freckleton, RP			Demographic threats to the sustainability of Brazil nut exploitation	SCIENCE			English	Article							BERTHOLLETIA-EXCELSA; POPULATION-DYNAMICS; DENSITY-DEPENDENCE; TROPICAL PALM; EXTRACTION; TREE	A comparative analysis of 23 populations of the Brazil nut tree ( Bertholletia excelsa) across the Brazilian, Peruvian, and Bolivian Amazon shows that the history and intensity of Brazil nut exploitation are major determinants of population size structure. Populations subjected to persistent levels of harvest lack juvenile trees less than 60 centimeters in diameter at breast height; only populations with a history of either light or recent exploitation contain large numbers of juvenile trees. A harvesting model confirms that intensive exploitation levels over the past century are such that juvenile recruitment is insufficient to maintain populations over the long term. Without management, intensively harvested populations will succumb to a process of senescence and demographic collapse, threatening this cornerstone of the Amazonian extractive economy.	Univ E Anglia, Ctr Ecol Evolut & Conservat, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; Univ Sao Paulo, Dept Ecol, BR-05508900 Sao Paulo, Brazil; PROMAB, Riberalta, Beni, Bolivia; Univ Utrecht, Dept Plant Ecol, NL-3508 TB Utrecht, Netherlands; EMBRAPA, Ctr Pesquisa Agroflorestal Acre, BR-69908970 Rio Branco, Acre, Brazil; Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; Univ Florida, Trop Conservat & Dev Program, Gainesville, FL 32611 USA; Museu Paraense Emilio Goeldi, Dept Bot, BR-66040170 Belem, Para, Brazil; ACCA, Proyecto Conservando Castanales, Puerto Maldonado, Madre De Dios, Peru; INPA, Dept Bot, BR-69083000 Manaus, Amazonas, Brazil; Embrapa Amazonia Oriental DFID, Projeto Dendrogene, BR-69095100 Belem, Para, Brazil; Mauritius Herbarium, MSIRI, Reduit, Mauritius	University of East Anglia; University of East Anglia; Universidade de Sao Paulo; Utrecht University; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); State University System of Florida; University of Florida; State University System of Florida; University of Florida; Museu Paraense Emilio Goeldi; Institute Nacional de Pesquisas da Amazonia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Peres, CA (corresponding author), Univ E Anglia, Ctr Ecol Evolut & Conservat, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England.		Watkinson, Andrew R/N-1649-2013; Freckleton, Rob P/B-6455-2013; Zuidema, Pieter A/C-8951-2009; Wadt, Lucia HO/M-1703-2013; Peres, Carlos Augusto/N-8275-2019; Baider, Claudia/C-2570-2009; Shepard, Glenn H./C-3667-2014; Shepard, Glenn/AAS-4059-2021; Peres, Carlos A./B-1276-2013; Yu, Douglas W./D-2536-2009; Gribel, Rogerio/C-5392-2013; SALOMÃO, RAFAEL/AAU-1306-2020; Peres, Carlos A./ABE-8361-2020	Zuidema, Pieter A/0000-0001-8100-1168; Baider, Claudia/0000-0002-2203-2076; Shepard, Glenn H./0000-0003-3195-8230; Shepard, Glenn/0000-0003-3195-8230; Peres, Carlos A./0000-0002-1588-8765; Yu, Douglas W./0000-0001-8551-5609; Gribel, Rogerio/0000-0002-0850-5578; SALOMÃO, RAFAEL/0000-0003-0947-0132; Peres, Carlos A./0000-0002-1588-8765; Wadt, Lucia/0000-0002-5018-7550; Freckleton, Robert/0000-0002-8338-864X				[Anonymous], FLORESTA AMAZONICA D; BAIDER C, 2000, DEMOGRAFIA ECOLOGIA; BOOT RGA, 1995, ECOL APPL, V5, P896, DOI 10.2307/2269340; CLAY JW, 1997, HARVESTING WILD SPEC, P246; Freckleton RP, 2003, J APPL ECOL, V40, P846, DOI 10.1046/j.1365-2664.2003.00842.x; HUBER J, 1910, B MUS PARAENSE HIST, V6, P781; *I BRAS GEOGR EST, 2002, PROD EXTR VEG SILV; *I NAC PESQ ESP, 2003, MON BRAZ AM FOR SAT; Matos DMS, 1999, ECOLOGY, V80, P2635, DOI 10.2307/177246; Nepstad D. C., 1992, Advances in Economic Botany, V9, P1; Peres CA, 1997, J TROP ECOL, V13, P69, DOI 10.1017/S0266467400010269; Peres CA, 1997, J TROP ECOL, V13, P595, DOI 10.1017/S0266467400010749; Peters C.M., 1994, SUSTAINABLE HARVEST; Pires JM, 1984, AMAZON LIMNOLOGY LAN, P581, DOI DOI 10.1007/978-94-009-6542-3; Zuidema PA, 2002, J TROP ECOL, V18, P1, DOI 10.1017/S0266467402002018; ZUIDEMA PA, 2003, ECOLOGY MANAGEMENT B, V6	16	208	216	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2112	2114		10.1126/science.1091698	http://dx.doi.org/10.1126/science.1091698			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684819				2022-12-24	WOS:000187385200041
J	Doran, T; Drever, F; Whitehead, M				Doran, T; Drever, F; Whitehead, M			Health of young and elderly informal carers: analysis of UK census data	BRITISH MEDICAL JOURNAL			English	Article									Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England	University of Liverpool	Doran, T (corresponding author), Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England.							Banks P, 2001, DISABIL SOC, V16, P797, DOI 10.1080/09687590120083967; *GEN REG OFF SCOTL, SCOTL CENS; MAHER J, 2002, CAREERS 2000; *NO IR STAT RES AG, 2001, NO IR CENS 2001 OUTP; *ONS, 2003, CENS 2001 S	5	44	44	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1388	1388		10.1136/bmj.327.7428.1388	http://dx.doi.org/10.1136/bmj.327.7428.1388			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755PL	14670886	Bronze, Green Published			2022-12-24	WOS:000187417900025
J	Khaldeeva, N; Hillis, SD; Voronin, E; Rakhmanova, A; Yakovlev, A; Jamieson, DJ; Ryder, RW				Khaldeeva, N; Hillis, SD; Voronin, E; Rakhmanova, A; Yakovlev, A; Jamieson, DJ; Ryder, RW			HIV-1 seroprevalence rates in women and relinquishment of infants to the state in St Petersburg, Russia, 2002	LANCET			English	Article								The effectiveness of rapid HIV-1 testing and nevirapine prophylaxis for HIV-Infected mothers without prenatal care has been shown. We found that from 1998 to 2002, HIV-1 seroprevalence in women giving birth in St Petersburg, Russia increased 100-fold: from 0.013% to 1.3% (p<0.0001). HIV-1 seroprevalence was 8% (114 of 1466) in women without prenatal care and 1% (376 of 37 645) in those with prenatal care (p<0.0001). All 376 HIV-1-infected women with, and 41% (47 of 114) of HIV-1-infected women without prenatal care received intrapartum antiretroviral therapy (p<0.0001). In women who were HIV-1 positive, 26% (30 of 114) of those without prenatal care and 4% (13 of 371) of those with prenatal care relinquished their infants to the custody of the state, compared with 10% (354 of 37 621) of HIV-1-negative women (p<0.0001).	Ctr Dis Control & Prevent, Atlanta, GA 30341 USA; St Petersburg Glaser Pediat AIDS Fdn Planning Gra, St Petersburg, Russia; City AIDS Ctr, St Petersburg, Russia; Republ Hosp Infect Dis, Clin AIDS Ctr, St Petersburg, Russia; City Hlth Comm, St Petersburg, Russia; Botkin Hosp, St Petersburg, Russia; Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA	Centers for Disease Control & Prevention - USA; University of North Carolina; University of North Carolina Chapel Hill	Hillis, SD (corresponding author), Ctr Dis Control & Prevent, Mailstop K-34,4770 Buford Hwy NE, Atlanta, GA 30341 USA.		Yakovlev, Alexey/H-2748-2015	Yakovlev, Alexey/0000-0003-4163-5769; Jamieson, Denise/0000-0003-2597-1201				*ALL RUSS CTR PUBL, 1998, WOM REPR HLTH SURV 1; Hamers FF, 2003, LANCET, V361, P1035, DOI 10.1016/S0140-6736(03)12831-0; *MENT DIS RIGHTS I, 1999, CHILDR RUSS I HUM RI; *UNAIDS JOINT UN P, 2002, CHILDR BRINK 2002 JO; *UNAIDS JOINT UN P, 2002, REP GLOB HIV AIDS EP	5	16	18	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 13	2003	362	9400					1981	1982		10.1016/S0140-6736(03)15019-2	http://dx.doi.org/10.1016/S0140-6736(03)15019-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683660				2022-12-24	WOS:000187210700013
J	Ganel, T; Goodale, MA				Ganel, T; Goodale, MA			Visual control of action but not perception requires analytical processing of object shape	NATURE			English	Article							SELECTIVE ATTENTION; RECOGNITION; INFORMATION; VIEWPOINT; PATHWAYS; FEATURES	The visual perception of object shape depends on ' holistic'(1 - 4) processing in which a given dimension cannot be perceptually isolated from the other dimensions of the object. The visual control of action ( such as grasping an object), however, which is mediated by cortical areas that are largely independent of those mediating conscious perception(5 - 8), must take into account only the most action- relevant dimension of an object without being misled by other non- relevant object features. Here we report the results of two experiments showing that vision for perception and vision for action deal with objects in a fundamentally different manner. We tested participants' ability to make perceptual judgements of the width of different rectangular objects or to grasp them across their width, while in both cases ignoring length(9,10). Participants could not ignore length when making perceptual judgements of width but they could completely ignore length when grasping the same objects. These results suggest that in situations in which the elementary dimensions of an object's shape are perceived in a holistic manner, the same dimensions are treated analytically when a visually guided action is directed at that same object.	Univ Western Ontario, Dept Psychol, CIHR Grp Act & Percept, London, ON N6A 5C2, Canada	Western University (University of Western Ontario)	Ganel, T (corresponding author), Univ Western Ontario, Dept Psychol, CIHR Grp Act & Percept, London, ON N6A 5C2, Canada.	tganel@uwo.ca	Ganel, Tzvi/B-9344-2011; Goodale, Melvyn A/M-5907-2013	Ganel, Tzvi/0000-0003-0658-0598; Goodale, Melvyn A/0000-0001-6748-0561				Bar M, 2001, J COGNITIVE NEUROSCI, V13, P793, DOI 10.1162/08989290152541458; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; DYKES JR, 1978, PERCEPT PSYCHOPHYS, V23, P36, DOI 10.3758/BF03214292; Edelman S, 1997, PHILOS T R SOC B, V352, P1191, DOI 10.1098/rstb.1997.0102; FELFOLDY GL, 1974, PERCEPT PSYCHOPHYS, V15, P453, DOI 10.3758/BF03199285; Ganel T, 2002, J EXP PSYCHOL HUMAN, V28, P854, DOI 10.1037//0096-1523.28.4.854; GARNER WR, 1978, J EXP PSYCHOL GEN, V107, P287, DOI 10.1037/0096-3445.107.3.287; GARNER WR, 1974, PROCESSING INFORMATI; Goodale MA, 1998, COGNITION, V67, P181, DOI 10.1016/S0010-0277(98)00017-1; GOODALE MA, 1994, CURR BIOL, V4, P604, DOI 10.1016/S0960-9822(00)00132-9; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODALE MA, 1994, NEUROPSYCHOLOGIA, V32, P1159, DOI 10.1016/0028-3932(94)90100-7; Goodale MA, 1996, ADV MOTOR LEARNING C, P87; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; HUMPHREY GK, 1994, PERCEPTION, V23, P1457, DOI 10.1068/p231457; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; Koffka K., 1935, PRINCIPLES GESTALT P; Kwok RM, 2003, NEUROPSYCHOLOGIA, V41, P932, DOI 10.1016/S0028-3932(02)00324-X; Law MB, 2002, PERCEPT PSYCHOPHYS, V64, P1017, DOI 10.3758/BF03194753; Macmillan NA, 1998, PERCEPT PSYCHOPHYS, V60, P250, DOI 10.3758/BF03206034; Maddox W. T., 1992, MULTIDIMENSIONAL MOD, P147; MARR D, 1980, PHILOS T ROY SOC B, V290, P199, DOI 10.1098/rstb.1980.0091; NATSOULAS T, 1983, AM J PSYCHOL, V96, P435, DOI 10.2307/1422567; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; POMERANTZ JR, 1989, J EXP PSYCHOL HUMAN, V15, P635, DOI 10.1037/0096-1523.15.4.635; Shalev L, 2000, J EXP PSYCHOL HUMAN, V26, P997, DOI 10.1037/0096-1523.26.3.997; Swinnen SP, 2002, J COGNITIVE NEUROSCI, V14, P463, DOI 10.1162/089892902317361976	29	151	156	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					664	667		10.1038/nature02156	http://dx.doi.org/10.1038/nature02156			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752DY	14668865				2022-12-24	WOS:000187132800042
J	Tonkin, LA; Bass, BL				Tonkin, LA; Bass, BL			Mutations in RNAi rescue aberrant chemotaxis of ADAR mutants	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; ADENOSINE DEAMINASES; MESSENGER-RNA; C-ELEGANS; RDE-1; GENE; INTERFERENCE; HAIRPINS; ACT		Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Bass, BL (corresponding author), Univ Utah, Dept Biochem, 20 North 1900 East, Salt Lake City, UT 84132 USA.				NIGMS NIH HHS [R01 GM044073, GM44073] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044073] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; Morse DP, 1999, P NATL ACAD SCI USA, V96, P6048, DOI 10.1073/pnas.96.11.6048; Morse DP, 2002, P NATL ACAD SCI USA, V99, P7906, DOI 10.1073/pnas.112704299; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Parrish S, 2001, RNA, V7, P1397; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	12	120	133	0	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1725	1725		10.1126/science.1091340	http://dx.doi.org/10.1126/science.1091340			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657490	Green Accepted			2022-12-24	WOS:000186970100037
J	Brady, M				Brady, M			Health care in remote Australian Indigenous communities	LANCET			English	Article									Australian Natl Univ, Ctr Aboriginal Econ Policy Res, Canberra, ACT 0200, Australia	Australian National University	Brady, M (corresponding author), Australian Natl Univ, Ctr Aboriginal Econ Policy Res, Canberra, ACT 0200, Australia.								0	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S36	S37		10.1016/S0140-6736(03)15069-6	http://dx.doi.org/10.1016/S0140-6736(03)15069-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698123				2022-12-24	WOS:000187790200019
J	Li, MO; Sarkisian, MR; Mehal, WZ; Rakic, P; Flavell, RA				Li, MO; Sarkisian, MR; Mehal, WZ; Rakic, P; Flavell, RA			Phosphatidylserine receptor is required for clearance of apoptotic cells	SCIENCE			English	Article							MEMBRANE PHOSPHATIDYLSERINE; LUNG DEVELOPMENT; DEATH; PHAGOCYTOSIS; MICE; RECOGNITION; ENGULFMENT; BRAIN; REDISTRIBUTION; MACROPHAGES	Cells undergoing apoptosis during development are removed by phagocytes, but the underlying mechanisms of this process are not fully understood. Phagocytes lacking the phosphatidylserine receptor (PSR) were defective in removing apoptotic cells. Consequently, in PSR-deficient mice, dead cells accumulated in the lung and brain, causing abnormal development and leading to neonatal lethality. A fraction of PSR knockout mice manifested a hyperplasic brain phenotype resembling that of mice deficient in the cell death - associated genes encoding Apaf-1, caspase-3, and caspase-9, which suggests that phagocytes may also be involved in promoting apoptosis. These data demonstrate a critical role for PSR in early stages of mammalian organogenesis and suggest that this receptor may be involved in respiratory distress syndromes and congenital brain malformations.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Digest Dis, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.			li, ming/0000-0002-1383-0535				Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Balasubramanian K, 1997, J BIOL CHEM, V272, P31113, DOI 10.1074/jbc.272.49.31113; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; Cole FS, 2001, PEDIATR RES, V50, P157, DOI 10.1203/00006450-200108000-00001; De Paepe ME, 1999, J PEDIATR SURG, V34, P863, DOI 10.1016/S0022-3468(99)90389-5; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 2001, SEMIN IMMUNOL, V13, P365, DOI 10.1006/smim.2001.0333; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Kresch MJ, 1998, PEDIATR RES, V43, P426, DOI 10.1203/00006450-199803000-00020; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Leonard JR, 2002, J NEUROPATH EXP NEUR, V61, P673, DOI 10.1093/jnen/61.8.673; Manfredi AA, 2002, APOPTOSIS, V7, P153, DOI 10.1023/A:1014366531885; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; SAMBRANO GR, 1995, P NATL ACAD SCI USA, V92, P1396, DOI 10.1073/pnas.92.5.1396; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; Scavo LM, 1998, AM J RESP CELL MOL, V18, P21, DOI 10.1165/ajrcmb.18.1.2744; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X	28	305	318	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1560	1563		10.1126/science.1087621	http://dx.doi.org/10.1126/science.1087621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645847				2022-12-24	WOS:000186802200042
J	Weigel, LM; Clewell, DB; Gill, SR; Clark, NC; McDougal, LK; Flannagan, SE; Kolonay, JF; Shetty, J; Killgore, GE; Tenover, FC				Weigel, LM; Clewell, DB; Gill, SR; Clark, NC; McDougal, LK; Flannagan, SE; Kolonay, JF; Shetty, J; Killgore, GE; Tenover, FC			Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus	SCIENCE			English	Article							GLYCOPEPTIDE RESISTANCE; UNITED-STATES; CELL-WALL; ENTEROCOCCI; EVOLUTION; SEQUENCE	Vancomycin is usually reserved for treatment of serious infections, including those caused by multidrug-resistant Staphylococcus aureus. A clinical isolate of S. aureus with high-level resistance to vancomycin ( minimal inhibitory concentration = 1024 mug/ml) was isolated in June 2002. This isolate harbored a 57.9-kilobase multiresistance conjugative plasmid within which Tn1546 (vanA) was integrated. Additional elements on the plasmid encoded resistance to trimethoprim (dfrA), beta-lactams (blaZ), aminoglycosides (aacA-aphD), and disinfectants ( qacC). Genetic analyses suggest that the long-anticipated transfer of vancomycin resistance to a methicillin-resistant S. aureus occurred in vivo by interspecies transfer of Tn1546 from a co-isolate of Enterococcus faecalis.	Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA; Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; Inst Genom Res, Rockville, MD 20850 USA; J Craig Center Sci Fdn Joint Technol Ctr, Rockville, MD 20850 USA	Centers for Disease Control & Prevention - USA; University of Michigan System; University of Michigan; J. Craig Venter Institute	Weigel, LM (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA.	lweigel@cdc.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095359] Funding Source: NIH RePORTER; NIAID NIH HHS [N01-AI-95359] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARTHUR M, 1993, J BACTERIOL, V175, P117, DOI 10.1128/JB.175.1.117-127.1993; Berg T, 1998, J BACTERIOL, V180, P4350, DOI 10.1128/JB.180.17.4350-4359.1998; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P10408, DOI 10.1021/bi00107a007; BYRNE ME, 1990, ANTIMICROB AGENTS CH, V34, P2106, DOI 10.1128/AAC.34.11.2106; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P902; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; CLARK NC, 1993, ANTIMICROB AGENTS CH, V37, P2311, DOI 10.1128/AAC.37.11.2311; Cui LZ, 2000, ANTIMICROB AGENTS CH, V44, P2276, DOI 10.1128/AAC.44.9.2276-2285.2000; DUTKAMALEN S, 1995, J CLIN MICROBIOL, V33, P24, DOI 10.1128/JCM.33.1.24-27.1995; Firth N, 2000, GRAM-POSITIVE PATHOGENS, P326; FLANNAGAN SE, IN PRESS ANTIMICROB; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; LECLERCQ R, 1988, NEW ENGL J MED, V319, P157, DOI 10.1056/NEJM198807213190307; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; MORTON TM, 1993, J BACTERIOL, V175, P4436, DOI 10.1128/JB.175.14.4436-4447.1993; NOBLE WC, 1992, FEMS MICROBIOL LETT, V93, P195; Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X; Roberts RB, 1998, J INFECT DIS, V178, P164, DOI 10.1086/515610; Sieradzki K, 1999, J BACTERIOL, V181, P7566, DOI 10.1128/JB.181.24.7566-7570.1999; Sieradzki R, 1999, J BIOL CHEM, V274, P18942, DOI 10.1074/jbc.274.27.18942; Walsh C, 1999, SCIENCE, V284, P442, DOI 10.1126/science.284.5413.442	21	647	702	4	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1569	1571		10.1126/science.1090956	http://dx.doi.org/10.1126/science.1090956			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645850				2022-12-24	WOS:000186802200045
J	Li, WH; Moore, MJ; Vasilieva, N; Sui, JH; Wong, SK; Berne, MA; Somasundaran, M; Sullivan, JL; Luzuriaga, K; Greenough, TC; Choe, H; Farzan, M				Li, WH; Moore, MJ; Vasilieva, N; Sui, JH; Wong, SK; Berne, MA; Somasundaran, M; Sullivan, JL; Luzuriaga, K; Greenough, TC; Choe, H; Farzan, M			Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus	NATURE			English	Article							MESSENGER-RNA EXPRESSION; AMINOPEPTIDASE-N; LOCALIZATION; HOMOLOG; CLONING; DOMAIN; SITE	Spike (S) proteins of coronaviruses, including the coronavirus that causes severe acute respiratory syndrome (SARS), associate with cellular receptors to mediate infection of their target cells(1,2). Here we identify a metallopeptidase, angiotensin-converting enzyme 2 (ACE2)(3,4), isolated from SARS coronavirus (SARS-CoV)permissive Vero E6 cells, that efficiently binds the S1 domain of the SARS-CoV S protein. We found that a soluble form of ACE2, but not of the related enzyme ACE1, blocked association of the S1 domain with Vero E6 cells. 293T cells transfected with ACE2, but not those transfected with human immunodeficiency virus-1 receptors, formed multinucleated syncytia with cells expressing S protein. Furthermore, SARS-CoV replicated efficiently on ACE2-transfected but not mock-transfected 293T cells. Finally, anti-ACE2 but not anti-ACE1 antibody blocked viral replication on Vero E6 cells. Together our data indicate that ACE2 is a functional receptor for SARS-CoV.	Harvard Univ, Sch Med, Childrens Hosp, Perlmutter Lab,Pulm Div,Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Dept Med Microbiol & Mol Genet, Brigham & Womens Hosp, Partners AIDS Res Ctr,Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; Tufts Univ, Sch Med, Tufts Univ Core Facil, Boston, MA 02111 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Tufts University; University of Massachusetts System; University of Massachusetts Worcester	Choe, H (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Perlmutter Lab,Pulm Div,Dept Pediat, Boston, MA 02115 USA.	hyeryun.choe@tch.harvard.edu; farzan@mbcrr.harvard.edu		Farzan, Michael/0000-0002-2990-5319; Li, Wenhui/0000-0003-1305-7404; SUI, JIANHUA/0000-0002-1272-9662				Bonavia A, 2003, J VIROL, V77, P2530, DOI 10.1128/JVI.77.4.2530-2538.2003; Breslin JJ, 2003, J VIROL, V77, P4435, DOI 10.1128/JVI.77.7.4435-4438.2003; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Dales NA, 2002, J AM CHEM SOC, V124, P11852, DOI 10.1021/ja0277226; DELMAS B, 1994, J VIROL, V68, P5216, DOI 10.1128/JVI.68.8.5216-5224.1994; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; DVEKSLER GS, 1993, J VIROL, V67, P1; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Harmer D, 2002, FEBS LETT, V532, P107, DOI 10.1016/S0014-5793(02)03640-2; Holmes KV, 2003, NEW ENGL J MED, V348, P1948, DOI 10.1056/NEJMp030078; HOLMES KV, 1993, ADV EXP MED BIOL, V342, P261; Huang LL, 2003, J BIOL CHEM, V278, P15532, DOI 10.1074/jbc.M212934200; Jackwood MW, 2001, AVIAN DIS, V45, P366, DOI 10.2307/1592976; Komatsu T, 2002, DNA SEQUENCE, V13, P217, DOI 10.1080/1042517021000021608; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; KUBO H, 1994, J VIROL, V68, P5403, DOI 10.1128/JVI.68.9.5403-5410.1994; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; Leung WK, 2003, GASTROENTEROLOGY, V125, P1011, DOI 10.1053/S0016-5085(03)01215-0; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; SPAAN W, 1988, J GEN VIROL, V69, P2939, DOI 10.1099/0022-1317-69-12-2939; Sturman L S, 1984, Adv Exp Med Biol, V173, P25; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Tresnan DB, 1998, ADV EXP MED BIOL, V440, P69; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0	30	3659	3961	16	335	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2003	426	6965					450	454		10.1038/nature02145	http://dx.doi.org/10.1038/nature02145			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647384	Green Published, Bronze			2022-12-24	WOS:000186800800040
J	Qurishi, N; Kreuzberg, C; Luchters, G; Effenberger, W; Kupfer, B; Sauerbruch, T; Rockstroh, JK; Spengler, U				Qurishi, N; Kreuzberg, C; Luchters, G; Effenberger, W; Kupfer, B; Sauerbruch, T; Rockstroh, JK; Spengler, U			Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEASE INHIBITOR; INFECTED PATIENTS; DRUG-USERS; NATURAL-HISTORY; DISEASE; PROGRESSION; VIREMIA; IMPACT; HCV	Background Highly active antiretroviral therapy (HAART) has improved the prognosis of HIV infection. However, replication of hepatitis C virus (HCV) is not inhibited by HAART, and treatment-related hepatotoxicity is common. To clarify the effect of HAART in HIV/HCV-coinfected patients, we studied liver-related mortality and overall mortality in 285 patients who were regularly treated during the period 1990-2002 at our department. Methods Survival was analysed retrospectively by Kaplan-Meier and Cox's regression analyses after patients (81% haemophiliacs) had been stratified into three groups according to their antiretroviral therapy (HAART n=93, available after 1995; treatment exclusively with nucleoside analogues n=55, available after 1992; or no treatment, n=137). Findings Liver-related mortality rates were 0.45, 0.69, and 1.70 per 100 person-years in the HAART, antiretroviral-treatment, and untreated groups. Kaplan-Meier analysis of liver related mortality confirmed the significant survival benefit in patients with antiretroviral therapy (p=0.018), and regression analysis identified HAART (odds ratio 0.106 [95% CI 0.020-0.564]), antiretroviral treatment (0.283 [0.103-0.780]), CD4-positive T-cell count (0.746 [0.641-0.868] per 0.05X10(9) cells/L), serum cholinesterase (0.962 [0.938-0.986] per 100 U/L), and age (1.065 [1.027-1.105] per year) as independent predictors of liver-related survival. Severe drug-related hepatotoxicity was seen in five patients treated with nucleoside analogues alone and 13 treated with HAART. No patient died from drug-related hepatotoxicity. Interpretation In addition to improved overall survival, antiretroviral therapy significantly reduced long-term liver related mortality in our patients. This survival benefit seems to outweigh by far the associated risks of severe hepatotoxicity.	Univ Bonn, Med Klin & Poliklin 1, Dept Internal Med, D-53105 Bonn, Germany; Univ Bonn, Inst Expt Hematol & Transfus Med, D-53105 Bonn, Germany; Univ Bonn, Inst Microbiol & Immunol, D-53105 Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Spengler, U (corresponding author), Univ Bonn, Med Klin & Poliklin 1, Dept Internal Med, Sigmund Freud Str 25, D-53105 Bonn, Germany.	spengler@uni-bonn.de						Benhamou Y, 2001, HEPATOLOGY, V34, P283, DOI 10.1053/jhep.2001.26517; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Cacoub P, 2001, CLIN INFECT DIS, V32, P1207, DOI 10.1086/319747; Carr A, 1997, LANCET, V349, P995, DOI 10.1016/S0140-6736(05)62892-9; *CDC, 1986, MMWR-MORBID MORTAL W, V35, P334; Daar ES, 2001, J INFECT DIS, V183, P589, DOI 10.1086/318539; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; Delladetsima J, 2002, HAEMOPHILIA, V8, P668, DOI 10.1046/j.1365-2516.2002.00670.x; Di Martino V, 2001, HEPATOLOGY, V34, P1193, DOI 10.1053/jhep.2001.29201; EYSTER ME, 1993, J ACQ IMMUN DEF SYND, V6, P602; Fialaire P, 1999, J INFECT DIS, V180, P574, DOI 10.1086/314910; Garcia-Samaniego J, 1998, J HEPATOL, V28, P526, DOI 10.1016/S0168-8278(98)80334-6; HAYASHI PH, 1991, J MED VIROL, V33, P177, DOI 10.1002/jmv.1890330307; Hernandez-Aguado I, 2001, EUR J EPIDEMIOL, V17, P539, DOI 10.1023/A:1014560431726; IMBERTI L, 1991, J VIROL METHODS, V34, P233, DOI 10.1016/0166-0934(91)90103-7; MARTIN P, 1989, GASTROENTEROLOGY, V97, P1559, DOI 10.1016/0016-5085(89)90405-8; Martin-Carbonero L, 2001, AIDS RES HUM RETROV, V17, P1467, DOI 10.1089/08892220152644160; Martinez-Sierra C, 2003, CLIN INFECT DIS, V36, P491, DOI 10.1086/367643; MEDINA DJ, 1994, ANTIMICROB AGENTS CH, V38, P1824, DOI 10.1128/AAC.38.8.1824; MILITO AD, 1999, J MED VIROL, V57, P140; Mokrzycki MH, 2000, CLIN INFECT DIS, V30, P198, DOI 10.1086/313594; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Perez-Olmeda M, 2000, AIDS, V14, P212, DOI 10.1097/00002030-200001280-00023; Pol S, 2002, J VIRAL HEPATITIS, V9, P1, DOI 10.1046/j.1365-2893.2002.00326.x; Puoti M, 2000, J ACQ IMMUN DEF SYND, V24, P211; Ragni MV, 1999, J INFECT DIS, V180, P2027, DOI 10.1086/315143; Ragni MV, 2001, J INFECT DIS, V183, P1112, DOI 10.1086/319273; Rizzieri DA, 1997, LANCET, V349, P775, DOI 10.1016/S0140-6736(05)60200-0; Rockstroh JK, 1996, AM J GASTROENTEROL, V91, P2563; Rockstroh JK, 1998, AIDS, V12, pS42; RUMI MG, 1990, ANN INTERN MED, V112, P379, DOI 10.7326/0003-4819-112-5-379; Rutschmann OT, 1998, J INFECT DIS, V177, P783, DOI 10.1086/517808; Saves M, 1999, AIDS, V13, pF115, DOI 10.1097/00002030-199912030-00002; SHERMAN KE, 1991, J INFECT DIS, V163, P414, DOI 10.1093/infdis/163.2.414; Soriano V, 1999, EUR J EPIDEMIOL, V15, P1, DOI 10.1023/A:1007506617734; Soto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3; Sterling RK, 2003, JAIDS-J ACQ IMM DEF, V32, P30, DOI 10.1097/00126334-200301010-00005; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V288, P199, DOI 10.1001/jama.288.2.199; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Takamatsu J, 2001, HAEMOPHILIA, V7, P575, DOI 10.1046/j.1365-2516.2001.00567.x; TELFER PT, 1994, BRIT J HAEMATOL, V88, P397, DOI 10.1111/j.1365-2141.1994.tb05038.x; Toyoda H, 1999, CLIN INFECT DIS, V29, P1332, DOI 10.1086/313480; VANGEMEN B, 1993, J VIROL METHODS, V43, P177, DOI 10.1016/0166-0934(93)90075-3; Vento S, 1998, AIDS, V12, P116; Woitas RP, 1997, J IMMUNOL, V159, P1012; Yokozaki S, 2000, BLOOD, V96, P4293; Zylberberg H, 1998, CLIN INFECT DIS, V26, P1104, DOI 10.1086/520281	48	398	407	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2003	362	9397					1708	1713		10.1016/S0140-6736(03)14844-1	http://dx.doi.org/10.1016/S0140-6736(03)14844-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746VE	14643119				2022-12-24	WOS:000186767700009
J	Grunewald, K; Desai, P; Winkler, DC; Heymann, JB; Belnap, DM; Baumeister, W; Steven, AC				Grunewald, K; Desai, P; Winkler, DC; Heymann, JB; Belnap, DM; Baumeister, W; Steven, AC			Three-dimensional structure of herpes simplex virus from cryo-electron tomography	SCIENCE			English	Article							CELLS; DNA; MICROSCOPY	Herpes simplex virus, a DNA virus of high complexity, consists of a nucleocapsid surrounded by the tegument-a protein compartment-and the envelope. The latter components, essential for infectivity, are pleiomorphic. Visualized in cryo-electron tomograms of isolated virions, the tegument was seen to form an asymmetric cap: On one side, the capsid closely approached the envelope; on the other side, they were separated by similar to35 nanometers of tegument. The tegument substructure was particulate, with some short actin-like. laments. The envelope contained 600 to 750 glycoprotein spikes that varied in length, spacing, and in the angles at which they emerge from the membrane. Their distribution was nonrandom, suggesting functional clustering.	NIAMSD, Struct Biol Lab, NIH, Bethesda, MD 20892 USA; Johns Hopkins Univ, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Johns Hopkins University; California Institute of Technology; Max Planck Society	Steven, AC (corresponding author), NIAMSD, Struct Biol Lab, NIH, Bethesda, MD 20892 USA.	Alasdair_Steven@nih.gov	Grünewald, Kay/AAW-3652-2020; Heymann, Bernard/F-6825-2011; Heymann, Bernard/H-8265-2019	Grünewald, Kay/0000-0002-4788-2691; Heymann, Bernard/0000-0002-8872-5326; Winkler, Dennis/0000-0003-1445-6554	NIAID NIH HHS [R01 AI033077, AI33077, R01 AI033077-10] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR027002] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Baker T., 1997, STRUCTURAL BIOL VIRU, P38; Belnap DM, 2000, P NATL ACAD SCI USA, V97, P73, DOI 10.1073/pnas.97.1.73; BOOY FP, 1991, CELL, V64, P1007, DOI 10.1016/0092-8674(91)90324-R; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406; Frank J, 1992, ELECT TOMOGRAPHY; Granzow H, 2001, J VIROL, V75, P3675, DOI 10.1128/JVI.75.8.3675-3684.2001; Grunewald K, 2003, BIOPHYS CHEM, V100, P577, DOI 10.1016/S0301-4622(02)00307-1; Lee GE, 2003, J VIROL, V77, P2038, DOI 10.1128/JVI.77.3.2038-2045.2003; McIntosh JR, 2001, J CELL BIOL, V153, pF25, DOI 10.1083/jcb.153.6.F25; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Mettenleiter TC, 2002, J VIROL, V76, P1537, DOI 10.1128/JVI.76.4.1537-1547.2002; Newcomb WW, 2000, J VIROL, V74, P1663, DOI 10.1128/JVI.74.4.1663-1673.2000; NEWCOMB WW, 1993, J MOL BIOL, V232, P499, DOI 10.1006/jmbi.1993.1406; Newcomb WW, 2001, J VIROL, V75, P10923, DOI 10.1128/JVI.75.22.10923-10932.2001; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Roizman B., 1974, COMPREHENSIVE VIROLO, P229, DOI DOI 10.1007/978-1-4684-2703-5_4; ROIZMAN B, 2001, FIELDS VIROLOGY, V2, P2399; Skepper JN, 2001, J VIROL, V75, P5697, DOI 10.1128/JVI.75.12.5697-5702.2001; Smith GA, 2002, ANNU REV CELL DEV BI, V18, P135, DOI 10.1146/annurev.cellbio.18.012502.105920; Spear PG, 2000, VIROLOGY, V275, P1, DOI 10.1006/viro.2000.0529; STANNARD LM, 1987, J GEN VIROL, V68, P715, DOI 10.1099/0022-1317-68-3-715; STEVEN AC, 1997, STRUCTURAL BIOL VIRU, P312; Trus BL, 1999, J VIROL, V73, P2181, DOI 10.1128/JVI.73.3.2181-2192.1999; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Whitley RJ, FIELDS VIROLOGY FIEL, V2, P297; Zhou ZH, 1999, J VIROL, V73, P3210, DOI 10.1128/JVI.73.4.3210-3218.1999; Zhou ZH, 2000, SCIENCE, V288, P877, DOI 10.1126/science.288.5467.877	28	407	420	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2003	302	5649					1396	1398		10.1126/science.1090284	http://dx.doi.org/10.1126/science.1090284			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631040				2022-12-24	WOS:000186683500052
J	Waisbren, SE; Albers, S; Amat, S; Ampola, M; Brewster, TG; Demmer, L; Eaton, RB; Greenstein, R; Korson, M; Larson, C; Marsden, D; Msall, M; Naylor, EW; Pueschel, S; Seashore, M; Shih, VE; Levy, HL				Waisbren, SE; Albers, S; Amat, S; Ampola, M; Brewster, TG; Demmer, L; Eaton, RB; Greenstein, R; Korson, M; Larson, C; Marsden, D; Msall, M; Naylor, EW; Pueschel, S; Seashore, M; Shih, VE; Levy, HL			Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TANDEM MASS-SPECTROMETRY; INBORN-ERRORS; DEFICIENCY; METABOLISM; INFANTS; PROGRAM; HEALTH; TESTS	Context Tandem mass spectrometry now allows newborn screening for more than 20 biochemical genetic disorders. Questions about the effectiveness and risks of expanded newborn screening for biochemical genetic disorders need to be answered prior to its widespread acceptance as a state-mandated program. Objectives To compare newborn identification by expanded screening with clinical identification of biochemical genetic disorders and to assess the impact on families of a false-positive screening result compared with a normal result in the expanded newborn screening program. Design Prospective study involving an inception cohort of newly diagnosed children. Setting Massachusetts, Maine, and a private laboratory in Pennsylvania with expanded newborn screening; other New England states with limited screening. Participants Families of 50 affected children identified through expanded newborn screening (82% of eligible cases); 33 affected children identified clinically (97% of eligible cases); 94 screened children with false-positive results (75% of eligible cases); and 81 screened children with normal results (63% of eligible cases). Main Outcome Measures Child's health and development and the Parental Stress Index. Results Within the first 6 months of life, 28% of children identified by newborn screening compared with 55% of clinically identified children required hospitalization (P=.02). One child identified by newborn screening compared with 8 (42%) identified clinically performed in the range of mental retardation (P<.001). Mothers in the screened group reported lower overall stress on the Parental Stress Index than mothers in the clinically identified group (z=3.38, P<.001). Children with false-positive results compared with children with normal results were twice as likely to experience hospitalization (21% [n=20] vs 10% [n=8], respectively; P=.06). Mothers of children in the false-positive group compared with mothers of children with normal screening results attained higher scores on the Parental Stress Index (z=4.25, P<.001) and the Parent-Child Dysfunction subscale (z=5.30, P<.001). Conclusions Expanded newborn screening may lead to improved health outcomes for affected children and lower stress for their parents. However, false-positive screening results may place families at risk for increased stress and parent-child dysfunction.	Childrens Hosp Boston, Boston, MA 02115 USA; Univ Munster, D-4400 Munster, Germany; Eastern Maine Med Ctr, Bangor, ME USA; Tufts Univ New England Med Ctr, Boston, MA 02111 USA; Maine Med Ctr, Portland, ME 04102 USA; Univ Massachusetts, Sch Med, New England Newborn Screening Program, Jamaica Plain, MA USA; Rhode Isl Hosp, Providence, RI USA; Univ Connecticut, Ctr Hlth, Farmington, CT USA; Pediat Screening Inc, Bridgeville, PA USA; Yale Univ, Sch Med, New Haven, CT USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; University of Munster; Eastern Maine Medical Center; Tufts Medical Center; Maine Medical Center; University of Massachusetts System; Lifespan Health Rhode Island; Rhode Island Hospital; University of Connecticut; Yale University; Harvard University; Massachusetts General Hospital	Waisbren, SE (corresponding author), Childrens Hosp Boston, IC Smith 108,300 Longwood Ave, Boston, MA 02115 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002085] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG02085] Funding Source: Medline; PHS HHS [5H46 MC 00158] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abidin RR., 1995, PSYCHOL ASSESSMENT R; Albers S, 2001, J INHERIT METAB DIS, V24, P303, DOI 10.1023/A:1010391623104; Andresen BS, 2001, AM J HUM GENET, V68, P1408, DOI 10.1086/320602; Atkinson K, 2001, PUBLIC HEALTH REP, V116, P122, DOI 10.1016/S0033-3549(04)50004-3; Bayley N., 1993, BAYLEY SCALES INFANT; Bear M, 1998, PUBLIC HEALTH NURS, V15, P50, DOI 10.1111/j.1525-1446.1998.tb00321.x; Chace DH, 2001, CHEM REV, V101, P445, DOI 10.1021/cr990077+; Cunningham G, 2002, NEW ENGL J MED, V346, P1084, DOI 10.1056/NEJM200204043461411; Filiano JJ, 2002, PEDIATR NEUROL, V26, P201, DOI 10.1016/S0887-8994(01)00384-8; GUTHRIE R, 1968, Birth Defects Original Article Series, V4, P92; GUTHRIE R, 1963, PEDIATRICS, V32, P338; Hermeren G, 1999, ACTA PAEDIATR, V88, P99, DOI 10.1080/080352599750029501; Hollingshead A. B., 1991, HDB RES DESIGN SOCIA, P351; Holtzman NA, 1999, CLIN CHEM, V45, P732; Insinga RP, 2002, J PEDIATR-US, V141, P524, DOI 10.1067/mpd.2002.128116; Leslie L K, 1996, Pediatr Rev, V17, P323, DOI 10.1542/pir.17-9-323; Levy HL, 1998, CLIN CHEM, V44, P2401; Levy HL, 2000, ANNU REV GENOM HUM G, V1, P139, DOI 10.1146/annurev.genom.1.1.139; MCNEIL TF, 1985, ACTA PSYCHIAT SCAND, V72, P491, DOI 10.1111/j.1600-0447.1985.tb02645.x; *NAT RES COUNC COM, 1975, GEN SCREEN PROGR PRI; *NEWB SCREEN TASK, 2000, PEDIATRICS, V106, P383; Paul D, 1999, PERSPECT BIOL MED, V42, P207; PIERCE GR, 1991, J PERS SOC PSYCHOL, V61, P1028, DOI 10.1037/0022-3514.61.6.1028; Pollitt RI, 1997, HEALTH TECHNOL ASSES, V1, pi; Pollitt RJ, 1999, ACTA PAEDIATR, V88, P40, DOI 10.1080/080352599750029358; Read CY, 2002, CLIN GENET, V61, P268, DOI 10.1034/j.1399-0004.2002.610405.x; Schoen EJ, 2002, PEDIATRICS, V110, P781, DOI 10.1542/peds.110.4.781; SORENSON JR, 1984, PEDIATRICS, V73, P183; Sparrow S. S., 2011, VINELAND ADAPTIVE BE, V2nd; *STATACORP, 1999, STAT STAT SOFTW REL; THERRELL BL, US NATL SCREENING ST; Thomason MJ, 1998, J PUBLIC HEALTH MED, V20, P331, DOI 10.1093/oxfordjournals.pubmed.a024777; THORNDIKE RL, 1986, STANFORDBINET INTELL; TYMSTRA T, 1986, FAM PRACT, V3, P92, DOI 10.1093/fampra/3.2.92; Waisbren SE, 2002, J INHERIT METAB DIS, V25, P599, DOI 10.1023/A:1022003726224; Wang SS, 1999, GENET MED, V1, P332; Weglage J, 2001, PEDIATR RES, V49, P532, DOI 10.1203/00006450-200104000-00015; Wilcken B, 2003, NEW ENGL J MED, V348, P2304, DOI 10.1056/NEJMoa025225; Zytkovicz TH, 2001, CLIN CHEM, V47, P1945	39	244	248	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2003	290	19					2564	2572		10.1001/jama.290.19.2564	http://dx.doi.org/10.1001/jama.290.19.2564			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	744DQ	14625333				2022-12-24	WOS:000186613000026
J	Jenkins, M				Jenkins, M			Prospects for biodiversity	SCIENCE			English	Article							WILD NATURE; ENDEMISM	Assuming no radical transformation in human behavior, we can expect important changes in biodiversity and ecosystem services by 2050. A considerable number of species extinctions will have taken place. Existing large blocks of tropical forest will be much reduced and fragmented, but temperate forests and some tropical forests will be stable or increasing in area, although the latter will be biotically impoverished. Marine ecosystems will be very different from today's, with few large marine predators, and freshwater biodiversity will be severely reduced almost everywhere. These changes will not, in themselves, threaten the survival of humans as a species.	UN, Environm Programme, World Conservat Monitoring Ctr, Cambridge CB3 ODL, England	United Nations Environment Programme	Jenkins, M (corresponding author), UN, Environm Programme, World Conservat Monitoring Ctr, 219C Huntingdon Rd, Cambridge CB3 ODL, England.							Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; BALMFORD A, 1994, NATURE, V372, P623, DOI 10.1038/372623a0; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Birdlife International, 2000, THREAT BIRDS WORLD; Bruinsma J, 2003, WORLD AGR 2015 2030; Caldecott JO, 1996, BIODIVERS CONSERV, V5, P699, DOI 10.1007/BF00051782; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; *ESA P WP, 180 ESAPWP; *FAO UN, 2000, 140 FAO; Groombridge B, 2002, WORLD ATLAS BIODIVER; Intergovernmental Panel on Climate Change, 2001, 3 ASS REP; Jenkins M, 2003, CONSERV BIOL, V17, P20, DOI 10.1046/j.1523-1739.2003.01719.x; Jepson P, 2001, SCIENCE, V292, P859, DOI 10.1126/science.1061727; LEADERWILLIAMS N, 2002, 27 IUCN SPEC SURV CO; LOH J, 2002, LIVING PLANET REPORT; Martin PS, 1984, QUATERNARY EXTINCTIO; PAULY D, IN PRESS SCIENCE; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; Schule W., 1992, P45; Steadman DW, 2002, SCIENCE, V298, P2136, DOI 10.1126/science.1078915; *UNESCO BERGH BOOK, 2003, UN WORLD WAT DEV REP; *WORLD CONS MON CT, 1998, FRESHW BIOD PREL GLO	22	328	340	4	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2003	302	5648					1175	1177		10.1126/science.1088666	http://dx.doi.org/10.1126/science.1088666			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14615529				2022-12-24	WOS:000186544300043
J	Glatzel, M; Abela, E; Maissen, M; Aguzzi, A				Glatzel, M; Abela, E; Maissen, M; Aguzzi, A			Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INCLUSION-BODY MYOSITIS; TONSIL BIOPSY; VARIANT CJD; CLASSIFICATION; VCJD; BSE	BACKGROUND: In patients with sporadic Creutzfeldt-Jakob disease, pathologic disease-associated prion protein (PrP(sup Sc)) has been identified only in the central nervous system and olfactory-nerve tissue. Understanding the distribution of PrP(sup Sc) in Creutzfeldt-Jakob disease is important for classification and diagnosis and perhaps even for prevention. METHODS: We used a highly sensitive method of detection -- involving the concentration of PrP(sup Sc) by differential precipitation with sodium phosphotungstic acid, which increased the sensitivity of Western blot analysis by up to three orders of magnitude -- to search for PrP(sup Sc) in extraneural organs of 36 patients with sporadic Creutzfeldt-Jakob disease who died between 1996 and 2002. RESULTS: PrP(sup Sc) was present in the brain tissue of all patients. In addition, we found PrP(sup Sc) in 10 of 28 spleen specimens and in 8 of 32 skeletal-muscle samples. Three patients had PrP(sup Sc) in both spleen and muscle specimens. Patients with extraneural PrP(sup Sc) had a significantly longer duration of disease and were more likely to have uncommon molecular variants of sporadic Creutzfeldt-Jakob disease than were patients without extraneural PrP(sup Sc). CONCLUSIONS: Using sensitive techniques, we identified extraneural deposition of PrP(sup Sc) in spleen and muscle samples from approximately one third of patients who died with sporadic Creutzfeldt-Jakob disease. Extraneural PrP(sup Sc) appears to correlate with a long duration of disease.	Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Natl Reference Ctr Prion Dis, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.		Glatzel, Markus/V-8844-2019; Aguzzi, Adriano/A-3351-2008; Glatzel, Markus/G-3356-2011	Glatzel, Markus/0000-0002-7720-8817; Glatzel, Markus/0000-0002-7720-8817; Aguzzi, Adriano/0000-0002-0344-6708; Abela, Eugenio/0000-0002-9356-1450				Aguzzi A, 2003, NATURE, V423, P127, DOI 10.1038/423127a; Aguzzi A, 2000, HAEMATOLOGICA, V85, P3; Aguzzi A, 2001, NAT REV MOL CELL BIO, V2, P118, DOI 10.1038/35052063; ASKANAS V, 1993, NEUROREPORT, V5, P25, DOI 10.1097/00001756-199310000-00006; Blattler T, 1997, NATURE, V389, P69, DOI 10.1038/37981; Bosque PJ, 2002, P NATL ACAD SCI USA, V99, P3812, DOI 10.1073/pnas.052707499; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Collinge J, 1997, NATURE, V389, P526, DOI 10.1038/39116; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collins S, 1999, LANCET, V353, P693, DOI 10.1016/S0140-6736(98)08138-0; Glatzel M, 2002, LANCET, V360, P139, DOI 10.1016/S0140-6736(02)09384-4; Hill AF, 1997, LANCET, V349, P99, DOI 10.1016/S0140-6736(97)24002-X; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hill AF, 2003, BRAIN, V126, P1333, DOI 10.1093/brain/awg125; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Joiner S, 2002, J NEUROL NEUROSUR PS, V73, P597, DOI 10.1136/jnnp.73.5.597; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Nakamura Y, 2000, EPIDEMIOL INFECT, V125, P201, DOI 10.1017/S0950268899004240; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rossetti AO, 2003, J NEUROL, V250, P491, DOI 10.1007/s00415-003-1006-3; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Wadsworth JDF, 1999, NAT CELL BIOL, V1, P55, DOI 10.1038/9030; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Windl O, 1999, HUM GENET, V105, P244, DOI 10.1007/s004390051096; Zanusso G, 2001, BRAIN PATHOL, V11, P182	31	266	274	0	9	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2003	349	19					1812	1820		10.1056/NEJMoa030351	http://dx.doi.org/10.1056/NEJMoa030351			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739NR	14602879				2022-12-24	WOS:000186353800005
J	Marshall, CH; Pielke, RA; Steyaert, LT				Marshall, CH; Pielke, RA; Steyaert, LT			Wetlands: Crop freezes and land-use change in Florida	NATURE			English	Editorial Material									Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA; US Geol Survey, EROS Data Ctr, Greenbelt, MD 20771 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	Colorado State University; United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Marshall, CH (corresponding author), Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA.		Pielke, Roger A/A-5015-2009					Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Miller K.A., 1991, CLIM RES, V1, P133, DOI DOI 10.3354/CR001133; Walko RL, 2000, J APPL METEOROL, V39, P931, DOI 10.1175/1520-0450(2000)039<0931:CABHMF>2.0.CO;2; [No title captured]; [No title captured]; [No title captured]	6	36	37	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2003	426	6962					29	30		10.1038/426029a	http://dx.doi.org/10.1038/426029a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603304				2022-12-24	WOS:000186370800028
J	Rak, A; Pylypenko, O; Durek, T; Watzke, A; Kushnir, S; Brunsveld, L; Waldmann, H; Goody, RS; Alexandrov, K				Rak, A; Pylypenko, O; Durek, T; Watzke, A; Kushnir, S; Brunsveld, L; Waldmann, H; Goody, RS; Alexandrov, K			Structure of Rab GDP-dissociation inhibitor in complex with prenylated YPT1 GTPase	SCIENCE			English	Article							IN-VITRO; PROTEINS; DOMAIN; GERANYLGERANYLTRANSFERASE; GDI1	Rab/Ypt guanosine triphosphatases (GTPases) represent a family of key membrane traffic regulators in eukaryotic cells whose function is governed by the guanosine diphosphate (GDP) dissociation inhibitor (RabGDI). Using a combination of chemical synthesis and protein engineering, we generated and crystallized the monoprenylated Ypt1: RabGDI complex. The structure of the complex was solved to 1.5 angstrom resolution and provides a structural basis for the ability of RabGDI to inhibit the release of nucleotide by Rab proteins. Isoprenoid binding requires a conformational change that opens a cavity in the hydrophobic core of its domain II. Analysis of the structure provides a molecular basis for understanding a RabGDI mutant that causes mental retardation in humans.	Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany; Max Planck Inst Mol Physiol, Dept Biol Chem, D-44227 Dortmund, Germany; Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany; Univ Dortmund, Dept Organ Chem, D-44227 Dortmund, Germany	Max Planck Society; Max Planck Society; Max Planck Society; Dortmund University of Technology	Alexandrov, K (corresponding author), Max Planck Inst Mol Physiol, Dept Phys Biochem, Otto Hahn Str 11, D-44227 Dortmund, Germany.		Alexandrov, Kirill/A-5830-2013; Durek, Thomas/I-8715-2014; Waldmann, Herbert/B-7406-2017; Goody, Roger S/J-8845-2014	Alexandrov, Kirill/0000-0002-0957-6511; Durek, Thomas/0000-0003-0686-227X; Waldmann, Herbert/0000-0002-9606-7247; Goody, Roger S/0000-0002-0772-0444; Brunsveld, Luc/0000-0001-5675-511X; Pylypenko, Olena/0000-0001-7073-5238				Alexandrov K, 2002, J AM CHEM SOC, V124, P5648, DOI 10.1021/ja017799e; Alory C, 2001, TRAFFIC, V2, P532, DOI 10.1034/j.1600-0854.2001.20803.x; An Y, 2003, STRUCTURE, V11, P347, DOI 10.1016/S0969-2126(03)00034-0; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; Constantinescu AT, 2002, STRUCTURE, V10, P569, DOI 10.1016/S0969-2126(02)00737-2; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; GARRETT MD, 1994, EMBO J, V13, P1718, DOI 10.1002/j.1460-2075.1994.tb06436.x; Gilbert PM, 2001, J BIOL CHEM, V276, P8014, DOI 10.1074/jbc.M008845200; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; HORIUCHI H, 1995, METHOD ENZYMOL, V257, P9; Kalinin A, 2001, PROTEIN EXPRES PURIF, V22, P84, DOI 10.1006/prep.2001.1423; Luan P, 2000, TRAFFIC, V1, P270, DOI 10.1034/j.1600-0854.2000.010309.x; Ludolph B, 2002, J AM CHEM SOC, V124, P5954, DOI 10.1021/ja025768t; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Pylypenko O, 2003, MOL CELL, V11, P483, DOI 10.1016/S1097-2765(03)00044-3; RAK A, UNPUB; Ricard CS, 2001, GENESIS, V31, P17, DOI 10.1002/gene.10000; Sakisaka T, 2002, EMBO J, V21, P6125, DOI 10.1093/emboj/cdf603; Schalk I, 1996, NATURE, V381, P42, DOI 10.1038/381042a0; Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8; Shen F, 1996, J BIOL CHEM, V271, P3692; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	25	158	163	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					646	650		10.1126/science.1087761	http://dx.doi.org/10.1126/science.1087761			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576435				2022-12-24	WOS:000186119900060
J	Qin, L; Kudla, U; Roze, EHA; Goverse, A; Popeijus, H; Nieuwland, J; Overmars, H; Jones, JT; Schots, A; Smant, G; Bakker, J; Helder, J				Qin, L; Kudla, U; Roze, EHA; Goverse, A; Popeijus, H; Nieuwland, J; Overmars, H; Jones, JT; Schots, A; Smant, G; Bakker, J; Helder, J			Plant degradation: A nematode expansin acting on plants	NATURE			English	Editorial Material							CELL WALLS		Univ Wageningen & Res Ctr, Nematol Lab, Grad Sch Expt Plant Sci, NL-6709 PD Wageningen, Netherlands; Univ Wageningen & Res Ctr, Lab Mol Recognit & Antibody Technol, Grad Sch Expt Plant Sci, NL-6709 PD Wageningen, Netherlands; Catholic Univ Nijmegen, Grad Sch Expt Plant Sci, Dept Expt Bot, NL-6525 ED Nijmegen, Netherlands; Scottish Crop Res Inst, Plant Pathogen Interact Programme, Dundee DD2 5DA, Scotland	Wageningen University & Research; Wageningen University & Research; Radboud University Nijmegen; James Hutton Institute	Qin, L (corresponding author), Univ Wageningen & Res Ctr, Nematol Lab, Grad Sch Expt Plant Sci, NL-6709 PD Wageningen, Netherlands.	hans.helder@wur.nl	Schots, Arjen/ABF-8014-2020; Schots, Arjen/U-1839-2017	Schots, Arjen/0000-0002-6036-7088; Schots, Arjen/0000-0002-6036-7088; Jones, John/0000-0003-2074-0551				Cosgrove DJ, 2000, CURR OPIN PLANT BIOL, V3, P73, DOI 10.1016/S1369-5266(99)00039-4; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Davies M, 2000, S AFR J SURG, V38, P3; Jaubert S, 2002, FEBS LETT, V522, P109, DOI 10.1016/S0014-5793(02)02906-X; Laine MJ, 2000, PHYSIOL MOL PLANT P, V57, P221, DOI 10.1006/pmpp.2000.0301; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; Popeijus H, 2000, NATURE, V406, P36, DOI 10.1038/35017641; Qin L, 2000, MOL PLANT MICROBE IN, V13, P830, DOI 10.1094/MPMI.2000.13.8.830; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Xu BZ, 2000, EUR J BIOCHEM, V267, P4970, DOI 10.1046/j.1432-1327.2000.01533.x	10	152	174	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2004	427	6969					30	30		10.1038/427030a	http://dx.doi.org/10.1038/427030a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YP	14702076	Bronze			2022-12-24	WOS:000187710000024
J	Tian, E; Zhan, FH; Walker, R; Rasmussen, E; Ma, YP; Barlogie, B; Shaughnessy, JD				Tian, E; Zhan, FH; Walker, R; Rasmussen, E; Ma, YP; Barlogie, B; Shaughnessy, JD			The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE MORPHOGENETIC PROTEIN-2; RECEPTOR-RELATED PROTEIN-5; GLOBAL GENE-EXPRESSION; STEM-CELL NICHE; OSTEOCLAST DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; QUANTITATIVE HISTOLOGY; MONOCLONAL GAMMOPATHY; LIGAND; OSTEOPROTEGERIN	Background: Myeloma cells may secrete factors that affect the function of osteoblasts, osteoclasts, or both. Methods: We subjected purified plasma cells from the bone marrow of patients with newly diagnosed multiple myeloma and control subjects to oligonucleotide microarray profiling and biochemical and immunohistochemical analyses to identify molecular determinants of osteolytic lesions. Results: We studied 45 control subjects, 36 patients with multiple myeloma in whom focal lesions of bone could not be detected by magnetic resonance imaging (MRI), and 137 patients in whom MRI detected such lesions. Different patterns of expression of 57 of approximately 10,000 genes from purified myeloma cells could be used to distinguish the two groups of patients (P<0.001). Permutation analysis, which adjusts the significance level to account for multiple comparisons in the data sets, showed that 4 of these 57 genes were significantly overexpressed by plasma cells from patients with focal lesions. One of these genes, dickkopf 1 (DKK1), and its corresponding protein (DKK1) were studied in detail because DKK1 is a secreted factor that has been linked to the function of osteoblasts. Immunohistochemical analysis of bone marrow-biopsy specimens showed that only myeloma cells contained detectable DKK1. Elevated DKK1 levels in bone marrow plasma and peripheral blood from patients with multiple myeloma correlated with the gene-expression patterns of DKK1 and were associated with the presence of focal bone lesions. Recombinant human DKK1 or bone marrow serum containing an elevated level of DKK1 inhibited the differentiation of osteoblast precursor cells in vitro. Conclusions: The production of DKK1, an inhibitor of osteoblast differentiation, by myeloma cells is associated with the presence of lytic bone lesions in patients with multiple myeloma.	Univ Arkansas Med Sci, Donna D & Donald M Lambert Lab Myeloma Genet, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Coll Med, Dept Radiol, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Coll Med, Dept Pathol, Little Rock, AR 72205 USA; Canc Res & Biostat, Seattle, WA USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Cancer Research & Biostatistics	Shaughnessy, JD (corresponding author), Univ Arkansas Med Sci, Donna D & Donald M Lambert Lab Myeloma Genet, Myeloma Inst Res & Therapy, 4301 W Markham St 776, Little Rock, AR 72205 USA.			Zhan, Fenghuang/0000-0001-6208-1676	NATIONAL CANCER INSTITUTE [R33CA097513, P01CA055819] Funding Source: NIH RePORTER; NCI NIH HHS [CA55819, CA97513] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Atkins GJ, 2003, J BONE MINER RES, V18, P1088, DOI 10.1359/jbmr.2003.18.6.1088; Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0; BARLOGIE B, IN PRESS BLOOD; BATAILLE R, 1990, BRIT J HAEMATOL, V76, P484, DOI 10.1111/j.1365-2141.1990.tb07904.x; BATAILLE R, 1986, BRIT J CANCER, V53, P805, DOI 10.1038/bjc.1986.136; BATAILLE R, 1991, J CLIN INVEST, V88, P62, DOI 10.1172/JCI115305; Berenson JR, 1996, NEW ENGL J MED, V334, P488, DOI 10.1056/NEJM199602223340802; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Fedi P, 1999, J BIOL CHEM, V274, P19465, DOI 10.1074/jbc.274.27.19465; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Grotewold L, 2002, EMBO J, V21, P966, DOI 10.1093/emboj/21.5.966; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; KATAGIRI T, 1995, J CELL BIOL, V128, pA713; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Roodman GD, 2001, J CLIN ONCOL, V19, P3562, DOI 10.1200/JCO.2001.19.15.3562; ROUX C, 1994, BONE, V15, P41, DOI 10.1016/8756-3282(94)90890-7; Sezer O, 2003, BLOOD, V101, P2094, DOI 10.1182/blood-2002-09-2684; Shaughnessy J, 2003, BLOOD, V101, P3849, DOI 10.1182/blood-2002-09-2873; Spinella-Jaegle S, 2001, BONE, V29, P323, DOI 10.1016/S8756-3282(01)00580-4; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; TAUBE T, 1992, EUR J HAEMATOL, V49, P192; Terpos E, 2003, BLOOD, V102, P1064, DOI 10.1182/blood-2003-02-0380; VALENTINOPRAN A, 1982, BRIT J HAEMATOL, V52, P601, DOI 10.1111/j.1365-2141.1982.tb03936.x; Westfall P. H., 1993, RESAMPLING BASED MUL, P360; Yaccoby S, 2002, BLOOD, V100, p607A; Zhan FH, 2003, BLOOD, V101, P1128, DOI 10.1182/blood-2002-06-1737; Zhan FH, 2002, BLOOD, V99, P1745, DOI 10.1182/blood.V99.5.1745; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	41	1111	1223	0	59	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2003	349	26					2483	2494		10.1056/NEJMoa030847	http://dx.doi.org/10.1056/NEJMoa030847			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757BT	14695408				2022-12-24	WOS:000187529500003
J	Weitz, G				Weitz, G			Love and death in Wagner's Tristan und Isolde - an epic anticholinergic crisis	BRITISH MEDICAL JOURNAL			English	Article							NIGHTSHADE; INGESTION		Med Univ Schleswig Holstein, Dept Internal Med 1, D-23538 Lubeck, Germany	University of Kiel; Schleswig Holstein University Hospital	Weitz, G (corresponding author), Med Univ Schleswig Holstein, Dept Internal Med 1, Campus Lubeck,Ratzeburger Allee 160, D-23538 Lubeck, Germany.							BETZ P, 1991, Archiv fuer Kriminologie, V188, P175; Carter AJ, 1996, BRIT MED J, V313, P1630, DOI 10.1136/bmj.313.7072.1630; Chessick RD, 1990, PSYCHOANALYTIC EXPLO, P465; COSMAN MP, 1983, ANNU REV NUTR, V3, P1, DOI 10.1146/annurev.nu.03.070183.000245; FUHNER H, 1926, ARCH EXP PATHOL PH, V111, P281; GEDIMAN HK, 1981, J AM PSYCHOANAL ASS, V29, P607, DOI 10.1177/000306518102900306; GOLDSMITH SR, 1968, J AMER MED ASSOC, V204, P169, DOI 10.1001/jama.204.2.169; GOWDY JM, 1972, J AMER MED ASSOC, V221, P585, DOI 10.1001/jama.221.6.585; HAULE J, 1990, DIVINE MADNESS ARCHE; HILL C, 1984, MUSIC REV, V45, P7; JACKSON S W, 1972, Journal of the History of Medicine and Allied Sciences, V27, P262; Karras DJ, 1996, AM J EMERG MED, V14, P478, DOI 10.1016/S0735-6757(96)90158-8; KNAPP R, 1984, MUS REV, V45, P10; MIKOLICH JR, 1975, ANN INTERN MED, V83, P321, DOI 10.7326/0003-4819-83-3-321; Muller JL, 1998, J TOXICOL-CLIN TOXIC, V36, P617, DOI 10.3109/15563659809028060; OBER PC, 1965, MONATSHEFTE DEUTSCHU, V57, P321; PAHLEN K, 1983, R WAGNER TRISTAN ISO; PIOMELLI D, 1994, HIST PHIL LIFE SCI, V16, P241; RICHEY J, 1994, MUS REV, V55, P97; SHAMPO MA, 1992, MAYO CLIN PROC, V67, P477, DOI 10.1016/S0025-6196(12)60396-6; Shannon M, 1999, J TOXICOL-CLIN TOXIC, V37, P709, DOI 10.1081/CLT-100102448; Volger Gisela, 1982, RAUSCH REALITAT DROG	22	7	7	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1469	1471		10.1136/bmj.327.7429.1469	http://dx.doi.org/10.1136/bmj.327.7429.1469			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684652	Green Published			2022-12-24	WOS:000187562700023
J	Venter, H; Shilling, RA; Velamakanni, S; Balakrishnan, L; van Veen, HW				Venter, H; Shilling, RA; Velamakanni, S; Balakrishnan, L; van Veen, HW			An ABC transporter with a secondary-active multidrug translocator domain	NATURE			English	Article							P-GLYCOPROTEIN; FUNCTIONAL RECONSTITUTION; ANTIBIOTIC-RESISTANCE; LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; INTRACELLULAR PH; DRUG TRANSPORT; BACTERIA; HOMOLOG; MSBA	Multidrug resistance, by which cells become resistant to multiple unrelated pharmaceuticals, is due to the extrusion of drugs from the cell's interior by active transporters such as the human multidrug resistance beta-glycoprotein(1). Two major classes of transporters mediate this extrusion(2,3). Primary-active transporters are dependent on ATP hydrolysis, whereas secondary-active transletters porters are driven by electrochemical ion gradients that exist across the plasma membrane. The ATP-binding cassette (ABC) transporter LmrA(4) is a primary drug transporter in Lactococcus lactis that can functionally substitute for P-glycoprotein in lung fibroblast cells(5). Here we have engineered a truncated LmrA protein that lacks the ATP-binding domain. Surprisingly, this truncated protein mediates a proton-ethidium symport reaction without the requirement for ATP. In other words, it functions as a secondary-active multidrug uptake system. These findings suggest that the evolutionary precursor of LmrA was a secondary-active substrate translocator that acquired an ATP-binding domain to enable primary-active multidrug efflux in L. lactis.	Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	van Veen, HW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.		van Veen, Hendrik W./A-4162-2008; Venter, Rietie/E-4795-2013	van Veen, Hendrik W./0000-0002-9658-8077; Venter, Rietie/0000-0001-5569-7755				Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; [Anonymous], [No title captured]; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Breeuwer P, 1996, APPL ENVIRON MICROB, V62, P178, DOI 10.1128/AEM.62.1.178-183.1996; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; Chang G, 2003, J MOL BIOL, V330, P419, DOI 10.1016/S0022-2836(03)00587-4; Eytan GD, 1996, J BIOL CHEM, V271, P3172, DOI 10.1074/jbc.271.6.3172; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cellbio.8.1.67; Howard EM, 2003, BIOCHEMISTRY-US, V42, P3544, DOI 10.1021/bi026706i; Janvilisri T, 2003, J BIOL CHEM, V278, P20645, DOI 10.1074/jbc.M301358200; KABACK HR, 1990, BACTERIA, V12, P151; KROLL RG, 1983, BIOCHEM J, V216, P709, DOI 10.1042/bj2160709; Kuroda M, 1997, J BIOL CHEM, V272, P326; Landwojtowicz E, 2002, BIOCHEMISTRY-US, V41, P8050, DOI 10.1021/bi025720s; Margolles A, 1999, BIOCHEMISTRY-US, V38, P16298, DOI 10.1021/bi990855s; Novo D, 1999, CYTOMETRY, V35, P55, DOI 10.1002/(SICI)1097-0320(19990101)35:1<55::AID-CYTO8>3.0.CO;2-2; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Putman M, 2000, MOL MICROBIOL, V36, P772, DOI 10.1046/j.1365-2958.2000.01871.x; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; Santai CT, 1999, BIOCHEMISTRY-US, V38, P4227, DOI 10.1021/bi981930m; SHAROM FJ, 1993, J BIOL CHEM, V268, P24197; THIEBAUT F, 1990, J HISTOCHEM CYTOCHEM, V38, P685, DOI 10.1177/38.5.1692055; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503; van Veen HW, 1998, NATURE, V391, P291, DOI 10.1038/34669; VANVEEN HW, 1993, J BIOL CHEM, V268, P19377; VanVeen HW, 1996, P NATL ACAD SCI USA, V93, P10668, DOI 10.1073/pnas.93.20.10668	26	96	98	3	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					866	870		10.1038/nature02173	http://dx.doi.org/10.1038/nature02173			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685244				2022-12-24	WOS:000187342000065
J	Hendrikson, CA; Howell, EE; Bush, DE; Miles, JS; Meininger, GR; Friedlander, T; Bushnell, AC; Chandra-Strobos, N				Hendrikson, CA; Howell, EE; Bush, DE; Miles, JS; Meininger, GR; Friedlander, T; Bushnell, AC; Chandra-Strobos, N			Chest pain relief by nitroglycerin does not predict active coronary artery disease	ANNALS OF INTERNAL MEDICINE			English	Article							ASSOCIATION TASK-FORCE; PRACTICE GUIDELINES COMMITTEE; RANDOMIZED-TRIAL; AMERICAN-COLLEGE; MYOCARDIAL-INFARCTION; EMERGENCY-DEPARTMENT; ACC/AHA GUIDELINES; UNSTABLE ANGINA; DIAGNOSIS; MANAGEMENT	Background: The belief that chest pain relief with nitroglycerin Indicates the presence of active coronary artery disease is common. However, this hypothesis has not been tested. Objective: To define the diagnostic and prognostic value of chest pain relief with nitroglycerin. Design: Prospective observational cohort study. Setting: urban community teaching hospital. Patients: 459 consecutive patients with chest pain admitted through the emergency department who received nitroglycerin from emergency services personnel or an emergency department nurse. Follow-up was obtained by telephone contact at 4 months. Measurements: Chest pain relief was defined as a decrease of at least 50% in patients' self-reported pain within 5 minutes of the Initial dose of sublingual or spray nitroglycerin. Active coronary artery disease was defined as any elevated serum enzyme levels, coronary angiography demonstrating a 70% or greater stenosis, or a positive exercise test result. Results: Nitroglycerin relieved chest pain in 39% of patients (181 of 459). In patients with active coronary artery disease as the likely cause of their chest pain, 35% (49 of 141) had chest pain relief with nitroglycerin. In contrast, in patients without active coronary artery disease, 41% (113 of 275) had chest pain relief (P > 0.2). Four-month clinical outcomes were similar in patients with or without chest pain relief with nitroglycerin (P > 0.2). Conclusions: These data suggest that, in a general population admitted for chest pain, relief of pain after nitroglycerin treatment does not predict active coronary artery disease and should not be used to guide diagnosis.	Johns Hopkins Bayview Med Ctr, Div Cardiol, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine	Chandra-Strobos, N (corresponding author), Johns Hopkins Bayview Med Ctr, Div Cardiol, 4940 Eastern Ave, Baltimore, MD 21224 USA.	nchandra@jhmi.edu	Friedlander, Tracy/AFK-5288-2022; Friedlander, Tracy/AAG-3839-2022		NHLBI NIH HHS [T32-HLO7227-26] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007227] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AG HLTH CAR POL R, 1992, CLIN PRACT GUID AC P; *AM HEART ASS, 2001, HEART STROK STAT UPD; *AM HEART ASS, 2002, WHAT IS ANG; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; Braunwald E, 2000, CIRCULATION, V102, P1193, DOI 10.1161/01.CIR.102.10.1193; CALIFF RM, 2003, ACUTE CORONARY SYNDR; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Decker WW, 2003, ANN EMERG MED, V41, P342, DOI 10.1067/mem.2003.78; DIAMOND GA, 1980, J CLIN INVEST, V65, P1210, DOI 10.1172/JCI109776; DIAMOND GA, 1983, J AM COLL CARDIOL, V1, P474; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Engelberg S, 2000, Prehosp Emerg Care, V4, P290, DOI 10.1080/10903120090940967; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; GOLDMAN L, 1982, NEW ENGL J MED, V307, P588, DOI 10.1056/NEJM198209023071004; Goodacre S, 2002, ACAD EMERG MED, V9, P203; Goodman SG, 2000, J AM COLL CARDIOL, V36, P693, DOI 10.1016/S0735-1097(00)00808-1; Goyal RK, 1996, ANN INTERN MED, V124, P1008, DOI 10.7326/0003-4819-124-11-199606010-00010; KAUL S, 1994, ANN INTERN MED, V121, P976, DOI 10.7326/0003-4819-121-12-199412150-00013; LEE TH, 2001, HARRISONS PRINCIPLES, P60; Mathew V, 2001, J AM COLL CARDIOL, V37, P2053, DOI 10.1016/S0735-1097(01)01291-8; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; Shry EA, 2002, AM J CARDIOL, V90, P1264, DOI 10.1016/S0002-9149(02)02850-3; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Simoons ML, 2001, LANCET, V357, P1915; SOX HC, 1981, ANN INTERN MED, V95, P680, DOI 10.7326/0003-4819-95-6-680; Storrow AB, 2000, ANN EMERG MED, V35, P449, DOI 10.1067/mem.2000.105601; Wallentin L, 2000, LANCET, V356, P9, DOI 10.1016/S0140-6736(00)02427-2; WEINER DA, 1979, NEW ENGL J MED, V301, P230, DOI 10.1056/NEJM197908023010502; Zarich SW, 2002, CLIN CHIM ACTA, V326, P185, DOI 10.1016/S0009-8981(02)00303-0	31	66	67	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2003	139	12					979	986		10.7326/0003-4819-139-12-200312160-00007	http://dx.doi.org/10.7326/0003-4819-139-12-200312160-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	756AG	14678917				2022-12-24	WOS:000187443200003
J	Ito, A; Nakao, M; Wandra, T				Ito, A; Nakao, M; Wandra, T			Human taeniasis and cysticercosis in Asia	LANCET			English	Review							IRIAN-JAYA; PHYLOGENETIC HYPOTHESIS; SOLIUM; INDONESIA; PAPUA; TAENIASIS/CYSTICERCOSIS; JAYAWIJAYA; TAPEWORMS; DIAGNOSIS; GENOTYPES	Context Human taeniasis caused by the pork, Taenia solium, or beef, T saginata, tapeworm arises after eating pork or beef contaminated with metacestodes, the larval stage of these parasites. Taeniasis with T solium can lead to neurocysticercosis and threaten others by accidental ingestion of eggs released from asymptomatic taeniasis patients. The 2003 World Health Assembly declared that T solium is of worldwide public-health importance, and that it is an eradicable parasitic disease worldwide. Adult taeniid tapeworms expelled from people in almost all Asian countries appeared to be T saginata (the so-called Asian Taenia), even though they ate pork. The organism is now named T asiatica, and has been found in Taiwan, Korea, China, Vietnam, and Indonesia. But it has been difficult to differentiate T saginata from beef and Asian Taenia from pork. Starting point Marshall Lightowlers and colleagues (Int J Parasitol 2003; 33: 1207-17) recently demonstrated that recombinant oncosphere vaccines against several taeniid cestodes, including T ovis, T saginata, T solium, and Echinococcus granulosus, are highly effective. Protection was almost 100%, in the laboratory and in the field. These researchers found several common features, including a predicted secretory signal sequence, and one or two copies of a fibronectin type III domain, each encoded by separate exons within the associated gene. Where next? Molecular and immunological techniques, including vaccine research and development of animal models for differentiation of taeniid species in humans, have greatly advanced over the past decade. The clinical importance of infections by these taeniids, including T asiatica, in humans, and the potential for cysticercosis attributable to T asiatica in humans, needs further study.	Asahikawa Med Coll, Dept Parasitol, Asahikawa, Hokkaido 0788510, Japan; Minist Hlth, Directorate Gen Communicable Dis Control & Enviro, Jakarta, Indonesia	Asahikawa Medical College; Ministry of Health - Indonesia	Ito, A (corresponding author), Asahikawa Med Coll, Dept Parasitol, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan.	akiraito@asahikawa-med.ac.jp	Ito, A./E-9377-2014; WANDRA, TONI/AAD-5736-2021	Ito, A./0000-0002-5070-9187; Wandra, Toni/0000-0002-4606-5411				[Anonymous], [No title captured]; de Queiroz A, 1998, J PARASITOL, V84, P379, DOI 10.2307/3284501; Eom Keeseon S., 1993, Korean Journal of Parasitology, V31, P1, DOI 10.3347/kjp.1993.31.1.1; Eom KS, 2002, J PARASITOL, V88, P758, DOI 10.1645/0022-3395(2002)088[0758:IOTAIC]2.0.CO;2; FAN PC, 1988, PARASITOL TODAY, V4, P86, DOI 10.1016/0169-4758(88)90204-9; Gonzalez AE, 2003, ACTA TROP, V87, P103, DOI 10.1016/S0001-706X(03)00025-1; GUJDUSEK DC, 1978, PNG MED J, V21, P329; Hoberg EP, 2002, MICROBES INFECT, V4, P859, DOI 10.1016/S1286-4579(02)01606-4; Hoberg EP, 2001, P ROY SOC B-BIOL SCI, V268, P781, DOI 10.1098/rspb.2000.1579; Hoberg EP, 2000, J PARASITOL, V86, P89, DOI 10.1645/0022-3395(2000)086[0089:APHFSO]2.0.CO;2; Ito A, 2001, Southeast Asian J Trop Med Public Health, V32 Suppl 2, P85; Ito A, 2003, ACTA TROP, V87, P95, DOI 10.1016/S0001-706X(03)00024-X; Ito A, 2003, TRENDS PARASITOL, V19, P377, DOI 10.1016/S1471-4922(03)00200-9; Ito A, 2003, ACTA TROP, V86, P3, DOI 10.1016/S0001-706X(02)00269-3; Ito A, 2002, J HELMINTHOL, V76, P311, DOI 10.1079/JOH2002128; ITO A, 1992, PARASITOL TODAY, V8, P182, DOI 10.1016/0169-4758(92)90259-5; Lightowlers MW, 2003, INT J PARASITOL, V33, P1207, DOI 10.1016/S0020-7519(03)00174-7; Margono SS, 2003, J HELMINTHOL, V77, P39, DOI 10.1079/JOH2002146; Nakao M, 2002, MITOCHONDRION, V1, P497, DOI 10.1016/S1567-7249(02)00040-5; Nakao M, 2002, PARASITOLOGY, V124, P657, DOI 10.1017/S0031182002001725; Nakao M, 2000, MOL BIOCHEM PARASIT, V111, P415, DOI 10.1016/S0166-6851(00)00334-0; Nakao M, 2003, INFECT GENET EVOL, V3, P159, DOI 10.1016/S1567-1348(03)00070-4; Pawlowski Zbigniew S., 2002, P1, DOI 10.1079/9780851996288.0001; RAJSHEKHAR V, 2000, SOLITARY CYSTICERCUS; Schantz PM, 1998, EMERG INFECT DIS, V2, P213, DOI [10.1128/9781555816957.ch12, DOI 10.1128/9781555816957.CH12]; Simanjuntak GM, 1997, PARASITOL TODAY, V13, P321, DOI 10.1016/S0169-4758(97)01104-6; Singh Gagandeep, 2002, P111, DOI 10.1079/9780851996288.0111; Subahar R, 2001, T ROY SOC TROP MED H, V95, P388, DOI 10.1016/S0035-9203(01)90190-7; Sutisna IP, 1999, TROP MED INT HEALTH, V4, P288, DOI 10.1046/j.1365-3156.1999.00394.x; Wandra T, 2000, T ROY SOC TROP MED H, V94, P46, DOI 10.1016/S0035-9203(00)90433-4; Wandra T, 2003, EMERG INFECT DIS, V9, P884; Willingham A Lee 3rd, 2003, Southeast Asian J Trop Med Public Health, V34 Suppl 1, P35; Yamasaki H, 2002, J CLIN MICROBIOL, V40, P3818, DOI 10.1128/JCM.40.10.3818-3821.2002; YAMASAKI H, IN PRESS J CLIN MICR	34	117	121	1	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2003	362	9399					1918	1920		10.1016/S0140-6736(03)14965-3	http://dx.doi.org/10.1016/S0140-6736(03)14965-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667751	Green Submitted			2022-12-24	WOS:000187011600025
J	Willingham, S; Outeiro, TF; DeVit, MJ; Lindquist, SL; Muchowski, PJ				Willingham, S; Outeiro, TF; DeVit, MJ; Lindquist, SL; Muchowski, PJ			Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; PARKINSONS-DISEASE; DROSOPHILA MODEL; SCA1 MICE; NEURODEGENERATION; MUTATION; SUPPRESSION; EXPRESSION; PROTEINS; HSP70	Genome-wide screens were performed in yeast to identify genes that enhance the toxicity of a mutant huntingtin fragment or of alpha-synuclein. Of 4850 haploid mutants containing deletions of nonessential genes, 52 were identified that were sensitive to a mutant huntingtin fragment, 86 that were sensitive to alpha-synuclein, and only one mutant that was sensitive to both. Genes that enhanced toxicity of the mutant huntingtin fragment clustered in the functionally related cellular processes of response to stress, protein folding, and ubiquitin-dependent protein catabolism, whereas genes that modified alpha-synuclein toxicity clustered in the processes of lipid metabolism and vesicle-mediated transport. Genes with human orthologs were overrepresented in our screens, suggesting that we may have discovered conserved and nonoverlapping sets of cell-autonomous genes and pathways that are relevant to Huntington's disease and Parkinson's disease.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Muchowski, PJ (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.		Outeiro, Tiago F/C-1067-2008; Outeiro, Tiago/L-7351-2019; Outeiro, Tiago/M-8106-2019	Outeiro, Tiago F/0000-0003-1679-1727; Outeiro, Tiago/0000-0003-1679-1727; 				Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Botstein D, 1997, SCIENCE, V277, P1259, DOI 10.1126/science.277.5330.1259; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.3.CO;2-5; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Scherzer CR, 2003, HUM MOL GENET, V12, P2457, DOI 10.1093/hmg/ddg265; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	30	324	341	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1769	1772		10.1126/science.1090389	http://dx.doi.org/10.1126/science.1090389			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657499				2022-12-24	WOS:000186970100049
J	Moller, C				Moller, C			Deafblindness: living with sensory deprivation	LANCET			English	Article									Sahlgrens Univ Hosp, Dept Audiol, S-41345 Gothenburg, Sweden	Sahlgrenska University Hospital	Moller, C (corresponding author), Sahlgrens Univ Hosp, Dept Audiol, S-41345 Gothenburg, Sweden.								0	34	35	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S46	S47						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698128				2022-12-24	WOS:000187790200024
J	Topol, EJ; Lauer, MS				Topol, EJ; Lauer, MS			The rudimentary phase of personalised medicine: coronary risk scores	LANCET			English	Editorial Material							CARDIOVASCULAR-DISEASE; PREDICTION		Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Topol, EJ (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.		Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177; Topol, Eric/0000-0002-1478-4729				Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; *NAT CHOL ED PROGR, RISK ASS TOOL EST 10; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	7	26	26	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 29	2003	362	9398					1776	1777		10.1016/S0140-6736(03)14941-0	http://dx.doi.org/10.1016/S0140-6736(03)14941-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654312				2022-12-24	WOS:000186872900005
J	Zheng, M; Jagota, A; Strano, MS; Santos, AP; Barone, P; Chou, SG; Diner, BA; Dresselhaus, MS; McLean, RS; Onoa, GB; Samsonidze, GG; Semke, ED; Usrey, M; Walls, DJ				Zheng, M; Jagota, A; Strano, MS; Santos, AP; Barone, P; Chou, SG; Diner, BA; Dresselhaus, MS; McLean, RS; Onoa, GB; Samsonidze, GG; Semke, ED; Usrey, M; Walls, DJ			Structure-based carbon nanotube sorting by sequence-dependent DNA assembly	SCIENCE			English	Article							SEPARATION	Wrapping of carbon nanotubes (CNTs) by single-stranded DNA (ssDNA) was found to be sequence-dependent. A systematic search of the ssDNA library selected a sequence d(GT) n, n = 10 to 45 that self-assembles into a helical structure around individual nanotubes in such a way that the electrostatics of the DNA-CNT hybrid depends on tube diameter and electronic properties, enabling nanotube separation by anion exchange chromatography. Optical absorption and Raman spectroscopy show that early fractions are enriched in the smaller diameter and metallic tubes, whereas late fractions are enriched in the larger diameter and semiconducting tubes.	DuPont Co Inc, Cent Res & Dev, Expt Stn, Wilmington, DE 19880 USA; Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; MIT, Dept Phys Elect Engn & Comp Sci, Cambridge, MA 02139 USA; CDTN, CNEN, Ctr Desenvolvimento Tecnol Nucl, BR-30123970 Belo Horizonte, MG, Brazil	DuPont; University of Illinois System; University of Illinois Urbana-Champaign; Massachusetts Institute of Technology (MIT); Centro de Desenvolvimento da Tecnologia Nuclear (CDTN); Comissao Nacional de Energia Nuclear (CNEN)	Zheng, M (corresponding author), DuPont Co Inc, Cent Res & Dev, Expt Stn, Wilmington, DE 19880 USA.		Samsonidze, Georgy/G-3613-2016; Santos, Adelina/V-3087-2019	Samsonidze, Georgy/0000-0002-3759-1794; 				Avouris P, 2002, ACCOUNTS CHEM RES, V35, P1026, DOI 10.1021/ar010152e; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; BENEDICT LX, 1995, PHYS REV B, V52, P8541, DOI 10.1103/PhysRevB.52.8541; Chattopadhyay D, 2003, J AM CHEM SOC, V125, P3370, DOI 10.1021/ja028599l; Chattopadhyay D, 2002, J AM CHEM SOC, V124, P728, DOI 10.1021/ja0172159; Dai HJ, 2002, ACCOUNTS CHEM RES, V35, P1035, DOI 10.1021/ar0101640; Doorn SK, 2002, J AM CHEM SOC, V124, P3169, DOI 10.1021/ja012364c; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; Jackson J.D., 2007, CLASSICAL ELECTRODYN; Krupke R, 2003, SCIENCE, V301, P344, DOI 10.1126/science.1086534; Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253; Manning GS, 2002, BIOPHYS CHEM, V101, P461, DOI 10.1016/S0301-4622(02)00162-X; MANNING GS, 1978, Q REV BIOPHYS, V11, P179, DOI 10.1017/S0033583500002031; MARSH TC, 1995, NUCLEIC ACIDS RES, V23, P696, DOI 10.1093/nar/23.4.696; Niyogi S, 2002, ACCOUNTS CHEM RES, V35, P1105, DOI 10.1021/ar010155r; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Saito R., 1998, PHYS PROPERTIES CARB; Sauvajol JL, 2002, CARBON, V40, P1697, DOI 10.1016/S0008-6223(02)00010-6; Strano MS, 2003, NANO LETT, V3, P1091, DOI 10.1021/nl034196n; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877	21	1429	1498	5	498	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1545	1548		10.1126/science.1091911	http://dx.doi.org/10.1126/science.1091911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645843				2022-12-24	WOS:000186802200037
J	Kim, SJ; Kim, YS; Yuan, JP; Petralia, RS; Worley, PF; Linden, DJ				Kim, SJ; Kim, YS; Yuan, JP; Petralia, RS; Worley, PF; Linden, DJ			Activation of the TRPC1 cation channel by metabotropic glutamate receptor mGluR1	NATURE			English	Article							LONG-TERM DEPRESSION; SYNAPTIC ACTIVATION; CEREBELLAR; CONDUCTANCE; RELEASE; DEFICIT; HOMER	Group I metabotropic glutamate receptors (consisting of mGluR1 and mGluR5) are G-protein-coupled neurotransmitter receptors(1) that are found in the perisynaptic region of the postsynaptic membrane(2). These receptors are not activated by single synaptic volleys but rather require bursts of activity(3-5). They are implicated in many forms of neural plasticity including hippocampal long-term potentiation and depression(6-8), cerebellar long-term depression(8-11), associative learning(7,11), and cocaine addiction(12). When activated, group I mGluRs engage two G-protein-dependent signalling mechanisms: stimulation of phospholipase C and activation of an unidentified, mixed-cation excitatory postsynaptic conductance (EPSC), displaying slow activation, in the plasma membrane(4,5,13-15). Here we report that the mGluR1-evoked slow EPSC is mediated by the TRPC1 cation channel. TRPC1 is expressed in perisynaptic regions of the cerebellar parallel fibre-Purkinje cell synapse and is physically associated with mGluR1. Manipulations that interfere with TRPC1 block the mGluR1-evoked slow EPSC in Purkinje cells; however, fast transmission mediated by AMPA-type glutamate receptors remains unaffected. Furthermore, co-expression of mGluR1 and TRPC1 in a heterologous system reconstituted a mGluR1-evoked conductance that closely resembles the slow EPSC in Purkinje cells.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Kangwon Natl Univ, Sch Med, Dept Physiol, Chunchon 20071, South Korea; NIDCD, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Kangwon National University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	pworley@jhmi.edu; dlinden@jhmi.edu	Kim, Sang Jeong/J-2740-2012	Kim, Sang Jeong/0000-0001-8931-3713				AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; BATCHELOR AM, 1994, NEUROSCIENCE, V63, P911, DOI 10.1016/0306-4522(94)90558-4; Bortolotto ZA, 1999, CURR OPIN NEUROBIOL, V9, P299, DOI 10.1016/S0959-4388(99)80044-0; Canepari M, 2001, J PHYSIOL-LONDON, V533, P765, DOI 10.1111/j.1469-7793.2001.00765.x; Chiamulera C, 2001, NAT NEUROSCI, V4, P873, DOI 10.1038/nn0901-873; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Gee CE, 2003, J PHYSIOL-LONDON, V546, P655, DOI 10.1113/jphysiol.2002.032961; HARTMANN J, 2002, SOC NEUR ABSTR; Hirono M, 1998, BIOCHEM BIOPH RES CO, V251, P753, DOI 10.1006/bbrc.1998.9465; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; KANO M, 1987, NATURE, V325, P276, DOI 10.1038/325276a0; Knopfel T, 2000, EUR J NEUROSCI, V12, P2199, DOI 10.1046/j.1460-9568.2000.00122.x; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Miyata M, 2001, EUR J NEUROSCI, V13, P1945, DOI 10.1046/j.0953-816x.2001.01570.x; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Narasimhan K, 1998, J NEUROPHYSIOL, V80, P2963, DOI 10.1152/jn.1998.80.6.2963; NUSSER Z, 1994, NEUROSCIENCE, V61, P421, DOI 10.1016/0306-4522(94)90421-9; Petralia RS, 2001, EUR J NEUROSCI, V13, P1722, DOI 10.1046/j.0953-816x.2001.01553.x; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tabata T, 2002, MOL CELL NEUROSCI, V20, P56, DOI 10.1006/mcne.2002.1118; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Tempia F, 2001, J NEUROPHYSIOL, V86, P1389, DOI 10.1152/jn.2001.86.3.1389; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520; Tozzi A, 2003, EUR J NEUROSCI, V18, P2133, DOI 10.1046/j.1460-9568.2003.02936.x; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5	30	283	291	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2003	426	6964					285	291		10.1038/nature02162	http://dx.doi.org/10.1038/nature02162			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14614461	Bronze			2022-12-24	WOS:000186660800043
J	Pebay-Peyroula, E; Dahout-Gonzalez, C; Kahn, R; Trezeguet, V; Lauquin, GJM; Brandolin, R				Pebay-Peyroula, E; Dahout-Gonzalez, C; Kahn, R; Trezeguet, V; Lauquin, GJM; Brandolin, R			Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside	NATURE			English	Article							ADENINE-NUCLEOTIDE CARRIER; BEEF-HEART MITOCHONDRIA; ELECTRON-DENSITY MAPS; ADP ATP CARRIER; OXIDATIVE-PHOSPHORYLATION; LIVER MITOCHONDRIA; TRITON X-100; PROTEIN; YEAST; ATRACTYLOSIDE	ATP, the principal energy currency of the cell, fuels most biosynthetic reactions in the cytoplasm by its hydrolysis into ADP and inorganic phosphate. Because resynthesis of ATP occurs in the mitochondrial matrix, ATP is exported into the cytoplasm while ADP is imported into the matrix. The exchange is accomplished by a single protein, the ADP/ATP carrier. Here we have solved the bovine carrier structure at a resolution of 2.2 Angstrom by X-ray crystallography in complex with an inhibitor, carboxyatractyloside. Six alpha-helices form a compact transmembrane domain, which, at the surface towards the space between inner and outer mitochondrial membranes, reveals a deep depression. At its bottom, a hexapeptide carrying the signature of nucleotide carriers ( RRRMMM) is located. Our structure, together with earlier biochemical results, suggests that transport substrates bind to the bottom of the cavity and that translocation results from a transient transition from a 'pit' to a 'channel' conformation.	Univ Grenoble 1, CNRS, CEA, Inst Biol Struct,UMR 5075, F-38027 Grenoble 1, France; Univ Grenoble 1, CNRS,CEA,UMR 5092, Dept Reponse & Dynam Cellulaires, Lab Biochim & Biophys Syst Integres, F-38054 Grenoble, France; CNRS, Inst Biochim & Genet Cellulaires, Lab Physiol Mol & Cellulaire, UMR 5095, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Pebay-Peyroula, E (corresponding author), Univ Grenoble 1, CNRS, CEA, Inst Biol Struct,UMR 5075, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.			Trezeguet, Veronique/0000-0003-2487-7571				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; AQUILA H, 1982, H-S Z PHYSIOL CHEM, V363, P345; BECK JC, 1968, P NATL ACAD SCI USA, V60, P186, DOI 10.1073/pnas.60.1.186; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001; BLOCK MR, 1984, BIOCHIM BIOPHYS ACTA, V767, P369, DOI 10.1016/0005-2728(84)90207-X; BLOCK MR, 1982, BIOCHEM BIOPH RES CO, V109, P471, DOI 10.1016/0006-291X(82)91745-4; BOGNER W, 1986, EUR J BIOCHEM, V161, P611, DOI 10.1111/j.1432-1033.1986.tb10485.x; BRANDOLIN G, 1989, BIOCHEMISTRY-US, V28, P1093, DOI 10.1021/bi00429a025; BRANDOLIN G, 1985, BIOCHEMISTRY-US, V24, P1991, DOI 10.1021/bi00329a029; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNI A, 1964, NATURE, V201, P1219, DOI 10.1038/2011219a0; CANDY HA, 1977, PHYTOCHEMISTRY, V16, P1308, DOI 10.1016/S0031-9422(00)94388-7; CRAIG JC, 1976, PHYTOCHEMISTRY, V15, P1178, DOI 10.1016/0031-9422(76)85126-6; Denessiouk KA, 2000, PROTEINS, V38, P310, DOI 10.1002/(SICI)1097-0134(20000215)38:3<310::AID-PROT7>3.0.CO;2-T; Dianoux AC, 2000, BIOCHEMISTRY-US, V39, P11477, DOI 10.1021/bi000618l; DUEE ED, 1965, BIOCHIM BIOPHYS ACTA, V107, P184, DOI 10.1016/0304-4165(65)90419-8; DUYCKAERTS C, 1980, EUR J BIOCHEM, V106, P1; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Fiore C, 2001, CLIN CHIM ACTA, V311, P125, DOI 10.1016/S0009-8981(01)00581-2; Fiore C, 1998, BIOCHIMIE, V80, P137, DOI 10.1016/S0300-9084(98)80020-5; Gropp T, 1999, BIOPHYS J, V77, P714, DOI 10.1016/S0006-3495(99)76926-2; HACKENBERG H, 1980, BIOCHEMISTRY-US, V19, P548, DOI 10.1021/bi00544a024; Harrenga A, 1999, J BIOL CHEM, V274, P33296, DOI 10.1074/jbc.274.47.33296; HEDDI A, 1993, J BIOL CHEM, V268, P12156; HOLLOWAY PW, 1973, ANAL BIOCHEM, V53, P304, DOI 10.1016/0003-2697(73)90436-3; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; KLINGENBERG M, 1989, ARCH BIOCHEM BIOPHYS, V270, P1, DOI 10.1016/0003-9861(89)90001-5; KOVAC L, 1967, SCIENCE, V158, P1564, DOI 10.1126/science.158.3808.1564; Kunji ERS, 2003, J BIOL CHEM, V278, P36985, DOI 10.1074/jbc.C300304200; MAJIMA E, 1993, J BIOL CHEM, V268, P22181; Moodie SL, 1996, J MOL BIOL, V263, P486, DOI 10.1006/jmbi.1996.0591; Muller V, 1997, BIOCHEMISTRY-US, V36, P16008, DOI 10.1021/bi971867l; Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; NELSON DR, 1993, J MOL BIOL, V230, P1159, DOI 10.1006/jmbi.1993.1233; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panneels V, 2003, BIOCHEM BIOPH RES CO, V300, P65, DOI 10.1016/S0006-291X(02)02795-X; PFAFF E, 1965, BIOCHIM BIOPHYS ACTA, V104, P312, DOI 10.1016/0304-4165(65)90258-8; TORRONI A, 1990, J BIOL CHEM, V265, P20589; Trezeguet V, 2000, BBA-BIOENERGETICS, V1457, P81, DOI 10.1016/S0005-2728(99)00115-2; VIGNAIS PV, 1976, BIOCHIM BIOPHYS ACTA, V456, P1, DOI 10.1016/0304-4173(76)90007-0; Walker J.E., 1992, CURR OPIN STRUC BIOL, V2, P519, DOI DOI 10.1016/0959-440X(92)90081-H; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401; Zeman I, 2003, J BIOENERG BIOMEMBR, V35, P243, DOI 10.1023/A:1024611731860	50	748	764	2	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2003	426	6962					39	44		10.1038/nature02056	http://dx.doi.org/10.1038/nature02056			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603310				2022-12-24	WOS:000186370800034
J	Shearman, AM; Cupples, LA; Demissie, S; Peter, I; Schmid, CH; Karas, RH; Mendelsohn, ME; Housman, DE; Levy, D				Shearman, AM; Cupples, LA; Demissie, S; Peter, I; Schmid, CH; Karas, RH; Mendelsohn, ME; Housman, DE; Levy, D			Association between estrogen receptor alpha gene variation and cardiovascular disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY-DISEASE; BONE-MINERAL DENSITY; HORMONE REPLACEMENT THERAPY; VITAMIN-D-RECEPTOR; POSTMENOPAUSAL WOMEN; PLUS PROGESTIN; BREAST-CANCER; HEART-DISEASE; MYOCARDIAL-INFARCTION; DISRUPTIVE MUTATION	Context Estrogen and related hormone therapies activate estrogen receptors, which in turn regulate genes for several cardiovascular disease (CVD) risk factors. Relatively little is known, however, about the impact of genetic variation in estrogen receptor a (ESR1) on CVD risk. Objective To investigate whether the ESR1 c.454-397T>C polymorphism is associated with CVD risk. Design, Setting, and Participants Prospective study of 1739 unrelated men and women from the population-based offspring cohort of the Framingham Heart Study, who were followed up from 1971 to 1998. Main Outcome Measures Total atherosclerotic CVD events, defined as recognized or unrecognized myocardial infarction (MI), angina pectoris, coronary insufficiency, intermittent claudication, coronary heart disease death, or atherothrombotic stroke (n=178); major atherosclerotic CVD, defined as recognized acute MI, coronary insufficiency, coronary heart disease death, or atherothrombotic stroke (n=83); and recognized acute MI (n=59). Results Twenty percent of participants (n=352) were homozygous for the ESR1 c.454-397C allele. After adjustment for covariates (age, sex, body mass index, hypertension, diabetes mellitus, total cholesterol, high-density lipoprotein cholesterol, and cigarette smoking), the CC genotype was significantly associated with major atherosclerotic CVD, with an odds ratio of 2.0 (95% confidence interval [CI], 1.3-3.2; P=.004) compared with individuals with the CT or TT genotypes. Participants with the CC genotype had 3.0-fold greater odds of MI (95% Cl, 1.7-5,2; P<.001) compared with those with the CT or TT genotype. The results remained significant when analyses were restricted to men; too few women had events to study them separately. Conclusions Individuals with the common ESR1 c.454-397CC genotype have a substantial increase in risk of MI. Whether ESR1 c.454-397T>C is causally related to MI risk or in linkage disequilibrium with 1 or more causal variants remains to be determined. These findings support the importance of estrogen receptors in CVD susceptibility, especially in men. Estrogen receptor variation also has potential to explain recent conflicting data regarding the effects of hormone therapy on CVD susceptibility in women.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; Tufts Univ New England Med Ctr, Dept Med, Div Clin Care Res, Biostat Res Ctr, Boston, MA USA; Tufts Univ New England Med Ctr, Dept Med, Mol Cardiol Res Inst, Boston, MA USA; Tufts Univ New England Med Ctr, Specialized Ctr Res Ischem Heart Dis, Boston, MA USA; NHLBI, Framingham Heart Study, Framingham, MA USA	Massachusetts Institute of Technology (MIT); Boston University; Tufts Medical Center; Tufts Medical Center; Tufts Medical Center; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Shearman, AM (corresponding author), MIT, Ctr Canc Res, E17-536, Cambridge, MA 02139 USA.	shearman@mit.edu	Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021; Schmid, Christopher H./J-2398-2014	Levy, Daniel/0000-0003-1843-8724; Schmid, Christopher H./0000-0002-0855-5313; Demissie, Serkalem/0000-0002-8009-0987; Cupples, L. Adrienne/0000-0003-0273-7965	NHLBI NIH HHS [N01-HC-25195, P50-HL63494, P50 HL63494, N01-HC-38038, R01-HL65230] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195, N01HC038038] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL063494, R01HL065230] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1999, NAT GENET, V22, P1; Becherini L, 2000, HUM MOL GENET, V9, P2043, DOI 10.1093/hmg/9.13.2043; Braunstein JB, 2002, CHEST, V121, P906, DOI 10.1378/chest.121.3.906; Brouchet L, 2001, CIRCULATION, V103, P423; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; CASTAGNOLI A, 1987, NUCLEIC ACIDS RES, V15, P866, DOI 10.1093/nar/15.2.866; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; Deng HW, 1999, OSTEOPOROSIS INT, V9, P499, DOI 10.1007/s001980050268; Evangelopoulos D, 2003, CLIN CHIM ACTA, V331, P37, DOI 10.1016/S0009-8981(03)00080-9; Ferrara A, 2003, CIRCULATION, V107, P43, DOI 10.1161/01.CIR.0000042701.17528.95; Herrington DM, 2002, CIRCULATION, V105, P1879, DOI 10.1161/01.CIR.0000016173.98826.88; Herrington DM, 2002, NEW ENGL J MED, V346, P967, DOI 10.1056/NEJMoa012952; Holmberg-Marttila D, 2000, CALCIFIED TISSUE INT, V66, P184, DOI 10.1007/PL00005836; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Jeng MH, 1998, ENDOCRINOLOGY, V139, P4164, DOI 10.1210/en.139.10.4164; Kang HJ, 2002, CANCER LETT, V178, P175, DOI 10.1016/S0304-3835(01)00861-8; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kim JG, 2001, MENOPAUSE, V8, P222, DOI 10.1097/00042192-200105000-00013; Kunnas TA, 2000, BRIT MED J, V321, P273, DOI 10.1136/bmj.321.7256.273; Langdahl BL, 2000, J BONE MINER RES, V15, P2222, DOI 10.1359/jbmr.2000.15.11.2222; Lau EMC, 2001, BONE, V29, P96, DOI 10.1016/S8756-3282(01)00481-1; Lehtimaki T, 2002, J MOL MED-JMM, V80, P176, DOI 10.1007/s00109-001-0311-5; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lu H, 2002, ARTERIOSCL THROM VAS, V22, P817, DOI 10.1161/01.ATV.0000014424.18209.21; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Matsubara Y, 1997, ARTERIOSCL THROM VAS, V17, P3006, DOI 10.1161/01.ATV.17.11.3006; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Mizunuma H, 1997, BONE, V21, P379, DOI 10.1016/S8756-3282(97)00178-6; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; Pare G, 2002, CIRC RES, V90, P1087, DOI 10.1161/01.RES.0000021114.92282.FA; Pendaries C, 2002, P NATL ACAD SCI USA, V99, P2205, DOI 10.1073/pnas.042688499; Petrovic D, 2003, CARDIOLOGY, V99, P163, DOI 10.1159/000070673; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sudhir K, 1997, CIRCULATION, V96, P3774; Sudhir K, 1997, LANCET, V349, P1146, DOI 10.1016/S0140-6736(05)63022-X; VANDENBROUCKE JP, 1994, LANCET, V344, P1453, DOI 10.1016/S0140-6736(94)90286-0; Waters DD, 2002, JAMA-J AM MED ASSOC, V288, P2432, DOI 10.1001/jama.288.19.2432; Willing M, 1998, J BONE MINER RES, V13, P695, DOI 10.1359/jbmr.1998.13.4.695; YAICH L, 1992, CANCER RES, V52, P77; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhu Y, 2002, SCIENCE, V295, P505, DOI 10.1126/science.1065250	43	230	234	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2003	290	17					2263	2270		10.1001/jama.290.17.2263	http://dx.doi.org/10.1001/jama.290.17.2263			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739PZ	14600184	Bronze			2022-12-24	WOS:000186356800020
J	Geijsen, N; Horoschak, M; Kim, K; Gribnau, J; Eggan, K; Daley, GQ				Geijsen, N; Horoschak, M; Kim, K; Gribnau, J; Eggan, K; Daley, GQ			Derivation of embryonic germ cells and male gametes from embryonic stem cells	NATURE			English	Article							MALE-STERILITY GENE; RET FINGER PROTEIN; IN-VITRO; YOLK-SAC; MOUSE; EXPRESSION; DAZ; DIFFERENTIATION; SPERMATOGENESIS; PROLIFERATION	Egg and sperm cells ( gametes) of the mouse are derived from a founder population of primordial germ cells that are set aside early in embryogenesis. Primordial germ cells arise from the proximal epiblast, a region of the early mouse embryo that also contributes to the first blood lineages of the embryonic yolk sac(1). Embryonic stem cells differentiate in vitro into cystic structures called embryoid bodies consisting of tissue lineages typical of the early mouse embryo(2,3). Because embryoid bodies sustain blood development, we reasoned that they might also support primordial germ cell formation. Here we isolate primordial germ cells from embryoid bodies, and derive continuously growing lines of embryonic germ cells. Embryonic germ cells show erasure of the methylation markers ( imprints) of the Igf2r and H19 genes, a property characteristic of the germlineage. We show that embryoid bodies support maturation of the primordial germ cells into haploid male gametes, which when injected into oocytes restore the somatic diploid chromosome complement and develop into blastocysts. Our ability to derive germ cells from embryonic stem cells provides an accessible in vitro model system for studies of germline epigenetic modification and mammalian gametogenesis.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Ctr Regenerat Med & Technol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University	Daley, GQ (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	george.daley@childrens.harvard.edu	Eggan, Kevin/P-7119-2018					BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Cao TY, 1996, DEV GENET, V19, P309, DOI 10.1002/(SICI)1520-6408(1996)19:4<309::AID-DVG4>3.3.CO;2-1; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; FENDERSON BA, 1984, DEV BIOL, V103, P117, DOI 10.1016/0012-1606(84)90013-7; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; KOSHIMIZU U, 1995, DEV BIOL, V168, P683, DOI 10.1006/dbio.1995.1113; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; LABOSKY PA, 1994, DEVELOPMENT, V120, P3197; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Lawson KA, 1994, CIBA F SYMP, V182, P84; Leahy A, 1999, J EXP ZOOL, V284, P67, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;67::AID-JEZ10&gt;3.0.CO;2-O; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Moore FL, 2003, P NATL ACAD SCI USA, V100, P538, DOI 10.1073/pnas.0234478100; Ogawa S, 1998, BIOCHEM BIOPH RES CO, V251, P515, DOI 10.1006/bbrc.1998.9502; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Seboun E, 1997, GENOMICS, V41, P227, DOI 10.1006/geno.1997.4635; SELIG S, 1992, EMBO J, V11, P1217, DOI 10.1002/j.1460-2075.1992.tb05162.x; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; Tezel G, 2002, PATHOL INT, V52, P623, DOI 10.1046/j.1440-1827.2002.01401.x; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; WASSARMAN PM, 1992, BIOL REPROD, V46, P186, DOI 10.1095/biolreprod46.2.186; Zandstra PW, 2000, BIOTECHNOL BIOENG, V69, P607, DOI 10.1002/1097-0290(20000920)69:6<607::AID-BIT4>3.3.CO;2-6	31	615	703	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2004	427	6970					148	154		10.1038/nature02247	http://dx.doi.org/10.1038/nature02247			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760YY	14668819				2022-12-24	WOS:000187863900034
J	Zhu, H; Zhu, JX; Lo, PS; Li, JM; Leung, KM; Rowlands, DK; Tsang, LL; Yu, MK; Jiang, JL; Lam, SY; Chung, YW; Zhou, ZM; Sha, JH; Chan, HC				Zhu, H; Zhu, JX; Lo, PS; Li, JM; Leung, KM; Rowlands, DK; Tsang, LL; Yu, MK; Jiang, JL; Lam, SY; Chung, YW; Zhou, ZM; Sha, JH; Chan, HC			Rescue of defective pancreatic secretion in cystic-fibrosis cells by suppression of a novel isoform of phospholipase C	LANCET			English	Article							CFTR CHLORIDE CHANNEL; PROTEIN-KINASE-C; DUCT CELLS; SURFACE EXPRESSION; ANION SECRETION; GENE; DELTA-F508-CFTR; PHOSPHORYLATION; MECHANISMS; MUTATION	Background Cystic fibrosis is caused by mutations in the gene encoding an ion-transport protein, the cystic-fibrosis transmembrane conductance regulator (CFTR). Defective secretion of anions is the primary cause of many of the clinical manifestations of cystic fibrosis, including pancreatic insufficiency. We aimed to identify a molecular mechanism from which a new method to circumvent defective pancreatic secretion could be derived. Methods Multiple-human-tissue RT-PCR and semiquantitative RT-PCR analyses were used to examine gene expression. An antisense technique was used in conjunction with radioimmunoassay, Fura-2 spectrofluorometry, immunohistochemistry, and the short-circuit current technique (Ussing chamber) for elucidation of gene function and its application in rescuing defective pancreatic secretion. Findings We cloned a newly identified gene, NYD-SP27, which has structural similarity to an isoform of phospholipase C. NYD-SP27 was expressed endogenously in human pancreatic-duct cells and upregulated in cystic fibrosis. Suppression of NYD-SP27, by transfection of its antisense into human cystic-fibrosis pancreatic-duct cells, resulted in augmentation of phospholipase-C-coupled calcium-ion release and protein kinase C activity, improvement in the amount of mutated CFTR reaching the plasma membrane, and restoration of cAMP-activated pancreatic anion secretion. Interpretation NYD-SP27 exerts an inhibitory effect on phospholipase-C-coupled processes that depend on calcium ions and protein kinase C, including CFTR trafficking and function. Its upregulation in pancreatic-duct cells may reveal a previously unsuspected defect in cystic fibrosis contributing to pancreatic insufficiency, and thus represents a new target for pharmacological intervention in cystic fibrosis.	Chinese Univ Hong Kong, Fac Med, Dept Physiol, Epithelial Cell Biol Res Ctr, Shatin, Hong Kong, Peoples R China; Nanjing Med Univ, Lab Reprod Med, Nanjing 210009, Peoples R China	Chinese University of Hong Kong; Nanjing Medical University	Chan, HC (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Physiol, Epithelial Cell Biol Res Ctr, Shatin, Hong Kong, Peoples R China.		Chan, Hsiao Chang/E-1507-2016	Rowlands, Dewi/0000-0001-5180-842X				ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Case R. M., 1993, P301; Chan HC, 1996, AM J PHYSIOL-CELL PH, V271, pC469, DOI 10.1152/ajpcell.1996.271.2.C469; Cheng HS, 1998, J MEMBRANE BIOL, V164, P155, DOI 10.1007/s002329900401; Cheng HS, 1999, BBA-BIOMEMBRANES, V1418, P31, DOI 10.1016/S0005-2736(99)00011-5; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Communi D, 2000, CELL SIGNAL, V12, P351, DOI 10.1016/S0898-6568(00)00083-8; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Egan ME, 2002, NAT MED, V8, P485, DOI 10.1038/nm0502-485; Estell K, 2003, MOL CELL BIOL, V23, P594, DOI 10.1128/MCB.23.2.594-606.2003; GADSBY DC, 1995, ANNU REV PHYSIOL, V57, P387; HADORN B, 1968, CAN MED ASSOC J, V98, P377; Maitra R, 2001, AM J PHYSIOL-CELL PH, V280, pC1031, DOI 10.1152/ajpcell.2001.280.5.C1031; Nousia-Arvanitakis S, 1999, J CLIN GASTROENTEROL, V29, P138, DOI 10.1097/00004836-199909000-00007; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schultz BD, 1999, PHYSL REV S, V79, P109; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; USSING HH, 1951, ACTA PHYSIOL SCAND, V23, P110, DOI 10.1111/j.1748-1716.1951.tb00800.x; Walkowiak J, 2001, EUR J CLIN INVEST, V31, P796, DOI 10.1046/j.1365-2362.2001.00876.x; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; WINPENNY JP, 1995, AM J PHYSIOL-CELL PH, V268, pC823, DOI 10.1152/ajpcell.1995.268.4.C823; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200; Zhou ZM, 2002, REPRODUCTION, V123, P227, DOI 10.1530/rep.0.1230227; Zsembery A, 2000, FASEB J, V14, P2345, DOI 10.1096/fj.99-0509com	26	15	19	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 20	2003	362	9401					2059	2065		10.1016/S0140-6736(03)15100-8	http://dx.doi.org/10.1016/S0140-6736(03)15100-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UJ	14697805				2022-12-24	WOS:000187429600010
J	Asbury, CL; Fehr, AN; Block, SM				Asbury, CL; Fehr, AN; Block, SM			Kinesin moves by an asymmetric hand-over-hand mechanism	SCIENCE			English	Article							OPTICAL FORCE CLAMP; COILED-COIL; 8-NM STEP; MICROTUBULES; MOLECULES; MOVEMENT; ATP; HYDROLYZES; REGION	Kinesin is a double-headed motor protein that moves along microtubules in 8-nanometer steps. Two broad classes of model have been invoked to explain kinesin movement: hand-over-hand and inchworm. In hand-over-hand models, the heads exchange leading and trailing roles with every step, whereas no such exchange is postulated for inchworm models, where one head always leads. By measuring the stepwise motion of individual enzymes, we find that some kinesin molecules exhibit a marked alternation in the dwell times between sequential steps, causing these motors to "limp" along the microtubule. Limping implies that kinesin molecules strictly alternate between two different conformations as they step, indicative of an asymmetric, hand-over-hand mechanism.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Stanford University	Block, SM (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051453] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051453] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERLINER E, 1995, NATURE, V373, P718, DOI 10.1038/373718a0; Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Coy DL, 1999, J BIOL CHEM, V274, P3667, DOI 10.1074/jbc.274.6.3667; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Hoenger A, 2000, J MOL BIOL, V297, P1087, DOI 10.1006/jmbi.2000.3627; Howard J, 1996, ANNU REV PHYSIOL, V58, P703, DOI 10.1146/annurev.ph.58.030196.003415; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; Li Y, 2003, NATURE, V424, P341, DOI 10.1038/nature01801; MANLY BFJ, 2001, RANDOMIZATION BOOTST, P34; MEYHOFER E, 1995, P NATL ACAD SCI USA, V92, P574, DOI 10.1073/pnas.92.2.574; Misura KMS, 2001, J BIOL CHEM, V276, P13273, DOI 10.1074/jbc.M009636200; RAY S, 1993, J CELL BIOL, V121, P1083, DOI 10.1083/jcb.121.5.1083; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; SONG YH, 1993, P NATL ACAD SCI USA, V90, P1671, DOI 10.1073/pnas.90.5.1671; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; SVOBODA K, 1995, BIOPHYS J, V68, pS69; Tripet B, 1997, J BIOL CHEM, V272, P8946; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; Visscher K, 1998, METHOD ENZYMOL, V298, P460, DOI 10.1016/S0076-6879(98)98040-5; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	28	419	435	6	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2130	2134		10.1126/science.1092985	http://dx.doi.org/10.1126/science.1092985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14657506	Green Accepted, Green Submitted			2022-12-24	WOS:000187385200047
J	Brake, JM; Daschner, MK; Luk, YY; Abbott, NL				Brake, JM; Daschner, MK; Luk, YY; Abbott, NL			Biomolecular interactions at phospholipid-decorated surfaces of liquid crystals	SCIENCE			English	Article							PORCINE PANCREAS; KINETIC-ANALYSIS; MONOLAYERS; MEMBRANES; STREPTAVIDIN; RECOGNITION; INTERFACE; CATALYSIS; BILAYERS; ZYMOGEN	The spontaneous assembly of phospholipids at planar interfaces between thermotropic liquid crystals and aqueous phases gives rise to patterned orientations of the liquid crystals that reflect the spatial and temporal organization of the phospholipids. Strong and weak specific-binding events involving proteins at these interfaces drive the reorganization of the phospholipids and trigger orientational transitions in the liquid crystals. Because these interfaces are fluid, processes involving the lateral organization of proteins ( such as the formation of protein- and phospholipid-rich domains) are also readily imaged by the orientational response of the liquid crystal, as are stereospecific enzymatic events. These results provide principles for label-free monitoring of aqueous streams for molecular and biomolecular species without the need for complex instrumentation.	Univ Wisconsin, Dept Biol & Chem Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Abbott, NL (corresponding author), Univ Wisconsin, Dept Biol & Chem Engn, 1415 Engn Dr, Madison, WI 53706 USA.							BLANKENBURG R, 1989, BIOCHEMISTRY-US, V28, P8214, DOI 10.1021/bi00446a037; BONSEN PPM, 1972, BIOCHIM BIOPHYS ACTA, V270, P364, DOI 10.1016/0005-2760(72)90200-7; CHARYCH DH, 1993, SCIENCE, V261, P585, DOI 10.1126/science.8342021; DAHMENLEVISON U, 1998, THIN SOLID FILMS, V616, P327; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; DEHAAS GH, 1971, BIOCHIM BIOPHYS ACTA, V239, P252, DOI 10.1016/0005-2760(71)90171-8; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Gast AP, 1999, BIOMOL ENG, V16, P21, DOI 10.1016/S1050-3862(99)00045-5; GRAINGER DW, 1992, J CONTROL RELEASE, V19, P201, DOI 10.1016/0168-3659(92)90077-5; Grant LM, 2002, BIOPHYS J, V82, P1373, DOI 10.1016/S0006-3495(02)75492-1; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Gupta VK, 1998, SCIENCE, V279, P2077, DOI 10.1126/science.279.5359.2077; HILTROP K, 1981, BER BUNSEN PHYS CHEM, V85, P582, DOI 10.1002/bbpc.19810850712; Hubbard JB, 1998, BIOPHYS CHEM, V75, P163, DOI 10.1016/S0301-4622(98)00199-9; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V1002, P127, DOI 10.1016/0005-2760(89)90281-6; KALB E, 1992, BIOCHIM BIOPHYS ACTA, V1103, P307, DOI 10.1016/0005-2736(92)90101-Q; Ransac S, 1997, METHOD ENZYMOL, V286, P263; Rao NM, 1997, BIOPHYS J, V73, P3066, DOI 10.1016/S0006-3495(97)78334-6; Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43; Song XD, 1999, ANAL CHEM, V71, P2097, DOI 10.1021/ac981145f; Stahelin RV, 2001, BIOCHEM J, V359, P679, DOI 10.1042/0264-6021:3590679; Tanaka K, 2000, LANGMUIR, V16, P2665, DOI 10.1021/la9909244; Walker RA, 1997, LANGMUIR, V13, P3070, DOI 10.1021/la961007q; Yang TL, 2001, ANAL CHEM, V73, P165, DOI 10.1021/ac000997o; ZOGRAFI G, 1971, CHEM PHYS LIPIDS, V7, P185, DOI 10.1016/0009-3084(71)90001-6	25	522	541	11	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2094	2097		10.1126/science.1091749	http://dx.doi.org/10.1126/science.1091749			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684814				2022-12-24	WOS:000187385200035
J	Lovelock, J				Lovelock, J			The living Earth	NATURE			English	Editorial Material							GAIA		Univ Oxford Green Coll, Oxford OX2 6HG, England	University of Oxford	Lovelock, J (corresponding author), Univ Oxford Green Coll, Woodstock Rd, Oxford OX2 6HG, England.							Hamilton WD, 1998, ETHOL ECOL EVOL, V10, P1, DOI 10.1080/08927014.1998.9522867; Kump Leo, 2004, EARTH SYSTEM; Lenton TM, 1998, NATURE, V394, P439, DOI 10.1038/28792; Lovelock J, 2000, AGES GAIA; Margulis L, 1999, SYMBIOTIC PLANET; SCHELLNHUBER HJ, 1998, EARTH SYSTEM ANAL IN; Turney Jon, 2003, LOVELOCK GAIA	7	67	70	5	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					769	770		10.1038/426769a	http://dx.doi.org/10.1038/426769a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685210				2022-12-24	WOS:000187342000030
J	Olsen, SJ; Chang, H; Cheung, TY; Tang, AF; Fisk, TL; Ooi, SP; Kuo, H; Jiang, DD; Chen, K; Lando, J; Hsu, K; Chen, T; Dowell, SF				Olsen, SJ; Chang, H; Cheung, TY; Tang, AF; Fisk, TL; Ooi, SP; Kuo, H; Jiang, DD; Chen, K; Lando, J; Hsu, K; Chen, T; Dowell, SF			Transmission of the severe acute respiratory syndrome on aircraft	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-FEATURES; SYNDROME SARS	BACKGROUND: The severe acute respiratory syndrome (SARS) spread rapidly around the world, largely because persons infected with the SARS-associated coronavirus (SARS-CoV) traveled on aircraft to distant cities. Although many infected persons traveled on commercial aircraft, the risk, if any, of in-flight transmission is unknown. METHODS: We attempted to interview passengers and crew members at least 10 days after they had taken one of three flights that transported a patient or patients with SARS. All index patients met the criteria of the World Health Organization for a probable case of SARS, and index or secondary cases were confirmed to be positive for SARS-CoV on reverse-transcriptase polymerase chain reaction or serologic testing. RESULTS: After one flight carrying a symptomatic person and 119 other persons, laboratory-confirmed SARS developed in 16 persons, 2 others were given diagnoses of probable SARS, and 4 were reported to have SARS but could not be interviewed. Among the 22 persons with illness, the mean time from the flight to the onset of symptoms was four days (range, two to eight), and there were no recognized exposures to patients with SARS before or after the flight. Illness in passengers was related to the physical proximity to the index patient, with illness reported in 8 of the 23 persons who were seated in the three rows in front of the index patient, as compared with 10 of the 88 persons who were seated elsewhere (relative risk, 3.1; 95 percent confidence interval, 1.4 to 6.9). In contrast, another flight carrying four symptomatic persons resulted in transmission to at most one other person, and no illness was documented in passengers on the flight that carried a person who had presymptomatic SARS. CONCLUSIONS: Transmission of SARS may occur on an aircraft when infected persons fly during the symptomatic phase of illness. Measures to reduce the risk of transmission are warranted.	Ctr Dis Control & Prevent, Int Emerging Infect Program, Nonthaburi, Thailand; Taiwan Ctr Dis Control, Dept Hlth, Taipei, Taiwan; Dept Hlth, Hong Kong, Hong Kong, Peoples R China; Emory Univ, Sch Med, Atlanta, GA USA; Minist Hlth, Epidemiol & Dis Control Div, Singapore, Singapore; Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA	Emory University; Ministry of Health-Singapore; Centers for Disease Control & Prevention - USA	Olsen, SJ (corresponding author), Ctr Dis Control & Prevent, Int Emerging Infect Program, Box 68,Amer Embassy, APO, AP 96546 USA.							[Anonymous], 2003, WKLY EPIDEMIOL REC, V78, P97; [Anonymous], 1995, MMWR-MORBID MORTAL W, V44, P137; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Booth CM, 2003, JAMA-J AM MED ASSOC, V290, P334; *CDCP, 2003, INT GUID CLEAN COMM; *CDCP, 2003, INT GUID SEV AC RESP; Demers RR, 2001, CHEST, V120, P1377, DOI 10.1378/chest.120.4.1377; GARNER JS, 1997, GUIDELINE ISOLATION; Hsu LY, 2003, EMERG INFECT DIS, V9, P713; *IATA, 2003, DID YOU KNOW FACTS I; KAHN J, 2003, INT HERALD TRIBUNE T, V1, P4; Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; LAKSHMANAN IAR, 2003, BOSTON GLOBE    0518; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Musher DM, 2003, NEW ENGL J MED, V348, P1256, DOI 10.1056/NEJMra021771; Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6; Wenzel RP, 1996, NEW ENGL J MED, V334, P981, DOI 10.1056/NEJM199604113341509; *WHO, 2003, UPD 59 REP GUANGX CH; *WHO, 2003, UPD 62 MOR 8000 CAS; World Health Organization, 2003, CAS DEF SURV SEV AC; World Health Organization, 2003, UPD 11 WHO REC NEW M; World Health Organization (WHO), 2003, SUMM PROB SARS CAS O; 2003, MMWR MORB MORTAL WKL, V52, P248; 2003, MMWR MORB MORTAL WKL, V52, P284; 2003, MMWR MORB MORTAL WKL, V52, P241; 1995, MMWR MORB MORTAL WKL, V44, P175; 2003, MMWR MORB MORTAL WKL, V52, P405	28	401	420	0	33	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2003	349	25					2416	2422		10.1056/NEJMoa031349	http://dx.doi.org/10.1056/NEJMoa031349			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754PJ	14681507	Bronze			2022-12-24	WOS:000187326200007
J	Hagen, T; Taylor, CT; Lam, F; Moncada, S				Hagen, T; Taylor, CT; Lam, F; Moncada, S			Redistribution of intracellular oxygen in hypoxia by nitric oxide: Effect on HIF1 alpha	SCIENCE			English	Article							INDUCIBLE FACTOR 1-ALPHA; COMPLEX-III; HEART-MITOCHONDRIA; ALPHA-SUBUNIT; HIF; TRANSCRIPTION; EXPRESSION; FACTOR-1-ALPHA; STABILIZATION; ACTIVATION	Cells exposed to low oxygen concentrations respond by initiating defense mechanisms, including the stabilization of hypoxia-inducible factor (HIF) 1alpha, a transcription factor that upregulates genes such as those involved in glycolysis and angiogenesis. Nitric oxide and other inhibitors of mitochondrial respiration prevent the stabilization of HIF1alpha during hypoxia. In studies of cultured cells, we show that this effect is a result of an increase in prolyl hydroxylase dependent degradation of HIF1alpha. With the use of Renilla luciferase to detect intracellular oxygen concentrations, we also demonstrate that, upon inhibition of mitochondrial respiration in hypoxia, oxygen is redistributed toward non-respiratory oxygen-dependent targets such as prolyl hydroxylases so that they do not register hypoxia. Thus, the signaling consequences of hypoxia may be profoundly modified by nitric oxide.	UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; Natl Univ Ireland Univ Coll Dublin, Conway Inst Biomed & Biochem Res, Dublin 4, Ireland	University of London; University College London; University College Dublin	Moncada, S (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	s.moncada@ucl.ac.uk		Taylor, Cormac/0000-0002-0946-1247				Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FANDREY J, 1994, BIOCHEM J, V303, P507, DOI 10.1042/bj3030507; Gnaiger E, 2002, BIOCHEM SOC T, V30, P252, DOI 10.1042/BST0300252; HAGEN T, UNPUB; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Mateo J, 2003, BIOCHEM J, V376, P537, DOI 10.1042/BJ20031155; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Poderoso JJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P85, DOI 10.1006/abbi.1996.0146; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Safran M, 2003, J CLIN INVEST, V111, P779, DOI 10.1172/JCI200318181; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Semenza GL, 2000, BIOCHEM PHARMACOL, V59, P47, DOI 10.1016/S0006-2952(99)00292-0; Trimmer BA, 2001, SCIENCE, V292, P2486, DOI 10.1126/science.1059833; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Waypa GB, 2002, CIRC RES, V91, P719, DOI 10.1161/01.RES.0000036751.04896.F1; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Yang ZZ, 2003, AM J PHYSIOL-RENAL, V284, pF1207, DOI 10.1152/ajprenal.00017.2002	24	600	623	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1975	1978		10.1126/science.1088805	http://dx.doi.org/10.1126/science.1088805			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671307				2022-12-24	WOS:000187174000064
J	Silver, RA; Lubke, J; Sakmann, B; Feldmeyer, D				Silver, RA; Lubke, J; Sakmann, B; Feldmeyer, D			High-probability uniquantal transmission at excitatory synapses in barrel cortex	SCIENCE			English	Article							PYRAMIDAL CELLS; SYNAPTIC CONNECTIONS; NEURONS; RELEASE; SINGLE; INFORMATION; LAYER-4; HIPPOCAMPUS; POTENTIALS; PLASTICITY	The number of vesicles released at excitatory synapses and the number of release sites per synaptic connection are key determinants of information processing in the cortex, yet they remain uncertain. Here we show that the number of functional release sites and the number of anatomically identified synaptic contacts are equal at connections between spiny stellate and pyramidal cells in rat barrel cortex. Moreover, our results indicate that the amount of transmitter released per synaptic contact is independent of release probability and the intrinsic release probability is high. These properties suggest that connections between layer 4 and layer 2/3 are tuned for reliable transmission of spatially distributed, timing-based signals.	UCL, Dept Physiol, London WC1E 6BT, England; Forschungszentrum Julich, Inst Med, D-52425 Julich, Germany; Max Planck Inst Med Res, Zellphysiol Abt, D-69120 Heidelberg, Germany	University of London; University College London; Helmholtz Association; Research Center Julich; Max Planck Society	Silver, RA (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	a.silver@ucl.ac.uk	Feldmeyer, Dirk/H-5940-2013; Lubke, Joachim/H-8762-2013	Feldmeyer, Dirk/0000-0002-1716-8972; Lubke, Joachim/0000-0002-4086-3199; Silver, Robin/0000-0002-5480-6638				Bekkers JM, 1999, J PHYSIOL-LONDON, V516, P227, DOI 10.1111/j.1469-7793.1999.227aa.x; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; CastroAlamancos MA, 1997, P NATL ACAD SCI USA, V94, P4161, DOI 10.1073/pnas.94.8.4161; Clements JD, 2000, TRENDS NEUROSCI, V23, P105, DOI 10.1016/S0166-2236(99)01520-9; Diamond JS, 1997, J NEUROSCI, V17, P4672; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Foster KA, 2002, NEURON, V36, P1115, DOI 10.1016/S0896-6273(02)01106-6; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; JACK JJB, 1981, J PHYSIOL-LONDON, V321, P65, DOI 10.1113/jphysiol.1981.sp013972; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Katz B., 1969, RELEASE NEURAL TRANS; KORN H, 1981, SCIENCE, V213, P898, DOI 10.1126/science.6266015; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; London M, 2002, NAT NEUROSCI, V5, P332, DOI 10.1038/nn826; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Reid CA, 1999, J PHYSIOL-LONDON, V518, P121, DOI 10.1111/j.1469-7793.1999.0121r.x; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; SILVER RA, 1998, CENTRAL SYNAPSES QUA, P130; VEREJONE.D, 1966, AUST J STAT, V8, P53, DOI 10.1111/j.1467-842X.1966.tb00164.x; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219	26	164	166	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1981	1984		10.1126/science.1087160	http://dx.doi.org/10.1126/science.1087160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671309				2022-12-24	WOS:000187174000066
J	Giot, L; Bader, JS; Brouwer, C; Chaudhuri, A; Kuang, B; Li, Y; Hao, YL; Ooi, CE; Godwin, B; Vitols, E; Vijayadamodar, G; Pochart, P; Machineni, H; Welsh, M; Kong, Y; Zerhusen, B; Malcolm, R; Varrone, Z; Collis, A; Minto, M; Burgess, S; McDaniel, L; Stimpson, E; Spriggs, F; Williams, J; Neurath, K; Ioime, N; Agee, M; Voss, E; Furtak, K; Renzulli, R; Aanensen, N; Carrolla, S; Bickelhaupt, E; Lazovatsky, Y; DaSilva, A; Zhong, J; Stanyon, CA; Finley, RL; White, KP; Braverman, M; Jarvie, T; Gold, S; Leach, M; Knight, J; Shimkets, RA; McKenna, MP; Chant, J; Rothberg, JM				Giot, L; Bader, JS; Brouwer, C; Chaudhuri, A; Kuang, B; Li, Y; Hao, YL; Ooi, CE; Godwin, B; Vitols, E; Vijayadamodar, G; Pochart, P; Machineni, H; Welsh, M; Kong, Y; Zerhusen, B; Malcolm, R; Varrone, Z; Collis, A; Minto, M; Burgess, S; McDaniel, L; Stimpson, E; Spriggs, F; Williams, J; Neurath, K; Ioime, N; Agee, M; Voss, E; Furtak, K; Renzulli, R; Aanensen, N; Carrolla, S; Bickelhaupt, E; Lazovatsky, Y; DaSilva, A; Zhong, J; Stanyon, CA; Finley, RL; White, KP; Braverman, M; Jarvie, T; Gold, S; Leach, M; Knight, J; Shimkets, RA; McKenna, MP; Chant, J; Rothberg, JM			A protein interaction map of Drosophila melanogaster	SCIENCE			English	Article							BINDING-PROTEIN; SYSTEMATIC ANALYSIS; UBIQUITIN-LIGASE; ADAPTER PROTEIN; IDENTIFICATION; REPRESSION; REAPER; DOMAIN; GRIM; RNA	Drosophila melanogaster is a proven model system for many aspects of human biology. Here we present a two-hybrid-based protein-interaction map of the fly proteome. A total of 10,623 predicted transcripts were isolated and screened against standard and normalized complementary DNA libraries to produce a draft map of 7048 proteins and 20,405 interactions. A computational method of rating two-hybrid interaction confidence was developed to re. ne this draft map to a higher confidence map of 4679 proteins and 4780 interactions. Statistical modeling of the network showed two levels of organization: a short-range organization, presumably corresponding to multiprotein complexes, and a more global organization, presumably corresponding to intercomplex connections. The network recapitulated known pathways, extended pathways, and uncovered previously unknown pathway components. This map serves as a starting point for a systems biology modeling of multicellular organisms, including humans.	GuraGen Corp, New Haven, CT 06511 USA; Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Wayne State University; Yale University	Chant, J (corresponding author), GuraGen Corp, 555 Long Wharf Dr, New Haven, CT 06511 USA.	jchant@curagen.com	Stanyon, Clem/AAM-5040-2020; guntain, sodsri/C-5090-2009; Bader, Joel/A-1818-2009; Kong, Yong/B-5105-2014	Bader, Joel/0000-0002-6020-4625; Kong, Yong/0000-0002-2881-5274; Stanyon, Clement/0000-0001-5030-6823; Finley, Russ/0000-0003-1144-6887	NHGRI NIH HHS [HG01536] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG001536, R01HG001536] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P342, DOI 10.1016/S0968-0004(99)01437-1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BADER JS, IN PRESS NATURE BIOT; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BARON BW, 1993, P NATL ACAD SCI USA, V90, P5262, DOI 10.1073/pnas.90.11.5262; Cai DS, 2003, J BIOL CHEM, V278, P25323, DOI 10.1074/jbc.M212430200; Christich A, 2002, CURR BIOL, V12, P137, DOI 10.1016/S0960-9822(01)00658-3; Courey AJ, 2001, GENE DEV, V15, P2786; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dong XZ, 1997, GENE DEV, V11, P94, DOI 10.1101/gad.11.1.94; Du C, 1998, MOL CELL, V2, P741, DOI 10.1016/S1097-2765(00)80289-0; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Feller SM, 2002, MECH DEVELOP, V116, P129, DOI 10.1016/S0925-4773(02)00147-8; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goldberg DS, 2003, P NATL ACAD SCI USA, V100, P4372, DOI 10.1073/pnas.0735871100; Graham P, 2003, BIOESSAYS, V25, P1, DOI 10.1002/bies.10207; Graveley BR, 2002, CELL, V109, P409, DOI 10.1016/S0092-8674(02)00750-X; Grosskortenhaus R, 2002, DEV CELL, V2, P29, DOI 10.1016/S1534-5807(01)00104-6; Guglielmi B, 2002, J BIOL CHEM, V277, P35712, DOI 10.1074/jbc.M205526200; Heinrichs V, 1997, P NATL ACAD SCI USA, V94, P115, DOI 10.1073/pnas.94.1.115; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jagla K, 2001, BIOESSAYS, V23, P125, DOI 10.1002/1521-1878(200102)23:2<125::AID-BIES1019>3.3.CO;2-3; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jimenez G, 1999, MOL CELL BIOL, V19, P2080; Jimenez G, 2000, GENE DEV, V14, P224; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Khush RS, 2002, CURR BIOL, V12, P1728, DOI 10.1016/S0960-9822(02)01214-9; KIM YJ, 1992, GENE DEV, V6, P2569, DOI 10.1101/gad.6.12b.2569; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Lai ZC, 1996, P NATL ACAD SCI USA, V93, P5025, DOI 10.1073/pnas.93.10.5025; Li SH, 2002, MOL CELL BIOL, V22, P6854, DOI 10.1128/MCB.22.19.6854-6865.2002; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; Lynch KW, 1996, GENE DEV, V10, P2089, DOI 10.1101/gad.10.16.2089; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; Pazman C, 2000, DEVELOPMENT, V127, P1715; Peracchia C, 2000, J BIOL CHEM, V275, P26220, DOI 10.1074/jbc.M004007200; Phizicky E, 2003, NATURE, V422, P208, DOI 10.1038/nature01512; Raj L, 2000, CURR BIOL, V10, P1265, DOI 10.1016/S0960-9822(00)00745-4; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Sitry D, 2002, J BIOL CHEM, V277, P42233, DOI 10.1074/jbc.M205254200; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Sotkis A, 2001, CELL COMMUN ADHES, V8, P277, DOI 10.3109/15419060109080737; Sprinzak E, 2001, J MOL BIOL, V311, P681, DOI 10.1006/jmbi.2001.4920; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wing JP, 2002, CURR BIOL, V12, P131, DOI 10.1016/S0960-9822(01)00664-9; Wing JP, 2002, NAT CELL BIOL, V4, P451, DOI 10.1038/ncb800; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200	57	1762	1834	2	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2003	302	5651					1727	1736		10.1126/science.1090289	http://dx.doi.org/10.1126/science.1090289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14605208				2022-12-24	WOS:000186970100038
J	Wu, XC; Li, Z; Zhou, BC; Dong, ZM				Wu, XC; Li, Z; Zhou, BC; Dong, ZM			A polydactylous amniote from the Triassic period	NATURE			English	Editorial Material							TETRAPOD LIMB; EVOLUTION		Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; Shanghai Sci & Technol Museum, Shanghai 200127, Peoples R China; Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Wu, XC (corresponding author), Canadian Museum Nat, POB 3443 Stn D, Ottawa, ON K1P 6P4, Canada.							Clack JA., 2012, GAINING GROUND ORIGI; COATES MI, 1990, NATURE, V347, P66, DOI 10.1038/347066a0; DANFORTH CH, 1947, AM J ANAT, V80, P143, DOI 10.1002/aja.1000800202; EDWARDS JL, 1989, AM ZOOL, V29, P235; GOULD SJ, 1991, NAT HIST, V1, P22; LEBEDEV OA, 1984, DOKL AKAD NAUK SSSR+, V278, P1470; Li Jin-Ling, 2002, Vertebrata Palasiatica, V40, P241; Motani R, 1999, J VERTEBR PALEONTOL, V19, P28, DOI 10.1080/02724634.1999.10011120; Radhakrishna U, 1999, AM J HUM GENET, V65, P645, DOI 10.1086/302557; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; SHUBIN NH, 1986, EVOL BIOL, V20, P319	11	21	25	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2003	426	6966					516	516		10.1038/426516a	http://dx.doi.org/10.1038/426516a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654831	Bronze			2022-12-24	WOS:000186944300028
J	Ryan, EA				Ryan, EA			Hormones and insulin resistance during pregnancy	LANCET			English	Editorial Material							SKELETAL-MUSCLE; OBESE WOMEN; PHOSPHORYLATION; EXPRESSION; ALPHA		Univ Alberta, Heritage Med Res Ctr, Dept Endocrinol & Metab, Edmonton, AB T6G 2S2, Canada	University of Alberta	Ryan, EA (corresponding author), Univ Alberta, Heritage Med Res Ctr, Dept Endocrinol & Metab, Edmonton, AB T6G 2S2, Canada.	Edmond.Ryan@UAlberta.ca						Catalano PM, 2002, AM J PHYSIOL-ENDOC M, V282, pE522, DOI 10.1152/ajpendo.00124.2001; Friedman JE, 1999, DIABETES, V48, P1807, DOI 10.2337/diabetes.48.9.1807; Kirwan JP, 2002, DIABETES, V51, P2207, DOI 10.2337/diabetes.51.7.2207; McTernan PG, 2002, J CLIN ENDOCR METAB, V87, P2407, DOI 10.1210/jc.87.5.2407; Melczer Z, 2003, ACTA OBSTET GYN SCAN, V82, P432; Nagaev I, 2001, BIOCHEM BIOPH RES CO, V285, P561, DOI 10.1006/bbrc.2001.5173; Shao JH, 2000, DIABETES, V49, P603, DOI 10.2337/diabetes.49.4.603; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sugden MC, 2003, ENDOCRINOLOGY, V144, P146, DOI 10.1210/en.2002-220811; Yura S, 2003, J CLIN ENDOCR METAB, V88, P1394, DOI 10.1210/jc.2002-011926	10	70	72	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1777	1778		10.1016/S0140-6736(03)14942-2	http://dx.doi.org/10.1016/S0140-6736(03)14942-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654313				2022-12-24	WOS:000186872900006
J	Dandonneau, Y; Vega, A; Loisel, H; du Penhoat, Y; Menkes, C				Dandonneau, Y; Vega, A; Loisel, H; du Penhoat, Y; Menkes, C			Oceanic Rossby waves acting as a "hay rake" for ecosystem floating by-products	SCIENCE			English	Article							SEA-SURFACE; PACIFIC; FLUXES; LIGHT; PHYTOPLANKTON; VARIABILITY; ATTENUATION; ABSORPTION; NUTRIENTS; WATERS	Recent satellite observations of Rossby waves and chlorophyll anomalies propagating in subtropical gyres have suggested that wave-induced upwelling could stimulate photosynthesis. Instead, we show that chlorophyll maxima are located in abnormally warm water, in Rossby wave - induced convergences. This excludes inputs of nutrients from deeper water. We argue that the sea color anomalies are not caused by chlorophyll but by floating particles evolved from the ecosystem and accumulated by Rossby waves, acting as "marine hay rakes," in convergence zones. Such processes may be determinant for the distribution of living organisms in oligotrophic areas.	IRD, IPSL, Lab Oceanog Dynam & Climatol, F-75252 Paris 05, France; IRD, Lab Etud Geophys & Oceanog Spatiale, Toulouse, France; Univ Littoral Cote dOpale, MREN, UMR 8013, Wimereux, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; Universite du Littoral-Cote-d'Opale	Dandonneau, Y (corresponding author), IRD, IPSL, Lab Oceanog Dynam & Climatol, F-75252 Paris 05, France.	yd@lodyc.jussieu.fr	menkes, christophe/H-9085-2016; menkes, christophe/X-6073-2019	menkes, christophe/0000-0002-1457-9696; menkes, christophe/0000-0002-1457-9696				Aufdenkampe AK, 2001, GLOBAL BIOGEOCHEM CY, V15, P101, DOI 10.1029/2000GB001268; Bricaud A, 1998, J GEOPHYS RES-OCEANS, V103, P31033, DOI 10.1029/98JC02712; BRICAUD A, 1995, J GEOPHYS RES-OCEANS, V100, P13321, DOI 10.1029/95JC00463; CARDER KL, 1989, LIMNOL OCEANOGR, V34, P68, DOI 10.4319/lo.1989.34.1.0068; Christian JR, 1997, J GEOPHYS RES-OCEANS, V102, P15667, DOI 10.1029/97JC00369; Cipollini P, 2001, GEOPHYS RES LETT, V28, P323, DOI 10.1029/1999GL011231; Claustre H, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014056; Claustre H, 1999, J GEOPHYS RES-OCEANS, V104, P3401, DOI 10.1029/98JC01334; CULLEN JJ, 1995, J GEOPHYS RES-OCEANS, V100, P13255, DOI 10.1029/95JC00454; Ducet N, 2000, J GEOPHYS RES-OCEANS, V105, P19477, DOI 10.1029/2000JC900063; Gill AE, 1982, ATMOSPHERE OCEAN DYN; HAURY LR, 1994, DEEP-SEA RES PT I, V41, P1191, DOI 10.1016/0967-0637(94)90040-X; Legendre L, 1998, J GEOPHYS RES-OCEANS, V103, P2897, DOI 10.1029/97JC02706; McGillicuddy DJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001987; McNeil JD, 1999, J GEOPHYS RES-OCEANS, V104, P15537, DOI 10.1029/1999JC900137; Mobley C.D., 1998, HYDROLIGHT 4 0 USERS; Neuer S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015393; O'Reilly JE, 1998, J GEOPHYS RES-OCEANS, V103, P24937, DOI 10.1029/98JC02160; Petzold T. J., 1972, 7278 SCRIPPS I OC; Romano JC, 1996, DEEP-SEA RES PT I, V43, P411, DOI 10.1016/0967-0637(96)00024-6; Siegel DA, 1996, DEEP-SEA RES PT II, V43, P321, DOI 10.1016/0967-0645(96)00088-4; Siegel DA, 2001, NATURE, V409, P576, DOI 10.1038/35054659; SMITH KL, 1989, NATURE, V337, P724, DOI 10.1038/337724a0; Uz BM, 2001, NATURE, V409, P597, DOI 10.1038/35054527; Vega A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015886; Villareal TA, 1996, J PLANKTON RES, V18, P1103, DOI 10.1093/plankt/18.7.1103; Wallace BB, 1999, LIMNOL OCEANOGR, V44, P273, DOI 10.4319/lo.1999.44.2.0273; YODER JA, 1994, NATURE, V371, P689, DOI 10.1038/371689a0; Zhang XD, 1998, APPL OPTICS, V37, P6525, DOI 10.1364/AO.37.006525	29	59	59	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1548	1551		10.1126/science.1090729	http://dx.doi.org/10.1126/science.1090729			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645844	Green Submitted			2022-12-24	WOS:000186802200038
J	Thompson, M; Haeusler, RA; Good, PD; Engelke, DR				Thompson, M; Haeusler, RA; Good, PD; Engelke, DR			Nucleolar clustering of dispersed tRNA genes	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; RIBONUCLEASE-P; YEAST; LOCALIZATION; 5S; HYBRIDIZATION; TRANSCRIPTION; COMPLEXES; SUBUNIT; REGION	Early transfer RNA (tRNA) processing events in Saccharomyces cerevisiae are co-ordinated in the nucleolus, the site normally associated with ribosome biosynthesis. To test whether spatial organization of the tRNA pathway begins with nucleolar clustering of the genes, we have probed the subnuclear location of five different tRNA gene families. The results show that tRNA genes, though dispersed in the linear genome, colocalize with 5S ribosomal DNA and U14 small nucleolar RNA at the nucleolus. Nucleolar localization requires tRNA gene transcription-complex formation, because inactivation of the promoter at a single locus removes its nucleolar association. This organization of tRNA genes must profoundly affect the spatial packaging of the genome and raises the question of whether gene types might be coordinated in three dimensions to regulate transcription.	Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Engelke, DR (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.			Haeusler, Rebecca/0000-0002-6973-9845	NIGMS NIH HHS [GM63142, T32 GM007544, R01 GM063142] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063142, T32GM007544] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bertrand E, 1998, GENE DEV, V12, P2463, DOI 10.1101/gad.12.16.2463; BOEKE JD, 1991, MOL CELLULAR BIOL YE, P193; Bolton EC, 2003, GENOME RES, V13, P254, DOI 10.1101/gr.612203; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Gasser SM, 2002, SCIENCE, V296, P1412, DOI 10.1126/science.1067703; Hediger F, 2002, CURR BIOL, V12, P2076, DOI 10.1016/S0960-9822(02)01338-6; HIGHETT MI, 1993, J CELL SCI, V105, P1151; HUIBREGTSE JM, 1989, MOL CELL BIOL, V9, P3244, DOI 10.1128/MCB.9.8.3244; HULL M, 1994, MOL CELL BIOL, V14, P3244; Jacobson MR, 1997, J CELL SCI, V110, P829; Jarrous N, 1999, J CELL BIOL, V146, P559, DOI 10.1083/jcb.146.3.559; KAPLAN FS, 1993, GENOMICS, V15, P123, DOI 10.1006/geno.1993.1020; Kendall A, 2000, P NATL ACAD SCI USA, V97, P13108, DOI 10.1073/pnas.240454997; KINSEY PT, 1991, NUCLEIC ACIDS RES, V19, P1317, DOI 10.1093/nar/19.6.1317; Lee B, 1996, P NATL ACAD SCI USA, V93, P11471, DOI 10.1073/pnas.93.21.11471; LEE Y, 1995, NUCLEIC ACIDS RES, V23, P634, DOI 10.1093/nar/23.4.634; LILJELUND P, 1992, P NATL ACAD SCI USA, V89, P9302, DOI 10.1073/pnas.89.19.9302; METZENBERG RL, 1985, P NATL ACAD SCI USA, V82, P2067, DOI 10.1073/pnas.82.7.2067; Montijn MB, 1999, CHROMOSOME RES, V7, P387, DOI 10.1023/A:1009272115295; NARAYANSWAMI S, 1990, CYTOMETRY, V11, P144, DOI 10.1002/cyto.990110117; OCONNOR JP, 1991, MOL CELL BIOL, V11, P425, DOI 10.1128/MCB.11.1.425; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Sarkar S, 1998, MOL BIOL CELL, V9, P3041, DOI 10.1091/mbc.9.11.3041; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241	26	245	267	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2003	302	5649					1399	1401		10.1126/science.1089814	http://dx.doi.org/10.1126/science.1089814			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631041	Green Published, Green Accepted			2022-12-24	WOS:000186683500053
J	McLaughlin, T; Abbasi, F; Cheal, K; Chu, J; Lamendola, C; Reaven, G				McLaughlin, T; Abbasi, F; Cheal, K; Chu, J; Lamendola, C; Reaven, G			Use of metabolic markers to identify overweight individuals who are insulin resistant	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; MEDIATED GLUCOSE DISPOSAL; HIGH-DENSITY-LIPOPROTEIN; DEPENDENT DIABETES-MELLITUS; WEIGHT-LOSS; HDL-CHOLESTEROL; OBESITY; RISK; HYPERINSULINEMIA; PREDICTOR	Background: Insulin resistance is more common in overweight individuals and is associated with increased risk for type 2 diabetes mellitus and cardiovascular disease. Given the current epidemic of obesity and the fact that lifestyle interventions, such as weight loss and exercise, decrease insulin resistance, a relatively simple means to identify overweight individuals who are insulin resistant would be clinically useful. Objective: To evaluate the ability of metabolic markers associated with insulin resistance and increased risk for cardiovascular disease to identify the subset of overweight individuals who are insulin resistant. Design: Cross-sectional study. Setting: General clinical research center. Patients: 258 nondiabetic, normotensive overweight volunteers. Measurements: Body mass index; fasting glucose, insulin, lipid and lipoprotein concentrations; and insulin-mediated glucose disposal as quantified by the steady-state plasma glucose concentration during the insulin suppression test. Overweight was defined as body mass index of 25 kg/m(2) or greater, and insulin resistance was defined as being in the top tertile of steady-state plasma glucose concentrations. Receiver-operating characteristic curve analysis was used to identify the best markers of insulin resistance; optimal cut-points were identified and analyzed for predictive power. Results: Plasma triglyceride concentration, ratio,of triglyceride to high-density lipoprotein cholesterol concentrations, and insulin concentration were the most useful metabolic markers in identifying insulin-resistant individuals. The optimal cut-points were 1.47 mmol/L (130 mg/dL) for triglycericle, 1.8 in SI units (3.0 in traditional units) for the triglyceride-high-density lipoprotein cholesterol ratio, and 109 pmol/L for insulin. Respective sensitivity and specifity for these cut-points were 67%, 64%, and 57% and 71%, 68%, and 85%. Their ability to identify insulin-resistant individuals was similar to the ability of the criteria proposed by the Adult Treatment Panel III to diagnose the metabolic syndrome (sensitivity, 52%, and specificity, 85%). Conclusions: Three relatively simple metabolic markers can help identify overweight individuals who are sufficiently insulin resistant to be at increased risk for various adverse outcomes. In the absence of a standardized insulin assay, we suggest that the most practical approach to identify overweight individuals who are insulin resistant is to use the cut-points for either triglycericle concentration or the triglyceride-high-density lipoprotein cholesterol concentration ratio.	Stanford Univ, Sch Med, Falk Cardiovasc Res Ctr, Div Cardiovasc Med, Stanford, CA 94305 USA	Stanford University	Reaven, G (corresponding author), Stanford Univ, Sch Med, Falk Cardiovasc Res Ctr, Div Cardiovasc Med, 300 Pasteur Dr, Stanford, CA 94305 USA.				NCRR NIH HHS [RR16071-01, RR000070-40] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016071] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abbasi F, 2002, J AM COLL CARDIOL, V40, P937, DOI 10.1016/S0735-1097(02)02051-X; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855; Facchini FS, 2001, J CLIN ENDOCR METAB, V86, P3574, DOI 10.1210/jc.86.8.3574; Galuska DA, 1999, JAMA-J AM MED ASSOC, V282, P1576, DOI 10.1001/jama.282.16.1576; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gaziano JM, 1997, CIRCULATION, V96, P2520, DOI 10.1161/01.CIR.96.8.2520; GREENFIELD MS, 1981, DIABETES, V30, P387, DOI 10.2337/diabetes.30.5.387; HALES CN, 1963, BIOCHEM J, V88, P137, DOI 10.1042/bj0880137; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Jeppesen J, 1998, J INTERN MED, V243, P293; Jeppesen J, 2001, ARCH INTERN MED, V161, P361, DOI 10.1001/archinte.161.3.361; Jones CNO, 2000, AM J PHYSIOL-ENDOC M, V278, pE501, DOI 10.1152/ajpendo.2000.278.3.E501; KADISH AH, 1968, CLIN CHEM, V14, P116; Khan LK, 2001, ANN INTERN MED, V134, P282, DOI 10.7326/0003-4819-134-4-200102200-00011; KINOSIAN B, 1994, ANN INTERN MED, V121, P641, DOI 10.7326/0003-4819-121-9-199411010-00002; Kuczmarski RJ, 1997, OBES RES, V5, P542, DOI 10.1002/j.1550-8528.1997.tb00575.x; LAWS A, 1992, J INTERN MED, V231, P25, DOI 10.1111/j.1365-2796.1992.tb00494.x; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; McLaughlin T, 2002, CIRCULATION, V106, P2908, DOI 10.1161/01.CIR.0000041046.32962.86; McLaughlin T, 2001, METABOLISM, V50, P795, DOI 10.1053/meta.2001.24210; McLaughlin T, 1999, J CLIN ENDOCR METAB, V84, P578, DOI 10.1210/jc.84.2.578; MILLER GJ, 1975, LANCET, V1, P16; OLEFSKY J, 1974, J CLIN INVEST, V53, P64, DOI 10.1172/JCI107560; PEI D, 1994, DIABETOLOGIA, V37, P843, DOI 10.1007/BF00404344; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; Reaven G, 2001, AM J CARDIOL, V87, P827, DOI 10.1016/S0002-9149(00)01521-6; REAVEN GM, 1993, DIABETES, V42, P1324, DOI 10.2337/diabetes.42.9.1324; REAVEN GM, 2001, HDB PHYSL 7, V2, P1169; SHEN SW, 1970, J CLIN INVEST, V49, P2151, DOI 10.1172/JCI106433; Tuan CY, 2003, AM J CARDIOL, V92, P606, DOI 10.1016/S0002-9149(03)00735-5; WAHLEFELD A., 1974, METHOD ENZYMAT AN, P1831; WHO Expert Comm, 1998, WHO TECH REP SER, V881, P1; Woodward M., 2014, EPIDEMIOLOGY STUDY D; Yeni-Komshian H, 2000, DIABETES CARE, V23, P171, DOI 10.2337/diacare.23.2.171; Yip J, 1998, J CLIN ENDOCR METAB, V83, P2773, DOI 10.1210/jc.83.8.2773; ZAVARONI I, 1994, J INTERN MED, V235, P51, DOI 10.1111/j.1365-2796.1994.tb01031.x; Zavaroni I, 1999, METABOLISM, V48, P989, DOI 10.1016/S0026-0495(99)90195-6	43	686	713	3	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2003	139	10					802	809		10.7326/0003-4819-139-10-200311180-00007	http://dx.doi.org/10.7326/0003-4819-139-10-200311180-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744ZV	14623617				2022-12-24	WOS:000186663500002
J	Stevens, AM; Hermes, HM; Rutledge, JC; Buyon, JP; Nelson, JL				Stevens, AM; Hermes, HM; Rutledge, JC; Buyon, JP; Nelson, JL			Myocardial-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block	LANCET			English	Article							UMBILICAL-CORD BLOOD; IN-SITU HYBRIDIZATION; BONE-MARROW; AUTOIMMUNE-DISEASE; CELLS; ANTIBODIES; CHIMERISM; ERYTHEMATOSUS; IDENTIFICATION; AUTOANTIBODIES	Background During pregnancy, maternal cells pass into the fetus, where they can persist for many years after birth. We investigated the presence of maternal cells in neonatal lupus syndrome (NLS), an autoimmune disease that develops in utero. The most serious complication of NLS is inflammation of the atrioventricular node leading to congenital heart block (CHB). Methods In a blinded case-control study, maternal (female) cells were detected and quantified in male NLS and control heart-tissue samples. We used fluorescence in-situ hybridisation to label X and Y chromosomes. Studies in transplantation suggest that donor cells can differentiate into somatic tissue cells. Therefore, we asked whether maternal cells transferred in utero have cellular plasticity. To simultaneously identify and characterise maternal cells, we developed a technique by which multiple phenotypic markers could be detected concurrently with fluorescence in-situ hybridisation in the same cells of a tissue section. Findings Maternal cells were found in 15 of 15 sections of NLS heart tissue, ranging from 0.025% to 2.2% of total cells. By contrast, maternal cells were found in two of eight control sections (0-0.1%). Very few maternal cells expressed the haemopoietic cell marker CD45. Most expressed sarcomeric alpha actin, a specific marker for cardiac myocytes. Interpretation Our findings suggest that differentiated tissue-specific maternal microchimerism can occur in neonates. Thus, semiallogeneic maternal cells could be the target of an immune response. Alternatively, maternal cells could contribute to a secondary process of tissue repair.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Childrens Hosp & Reg Med Ctr, Seattle, WA USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Hosp Joint Dis & Med Ctr, New York, NY USA; Univ Washington, Dept Med, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; University of Washington; University of Washington Seattle	Stevens, AM (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,D2-100,POB 19024, Seattle, WA 98109 USA.	astevens@fhcrc.org		Buyon, Jill/0000-0002-3852-7129	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041721] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI041721] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARNAIZVILLENA A, 1989, ARTHRITIS RHEUM-US, V32, P1421, DOI 10.1002/anr.1780321111; Artlett CM, 2000, LANCET, V356, P2155, DOI 10.1016/S0140-6736(00)03499-1; BENIISCHKE K, 1990, PATHOLOGY HUMAN PLAC, P684; Boutjdir M, 1997, CIRC RES, V80, P354, DOI 10.1161/01.RES.80.3.354; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Brucato A, 2001, ARTHRITIS RHEUM-US, V44, P1832, DOI 10.1002/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C; BUYON JP, 1995, LUPUS, V4, P116, DOI 10.1177/096120339500400207; CANNAT A, 1973, BIOMEDICINE, V19, P108; DESAI RG, 1963, BLOOD, V21, P665, DOI 10.1182/blood.V21.6.665.665; HALL JM, 1995, BLOOD, V86, P2829; HORSFALL AC, 1991, J AUTOIMMUN, V4, P165, DOI 10.1016/0896-8411(91)90015-5; Johnson KL, 2000, BIOTECHNIQUES, V29, P1220, DOI 10.2144/00296st01; Kita H, 2002, J EXP MED, V195, P113, DOI 10.1084/jem.20010956; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Laflamme MA, 2002, CIRC RES, V90, P634, DOI 10.1161/01.RES.0000014822.62629.EB; Lagaaij EL, 2001, LANCET, V357, P33, DOI 10.1016/S0140-6736(00)03569-8; Lee TH, 1999, BLOOD, V93, P3127; Lo YMD, 2000, CLIN CHEM, V46, P1301; Lo YMD, 1996, BLOOD, V88, P4390; Lo YMD, 1998, BRIT J HAEMATOL, V100, P605; Maloney S, 1999, J CLIN INVEST, V104, P41, DOI 10.1172/JCI6611; Miranda-Carus ME, 1998, J IMMUNOL, V161, P5886; Miyagawa S, 1997, ARTHRITIS RHEUM, V40, P982, DOI 10.1002/art.1780400532; Nelson JL, 2002, TRENDS MOL MED, V8, P109, DOI 10.1016/S1471-4914(01)02269-9; OREILLY RJ, 1973, TRANSPLANTATION, V15, P505; Petit T, 1997, BRIT J HAEMATOL, V98, P767, DOI 10.1046/j.1365-2141.1997.2603076.x; Petit T, 1995, EXP HEMATOL, V23, P1601; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Reed AM, 2000, LANCET, V356, P2156, DOI 10.1016/S0140-6736(00)03500-5; REICHLIN M, 1994, ARTHRITIS RHEUM, V37, P1698, DOI 10.1002/art.1780371120; Rinkevich B, 2001, HUM IMMUNOL, V62, P651, DOI 10.1016/S0198-8859(01)00249-X; Saleeb S, 1999, ARTHRITIS RHEUM, V42, P2335, DOI 10.1002/1529-0131(199911)42:11<2335::AID-ANR12>3.0.CO;2-3; Setiady YY, 2003, J IMMUNOL, V170, P4656, DOI 10.4049/jimmunol.170.9.4656; SOCIE G, 1994, BLOOD, V83, P340; Stevens Anne, 2002, NEOREVIEWS, V3, pe11, DOI DOI 10.1542/NEO.3-1-E11; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Tran HB, 2002, ARTHRITIS RHEUM-US, V46, P1572, DOI 10.1002/art.10316; Tseng CE, 1997, RHEUM DIS CLIN N AM, V23, P31, DOI 10.1016/S0889-857X(05)70313-6; VANDERVEEN FM, 1982, ADV EXP MED BIOL, V149, P669; WATSON RM, 1984, MEDICINE, V63, P362, DOI 10.1097/00005792-198411000-00003; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	42	103	113	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2003	362	9396					1617	1623		10.1016/S0140-6736(03)14795-2	http://dx.doi.org/10.1016/S0140-6736(03)14795-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744MZ	14630442				2022-12-24	WOS:000186637400010
J	Cao, K; Nakajima, R; Meyer, HH; Zheng, YX				Cao, K; Nakajima, R; Meyer, HH; Zheng, YX			The AAA-ATPase Cdc48/p97 regulates spindle disassembly at the end of mitosis	CELL			English	Article							MICROTUBULE DYNAMIC INSTABILITY; XENOPUS EGG EXTRACTS; CELL-CYCLE; MITOTIC-SPINDLE; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; PROTEIN DISLOCATION; IMPORTIN-ALPHA; RAN	Spindle disassembly at the end of mitosis is a complex and poorly understood process. Here, we report that the AAA-ATPase Cdc48/p97 and its adapters Ufd1-Np14, which have a well-established role in membrane functions, also regulate spindle disassembly by modulating microtubule dynamics and bundling at the end of mitosis. In the absence of p97-Ufd1-Np14 function, microtubules in Xenopus egg extracts remain as monopolar spindles attached to condensed chromosomes after Cdc2 kinase activity has returned to the interphase level. Consequently, interphase microtubule arrays and nuclei are not established. Genetic analyses of Cdc48, the yeast homolog of p97, reveal that Cdc48 is also required for disassembly of mitotic spindles after execution of the mitotic exit pathway. Furthermore, Cdc48/p97-Ufd1-Np14 directly binds to spindle assembly factors and regulates their interaction with microtubules at the end of mitosis. Therefore, Cdc48/p97-Ufd1-Np14 is an essential chaperone that regulates transformation of the microtubule structure as cells reenter interphase.	Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21210 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21210 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; ETH Honggerberg, Inst Biochem, CH-8093 Zurich, Switzerland	Carnegie Institution for Science; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Zheng, YX (corresponding author), Carnegie Inst Sci, Dept Embryol, 115 W Univ Pkwy, Baltimore, MD 21210 USA.	zheng@ciwemb.edu	Meyer, Hemmo/GNH-5784-2022	Meyer, Hemmo/0000-0003-1883-1796				Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Cassimeris L, 1999, CURR OPIN CELL BIOL, V11, P134, DOI 10.1016/S0955-0674(99)80017-9; Cheng L, 1998, MOL CELL BIOL, V18, P7360, DOI 10.1128/MCB.18.12.7360; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; FELIX MA, 1989, EMBO J, V8, P3059, DOI 10.1002/j.1460-2075.1989.tb08457.x; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; GLIKSMAN NR, 1992, J CELL BIOL, V119, P1271, DOI 10.1083/jcb.119.5.1271; GLIKSMAN NR, 1993, MOL BIOL CELL, V4, P1035, DOI 10.1091/mbc.4.10.1035; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Hoyt MA, 2000, CELL, V102, P267, DOI 10.1016/S0092-8674(00)00031-3; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jarosch E, 2002, TRAFFIC, V3, P530, DOI 10.1034/j.1600-0854.2002.30803.x; Jensen S, 2002, CURR BIOL, V12, pR221, DOI 10.1016/S0960-9822(02)00756-X; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; McNally FJ, 1996, CURR OPIN CELL BIOL, V8, P23, DOI 10.1016/S0955-0674(96)80044-5; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; MITCHISON TJ, 1986, METHOD ENZYMOL, V134, P261; MOIR D, 1982, GENETICS, V100, P547; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; PELLMAN D, 1995, J CELL BIOL, V130, P1373, DOI 10.1083/jcb.130.6.1373; Qian YW, 1999, MOL CELL BIOL, V19, P8625; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Shirasu-Hiza M, 2003, J CELL BIOL, V161, P349, DOI 10.1083/jcb.200211095; Song SG, 2001, J CELL BIOL, V152, P451, DOI 10.1083/jcb.152.3.451; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; van Breugel M, 2003, J CELL BIOL, V161, P359, DOI 10.1083/jcb.200211097; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; VERDE F, 1990, NATURE, V343, P233, DOI 10.1038/343233a0; Walczak CE, 1997, J CELL BIOL, V136, P859, DOI 10.1083/jcb.136.4.859; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Zhai Y, 1996, J CELL BIOL, V135, P201, DOI 10.1083/jcb.135.1.201	58	166	174	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2003	115	3					355	367		10.1016/S0092-8674(03)00815-8	http://dx.doi.org/10.1016/S0092-8674(03)00815-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	740RH	14636562	Bronze			2022-12-24	WOS:000186415000014
J	Zhong, NS; Zheng, BJ; Li, YM; Poon, LLM; Xie, ZH; Chan, KH; Li, PH; Tan, SY; Chang, Q; Xie, JP; Liu, XQ; Xu, J; Li, DX; Yuen, KY; Peiris, JSM; Guan, Y				Zhong, NS; Zheng, BJ; Li, YM; Poon, LLM; Xie, ZH; Chan, KH; Li, PH; Tan, SY; Chang, Q; Xie, JP; Liu, XQ; Xu, J; Li, DX; Yuen, KY; Peiris, JSM; Guan, Y			Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003	LANCET			English	Article							HONG-KONG; CORONAVIRUS	Background An epidemic of severe acute respiratory syndrome (SARS) has been associated with an outbreak of atypical pneumonia originating in Guangdong Province, People's Republic of China. We aimed to identify the causative agent in the Guangdong outbreak and describe the emergence and spread of the disease within the province. Methods We analysed epidemiological information and collected serum and nasopharyngeal aspirates from patients with SARS in Guangdong in mid-February, 2003. We did virus isolation, serological tests, and molecular assays to identify the causative agent. Findings SARS had been circulating in other cities of Guangdong Province for about 2 months before causing a major outbreak in Guangzhou, the province's capital. A novel coronavirus, SARS coronavirus (CoV), was isolated from specimens from three patients with SARS. Viral antigens were also directly detected in nasopharyngeal aspirates from these patients. 48 of 55 (87%) patients had antibodies to SARS CoV in their convalescent sera. Genetic analysis showed that the SARS CoV isolates from Guangzhou shared the same origin with those in other countries, and had a phylogenetic pathway that matched the spread of SARS to the other parts of the world. Interpretation SARS CoV is the infectious agent responsible for the epidemic outbreak of SARS in Guangdong. The virus isolated from patients in Guangdong is the prototype of the SARS CoV in other regions and countries.	Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Guangzhou Med Coll, Guangzhou Inst Resp Dis, Guangzhou, Guangdong Prov, Peoples R China; Guangzhou Chest Hosp, Guangzhou, Guangdong Prov, Peoples R China; Guangzhou Childrens Hosp, Guangzhou, Guangdong Prov, Peoples R China	University of Hong Kong; Guangzhou Medical University	Guan, Y (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Univ Pathol Bldg,Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.		Chan, Kwok Hung/ABD-5399-2021; Poon, Leo Lit Man/C-4382-2009; Poon, Leo/AAP-6887-2020; Yuen, Kwok Yung/C-4465-2009; Peiris, Joseph Sriyal Malik/C-4380-2009	Poon, Leo Lit Man/0000-0002-9101-7953; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Yuen, Kwok-yung/0000-0002-2083-1552; li, yimin/0000-0003-0810-5256; Guan, Yi/0000-0001-6057-9243	PHS HHS [A195357] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 2003, WKLY EPIDEMIOL REC, V78, P81; DEJONG JC, 1997, NATURE, V389, P544; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; *GUANGD PUBL HLTH, 2003, 2 GUANGD PUBL HLTH O; HOLLAND JJ, 1991, J VIROL, V65, P1960; Knipe D, 2001, FIELDS VIROLOGY, P1187; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; [彭国文 Peng Guowen], 2003, [中华流行病学杂志, Chinese Journal of Epidemiology], V24, P350; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; SHORTRIDGE KF, 1982, LANCET, V2, P812; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; *WHO, CAS DEF SURV SEV AC; World Health Organization, CUM NUMB REP PROB CA; 2003, MMWR MORB MORT WKL R, V52, P241	20	870	932	17	178	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 25	2003	362	9393					1353	1358		10.1016/S0140-6736(03)14630-2	http://dx.doi.org/10.1016/S0140-6736(03)14630-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735YX	14585636	Green Published, Bronze			2022-12-24	WOS:000186143300008
J	Peter, BJ; Kent, HM; Mills, IG; Vallis, Y; Butler, PJG; Evans, PR; McMahon, HT				Peter, BJ; Kent, HM; Mills, IG; Vallis, Y; Butler, PJG; Evans, PR; McMahon, HT			BAR domains as sensors of membrane curvature: The amphiphysin BAR structure	SCIENCE			English	Article							GTPASE-ACTIVATING PROTEIN; SYNAPTIC VESICLE ENDOCYTOSIS; CLATHRIN-MEDIATED ENDOCYTOSIS; ADP-RIBOSYLATION FACTORS; ACTIN CYTOSKELETON; DROSOPHILA AMPHIPHYSIN; LYSOPHOSPHATIDIC ACID; TERMINAL DOMAIN; SH3 DOMAIN; BINDING	The BAR (Bin/amphiphysin/Rvs) domain is the most conserved feature in amphiphysins from yeast to human and is also found in endophilins and nadrins. We solved the structure of the Drosophila amphiphysin BAR domain. It is a crescent-shaped dimer that binds preferentially to highly curved negatively charged membranes. With its N-terminal amphipathic helix and BAR domain (N-BAR), amphiphysin can drive membrane curvature in vitro and in vivo. The structure is similar to that of arfaptin2, which we find also binds and tubulates membranes. From this, we predict that BAR domains are in many protein families, including sorting nexins, centaurins, and oligophrenins. The universal and minimal BAR domain is a dimerization, membrane-binding, and curvature-sensing module.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Evans, PR (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	pre@mrc-lmb.cam.ac.uk; hmm@mrc-lmb.cam.ac.uk	Mills, Ian/AAK-9292-2020; Peter, Brian/AAZ-7323-2020	Mills, Ian/0000-0001-5347-5083; 				Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Billuart P, 1998, PATHOL BIOL, V46, P678; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; Drake MT, 2001, J BIOL CHEM, V276, P28700, DOI 10.1074/jbc.M104226200; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fauchereau F, 2003, MOL CELL NEUROSCI, V23, P574, DOI 10.1016/S1044-7431(03)00078-2; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Ge K, 2000, GENOMICS, V67, P210, DOI 10.1006/geno.2000.6216; Greiner J, 2003, INT J CANCER, V106, P224, DOI 10.1002/ijc.11200; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; Harada A, 2000, J BIOL CHEM, V275, P36885, DOI 10.1074/jbc.M004069200; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; Jackson TR, 2000, TRENDS BIOCHEM SCI, V25, P489, DOI 10.1016/S0968-0004(00)01644-3; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Leventis PA, 2001, TRAFFIC, V2, P839; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; McMahon HT, 1997, FEBS LETT, V413, P319, DOI 10.1016/S0014-5793(97)00928-9; Modregger J, 2003, J BIOL CHEM, V278, P4160, DOI 10.1074/jbc.M208568200; Nie ZZ, 2002, J BIOL CHEM, V277, P48965, DOI 10.1074/jbc.M202969200; PETER BJ, UNPUB; Pilon M, 2000, MOL BIOL CELL, V11, P3277, DOI 10.1091/mbc.11.10.3277; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Reinhard C, 2003, P NATL ACAD SCI USA, V100, P8253, DOI 10.1073/pnas.1432391100; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; Salazar MA, 2003, J BIOL CHEM, V278, P49031, DOI 10.1074/jbc.M308104200; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Shin OH, 2001, BIOCHEM BIOPH RES CO, V285, P1267, DOI 10.1006/bbrc.2001.5330; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; Spitzenberger F, 2003, J BIOL CHEM, V278, P26166, DOI 10.1074/jbc.M213222200; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wigge P, 1997, CURR BIOL, V7, P554, DOI 10.1016/S0960-9822(06)00254-5; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Zelhof AC, 2001, DEVELOPMENT, V128, P5005; Zhang B, 2002, TRAFFIC, V3, P452, DOI 10.1034/j.1600-0854.2002.30702.x	46	1272	1306	0	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2004	303	5657					495	499		10.1126/science.1092586	http://dx.doi.org/10.1126/science.1092586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765XM	14645856				2022-12-24	WOS:000188316400030
J	Sarmiento, JL; Gruber, N; Brzezinski, MA; Dunne, JP				Sarmiento, JL; Gruber, N; Brzezinski, MA; Dunne, JP			High-latitude controls of thermocline nutrients and low latitude biological productivity	NATURE			English	Article							SOUTHERN-OCEAN; NORTH; SI; CYCLE; MODE	The ocean's biological pump strips nutrients out of the surface waters and exports them into the thermocline and deep waters. If there were no return path of nutrients from deep waters, the biological pump would eventually deplete the surface waters and thermocline of nutrients; surface biological productivity would plummet. Here we make use of the combined distributions of silicic acid and nitrate to trace the main nutrient return path from deep waters by upwelling in the Southern Ocean(1) and subsequent entrainment into subantarctic mode water. We show that the subantarctic mode water, which spreads throughout the entire Southern Hemisphere(2,3) and North Atlantic Ocean(3), is the main source of nutrients for the thermocline. We also find that an additional return path exists in the northwest corner of the Pacific Ocean, where enhanced vertical mixing, perhaps driven by tides(4), brings abyssal nutrients to the surface and supplies them to the thermocline of the North Pacific. Our analysis has important implications for our understanding of large-scale controls on the nature and magnitude of low-latitude biological productivity and its sensitivity to climate change.	Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA; Univ Calif Los Angeles, IGPP, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Atmospher Sci, Los Angeles, CA 90095 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; National Oceanic Atmospheric Admin (NOAA) - USA	Sarmiento, JL (corresponding author), Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA.	jls@princeton.edu	Gruber, Nicolas/B-7013-2009; Dunne, John P/F-8086-2012	Gruber, Nicolas/0000-0002-2085-2310; Dunne, John P/0000-0002-8794-0489				Belkin IM, 1996, J GEOPHYS RES-OCEANS, V101, P3675, DOI 10.1029/95JC02750; Brzezinski MA, 2003, DEEP-SEA RES PT II, V50, P619, DOI 10.1016/S0967-0645(02)00587-8; Dugdale RC, 2002, DEEP-SEA RES PT II, V49, P2513, DOI 10.1016/S0967-0645(02)00046-2; Franck VM, 2000, DEEP-SEA RES PT II, V47, P3315; Gnanadesikan A, 2001, DEEP-SEA RES PT II, V49, P363; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Hanawa K., 2001, INT GEOPHYS, Vpp, P373, DOI [DOI 10.1016/S0074-6142(01)80129-7, 10.1016/S0074-6142(01)80129-7]; KARA AB, 2003, J GEOPHYS RES, V108, DOI DOI 10.1029/2000C000736; LEDWELL JR, 1993, NATURE, V364, P701, DOI 10.1038/364701a0; Levitus S., 1998, WORLD OCEAN DATABASE, V1; McCartney M.S., 1977, VOYAGE DISCOVERY GEO, P103; McCartney MS, 1982, J MAR RES, V40, P427; Moore JK, 1999, J GEOPHYS RES-OCEANS, V104, P3059, DOI 10.1029/1998JC900032; Nakamura T, 2000, J PHYS OCEANOGR, V30, P1601, DOI 10.1175/1520-0485(2000)030<1601:TGOLAU>2.0.CO;2; Pollard RT, 2002, DEEP-SEA RES PT II, V49, P3289, DOI 10.1016/S0967-0645(02)00084-X; Ragueneau O, 2000, GLOBAL PLANET CHANGE, V26, P317, DOI 10.1016/S0921-8181(00)00052-7; Reid JL, 1997, PROG OCEANOGR, V39, P263, DOI 10.1016/S0079-6611(97)00012-8; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; SARMIENTO JL, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI DOI 10.1029/2002GB00191; Sigman DM, 1999, GLOBAL BIOGEOCHEM CY, V13, P1149, DOI 10.1029/1999GB900038; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Sloyan BM, 2001, J PHYS OCEANOGR, V31, P1005, DOI 10.1175/1520-0485(2001)031<1005:CRAMOA>2.0.CO;2; Speer K, 2000, J PHYS OCEANOGR, V30, P3212, DOI 10.1175/1520-0485(2000)030<3212:TDDC>2.0.CO;2; TALLEY LD, 1991, DEEP-SEA RES, V38, pS171, DOI 10.1016/S0198-0149(12)80009-4; Talley LD, 1997, J PHYS OCEANOGR, V27, P1795, DOI 10.1175/1520-0485(1997)027<1795:NPIWTI>2.0.CO;2; TOGGWEILER JR, 1991, J GEOPHYS RES-OCEANS, V96, P20467, DOI 10.1029/91JC02063; TOGGWEILER JR, 1993, GLOBAL CARBON CYCLE, P333; Tsunogai S, 2002, J OCEANOGR, V58, P245, DOI 10.1023/A:1015805607724; Yasuda I, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001037; Yasuda I, 2001, J GEOPHYS RES-OCEANS, V106, P6931, DOI 10.1029/1999JC000154	30	862	877	4	210	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2004	427	6969					56	60		10.1038/nature02127	http://dx.doi.org/10.1038/nature02127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YP	14702082				2022-12-24	WOS:000187710000031
J	Gostin, LO; Bayer, R; Fairchild, AL				Gostin, LO; Bayer, R; Fairchild, AL			Ethical and legal challenges posed by severe acute respiratory syndrome - Implications for the control of severe infectious disease threats	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; TERRORISM; EPIDEMIC; CARE; LAW	The appearance and spread of severe acute respiratory syndrome (SARS) on a global level raised vital legal and ethical issues. National and international responses to SARS have profound implications for 3 important ethical values:, privacy, liberty, and the duty to protect the public's health. This article examines, through legal and ethical lenses, various methods that countries used in reaction to the SARS outbreak: surveillance and contact tracing, isolation and quarantine, and travel restrictions. These responses, at least in some combination, succeeded in bringing the outbreak to an end. The article articulates a set of legal and ethical recommendations for responding to infectious disease threats, seeking to reconcile the tension between the public's health and individual rights to privacy, liberty, and freedom of movement. The ethical values that inform the recommendations include the precautionary principle, the least restrictive/intrusive alternative, justice, and transparency. Development of a set of legal and ethical recommendations becomes even more essential when, as was true with SARS and will undoubtedly be the case with future epidemics, scientific uncertainty is pervasive,and urgent public health action is required.	Georgetown Univ, Ctr Law, Ctr Law & Publ Hlth, Washington, DC 20001 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; Columbia Univ, Dept Sociomed Sci, Ctr Hist & Eth Publ Hlth, Joseph L Mailman Sch Publ Hlth, New York, NY USA	Georgetown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Columbia University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, Ctr Law & Publ Hlth, 600 New Jersey Ave NW, Washington, DC 20001 USA.		Fairchild, Amy/F-1811-2018	Fairchild, Amy/0000-0002-1292-7212				ALTMAN LK, 2003, NY TIMES        0428, pA1; [Anonymous], 1991, Law Med Health Care, V19, P247; [Anonymous], 2003, MMWR MORB MORTAL WKL, V52, P226; [Anonymous], 1995, CONTROL COMMUNICABLE; Applegate JS, 2000, HUM ECOL RISK ASSESS, V6, P413, DOI 10.1080/10807030091124554; Barbera J, 2001, JAMA-J AM MED ASSOC, V286, P2711, DOI 10.1001/jama.286.21.2711; BAYER R, 1986, JAMA-J AM MED ASSOC, V256, P1768, DOI 10.1001/jama.256.13.1768; Bloom BR, 2003, SCIENCE, V300, P701, DOI 10.1126/science.300.5620.701; Bradsher K, 2003, NY TIMES, pA1; BRADSHER K, 2003, NY TIMES        0425, pA20; BROWN DL, 2003, WASHINGTON POST 0424, pA20; *CDC, 2003, MMWR-MORBID MORTAL W, V52, P436; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P270; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P40; CHENG M, 2003, NEW YORK NEWSDA 0517, pA4; Cohn M. R., 2003, TORONTO STAR    0421, pAl; COOPER MH, 2003, CQ RES          0620; DONOVAN K, 2003, TORONTO STAR    0425, pA14; Feinberg J., 1987, MORAL LIMITS CRIMINA; Fidler DP, 2003, EMERG INFECT DIS, V9, P285, DOI 10.3201/eid0903.020336; FUJIWARA PI, TB CONTR NEW YORK CI; GARRETT L, 2003, NEWSDAY         0629, pA5; Gerberding JL, 2003, NEW ENGL J MED, V348, P2030, DOI 10.1056/NEJMe030067; Gostin LO, 1997, NEW ENGL J MED, V337, P1162, DOI 10.1056/NEJM199710163371611; Gostin LO, 2002, HEALTH AFFAIR, V21, P79, DOI 10.1377/hlthaff.21.6.79; Gostin LO, 2000, PUBLIC HLTH LAW POWE; *HARV U HLTH SERV, U ANN POL REG VIS SU; Kahn Joseph, 2003, NY TIMES        0701, pA; KRAUSS C, 2003, NY TIMES        0610, pA13; KUEPPER GJ, HONG KONG EXPERIENCE; LONG S, 2003, STRAITS TIMES S 0511; MARSHALL T, 2003, LOS ANGELES TIM 0428, P1; Masur H, 2003, JAMA-J AM MED ASSOC, V289, P2861, DOI 10.1001/jama.289.21.JED30036; MAYNARD M, 2003, NY TIMES        0511, P5; MAYNARD M, 2003, NY TIMES        0511, P6; MCNEIL DG, 2003, NYT             0314, pA1; MORRIS J, 2000, RETHINKING RISK PREC, P1; MURPHY DE, 2003, NY TIMES, pA12; NAKASHIMA E, 2003, WASHINGTON POST 0501, pA11; PADDOCK R, 2003, LOS ANGELES TIM 0508, P1; PERL T, 2003, REPORT TORONTO ETHIC; Rider D., 2003, OTTAWA CITIZEN  0404, pA10; RIDER D, 2003, OTTAWA CITIZEN  0420, pA1; SHELDON P, 2003, NY TIMES        0507, pA10; Sorenson C., 2003, TORONTO STAR    0404; STERNBERG S, 2003, US TODAY        0424, pA1; *UN EC SOC COUNC, ECN419854 UN; WAYNE A, 2003, NY TIMES        0610, pF4; WHO, GUID MASS GATH HOST; *WHO, UPD 70 SING REM LIST; *WHO, UPD 58 1 GLOB CONS S; *WHO, UPD 95 CHRON TRAV RE; *WHO, CURR INT HLTH REG IH; *WHO, 2003, WKLY EPIDEMIOL REC, V78, P98; *WHO, CAS DEF SURV SEV AC; World Health Organization, REV INT HLTH REG SEV; World Health Organization, UPD 95 SARS CHRON SE; World Health Organization, 2003, SEV AC RESP SYNDR SA; World Health Organization, CUM NUMB REP PROB CA; World Health Organization (WHO), 2003, WKLY EPIDEMIOL REC, V78, P161; Wynia MK, 2002, SCIENCE, V296, P1613, DOI 10.1126/science.1072921; 1999, INT COVENANT CIVIL P; 2003, MMWR MORB MORTAL WKL, V52, P680; FREEDOM MOVEMENT TRA; SHELTERING PLACE; 2003, STRAITS TIMES S 0425; POLICE SYSTEM TRACKI	67	128	132	2	27	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2003	290	24					3229	3237		10.1001/jama.290.24.3229	http://dx.doi.org/10.1001/jama.290.24.3229			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	756TR	14693876				2022-12-24	WOS:000187499300027
J	Buckling, A; Wills, MA; Colegrave, N				Buckling, A; Wills, MA; Colegrave, N			Adaptation limits diversification of experimental bacterial populations	SCIENCE			English	Article							EXPERIMENTAL EVOLUTION; GENETIC-POLYMORPHISM; PEAKS; DIVERSITY; FITNESS	Adaptation to a specific niche theoretically constrains a population's ability to subsequently diversify into other niches. We tested this theory using the bacterium Pseudomonas fluorescens, which diversifies into niche specialists when propagated in laboratory microcosms. Numerically dominant genotypes were allowed to diversify in isolation. As predicted, populations increased in fitness through time but showed a greatly decreased ability to diversify. Subsequent experiments demonstrated that niche generalists and reductions in intrinsic evolvability were not responsible for our data. These results show that niche specialization may come with a cost of reduced potential to diversify.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Bath; University of Edinburgh	Buckling, A (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssagjb@bath.ac.uk	Colegrave, Nick/F-3916-2010; Wills, Matthew Albion/AAE-1790-2019	Buckling, Angus/0000-0003-1170-4604; Wills, Matthew/0000-0002-7344-7749				Ayala F.J., 1974, Annual Rev Ecol Syst, V5, P115, DOI 10.1146/annurev.es.05.110174.000555; BELL G, 1997, SELECTION MECH EVOLU; Buckling A, 2002, NATURE, V420, P496, DOI 10.1038/nature01164; Buckling A, 2000, NATURE, V408, P961, DOI 10.1038/35050080; FOBZHANSKY T, 1937, GENETICS ORIGIN SPEC; HEDRICK PW, 1976, ANNU REV ECOL SYST, V7, P1, DOI 10.1146/annurev.es.07.110176.000245; HEDRICK PW, 1986, ANNU REV ECOL SYST, V17, P535; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; KORONA R, 1994, P NATL ACAD SCI USA, V91, P9037, DOI 10.1073/pnas.91.19.9037; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; Muller HJ, 1939, BIOL REV CAMB PHILOS, V14, P261, DOI 10.1111/j.1469-185X.1939.tb00934.x; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rainey PB, 1996, MOL MICROBIOL, V19, P521, DOI 10.1046/j.1365-2958.1996.391926.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROSENZWEIG RF, 1994, GENETICS, V137, P903; Rozen DE, 2000, AM NAT, V155, P24, DOI 10.1086/303299; Schluter D, 2000, AM NAT, V156, pS4, DOI 10.1086/303412; Schluter D, 2000, ECOLOGY ADAPTIVE RAD; Templeton A., 2000, EPISTASIS EVOLUTIONA; Vamosi SM, 2002, P ROY SOC B-BIOL SCI, V269, P923, DOI 10.1098/rspb.2001.1946; Wade Michael J., 2000, P213; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; Wright S, 1931, GENETICS, V16, P0097	24	82	87	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2107	2109		10.1126/science.1088848	http://dx.doi.org/10.1126/science.1088848			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684817	Green Submitted			2022-12-24	WOS:000187385200039
J	Ganesh, L; Burstein, E; Guha-Nijogi, A; Louder, MK; Mascola, JR; Klomp, LWJ; Wijmenga, C; Duckett, CS; Nabel, GJ				Ganesh, L; Burstein, E; Guha-Nijogi, A; Louder, MK; Mascola, JR; Klomp, LWJ; Wijmenga, C; Duckett, CS; Nabel, GJ			The gene product Murr1 restricts HIV-1 replication in resting CD4(+) lymphocytes	NATURE			English	Article							NF-KAPPA-B; HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELLS; UBIQUITINATION; ACTIVATION; ALPHA; TRANSCRIPTION; INFECTION; COMPLEX; PHOSPHORYLATION	Although human immunodeficiency virus-1 (HIV-1) infects quiescent and proliferating CD4(+) lymphocytes, the virus replicates poorly in resting T cells(1-6). Factors that block viral replication in these cells might help to prolong the asymptomatic phase of HIV infection(7); however, the molecular mechanisms that control this process are not fully understood. Here we show that Murr1, a gene product known previously for its involvement in copper regulation(8,9), inhibits HIV-1 growth in unstimulated CD4(+) T cells. This inhibition was mediated in part through its ability to inhibit basal and cytokine-stimulated nuclear factor (NF)-kappaB activity. Knockdown of Murr1 increased NF-kappaB activity and decreased IkappaB-alpha concentrations by facilitating phospho-IkappaB-alpha degradation by the proteasome. Murr1 was detected in CD4(+) T cells, and RNA-mediated interference of Murr1 in primary resting CD4(+) lymphocytes increased HIV-1 replication. Through its effects on the proteasome, Murr1 acts as a genetic restriction factor that inhibits HIV-1 replication in lymphocytes, which could contribute to the regulation of asymptomatic HIV infection and the progression of AIDS.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Univ Med Ctr Utrecht, NL-3584 EA Utrecht, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Michigan System; University of Michigan; Utrecht University; Utrecht University Medical Center	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bldg 40,Room 4502,MSC-3005,40 Convent Dr, Bethesda, MD 20892 USA.		Wijmenga, Cisca/AAE-7719-2019; Burstein, Ezra/B-7247-2016; Mascola, John/AAI-7193-2021; Wijmenga, Cisca/D-2173-2009	Wijmenga, Cisca/0000-0002-5635-1614; Burstein, Ezra/0000-0003-4341-6367; Duckett, Colin/0000-0001-9413-2263				ADAMS M, 1994, P NATL ACAD SCI USA, V91, P3862, DOI 10.1073/pnas.91.9.3862; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hofer-Warbinek R, 2000, J BIOL CHEM, V275, P22064, DOI 10.1074/jbc.M910346199; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kiernan RE, 2001, MOL CELL BIOL, V21, P7956, DOI 10.1128/MCB.21.23.7956-7970.2001; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Mascola JR, 2002, J VIROL, V76, P4810, DOI 10.1128/JVI.76.10.4810-4821.2002; MCDOUGAL JS, 1985, J IMMUNOL, V135, P3151; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; POMERANTZ RJ, 1992, J VIROL, V66, P1809, DOI 10.1128/JVI.66.3.1809-1813.1992; RICHTER BW, 2000, SCI STKE; Schmid JA, 2000, J BIOL CHEM, V275, P17035, DOI 10.1074/jbc.M000291200; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; ZACK JA, 1992, J VIROL, V66, P1717, DOI 10.1128/JVI.66.3.1717-1725.1992; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	31	188	193	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					853	857		10.1038/nature02171	http://dx.doi.org/10.1038/nature02171			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685242	Green Published			2022-12-24	WOS:000187342000062
J	McMichael, AJ; Butler, CD; Folke, C				McMichael, AJ; Butler, CD; Folke, C			New visions for addressing sustainability	SCIENCE			English	Article							POPULATION; GROWTH	Attaining sustainability will require concerted interactive efforts among disciplines, many of which have not yet recognized, and internalized, the relevance of environmental issues to their main intellectual discourse. The inability of key scientific disciplines to engage interactively is an obstacle to the actual attainment of sustainability. For example, in the list of Millennium Development Goals from the United Nations World Summit on Sustainable Development, Johannesburg, 2002, the seventh of the eight goals, to "ensure environmental sustainability," is presented separately from the parallel goals of reducing fertility and poverty, improving gains in equity, improving material conditions, and enhancing population health. A more integrated and consilient approach to sustainability is urgently needed.	Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia; Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden	Australian National University; Stockholm University	McMichael, AJ (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.	tony.mcmichael@anu.edu.au	Folke, Carl/Z-1545-2019	Folke, Carl/0000-0002-4050-3281; Butler, Colin/0000-0002-2942-5294				ABERNETHY V, 1993, POPULATION POLITICS; Aguirre A.A., 2002, CONSERVATION MED ECO; Andre C, 1998, J ECON BEHAV ORGAN, V34, P1, DOI 10.1016/S0167-2681(97)00045-0; [Anonymous], 2001, PANARCHY UNDERSTANDI; ARROW K, 1995, SCIENCE, V268, P520, DOI 10.1126/science.268.5210.520; Arthur WB, 1999, SCIENCE, V284, P107, DOI 10.1126/science.284.5411.107; Berkes F., 2003, NAVIGATING SOCIAL EC, V1, P30; BERKMAN LF, 2001, SOCIAL EPIDEMIOLOGY; Butler C, 2000, ECOSYST HEALTH, V6, P171, DOI 10.1046/j.1526-0992.2000.006003171.x; Butler CD, 2000, GLOBAL CHANGE HUMAN, V1, P156, DOI DOI 10.1023/A:1010029222095; COHEN JE, 1995, SCIENCE, V269, P341, DOI 10.1126/science.7618100; COSTANZA R, 1997, DEV ECOLOGICAL EC; DAILY GC, 1992, BIOSCIENCE, V42, P761, DOI 10.2307/1311995; DEMENY P, 1988, POPUL DEV REV, V14, P213, DOI 10.2307/2808097; EASTERLIN RA, 1971, AM ECON REV, V61, P399; Levin S., 1999, FRAGILE DOMINION; Lubchenco J, 1998, SCIENCE, V279, P491, DOI 10.1126/science.279.5350.491; Maler KG, 2000, EUR ECON REV, V44, P645, DOI 10.1016/S0014-2921(00)00043-X; MCINTOSH RJ, 2000, WAY WIND BLOWS; McMichael AJ, 2000, LANCET, V356, P495, DOI 10.1016/S0140-6736(00)02564-2; McMichael AJ, 1999, AM J EPIDEMIOL, V149, P887; National Research Council, 1999, OUR COMM JOURN TRANS; Ostrom E., 2002, DRAMA COMMONS; Raven PH, 2002, SCIENCE, V297, P954, DOI 10.1126/science.297.5583.954; Redman C.L., 1999, HUMAN IMPACT ANCIENT; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; STERN PC, 1993, SCIENCE, V260, P1897, DOI 10.1126/science.260.5116.1897; WHITE L, 1967, SCIENCE, V155, P1203, DOI 10.1126/science.155.3767.1203; Wilkins DA, 1999, TRENDS ECOL EVOL, V14, P69, DOI 10.1016/S0169-5347(98)01449-9	29	136	144	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1919	1920						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752NL	14671290				2022-12-24	WOS:000187174000045
J	Greenberg, AJ; Moran, JR; Coyne, JA; Wu, CI				Greenberg, AJ; Moran, JR; Coyne, JA; Wu, CI			Ecological adaptation during incipient speciation revealed by precise gene replacement	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; SEXUAL ISOLATION; HYDROCARBON POLYMORPHISM; REPRODUCTIVE ISOLATION; DESATURASE GENE; COLD TOLERANCE; EVOLUTION; TEMPERATURE; POPULATIONS; STARVATION	To understand the role of adaptation in speciation, one must characterize the ecologically relevant phenotypic effects of naturally occurring alleles at loci potentially causing reproductive isolation. The desaturase2 gene of Drosophila melanogaster is such a locus. Two geographically differentiated ds2 alleles underlie a pheromonal difference between the Zimbabwe and Cosmopolitan races. We used a site-directed gene replacement technique to introduce an allele of ds2 from the Zimbabwe population into Cosmopolitan flies. We show that the Cosmopolitan allele confers resistance to cold as well as susceptibility to starvation when the entire genetic background is otherwise identical. We conclude that ecological adaptation likely accompanies sexual isolation between the two behavioral races of D. melanogaster.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Wu, CI (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57th St, Chicago, IL 60637 USA.			Greenberg, Anthony/0000-0003-3296-5811				Cossins AR, 1994, TEMPERATURE ADAPTATI; Coyne JA, 1996, GENETICS, V143, P353; COYNE JA, 1983, EVOLUTION, V37, P1101, DOI 10.1111/j.1558-5646.1983.tb00225.x; Coyne JA, 1999, GENET RES, V73, P189, DOI 10.1017/S0016672398003723; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; Dallerac R, 2000, P NATL ACAD SCI USA, V97, P9449, DOI 10.1073/pnas.150243997; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; Doi M, 2001, P NATL ACAD SCI USA, V98, P6714, DOI 10.1073/pnas.091421598; Fang S, 2002, GENETICS, V162, P781; Gibert P, 2001, PHYSIOL BIOCHEM ZOOL, V74, P429, DOI 10.1086/320429; Gibert P, 2001, EVOLUTION, V55, P1063, DOI 10.1554/0014-3820(2001)055[1063:CCTAMC]2.0.CO;2; Hawthorne DJ, 2001, NATURE, V412, P904, DOI 10.1038/35091062; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Hoffmann AA, 2001, EVOLUTION, V55, P1621, DOI 10.1111/j.0014-3820.2001.tb00681.x; Hollocher H, 1997, EVOLUTION, V51, P1175, DOI 10.1111/j.1558-5646.1997.tb03965.x; Hollocher H, 1997, GENETICS, V147, P1191; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; Karan D, 2000, J THERM BIOL, V25, P345, DOI 10.1016/S0306-4565(99)00106-0; KIMURA MT, 1988, EVOLUTION, V42, P1288, DOI 10.1111/j.1558-5646.1988.tb04188.x; Knipple DC, 2002, GENETICS, V162, P1737; LAURIEAHLBERG CC, 1987, GENETICS, V115, P129; LOCKEY KH, 1988, COMP BIOCHEM PHYS B, V89, P595, DOI 10.1016/0305-0491(88)90305-7; Ohtsu T, 1998, EUR J BIOCHEM, V252, P608, DOI 10.1046/j.1432-1327.1998.2520608.x; Parkash R, 2000, EVOL ECOL RES, V2, P685; PARTRIDGE L, 1994, EVOLUTION, V48, P1269, DOI [10.1111/j.1558-5646.1994.tb05311.x, 10.2307/2410384]; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Rong YS, 2001, GENETICS, V157, P1307; Schluter D, 2000, ECOLOGY ADAPTIVE RAD; Takahashi A, 2001, P NATL ACAD SCI USA, V98, P3920, DOI 10.1073/pnas.061465098; Tiku PE, 1996, SCIENCE, V271, P815, DOI 10.1126/science.271.5250.815; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Ting CT, 2001, P NATL ACAD SCI USA, V98, P6709, DOI 10.1073/pnas.121418898; WU CI, 1995, P NATL ACAD SCI USA, V92, P2519, DOI 10.1073/pnas.92.7.2519; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x	37	132	136	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1754	1757		10.1126/science.1090432	http://dx.doi.org/10.1126/science.1090432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657496				2022-12-24	WOS:000186970100045
J	Outeiro, TF; Lindquist, S				Outeiro, TF; Lindquist, S			Yeast cells provide insight into alpha-synuclein biology and pathobiology	SCIENCE			English	Article							PARKINSONS-DISEASE; PHOSPHOLIPASE-D; MEMBRANE INTERACTIONS; PROTEIN AGGREGATION; BINDING PROTEINS; FATTY-ACIDS; MUTATIONS; SYSTEM; NEURODEGENERATION; OLIGOMERIZATION	Alpha-synuclein is implicated in several neurodegenerative disorders, such as Parkinson's disease and multiple system atrophy, yet its functions remain obscure. When expressed in yeast, alpha-synuclein associated with the plasma membrane in a highly selective manner, before forming cytoplasmic inclusions through a concentration-dependent, nucleated process. Alpha-synuclein inhibited phospholipase D, induced lipid droplet accumulation, and affected vesicle trafficking. This readily manipulable system provides an opportunity to dissect the molecular pathways underlying normal alpha-synuclein biology and the pathogenic consequences of its misfolding.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Outeiro, Tiago F/C-1067-2008; Outeiro, Tiago/M-8106-2019; Outeiro, Tiago/L-7351-2019	Outeiro, Tiago F/0000-0003-1679-1727; Outeiro, Tiago/0000-0003-1679-1727	NINDS NIH HHS [NS044829-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS044829] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Berke SJS, 2003, CURR OPIN GENET DEV, V13, P253, DOI 10.1016/S0959-437X(03)00053-4; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Dawson TM, 2003, J CLIN INVEST, V111, P145, DOI 10.1172/JCI200317575; Gasser T, 2001, J NEUROL, V248, P833, DOI 10.1007/s004150170066; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Lucking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rudge SA, 2001, GENETICS, V158, P1431; Sampathu DM, 2003, AM J PATHOL, V163, P91, DOI 10.1016/S0002-9440(10)63633-4; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sreenivas A, 1998, J BIOL CHEM, V273, P16635, DOI 10.1074/jbc.273.27.16635; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389	30	587	608	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1772	1775		10.1126/science.1090439	http://dx.doi.org/10.1126/science.1090439			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657500	Green Accepted			2022-12-24	WOS:000186970100050
J	Bigay, J; Gounon, P; Robineau, S; Antonny, B				Bigay, J; Gounon, P; Robineau, S; Antonny, B			Lipid packing sensed by ArfGAP1 couples COPI coat disassembly to membrane bilayer curvature	NATURE			English	Article							ADP-RIBOSYLATION FACTOR; GTPASE-ACTIVATING PROTEIN; GOLGI MEMBRANES; BINDING PROTEIN; VESICLES; COMPLEX; LIPOSOMES; FACTOR-1; NUCLEOTIDE; TRANSPORT	Protein coats deform flat lipid membranes into buds and capture membrane proteins to form transport vesicles(1-3). The assembly/ disassembly cycle of the COPI coat on Golgi membranes is coupled to the GTP/GDP cycle of the small G protein Arf1. At the heart of this coupling is the specific interaction of membrane-bound Arf1 - GTP with coatomer, a complex of seven proteins that forms the building unit of the COPI coat(4-7). Although COPI coat disassembly requires the catalysis of GTP hydrolysis in Arf1 by a specific GTPase-activating protein (ArfGAP1)(8-10), the precise timing of this reaction during COPI vesicle formation is not known. Using time-resolved assays for COPI dynamics on liposomes of controlled size, we show that the rate of ArfGAP1-catalysed GTP hydrolysis in Arf1 and the rate of COPI disassembly increase over two orders of magnitude as the curvature of the lipid bilayer increases and approaches that of a typical transport vesicle. This leads to a model for COPI dynamics in which GTP hydrolysis in Arf1 is organized temporally and spatially according to the changes in lipid packing induced by the coat.	CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; Univ Nice, Ctr Commun Microscopie Appl, F-06103 Nice 2, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Antonny, B (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.		Antonny, Bruno/ABH-7434-2020	Antonny, Bruno/0000-0002-9166-8668; Joelle, BIGAY/0000-0002-7487-3416				Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; Antonny B, 2003, EMBO REP, V4, P419, DOI 10.1038/sj.embor.embor812; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; CHABRE M, 1990, TRENDS BIOCHEM SCI, V15, P6, DOI 10.1016/0968-0004(90)90117-T; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; FINAZZI D, 1994, J BIOL CHEM, V269, P13325; FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337; Goldberg J, 2000, CELL, V100, P671, DOI 10.1016/S0092-8674(00)80703-5; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Matsuoka K, 2000, METHODS, V20, P417, DOI 10.1006/meth.2000.0955; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Nickel W, 2001, METHOD ENZYMOL, V329, P388; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Reinhard C, 2003, P NATL ACAD SCI USA, V100, P8253, DOI 10.1073/pnas.1432391100; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Stamnes M, 1998, P NATL ACAD SCI USA, V95, P13676, DOI 10.1073/pnas.95.23.13676; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; Yanagisawa LL, 2002, MOL BIOL CELL, V13, P2193, DOI 10.1091/mbc.01-11-0563; YANG NC, 1969, MOL PHOTOCHEM, V1, P159; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418; Zhu YX, 1998, MOL BIOL CELL, V9, P1323, DOI 10.1091/mbc.9.6.1323	30	250	254	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2003	426	6966					563	566		10.1038/nature02108	http://dx.doi.org/10.1038/nature02108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654841				2022-12-24	WOS:000186944300040
J	Kappelman, J; Rasmussen, DT; Sanders, WJ; Feseha, M; Bown, T; Copeland, P; Crabaugh, J; Fleagle, J; Glantz, M; Gordon, A; Jacobs, B; Maga, M; Muldoon, K; Pan, A; Pyne, L; Richmond, B; Ryan, T; Seiffert, ER; Sen, S; Todd, L; Wiemann, MC; Winkler, A				Kappelman, J; Rasmussen, DT; Sanders, WJ; Feseha, M; Bown, T; Copeland, P; Crabaugh, J; Fleagle, J; Glantz, M; Gordon, A; Jacobs, B; Maga, M; Muldoon, K; Pan, A; Pyne, L; Richmond, B; Ryan, T; Seiffert, ER; Sen, S; Todd, L; Wiemann, MC; Winkler, A			Oligocene mammals from Ethiopia and faunal exchange between Afro-Arabia and Eurasia	NATURE			English	Article							FLOOD VOLCANISM; MIOCENE; PROBOSCIDEANS; HIGHLANDS; MOROCCO; YEMEN	Afro-Arabian mammalian communities underwent a marked transition near the Oligocene/Miocene boundary at approximately 24 million years (Myr) ago. Although it is well documented that the endemic paenungulate taxa were replaced by migrants from the Northern Hemisphere, the timing and evolutionary dynamics of this transition have long been a mystery because faunas from about 32 to 24 Myr ago are largely unknown(1). Here we report a late Oligocene fossil assemblage from Ethiopia, which constrains the migration to postdate 27 Myr ago, and yields new insight into the indigenous faunal dynamics that preceded this event. The fauna is composed of large paenungulate herbivores and reveals not only which earlier taxa persisted into the late Oligocene epoch but also demonstrates that one group, the Proboscidea, underwent a marked diversification. When Eurasian immigrants entered Afro-Arabia, a pattern of winners and losers among the endemics emerged: less diverse taxa such as arsinoitheres became extinct, moderately species-rich groups such as hyracoids continued into the Miocene with reduced diversity, whereas the proboscideans successfully carried their adaptive radiation out of Afro-Arabia and across the world.	Univ Texas, Dept Anthropol, Austin, TX 78712 USA; Univ Texas, Dept Geol Sci, Austin, TX 78712 USA; Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; Univ Houston, Dept Geosci, Houston, TX 77204 USA; Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA; SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; Colorado State Univ, Dept Anthropol, Ft Collins, CO 80523 USA; So Methodist Univ, Dept Geol Sci, Dallas, TX 75275 USA; George Washington Univ, Dept Anthropol, Washington, DC 20052 USA; Duke Univ, Dept Biol Anthropol & Anat, Durham, NC 27708 USA; Museum Natl Hist Nat, Lab Paleontol, F-75005 Paris, France; Forest Serv, Ctr Wood Anat Res, USDA, Forest Prod Lab, Madison, WI 53705 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Washington University (WUSTL); University of Michigan System; University of Michigan; University of Houston System; University of Houston; University of Wyoming; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Colorado State University; Southern Methodist University; George Washington University; Duke University; Museum National d'Histoire Naturelle (MNHN); United States Department of Agriculture (USDA); United States Forest Service; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Kappelman, J (corresponding author), Univ Texas, Dept Anthropol, Austin, TX 78712 USA.		Gordon, Adam/AAB-9006-2019; Copeland, Pete/A-9823-2008	Gordon, Adam/0000-0002-1807-4644; Maga, A. Murat/0000-0002-7921-9018; PAN, AARON/0000-0002-3286-3105				Andrews CW, 1906, DESCRIPTIVE CATALOGU, P1; Baker J, 1996, EARTH PLANET SC LETT, V138, P39, DOI 10.1016/0012-821X(95)00229-6; BOSCHETTO HB, 1992, J HUM EVOL, V22, P47, DOI 10.1016/0047-2484(92)90029-9; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Coppens Y., 1978, P336; Court N, 1995, J VERTEBR PALEONTOL, V15, P650, DOI 10.1080/02724634.1995.10011254; FESEHA M, 2001, SEQUENCE STRATIGRAPH; Gheerbrant E, 2002, ACTA PALAEONTOL POL, V47, P493; Gheerbrant E, 1996, NATURE, V383, P68, DOI 10.1038/383068a0; Harris J.M., 1978, P315; Hofmann C, 1997, NATURE, V389, P838, DOI 10.1038/39853; Maglio V.J., 1978, P603; MURDOCK TG, 1944, MINERAL INVESTIGATIO, V19; PICKFORD M, 1986, COMPTES RENDUS ACD S, V19, P1305; Pickford M., 1986, MUNCHNER GEOWISS ABH, V8, P1; Rasmussen D.T., 1988, Journal of Vertebrate Paleontology, V8, P67; RASMUSSEN DT, 1989, EVOLUTION PERISSODAC, P57; Rochette P, 1998, EARTH PLANET SC LETT, V164, P497, DOI 10.1016/S0012-821X(98)00241-6; Sanders WJ, 2002, J VERTEBR PALEONTOL, V22, P388, DOI 10.1671/0272-4634(2002)022[0388:NPFTEM]2.0.CO;2; SHOSHANI J, 2001, 8 INT THER C JOH, P128; Spell TL, 1996, GEOL SOC AM BULL, V108, P1549, DOI 10.1130/0016-7606(1996)108<1549:CTRJVF>2.3.CO;2; Tanner L.G., 1978, P279; TASSY P, 1985, MEMOIRES SCI TERRE U, V8534, P1; Thomas H, 1999, FOSSIL VERTEBRATES OF ARABIA, P430; Ukstins IA, 2002, EARTH PLANET SC LETT, V198, P289, DOI 10.1016/S0012-821X(02)00525-3; Wight A.W.R., 1980, GEOLOGY LIBYA, P309; YEMANE K, 1987, J AFR EARTH SCI, V6, P91, DOI 10.1016/0899-5362(87)90110-2; YEMANE K, 1987, PALAEOGEOGR PALAEOCL, V60, P123, DOI 10.1016/0031-0182(87)90028-9; YEMANE K, 1985, NATURE, V318, P653, DOI 10.1038/318653a0	29	105	112	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2003	426	6966					549	552		10.1038/nature02102	http://dx.doi.org/10.1038/nature02102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654838	Green Published			2022-12-24	WOS:000186944300036
J	Lin, M; Storer, B; Martin, PJ; Tseng, L; Gooley, T; Chen, P; Hansen, JA				Lin, M; Storer, B; Martin, PJ; Tseng, L; Gooley, T; Chen, P; Hansen, JA			Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic cell transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MARROW-TRANSPLANTATION; SINGLE NUCLEOTIDE POLYMORPHISMS; GENE POLYMORPHISMS; TNF-ALPHA; INTERFERON-GAMMA; IL-10 PRODUCTION; T-CELLS; CD4(+); ASSOCIATE; SIBLINGS	BACKGROUND: Polymorphisms in cytokine genes can influence immune responses, inflammation, and tissue injury and may affect the outcome of hematopoietic stem-cell transplantation. METHODS: We analyzed single-nucleotide polymorphisms in the genes for interleukin-1(beta), interleukin-1-receptor antagonist, interleukin-6, interleukin-10 (IL10), and tumor necrosis factor (alpha) in 570 transplant recipients and their HLA-identical sibling donors. Genotypes were tested for an association with graft-versus-host disease (GVHD) by multivariable analysis. A second cohort of 423 transplant recipients was independently analyzed for the genotype associations identified in the first cohort. RESULTS: The recipient's IL10 promoter region genotype was significantly associated with the risk of acute GVHD in the first cohort. Analysis of all 993 transplant recipients showed that, as compared with the C/C genotype, the IL10 -592A/A genotype was associated with a decreased risk of grade III or IV acute GVHD (hazard ratio, 0.4; 95 percent confidence interval, 0.2 to 0.9; P=0.02) and death in remission (hazard ratio, 0.6; 95 percent confidence interval, 0.3 to 1.0; P=0.05). A haplotype analysis showed that the IL10 -592A allele was a specific marker for a promoter haplotype, T-C-A-T-A, defined by five polymorphisms at positions -3575, -2763, -1082, -819, and -592, respectively. CONCLUSIONS: Among recipients of hematopoietic cells from an HLA-identical sibling, the IL10 -592A allele is a marker of a favorable outcome after transplantation.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Sch Med, Seattle, WA USA; Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan; Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; Natl Taiwan Univ, Canc Res Ctr, Taipei 10764, Taiwan	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Hansen, JA (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,D2-100,POB 19024, Seattle, WA 98109 USA.			Chen, Pei-Jer/0000-0001-8316-3785; TSENG, LI-HUI/0000-0002-8308-6772	NCI NIH HHS [CA15704, CA18221, CA18029] Funding Source: Medline; NIAID NIH HHS [AI33484, AI49213] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA018221, P30CA015704, P01CA018029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI033484] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersen P. K., 2012, STAT MODELS BASED CO; BACCHETTA R, 1994, J EXP MED, V179, P493, DOI 10.1084/jem.179.2.493; BEATTY PG, 1985, NEW ENGL J MED, V313, P765, DOI 10.1056/NEJM198509263131301; Bidwell J, 1999, GENES IMMUN, V1, P3, DOI 10.1038/sj.gene.6363645; Blazar BR, 1998, TRANSPLANTATION, V66, P1220, DOI 10.1097/00007890-199811150-00018; BLAZAR BR, 1995, BLOOD, V85, P842, DOI 10.1182/blood.V85.3.842.bloodjournal853842; Cavet J, 1999, BLOOD, V94, P3941, DOI 10.1182/blood.V94.11.3941.423k10_3941_3946; Cavet J, 2001, BLOOD, V98, P1594, DOI 10.1182/blood.V98.5.1594; Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y; Cullup H, 2001, BRIT J HAEMATOL, V113, P807, DOI 10.1046/j.1365-2141.2001.02811.x; DING L, 1993, J IMMUNOL, V151, P1224; FERRARA JLM, 1991, NEW ENGL J MED, V324, P667; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibson AW, 2001, J IMMUNOL, V166, P3915, DOI 10.4049/jimmunol.166.6.3915; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; HANSEN JA, 1992, MANUAL CLIN LAB IMMU, P850; HARTL DL, 1997, PRINCIPLES POPULATIO, P71; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Holler E, 2000, BONE MARROW TRANSPL, V25, P237, DOI 10.1038/sj.bmt.1702126; Keijsers Vivian, 1997, Arthritis and Rheumatism, V40, pS179; Koss K, 2000, GENES IMMUN, V1, P185, DOI 10.1038/sj.gene.6363657; Krenger W, 1997, TRANSPLANTATION, V64, P553, DOI 10.1097/00007890-199708270-00001; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Lin MT, 2001, BLOOD, V98, P3172, DOI 10.1182/blood.V98.10.3172; MORISHIMA Y, 1989, BLOOD, V74, P2252, DOI 10.1182/blood.V74.6.2252.2252; PERREAULT C, 1990, BLOOD, V76, P1269; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Sasazuki T, 1999, NEW ENGL J MED, V340, P402; SMITH SR, 1995, TRANSPLANTATION, V59, P890, DOI 10.1097/00007890-199503270-00016; Socie G, 2001, TRANSPLANTATION, V72, P699, DOI 10.1097/00007890-200108270-00024; SULLIVAN KM, 1991, SEMIN HEMATOL, V28, P250; Takahashi H, 2000, BONE MARROW TRANSPL, V26, P1317, DOI 10.1038/sj.bmt.1702724; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; Tegoshi H, 2002, HUM IMMUNOL, V63, P121, DOI 10.1016/S0198-8859(01)00363-9; Tseng LH, 2002, J IMMUNOL METHODS, V267, P151, DOI 10.1016/S0022-1759(02)00165-5; Tseng LH, 2002, TISSUE ANTIGENS, V59, P280, DOI 10.1034/j.1399-0039.2002.590405.x; Tseng LH, 2001, TISSUE ANTIGENS, V57, P318, DOI 10.1034/j.1399-0039.2001.057004318.x; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Zeller JC, 1999, J IMMUNOL, V163, P3684	40	298	317	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2003	349	23					2201	2210		10.1056/NEJMoa022060	http://dx.doi.org/10.1056/NEJMoa022060			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LH	14657427	Bronze			2022-12-24	WOS:000186921700006
J	Hansen, H; Groce, N				Hansen, H; Groce, N			Human immunodeficiency virus and quarantine in Cuba	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AIDS; HIV		Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Hansen, H (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.		Chesters, Heather/C-6089-2009	Groce, Nora/0000-0002-7885-7042				Avila JP, 1996, BIOMED PHARMACOTHER, V50, P216, DOI 10.1016/0753-3322(96)87661-X; BAYER R, 1989, NEW ENGL J MED, V320, P1022, DOI 10.1056/NEJM198904133201529; Burr C, 1997, LANCET, V350, P647, DOI 10.1016/S0140-6736(05)63342-9; CASTILLO OG, 2003, TOURISM DEV LOCOMOTI; Farmer P, 1996, EMERG INFECT DIS, V2, P259, DOI 10.3201/eid0204.960402; FEINSILVER JM, 1989, LAT AM RES REV, V24, P1; Hansen H, 2001, Med Anthropol, V19, P259; KEYS S, 1997, AIDS WKLY PLUS  0901, P21; PEREZSTABLE EJ, 1991, AM J PUBLIC HEALTH, V81, P563, DOI 10.2105/AJPH.81.5.563; SANTANA S, 1991, INT J HEALTH SERV, V21, P511, DOI 10.2190/PPF0-X27G-LF4X-XEYC; SCHEPERHUGHES N, 1994, SOC SCI MED, V39, P991, DOI 10.1016/0277-9536(94)90210-0; SCHEPERHUGHES N, 1993, LANCET, V342, P965, DOI 10.1016/0140-6736(93)92006-F; Swanson J M, 1995, J Assoc Nurses AIDS Care, V6, P33, DOI 10.1016/S1055-3290(05)80027-5; *UNAIDS, 2003, FACT SHEET CUB; Waitzkin H, 1997, J FAM PRACTICE, V45, P250	15	16	16	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2003	290	21					2875	2875		10.1001/jama.290.21.2875	http://dx.doi.org/10.1001/jama.290.21.2875			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	748QP	14657076	Bronze			2022-12-24	WOS:000186872800034
J	Hehenkamp, A; Hargreaves, S				Hehenkamp, A; Hargreaves, S			Tuberculosis treatment in complex emergencies: South Sudan	LANCET			English	Article									Med Sans Frontieres, London EC1N 8QX, England	Doctors Without Borders				Hargreaves, Sally/0000-0003-2974-4348					0	16	16	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S30	S31		10.1016/S0140-6736(03)15066-0	http://dx.doi.org/10.1016/S0140-6736(03)15066-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698120				2022-12-24	WOS:000187790200016
J	Courchamp, F; Woodroffe, R; Roemer, G				Courchamp, F; Woodroffe, R; Roemer, G			Removing protected populations to save endangered species	SCIENCE			English	Article									New Mexico State Univ, Dept Fishery & Wildlife Sci, Las Cruces, NM 88003 USA; Univ Paris 11, F-91405 Orsay, France; Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA	New Mexico State University; UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Davis	Roemer, G (corresponding author), New Mexico State Univ, Dept Fishery & Wildlife Sci, Las Cruces, NM 88003 USA.		burke, daniel/D-3668-2009; Courchamp, Franck/ABE-7204-2020	Courchamp, Franck/0000-0001-7605-4548				COONAN T, 2003, ISLAND FOX CAPTIVE B; ROEMER G, IN PRESS FOXES JACKA; Roemer GW, 2002, P NATL ACAD SCI USA, V99, P791, DOI 10.1073/pnas.012422499; *US NAT PARK SERV, 2003, SANT CRUZ ISL PRIM R	4	75	77	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1532	1532		10.1126/science.1089492	http://dx.doi.org/10.1126/science.1089492			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645839				2022-12-24	WOS:000186802200032
J	Bertrand, V; Hudson, C; Caillol, D; Popovici, C; Lemaire, P				Bertrand, V; Hudson, C; Caillol, D; Popovici, C; Lemaire, P			Neural tissue in ascidian embryos is induced by FGF9/16/20, acting via a combination of maternal GATA and Ets transcription factors	CELL			English	Article							CHORDATE CIONA-INTESTINALIS; FIBROBLAST-GROWTH-FACTOR; XENOPUS EMBRYOS; NERVOUS-SYSTEM; HOMEOBOX GENE; CELL FATE; EXPRESSION; INDUCTION; SPECIFICATION; NOTOCHORD	In chordates, formation of neural tissue from ectodermal cells requires an induction. The molecular nature of the inducer remains controversial in vertebrates. Here, using the early neural marker Otx as an entry point, we dissected the neural induction pathway in the simple embryos of Ciona intestinalis. We first isolated the regulatory element driving Otx expression in the prospective neural tissue, showed that this element directly responds to FGF signaling and that FGF9/16/20 acts as an endogenous neural inducer. Binding site analysis and gene loss of function established that FGF9/16/20 induces neural tissue in the ectoderm via a synergy between two maternal response factors. Ets1/2 mediates general FGF responsiveness, while the restricted activity of GATAa targets the neural program to the ectoderm. Thus, our study identifies an endogenous FGF neural inducer and its early downstream gene cascade. It also reveals a role for GATA factors in FGF signaling.	Univ Mediterranee, AP Marseille, CNRS, INSERM,Lab Genet & Physiol Dev,IBDM, F-13288 Marseille 9, France; CNRS, UPMC, Stn Zool, Unite Biol Dev,UMR 7009, F-06230 Villefranche Sur Mer, France; INSERM, Mol Oncol Lab, U119, IFR 57, F-13009 Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bertrand, V (corresponding author), Univ Mediterranee, AP Marseille, CNRS, INSERM,Lab Genet & Physiol Dev,IBDM, Parc Sci Luminy,Case 907, F-13288 Marseille 9, France.		Lemaire, Patrick/D-4237-2009; Hudson, Clare/X-7618-2019; Lemaire, Patrick/P-8228-2019; POPOVICI, Cornel/A-2027-2009; Lemaire, Patrick/B-5560-2012	Hudson, Clare/0000-0003-1585-8328; Lemaire, Patrick/0000-0003-4925-2009; POPOVICI, Cornel/0000-0001-8226-3127; Lemaire, Patrick/0000-0003-4925-2009; Bertrand, Vincent/0000-0002-9036-2544				Akanuma T, 2002, DEV GENES EVOL, V212, P459, DOI 10.1007/s00427-002-0264-x; Corbo JC, 1998, DEV BIOL, V203, P358, DOI 10.1006/dbio.1998.9067; Corbo JC, 1997, DEVELOPMENT, V124, P589; D'Ambrosio P, 2003, DEV DYNAM, V226, P145, DOI 10.1002/dvdy.10216; Darras S, 2001, DEV BIOL, V236, P271, DOI 10.1006/dbio.2001.0339; Darras S, 1997, DEVELOPMENT, V124, P4275; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Erives A, 1998, DEV BIOL, V194, P213, DOI 10.1006/dbio.1997.8810; Garcia-Garcia MJ, 1999, DEVELOPMENT, V126, P3523; Hardcastle Z, 2000, CURR BIOL, V10, P1511, DOI 10.1016/S0960-9822(00)00825-3; Harland R, 2000, CURR OPIN GENET DEV, V10, P357, DOI 10.1016/S0959-437X(00)00096-4; HemmatiBrivanlou A, 1997, CELL, V88, P13, DOI 10.1016/S0092-8674(00)81853-X; HIKOSAKA A, 1994, DEV BIOL, V166, P763, DOI 10.1006/dbio.1994.1354; Hongo I, 1999, DEV BIOL, V216, P561, DOI 10.1006/dbio.1999.9515; Hudson C, 2003, DEVELOPMENT, V130, P147, DOI 10.1242/dev.00200; Hudson C, 2001, MECH DEVELOP, V100, P189, DOI 10.1016/S0925-4773(00)00528-1; Imai KS, 2002, DEVELOPMENT, V129, P1729; Inazawa T, 1998, J PHYSIOL-LONDON, V511, P347, DOI 10.1111/j.1469-7793.1998.347bh.x; Jiang YM, 1996, DEV BIOL, V174, P258, DOI 10.1006/dbio.1996.0071; Kawachi K, 2003, J BIOL CHEM, V278, P5473, DOI 10.1074/jbc.M211054200; KELLEY C, 1994, DEV BIOL, V165, P193, DOI 10.1006/dbio.1994.1246; Koga C, 1999, BIOCHEM BIOPH RES CO, V261, P756, DOI 10.1006/bbrc.1999.1039; Launay C, 1996, DEVELOPMENT, V122, P869; Lemaire P, 2002, DEV BIOL, V252, P151, DOI 10.1006/dbio.2002.0861; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Liang QR, 2001, MOL CELL BIOL, V21, P7460, DOI 10.1128/MCB.21.21.7460-7469.2001; Locascio A, 1999, DEVELOPMENT, V126, P4737; Miya T, 2003, DEV BIOL, V261, P25, DOI 10.1016/S0012-1606(03)00246-X; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; NEAVE B, 1995, MECH DEVELOP, V51, P169, DOI 10.1016/0925-4773(95)00351-7; Nishida H, 2002, BIOESSAYS, V24, P613, DOI 10.1002/bies.10099; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; Oishi I, 1999, GENES CELLS, V4, P41, DOI 10.1046/j.1365-2443.1999.00234.x; Partington GA, 1997, DEV BIOL, V181, P144, DOI 10.1006/dbio.1996.8432; Ristoratore F, 1999, DEVELOPMENT, V126, P5149; Satou Y, 2002, DEV GENES EVOL, V212, P432, DOI 10.1007/s00427-002-0266-8; Satou Y, 2002, GENESIS, V33, P153, DOI 10.1002/gene.10119; Satou Y, 2001, GENESIS, V30, P103, DOI 10.1002/gene.1040; Sheng GJ, 1999, MECH DEVELOP, V87, P213, DOI 10.1016/S0925-4773(99)00150-1; Shibata K, 1998, BIOCHEM BIOPH RES CO, V252, P241, DOI 10.1006/bbrc.1998.9490; Song JW, 1996, DEV DYNAM, V206, P427, DOI 10.1002/(SICI)1097-0177(199608)206:4<427::AID-AJA8>3.0.CO;2-K; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Streit A, 1999, TRENDS GENET, V15, P20, DOI 10.1016/S0168-9525(98)01620-5; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; Wada S, 1996, MECH DEVELOP, V60, P59, DOI 10.1016/S0925-4773(96)00600-4; Wada S, 2002, DEV DYNAM, V225, P46, DOI 10.1002/dvdy.10135; Wada S, 1999, MECH DEVELOP, V82, P67, DOI 10.1016/S0925-4773(99)00012-X; WHITTAKER JR, 1973, P NATL ACAD SCI USA, V70, P2096, DOI 10.1073/pnas.70.7.2096; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; Xu RH, 1997, MOL CELL BIOL, V17, P436, DOI 10.1128/MCB.17.1.436; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; ZON LI, 1991, P NATL ACAD SCI USA, V88, P10642, DOI 10.1073/pnas.88.23.10642	53	203	204	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 26	2003	115	5					615	627		10.1016/S0092-8674(03)00928-0	http://dx.doi.org/10.1016/S0092-8674(03)00928-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651852	Bronze			2022-12-24	WOS:000186885600011
J	Miao, L; Vanderlinde, O; Stewart, M; Roberts, TM				Miao, L; Vanderlinde, O; Stewart, M; Roberts, TM			Retraction in amoeboid cell motility powered by cytoskeletal dynamics	SCIENCE			English	Article							PROTEIN MSP CYTOSKELETON; ACTIN-BASED MOTILITY; HEAVY-CHAIN GENE; NEMATODE SPERM; ASCARIS SPERM; BODY; DEPOLYMERIZATION; TRANSLOCATION; NUCLEATION; MECHANISM	Cells crawl by coupling protrusion of their leading edge with retraction of their cell body. Protrusion is generated by the polymerization and bundling of. laments, but the mechanism of retraction is less clear. We have reconstituted retraction in vitro by adding Yersinia tyrosine phosphatase to the major sperm protein-based motility apparatus assembled from Ascaris sperm extracts. Retraction in vitro parallels that observed in vivo and is generated primarily by disassembly and rearrangement of the cytoskeleton. Therefore, cytoskeletal dynamics alone, unassisted by conventional motors, are able to generate both of these central components of amoeboid locomotion.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	State University System of Florida; Florida State University; MRC Laboratory Molecular Biology	Roberts, TM (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	roberts@bio.fsu.edu		Miao, Long/0000-0002-0562-6681	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029994] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37GM29994] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson KI, 1996, J CELL BIOL, V134, P1209, DOI 10.1083/jcb.134.5.1209; Berg, 2018, RANDOM WALKS BIOL; Bottino D, 2002, J CELL SCI, V115, P367; Bray D, 2001, CELL MOVEMENTS MOL M; Bullock TL, 1998, NAT STRUCT BIOL, V5, P184, DOI 10.1038/nsb0398-184; Cameron LA, 2001, CURR BIOL, V11, P130, DOI 10.1016/S0960-9822(01)00022-7; Carlier MF, 2003, BIOESSAYS, V25, P336, DOI 10.1002/bies.10257; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Feringa BL, 2000, NATURE, V408, P151, DOI 10.1038/35041665; HUXLEY HE, 1973, NATURE, V244, P445, DOI 10.1038/243445a0; Italiano JE, 1996, CELL, V84, P105, DOI 10.1016/S0092-8674(00)80997-6; Italiano JE, 1999, J CELL BIOL, V146, P1087, DOI 10.1083/jcb.146.5.1087; KING KL, 1994, CELL MOTIL CYTOSKEL, V27, P193, DOI 10.1002/cm.970270302; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; LeClaire LL, 2003, J CELL SCI, V116, P2655, DOI 10.1242/jcs.00469; LI Y, 1992, ANNU REV MATER SCI, V22, P243; LOMBILLO VA, 1995, NATURE, V373, P161, DOI 10.1038/373161a0; Pollard TD, 2003, CELL, V113, P549, DOI 10.1016/S0092-8674(03)00357-X; Roberts TM, 2000, J CELL BIOL, V149, P7, DOI 10.1083/jcb.149.1.7; Roberts TM, 1998, J CELL BIOL, V140, P367, DOI 10.1083/jcb.140.2.367; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Theriot JA, 1996, CELL, V84, P1, DOI 10.1016/S0092-8674(00)80068-9; Uchida KSK, 2003, J CELL SCI, V116, P51, DOI 10.1242/jcs.00195; WATERMANSTORER CM, 1995, J CELL BIOL, V130, P1161, DOI 10.1083/jcb.130.5.1161	26	49	53	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2003	302	5649					1405	1407		10.1126/science.1089129	http://dx.doi.org/10.1126/science.1089129			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631043				2022-12-24	WOS:000186683500055
J	Roberts, DL; Solow, AR				Roberts, DL; Solow, AR			Flightless birds - When did the dodo become extinct?	NATURE			English	Editorial Material									Royal Bot Gardens, Richmond TW9 3AE, Surrey, England; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Royal Botanic Gardens, Kew; Woods Hole Oceanographic Institution	Roberts, DL (corresponding author), Royal Bot Gardens, Richmond TW9 3AE, Surrey, England.			Roberts, David/0000-0001-6788-2691				Cheke A.S., 1987, P5, DOI 10.1017/CBO9780511735769.003; COOKE P, 1980, BIOMETRIKA, V67, P257; Fuller E., 2002, DODO BRIEF HIST	3	117	125	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2003	426	6964					245	245		10.1038/426245a	http://dx.doi.org/10.1038/426245a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628039				2022-12-24	WOS:000186660800031
J	Smith, RJ; Muir, RDJ; Walpole, MJ; Balmford, A; Leader-Williams, N				Smith, RJ; Muir, RDJ; Walpole, MJ; Balmford, A; Leader-Williams, N			Governance and the loss of biodiversity	NATURE			English	Article							CONSERVATION; COSTS	Most of the world's biodiversity occurs within developing countries that require donor support to build their conservation capacity(1). Unfortunately, some of these countries experience high levels of political corruption(2), which may limit the success of conservation projects by reducing effective funding levels and distorting priorities(3). We investigated whether changes in three well surveyed and widespread components of biodiversity were associated with national governance scores and other socioeconomic measures. Here we show that governance scores were correlated with changes in total forest cover, but not with changes in natural forest cover. We found strong associations between governance scores and changes in the numbers of African elephants and black rhinoceroses, and these socio-economic factors explained observed patterns better than any others. Finally, we show that countries rich in species and identified as containing priority areas for conservation have lower governance scores than other nations. These results stress the need for conservationists to develop and implement policies that reduce the effects of political corruption and, in this regard, we question the universal applicability of an influential approach to conservation that seeks to ban international trade in endangered species.	Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NS, Kent, England; Univ Cambridge, Dept Zool, Conservat Biol Grp, Cambridge CB2 3EJ, England	University of Kent; University of Cambridge	Smith, RJ (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NS, Kent, England.	R.J.Smith@kent.ac.uk	Smith, Robert J/D-9660-2011	Smith, Robert J/0000-0003-1599-9171; Balmford, Andrew/0000-0002-0144-3589				Archabald K, 2001, ENVIRON CONSERV, V28, P135, DOI 10.1017/S0376892901000145; Azfar O, 2001, ANN AM ACAD POLIT SS, V573, P42, DOI 10.1177/0002716201573001003; Balmford A, 2003, ORYX, V37, P238, DOI 10.1017/S0030605303000413; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Barnes R., 1999, AFRICAN ELEPHANT DAT; BARNES RFW, 1995, BIOL CONSERV, V71, P125, DOI 10.1016/0006-3207(94)00014-H; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Didia DO, 1997, GLOBAL ENVIRON CHANG, V7, P63, DOI 10.1016/S0959-3780(96)00024-6; Emslie R., 1999, AFRICAN RHINO STATUS; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Hughey KFD, 2003, CONSERV BIOL, V17, P93, DOI 10.1046/j.1523-1739.2003.01317.x; *INT I ENV DEV, 1994, WHOS ED OV COMM APPR; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; James A. N., 1999, GLOBAL REV PROTECTED; Jepson P, 2001, SCIENCE, V292, P859, DOI 10.1126/science.1061727; Kaufmann D, 1997, FOREIGN POLICY, P114, DOI 10.2307/1149337; LEADERWILLIAMS N, 1988, NATURE, V336, P533, DOI 10.1038/336533a0; Leakey R., 2001, WILDLIFE WARS MY BAT; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; MYERS N, 1992, PRIMARY SOURCE TROPI; Oldfield S., 2002, TRADE WILDLIFE REGUL; Robertson JMY, 2001, ORYX, V35, P26, DOI 10.1046/j.1365-3008.2001.00149.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Salafsky N, 2002, CONSERV BIOL, V16, P1469, DOI 10.1046/j.1523-1739.2002.01232.x; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Transparency International, 2002, CORR PERC IND 2002; Walpole MJ, 2001, NATURE, V413, P771, DOI 10.1038/35101762; Whitten T, 2001, CONSERV BIOL, V15, P1, DOI 10.1046/j.1523-1739.2001.01_01.x; *WORLD WID FUND NA, 1999, LIV PLAN CAMP CALL A	30	268	278	1	162	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 6	2003	426	6962					67	70		10.1038/nature02025	http://dx.doi.org/10.1038/nature02025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603318				2022-12-24	WOS:000186370800042
J	Gilg, O; Hanski, I; Sittler, B				Gilg, O; Hanski, I; Sittler, B			Cyclic dynamics in a simple vertebrate predator-prey community	SCIENCE			English	Article							DICROSTONYX-GROENLANDICUS; POPULATION-CYCLES; RODENT DYNAMICS; LEMMINGS; MODEL	The collared lemming in the high-Arctic tundra in Greenland is preyed upon by four species of predators that show marked differences in the numbers of lemmings each consumes and in the dependence of their dynamics on lemming density. A predator-prey model based on the field-estimated predator responses robustly predicts 4-year periodicity in lemming dynamics, in agreement with long-term empirical data. There is no indication in the field that food or space limits lemming population growth, nor is there need in the model to consider those factors. The cyclic dynamics are driven by a 1-year delay in the numerical response of the stoat and stabilized by strongly density-dependent predation by the arctic fox, the snowy owl, and the long-tailed skua.	Univ Helsinki, Dept Systemat & Ecol, Div Populat Biol, FIN-00014 Helsinki, Finland; INRA, IRD, Equipe Biol & Gest Pullulat, CBGP, F-34988 Montferrier Sur Lez, Lez, France; Univ Freiburg, Inst Landespflege, D-79085 Freiburg, Germany	University of Helsinki; INRAE; Institut de Recherche pour le Developpement (IRD); University of Freiburg	Gilg, O (corresponding author), Univ Helsinki, Dept Systemat & Ecol, Div Populat Biol, POB 65, FIN-00014 Helsinki, Finland.	olivier.gilg@libertysurf.fr	GILG, Olivier/C-2588-2008	GILG, Olivier/0000-0002-9083-4492				ANDERSSON M, 1976, J ANIM ECOL, V45, P537, DOI 10.2307/3890; Batzli G.O., 1980, ARCTIC ECOSYSTEM COA, P335, DOI DOI 10.1575/1912/222; Berg T.B., 2003, THESIS U COPENHAGEN; CHERNYAVSKII FB, 1975, MATERIALY EKOLOGII M, P13; CHERNYAVSKY FB, 1981, ECOLOGY BIRDS MAMMAL; CHESSON P, 1994, THEOR POPUL BIOL, V45, P227, DOI 10.1006/tpbi.1994.1013; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; DUNAEVA T N, 1978, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V83, P18; DUNAEVA TN, 1948, P I GEOGRAPHY ACAD S, V51, P78; FITZGERALD BM, 1977, J ANIM ECOL, V46, P367, DOI 10.2307/3818; Gilg O, 2002, OIKOS, V99, P499, DOI 10.1034/j.1600-0706.2002.11989.x; GILG O, 2002, THESIS U FRANCHE COM; HANSKI I, 1995, ECOLOGY, V76, P840, DOI 10.2307/1939349; HANSKI I, 1993, NATURE, V364, P232, DOI 10.1038/364232a0; Hanski I, 2001, ECOLOGY, V82, P1505, DOI 10.2307/2679796; HENRY GHR, 1990, CAN J BOT, V68, P2660, DOI 10.1139/b90-336; Klemola T, 2003, ADV ECOL RES, V33, P75, DOI 10.1016/S0065-2504(03)33010-7; Lambin X, 2002, POPULATION CYCLES: THE CASE FOR TROPHIC INTERACTIONS, P155; MIKKELSEN PS, 1994, NORDOST GRONLAND 190; Millar JS, 2001, ECOSCIENCE, V8, P145, DOI 10.1080/11956860.2001.11682639; Oli MK, 2003, TRENDS ECOL EVOL, V18, P105, DOI 10.1016/S0169-5347(03)00005-3; SITTLER B, 1995, ANN ZOOL FENN, V32, P79; Sittler B, 2000, ARCTIC, V53, P53; Turchin P, 1997, AM NAT, V149, P842, DOI 10.1086/286027; Turchin P, 2001, ECOL LETT, V4, P267, DOI 10.1046/j.1461-0248.2001.00204.x; Turchin P, 2000, NATURE, V405, P562, DOI 10.1038/35014595; Turchin Peter, 2003, Monographs in Population Biology, V35, pi	27	234	245	7	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2003	302	5646					866	868		10.1126/science.1087509	http://dx.doi.org/10.1126/science.1087509			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593179				2022-12-24	WOS:000186258000049
J	Kubori, T; Galan, JE				Kubori, T; Galan, JE			Temporal regulation of Salmonella virulence effector function by proteasome-dependent protein degradation	CELL			English	Article							III SECRETION SYSTEM; YERSINIA-ENTEROCOLITICA; BACTERIAL TOXIN; HOST-CELLS; TYPHIMURIUM; CHAPERONE; IDENTIFICATION; YOPE; TRANSLOCATION; GENES	Salmonella enterica invasion of host cells requires the reversible activation of the Rho-family GTPases Cdc42 and Rac1 by the bacterially encoded GEF SopE and the GAP SptP, which exert their function at different times during infection and are delivered into host cells by a type III secretion system. We found that SopE and SptP are delivered in equivalent amounts early during infection. However, SopE is rapidly degraded through a proteosome-mediated pathway, while SptP exhibits much slower degradation kinetics. The half-lives of these effector proteins are determined by their secretion and translocation domains. Chimeric protein analysis indicated that delivery of SptP into host cells by the SopE secretion and translocation domain drastically shortened its half-life. Conversely, delivery of SopE by the SptP secretion and translocation signals significantly increased its half-life, resulting in persistent actin cytoskeleton rearrangements. This regulatory mechanism constitutes a remarkable example of a pathogen's adaptation to modulate cellular functions.	Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.	jorge.galan@yale.edu	Kubori, Tomoko/AAH-3609-2019	Kubori, Tomoko/0000-0003-1098-6021	NIAID NIH HHS [AI30492] Funding Source: Medline; NIGMS NIH HHS [GM52543] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI030492, R29AI030492, R01AI030492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052543] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Boyd AP, 2000, J BACTERIOL, V182, P4811, DOI 10.1128/JB.182.17.4811-4821.2000; Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329; Chen LM, 1996, MOL MICROBIOL, V21, P1101, DOI 10.1046/j.1365-2958.1996.471410.x; Chen LM, 1996, SCIENCE, V274, P2115, DOI 10.1126/science.274.5295.2115; Cheng LW, 1997, MOL MICROBIOL, V24, P757, DOI 10.1046/j.1365-2958.1997.3831750.x; Collazo CM, 1997, MOL MICROBIOL, V24, P747, DOI 10.1046/j.1365-2958.1997.3781740.x; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Francis MS, 2001, MOL MICROBIOL, V42, P1075, DOI 10.1046/j.1365-2958.2001.02702.x; Fu YX, 1998, J BACTERIOL, V180, P3393, DOI 10.1128/JB.180.13.3393-3399.1998; Fu YX, 1998, MOL MICROBIOL, V27, P359, DOI 10.1046/j.1365-2958.1998.00684.x; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lucas RL, 2000, MOL MICROBIOL, V36, P1024, DOI 10.1046/j.1365-2958.2000.01961.x; Marcus SL, 2002, CELL MICROBIOL, V4, P435, DOI 10.1046/j.1462-5822.2002.00202.x; MICHIELS T, 1991, J BACTERIOL, V173, P1677, DOI 10.1128/jb.173.5.1677-1685.1991; OBERT S, 1994, MOL CELL BIOL, V14, P1333, DOI 10.1128/MCB.14.2.1333; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Page AL, 2002, MOL MICROBIOL, V46, P1, DOI 10.1046/j.1365-2958.2002.03138.x; Schesser K, 1996, J BACTERIOL, V178, P7227, DOI 10.1128/jb.178.24.7227-7233.1996; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Stebbins CE, 2000, MOL CELL, V6, P1449, DOI 10.1016/S1097-2765(00)00141-6; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Stender S, 2000, MOL MICROBIOL, V36, P1206, DOI 10.1046/j.1365-2958.2000.01933.x; WATTIAU P, 1993, MOL MICROBIOL, V8, P123, DOI 10.1111/j.1365-2958.1993.tb01209.x; WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493; Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	40	217	224	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2003	115	3					333	342		10.1016/S0092-8674(03)00849-3	http://dx.doi.org/10.1016/S0092-8674(03)00849-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	740RH	14636560	Bronze			2022-12-24	WOS:000186415000012
J	Zoghbi, HY				Zoghbi, HY			Postnatal neurodevelopmental disorders: Meeting at the synapse?	SCIENCE			English	Article							LINKED MENTAL-RETARDATION; CPG-BINDING PROTEIN-2; RETT-SYNDROME BRAIN; AUTISTIC DISORDER; MECP2 MUTATIONS; DNA METHYLATION; PROXIMAL 15Q; ANGELMAN-SYNDROME; INFANTILE-AUTISM; SYNDROME GENE	We often think of neurodevelopmental disorders as beginning before birth, and many certainly do. A handful, however, strike many months after birth, following a period of apparently normal growth and development. Autism and Rett syndrome are two such disorders, and here I consider some of their similarities at the phenotypic and pathogenic levels. I propose that both disorders result from disruption of postnatal or experience-dependent synaptic plasticity.	Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	hzoghbi@bcm.tmc.edu		Zoghbi, Huda/0000-0002-0700-3349	NICHD NIH HHS [HD 40301] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD040301] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Akbarian S, 2001, NEUROBIOL DIS, V8, P784, DOI 10.1006/nbdi.2001.0420; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Amir RE, 2000, ANN NEUROL, V47, P670, DOI 10.1002/1531-8249(200005)47:5<670::AID-ANA20>3.3.CO;2-6; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Armstrong DD, 1999, PEDIATR NEUROL, V20, P125, DOI 10.1016/S0887-8994(98)00124-6; Armstrong J, 2001, ANN NEUROL, V50, P692, DOI 10.1002/ana.1272; Aylward EH, 1999, NEUROLOGY, V53, P2145, DOI 10.1212/WNL.53.9.2145; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; BAILEY A, 1993, LANCET, V341, P1225, DOI 10.1016/0140-6736(93)91065-T; BAKER P, 1994, J AUTISM DEV DISORD, V24, P529, DOI 10.1007/BF02172133; Balmer D, 2003, J MOL MED-JMM, V81, P61, DOI 10.1007/s00109-002-0396-5; BAUMAN ML, 1995, NEUROPEDIATRICS, V26, P105, DOI 10.1055/s-2007-979737; Beaudet Arthur L., 2002, Genetics in Medicine, V4, P399, DOI 10.1097/00125817-200209000-00013; BELICHENKO PV, 1994, NEUROREPORT, V5, P1509, DOI 10.1097/00001756-199407000-00025; Bienvenu T, 2000, HUM MOL GENET, V9, P1377, DOI 10.1093/hmg/9.9.1377; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bolton PF, 2001, AM J MED GENET, V105, P675, DOI 10.1002/ajmg.1551; Boyar FZ, 2001, CLIN GENET, V60, P421, DOI 10.1034/j.1399-0004.2001.600604.x; Carney RM, 2003, PEDIATR NEUROL, V28, P205, DOI 10.1016/S0887-8994(02)00624-0; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; CHENG SD, 1994, AM J HUM GENET, V55, P753; Cohen D, 2002, AM J PSYCHIAT, V159, P148, DOI 10.1176/appi.ajp.159.1.148-a; Cohen DRS, 2003, MOL CELL NEUROSCI, V22, P417, DOI 10.1016/S1044-7431(03)00026-5; Colantuoni C, 2001, NEUROBIOL DIS, V8, P847, DOI 10.1006/nbdi.2001.0428; Cook EH, 1997, AM J HUM GENET, V60, P928; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Couvert P, 2001, HUM MOL GENET, V10, P941, DOI 10.1093/hmg/10.9.941; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Frith U, 2001, NEURON, V32, P969, DOI 10.1016/S0896-6273(01)00552-9; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; GLAZE DG, 1987, ARCH NEUROL-CHICAGO, V44, P1053, DOI 10.1001/archneur.1987.00520220051016; Gurrieri F, 1999, NEUROLOGY, V52, P1694, DOI 10.1212/WNL.52.8.1694; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Hardan AY, 2001, J CHILD NEUROL, V16, P421, DOI 10.2310/7010.2001.7113; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Herbert MR, 2003, BRAIN, V126, P1182, DOI 10.1093/brain/awg110; Hoffbuhr K, 2001, NEUROLOGY, V56, P1486, DOI 10.1212/WNL.56.11.1486; HOTOPF M, 1995, J AUTISM DEV DISORD, V25, P41, DOI 10.1007/BF02178166; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; JELLINGER K, 1986, AM J MED GENET, V24, P259; Jung BP, 2003, J NEUROBIOL, V55, P86, DOI 10.1002/neu.10201; Kanner L, 1943, NERV CHILD, V2, P217; Kashiwagi A, 2003, J HUM GENET, V48, P194, DOI 10.1007/s10038-003-0009-3; Kemper TL, 1998, J NEUROPATH EXP NEUR, V57, P645, DOI 10.1097/00005072-199807000-00001; Klauck SM, 2002, AM J HUM GENET, V70, P1034, DOI 10.1086/339553; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Konstantareas MM, 1999, J AUTISM DEV DISORD, V29, P275, DOI 10.1023/A:1022155201662; Laan LAEM, 2002, EPILEPSIA, V43, P1590, DOI 10.1046/j.1528-1157.2002.30802.x; LaSalle JM, 2001, HUM MOL GENET, V10, P1729, DOI 10.1093/hmg/10.17.1729; Luna B, 2002, NEUROLOGY, V59, P834, DOI 10.1212/WNL.59.6.834; Meloni I, 2000, AM J HUM GENET, V67, P982, DOI 10.1086/303078; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; NIELSEN JB, 1990, ARCH NEUROL-CHICAGO, V47, P982, DOI 10.1001/archneur.1990.00530090054013; Orrico A, 2000, FEBS LETT, V481, P285, DOI 10.1016/S0014-5793(00)01994-3; PICKLES A, 1995, AM J HUM GENET, V57, P717; Raymond GV, 1996, ACTA NEUROPATHOL, V91, P117; REISS AL, 1993, ANN NEUROL, V34, P227, DOI 10.1002/ana.410340220; Rett A, 1966, Wien Med Wochenschr, V116, P723; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schroer RJ, 1998, AM J MED GENET, V76, P327, DOI 10.1002/(SICI)1096-8628(19980401)76:4<327::AID-AJMG8>3.0.CO;2-M; Shahbazian MD, 2002, AM J HUM GENET, V71, P1259, DOI 10.1086/345360; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Silva AE, 2002, ARQ NEURO-PSIQUIAT, V60, P290, DOI 10.1590/S0004-282X2002000200021; Stancheva I, 2003, MOL CELL, V12, P425, DOI 10.1016/S1097-2765(03)00276-4; Steffenburg S, 1996, PEDIATR NEUROL, V14, P131, DOI 10.1016/0887-8994(96)00011-2; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Thomas JA, 2003, AM J MED GENET A, V119A, P111, DOI 10.1002/ajmg.a.10176; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; VERMA NP, 1986, ELECTROEN CLIN NEURO, V64, P394, DOI 10.1016/0013-4694(86)90072-6; Villard L, 2000, NEUROLOGY, V55, P1188, DOI 10.1212/WNL.55.8.1188; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Watson P, 2001, J MED GENET, V38, P224, DOI 10.1136/jmg.38.4.224; Wilson S, 2003, DEV MED CHILD NEUROL, V45, P508, DOI 10.1111/j.1469-8749.2003.tb00950.x; Winnepenninckx B, 2002, HUM MUTAT, V20, P249, DOI 10.1002/humu.10130; Wolpert CM, 2000, AM J MED GENET, V96, P365, DOI 10.1002/1096-8628(20000612)96:3<365::AID-AJMG25>3.0.CO;2-X; World Health Organization, 1992, INT STAT CLASS DIS R	81	506	528	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2003	302	5646					826	830		10.1126/science.1089071	http://dx.doi.org/10.1126/science.1089071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593168				2022-12-24	WOS:000186258000038
J	Dasen, JS; Liu, JP; Jessell, TM				Dasen, JS; Liu, JP; Jessell, TM			Motor neuron columnar fate imposed by sequential phases of Hox-c activity	NATURE			English	Article							SPINAL-CORD; HOMEODOMAIN PROTEIN; SUBTYPE IDENTITY; HOMEOTIC TRANSFORMATIONS; TRANSCRIPTIONAL CODES; POSITIONAL IDENTITY; GENES; EXPRESSION; MICE; SPECIFICATION	The organization of neurons into columns is a prominent feature of central nervous systemstructure and function. In many regions of the central nervous system the grouping of neurons into columns links cell-body position to axonal trajectory, thus contributing to the establishment of topographic neural maps. This link is prominent in the developing spinal cord, where columnar sets of motor neurons innervate distinct targets in the periphery. We show here that sequential phases of Hox-c protein expression and activity control the columnar differentiation of spinal motor neurons. Hox expression in neural progenitors is established by graded fibroblast growth factor signalling and translated into a distinct motor neuron Hox pattern. Motor neuron columnar fate then emerges through cell autonomous repressor and activator functions of Hox proteins. Hox proteins also direct the expression of genes that establish motor topographic projections, thus implicating Hox proteins as critical determinants of spinal motor neuron identity and organization.	Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA; Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA	Columbia University; Howard Hughes Medical Institute; University of Virginia	Jessell, TM (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, 701 W 168th St, New York, NY 10032 USA.							Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Bell E, 1999, SCIENCE, V284, P2168, DOI 10.1126/science.284.5423.2168; Brend T, 2003, DEVELOPMENT, V130, P2717, DOI 10.1242/dev.00471; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Cai J, 2000, GENESIS, V27, P6, DOI 10.1002/1526-968X(200005)27:1<6::AID-GENE20>3.3.CO;2-F; Carpenter EM, 2002, DEV NEUROSCI-BASEL, V24, P24, DOI 10.1159/000064943; Chen F, 1999, P NATL ACAD SCI USA, V96, P541, DOI 10.1073/pnas.96.2.541; Cohn MJ, 1997, NATURE, V387, P97, DOI 10.1038/387097a0; COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; Cooper KL, 2003, DEV BIOL, V253, P200, DOI 10.1016/S0012-1606(02)00018-0; DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5; Ensini M, 1998, DEVELOPMENT, V125, P969; Gabay L, 1997, DEVELOPMENT, V124, P3535; Garcia-Gasca A, 2000, DEV DYNAM, V219, P261, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1048>3.0.CO;2-3; Goddard JM, 1996, DEVELOPMENT, V122, P3217; GUTMAN CR, 1993, BRAIN RES, V609, P129, DOI 10.1016/0006-8993(93)90865-K; Hart KC, 2000, ONCOGENE, V19, P3309, DOI 10.1038/sj.onc.1203650; HOLLYDAY M, 1980, J COMP NEUROL, V194, P143, DOI 10.1002/cne.901940108; HOLLYDAY M, 1990, J COMP NEUROL, V302, P575, DOI 10.1002/cne.903020313; Hollyday M., 1980, Current Topics in Developmental Biology, V15, P181; JAYNES JB, 1991, EMBO J, V10, P1427, DOI 10.1002/j.1460-2075.1991.tb07663.x; JEGALIAN BG, 1992, CELL, V71, P901, DOI 10.1016/0092-8674(92)90387-R; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; KOSTIC D, 1994, MECH DEVELOP, V46, P231, DOI 10.1016/0925-4773(94)90073-6; Lance-Jones C, 2001, DEVELOPMENT, V128, P2255; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; Li XL, 1999, P NATL ACAD SCI USA, V96, P6802, DOI 10.1073/pnas.96.12.6802; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; PRASAD A, 1991, J COMP NEUROL, V307, P237, DOI 10.1002/cne.903070207; Rossel M, 1999, DEVELOPMENT, V126, P5027; Sanders TA, 2002, J NEUROSCI, V22, P10742; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Sockanathan S, 2003, NEURON, V40, P97, DOI 10.1016/S0896-6273(03)00532-4; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0; Suemori H, 2000, DEV BIOL, V220, P333, DOI 10.1006/dbio.2000.9651; Tiret L, 1998, DEVELOPMENT, V125, P279; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Wahba GM, 2001, DEV BIOL, V231, P87, DOI 10.1006/dbio.2000.0130; William CM, 2003, DEVELOPMENT, V130, P1523, DOI 10.1242/dev.00358	49	261	267	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2003	425	6961					926	933		10.1038/nature02051	http://dx.doi.org/10.1038/nature02051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14586461				2022-12-24	WOS:000186230600033
J	Abbott, A				Abbott, A			Neuroscience - Genomics on the brain	NATURE			English	News Item																		Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033	1	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					757	757		10.1038/426757a	http://dx.doi.org/10.1038/426757a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685199	Bronze			2022-12-24	WOS:000187342000020
J	Hanada, K; Kumagai, K; Yasuda, S; Miura, Y; Kawano, M; Fukasawa, M; Nishijima, M				Hanada, K; Kumagai, K; Yasuda, S; Miura, Y; Kawano, M; Fukasawa, M; Nishijima, M			Molecular machinery for non-vesicular trafficking of ceramide	NATURE			English	Article							ENDOPLASMIC-RETICULUM; GOLGI-APPARATUS; SPHINGOMYELIN SYNTHESIS; BINDING PROTEIN; TRANSPORT; STAR; IDENTIFICATION; PHOSPHORYLATES; ACCUMULATION; RESISTANT	Synthesis and sorting of lipids are essential for membrane biogenesis; however, the mechanisms underlying the transport of membrane lipids remain little understood. Ceramide is synthesized at the endoplasmic reticulum and translocated to the Golgi compartment for conversion to sphingomyelin. The main pathway of ceramide transport to the Golgi is genetically impaired in a mammalian mutant cell line, LY-A. Here we identify CERT as the factor defective in LY-A cells. CERT, which is identical to a splicing variant of Goodpasture antigen-binding protein, is a cytoplasmic protein with a phosphatidylinositol-4-monophosphate- binding (PtdIns4P) domain and a putative domain for catalysing lipid transfer. In vitro assays show that this lipid-transfer-catalysing domain specifically extracts ceramide from phospholipid bilayers. CERT expressed in LY-A cells has an amino acid substitution that destroys its PtdIns4P-binding activity, thereby impairing its Golgi-targeting function. We conclude that CERT mediates the intracellular trafficking of ceramide in a non-vesicular manner.	Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan	National Institute of Infectious Diseases (NIID)	Hanada, K (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	hanak@nih.go.jp	Kumagai, Keigo/AAG-1385-2021	KAWANO-KAWADA, Miyuki/0000-0002-1168-9291; Kumagai, Keigo/0000-0002-1663-2905; Hanada, Kentaro/0000-0003-1383-2781; YASUDA, Satoshi/0000-0002-1011-0815				AKEROYD R, 1981, EUR J BIOCHEM, V114, P385, DOI 10.1111/j.1432-1033.1981.tb05158.x; ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Ardail D, 2003, BIOCHEM J, V371, P1013, DOI 10.1042/BJ20021834; BANERJEE A, 1993, J BIOL CHEM, V268, P5668; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; De Matteis MA, 2002, CURR OPIN CELL BIOL, V14, P434, DOI 10.1016/S0955-0674(02)00357-5; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Fukasawa M, 2000, J BIOL CHEM, V275, P34028, DOI 10.1074/jbc.M005151200; Fukasawa M, 1999, J CELL BIOL, V144, P673, DOI 10.1083/jcb.144.4.673; Funakoshi T, 2000, J BIOL CHEM, V275, P29938, DOI 10.1074/jbc.M004470200; Funato K, 2001, J CELL BIOL, V155, P949, DOI 10.1083/jcb.200105033; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; Kallen CB, 1998, J BIOL CHEM, V273, P26285, DOI 10.1074/jbc.273.41.26285; KASPER AM, 1981, BIOCHIM BIOPHYS ACTA, V664, P22, DOI 10.1016/0005-2760(81)90025-4; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Maxfield FR, 2002, J CLIN INVEST, V110, P891, DOI 10.1172/JCI200216500; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; Raya A, 2000, J BIOL CHEM, V275, P40392, DOI 10.1074/jbc.M002769200; Simon CG, 1999, BIOCHEMISTRY-US, V38, P14676, DOI 10.1021/bi991537w; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; van Meer G, 2000, BBA-MOL CELL BIOL L, V1486, P145, DOI 10.1016/S1388-1981(00)00054-8; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Viani P, 2003, J BIOL CHEM, V278, P9592, DOI 10.1074/jbc.M207729200; VOELKER DR, 2002, BIOCH LIPIDS LIPOPRO, P449; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Yasuda S, 2003, J BIOL CHEM, V278, P4176, DOI 10.1074/jbc.M209602200; Yasuda S, 2001, J BIOL CHEM, V276, P43994, DOI 10.1074/jbc.M104884200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	40	781	803	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2003	426	6968					803	809		10.1038/nature02188	http://dx.doi.org/10.1038/nature02188			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685229				2022-12-24	WOS:000187342000048
J	Macfarlane, GJ; Biggs, AM; Maconochie, N; Hotopf, M; Doyle, P; Lunt, M				Macfarlane, GJ; Biggs, AM; Maconochie, N; Hotopf, M; Doyle, P; Lunt, M			Incidence of cancer among UK Gulf War veterans: cohort study	BRITISH MEDICAL JOURNAL			English	Article							HEALTH; MORTALITY	Objectives To determine whether incidence rates of cancer are higher in UK service personnel who were deployed in the Gulf war than in those not deployed and whether any increased risk of cancer is related to self reported exposures to potentially hazardous material during the period of deployment. Design A cohort study with follow up from 1 April 1991 (the end of the Gulf war) to 31 July 2002. Participants 51721 Gulf war veterans and 50 755 service personnel matched for age, sex, rank, service, and level of fitness who were not deployed in the Gulf (the Era cohort). Main outcome measures Incident cancers, identified on the NHS central register. Results There were 270 incident cancers among the Gulf cohort and 269 among the Era cohort (incidence rate ratio 0.99, 95% confidence interval 0.83 to 1.17). There was no excess in site specific cancers among the Gulf cohort. Adjustment for lifestyle factors (smoking and alcohol consumption) did not alter these results. In the Gulf cohort, risk of cancer was not related to multiple vaccinations or exposure to pesticides or depleted uranium during deployment. Conclusion There is no current excess risk of cancer overall nor of site specific cancers in Gulf war veterans. Specific exposures during deployment have not resulted in a subsequent increased risk of cancer. The long latent period for cancer, however, necessitates the continued follow up of these cohorts.	Univ Manchester, Sch Epidemiol & Hlth Sci, Unit Chron Dis Epidemiol & Hlth Sci, Manchester M13 9PT, Lancs, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Guys Kings & St Thomass Sch Med, Dept Psychol Med, Gulf War Illnesses Res Unit, London SE5 8AZ, England; Univ Manchester, Sch Epidemiol & Hlth Sci, Epidemiol Unit, Arthrit Res Campaign, Manchester M13 9PL, Lancs, England	University of Manchester; University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London; University of Manchester	Macfarlane, GJ (corresponding author), Univ Manchester, Sch Epidemiol & Hlth Sci, Unit Chron Dis Epidemiol & Hlth Sci, Manchester M13 9PT, Lancs, England.		Lunt, Mark/N-3413-2019; Hotopf, Matthew/E-4971-2010; Lunt, Mark/A-7132-2014; Macfarlane, Gary J/I-9521-2014	Lunt, Mark/0000-0002-2391-5575; Lunt, Mark/0000-0002-2391-5575; Macfarlane, Gary J/0000-0003-2322-3314; Hotopf, Matthew/0000-0002-3980-4466				Cherry N, 2001, OCCUP ENVIRON MED, V58, P291, DOI 10.1136/oem.58.5.291; Everitt B, 2002, PSYCHOL MED, V32, P1371, DOI 10.1017/S0033291702006311; Kang HK, 2001, AM J EPIDEMIOL, V154, P399, DOI 10.1093/aje/154.5.399; Knoke JD, 1998, EPIDEMIOLOGY, V9, P648, DOI 10.1097/00001648-199811000-00015; Macfarlane GJ, 2000, LANCET, V356, P17, DOI 10.1016/S0140-6736(00)02428-4; Maconochie N, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-4; *ROYAL SOC, 2002, HLTH EFF DEPL UR M 1; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7	8	30	30	1	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1373	1375		10.1136/bmj.327.7428.1373	http://dx.doi.org/10.1136/bmj.327.7428.1373			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670879	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000187417900016
J	Utzinger, J; Bergquist, R; Xiao, SH; Singer, BH; Tanner, M				Utzinger, J; Bergquist, R; Xiao, SH; Singer, BH; Tanner, M			Sustainable schistosomiasis control - the way forward	LANCET			English	Editorial Material							SUB-SAHARAN AFRICA; HELMINTH INFECTIONS; SANITATION; EFFICACY		Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; WHO, UNDP, World Bank, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland; Chinese Ctr Dis Control & Prevent, Inst Parasit Dis, Shanghai, Peoples R China; Swiss Trop Inst, CH-4002 Basel, Switzerland	Princeton University; The World Bank; World Health Organization; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; University of Basel; Swiss Tropical & Public Health Institute	Utzinger, J (corresponding author), Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA.							Asaolu SO, 2003, ACTA TROP, V86, P283, DOI 10.1016/S0001-706X(03)00060-3; Bergquist NR, 2002, TRENDS PARASITOL, V18, P309, DOI 10.1016/S1471-4922(02)02301-2; Brooker S, 2000, ADV PARASIT, V47, P245, DOI 10.1016/S0065-308X(00)47011-9; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; El Khoby T, 1998, PARASITOL TODAY, V14, P92, DOI 10.1016/S0169-4758(97)01206-4; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; Fincham JE, 2003, ACTA TROP, V86, P315, DOI 10.1016/S0001-706X(03)00063-9; Guyatt HL, 2001, B WORLD HEALTH ORGAN, V79, P695; Katz N, 1998, MEM I OSWALDO CRUZ, V93, P33, DOI 10.1590/S0074-02761998000700005; Lengeler C, 2002, B WORLD HEALTH ORGAN, V80, P235; N'Goran EK, 2003, ANN TROP MED PARASIT, V97, P37, DOI 10.1179/000349803125002553; Savioli L, 1999, MONITORING HELMINTH; Utzinger J, 2003, ANTIMICROB AGENTS CH, V47, P1487, DOI 10.1128/AAC.47.5.1487-1495.2003; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Watts J, 2003, LANCET, V361, P1022, DOI 10.1016/S0140-6736(03)12849-8; WEHAB Working Group, 2002, FRAM ACT WAT SAN; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; WHO, 2002, WHO TECH REP SER; *WHO, 2002, GLOB PLAN STOP TUB; 2002, WORLD BANK LOAN PROG	20	153	157	1	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1932	1934		10.1016/S0140-6736(03)14968-9	http://dx.doi.org/10.1016/S0140-6736(03)14968-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667754				2022-12-24	WOS:000187011600028
J	Finger, C				Finger, C			Health care in indigenous populations: The Xingu Indian park	LANCET			English	Article											Finger, C (corresponding author), R Pascoat Vita 405,Apt 83, BR-05445000 Sao Paulo, Brazil.								0	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S38	S39		10.1016/S0140-6736(03)15070-2	http://dx.doi.org/10.1016/S0140-6736(03)15070-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698124				2022-12-24	WOS:000187790200020
J	Kuhlman, B; Dantas, G; Ireton, GC; Varani, G; Stoddard, BL; Baker, D				Kuhlman, B; Dantas, G; Ireton, GC; Varani, G; Stoddard, BL; Baker, D			Design of a novel globular protein fold with atomic-level accuracy	SCIENCE			English	Article							AMINO-ACID-SEQUENCE; DE-NOVO DESIGN; ELECTRON-DENSITY; SPECIFICITY; PREDICTION; SELECTION; DATABASE; VARIANT; SURFACE; DOMAIN	A major challenge of computational protein design is the creation of novel proteins with arbitrarily chosen three-dimensional structures. Here, we used a general computational strategy that iterates between sequence design and structure prediction to design a 93-residue alpha/beta protein called Top7 with a novel sequence and topology. Top7 was found experimentally to be folded and extremely stable, and the x-ray crystal structure of Top7 is similar (root mean square deviation equals 1.2 angstroms) to the design model. The ability to design a new protein fold makes possible the exploration of the large regions of the protein universe not yet observed in nature.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.		Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Kuhlman, Brian/0000-0003-4907-9699; Dantas, Gautam/0000-0003-0455-8370				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bonneau R, 2001, PROTEINS, P119; Bowers PM, 2000, J BIOMOL NMR, V18, P311, DOI 10.1023/A:1026744431105; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; DESJARLAIS JR, 1995, PROTEIN SCI, V4, P2006, DOI 10.1002/pro.5560041006; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hubbard TJP, 1997, NUCLEIC ACIDS RES, V25, P236, DOI 10.1093/nar/25.1.236; Jaramillo A, 2002, P NATL ACAD SCI USA, V99, P13554, DOI 10.1073/pnas.212068599; Jin WZ, 2003, STRUCTURE, V11, P581, DOI 10.1016/S0969-2126(03)00075-3; Johnson EC, 1999, STRUCTURE, V7, P967, DOI 10.1016/S0969-2126(99)80123-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keating AE, 2001, P NATL ACAD SCI USA, V98, P14825, DOI 10.1073/pnas.261563398; KISSINGER CR, EPMR PROGRAM CRYSTAL; Koehl P, 1999, J MOL BIOL, V293, P1161, DOI 10.1006/jmbi.1999.3211; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2002, J MOL BIOL, V315, P471, DOI 10.1006/jmbi.2001.5229; Larson SM, 2002, PROTEIN SCI, V11, P2804, DOI 10.1110/ps.0203902; LAZARIDIS T, 1999, PROTEINS, V35, P132; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mirny L, 2001, J MOL BIOL, V308, P123, DOI 10.1006/jmbi.2001.4602; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; MURZIN AV, COMMUNICATION; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; Raha K, 2000, PROTEIN SCI, V9, P1106, DOI 10.1110/ps.9.6.1106; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; ROHL C, IN PRESS METHODS ENZ; Su A, 1997, PROTEIN SCI, V6, P1701, DOI 10.1002/pro.5560060810	36	1147	1195	8	264	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2003	302	5649					1364	1368		10.1126/science.1089427	http://dx.doi.org/10.1126/science.1089427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631033				2022-12-24	WOS:000186683500043
J	Dufour, SC; Felbeck, H				Dufour, SC; Felbeck, H			Sulphide mining by the superextensile foot of symbiotic thyasirid bivalves	NATURE			English	Article							MOLLUSKS; ADAPTATIONS; TRANSPORT; HABITAT	In a symbiotic association between an invertebrate host and chemoautotrophic bacteria, each partner has different metabolic requirements, and the host typically supplies the bacteria with necessary reduced chemicals ( sulphide or methane). Some combination of anatomical, physiological and behavioural adaptations in the host often facilitates uptake and transport of reduced chemicals to the symbionts(1-4). We have studied five species of bivalve molluscs of the family Thyasiridae ( that is, thyasirids) three of which harbour chemoautotrophic bacteria. Here we show that the symbiotic bivalves extend their feet to form elongated and ramifying burrows in the sediment, most probably to gain access to reduced sulphur. Closely related bivalves ( including some thyasirid species) without bacterial symbionts show no comparable foot extension behaviour. The length and number of burrows formed by chemosymbiotic thyasirids are related to the concentration of hydrogen sulphide in the sediment. The burrows are formed by the foot of each bivalve, which can extend up to 30 times the length of the shell, and may be the most extreme case of animal structure elongation documented to date.	Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Dufour, SC (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.							ALLEN JA, 1958, PHILOS T R SOC B, V241, P421, DOI 10.1098/rstb.1958.0010; ALLEN JA, 1953, NATURE, V171, P1117, DOI 10.1038/1711117b0; ARP AJ, 1984, PHYSIOL ZOOL, V57, P648, DOI 10.1086/physzool.57.6.30155991; CHILDRESS JJ, 1993, J EXP BIOL, V179, P131; CHILDRESS JJ, 1986, SCI AM, V256, P114; DANDO PR, 1986, J MAR BIOL ASSOC UK, V66, P915, DOI 10.1017/S0025315400048529; DANDO PR, 1986, PROC R SOC SER B-BIO, V227, P227, DOI 10.1098/rspb.1986.0021; GIERE O, 1991, MAR ECOL PROG SER, V68, P287; GILBOAGARBER N, 1971, ANAL BIOCHEM, V43, P129, DOI 10.1016/0003-2697(71)90116-3; Julian D, 1999, J EXP BIOL, V202, P2245; LEPENNEC M, 1995, COMP BIOCHEM PHYS A, V111, P183, DOI 10.1016/0300-9629(94)00211-B; McALESTER A. LEE, 1966, MALACOLOGIA, V3, P433; PAYNE CM, 1991, PHILOS T ROY SOC B, V334, P481, DOI 10.1098/rstb.1991.0128; REID RGB, 1986, VELIGER, V29, P3; Seilacher A., 1990, Historical Biology, V3, P289; SOUTHWARD EC, 1986, J MAR BIOL ASSOC UK, V66, P889, DOI 10.1017/S0025315400048517; Stanley S.M., 1970, GEOLOGICAL SOC AM, V125, P1, DOI 10.1130/MEM125-p1; TRUEMAN ER, 1986, J MOLLUS STUD, V52, P265, DOI 10.1093/mollus/52.3.265; Zuschin Martin, 2001, Historical Biology, V15, P123	19	59	64	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2003	426	6962					65	67		10.1038/nature02095	http://dx.doi.org/10.1038/nature02095			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603317				2022-12-24	WOS:000186370800041
J	Karl, DM; Laws, EA; Morris, P; Williams, PJL; Emerson, S				Karl, DM; Laws, EA; Morris, P; Williams, PJL; Emerson, S			Global carbon cycle - Metabolic balance of the open sea	NATURE			English	Editorial Material							PRODUCTIVITY; RESPIRATION; FLUX		Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; Univ Coll N Wales, Sch Ocean Sci, Menai Bridge LL59 5PP, Gwynedd, Wales; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Hawaii System; Bangor University; University of Washington; University of Washington Seattle	Karl, DM (corresponding author), Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA.	dkarl@hawaii.edu	Karl, David/AFP-3837-2022	Karl, David/0000-0002-6660-6721				delGiorgio PA, 1997, NATURE, V385, P148, DOI 10.1038/385148a0; Duarte CM, 1998, SCIENCE, V281, P234, DOI 10.1126/science.281.5374.234; Duarte CM, 1999, SCIENCE, V284, P1735, DOI DOI 10.1126/SCIENCE.284.5421.1735B; Emerson S, 1997, NATURE, V389, P951, DOI 10.1038/40111; EMERSON S, 1995, J GEOPHYS RES-OCEANS, V100, P15873, DOI 10.1029/95JC01333; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Gregg MC, 2003, NATURE, V422, P513, DOI 10.1038/nature01507; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; Najjar RG, 2000, GLOBAL BIOGEOCHEM CY, V14, P573, DOI 10.1029/1999GB900086; Uz BM, 2001, NATURE, V409, P597, DOI 10.1038/35054527; Williams P. J. le B, 2002, PHYTOPLANKTON PRODUC, P222, DOI [10.1002/9780470995204.ch9, DOI 10.1002/9780470995204.CH9]; Young RW, 1991, GLOBAL BIOGEOCHEM CY, V5, P119, DOI 10.1029/91GB00927	12	143	146	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2003	426	6962					32	32		10.1038/426032a	http://dx.doi.org/10.1038/426032a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603308	Bronze			2022-12-24	WOS:000186370800032
J	Messerli, FH				Messerli, FH			ALLHAT, or the soft science of the secondary end point	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DIURETIC THERAPY; METAANALYSIS; HYPERTENSION; OUTCOMES; RISK	The recent Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) showed that the primary end point, coronary heart disease, was identical in the chlorthalidone, lisinopril, and amlodipine groups. Yet the major conclusion of this trial was that thiazide diuretics are superior in preventing 1 or more major forms of cardiovascular disease and should be preferred for first-line antihypertensive therapy. This conclusion was based solely on an analysis of secondary end points and cost As evidenced by the dictum to "use thiazides for most patients with uncomplicated hypertension" in the Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, this interpretation of, ALLHAT broadly adumbrated these guidelines. Although diuretics will rightfully remain a cornerstone in anti hypertensive therapy, we should remember (as we were told by the ALLHAT investigators) that secondary end points are "soft data" that should not form a basis for main conclusions or lead to a labeling of a drug class as preferred.	Ochsner Clin Fdn, New Orleans, LA 70121 USA	Ochsner Health System	Messerli, FH (corresponding author), Ochsner Clin Fdn, 1514 Jefferson Highway, New Orleans, LA 70121 USA.	fmesserli@aol.com	Messerli, Franz/AAR-4783-2021					ALTMAN LK, 2000, NY TIMES        0829, pA17; [Anonymous], 1990, Circulation, V82, P1616; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLUCCI WS, 1986, NEW ENGL J MED, V314, P290, DOI 10.1056/NEJM198601303140506; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lindholm LH, 2003, J HYPERTENS, V21, P1563, DOI 10.1097/00004872-200308000-00022; McAlister FA, 2003, ANN INTERN MED, V138, P938, DOI 10.7326/0003-4819-138-11-200306030-00016; MESSERLI FH, 1995, ANN INTERN MED, V123, P888, DOI 10.7326/0003-4819-123-11-199512010-00015; Messerli FH, 2003, JAMA-J AM MED ASSOC, V289, P2067, DOI 10.1001/jama.289.16.2067; Messerli FH, 1998, JAMA-J AM MED ASSOC, V279, P1903, DOI 10.1001/jama.279.23.1903; Messerli FH, 1999, EUR HEART J, V20, P1441, DOI 10.1053/euhj.1999.1534; MESSERLI FH, 2003, JAMA-J AM MED ASSOC, V289, P2069; MESSERLI FH, IN PRESS AM J HYPERT; Pahor M, 2000, LANCET, V356, P1949, DOI 10.1016/S0140-6736(00)03306-7; Schrier RW, 2000, HYPERTENSION, V35, P1031, DOI 10.1161/01.HYP.35.5.1031; Tenenbaum A, 2001, AM J MED, V110, P143, DOI 10.1016/S0002-9343(00)00674-4; The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; Younis N, 2003, LANCET, V361, P195, DOI 10.1016/S0140-6736(03)12267-2; Yusuf S, 2000, NEW ENGL J MED, V342, P145	21	34	35	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2003	139	9					777	780		10.7326/0003-4819-139-9-200311040-00012	http://dx.doi.org/10.7326/0003-4819-139-9-200311040-00012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738XJ	14597462				2022-12-24	WOS:000186312900007
J	Liu, HB; Gao, JM; Lynch, SR; Saito, YD; Maynard, L; Kool, ET				Liu, HB; Gao, JM; Lynch, SR; Saito, YD; Maynard, L; Kool, ET			A four-base paired genetic helix with expanded size	SCIENCE			English	Article							NUCLEIC-ACIDS; BASE-PAIR; LIN-BENZOADENOSINE; HYDROPHOBIC BASE; DNA; OLIGONUCLEOTIDES; RECOGNITION; ISOGUANINE; ALPHABET; THYMINE	We describe a new molecular class of genetic-pairing system that has a native DNA backbone but has all four base pairs replaced by new, larger pairs. The base pairs include size-expanded analogs of thymine and of adenine, both extended by the width of a benzene ring (2.4 Angstrom). The expanded-diameter double helices are more thermodynamically stable than the Watson-Crick helix, likely because of enhanced base stacking. Structural data confirm a right-handed, double-stranded, and base-paired helical form. Because of the larger base size, all the pairs of this helical system are fluorescent, which suggests practical applications in detection of natural DNA and RNA. Our findings establish that there is no apparent structural or thermodynamic prohibition against genetic systems having sizes different from the natural one.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Kool, ET (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.			Gao, Jianmin/0000-0001-9341-1287; Kool, Eric/0000-0002-7310-2935	NIGMS NIH HHS [GM52956, GM63587] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063587, R01GM052956] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benner SA, 1998, PURE APPL CHEM, V70, P263, DOI 10.1351/pac199870020263; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; Eschenmoser A, 1999, SCIENCE, V284, P2118, DOI 10.1126/science.284.5423.2118; Groebke K, 1998, HELV CHIM ACTA, V81, P375, DOI 10.1002/hlca.19980810302; HOFFER M, 1960, CHEM BER-RECL, V93, P2777, DOI 10.1002/cber.19600931204; Hoffmann MFH, 2000, HELV CHIM ACTA, V83, P2580, DOI 10.1002/1522-2675(20000906)83:9<2580::AID-HLCA2580>3.0.CO;2-6; KAUFFMAN RF, 1978, BIOCHEMISTRY-US, V17, P3686, DOI 10.1021/bi00611a002; Koshkin AA, 1998, TETRAHEDRON, V54, P3607, DOI 10.1016/S0040-4020(98)00094-5; LEONARD NJ, 1976, J AM CHEM SOC, V98, P3987, DOI 10.1021/ja00429a040; LESSOR RA, 1984, BIOCHEMISTRY-US, V23, P3868, DOI 10.1021/bi00312a012; Liu H., UNPUB; Matray TJ, 1998, J AM CHEM SOC, V120, P6191, DOI 10.1021/ja9803310; MATSUKURA M, 1987, P NATL ACAD SCI USA, V84, P7706, DOI 10.1073/pnas.84.21.7706; McMinn DL, 1999, J AM CHEM SOC, V121, P11585, DOI 10.1021/ja9925150; Michel J, 1996, NUCLEIC ACIDS RES, V24, P1127, DOI 10.1093/nar/24.6.1127; Mitsui T, 2003, J AM CHEM SOC, V125, P5298, DOI 10.1021/ja028806h; MURAKAMI A, 1985, BIOCHEMISTRY-US, V24, P4041, DOI 10.1021/bi00336a036; PICCIRILLI JA, 1990, NATURE, V343, P33, DOI 10.1038/343033a0; PRAKASH G, 1992, J AM CHEM SOC, V114, P3523, DOI 10.1021/ja00035a056; RAPPAPORT HP, 1988, NUCLEIC ACIDS RES, V16, P7253, DOI 10.1093/nar/16.15.7253; Seela F, 1998, NUCLEOS NUCLEOT, V17, P2045, DOI 10.1080/07328319808004745; SEELA F, 1997, BIOORG MED CHEM LETT, V17, P2173; Tanaka K, 2003, SCIENCE, V299, P1212, DOI 10.1126/science.1080587	23	206	216	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2003	302	5646					868	871		10.1126/science.1088334	http://dx.doi.org/10.1126/science.1088334			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593180				2022-12-24	WOS:000186258000050
J	MacMicking, JD; Taylor, GA; McKinney, JD				MacMicking, JD; Taylor, GA; McKinney, JD			Immune control of tuberculosis by IFN-gamma-inducible LRG-47	SCIENCE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; ENDOPLASMIC-RETICULUM; NITRIC-OXIDE; MACROPHAGES; RESISTANCE; RESPONSES; ROLES	Interferon-gamma (IFN-gamma) provides an essential component of immunity to tuberculosis by activating infected host macrophages to directly inhibit the replication of Mycobacterium tuberculosis (Mtb). IFN-gamma-inducible nitric oxide synthase 2 (NOS2) is considered a principal effector mechanism, although other pathways may also exist. Here, we identify one member of a newly emerging 47-kilodalton (p47) guanosine triphosphatase family, LRG-47, that acts independently of NOS2 to protect against disease. Mice lacking LRG-47 failed to control Mtb replication, unlike those missing the related p47 guanosine triphosphatases IRG-47 or IGTP. Defective bacterial killing in IFN-gamma-activated LRG-47(-/-) macrophages was associated with impaired maturation of Mtb-containing phagosomes, vesicles that otherwise recruited LRG-47 in wild-type cells. Thus, LRG-47 may serve as a critical vacuolar trafficking component used to dispose of intracellular pathogens like Mtb.	Rockefeller Univ, Lab Infect Biol, New York, NY 10021 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27705 USA; Duke Univ, Med Ctr, Dept Immunol, Div Geriatr, Durham, NC 27705 USA; Duke Univ, Med Ctr, Ctr Aging & Human Dev, Durham, NC 27705 USA; Durham Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Durham, NC 27705 USA	Rockefeller University; Duke University; Duke University; Duke University; Geriatric Research Education & Clinical Center	MacMicking, JD (corresponding author), Rockefeller Univ, Lab Infect Biol, 1230 York Ave, New York, NY 10021 USA.	macmicj@mail.rockefeller.edu			PHS HHS [R01 A1051702] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boehm U, 1998, J IMMUNOL, V161, P6715; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Clemens DL, 1996, J EXP MED, V184, P1349, DOI 10.1084/jem.184.4.1349; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Hackam DJ, 1998, J EXP MED, V188, P351, DOI 10.1084/jem.188.2.351; HART PD, 1991, J EXP MED, V174, P881, DOI 10.1084/jem.174.4.881; Hayashi T, 2001, INFECT IMMUN, V69, P6156, DOI 10.1128/IAI.69.10.6156-6164.2001; Kincaid EZ, 2003, J IMMUNOL, V171, P2042, DOI 10.4049/jimmunol.171.4.2042; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MacMicking JD, 2003, HANDB EXP PHARM, V158, P409; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Mazurek GH, 2001, JAMA-J AM MED ASSOC, V286, P1740, DOI 10.1001/jama.286.14.1740; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; OLAKAMNI O, 2003, J BIOL CHEM, V277, P49727; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Taylor GA, 1997, J BIOL CHEM, V272, P10639; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Zerrahn J, 2002, J IMMUNOL, V168, P3428, DOI 10.4049/jimmunol.168.7.3428	31	517	545	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2003	302	5645					654	659		10.1126/science.1088063	http://dx.doi.org/10.1126/science.1088063			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576437				2022-12-24	WOS:000186119900062
J	van den Berg, B; Clemons, WM; Collinson, I; Modis, Y; Hartmann, E; Harrison, SC; Rapoport, TA				van den Berg, B; Clemons, WM; Collinson, I; Modis, Y; Hartmann, E; Harrison, SC; Rapoport, TA			X-ray structure of a protein-conducting channel	NATURE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL SEQUENCE RECOGNITION; ESCHERICHIA-COLI; ER MEMBRANE; CROSS-LINKING; PREPROTEIN TRANSLOCATION; SEC PROTEINS; COMPLEX; TRANSPORT; ANGSTROM	A conserved heterotrimeric membrane protein complex, the Sec61 or SecY complex, forms a protein-conducting channel, allowing polypeptides to be transferred across or integrated into membranes. We report the crystal structure of the complex from Methanococcus jannaschii at a resolution of 3.2 Angstrom. The structure suggests that one copy of the heterotrimer serves as a functional translocation channel. The alpha-subunit has two linked halves, transmembrane segments 1-5 and 6-10, clamped together by the gamma-subunit. A cytoplasmic funnel leading into the channel is plugged by a short helix. Plug displacement can open the channel into an 'hourglass' with a ring of hydrophobic residues at its constriction. This ring may form a seal around the translocating polypeptide, hindering the permeation of other molecules. The structure also suggests mechanisms for signal-sequence recognition and for the lateral exit of transmembrane segments of nascent membrane proteins into lipid, and indicates binding sites for partners that provide the driving force for translocation.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Max Planck Inst Biophys, D-60439 Frankfurt, Germany; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Med Univ Lubeck, Inst Biol, D-23538 Lubeck, Germany	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Max Planck Society; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; University of Lubeck	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu	Clemons, William M/D-1026-2009; Hartmann, Enno/C-5687-2013	Clemons, William M/0000-0002-0021-889X; Modis, Yorgo/0000-0002-6084-0429; Collinson, Ian/0000-0002-3931-0503; van den Berg, Bert/0000-0003-1966-8804				Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; BIEKER KL, 1990, J BIOENERG BIOMEMBR, V22, P291, DOI 10.1007/BF00763169; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; DERMAN AI, 1993, EMBO J, V12, P879, DOI 10.1002/j.1460-2075.1993.tb05728.x; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; FLOWER AM, 1995, EMBO J, V14, P884, DOI 10.1002/j.1460-2075.1995.tb07070.x; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Heritage D, 2001, J BIOL CHEM, V276, P22655, DOI 10.1074/jbc.M102409200; Irihimovitch V, 2003, J BIOL CHEM, V278, P12881, DOI 10.1074/jbc.M210762200; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; KIM YJ, 1994, CELL, V78, P845; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; KURZCHALIA TV, 1988, EUR J BIOCHEM, V172, P663, DOI 10.1111/j.1432-1033.1988.tb13940.x; Manting EH, 2000, EMBO J, V19, P852, DOI 10.1093/emboj/19.5.852; Matlack KES, 1998, CELL, V92, P381, DOI 10.1016/S0092-8674(00)80930-7; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Mingarro I, 2000, BMC Cell Biol, V1, P3, DOI 10.1186/1471-2121-1-3; Morgan DG, 2002, J MOL BIOL, V324, P871, DOI 10.1016/S0022-2836(02)01111-7; Mori H, 2003, J BIOL CHEM, V278, P14257, DOI 10.1074/jbc.M300230200; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; MURPHY CK, 1994, P NATL ACAD SCI USA, V91, P2557, DOI 10.1073/pnas.91.7.2557; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; PLATH K, IN PRESS MOL BIOL CE; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Raden D, 2000, J CELL BIOL, V150, P53, DOI 10.1083/jcb.150.1.53; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Satoh Y, 2003, BIOCHEMISTRY-US, V42, P7442, DOI 10.1021/bi034333v; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; TANI K, 1990, J BIOL CHEM, V265, P17341; van der Sluis EO, 2002, FEBS LETT, V527, P159, DOI 10.1016/S0014-5793(02)03202-7; Veenendaal AKJ, 2001, J BIOL CHEM, V276, P32559, DOI 10.1074/jbc.M103912200; Yahr TL, 2000, EMBO J, V19, P4393, DOI 10.1093/emboj/19.16.4393	50	953	975	1	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2004	427	6969					36	44		10.1038/nature02218	http://dx.doi.org/10.1038/nature02218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YP	14661030				2022-12-24	WOS:000187710000026
J	Kvalsvig, A				Kvalsvig, A			Ask the elephant	LANCET			English	Article											Kvalsvig, A (corresponding author), 600 Makara Rd, Wellington, New Zealand.								0	9	9	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 20	2003	362	9401					2079	2080		10.1016/S0140-6736(03)15105-7	http://dx.doi.org/10.1016/S0140-6736(03)15105-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UJ	14697810				2022-12-24	WOS:000187429600024
J	Dennis, C				Dennis, C			Genomics - Compare and contrast	NATURE			English	News Item							SEQUENCES; REGIONS											Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; Frazer KA, 2003, GENOME RES, V13, P341, DOI 10.1101/gr.554603; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858	8	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					750	751		10.1038/426750b	http://dx.doi.org/10.1038/426750b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685190	Bronze			2022-12-24	WOS:000187342000013
J	Huynh, KD; Lee, JT				Huynh, KD; Lee, JT			Inheritance of a pre-inactivated paternal X chromosome in early mouse embryos	NATURE			English	Article							XIST RNA ACCUMULATION; GENE-EXPRESSION; STAGE	In mammals, dosage compensation ensures equal X-chromosome expression between males (XY) and females (XX) by transcriptionally silencing one X chromosome in XX embryos(1). In the prevailing view, the XX zygote inherits two active X chromosomes, one each from the mother and father, and X inactivation does not occur until after implantation(2-6). Here, we report evidence to the contrary in mice. We find that one X chromosome is already silent at zygotic gene activation (2-cell stage). This X chromosome is paternal in origin and exhibits a gradient of silencing. Genes close to the X-inactivation centre show the greatest degree of inactivation, whereas more distal genes show variable inactivation and can partially escape silencing. After implantation, imprinted silencing in extraembryonic tissues becomes globalized and more complete on a gene-by-gene basis. These results argue that the XX embryo is in fact dosage compensated at conception along much of the X chromosome. We propose that imprinted X inactivation results from inheritance of a pre-inactivated X chromosome from the paternal germ line.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol,Howard Hughes Med Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute	Lee, JT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol,Howard Hughes Med Inst, Boston, MA 02114 USA.	lee@frodo.mgh.harvard.edu						ADLER DA, 1977, NATURE, V267, P838, DOI 10.1038/267838a0; Carrel L, 1996, HUM MOL GENET, V5, P391, DOI 10.1093/hmg/5.3.391; Chadwick BP, 2003, DEV CELL, V4, P445, DOI 10.1016/S1534-5807(03)00097-2; Duthie SM, 1999, HUM MOL GENET, V8, P195, DOI 10.1093/hmg/8.2.195; EPSTEIN CJ, 1978, NATURE, V274, P500, DOI 10.1038/274500a0; Graves JAM, 1996, ANNU REV GENET, V30, P233, DOI 10.1146/annurev.genet.30.1.233; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Hartshorn C, 2003, MOL REPROD DEV, V64, P41, DOI 10.1002/mrd.10223; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Huynh KD, 2001, CURR OPIN CELL BIOL, V13, P690, DOI 10.1016/S0955-0674(00)00272-6; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; KRATZER PG, 1978, NATURE, V274, P503, DOI 10.1038/274503a0; KRIETSCH WKG, 1982, DIFFERENTIATION, V23, P141, DOI 10.1111/j.1432-0436.1982.tb01276.x; Latham KE, 2000, BIOL REPROD, V63, P64, DOI 10.1095/biolreprod63.1.64; Lee JT, 2003, CURR BIOL, V13, pR242, DOI 10.1016/S0960-9822(03)00162-3; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; LYON MF, 1999, RESULTS PROBLEMS CEL, P73; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Matsui J, 2001, HUM MOL GENET, V10, P1393, DOI 10.1093/hmg/10.13.1393; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; MUKHERJEE AB, 1976, P NATL ACAD SCI USA, V73, P1608, DOI 10.1073/pnas.73.5.1608; NOTHIAS JY, 1995, J BIOL CHEM, V270, P22077, DOI 10.1074/jbc.270.38.22077; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	30	293	301	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2003	426	6968					857	862		10.1038/nature02222	http://dx.doi.org/10.1038/nature02222			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14661031				2022-12-24	WOS:000187342000063
J	Carnethon, MR; Gidding, SS; Nehgme, R; Sidney, S; Jacobs, DR; Liu, K				Carnethon, MR; Gidding, SS; Nehgme, R; Sidney, S; Jacobs, DR; Liu, K			Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; FOLLOW-UP; EXERCISE; HYPERTENSION; MEN; WEIGHT; OVERWEIGHT; PREVENTION; GLUCOSE	Context Low cardiorespiratory fitness is an established risk factor for cardiovascular and total mortality; however, mechanisms responsible for these associations are uncertain. Objective To test whether low fitness, estimated by short duration on a maximal treadmill test, predicted the development of cardiovascular disease risk factors and whether improving fitness (increase in treadmill test duration between examinations) was associated with risk reduction. Design, Setting, and Participants Population-based longitudinal cohort study of men and women 18 to 30 years of age in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Participants who completed the treadmill examination according to the Balke protocol at baseline were followed up from 1985-1986 to 2000-2001. A subset of participants (n=2478) repeated the exercise test in 1992-1993. Main Outcome Measures Incident type 2 diabetes, hypertension, the metabolic syndrome (defined according to National Cholesterol Education Program Adult-Treatment Panel 111), and hypercholesterolemia (low-density lipoprotein cholesterol greater than or equal to160 mg/dL [4.14 mmol/L]). Results During the 15-year study period, the rates of incident diabetes, hypertension, the metabolic syndrome, and hypercholesterolemia were 2.8, 13.0, 10.2, and 11.7 per 1000 person-years, respectively. After adjustment for age, race, sex, smoking, and family history of diabetes, hypertension, or premature myocardial infarction, participants with low fitness (<20th percentile) were 3- to 6-fold more likely to develop diabetes, hypertension, and the metabolic syndrome than participants with high fitness ( >= 60th percentile), all P<.001. Adjusting for baseline body mass index diminished the strength of these associations to 2-fold (all P<.001). In contrast, the association between low fitness and hypercholesterolemia was modest (hazard ratio [HR], 1.4; 95% confidence interval [CI], 1.1-1.7; P=.02) and attenuated to marginal significance after body mass index adjustment (P=13). Improved fitness over 7 years was associated with a reduced risk of developing diabetes (HR, 0.4; 95% Cl, 0.2-1.0; P=.04) and the metabolic syndrome (HR, 0.5; 95% Cl, 0.3-0.7; P<.001), but the strength and significance of these associations was reduced after accounting for changes in weight. Conclusions Poor fitness in young adults is associated with the development of cardiovascular disease risk factors. These associations involve obesity and may be modified by improving fitness.	Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Thomas Jefferson Univ, Nemours Cardiac Ctr, Wilmington, DE USA; Thomas Jefferson Univ, Dept Pediat, Wilmington, DE USA; Kaiser Permanente Med Care Program, Div Res, Oakland, CA 94611 USA; Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA	Northwestern University; Feinberg School of Medicine; Jefferson University; Jefferson University; Kaiser Permanente; University of Minnesota System; University of Minnesota Twin Cities	Carnethon, MR (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Suite 1102, Chicago, IL 60611 USA.	carnethon@northwestern.edu		Jacobs, David/0000-0002-7232-0543; Gidding, Samuel/0000-0002-8557-7225	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048049, N01HC048048, N01HC095095, N01HC048050, N01HC048047] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL073249] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARIAS E, 2003, DEATHS PRELIMINARY D; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BLAIR SN, 1984, JAMA-J AM MED ASSOC, V252, P487, DOI 10.1001/jama.252.4.487; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Borg G A, 1974, Exerc Sport Sci Rev, V2, P131; Caspersen CJ, 2000, MED SCI SPORT EXER, V32, P1601; Centers for Disease Control and Prevention, 1996, PHYS ACT HLTH REP SU; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Durstine J L, 1994, Exerc Sport Sci Rev, V22, P477; EKELUND LG, 1988, NEW ENGL J MED, V319, P1379, DOI 10.1056/NEJM198811243192104; Fagard RH, 1999, MED SCI SPORT EXER, V31, pS624, DOI 10.1097/00005768-199911001-00022; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; Jacobs David R Jr, 1989, J Cardiopulm Rehabil, V9, P448, DOI 10.1097/00008483-198911000-00003; Juhaeri, 2002, INT J OBESITY, V26, P58, DOI 10.1038/sj.ijo.0801846; Kraus WE, 2002, NEW ENGL J MED, V347, P1483, DOI [10.1056/NEJMoa020194, DOI 10.1056/NEJMoa020194, DOI 10.1056/NEJMOA020194]; Laaksonen DE, 2002, DIABETES CARE, V25, P1612, DOI 10.2337/diacare.25.9.1612; Lee CD, 2002, MED SCI SPORT EXER, V34, P592; Lee CD, 2002, MED SCI SPORT EXER, V34, P735; Melanson EL, 2001, EUR J APPL PHYSIOL, V85, P442, DOI 10.1007/s004210100479; Mora S, 2003, JAMA-J AM MED ASSOC, V290, P1600, DOI 10.1001/jama.290.12.1600; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Perseghin G, 1996, NEW ENGL J MED, V335, P1357, DOI 10.1056/NEJM199610313351804; Petrella RJ, 2003, AM J PREV MED, V24, P316, DOI 10.1016/S0749-3797(03)00022-9; POLLOCK ML, 1976, AM HEART J, V92, P39, DOI 10.1016/S0002-8703(76)80401-2; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Sidney S, 1998, MED SCI SPORT EXER, V30, P427, DOI 10.1097/00005768-199803000-00014; SIDNEY S, 1992, MED SCI SPORT EXER, V24, P177; STAMLER R, 1978, JAMA-J AM MED ASSOC, V240, P1607, DOI 10.1001/jama.240.15.1607; STEFANICK ML, 1984, PHYSICAL ACTIVITY FI, P417; Sternfeld B, 1999, ANN EPIDEMIOL, V9, P25, DOI 10.1016/S1047-2797(98)00030-1; WARNICK GR, 1982, CLIN CHEM, V28, P1379; Wei M, 1999, ANN INTERN MED, V130, P89, DOI 10.7326/0003-4819-130-2-199901190-00002; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547	38	425	436	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2003	290	23					3092	3100		10.1001/jama.290.23.3092	http://dx.doi.org/10.1001/jama.290.23.3092			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753ZB	14679272	Bronze			2022-12-24	WOS:000187277300028
J	Chatterjee, S; Callaway, EM				Chatterjee, S; Callaway, EM			Parallel colour-opponent pathways to primary visual cortex	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; S-CONE; GANGLION-CELLS; OLD-WORLD; MORPHOLOGY; RETINA; ORGANIZATION; MECHANISMS; LAMINAE; AXONS	The trichromatic primate retina parses the colour content of a visual scene into ' red/ green' and ` blue/ yellow' representations(1 - 2). Cortical circuits must combine the information encoded in these colour- opponent signals to reconstruct the full range of perceived colours(3). Red/ green and blue/ yellow inputs are relayed by the lateral geniculate nucleus ( LGN) of thalamus to primary visual cortex ( V1), so understanding how cortical circuits transform these signals requires understanding how LGN inputs to V1 are organized. Here we report direct recordings from LGN afferent axons in muscimol- inactivated V1. We found that blue/ yellow afferents terminated exclusively in superficial cortical layers 3B and 4A, whereas red/ green afferents were encountered only in deeper cortex, in lower layer 4C. We also describe a distinct cortical target for ' blue- OFF' cells, whose afferents terminated in layer 4A and seemed patchy in organization. The more common ` blue- ON' afferents were found in 4A as well as lower layer 2/ 3. Chromatic information is thus conveyed to V1 by parallel, anatomically segregated colour- opponent systems, to be combined at a later stage of the colour circuit.	Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA; Univ Calif San Diego, Neurosci Program, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Chatterjee, S (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	sochatte@ucsd.edu	Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267				Ahmad KM, 2003, VISUAL NEUROSCI, V20, P189, DOI 10.1017/S0952523803202091; BLASDEL GG, 1984, J NEUROSCI, V4, P880; BLASDEL GG, 1983, J NEUROSCI, V3, P1389; Calkins DJ, 1999, NEURON, V24, P313, DOI 10.1016/S0896-6273(00)80846-6; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chatterjee S, 2002, NEURON, V35, P1135, DOI 10.1016/S0896-6273(02)00874-7; Chichilnisky EJ, 1999, NAT NEUROSCI, V2, P889, DOI 10.1038/13189; CONLEY M, 1989, VISUAL NEUROSCI, V2, P287, DOI 10.1017/S0952523800001206; Dacey DM, 2000, ANNU REV NEUROSCI, V23, P743, DOI 10.1146/annurev.neuro.23.1.743; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Dacey DM, 2003, NEURON, V37, P15, DOI 10.1016/S0896-6273(02)01143-1; De Valois RL, 2000, P NATL ACAD SCI USA, V97, P4997, DOI 10.1073/pnas.97.9.4997; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; HENDRICKSON AE, 1978, J COMP NEUROL, V182, P123, DOI 10.1002/cne.901820108; Hendry SHC, 2000, ANNU REV NEUROSCI, V23, P127, DOI 10.1146/annurev.neuro.23.1.127; HENDRY SHC, 1994, SCIENCE, V264, P575, DOI 10.1126/science.8160015; HUBEL DH, 1972, J COMP NEUROL, V146, P421, DOI 10.1002/cne.901460402; Klug K, 2003, J NEUROSCI, V23, P9881; LENNIE P, 1988, CRIT REV NEUROBIOL, V3, P333; LEVENTHAL AG, 1981, SCIENCE, V213, P1139, DOI 10.1126/science.7268423; Martin PR, 1997, EUR J NEUROSCI, V9, P1536, DOI 10.1111/j.1460-9568.1997.tb01509.x; MICHAEL CR, 1988, P NATL ACAD SCI USA, V85, P4914, DOI 10.1073/pnas.85.13.4914; Reid RC, 2002, J NEUROSCI, V22, P6158; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; RODIECK RW, 1993, J COMP NEUROL, V338, P289, DOI 10.1002/cne.903380211; SCHILLER PH, 1978, J NEUROPHYSIOL, V41, P788, DOI 10.1152/jn.1978.41.3.788; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; VALBERG A, 1986, VISION RES, V26, P1061, DOI 10.1016/0042-6989(86)90040-4; Wandell B. A., 1995, FDN VISION, P413; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115	30	147	153	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					668	671		10.1038/nature02167	http://dx.doi.org/10.1038/nature02167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668866				2022-12-24	WOS:000187132800043
J	White, MF				White, MF			Insulin signaling in health and disease	SCIENCE			English	Article							STIMULATES TYROSINE PHOSPHORYLATION; RECEPTOR SUBSTRATE-2; RESISTANCE; GROWTH; CELLS; PROTEIN; OBESITY	The signaling pathways used by insulin have been identified [M. White, Insulin Signaling Pathway, Sci. STKE (Connections Map, as seen November 2003), http://stke.sciencemag. org/cgi/cm/cmp_12069]. Now our challenge is to understand how the failure of these signals is associated with obesity and the progressive failure of pancreatic beta cells that leads to diabetes. Whether better management of chronic inflammation can improve insulin action is an important area of investigation. Drugs that stimulate IRS2 (insulin receptor substrate protein 2) synthesis or signaling might be a good starting point. This knowledge will lead to rational strategies that prevent or cure diabetes.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Howard Hughes Med Inst, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Howard Hughes Medical Institute	White, MF (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Howard Hughes Med Inst, 1 Joslin Pl, Boston, MA 02215 USA.							Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Bliss M., 1982, DISCOVERY INSULIN; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; KASUGA M, 1982, NATURE, V298, P667, DOI 10.1038/298667a0; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; KREBS DL, 2003, SCI STKE, pE6; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; WHITE MF, 2003, SCI STKE; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	21	490	529	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1710	1711		10.1126/science.1092952	http://dx.doi.org/10.1126/science.1092952			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657487	Green Submitted			2022-12-24	WOS:000186970100034
J	Go, AS; Hylek, EM; Chang, YC; Phillips, KA; Henault, LE; Capra, AM; Jensvold, NG; Selby, JV; Singer, DE				Go, AS; Hylek, EM; Chang, YC; Phillips, KA; Henault, LE; Capra, AM; Jensvold, NG; Selby, JV; Singer, DE			Anticoagulation therapy for stroke prevention in atrial fibrillation - How well do randomized trials translate into clinical practice?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; ORAL ANTICOAGULATION; ANTITHROMBOTIC THERAPY; PREDICTING STROKE; RHYTHM CONTROL; INTENSITY; WARFARIN; VALIDATION; MORTALITY; EFFICACY	Context Warfarin has been shown to be highly efficacious for preventing thromboembolism in atrial fibrillation in randomized trials, but its effectiveness and safety in clinical practice is less clear. Objective To evaluate the effect of warfarin on risk of thromboembolism, hemorrhage, and death in atrial fibrillation within a usual care setting. Design Cohort study assembled between July 1, 1996, and December 31,1997, and followed up through August 31, 1999. Setting Large integrated health care system in Northern California. Patients Of 13559 adults with nonvalvular atrial fibrillation, 11526 were studied, 43% of whom were women, mean age 71 years, with no known contraindications to anticoagulation at baseline. Main Outcomes Ischemic stroke, peripheral embolism, hemorrhage, and death according to warfarin use and comorbidity status, as determined by automated databases, review of medical records, and state mortality files. Results Among 11526 patients, 397 incident thromboembolic events (372 ischemic strokes, 25 peripheral embolism) occurred during 25341 person-years of follow-up, and warfarin therapy was associated with a 51% (95% confidence interval [CI], 39%-60%) lower risk of thromboembolism compared with no warfarin therapy (either no antithrombotic therapy or aspirin) after adjusting for potential confounders and likelihood of receiving warfarin. Warfarin was effective in reducing thromboembolic risk in the presence or absence of risk factors for stroke. A nested case-control analysis estimated a 64% reduction in odds of thromboembolism with warfarin compared with no antithrombotic therapy. Warfarin was also associated with a reduced risk of all-cause mortality. (adjusted hazard ratio, 0.69; 95% CI, 0.61-0.77). Intracranial hemorrhage was uncommon, but the rate was moderately higher among those taking vs those not taking warfarin (0.46 vs 0.23 per 100 person-years, respectively; P=.003, adjusted hazard ratio, 1.97; 95% CI, 1.24-3.13). However, warfarin therapy was not associated with an increased adjusted risk of nonintracranial major hemorrhage. The effects of warfarin were similar when patients with contraindications at baseline were analyzed separately or combined with those without contraindications (total cohort of 13559). Conclusions Warfarin is very effective for preventing ischemic stroke inpatients with atrial fibrillation in clinical practice while the absolute increase in the risk of intracranial hemorrhage is small. Results of randomized trials of anticoagulation translate well into clinical care for patients with atrial fibrillation.	Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Massachusetts Gen Hosp, Dept Med, Div Gen Med, Clin Epidemiol Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Go, AS (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway St,3rd Floor, Oakland, CA 94612 USA.	Alan.S.Go@kp.org	Go, Alan S./AAE-7745-2019	Hylek, Elaine/0000-0001-8263-8304	NIA NIH HHS [AG15478] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG015478] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Albers GW, 2001, CHEST, V119, p194S, DOI 10.1378/chest.119.1_suppl.194S; [Anonymous], 1997, ARCH INTERN MED, V157, P1237; Ansell JE, 1997, ANN PHARMACOTHER, V31, P604, DOI 10.1177/106002809703100516; ARELLANO MG, 1984, AM J PUBLIC HEALTH, V74, P1324, DOI 10.2105/AJPH.74.12.1324; Aronow WS, 1999, J AM GERIATR SOC, V47, P366, DOI 10.1111/j.1532-5415.1999.tb03004.x; Blackshear JL, 1996, LANCET, V348, P633; Caro JJ, 2000, CAN MED ASSOC J, V162, P973; Caro JJ, 1999, CAN MED ASSOC J, V161, P493; CARO JJ, 1999, CMAJ, V161, P533; CONNOLLY SJ, 1991, J AM COLL CARDIOL, V18, P349, DOI 10.1016/0735-1097(91)90585-W; Diggle PJ, 2002, ANAL LONGITUDINAL DA; ERNSTER VL, 1994, PREV MED, V23, P587, DOI 10.1006/pmed.1994.1093; Evans A, 2001, ARCH INTERN MED, V161, P1443, DOI 10.1001/archinte.161.11.1443; Evans A, 2001, STROKE, V32, P2828, DOI 10.1161/hs1201.099520; Evans A, 2000, STROKE, V31, P2106, DOI 10.1161/01.STR.31.9.2106; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; EZEKOWITZ MD, 1993, NEW ENGL J MED, V328, P148; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Frost L, 2002, J INTERN MED, V252, P64, DOI 10.1046/j.1365-2796.2002.01009.x; Gage BF, 2000, STROKE, V31, P822, DOI 10.1161/01.STR.31.4.822; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; Go AS, 2000, CIRCULATION, V102, P11, DOI 10.1161/01.CIR.102.1.11; Goldenberg GM, 1999, CLIN DRUG INVEST, V17, P483, DOI 10.2165/00044011-199917060-00009; GOTTLIEB LK, 1994, ARCH INTERN MED, V154, P1945, DOI 10.1001/archinte.154.17.1945; Greenland S, 2001, ANNU REV PUBL HEALTH, V22, P189, DOI 10.1146/annurev.publhealth.22.1.189; Hart RG, 2000, CEREBROVASC DIS, V10, P39, DOI 10.1159/000016023; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Hylek EM, 1996, NEW ENGL J MED, V335, P540, DOI 10.1056/NEJM199608223350802; Kalra L, 2000, BMJ-BRIT MED J, V320, P1236, DOI 10.1136/bmj.320.7244.1236; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; Kleinbaum DG, 1998, APPL REGRESSION ANAL; KOPECKY SL, 1987, NEW ENGL J MED, V317, P669, DOI 10.1056/NEJM198709103171104; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Schlesselman JJ, 1982, CASE CONTROL STUDIES; SELBY JV, 1994, EPIDEMIOL REV, V16, P90, DOI 10.1093/oxfordjournals.epirev.a036148; Stokes ME, 2000, CATEGORICAL DATA ANA; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; van Walraven C, 2002, JAMA-J AM MED ASSOC, V288, P2441, DOI 10.1001/jama.288.19.2441; Wang TJ, 2003, JAMA-J AM MED ASSOC, V290, P1049, DOI 10.1001/jama.290.8.1049; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	49	570	592	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2003	290	20					2685	2692		10.1001/jama.290.20.2685	http://dx.doi.org/10.1001/jama.290.20.2685			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	747CR	14645310	Bronze			2022-12-24	WOS:000186788100020
J	Hughes-Davies, L; Huntsman, D; Ruas, M; Fuks, F; Bye, J; Chin, SF; Milner, J; Brown, LA; Hsu, F; Gilks, B; Nielsen, T; Schulzer, M; Chia, S; Ragaz, J; Cahn, A; Linger, L; Ozdag, H; Cattaneo, E; Jordanova, ES; Schuuring, E; Yu, DS; Venkitaraman, A; Ponder, B; Doherty, A; Aparicio, S; Bentley, D; Theillet, C; Ponting, CP; Caldas, C; Kouzarides, T				Hughes-Davies, L; Huntsman, D; Ruas, M; Fuks, F; Bye, J; Chin, SF; Milner, J; Brown, LA; Hsu, F; Gilks, B; Nielsen, T; Schulzer, M; Chia, S; Ragaz, J; Cahn, A; Linger, L; Ozdag, H; Cattaneo, E; Jordanova, ES; Schuuring, E; Yu, DS; Venkitaraman, A; Ponder, B; Doherty, A; Aparicio, S; Bentley, D; Theillet, C; Ponting, CP; Caldas, C; Kouzarides, T			EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer	CELL			English	Article							HISTONE H3; LYSINE 9; DOMAIN; METHYLATION; PROTEINS; CHROMO; GENE; METHYLTRANSFERASE; SUSCEPTIBILITY; EXPRESSION	The BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicated in DNA repair and transcriptional regulation. Here we identify a protein, EMSY, which binds BRCA2 within a region (exon 3) deleted in cancer. EMSY is capable of silencing the activation potential of BRCA2 exon 3, associates with chromatin regulators HP1beta and BS69, and localizes to sites of repair following DNA damage. EMSY maps to chromosome 11q13.5, a region known to be involved in breast and ovarian cancer. We show that the EMSY gene is amplified almost exclusively in sporadic breast cancer (13%) and higher-grade ovarian cancer (17%). In addition, EMSY amplification is associated with worse survival, particularly in node-negative breast cancer, suggesting that it may be of prognostic value. The remarkable clinical overlap between sporadic EMSY amplification and familial BRCA2 deletion implicates a BRCA2 pathway in sporadic breast and ovarian cancer.	Canc Res UK, Wellcome Trust Inst, Cambridge CB2 1QR, England; Canc Res UK, Dept Pathol, Cambridge CB2 1QR, England; Univ Cambridge, Dept Oncol, MRC, Res Ctr, Cambridge CB2 2XZ, England; Vancouver Gen Hosp, Dept Pathol, Genet Pathol Evaluat Ctr, Vancouver, BC V6H 3Z6, Canada; Vancouver Gen Hosp, Prostate Ctr, Vancouver, BC V6H 3Z6, Canada; British Columbia Canc Agcy, Dept Pathol, Vancouver, BC V6H 3Z6, Canada; Univ British Columbia, Vancouver, BC V6H 3Z6, Canada; Wellcome Trust Sanger Inst Hinxton, Cambridge CB10 1SA, England; Univ British Columbia, Dept Stat & Med, Vancouver, BC V6T 2B5, Canada; British Columbia Canc Agcy, Dept Med Oncol, Vancouver, BC V5Z 4E6, Canada; Leiden Univ, Ctr Med, Dept Pathol, NL-2300 RC Leiden, Netherlands; Univ Groningen Hosp, Dept Pathol, NL-9700 RB Groningen, Netherlands; MRC, Canc Cell Unit, Res Ctr, Cambridge CB2 2XZ, England; Cambridge Inst Med Res, Cambridge CB2 2XZ, England; Ctr Val Aurelle, INSERM, EMI 229, Montpellier, France; Univ Oxford, MRC, Funct Genet Unit, Oxford OX1 3QX, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; Wellcome Trust Sanger Institute; University of British Columbia; British Columbia Cancer Agency; Leiden University; Leiden University - Excl LUMC; University of Groningen; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); University of Oxford	Hughes-Davies, L (corresponding author), Canc Res UK, Wellcome Trust Inst, Tennsi Court Rd, Cambridge CB2 1QR, England.	lh205@cus.cam.ac.uk; cc234@cam.ac.uk; tkl06@mole.bio.cam.ac.uk	Caldas, Carlos/U-7250-2019; Huntsman, David/ABE-6082-2020; Theillet, Charles/O-7634-2018; Ponting, Chris/AAV-2621-2021; Özdag, Hilal/C-9929-2009; Caldas, Carlos/A-7543-2008	Caldas, Carlos/0000-0003-3547-1489; Özdag, Hilal/0000-0001-7940-2499; Jordanova, Ekaterina/0000-0003-3890-7102; Ponting, Chris/0000-0003-0202-7816; chin, suet-feung/0000-0001-5697-1082; Aparicio, Samuel/0000-0002-0487-9599; Doherty, Aidan/0000-0002-6370-1109; Kouzarides, Tony/0000-0002-8918-4162; Brown, Lindsay/0000-0002-2790-5112; Theillet, Charles/0000-0001-5555-2759; Ruas, Margarida/0000-0002-4872-7618; Jordanova, Ekaterina S./0000-0002-8121-1322; CATTANEO, ELENA/0000-0002-0755-4917				Ansieau S, 2002, J BIOL CHEM, V277, P4906, DOI 10.1074/jbc.M110078200; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bekri S, 1997, CYTOGENET CELL GENET, V79, P125, DOI 10.1159/000134699; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bornemann D, 1998, GENETICS, V150, P675; Boyd J, 2000, JAMA-J AM MED ASSOC, V283, P2260, DOI 10.1001/jama.283.17.2260; Collins N, 1997, BRIT J CANCER, V76, P1150, DOI 10.1038/bjc.1997.526; Courjal F, 1997, CANCER RES, V57, P4360; COX DR, 1972, J R STAT SOC B, V34, P187; Dobrovic A, 1997, CANCER RES, V57, P3347; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; Gayther SA, 1998, J MAMMARY GLAND BIOL, V3, P365, DOI 10.1023/A:1018779830743; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Milner J, 1997, NATURE, V386, P772, DOI 10.1038/386772a0; Myung K, 2003, P NATL ACAD SCI USA, V100, P6640, DOI 10.1073/pnas.1232239100; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Nordling M, 1998, CANCER RES, V58, P1372; Ormandy CJ, 2003, BREAST CANCER RES TR, V78, P323, DOI 10.1023/A:1023033708204; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shin S, 2003, P NATL ACAD SCI USA, V100, P7201, DOI 10.1073/pnas.1132020100; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Yang L, 2003, BIOCHEM J, V369, P651, DOI 10.1042/BJ20020854; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049	37	341	366	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 26	2003	115	5					523	535		10.1016/S0092-8674(03)00930-9	http://dx.doi.org/10.1016/S0092-8674(03)00930-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651845	Bronze			2022-12-24	WOS:000186885600004
J	McLeod, P; Reed, N; Dienes, Z				McLeod, P; Reed, N; Dienes, Z			Psychophysics - How fielders arrive in time to catch the ball	NATURE			English	Editorial Material									Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Univ Sussex, Dept Expt Psychol, Brighton BN1 9QG, E Sussex, England	University of Oxford; University of Sussex	McLeod, P (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.			Reed, Nick/0000-0002-7794-6123; Dienes, Zoltan/0000-0001-7454-3161				Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; LAND MF, 1974, J COMP PHYSIOL, V89, P331, DOI 10.1007/BF00695351; McLeod P, 2001, J EXP PSYCHOL HUMAN, V27, P1347, DOI 10.1037/0096-1523.27.6.1347; MCLEOD P, UNPUB J EXP PSYCHOL; TRESILIAN JR, 1995, Q J EXP PSYCHOL-A, V48, P688, DOI 10.1080/14640749508401411	5	40	42	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2003	426	6964					244	245		10.1038/426244a	http://dx.doi.org/10.1038/426244a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628038				2022-12-24	WOS:000186660800030
J	Seymour, RS; White, CR; Gibernan, M				Seymour, RS; White, CR; Gibernan, M			Environmental biology: Heat reward for insect pollinators	NATURE			English	Editorial Material							PHILODENDRON; INFLORESCENCES; RESPIRATION		Univ Adelaide, Adelaide, SA 5005, Australia; Univ Toulouse 3, Lab Evolut & Divers Biol, F-31062 Toulouse, France	University of Adelaide; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Seymour, RS (corresponding author), Univ Adelaide, Adelaide, SA 5005, Australia.	roger.seymour@adelaide.edu.au	White, Craig R/F-9062-2010; Seymour, Roger/C-3469-2009; Gibernau, Marc/A-7388-2010	White, Craig R/0000-0002-0200-2187; Seymour, Roger/0000-0002-3395-0059; 				Barabe D, 2002, BOT J LINN SOC, V139, P79, DOI 10.1046/j.1095-8339.2002.00040.x; BARTHOLOMEW GA, 1977, SCIENCE, V195, P882, DOI 10.1126/science.841312; Bernhardt P, 2000, PLANT SYST EVOL, V222, P293, DOI 10.1007/BF00984108; Endress P.K., 1994, DIVERSITY EVOLUTIONA; Gibernau M, 2000, CAN J BOT, V78, P685, DOI 10.1139/cjb-78-5-685; GOTTSBERGER G, 1991, BIOTROPICA, V23, P23, DOI 10.2307/2388684; GOTTSBERGER G, 1988, TAXON, V37, P630, DOI 10.2307/1221105; Heinrich B., 1993, HOT BLOODED INSECTS; Schatz GE, 1990, REPROD ECOLOGY TROPI, P69; Seymour RS, 1999, J EXP BOT, V50, P845, DOI 10.1093/jexbot/50.335.845; Seymour RS, 1997, ENDEAVOUR, V21, P125, DOI 10.1016/S0160-9327(97)80222-0; Seymour RS, 1999, P ROY SOC B-BIOL SCI, V266, P1975, DOI 10.1098/rspb.1999.0875; Thien LB, 2000, INT J PLANT SCI, V161, pS225, DOI 10.1086/317575	13	156	164	4	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2003	426	6964					243	244		10.1038/426243a	http://dx.doi.org/10.1038/426243a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628037				2022-12-24	WOS:000186660800029
J	Stankiewicz, BA				Stankiewicz, BA			Integration of geoscience and engineering in the oil industry - just a dream?	NATURE			English	Editorial Material								The past two decades of the twentieth century have been very 'rocky' for the oil industry, as shown by the overall negative perception of the oil companies by the general public. Fluctuating oil prices, many rounds of staff redundancies, environmental disasters and budget cuts supported the overall image of the oil industry as being 'the technology impaired and environmentally insensible giant'. But advances and positive changes have been quietly happening in most of the oil companies. In the twenty-first century, we will witness the metamorphosis of the oil and gas companies into energy businesses - the era of cleaner and safer oil and gas production, and alternative energy resources such as wind, solar and hydrogen is already underway.	Shell Int Explorat & Prod BV, NL-2280 AB Rijswijk, Netherlands	Royal Dutch Shell	Stankiewicz, BA (corresponding author), Shell Int Explorat & Prod BV, Volmerlaan 8, NL-2280 AB Rijswijk, Netherlands.	astankiewicz@wanadoo.nl						Hammami A, 2000, ENERG FUEL, V14, P14, DOI 10.1021/ef990104z; Hammami A, 1999, SPE J, V4, P9, DOI 10.2118/54021-PA; Jamaluddin AKM, 2002, J CAN PETROL TECHNOL, V41, P25; Karan K, 2003, PETROL SCI TECHNOL, V21, P629, DOI 10.1081/LFT-120018543; KOOL H, 2002, PETROMI, V28, P26; MACLEOD G, 2004, INTEGRATION ORGANIC; MEHTA A, 2000, ANN NY ACAD SCI, V912, P361; Ratulowski J, 2003, SPE RESERV EVAL ENG, V6, P168, DOI 10.2118/84777-PA; STANKIEWICZ BA, 2001, 20 INT M ORG GEOCH, V1, P121; Yergin D., 1991, PRIZE; [No title captured]	11	5	5	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2003	426	6964					360	363		10.1038/nature02136	http://dx.doi.org/10.1038/nature02136			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628066				2022-12-24	WOS:000186660800058
J	Guskiewicz, KM; McCrea, M; Marshall, SW; Cantu, RC; Randolph, C; Barr, W; Onate, JA; Kelly, JP				Guskiewicz, KM; McCrea, M; Marshall, SW; Cantu, RC; Randolph, C; Barr, W; Onate, JA; Kelly, JP			Cumulative effects associated with recurrent concussion in collegiate football players - The NCAA Concussion Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXPERIMENTAL HEAD-INJURY; LONGITUDINAL DATA-ANALYSIS; POISSON REGRESSION-MODELS; SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN INJURY; NEUROPSYCHOLOGICAL DEFICITS; CEREBRAL CONCUSSION; SAFE RETURN; PERFORMANCE; METABOLISM	Context Approximately 300000 sport-related concussions occur annually in the United States, and the likelihood of serious sequelae may increase with repeated head injury. Objective To estimate the incidence of concussion and time to recovery after concussion in collegiate football players. Design, Setting, and Participants Prospective cohort study of 2905 football players from 25 US colleges were tested at preseason baseline in 1999, 2000, and 2001 on a variety of measures and followed up prospectively to ascertain concussion occurrence. Players injured with a concussion were monitored until their concussion symptoms resolved and were followed up for repeat concussions until completion of their collegiate football career or until the end of the 2001 football season. Main Outcome Measures Incidence of concussion and repeat concusion; type and duration of symptoms and course of recovery among players who were injured with a concussion during the seasons. Results During follow-up of 4251 player-seasons, 184 players (6.3%) had a concussion, and 12 (6.5%) of these players had a repeat concussion within the same season. There was an association between reported number of previous concussions and likelihood of incident concussion. Players reporting a history of 3 or more previous concussions were 3.0 (95% confidence interval, 1.6-5.6) times more likely to have an incident concussion than players with no concussion history. Headache was the most commonly reported symptom at the time of injury (85.2%), and mean overall symptom duration was 82 hours. Slowed recovery was associated with a history of multiple previous concussions (30.0% of those with greater than or equal to3 previous concussions had symptoms lasting >1 week compared with 14.6% of those with 1 previous concussion). Of the 12 incident within-season repeat concussions, 11 (91.7%) occurred within 10 days of the first injury, and 9 (75.0%) occurred within 7 days of the first injury. Conclusions Our study suggests that players with a history of previous concussions are more likely to have future concussive injuries than those with no history; 1 in 15 players With a concussion may have additional concussions in the same playing season; and previous concussions may be associated with slower recovery of neurological function.	Univ N Carolina, Sports Med Res Lab, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Orthopaed, Chapel Hill, NC USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; Waukesha Mem Hosp, Ctr Neurosci, Waukesha, WI USA; Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; Emerson Hosp, Neurosurg Serv, Concord, MA USA; Northwestern Univ, Feinberg Sch Med, Chicago Neurol Inst, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; Loyola Univ, Sch Med, Dept Neurol, Maywood, IL 60153 USA; NYU, Sch Med, Dept Neurol, New York, NY USA; Boston Univ, Sargent Coll Hlth & Rehabil Sci, Dept Rehabil Sci, Athlet Training Program, Boston, MA 02215 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Medical College of Wisconsin; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Loyola University Chicago; New York University; Boston University	Guskiewicz, KM (corresponding author), Univ N Carolina, Sports Med Res Lab, Dept Exercise & Sport Sci, CB 8700,211 Fetzer, Chapel Hill, NC 27599 USA.		Onate, James/E-3790-2011	Barr, William/0000-0001-7711-7758; Guskiewicz, Kevin/0000-0002-8682-2130; Marshall, Stephen/0000-0002-2664-9233				ALBRIGHT JP, 1985, AM J SPORT MED, V13, P147, DOI 10.1177/036354658501300301; Barth J.T., 1989, MILD HEAD INJURY, P257; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Barth JT, 2001, J ATHL TRAINING, V36, P253; Bruce D A, 1982, Clin Sports Med, V1, P495; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; Cantu, 1991, Adolesc Med, V2, P141; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; Cantu RC, 2001, J ATHL TRAINING, V36, P244; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P224; *COL MED SOC SPORT, 1994, P MILD BRAIN INJ SPO, P106; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Committee on Head Injury Nomenclature of Congress of Neurological Surgeons, 1966, CLIN NEUROSURG, V12, P386; Dick R, 2002, 2001 2002 NCAA INJUR; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Erlanger D, 2001, J ATHL TRAINING, V36, P280; FROME EL, 1985, AM J EPIDEMIOL, V121, P309, DOI 10.1093/oxfordjournals.aje.a114001; FROME EL, 1983, BIOMETRICS, V39, P665, DOI 10.2307/2531094; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Giza C. C., 2000, NEUROLOGIC ATHLETIC, P80; Giza CC, 2001, J ATHL TRAINING, V36, P228; Greenland S, 1998, MODERN EPIDEMIOLOGY; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; GUSKIEWICZ KM, 1997, MED SCI SPORTS EXERC, V29, P213; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; JORDAN B, 1994, P MILD BRAIN INJ SPO, P43; Kelly JP, 1997, NEUROLOGY, V48, P581; Kelly JP, 2001, J ATHL TRAINING, V36, P249; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, J ATHL TRAINING, V36, P274; MCCREA M, IN PRESS CLIN J SPOR; MCCULLOCH CE, 2001, GEN LINEAR MIXED MOD, P223; MEYER JS, 1970, J NEUROSURG, V32, P304, DOI 10.3171/jns.1970.32.3.0304; *NAT COLL ATHL ASS, 2002, 1981 1982 2001 2002; Nelson S, 1966, HEAD INJURY, P444; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; NILSSON B, 1977, J NEUROSURG, V47, P252, DOI 10.3171/jns.1977.47.2.0252; NILSSON B, 1977, J NEUROSURG, V47, P274, DOI 10.3171/jns.1977.47.2.0274; Ommaya A, 1994, P MILD BRAIN INJ SPO, P72; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; PRINCE DA, 1973, BRAIN RES, V50, P489, DOI 10.1016/0006-8993(73)90758-0; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; WILBERGER JE, 1993, SPORTS MED, V15, P338, DOI 10.2165/00007256-199315050-00005; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	54	1118	1132	5	250	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2003	290	19					2549	2555		10.1001/jama.290.19.2549	http://dx.doi.org/10.1001/jama.290.19.2549			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744DQ	14625331	Bronze			2022-12-24	WOS:000186613000024
J	Jaenicke-Despres, V; Buckler, ES; Smith, BD; Gilbert, MTP; Cooper, A; Doebley, J; Paabo, S				Jaenicke-Despres, V; Buckler, ES; Smith, BD; Gilbert, MTP; Cooper, A; Doebley, J; Paabo, S			Early allelic selection in maize as revealed by ancient DNA	SCIENCE			English	Article							BRANCH CHAIN-LENGTH; PROLAMIN BOX; DOMESTICATION; STARCH; EVOLUTION; DETERMINANT; DOMINANCE; DIVERSITY; GENES	Maize was domesticated from teosinte, a wild grass, by similar to6300 years ago in Mexico. After initial domestication, early farmers continued to select for advantageous morphological and biochemical traits in this important crop. However, the timing and sequence of character selection are, thus far, known only for morphological features discernible in corn cobs. We have analyzed three genes involved in the control of plant architecture, storage protein synthesis, and starch production from archaeological maize samples from Mexico and the southwestern United States. The results reveal that the alleles typical of contemporary maize were present in Mexican maize by 4400 years ago. However, as recently as 2000 years ago, allelic selection at one of the genes may not yet have been complete.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; ARS, USDA, Raleigh, NC 27695 USA; N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Washington, DC 20560 USA; Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, Oxford OX1 3PS, England; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	Max Planck Society; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Oxford; University of Wisconsin System; University of Wisconsin Madison	Paabo, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.		Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019; Cooper, Alan/E-8171-2012; Gilbert, Marcus TP/A-8936-2013	Buckler, Edward/0000-0002-3100-371X; Cooper, Alan/0000-0002-7738-7851; Gilbert, Marcus TP/0000-0002-5805-7195				Benz BF, 2001, P NATL ACAD SCI USA, V98, P2104, DOI 10.1073/pnas.98.4.2104; Benz BF, 2000, CURR ANTHROPOL, V41, P459; Buckler ES, 2001, GENET RES, V77, P213, DOI 10.1017/S0016672301005158; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1995, GENETICS, V141, P333; DOEBLEY J, 1992, TRENDS GENET, V8, P302, DOI 10.1016/0168-9525(92)90261-2; HANDT O, 1994, EXPERIENTIA, V50, P524, DOI 10.1007/BF01921720; Handt O, 1996, AM J HUM GENET, V59, P368; Huckell BB, 1996, J WORLD PREHIST, V10, P305, DOI 10.1007/BF02286419; JAMES MG, 1995, PLANT CELL, V7, P417, DOI 10.1105/tpc.7.4.417; Jane J, 1999, CEREAL CHEM, V76, P629, DOI 10.1094/CCHEM.1999.76.5.629; JANE JL, 1992, CEREAL CHEM, V69, P60; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Piperno DR, 2001, P NATL ACAD SCI USA, V98, P2101, DOI 10.1073/pnas.98.4.2101; Rahman A, 1998, PLANT PHYSIOL, V117, P425, DOI 10.1104/pp.117.2.425; Smith B.D., 1998, EMERGENCE AGR; Smith BD, 1997, LAT AM ANTIQ, V8, P342, DOI 10.2307/972107; SMITH BD, 1989, SCIENCE, V246, P1566, DOI 10.1126/science.246.4937.1566; UEDA T, 1994, MOL CELL BIOL, V14, P4350, DOI 10.1128/MCB.14.7.4350; VicenteCarbajosa J, 1997, P NATL ACAD SCI USA, V94, P7685, DOI 10.1073/pnas.94.14.7685; Vigouroux Y, 2002, P NATL ACAD SCI USA, V99, P9650, DOI 10.1073/pnas.112324299; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Wang ZD, 1998, GENE, V223, P321, DOI 10.1016/S0378-1119(98)00244-3; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999	24	182	192	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2003	302	5648					1206	1208		10.1126/science.1089056	http://dx.doi.org/10.1126/science.1089056			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14615538				2022-12-24	WOS:000186544300053
J	Libina, N; Berman, JR; Kenyon, C				Libina, N; Berman, JR; Kenyon, C			Tissue-specific activities of C-elegans DAF-16 in the regulation of lifespan	CELL			English	Article							CAENORHABDITIS-ELEGANS; INSULIN-RECEPTOR; STRESS RESISTANCE; INTERACTING GENES; OXIDATIVE STRESS; DAUER FORMATION; FAMILY-MEMBER; LONGEVITY; NEMATODE; IDENTIFICATION	In C. elegans, the transcription factor DAF-16 promotes longevity in response to reduced insulin/IGF-1 signaling or germline ablation. In this study, we have asked how different tissues interact to specify the life-span of the animal. We find that several tissues act as signaling centers. In particular, DAF-16 activity in the intestine, which is also the animal's adipose tissue, completely restores the longevity of daf-16(-) germline-deficient animals, and increases the lifespans of daf-16(-) insulin/IGF-1-pathway mutants substantially. Our findings indicate that DAF-16 may control two types of downstream signals: DAF-16 activity in signaling cells upregulates DAF-16 in specific responding tissues, possibly via regulation of insulin-like peptides, and also evokes DAF-16-independent responses. We suggest that this network of tissue interactions and feedback regulation allows the tissues to equilibrate and fine-tune their expression of downstream genes, which, in turn, coordinates their rates of aging within the animal.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Miss Bay Genentech Hall,600 16th St,Room S312D, San Francisco, CA 94143 USA.	ckenyon@biochem.ucsf.edu		Kenyon, Cynthia/0000-0003-3446-2636	NATIONAL INSTITUTE ON AGING [R37AG011816, R01AG011816] Funding Source: NIH RePORTER; NIA NIH HHS [AG11816] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AAMODT EJ, 1991, SCIENCE, V252, P579, DOI 10.1126/science.2020855; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; APFELD J, 1999, THESIS U CALIFORNIA; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; den Boer BGW, 1998, DEVELOPMENT, V125, P3213; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Garigan D, 2002, GENETICS, V161, P1101; Gems D, 1998, GENETICS, V150, P129; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; GOTTLIEB S, 1994, GENETICS, V137, P107; HEDGECOCK EM, 1995, GENETICS, V141, P989; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; HERMAN RK, 1984, GENETICS, V108, P165; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kawano T, 2000, BIOCHEM BIOPH RES CO, V273, P431, DOI 10.1006/bbrc.2000.2971; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; LABOUESSE M, 1994, DEVELOPMENT, V120, P2359; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LARSEN PL, 1995, GENETICS, V139, P1567; LAWLESS JF, 1982, MODELS METHODS LIFET; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; LITHGOW GJ, 1994, J GERONTOL, V49, pB270, DOI 10.1093/geronj/49.6.B270; Lundquist EA, 1998, NEURON, V21, P385, DOI 10.1016/S0896-6273(00)80547-4; MADURO M, 1995, GENETICS, V141, P977; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Mello C, 1995, METHOD CELL BIOL, V48, P451; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Murakami S, 2001, CURR BIOL, V11, P1517, DOI 10.1016/S0960-9822(01)00453-5; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ookuma S, 2003, CURR BIOL, V13, P427, DOI 10.1016/S0960-9822(03)00108-8; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; RIDDLE DL, 1997, ELEGANS, V2, P739; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; VOWELS JJ, 1992, GENETICS, V130, P105; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Yu H, 2001, J MOL BIOL, V314, P1017, DOI 10.1006/jmbi.2000.5210	58	564	592	4	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2003	115	4					489	502		10.1016/S0092-8674(03)00889-4	http://dx.doi.org/10.1016/S0092-8674(03)00889-4			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	744KB	14622602	Bronze			2022-12-24	WOS:000186627100014
J	Guthrie, RD				Guthrie, RD			Rapid body size decline in Alaskan Pleistocene horses before extinction	NATURE			English	Article							POLLEN RECORDS; BERINGIA; TRANSITION; EUROPE; STEPPE; END	About 70% of North American large mammal species were lost at the end of the Pleistocene epoch(1). The causes of this extinction the role of humans versus that of climate-have been the focus of much controversy(1-6). Horses have figured centrally in that debate, because equid species dominated North American late Pleistocene faunas in terms of abundance, geographical distribution, and species variety, yet none survived into the Holocene epoch. The timing of these equid regional extinctions and accompanying evolutionary changes are poorly known. In an attempt to document better the decline and demise of two Alaskan Pleistocene equids, I selected a large number of fossils from the latest Pleistocene for radiocarbon dating. Here I show that horses underwent a rapid decline in body size before extinction, and I propose that the size decline and subsequent regional extinction at 12,500 radiocarbon years before present are best attributed to a coincident climatic/vegetational shift. The present data do not support human overkill(1) and several other proposed extinction causes(2,3), and also show that large mammal species responded somewhat individualistically to climate changes(4-6) at the end of the Pleistocene.	Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks	Guthrie, RD (corresponding author), Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA.							Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; AMTHEUS P, 2003, 3 INT MAMM C 3 5 YUK; ANDERSON PM, 1988, QUATERNARY RES, V29, P263, DOI 10.1016/0033-5894(88)90035-X; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; EISENMANN V, 1982, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V4, P75; FORSTEN A, 1991, MAMMALIA, V55, P407, DOI 10.1515/mamm.1991.55.3.407; FORSTREN A, 1982, J MAMMAL, V67, P422; Goetcheus VG, 2001, QUATERNARY SCI REV, V20, P135, DOI 10.1016/S0277-3791(00)00127-X; Graham RW, 1984, QUATERNARY EXTINCTIO; Guthrie R.D., 1984, P259; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; Guthrie R. Dale, 2001, BAR International Series, V944, P32; Guthrie RD, 2001, QUATERNARY SCI REV, V20, P549; GUTHRIE RD, 1965, EVOLUTION, V19, P214, DOI 10.1111/j.1558-5646.1965.tb01708.x; GUTHRIE RD, 1984, MAMMOTH HOT SPRINGS, V1, P42; GUTHRIE RD, 1964, CONTRIBUTIONS VERTEB, P482; Harington C.R., 2003, ANNOTATED BIBLIO QUA; Holmes CE, 2001, ARCTIC ANTHROPOL, V38, P154; Kachigan S.K., 1991, MULTIVARIATE STAT AN; Lamb H.F., 1988, VEGETATION HIST, P519, DOI DOI 10.1007/978-94-009-3081-0_14; LOWE JJ, 1994, J QUATERNARY SCI, V9, P185, DOI 10.1002/jqs.3390090215; LOZHKIN AV, 1993, QUATERNARY RES, V39, P314, DOI 10.1006/qres.1993.1038; MacPhee Ross D.E., 1997, P169; Martin P. S., 1984, QUATERNARY EXTINCTIO, P345; MCDONALD J, 1984, QUATERNARY EXTINCTIO, P409; Sher AV, 1997, NATO ASI SER SER I, V47, P319; Stuart AJ, 2002, QUATERNARY SCI REV, V21, P1559, DOI 10.1016/S0277-3791(02)00026-4; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Wilson MC, 1996, QUATERN INT, V32, P97, DOI 10.1016/S1040-6182(96)90017-8; ZIMOV SA, 1995, AM NAT, V146, P765, DOI 10.1086/285824	31	157	170	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2003	426	6963					169	171		10.1038/nature02098	http://dx.doi.org/10.1038/nature02098			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614503				2022-12-24	WOS:000186517200040
J	Yamada, K; Lim, J; Dale, JM; Chen, HM; Shinn, P; Palm, CJ; Southwick, AM; Wu, HC; Kim, C; Nguyen, M; Pham, P; Cheuk, R; Karlin-Newmann, G; Liu, SX; Lam, B; Sakano, H; Wu, T; Yu, GX; Miranda, M; Quach, HL; Tripp, M; Chang, CH; Lee, JM; Toriumi, M; Chan, MMH; Tang, CC; Onodera, CS; Deng, JM; Akiyama, K; Ansari, Y; Arakawa, T; Banh, J; Banno, F; Bowser, L; Brooks, S; Carninci, P; Chao, QM; Choy, N; Enju, A; Goldsmith, AD; Gurjal, M; Hansen, NF; Hayashizaki, Y; Johnson-Hopson, C; Hsuan, VW; Iida, K; Karnes, M; Khan, S; Koesema, E; Ishida, J; Jiang, PX; Jones, T; Kawai, J; Kamiya, A; Meyers, C; Nakajima, M; Narusaka, M; Seki, M; Sakurai, T; Satou, M; Tamse, R; Vaysberg, M; Wallender, EK; Wong, C; Yamamura, Y; Yuan, SL; Shinozaki, K; Davis, RW; Theologis, A; Ecker, JR				Yamada, K; Lim, J; Dale, JM; Chen, HM; Shinn, P; Palm, CJ; Southwick, AM; Wu, HC; Kim, C; Nguyen, M; Pham, P; Cheuk, R; Karlin-Newmann, G; Liu, SX; Lam, B; Sakano, H; Wu, T; Yu, GX; Miranda, M; Quach, HL; Tripp, M; Chang, CH; Lee, JM; Toriumi, M; Chan, MMH; Tang, CC; Onodera, CS; Deng, JM; Akiyama, K; Ansari, Y; Arakawa, T; Banh, J; Banno, F; Bowser, L; Brooks, S; Carninci, P; Chao, QM; Choy, N; Enju, A; Goldsmith, AD; Gurjal, M; Hansen, NF; Hayashizaki, Y; Johnson-Hopson, C; Hsuan, VW; Iida, K; Karnes, M; Khan, S; Koesema, E; Ishida, J; Jiang, PX; Jones, T; Kawai, J; Kamiya, A; Meyers, C; Nakajima, M; Narusaka, M; Seki, M; Sakurai, T; Satou, M; Tamse, R; Vaysberg, M; Wallender, EK; Wong, C; Yamamura, Y; Yuan, SL; Shinozaki, K; Davis, RW; Theologis, A; Ecker, JR			Empirical analysis of transcriptional activity in the Arabidopsis genome	SCIENCE			English	Article							FULL-LENGTH; FUNCTIONAL ANNOTATION; SEQUENCE; GENES; PREDICTION; CLONING; CDNAS; DNA; L.	Functional analysis of a genome requires accurate gene structure information and a complete gene inventory. A dual experimental strategy was used to verify and correct the initial genome sequence annotation of the reference plant Arabidopsis. Sequencing full-length cDNAs and hybridizations using RNA populations from various tissues to a set of high-density oligonucleotide arrays spanning the entire genome allowed the accurate annotation of thousands of gene structures. We identified 5817 novel transcription units, including a substantial amount of antisense gene transcription, and 40 genes within the genetically defined centromeres. This approach resulted in completion of similar to30% of the Arabidopsis ORFeome as a resource for global functional experimentation of the plant proteome.	Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; Ctr Plant Gene Express, Albany, CA 94710 USA; Univ Penn, Dept Biol, Arabidopsis Thaliana Genome Ctr, Philadelphia, PA 19104 USA; Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; RIKEN, Yokohama Inst, Genom Sci Ctr,Plant Mutat Explorat Team, Plant Funct Genom Res Grp, Tsukuba, Ibaraki 3050074, Japan; RIKEN, Discovery & Res Inst, Genome Sci Lab, Wako, Saitama 3510198, Japan; RIKEN GSC, Yokohama Inst, Lab Genome Explorat Res Grp, Kanagawa 2300045, Japan; RIKEN, Tsukuba Inst, Plant Mol Biol Lab, Tsukuba, Ibaraki 3050074, Japan; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Salk Institute; University of Pennsylvania; Stanford University; RIKEN; RIKEN; RIKEN; RIKEN; Stanford University	Ecker, JR (corresponding author), Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	theo@nature.berkeley.edu; ecker@salk.edu	Hayashizaki, Yoshihide/N-6590-2015; Sakurai, Tetsuya/B-2690-2010; Seki, Motoaki/I-2854-2012; Shinozaki, Kazuo/G-4202-2013; Kawai, Jun/A-6451-2016; Carninci, Piero/K-1568-2014; Ecker, Joseph R/B-9144-2008	Sakurai, Tetsuya/0000-0003-2046-8973; Seki, Motoaki/0000-0001-8288-0467; Shinozaki, Kazuo/0000-0002-6317-9867; Carninci, Piero/0000-0001-7202-7243; Ecker, Joseph R/0000-0001-5799-5895; Sakano, Hitomi/0000-0002-7471-8352; Yuan, Shiaulou/0000-0002-5061-6132; IIDA, Kei/0000-0001-7130-8705; Koesema, Eric/0000-0002-7743-0127; Chen, Huaming/0000-0001-5289-7882				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Brizuela L, 2002, ARCH MED RES, V33, P318, DOI 10.1016/S0188-4409(02)00372-7; Carninci P, 2001, GENOMICS, V77, P79, DOI 10.1006/geno.2001.6601; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Haas BJ, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-6-RESEARCH0029; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kirst M, 2003, P NATL ACAD SCI USA, V100, P7383, DOI 10.1073/pnas.1132171100; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; *MAMM GEN COLL PRO, 2003, P NATL ACAD SCI USA, V99, P16899; Mathe C, 2002, NUCLEIC ACIDS RES, V30, P4103, DOI 10.1093/nar/gkf543; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; MEYEROWITZ EM, 1994, ARABIDOPSIS; Morillon A, 2003, SCIENCE, V300, P492, DOI 10.1126/science.1081379; *NAT AC SCI REP, 2002, NAT PLANT GEN IN OBJ; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Osato N, 2002, GENOME RES, V12, P1127, DOI 10.1101/gr.75202; Reboul J, 2001, NAT GENET, V27, P332, DOI 10.1038/85913; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Salanoubat M, 2000, NATURE, V408, P820, DOI 10.1038/35048706; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Steinmetz LM, 2000, BIOTECHNOL GENET ENG, V17, P109, DOI 10.1080/02648725.2000.10647990; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; Tabata S, 2000, NATURE, V408, P823, DOI 10.1038/35048507; Theologis A, 2000, NATURE, V408, P816, DOI 10.1038/35048500; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; Vidal M, 2001, CELL, V104, P333, DOI 10.1016/S0092-8674(01)00221-5; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Xiao YL, 2002, PLANT PHYSIOL, V130, P2118, DOI 10.1104/pp.010207; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Zhang MQ, 2002, NAT REV GENET, V3, P698, DOI 10.1038/nrg890	40	705	9092	9	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2003	302	5646					842	846		10.1126/science.1088305	http://dx.doi.org/10.1126/science.1088305			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593172				2022-12-24	WOS:000186258000042
J	Tumbar, T; Guasch, G; Greco, V; Blanpain, C; Lowry, WE; Rendl, M; Fuchs, E				Tumbar, T; Guasch, G; Greco, V; Blanpain, C; Lowry, WE; Rendl, M; Fuchs, E			Defining the epithelial stem cell niche in skin	SCIENCE			English	Article							GROWTH-FACTOR-BETA; LABEL-RETAINING CELLS; HAIR FOLLICLE BULGE; SELF-RENEWAL; WNT; GENE; EXPRESSION; EPIDERMIS; MICE; PROLIFERATION	Many adult regenerative cells divide infrequently but have high proliferative capacity. We developed a strategy to fluorescently label slow-cycling cells in a cell type-specific fashion. We used this method to purify the label-retaining cells (LRCs) that mark the skin stem cell (SC) niche. We found that these cells rarely divide within their niche but change properties abruptly when stimulated to exit. We determined their transcriptional pro. le, which, when compared to progeny and other SCs, defines the niche. Many of the > 100 messenger RNAs preferentially expressed in the niche encode surface receptors and secreted proteins, enabling LRCs to signal and respond to their environment.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016; Blanpain, Cedric/ABD-8392-2021; Tumbar, Tudorita/A-1916-2014	Guasch, Geraldine/0000-0001-7362-9318; Tumbar, Tudorita/0000-0002-2273-1889; Rendl, Michael/0000-0001-6326-620X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063663, R01AR050452] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR050452-04, R01 AR050452, R01 AR063663] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Botchkarev VA, 2003, J INVEST DERMATOL, V120, P168, DOI 10.1046/j.1523-1747.2003.12003.x; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Garcion E, 2001, DEVELOPMENT, V128, P2485; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Iavarone A, 1999, MOL CELL BIOL, V19, P916; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Ito M, 2001, J INVEST DERMATOL, V116, P956, DOI 10.1046/j.0022-202x.2001.01369.x; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lyle S, 1999, J INVEST DERM SYMP P, V4, P296, DOI 10.1038/sj.jidsp.5640233; Mackenzie IC, 1997, J INVEST DERMATOL, V109, P377, DOI 10.1111/1523-1747.ep12336255; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; POTTEN CS, 1988, J CELL SCI, P45; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Sander G, 2000, J INVEST DERMATOL, V115, P753, DOI 10.1046/j.1523-1747.2000.00122.x; Sette C, 2000, INT J DEV BIOL, V44, P599; Soma Y, 2002, ARCH DERMATOL RES, V293, P609, DOI 10.1007/s00403-001-0279-6; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100	33	1494	1579	5	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2004	303	5656					359	363		10.1126/science.1092436	http://dx.doi.org/10.1126/science.1092436			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14671312	Green Accepted			2022-12-24	WOS:000188111800040
J	Metivier, R; Penot, G; Hubner, MR; Reid, G; Brand, H; Kos, M; Gannon, F				Metivier, R; Penot, G; Hubner, MR; Reid, G; Brand, H; Kos, M; Gannon, F			Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter	CELL			English	Article							RNA-POLYMERASE-II; IN-VIVO; TRANSCRIPTIONAL ACTIVATION; GLUCOCORTICOID-RECEPTOR; COACTIVATOR COMPLEXES; HISTONE MODIFICATIONS; CHROMATIN STRUCTURE; DISTINCT PATTERNS; NUCLEAR RECEPTORS; GENE-EXPRESSION	Transcriptional activation of a gene involves an orchestrated recruitment of components of the basal transcription machinery and intermediate factors, concomitant with an alteration in local chromatin structure generated by posttranslational modifications of histone tails and nucleosome remodeling. We provide here a comprehensive picture of events resulting in transcriptional activation of a gene, through evaluating the estrogen receptor-alpha (NR3A1) target pS2 gene promoter in MCF-7 cells. This description integrates chromatin remodeling with a kinetic evaluation of cyclical networks of association of 46 transcription factors with the promoter, as determined by chromatin immunoprecipitation assays. We define the concept of a "transcriptional clock" that directs and achieves the sequential and combinatorial assembly of a transcriptionally productive complex on a promoter. Furthermore, the unanticipated findings of key roles for histone deacetylases and nucleosome-remodeling complexes in limiting transcription implies that transcriptional activation is a cyclical process that requires both activating and repressive epigenetic processes.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Metivier, R (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	raphael.metivier@embl-heidelberg.de; frank.gannon@embo.org	Gannon, Frank/G-1194-2015; jia, xu/A-8386-2016; Kos, Martin/E-2534-2011	Kos, Martin/0000-0002-3337-9681; Reid, George/0000-0002-0298-693X				Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Alvarez M, 2003, GENE, V313, P43, DOI 10.1016/S0378-1119(03)00627-9; Belandia B, 2003, CELL, V114, P277, DOI 10.1016/S0092-8674(03)00599-3; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Berk AJ, 1999, CURR OPIN CELL BIOL, V11, P330, DOI 10.1016/S0955-0674(99)80045-3; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Burakov D, 2002, J BIOL CHEM, V277, P14359, DOI 10.1074/jbc.C200099200; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Dillon N, 2002, TRENDS GENET, V18, P252, DOI 10.1016/S0168-9525(02)02648-3; Emerson BM, 2002, CELL, V109, P267, DOI 10.1016/S0092-8674(02)00740-7; Endoh H, 1999, MOL CELL BIOL, V19, P5363; Feigelson HS, 1996, CARCINOGENESIS, V17, P2279, DOI 10.1093/carcin/17.11.2279; Ferdous A, 2002, BIOCHEMISTRY-US, V41, P12798, DOI 10.1021/bi020425t; Fletcher TM, 2002, MOL CELL BIOL, V22, P3255, DOI 10.1128/MCB.22.10.3255-3263.2002; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Guermah M, 2001, MOL CELL BIOL, V21, P6882, DOI 10.1128/MCB.21.20.6882-6894.2001; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jepsen K, 2002, J CELL SCI, V115, P689; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Lee JW, 2001, CELL MOL LIFE SCI, V58, P289, DOI 10.1007/PL00000856; Li XT, 2003, MOL CELL BIOL, V23, P3763, DOI 10.1128/MCB.23.11.3763-3773.2003; Liu Z, 2001, P NATL ACAD SCI USA, V98, P12426, DOI 10.1073/pnas.231474798; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Marmorstein R, 2001, NAT REV MOL CELL BIO, V2, P422, DOI 10.1038/35073047; Martens JHA, 2003, MOL CELL BIOL, V23, P1808, DOI 10.1128/MCB.23.5.1808-1816.2003; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Nye AC, 2002, MOL CELL BIOL, V22, P3437, DOI 10.1128/MCB.22.10.3437-3449.2002; Ogbourne S, 1998, BIOCHEM J, V331, P1; ONATE SA, 1995, SCIENCE, V270, P1354; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Perissi V, 1999, P NATL ACAD SCI USA, V96, P3652, DOI 10.1073/pnas.96.7.3652; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Sabbah M, 1998, BIOCHEM J, V336, P639, DOI 10.1042/bj3360639; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Sewack GF, 1997, J BIOL CHEM, V272, P31118, DOI 10.1074/jbc.272.49.31118; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sharma VM, 2003, GENE DEV, V17, P502, DOI 10.1101/gad.1039503; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; Vermeulen W, 2002, MOL CELL, V10, P1264, DOI 10.1016/S1097-2765(02)00795-5; VILLALOBOS M, 1995, ENVIRON HEALTH PERSP, V103, P844, DOI 10.2307/3432398; WAMMACK A, 2001, J BIOL CHEM, V276, P45939; Wang CG, 2001, J BIOL CHEM, V276, P18375, DOI 10.1074/jbc.M100800200; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; WOLFFE A, 1992, CHROMATIN STRUCTURE; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Wu SY, 1999, J BIOL CHEM, V274, P23480, DOI 10.1074/jbc.274.33.23480; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961	74	1207	1239	0	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2003	115	6					751	763		10.1016/S0092-8674(03)00934-6	http://dx.doi.org/10.1016/S0092-8674(03)00934-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675539	Bronze			2022-12-24	WOS:000187366100014
J	Povich, MS; Raymond, JC; Jones, GH; Uzzo, M; Ko, YK; Feldman, PD; Smith, PL; Marsden, BG; Woods, TN				Povich, MS; Raymond, JC; Jones, GH; Uzzo, M; Ko, YK; Feldman, PD; Smith, PL; Marsden, BG; Woods, TN			Doubly ionized carbon observed in the plasma tail of comet Kudo-Fujikawa	SCIENCE			English	Article							BETA-PICTORIS; SOLAR; DUST; CO	Comet C/2002 X5 (Kudo-Fujikawa) was observed near its perihelion of 0.19 astronomical unit by the Ultraviolet Coronagraph Spectrometer aboard the Solar and Heliospheric Observatory spacecraft. Images of the comet reconstructed from high-resolution spectra reveal a quasi-spherical cloud of neutral hydrogen and a variable tail of C+ and C2+ that disconnects from the comet and subsequently regenerates. The high abundance of C2+ and C+, at least 24% relative to water, cannot be explained by photodissociation of carbon monoxide and is instead attributed to the evaporation and subsequent photoionization of atomic carbon from organic refractory compounds present in the cometary dust grains. This result serves to strengthen the connection between comets and the material from which the Solar System formed.	Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Johns Hopkins University; University of Colorado System; University of Colorado Boulder	Povich, MS (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.		Jones, Geraint H./C-1682-2008	Jones, Geraint H./0000-0002-5859-1136				ALFVEN H, 1957, TELLUS, V9, P92, DOI 10.1111/j.2153-3490.1957.tb01855.x; Bouret JC, 2002, ASTRON ASTROPHYS, V390, P1049, DOI 10.1051/0004-6361:20020741; BOUT M, 2003, B AM ASTRON SOC, V35, P988; Brandt JC, 2000, ICARUS, V148, P52, DOI 10.1006/icar.2000.6484; COMBI MR, 1988, ASTROPHYS J, V327, P1026, DOI 10.1086/166260; Curdt W, 2001, ASTRON ASTROPHYS, V375, P591, DOI 10.1051/0004-6361:20010364; DiSanti MA, 2001, ICARUS, V153, P361, DOI 10.1006/icar.2001.6695; Feldman PD, 2002, ASTROPHYS J, V576, pL91, DOI 10.1086/343089; GOMBOSI TI, 1996, J GEOPHYS RES, V101, P15223; Greenberg JM, 1999, SPACE SCI REV, V90, P149, DOI 10.1023/A:1005298014670; HUEBNER WF, 1992, ASTROPHYS SPACE SCI, V195, P1, DOI 10.1007/BF00644558; Kohl JL, 1995, SOL PHYS, V162, P313, DOI 10.1007/BF00733433; LAMY PL, 1988, ICARUS, V76, P100, DOI 10.1016/0019-1035(88)90142-X; NAKANO S, 2002, 8032 INT ASTR UN; Raymond JC, 2002, ASTROPHYS J, V564, P1054, DOI 10.1086/324545; Sheeley NR, 1999, J GEOPHYS RES-SPACE, V104, P24739, DOI 10.1029/1999JA900308; Verner DA, 1996, ASTROPHYS J, V465, P487, DOI 10.1086/177435; Vidal-Madjar A, 1998, PLANET SPACE SCI, V46, P629, DOI 10.1016/S0032-0633(97)00192-X; WATANABE J, 2002, 8033 INT ASTR UN; Woods TN, 1998, P SOC PHOTO-OPT INS, V3442, P180, DOI 10.1117/12.330255; Yi Y, 1996, J GEOPHYS RES-SPACE, V101, P27585, DOI 10.1029/96JA02235	21	24	24	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1949	1952		10.1126/science.1092142	http://dx.doi.org/10.1126/science.1092142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671299				2022-12-24	WOS:000187174000056
J	Coltman, DW; O'Donoghue, P; Jorgenson, JT; Hogg, JT; Strobeck, C; Festa-Bianchet, M				Coltman, DW; O'Donoghue, P; Jorgenson, JT; Hogg, JT; Strobeck, C; Festa-Bianchet, M			Undesirable evolutionary consequences of trophy hunting	NATURE			English	Article							DEER CERVUS-ELAPHUS; POPULATION-DYNAMICS; BIGHORN SHEEP; CONSERVATION; REPRODUCTION; MANAGEMENT; SELECTION; SIZE; RAMS	Phenotype- based selective harvests, including trophy hunting, can have important implications for sustainable wildlife management if they target heritable traits(1 - 3). Here we show that in an evolutionary response to sport hunting of bighorn trophy rams ( Ovis canadensis) body weight and horn size have declined significantly over time. We used quantitative genetic analyses, based on a partly genetically reconstructed pedigree from a 30- year study of a wild population in which trophy hunting targeted rams with rapidly growing horns(4), to explore the evolutionary response to hunter selection on ram weight and horn size. Both traits were highly heritable, and trophy- harvested rams were of significantly higher genetic ' breeding value' for weight and horn size than rams that were not harvested. Rams of high breeding value were also shot at an early age, and thus did not achieve high reproductive success(5). Declines in mean breeding values for weight and horn size therefore occurred in response to unrestricted trophy hunting, resulting in the production of smaller- horned, lighter rams, and fewer trophies.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Alberta Dept Sustainable Dev, Fish & Wildlife Div, Canmore, AB T0L 0M0, Canada; Montana Conservat Sci Inst, Missoula, MT 59803 USA; Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada	University of Sheffield; University of Alberta; University of Sherbrooke	Coltman, DW (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.		Coltman, David W/A-4453-2012; Strobeck, Curtis/E-9998-2011	Coltman, David W/0000-0002-1268-2307; Festa-Bianchet, Marco/0000-0002-2352-3379				Ashley MV, 2003, BIOL CONSERV, V111, P115, DOI 10.1016/S0006-3207(02)00279-3; Clutton-Brock TH, 2002, NATURE, V415, P633, DOI 10.1038/415633a; Coltman DW, 2001, EVOLUTION, V55, P2116, DOI 10.1111/j.0014-3820.2001.tb01326.x; Coltman DW, 2002, P ROY SOC B-BIOL SCI, V269, P165, DOI 10.1098/rspb.2001.1851; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; CRAWFORD AM, 1995, GENETICS, V140, P703; Festa-Bianchet M, 2003, ANIMAL BEHAVIOR AND WILDLIFE CONSERVATION, P191; FestaBianchet M, 1996, CAN J ZOOL, V74, P330, DOI 10.1139/z96-041; FESTABIANCHET M, IN PRESS BEHAV ECOL; GINSBERG JR, 1994, CONSERV BIOL, V8, P157, DOI 10.1046/j.1523-1739.1994.08010157.x; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; GROENEVELD E, 1992, ARCH ANIM BREED, V15, P399; GROENEVELD E, 1995, USERS GUIDE REML VCE; Harris RB, 2002, WILDLIFE SOC B, V30, P634; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Hogg JT, 1997, BEHAV ECOL SOCIOBIOL, V41, P33, DOI 10.1007/s002650050361; JACHMANN H, 1995, AFR J ECOL, V33, P230, DOI 10.1111/j.1365-2028.1995.tb00800.x; JORGENSON JT, 1993, J WILDLIFE MANAGE, V57, P429, DOI 10.2307/3809267; Jorgenson JT, 1998, J WILDLIFE MANAGE, V62, P1011, DOI 10.2307/3802554; Langvatn R, 1999, WILDLIFE BIOL, V5, P213; Laurian C, 2000, J APPL ECOL, V37, P515, DOI 10.1046/j.1365-2664.2000.00520.x; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; Lynch M., 1998, AM J HUM GENET; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Merila J, 2001, NATURE, V412, P76, DOI 10.1038/35083580; Milner-Gulland EJ, 2003, NATURE, V422, P135, DOI 10.1038/422135a; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Slate J, 1998, ANIM GENET, V29, P307, DOI 10.1046/j.1365-2052.1998.00347.x; THELEN TH, 1991, J WILDLIFE MANAGE, V55, P243, DOI 10.2307/3809146; [No title captured]	30	545	555	8	609	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					655	658		10.1038/nature02177	http://dx.doi.org/10.1038/nature02177			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668862				2022-12-24	WOS:000187132800039
J	Yokoyama, K; Doi, Y; Yamane, K; Kurokawa, H; Shibata, N; Shibayama, K; Yagi, T; Kato, H; Arakawa, Y				Yokoyama, K; Doi, Y; Yamane, K; Kurokawa, H; Shibata, N; Shibayama, K; Yagi, T; Kato, H; Arakawa, Y			Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa	LANCET			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; AMINOGLYCOSIDE ANTIBIOTICS; MICROMONOSPORA-PURPUREA; GENTAMICIN; ARBEKACIN; BACTERIA; TRENDS; DNA	Background Bacteria develop resistance to aminoglycosides by producing aminoglycoside-modifying enzymes such as acetyltransferase, phosphorylase, and adenyltransferase. These enzymes, however, cannot confer consistent resistance to various aminoglycosides because of their substrate specificity. Notwithstanding, a Pseudomonas aeruginosa strain AR-2 showing high-level resistance (minimum inhibitory concentration >1024 mg/L) to various aminoglycosides was isolated clinically. We aimed to clone and characterise the genetic determinant of this resistance. Methods We used conventional methods for DNA manipulation, susceptibility testing, and gene analyses to clone and characterise the genetic determinant of the resistance seen. PCR detection of the gene was also done on a stock of P aeruginosa strains that were isolated clinically since 1997. Findings An aminoglycoside-resistance gene, designated rmtA, was identified in P aeruginosa AR-2. The Escherichia coli transformant and transconjugant harbouring the rmtA gene showed very high-level resistance to various aminoglycosides, including amikacin, tobramycin, isepamicin, arbekacin, kanamycin, and gentamicin. The 756-bp nucleotide rmtA gene encoded a protein, RmtA. This protein showed considerable similarity to the 16S rRNA methylases of aminoglycoside-producing actinomycetes, which protect bacterial 16S rRNA from intrinsic aminoglycosides by methylation. Incorporation of radiolabelled methyl groups into the 30S ribosome was detected in the presence of RmtA. Of 1113 clinically isolated P aeruginosa strains, nine carried the rmtA gene, as shown by PCR analyses. Interpretation Our findings strongly suggest intergeneric lateral gene transfer of 16S rRNA methylase gene from some aminoglycoside-producing microorganisms to P aeruginosa. Further dissemination of the rmtA gene in nosocomial bacteria could be a matter of concern in the future.	Natl Inst Infect Dis, Dept Bacterial Pathogenesis & Infect Control, Tokyo 2080011, Japan	National Institute of Infectious Diseases (NIID)	Arakawa, Y (corresponding author), Natl Inst Infect Dis, Dept Bacterial Pathogenesis & Infect Control, 4-7-1 Gakuen, Tokyo 2080011, Japan.		Yagi, Tetsuya/J-3303-2012; Arakawa, Yoshichika/P-5997-2015	Doi, Yohei/0000-0002-9620-2525				Arakawa Y, 2000, EMERG INFECT DIS, V6, P572, DOI 10.3201/eid0606.000604; Bootsma HJ, 2000, MOL MICROBIOL, V36, P93, DOI 10.1046/j.1365-2958.2000.01828.x; *DNA DAT BANK JAP, DDBJ HOM SEARCH SYST; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Gonzalez-Zorn B, 2003, LANCET INFECT DIS, V3, P67, DOI 10.1016/S1473-3099(03)00510-3; INOUE M, 1994, DRUG EXP CLIN RES, V20, P233; Jones AM, 2001, LANCET, V358, P557, DOI 10.1016/S0140-6736(01)05714-2; KELEMEN GH, 1991, GENE, V98, P53, DOI 10.1016/0378-1119(91)90103-I; Kondo S., 1999, J Infect Chemother, V5, P1, DOI 10.1007/s101560050001; Kurokawa H, 1999, LANCET, V354, P955, DOI 10.1016/S0140-6736(05)75707-X; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; *NAT COMM CLIN LAB, 2002, M100S12 NCCLS; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; PRICE KE, 1986, AM J MED, V80, P182, DOI 10.1016/0002-9343(86)90499-7; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; SKEGGS PA, 1985, MOL GEN GENET, V200, P415, DOI 10.1007/BF00425725; Tacconelli E, 2002, EMERG INFECT DIS, V8, P220, DOI 10.3201/eid0802.010121; TANAKA N, 1983, ANTIMICROB AGENTS CH, V24, P797, DOI 10.1128/AAC.24.5.797; THOMPSON J, 1985, MOL GEN GENET, V201, P168, DOI 10.1007/BF00425655; THORNSBERRY C, 1980, ANTIMICROB AGENTS CH, V18, P338, DOI 10.1128/AAC.18.2.338; Umezawa H, 1979, Jpn J Antibiot, V32 Suppl, pS1; Watanabe T, 1997, J ANTIMICROB CHEMOTH, V39, P471, DOI 10.1093/jac/39.4.471; Westbrock-Wadman S, 1999, ANTIMICROB AGENTS CH, V43, P2975, DOI 10.1128/AAC.43.12.2975	25	169	243	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1888	1893		10.1016/S0140-6736(03)14959-8	http://dx.doi.org/10.1016/S0140-6736(03)14959-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667745				2022-12-24	WOS:000187011600009
J	Shibata, Y; Branicky, R; Landaverde, IO; Hekimi, S				Shibata, Y; Branicky, R; Landaverde, IO; Hekimi, S			Redox regulation of germline and vulval development in Caenorhabditis elegans	SCIENCE			English	Article							LIVED CLK-1 MUTANTS; C-ELEGANS; TRANSFER PROTEIN; GENE; ABETALIPOPROTEINEMIA; MUTATIONS; KINASE	In vitro studies have indicated that reactive oxygen species (ROS) and the oxidation of signaling molecules are important mediators of signal transduction. We have identified two pathways by which the altered redox chemistry of the clk-1 mutants of Caenorhabditis elegans acts in vivo on germline development. One pathway depends on the oxidation of an analog of vertebrate low density lipoprotein (LDL) and acts on the germline through the Ack-related tyrosine kinase (ARK-1) kinase and inositol trisphosphate (IP3) signaling. The other pathway is the oncogenic ras signaling pathway, whose action on germline as well as vulval development appears to be modulated by cytoplasmic ROS.	McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Hekimi, S (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.		Shibata, Yukimasa/H-8467-2017					ALLEVA R, 1995, P NATL ACAD SCI USA, V92, P9388, DOI 10.1073/pnas.92.20.9388; Berriot-Varoqueaux N, 2000, ANNU REV NUTR, V20, P663, DOI 10.1146/annurev.nutr.20.1.663; Branicky R, 2001, GENETICS, V159, P997; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Ernster L., 1993, CLIN INVESTIGATOR, V71, P60; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Guo ZM, 2001, ARTERIOSCL THROM VAS, V21, P1131, DOI 10.1161/hq0701.092092; Hihi AK, 2002, J BIOL CHEM, V277, P2202, DOI 10.1074/jbc.M109034200; Hopper NA, 2000, MOL CELL, V6, P65, DOI 10.1016/S1097-2765(00)00008-3; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jacobs D, 1998, GENETICS, V149, P1809; Jonassen T, 2002, J BIOL CHEM, V277, P45020, DOI 10.1074/jbc.M204758200; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Miyadera H, 2002, FEBS LETT, V512, P33, DOI 10.1016/S0014-5793(02)02282-2; Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200; Morey M, 2001, DEV BIOL, V238, P145, DOI 10.1006/dbio.2001.0389; Segrest JP, 2001, J LIPID RES, V42, P1346; SHARP D, 1993, NATURE, V365, P65, DOI 10.1038/365065a0; SHIBATA Y, UNPUB; SPIETH J, 1991, J MOL EVOL, V32, P429, DOI 10.1007/BF02101283; Sternberg PW, 1998, TRENDS GENET, V14, P466, DOI 10.1016/S0168-9525(98)01592-3; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; WONG A, 1995, GENETICS, V139, P1247	26	96	120	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1779	1782		10.1126/science.1087167	http://dx.doi.org/10.1126/science.1087167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657502				2022-12-24	WOS:000186970100052
J	Wang, HR; Zhang, Y; Ozdamar, B; Ogunjimi, AA; Alexandrova, E; Thomsen, GH; Wrana, JL				Wang, HR; Zhang, Y; Ozdamar, B; Ogunjimi, AA; Alexandrova, E; Thomsen, GH; Wrana, JL			Regulation of cell polarity and protrusion formation by targeting RhoA for degradation	SCIENCE			English	Article							PROTEIN-KINASE-C; E3 UBIQUITIN LIGASE; CAENORHABDITIS-ELEGANS; FAMILY GTPASES; COMPLEX; CDC42; SMURF2; TRANSFORMATION; CYTOSKELETON; ADHESION	The Rho family of small guanosine triphosphatases regulates actin cytoskeleton dynamics that underlie cellular functions such as cell shape changes, migration, and polarity. We found that Smurf1, a HECT domain E3 ubiquitin ligase, regulated cell polarity and protrusive activity and was required to maintain the transformed morphology and motility of a tumor cell. Atypical protein kinase C zeta (PKCzeta), an effector of the Cdc42/Rac1-PAR6 polarity complex, recruited Smurf1 to cellular protrusions, where it controlled the local level of RhoA. Smurf1 thus links the polarity complex to degradation of RhoA in lamellipodia and filopodia to prevent RhoA signaling during dynamic membrane movements.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M56 1X5, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; SUNY Stony Brook, Dept Biochem & Cell Biol, Ctr Dev Genet, Stony Brook, NY 11794 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wrana, JL (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, 600 Univ Ave, Toronto, ON M56 1X5, Canada.		Wrana, Jeffrey/F-8857-2013	Wang, Hong-Rui/0000-0002-2916-8849	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032429] Funding Source: NIH RePORTER; NICHD NIH HHS [HD32429, R01 HD032429-07, R01 HD032429-06, R01 HD032429] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bao J, UNPUB; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Coghlan MP, 2000, MOL CELL BIOL, V20, P2880, DOI 10.1128/MCB.20.8.2880-2889.2000; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gao L, 2002, CURR BIOL, V12, P221, DOI 10.1016/S0960-9822(01)00663-7; Gomes JE, 2002, CURR BIOL, V12, pR444, DOI 10.1016/S0960-9822(02)00939-9; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Hall A, 1999, BRIT J CANCER, V80, P25; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hung TJ, 1999, DEVELOPMENT, V126, P127; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Qiu RG, 1997, MOL CELL BIOL, V17, P3449, DOI 10.1128/MCB.17.6.3449; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Suzuki A, 2002, J CELL SCI, V115, P3565, DOI 10.1242/jcs.00032; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Van Aelst L, 2002, GENE DEV, V16, P1032, DOI 10.1101/gad.978802; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	34	429	443	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1775	1779		10.1126/science.1090772	http://dx.doi.org/10.1126/science.1090772			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657501				2022-12-24	WOS:000186970100051
J	Hubbuck, C				Hubbuck, C			Treatment of children with severe burns	LANCET			English	Article									Frenchay Hosp, Barbara Russell Childrens Unit, Bristol BS16 1LE, Avon, England		Hubbuck, C (corresponding author), Frenchay Hosp, Barbara Russell Childrens Unit, Bristol BS16 1LE, Avon, England.								0	2	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S44	S45		10.1016/S0140-6736(03)15073-8	http://dx.doi.org/10.1016/S0140-6736(03)15073-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698127				2022-12-24	WOS:000187790200023
J	Chim, SSC; Tsui, SKW; Chan, KCA; Au, TCC; Hung, ECW; Tong, YK; Chiu, RWK; Ng, EKO; Chan, PKS; Chu, CM; Sung, JJY; Tam, JS; Fung, KP; Waye, MMY; Lee, CY; Yuen, KY; Lo, YMD				Chim, SSC; Tsui, SKW; Chan, KCA; Au, TCC; Hung, ECW; Tong, YK; Chiu, RWK; Ng, EKO; Chan, PKS; Chu, CM; Sung, JJY; Tam, JS; Fung, KP; Waye, MMY; Lee, CY; Yuen, KY; Lo, YMD		CUHK Molecular SARS Res Grp	Genomic characterisation of the severe acute respiratory syndrome coronavirus of Amoy Gardens outbreak in Hong Kong	LANCET			English	Article								Severe acute respiratory syndrome (SARS) is a global health concern. In Hong Kong, two major outbreaks, one hospital based and the other in the Amoy Gardens apartments, were identified. The frequency of diarrhoea, admission to intensive care, and mortality differed significantly between the two outbreaks. We did genomic sequencing for viral isolates from five Amoy Gardens patients. The virus sequence was identical in four of these five patients. The sequence data from one hospital case and the four identical community cases had only three nucleotide differences. Alterations in the SARS coronavirus genome are unlikely to have caused the distinctive clinical features of the Amoy Gardens patients, and these results highlight the importance of non-viral genomic factors in this outbreak.	Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Biochem, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Paediat, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; United Christian Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; United Christian Hospital; University of Hong Kong	Lo, YMD (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Room 38023,F Clin Sci Bldg,30-32 Ngan Shing St, Shatin, Hong Kong, Peoples R China.	loym@cuhk.edu.hk	Ng, Enders/T-3881-2019; Chan, K.C. Allen/M-2930-2013; Wong, Chi Hang/C-6909-2015; Wong, Chi Hang/ABE-8673-2021; Chan, Martin/B-3588-2009; Lo, Yuk Ming Dennis/D-4468-2011; Chan, Paul KS/J-9360-2013; Sung, Joseph J. Y./R-3203-2018; 韋妙宜教授, Mary Miu Yee Waye/A-9674-2008; Fung, Kwok Pui/R-9708-2018; Chim, Stephen SC/O-6271-2016; Tsui, Stephen Kwok-Wing/E-4385-2015; Ng, Enders K.O./F-2787-2010	Ng, Enders/0000-0002-6955-0030; Chan, K.C. Allen/0000-0003-1780-1691; Wong, Chi Hang/0000-0003-4157-6287; Wong, Chi Hang/0000-0003-4157-6287; Chan, Martin/0000-0002-1568-1596; Lo, Yuk Ming Dennis/0000-0001-8746-0293; Chan, Paul KS/0000-0002-6360-4608; Sung, Joseph J. Y./0000-0003-3125-5199; 韋妙宜教授, Mary Miu Yee Waye/0000-0002-2582-4917; Fung, Kwok Pui/0000-0001-6214-5123; Chim, Stephen SC/0000-0002-2152-7050; Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; Ng, Enders K.O./0000-0002-6955-0030; Yuen, Kwok-yung/0000-0002-2083-1552; Ng, Enders Kai-on/0000-0002-5293-3529; Chan, Anna/0000-0003-2176-5734				Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952	4	41	49	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1807	1808		10.1016/S0140-6736(03)14901-X	http://dx.doi.org/10.1016/S0140-6736(03)14901-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654320	Green Published, Bronze			2022-12-24	WOS:000186872900013
J	Marshall, T				Marshall, T			Coronary heart disease prevention: insights from modelling incremental cost effectiveness	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; RISK; METAANALYSIS; ASPIRIN; STATINS	Objective To determine which treatments for preventing coronary heart disease should be offered to which patients by assessing their incremental cost effectiveness. Design Modelling study Data sources Cost estimates (for NHS) and estimates of effectiveness obtained for aspirin, antihypertensive drugs, statins and clopidogrel. Data synthesis Treatment effects were assumed to be independent, and cost per coronary event prevented was calculated for treatments individually and in combination across patients at a range of coronary risks. Results ne most cost effective preventive treatments are aspirin, initial antihypertensive treatment (bendrofluazide and atenolol), and intensive andhypertensive treatment (bendrofluazide, atenolol and enalapril), whereas simvastatin and clopidogrel are the least cost effective (cost per coronary event prevented in a patient at 10% coronary risk over five years is pound3500 for aspirin, pound12500 for initial antihypertensives, pound18300 for intensive antihypertensives, pound60000 for clopidogrel, and pound61400 for simvastatin). Aspirin in a patient at 5% five year coronary risk costs less than a fifth as much per event prevented (pound7900) as simvastatin in a patient at 30% five year risk (pound40800). Discussion A cost effective prevention strategy would offer aspirin and initial antihypertensive treatment to all patients at greater than 7.5% five year coronary risk before offering statins or clopidogrel to patients at greater than 15% five year coronary risk. Incremental cost effectiveness analysis of treatments produces robust, practical cost effectiveness rankings that can be used to inform treatment guidelines.	Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Marshall, T (corresponding author), Partners Healthcare, 1620 Tremont St, Boston, MA 02120 USA.	T.P.Marshall@bham.ac.uk		Marshall, Tom/0000-0001-9277-5214				ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; *BRIT MED ASS ROYA, 2002, 44 BMA RPS; Britton A, 1998, HLTH TECHNOLOGY ASSE, V2, P1; CASPOZ JM, 2002, NEW ENGL J MED, V346, P1800; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Department of Health, 2000, NAT SERV FRAM COR HE, P1; Ebrahim S, 1999, Health Technol Assess, V3, pi; EBRAHIM S, 1999, HEALTH TECHNOL ASSES, V3, P1; Gaspoz J, 2002, NEW ENGL J MED, V346, P1800, DOI 10.1056/NEJM200206063462309; Gueyffier F, 1997, ANN INTERN MED, V126, P761, DOI 10.7326/0003-4819-126-10-199705150-00002; HANKEY GJ, 2000, COCHRANE DB SYST REV, V2; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Law MR, 2002, BMJ-BRIT MED J, V324, P1570, DOI 10.1136/bmj.324.7353.1570; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Marshall T, 2002, BMJ-BRIT MED J, V325, P197, DOI 10.1136/bmj.325.7357.197; *NAT I CLIN EXC, 2001, NICE TECHN GUID MAN; Neal B, 2000, LANCET, V356, P1955; Netten A., 2001, UNIT COSTS HLTH SOCI; *PRESCR PRIC AUTH, 2002, DRUG TAR; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; *STAT OFF, 2000, HLTH SURV ENGL 1998; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wood D, 1998, HEART, V80, pS1; Yusuf S, 2002, LANCET, V360, P2, DOI 10.1016/S0140-6736(02)09358-3	27	40	43	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2003	327	7426					1264	1267		10.1136/bmj.327.7426.1264	http://dx.doi.org/10.1136/bmj.327.7426.1264			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749VD	14644970	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000186948800019
J	Hungate, BA; Dukes, JS; Shaw, MR; Luo, YQ; Field, CB				Hungate, BA; Dukes, JS; Shaw, MR; Luo, YQ; Field, CB			Nitrogen and climate change	SCIENCE			English	Editorial Material							CO2; DEPOSITION; RESPONSES; STORAGE; WORLD		No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; No Arizona Univ, Merriam Powell Ctr Environm Res, Flagstaff, AZ 86011 USA; Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA	Northern Arizona University; Northern Arizona University; Carnegie Institution for Science; University of Oklahoma System; University of Oklahoma - Norman	Hungate, BA (corresponding author), No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA.	bruce.hungate@nau.edu	Dukes, Jeffrey S/C-9765-2009; Hungate, Bruce/F-8991-2011; Dukes, Jeffrey/AAD-8791-2019	Dukes, Jeffrey S/0000-0001-9482-7743; Hungate, Bruce/0000-0002-7337-1887; 				Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; Gill RA, 2002, NATURE, V417, P279, DOI 10.1038/417279a; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Hungate BA, 1999, CARBON DIOXIDE ENV S, P265, DOI DOI 10.1016/B978-012460370-7/50011-5; Kicklighter DW, 1999, TELLUS B, V51, P343, DOI 10.1034/j.1600-0889.1999.00017.x; Lutz W, 2001, NATURE, V412, P543, DOI 10.1038/35087589; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; RASTETTER EB, 1992, WATER AIR SOIL POLL, V64, P327, DOI 10.1007/BF00477109; Schlesinger W.H., 1997, BIOGEOCHEMISTRY ANAL, V2nd Edition; Townsend AR, 1996, ECOL APPL, V6, P806, DOI 10.2307/2269486	11	597	657	8	354	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1512	1513		10.1126/science.1091390	http://dx.doi.org/10.1126/science.1091390			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645831				2022-12-24	WOS:000186802200024
J	Ruefli-Brasse, AA; French, DM; Dixit, VM				Ruefli-Brasse, AA; French, DM; Dixit, VM			Regulation of NF-kappa B-dependent lymphocyte activation and development by paracaspase	SCIENCE			English	Article							MALT LYMPHOMA; MARGINAL-ZONE; IMMUNE-RESPONSES; BCL10; CARMA1; CELLS; PROLIFERATION; PROTEINS	Paracaspase (MALT1), a member of an evolutionarily conserved superfamily of caspase-like proteins, has been shown to bind and colocalize with the protein Bcl10 in vitro and, because of this association, has been suggested to be involved in the CARMA1-Bcl10 pathway of antigen-induced nuclear factor kappaB (NF-kappaB) activation. We demonstrate that primary T and B lymphocytes from para-caspase-deficient mice are defective in antigen-receptor-induced NF-kappaB activation, cytokine production, and proliferation. Paracaspase acts downstream of Bcl10 to induce NF-kappaB activation and is required for the normal development of B cells, indicating that paracaspase provides the missing link between Bcl10 and activation of the IkappaB kinase complex.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.		dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326				Bertoni Francesco, 2002, Hematol J, V3, P10, DOI 10.1038/sj.thj.6200146; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Pohl T, 2002, P NATL ACAD SCI USA, V99, P4514, DOI 10.1073/pnas.072071599; RUEFLIBRASSE AA, UNPUB; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vega F, 2001, ADV ANAT PATHOL, V8, P313, DOI 10.1097/00125480-200111000-00001; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767	18	293	316	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1581	1584		10.1126/science.1090769	http://dx.doi.org/10.1126/science.1090769			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14576442				2022-12-24	WOS:000186802200049
J	Stroebel, D; Choquet, Y; Popot, JL; Picot, D				Stroebel, D; Choquet, Y; Popot, JL; Picot, D			An atypical haem in the cytochrome b(6)f complex	NATURE			English	Article							ELECTRON-TRANSFER; BC(1) COMPLEX; CRYSTAL-STRUCTURE; CHLOROPHYLL-A; BF COMPLEX; CHLOROPLAST; PROTEIN; SPINACH; SUBUNIT; DOMAIN	Photosystems I and II ( PSI and II) are reaction centres that capture light energy in order to drive oxygenic photosynthesis; however, they can only do so by interacting with the multisubunit cytochrome b(6)f complex. This complex receives electrons from PSII and passes them to PSI, pumping protons across the membrane and powering the Q-cycle. Unlike the mitochondrial and bacterial homologue cytochrome bc(1), cytochrome b(6)f can switch to a cyclic mode of electron transfer around PSI using an unknown pathway. Here we present the X-ray structure at 3.1 Angstrom of cytochrome b(6)f from the alga Chlamydomonas reinhardtii. The structure bears similarities to cytochrome bc(1) but also exhibits some unique features, such as binding chlorophyll, beta-carotene and an unexpected haem sharing a quinone site. This haem is atypical as it is covalently bound by one thioether linkage and has no axial amino acid ligand. This haem may be the missing link in oxygenic photosynthesis.	Univ Paris 07, CNRS, UMR 7099, Lab Physicochim Mol Membranes Biol, F-75005 Paris, France; Inst Biol Physicochim, CNRS, UPR 1261, Lab Physiol Membranaire & Mol Chloroplaste, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Picot, D (corresponding author), Univ Paris 07, CNRS, UMR 7099, Lab Physicochim Mol Membranes Biol, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	Jean-Luc.Popot@ibpc.fr; Daniel.Picot@ibpc.fr	Choquet, Yves/ABE-3084-2020; Choquet, Yves/M-5533-2019	Choquet, Yves/0000-0003-4760-3397; Picot, Daniel/0000-0002-1375-1490				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Breyton C, 1997, J BIOL CHEM, V272, P21892, DOI 10.1074/jbc.272.35.21892; Breyton C, 2000, BBA-BIOENERGETICS, V1459, P467, DOI 10.1016/S0005-2728(00)00185-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrell CJ, 1997, STRUCTURE, V5, P1613, DOI 10.1016/S0969-2126(97)00309-2; Choquet Y, 2003, PLANT CELL, V15, P1443, DOI 10.1105/tpc.011692; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V726, P149, DOI 10.1016/0304-4173(83)90004-6; Crofts AR, 1999, P NATL ACAD SCI USA, V96, P10021, DOI 10.1073/pnas.96.18.10021; Darrouzet E, 2001, TRENDS BIOCHEM SCI, V26, P445, DOI 10.1016/S0968-0004(01)01897-7; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Finazzi G, 2002, BIOCHEMISTRY-US, V41, P7475, DOI 10.1021/bi025714w; Hart SE, 2003, BIOCHEMISTRY-US, V42, P4829, DOI 10.1021/bi020674h; Hirst J, 2001, BIOCHEMISTRY-US, V40, P1274, DOI 10.1021/bi002090q; HOFLE G, 1984, LIEBIGS ANN CHEM, P1883; HOPE AB, 1993, BIOCHIM BIOPHYS ACTA, V1143, P1, DOI 10.1016/0005-2728(93)90210-7; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; HURT E, 1981, EUR J BIOCHEM, V117, P591; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; JOLIOT P, 1988, BIOCHIM BIOPHYS ACTA, V933, P319, DOI 10.1016/0005-2728(88)90039-4; Joliot P, 1998, BIOCHEMISTRY-US, V37, P10404, DOI 10.1021/bi980546m; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuras R, 1997, J BIOL CHEM, V272, P32427, DOI 10.1074/jbc.272.51.32427; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; LAVERGNE J, 1983, BIOCHIM BIOPHYS ACTA, V725, P25, DOI 10.1016/0005-2728(83)90220-7; MARTINEZ SE, 1994, STRUCTURE, V2, P95, DOI 10.1016/S0969-2126(00)00012-5; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; MUKAI K, 1989, EUR J BIOCHEM, V178, P649, DOI 10.1111/j.1432-1033.1989.tb14494.x; MURAKAMI S, 1970, J CELL BIOL, V47, P332, DOI 10.1083/jcb.47.2.332; NITSCHKE W, 1987, BIOCHIM BIOPHYS ACTA, V892, P314, DOI 10.1016/0005-2728(87)90235-0; Peterman EJG, 1998, BIOPHYS J, V75, P389, DOI 10.1016/S0006-3495(98)77523-X; Pierre Y, 1997, J BIOL CHEM, V272, P21901, DOI 10.1074/jbc.272.35.21901; PIERRE Y, 1995, J BIOL CHEM, V270, P29342, DOI 10.1074/jbc.270.49.29342; Pond AE, 1999, BIOCHEMISTRY-US, V38, P7601, DOI 10.1021/bi9825448; Sainz G, 2000, BIOCHEMISTRY-US, V39, P9164, DOI 10.1021/bi0004596; Sazanov LA, 1998, P NATL ACAD SCI USA, V95, P1319, DOI 10.1073/pnas.95.3.1319; Schoepp B, 2000, J BIOL CHEM, V275, P5275, DOI 10.1074/jbc.275.8.5275; Schutz M, 2000, J MOL BIOL, V300, P663, DOI 10.1006/jmbi.2000.3915; Whitelegge JP, 2002, MOL CELL PROTEOMICS, V1, P816, DOI 10.1074/mcp.M200045-MCP200; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Yan JS, 2001, BBA-BIOENERGETICS, V1506, P182, DOI 10.1016/S0005-2728(01)00212-2; Yu J, 1998, J BIOL CHEM, V273, P8860, DOI 10.1074/jbc.273.15.8860; Zhang HM, 1999, J BIOL CHEM, V274, P1581, DOI 10.1074/jbc.274.3.1581; Zhang HM, 2003, P NATL ACAD SCI USA, V100, P5160, DOI 10.1073/pnas.0931431100; Zhang HM, 2001, J BIOL CHEM, V276, P38159; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zito F, 1998, BIOCHEMISTRY-US, V37, P10395, DOI 10.1021/bi980238o	51	513	549	3	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2003	426	6965					413	418		10.1038/nature02155	http://dx.doi.org/10.1038/nature02155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647374				2022-12-24	WOS:000186800800030
J	Yamaguchi, S; Isejima, H; Matsuo, T; Okura, R; Yagita, K; Kobayashi, M; Okamura, H				Yamaguchi, S; Isejima, H; Matsuo, T; Okura, R; Yagita, K; Kobayashi, M; Okamura, H			Synchronization of cellular clocks in the suprachiasmatic nucleus	SCIENCE			English	Article							CIRCADIAN-RHYTHMS; MPER1 GENE; MOUSE; TETRODOTOXIN	Individual cellular clocks in the suprachiasmatic nucleus (SCN), the circadian center, are integrated into a stable and robust pacemaker with a period length of about 24 hours. We used real-time analysis of gene expression to show synchronized rhythms of clock gene transcription across hundreds of neurons within the mammalian SCN in organotypic slice culture. Differentially phased neuronal clocks are topographically arranged across the SCN. A protein synthesis inhibitor set all cell clocks to the same initial phase and, after withdrawal, intrinsic interactions among cell clocks reestablished the stable program of gene expression across the assemblage. Na+-dependent action potentials contributed to establishing cellular synchrony and maintaining spontaneous oscillation across the SCN.	Kobe Univ, Grad Sch Med, Dept Brain Sci, Div Mol Brain Sci, Kobe, Hyogo 6500017, Japan; Yamaguchi Univ, Dept Phys Informat & Biol, Yamaguchi 7538512, Japan; Tohoku Inst Technol, Dept Elect, Sendai, Miyagi 9828577, Japan	Kobe University; Yamaguchi University; Tohoku Institute Technology	Okamura, H (corresponding author), Kobe Univ, Grad Sch Med, Dept Brain Sci, Div Mol Brain Sci, Kobe, Hyogo 6500017, Japan.	okamurah@kobe-u.ac.jp	MATSUO, Takuya/I-7493-2014	Okamura, Hitoshi/0000-0002-3013-4881; Ookura, Ryusuke/0000-0002-6045-9193				Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Asai M, 2001, CURR BIOL, V11, P1524, DOI 10.1016/S0960-9822(01)00445-6; BOUSKILA Y, 1993, P NATL ACAD SCI USA, V90, P3207, DOI 10.1073/pnas.90.8.3207; Colwell CS, 2000, J NEUROBIOL, V43, P379, DOI 10.1002/1097-4695(20000615)43:4<379::AID-NEU6>3.0.CO;2-0; Cutler DJ, 2003, EUR J NEUROSCI, V17, P197, DOI 10.1046/j.1460-9568.2003.02425.x; Honma S, 2000, NEUROSCI LETT, V294, P113, DOI 10.1016/S0304-3940(00)01558-5; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Moore RY, 1997, ANNU REV MED, V48, P253, DOI 10.1146/annurev.med.48.1.253; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Quintero JE, 2003, J NEUROSCI, V23, P8070; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; SCHWARTZ WJ, 1985, J NEUROSCI, V5, P2771; SHIBATA S, 1993, BRAIN RES, V606, P259, DOI 10.1016/0006-8993(93)90993-W; TOMINAGA K, 1994, NEUROSCIENCE, V59, P1025, DOI 10.1016/0306-4522(94)90303-4; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamaguchi S, 2000, CURR BIOL, V10, P873, DOI 10.1016/S0960-9822(00)00602-3; Yamaguchi S, 2001, NATURE, V409, P684, DOI 10.1038/35055628	21	695	704	0	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2003	302	5649					1408	1412		10.1126/science.1089287	http://dx.doi.org/10.1126/science.1089287			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631044				2022-12-24	WOS:000186683500056
J	Krack, P; Batir, A; Van Blercom, N; Chabardes, S; Fraix, V; Ardouin, C; Koudsie, A; Limousin, PD; Benazzouz, A; LeBas, JF; Benabid, AL; Pollak, P				Krack, P; Batir, A; Van Blercom, N; Chabardes, S; Fraix, V; Ardouin, C; Koudsie, A; Limousin, PD; Benazzouz, A; LeBas, JF; Benabid, AL; Pollak, P			Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEEP-BRAIN-STIMULATION; RATING-SCALE; POSTEROVENTRAL PALLIDOTOMY; UNILATERAL PALLIDOTOMY; GLOBUS-PALLIDUS; MOTOR FUNCTION; LEVODOPA; FLUCTUATIONS; DEPRESSION; SPECTRUM	Background: Although the short-term benefits of bilateral stimulation of the subthalamic nucleus in patients with advanced Parkinson's disease have been well documented, the long-term outcomes of the procedure are unknown. Methods: We conducted a five-year prospective study of the first 49 consecutive patients whom we treated with bilateral stimulation of the subthalamic nucleus. Patients were assessed at one, three, and five years with levodopa (on medication) and without levodopa (off medication), with use of the Unified Parkinson's Disease Rating Scale. Seven patients did not complete the study: three died, and four were lost to follow-up. Results: As compared with base line, the patients' scores at five years for motor function while off medication improved by 54 percent (P<0.001) and those for activities of daily living improved by 49 percent (P<0.001). Speech was the only motor function for which off-medication scores did not improve. The scores for motor function on medication did not improve one year after surgery, except for the dyskinesia scores. On-medication akinesia, speech, postural stability, and freezing of gait worsened between year 1 and year 5 (P<0.001 for all comparisons). At five years, the dose of dopaminergic treatment and the duration and severity of levodopa-induced dyskinesia were reduced, as compared with base line (P<0.001 for each comparison). The average scores for cognitive performance remained unchanged, but dementia developed in three patients after three years. Mean depression scores remained unchanged. Severe adverse events included a large intracerebral hemorrhage in one patient. One patient committed suicide. Conclusions: Patients with advanced Parkinson's disease who were treated with bilateral stimulation of the subthalamic nucleus had marked improvements over five years in motor function while off medication and in dyskinesia while on medication. There was no control group, but worsening of akinesia, speech, postural stability, freezing of gait, and cognitive function between the first and the fifth year is consistent with the natural history of Parkinson's disease.	Univ Grenoble 1, Dept Clin & Biol Neurosci, Grenoble, France; Univ Grenoble 1, Dept Magnet Resonance Imaging, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Krack, P (corresponding author), CHU Grenoble, Dept Neurol, Dept Clin & Biol Neurosci, BP 217, F-38043 Grenoble 9, France.	paul.krack@ujf-grenoble.fr	Benazzouz, Abdelhamid/E-5050-2016; Benabid, Alim L/Q-3506-2017; FRAIX, VALERIE/AAC-3616-2019	Krack, Paul/0000-0002-3508-7295				Albanese A, 2001, MOVEMENT DISORD, V16, P197, DOI 10.1002/mds.1069; Alkhani A, 2001, J NEUROSURG, V94, P43, DOI 10.3171/jns.2001.94.1.0043; American Psychological Association, 1994, DIAGN STAT MAN MENT, V4th; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berney A, 2002, NEUROLOGY, V59, P1427, DOI 10.1212/01.WNL.0000032756.14298.18; BONNET AM, 1987, NEUROLOGY, V37, P1539, DOI 10.1212/WNL.37.9.1539; De Bie RMA, 2002, MOVEMENT DISORD, V17, P533, DOI 10.1002/mds.10090; Doshi PK, 2002, MOVEMENT DISORD, V17, P1084, DOI 10.1002/mds.10198; Durif F, 2002, MOVEMENT DISORD, V17, P803, DOI 10.1002/mds.10128; Fahn S.E., 1987, RECENT DEV PARKINSON, V153, P293; Fine J, 2000, NEW ENGL J MED, V342, P1708, DOI 10.1056/NEJM200006083422304; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Funkiewiez A, 2003, MOVEMENT DISORD, V18, P524, DOI 10.1002/mds.10441; Ghika J, 1998, J NEUROSURG, V89, P713, DOI 10.3171/jns.1998.89.5.0713; Ghika J, 1999, J NEUROSURG, V91, P313, DOI 10.3171/jns.1999.91.2.0313; Goetz CG, 2002, MOVEMENT DISORD, V17, P283, DOI 10.1002/mds.10024; Goetz CG, 2000, NEUROLOGY, V54, P710, DOI 10.1212/WNL.54.3.710; GREENE P, 1993, ADV NEUROL, V60, P703; Hariz GM, 2003, MOVEMENT DISORD, V18, P373, DOI 10.1002/mds.10386; Hariz MI, 2001, J NEUROSURG, V94, P552, DOI 10.3171/jns.2001.94.4.0552; Hoehn MM, 1969, 3 S PARK DIS, P274; Houeto JL, 2002, J NEUROL NEUROSUR PS, V72, P701, DOI 10.1136/jnnp.72.6.701; Jahanshahi M, 2000, BRAIN, V123, P1142, DOI 10.1093/brain/123.6.1142; KLAWANS HL, 1986, MOVEMENT DISORD, V3, P187; Krack P, 2002, MOVEMENT DISORD, V17, pS188, DOI 10.1002/mds.10163; Krack P, 1997, LANCET, V350, P1676, DOI 10.1016/S0140-6736(05)64273-0; Krack P, 1999, BRAIN, V122, P1133, DOI 10.1093/brain/122.6.1133; Kumar R, 1998, NEUROLOGY, V51, P850, DOI 10.1212/WNL.51.3.850; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; LANGSTON JW, 1992, MOVEMENT DISORD, V7, P2, DOI 10.1002/mds.870070103; Limousin P, 1998, NEW ENGL J MED, V339, P1105, DOI 10.1056/NEJM199810153391603; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; MARKHAM CH, 1986, ANN NEUROL, V19, P365, DOI 10.1002/ana.410190410; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; Oh MY, 2002, NEUROSURGERY, V50, P1268; Pahwa R, 2003, J NEUROSURG, V99, P71, DOI 10.3171/jns.2003.99.1.0071; Pillon B, 2000, NEUROLOGY, V55, P411, DOI 10.1212/WNL.55.3.411; Rehncrona S, 2003, MOVEMENT DISORD, V18, P163, DOI 10.1002/mds.10309; RICHARDS M, 1994, MOVEMENT DISORD, V9, P89, DOI 10.1002/mds.870090114; RILEY DE, 1993, NEUROLOGY, V43, P1459, DOI 10.1212/WNL.43.8.1459; Romito LM, 2002, MOVEMENT DISORD, V17, P1371, DOI 10.1002/mds.10265; SCHMIDT R, 1994, NEUROLOGY, V44, P964, DOI 10.1212/WNL.44.5.964; Schwab R.S., 1969, 3 S PARK DIS, P152; Speelman JD, 1998, MOVEMENT DISORD, V13, P103; Valldeoriola F, 2002, J NEUROL, V249, P1671, DOI 10.1007/s00415-002-0897-8; Zhang H, 2003, NEUROSURGERY, V52, P89, DOI 10.1227/01.NEU.0000038933.95427.AE	46	1551	1583	1	188	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2003	349	20					1925	1934		10.1056/NEJMoa035275	http://dx.doi.org/10.1056/NEJMoa035275			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742EA	14614167	Green Published, Bronze			2022-12-24	WOS:000186502400007
J	Lei, M; Podell, ER; Baumann, P; Cech, TR				Lei, M; Podell, ER; Baumann, P; Cech, TR			DNA self-recognition in the structure of Pot1 bound to telomeric single-stranded DNA	NATURE			English	Article							END-BINDING-PROTEIN; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; DOMAIN; PROTECTION; SEQUENCE	Telomeres, specialized protein-DNA complexes that cap the ends of linear chromosomes, are essential for protecting chromosomes from degradation and end-to-end fusions(1,2). The Pot1 (protection of telomeres 1) protein is a widely distributed eukaryotic end-capping protein, having been identified in fission yeast, microsporidia, plants and animals(3,4). Schizosaccharomyces pombe Pot1p is essential for telomere maintenance(3), and human POT1 has been implicated in telomerase regulation(5,6). Pot1 binds telomeric single-stranded DNA (ssDNA) with exceptionally high sequence specificity(7), the molecular basis of which has been unknown. Here we describe the 1.9-Angstrom-resolution crystal structure of the amino-terminal DNA-binding domain of S. pombe Pot1p complexed with ssDNA. The protein adopts an oligonucleotide/oligosaccharide-binding (OB) fold(8) with two loops that protrude to form a clamp for ssDNA binding. The structure explains the sequence specificity of binding: in the context of the Pot1 protein, DNA self-recognition involving base-stacking and unusual G-T base pairs compacts the DNA. Any sequence change disrupts the ability of the DNA to form this structure, preventing it from contacting the array of protein hydrogen-bonding groups. The structure also explains how Pot1p avoids binding the vast excess of RNA in the nucleus.	Univ Colorado, Dept Chem & Biochem, Howard Hughes Med Inst, Boulder, CO 80309 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Stowers Institute for Medical Research	Cech, TR (corresponding author), Univ Colorado, Dept Chem & Biochem, Howard Hughes Med Inst, Campus Box 215, Boulder, CO 80309 USA.	thomas.cech@colorado.edu		Baumann, Peter/0000-0003-4892-1485				Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; Bastin-Shanower SA, 2001, J BIOL CHEM, V276, P36446, DOI 10.1074/jbc.M104386200; Baumann P, 2002, MOL CELL BIOL, V22, P8079, DOI 10.1128/MCB.22.22.8079-8087.2002; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryan TM, 1999, CURR OPIN CELL BIOL, V11, P318, DOI 10.1016/S0955-0674(99)80043-X; Cervantes RB, 2002, CURR OPIN CELL BIOL, V14, P351, DOI 10.1016/S0955-0674(02)00325-3; Chandra A, 2001, GENE DEV, V15, P404, DOI 10.1101/gad.861001; Classen S, 2003, BIOCHEMISTRY-US, V42, P9269, DOI 10.1021/bi0273718; Classen S, 2001, J MOL BIOL, V314, P1113, DOI 10.1006/jmbi.2000.5191; Colgin LM, 2003, CURR BIOL, V13, P942, DOI 10.1016/S0960-9822(03)00339-7; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; GRAY JT, 1991, CELL, V67, P807, DOI 10.1016/0092-8674(91)90075-A; Hollis T, 2001, P NATL ACAD SCI USA, V98, P9557, DOI 10.1073/pnas.171317698; Horvath MP, 1998, CELL, V95, P963, DOI 10.1016/S0092-8674(00)81720-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lei M, 2002, BIOCHEMISTRY-US, V41, P14560, DOI 10.1021/bi026674z; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mitton-Fry RM, 2002, SCIENCE, V296, P145, DOI 10.1126/science.1068799; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; NICHOLLS A, 1991, J COMPUT CHEM, V270, P26184; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; Peersen OB, 2002, NAT STRUCT BIOL, V9, P182, DOI 10.1038/nsb761; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506	30	171	181	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2003	426	6963					198	203		10.1038/nature02092	http://dx.doi.org/10.1038/nature02092			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614509				2022-12-24	WOS:000186517200048
J	Pearce, EL; Mullen, AC; Martins, GA; Krawczyk, CM; Hutchins, AS; Zediak, VP; Banica, M; DiCioccio, CB; Gross, DA; Mao, C; Shen, H; Cereb, N; Yang, SY; Lindsten, T; Rossant, J; Hunter, CA; Reiner, SL				Pearce, EL; Mullen, AC; Martins, GA; Krawczyk, CM; Hutchins, AS; Zediak, VP; Banica, M; DiCioccio, CB; Gross, DA; Mao, C; Shen, H; Cereb, N; Yang, SY; Lindsten, T; Rossant, J; Hunter, CA; Reiner, SL			Control of effector CD8(+) T cell function by the transcription factor Eomesodermin	SCIENCE			English	Article							LINEAGE COMMITMENT; BET; GENE; MEMORY; DIFFERENTIATION; INDUCTION; FOXP3; CD4	Activated CD8(+) T cells play a critical role in host defense against viruses, intracellular microbes, and tumors. It is not clear if a key regulatory transcription factor unites the effector functions of CD8(+) T cells. We now show that Eomesodermin (Eomes), a paralogue of T-bet, is induced in effector CD8(+) T cells in vitro and in vivo. Ectopic expression of Eomes was sufficient to invoke attributes of effector CD8(+) T cells, including interferon-gamma (IFN-gamma), perforin, and granzyme B. Loss-of-function analysis suggests Eomes may also be necessary for full effector differentiation of CD8(+) T cells. We suggest that Eomesodermin is likely to complement the actions of T-bet and act as a key regulatory gene in the development of cell-mediated immunity.	Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Ctr Genet Polymorphism, Ossining, NY 10562 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Reiner, SL (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.		Hunter, Christopher/H-1970-2011	Mao, Chai-An/0000-0002-9700-6964; Mullen, Alan/0000-0002-4096-3106	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042370] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-042370] Funding Source: Medline; NIGMS NIH HHS [GM-07229] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CEREB N, UNPUB; Conlon FL, 2001, DEVELOPMENT, V128, P3749; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Horton AC, 2002, J EXP ZOOL, V294, P112, DOI 10.1002/jez.10151; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; MAO C, UNPUB; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; REINER SL, UNPUB; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Yi CH, 1999, GENOMICS, V55, P10, DOI 10.1006/geno.1998.5632; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	21	742	761	3	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2003	302	5647					1041	1043		10.1126/science.1090148	http://dx.doi.org/10.1126/science.1090148			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605368				2022-12-24	WOS:000186396300047
J	Billas, IML; Iwema, T; Garnier, JM; Mitschler, A; Rochel, N; Moras, D				Billas, IML; Iwema, T; Garnier, JM; Mitschler, A; Rochel, N; Moras, D			Structural adaptability in the ligand-binding pocket of the ecdysone hormone receptor	NATURE			English	Article							CRYSTAL-STRUCTURE; NUCLEAR RECEPTOR; HETERODIMERIC COMPLEX; DOMAIN; ALPHA; ACTIVATION; REVEALS; INSECT; BETA; ECR	The ecdysteroid hormones coordinate the major stages of insect development, notably moulting and metamorphosis, by binding to the ecdysone receptor (EcR); a ligand-inducible nuclear transcription factor(1,2). To bind either ligand or DNA, EcR must form a heterodimer with ultraspiracle (USP), the homologue of retinoid-X receptor(3-5). Here we report the crystal structures of the ligand-binding domains of the moth Heliothis virescens EcR - USP heterodimer in complex with the ecdysteroid ponasterone A and with a non-steroidal, lepidopteran-specific agonist BYI06830 used in agrochemical pest control. The two structures of EcR - USP emphasize the universality of heterodimerization as a general mechanism common to both vertebrates and invertebrates. Comparison of the EcR structures in complex with steroidal and non-steroidal ligands reveals radically different and only partially overlapping ligand-binding pockets that could not be predicted by molecular modelling and docking studies(6,7). These findings offer new perspectives for the design of insect-specific, environmentally safe insecticides. The concept of a ligand-dependent binding pocket in EcR provides an insight into the moulding of nuclear receptors to their ligand, and has potential applications for human nuclear receptors.	Univ Strasbourg 1, IGBMC, Dept Biol & Genom Struct, CNRS,INSERM, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Moras, D (corresponding author), Univ Strasbourg 1, IGBMC, Dept Biol & Genom Struct, CNRS,INSERM, Parc Innovat BP10142, F-67404 Illkirch Graffenstaden, France.	moras@igbmc.u-strasbg.fr	Rochel, Natacha/A-5718-2016; Billas, Isabelle M.L./I-2790-2016	Rochel, Natacha/0000-0002-3573-5889; Billas, Isabelle M.L./0000-0003-2323-4208				Arbeitman MN, 2000, CELL, V101, P67, DOI 10.1016/S0092-8674(00)80624-8; Baker KD, 2000, INSECT BIOCHEM MOLEC, V30, P1037, DOI 10.1016/S0965-1748(00)00075-8; Billas IML, 2001, J BIOL CHEM, V276, P7465, DOI 10.1074/jbc.M008926200; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clayton GM, 2001, P NATL ACAD SCI USA, V98, P1549, DOI 10.1073/pnas.041611298; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Farnegardh M, 2003, J BIOL CHEM, V278, P38821, DOI 10.1074/jbc.M304842200; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Greiner EF, 1996, P NATL ACAD SCI USA, V93, P10105, DOI 10.1073/pnas.93.19.10105; HENRICH VC, 1995, INSECT BIOCHEM MOLEC, V25, P881, DOI 10.1016/0965-1748(95)00030-Y; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 2003, MOL ENDOCRINOL, V17, P716, DOI 10.1210/me.2002-0287; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kasuya A, 2003, J MOL MODEL, V9, P58, DOI 10.1007/s00894-002-0113-x; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Kumar MB, 2002, P NATL ACAD SCI USA, V99, P14710, DOI 10.1073/pnas.222278999; MOHAMMEDALI AK, 1995, CAN J CHEM, V73, P550, DOI 10.1139/v95-071; Potier N, 2003, PROTEIN SCI, V12, P725, DOI 10.1110/ps.0232503; Riddiford LM, 2001, VITAM HORM, V60, P1; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Svensson S, 2003, EMBO J, V22, P4625, DOI 10.1093/emboj/cdg456; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Toya T, 2002, BIOCHEM BIOPH RES CO, V292, P1087, DOI 10.1006/bbrc.2002.6771; Wurtz JM, 2000, PROTEIN SCI, V9, P1073, DOI 10.1110/ps.9.6.1073; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F	30	191	200	5	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2003	426	6962					91	96		10.1038/nature02112	http://dx.doi.org/10.1038/nature02112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14595375				2022-12-24	WOS:000186370800048
J	Rose, CR; Blum, R; Pichler, B; Lepier, A; Kafitz, KW; Konnerth, A				Rose, CR; Blum, R; Pichler, B; Lepier, A; Kafitz, KW; Konnerth, A			Truncated TrkB-T1 mediates neurotrophin-evoked calcium signalling in glia cells	NATURE			English	Article							NERVOUS-SYSTEM; TYROSINE KINASE; FULL-LENGTH; RECEPTOR; TRANSDUCTION; PROTEIN; BDNF; ACTIVATION; ASTROCYTES; INHIBITOR	The neurotrophin receptor TrkB is essential for normal function of the mammalian brain(1-3). It is expressed in three splice variants. Full-length receptors (TrkB(FL)) possess an intracellular tyrosine kinase domain and are considered as those TrkB receptors that mediate the crucial effects of brain-derived neurotrophic factor (BDNF) or neurotrophin 4/5 (NT- 4/5). By contrast, truncated receptors (TrkB-T1 and TrkB-T2) lack tyrosine kinase activity and have not been reported to elicit rapid intracellular signalling(4). Here we show that astrocytes predominately express TrkB-T1 and respond to brief application of BDNF by releasing calcium from intracellular stores. The calcium transients are insensitive to the tyrosine kinase blocker K-252a and persist in mutant mice lacking TrkB(FL). By contrast, neurons produce rapid BDNF-evoked signals through TrkB(FL) and the Na(v)1.9 channel(5,6). Expression of antisense TrkB messenger RNA strongly reduces BDNF-evoked calcium signals in glia. Thus, our results show that, unexpectedly, TrkB-T1 has a direct signalling role in mediating inositol-1,4,5-trisphosphate-dependent calcium release; in addition, they identify a previously unknown mechanism of neurotrophin action in the brain.	Univ Munich, Inst Physiol, D-80336 Munich, Germany	University of Munich	Rose, CR (corresponding author), Univ Munich, Inst Physiol, D-80336 Munich, Germany.		Blum, Robert/E-8899-2013	Blum, Robert/0000-0002-5270-3854				BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; Baxter GT, 1997, J NEUROSCI, V17, P2683; Bezzi P, 2001, CURR OPIN NEUROBIOL, V11, P387, DOI 10.1016/S0959-4388(00)00223-3; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Blum R, 2002, NATURE, V419, P687, DOI 10.1038/nature01085; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; Climent E, 2000, NEUROSCI LETT, V288, P53, DOI 10.1016/S0304-3940(00)01207-6; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hapner SJ, 1998, DEV BIOL, V201, P90, DOI 10.1006/dbio.1998.8970; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; HELMS JB, 1995, FEBS LETT, V369, P84, DOI 10.1016/0014-5793(95)00620-O; Idestrup CP, 1998, NEUROSCIENCE, V86, P913, DOI 10.1016/S0306-4522(98)00128-6; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KNUSEL B, 1992, J NEUROCHEM, V59, P1987; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; Kryl D, 2000, BIOCHEM BIOPH RES CO, V279, P925, DOI 10.1006/bbrc.2000.4058; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Newman E A, 2001, Prog Brain Res, V132, P241; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Rasmussen R., 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; ROBACK JD, 1995, EUR J NEUROSCI, V7, P849, DOI 10.1111/j.1460-9568.1995.tb01072.x; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Thoenen H, 2000, PROG BRAIN RES, V128, P183; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99	30	284	291	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2003	426	6962					74	78		10.1038/nature01983	http://dx.doi.org/10.1038/nature01983			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603320				2022-12-24	WOS:000186370800044
J	Behr, E; Wood, DA; Wright, M; Syrris, P; Sheppard, MN; Casey, A; Davies, MJ; McKenna, W				Behr, E; Wood, DA; Wright, M; Syrris, P; Sheppard, MN; Casey, A; Davies, MJ; McKenna, W		SADS Steering Grp	Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome	LANCET			English	Article							LONG-QT SYNDROME	4.1% of sudden cardiac deaths in the 16-64 age-group are unexplained. In this group, cardiac pathological findings are normal and toxicological tests are negative; termed sudden arrythmic death syndrome (SADS). We searched for evidence of inherited cardiac disease in cases of SADS. Of 147 first-degree relatives of 32 people who died of SADS, 109 (74%) underwent cardiological assessment. Seven (22%) of the 32 families were diagnosed with inherited cardiac disease: four with long QT syndrome; one with non-structural cardiac electrophysiological disease; one with myotonic dystrophy; and one with hypertrophic cardiomyopathy. Families of people who die of SADS should be offered assessment in centres with experience of inherited cardiac disease.	Univ London St Georges Hosp, Sch Med, London SW17 0RE, England; Univ London Imperial Coll Sci Technol & Med, Imperial Coll Sch Med, Natl Heart & Lung Inst, London, England	St Georges University London; Imperial College London	McKenna, W (corresponding author), Natl Heart Hosp, 16-18 Westmoreland St, London W1G 8PH, England.		SYRRIS, PETROS/C-1703-2008; Sheppard, Mary N/AAB-3364-2019; McKenna, William J/C-3243-2008	SYRRIS, PETROS/0000-0002-2363-8758; Sheppard, Mary N/0000-0003-2724-3881; McKenna, William J/0000-0001-7994-2460; Behr, Elijah/0000-0002-8731-2853				Bowker TJ, 2003, QJM-INT J MED, V96, P269, DOI 10.1093/qjmed/hcg038; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Priori SG, 1999, CIRCULATION, V99, P529, DOI 10.1161/01.CIR.99.4.529; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Viskin S, 1999, LANCET, V354, P1625, DOI 10.1016/S0140-6736(99)02107-8	5	216	222	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 1	2003	362	9394					1457	1459		10.1016/S0140-6736(03)14692-2	http://dx.doi.org/10.1016/S0140-6736(03)14692-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739PX	14602442				2022-12-24	WOS:000186356600014
J	Merikangas, KR; Risch, N				Merikangas, KR; Risch, N			Genomic priorities and public health	SCIENCE			English	Article							GENETIC EPIDEMIOLOGY; ADOLESCENT SMOKING; DIABETES-MELLITUS; ALZHEIMER-DISEASE; COMPLEX TRAITS; FAMILY-HISTORY; LIFE-STYLE; STRATEGIES; CANCER; RISK	Given the continuing difficulty of identifying genes for complex disorders in a robust, replicable manner, and the extensive resources devoted to this effort, it is becoming increasingly important to analyze the relative benefits of genomics research for public health applications and for the understanding of disease pathogenesis. To establish priorities for genetics research, we review and evaluate several characteristics of selected exemplary complex diseases, including phenotypic accuracy, knowledge of specific and nonspecific genetic and environmental risk factors, and population prevalence and impact. We propose that complex diseases with the strongest evidence for genetic etiology, limited ability to modify exposure or risk factors, and high public health impact should have the highest priority for genetics research.	NIMH, Sec Dev Genet Epidemiol, Mood & Anxiety Disorders Progrma, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Kaiser Permanente, Div Res, Oakland, CA 94612 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Stanford University; Kaiser Permanente	Merikangas, KR (corresponding author), NIMH, Sec Dev Genet Epidemiol, Mood & Anxiety Disorders Progrma, NIH,Dept Hlth & Human Serv, 15K N Dr,Mail Stop Code 2670, Bethesda, MD 20892 USA.	kathleen.merikangas@nih.gov		Merikangas, Kathkeen/0000-0002-4667-2414	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002804, Z01MH002804] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akerblom HK, 2002, AM J MED GENET, V115, P18, DOI 10.1002/ajmg.10340; *AM CANC SOC, 2003, CANC FACTS FIG 2003; Avenevoli S, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1360-0443.98.s1.2.x; Baird P, 2001, Community Genet, V4, P77, DOI 10.1159/000051161; Baird PA, 2002, PERSPECT BIOL MED, V45, P516, DOI 10.1353/pbm.2002.0061; BOOMSMA DI, 1994, ADDICTION, V89, P219, DOI 10.1111/j.1360-0443.1994.tb00881.x; Breslau N, 2001, ARCH GEN PSYCHIAT, V58, P810, DOI 10.1001/archpsyc.58.9.810; Calabrese EJ, 1997, ENVIRON HEALTH PERSP, V105, P1354, DOI 10.2307/3433755; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; *CDC, 2001, SURV EP AIDS SURV SP; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; GOLDMAN D, 1993, RECENT DEV ALCOHOLIS, V2; Goldner EM, 2002, CAN J PSYCHIAT, V47, P833, DOI 10.1177/070674370204700904; Gottesman I. I., 1972, SCHIZOPHRENIA GENETI; Haga SB, 2003, NAT GENET, V34, P347, DOI 10.1038/ng0803-347; HANLEY AJG, 1995, INT J EPIDEMIOL, V24, P255, DOI 10.1093/ije/24.2.255; Harrison TA, 2003, AM J PREV MED, V24, P152, DOI 10.1016/S0749-3797(02)00588-3; Hendrie HC, 1998, AM J GERIAT PSYCHIAT, V6, pS3, DOI 10.1097/00019442-199821001-00002; Ishibe N, 1997, CANCER CAUSE CONTROL, V8, P504, DOI 10.1023/A:1018421724776; Kenny S.J., 1995, NIH PUBLICATION, P47; Khoury MJ, 2003, GENET MED, V5, P261, DOI 10.1097/01.GIM.0000076977.90682.A5; Khoury MJ, 1996, AM J PUBLIC HEALTH, V86, P1717, DOI 10.2105/AJPH.86.12.1717; KIDD K, COMMUNICATION; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x; Lantz PM, 2000, TOB CONTROL, V9, P47, DOI 10.1136/tc.9.1.47; Little J, 2003, AM J EPIDEMIOL, V157, P667, DOI 10.1093/aje/kwg048; MERIKANGAS KR, 1990, PSYCHOL MED, V20, P11, DOI 10.1017/S0033291700013192; MERIKANGAS KR, UNPUB AM J EPIDEMIOL; Newschaffer CJ, 2002, EPIDEMIOL REV, V24, P137, DOI 10.1093/epirev/mxf010; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Pollitt RJ, 2001, J INHERIT METAB DIS, V24, P299, DOI 10.1023/A:1010339606265; RAVUSSIN E, 1994, DIABETES CARE, V17, P1067, DOI 10.2337/diacare.17.9.1067; REWERS M, 1995, NIH PUBLICATION, P179; Rich SS, 2002, DIABETES, V51, pS288, DOI 10.2337/diabetes.51.2007.S288; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 2001, CANCER EPIDEM BIOMAR, V10, P733; ROSE G, 1997, STRATEGY PREVENTIVE; Rose JS, 1999, MERRILL PALMER QUART, V45, P62; Sadovnick AD, 2002, CLIN NEUROL NEUROSUR, V104, P199, DOI 10.1016/S0303-8467(02)00038-0; SHAPER AG, 1991, ACTA PAEDIATR SCAND, P73; Shostak S, 2003, SOC SCI MED, V56, P2327, DOI 10.1016/S0277-9536(02)00231-9; SLATTERY ML, 1993, JAMA-J AM MED ASSOC, V270, P1563, DOI 10.1001/jama.270.13.1563; Slooter AJC, 1997, EPIDEMIOL REV, V19, P107, DOI 10.1093/oxfordjournals.epirev.a017933; Sobngwi E, 2003, LANCET, V361, P1861, DOI 10.1016/S0140-6736(03)13505-2; Susser M, 1996, AM J PUBLIC HEALTH, V86, P668, DOI 10.2105/AJPH.86.5.668; Susser M, 1998, J EPIDEMIOL COMMUN H, V52, P608, DOI 10.1136/jech.52.10.608; Trevisan R, 1998, NEPHROL DIAL TRANSPL, V13, P2, DOI 10.1093/ndt/13.suppl_8.2; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	51	185	190	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2003	302	5645					599	601		10.1126/science.1091468	http://dx.doi.org/10.1126/science.1091468			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	735MV	14576422				2022-12-24	WOS:000186119900045
J	Furness, S; Connor, J; Robinson, E; Norton, R; Ameratunga, S; Jackson, R				Furness, S; Connor, J; Robinson, E; Norton, R; Ameratunga, S; Jackson, R			Car colour and risk of car crash injury: population based case control study	BRITISH MEDICAL JOURNAL			English	Article							DRIVER SLEEPINESS		Univ Auckland, Sch Populat Hlth, Epidemiol & Biostat Sect, Auckland 1, New Zealand; Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia	University of Auckland; University of Sydney	Furness, S (corresponding author), Univ Auckland, Sch Populat Hlth, Epidemiol & Biostat Sect, Private Bag 92019, Auckland 1, New Zealand.			Connor, Jennie/0000-0002-3209-8693; Jackson, Rod/0000-0001-5914-6934; Ameratunga, Shanthi/0000-0001-8042-2251				Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Connor J, 2001, SLEEP, V24, P688, DOI 10.1093/sleep/24.6.688; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Lardelli-Claret P, 2002, EPIDEMIOLOGY, V13, P721, DOI 10.1097/00001648-200211000-00019; Peden M, 2002, INJURY CHART BOOK GR	5	11	12	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1455	1456		10.1136/bmj.327.7429.1455	http://dx.doi.org/10.1136/bmj.327.7429.1455			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	757LA	14684646	Green Published			2022-12-24	WOS:000187562700017
J	Anderson, RM; Latorre-Esteves, M; Neves, AR; Lavu, S; Medvedik, O; Taylor, C; Howitz, KT; Santos, H; Sinclair, DA				Anderson, RM; Latorre-Esteves, M; Neves, AR; Lavu, S; Medvedik, O; Taylor, C; Howitz, KT; Santos, H; Sinclair, DA			Yeast life-span extension by calorie restriction is independent of NAD fluctuation	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN SIR2; NICOTINAMIDE; REGULATOR; LONGEVITY; STRESS	Calorie restriction (CR) slows aging in numerous species. In the yeast Saccharomyces cerevisiae, this effect requires Sir2, a conserved NAD(+)-dependent deacetylase. We report that CR reduces nuclear NAD(+) levels in vivo. Moreover, the activity of Sir2 and its human homologue SIRT1 are not affected by physiological alterations in the NAD(+): NADH ratio. These data implicate alternate mechanisms of Sir2 regulation by CR.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal; Biomol Res Labs Inc, Plymouth Meeting, PA 19462 USA	Harvard University; Harvard Medical School; Universidade Nova de Lisboa	Sinclair, DA (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.	David_Sinclair@hms.harvard.edu	Latorre-Esteves, Magda/GMW-6353-2022; Santos, Helena/B-9141-2011; Neves, Ana/B-9476-2008	Santos, Helena/0000-0002-8050-9485; Neves, Ana/0000-0003-4896-9585; Sinclair, David/0000-0002-9936-436X	NIA NIH HHS [R37 AG028730, R01 AG019972, R01 AG028730, R01 AG019719, P01 AG027916] Funding Source: Medline; NIGMS NIH HHS [R01 GM068072] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028730, R37AG028730, R01AG019719, R01AG019972, P01AG027916] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; ANDERSON RW, UNPUB; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jiang JC, 2000, FASEB J, V14, P2135; Kaeberlein M, 2002, MOL CELL BIOL, V22, P8056, DOI 10.1128/MCB.22.22.8056-8066.2002; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Neves AR, 2002, J BIOL CHEM, V277, P28088, DOI 10.1074/jbc.M202573200; Pahlman AK, 2001, J BIOL CHEM, V276, P3555, DOI 10.1074/jbc.M007164200; PAINE PL, 1975, J CELL BIOL, V66, P652, DOI 10.1083/jcb.66.3.652; Penfound T, 1999, J BACTERIOL, V181, P648, DOI 10.1128/JB.181.2.648-655.1999; Sandmeier JJ, 2002, GENETICS, V160, P877; Shama S, 1998, EXP CELL RES, V245, P379, DOI 10.1006/excr.1998.4279; Sies H, 1982, METABOLIC COMPARTMEN; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Swiecilo A, 2000, ACTA BIOCHIM POL, V47, P355; UNKEFER CJ, 1984, J BIOL CHEM, V259, P2311; Wei YM, 2001, BIOCHEMISTRY-US, V40, P11279, DOI 10.1021/bi011085z; Zhang QH, 2002, SCIENCE, V295, P1895	23	125	133	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2124	2126		10.1126/science.1088697	http://dx.doi.org/10.1126/science.1088697			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14605207	Green Accepted			2022-12-24	WOS:000187385200045
J	Boulware, LE; Jaar, BG; Tarver-Carr, ME; Brancati, FL; Powe, NR				Boulware, LE; Jaar, BG; Tarver-Carr, ME; Brancati, FL; Powe, NR			Screening for proteinuria in US adults - A cost-effectiveness analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							3RD NATIONAL-HEALTH; PERCUTANEOUS RENAL BIOPSY; BLOOD-PRESSURE CONTROL; CHRONIC KIDNEY-DISEASE; QUALITY-OF-LIFE; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; FOLLOW-UP; MULTIFACTORIAL INTERVENTION; MEDICATION ADHERENCE	Context Chronic kidney disease is a growing public health problem. Screening for early identification could improve health but could also lead to unnecessary harms and excess costs. Objective To assess the value of periodic, population-based dipstick screening for early detection of urine protein in adults with neither hypertension nor diabetes and in adults with hypertension. Design, Setting, and Population Cost-effectiveness analysis using a Markov decision analytic model to compare a strategy of annual screening with no screening (usual care) for proteinuria at age 50 years followed by treatment with an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin II-receptor blocker (ARB). Main Outcome Measure Cost per quality-adjusted life-year (QALY). Results For persons with neither hypertension nor diabetes, the cost-effectiveness ratio for screening vs no screening (usual care) was unfavorable ($282 818 per QALY; incremental cost of $616 and a gain of 0.0022 QALYs per person). However, screening such persons beginning at age 60 years yielded a more favorable ratio ($53 372 per QALY). For persons with hypertension, the ratio was highly favorable ($18621 per QALY; incremental cost of $476 and a gain of 0.03 QALYs per person). Cost-effectiveness was mediated by both chronic kidney disease progression and death prevention benefits of ACE inhibitor and ARB therapy. Influential parameters that might make screening for the general population more cost-effective include a greater incidence of proteinuria, age at screening ($53 372 per QALY for persons beginning screening at age 60 years), or lower frequency of screening (every 10 years: $80700 per QALY at age 50 years; $6195 per QALY at age 60 years; and $5486 per QALY at age 70 years). Conclusions Early detection of urine protein to slow progression of chronic kidney disease and decrease mortality is not cost-effective unless selectively directed toward high-risk groups (older persons and persons with hypertension) or conducted at an infrequent interval of 10 years.	Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Boulware, LE (corresponding author), Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, 2024 E Monument St,Suite 2-635, Baltimore, MD 21205 USA.	lboulwa@jhmi.edu	Jaar, Bernard/B-1917-2009	Jaar, Bernard/0000-0003-1210-7115; Boulware, Ebony/0000-0002-8650-4212	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059616] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008; American Diabetes Association, 2003, DIABETES CARE, V26, pS80, DOI DOI 10.2337/DIACARE.26.2007.S80; Barat I, 2001, BRIT J CLIN PHARMACO, V51, P615, DOI 10.1046/j.0306-5251.2001.01401.x; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Cabana MD, 2000, ARCH PEDIAT ADOL MED, V154, P685, DOI 10.1001/archpedi.154.7.685; CAREL RS, 1987, CLIN CHEM, V33, P2106; CHANG P, PHARM MARKET SHARE D; CHERRY DK, 2002, NATL AMBULATORY MED; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Ciechanowski PS, 2001, AM J PSYCHIAT, V158, P29, DOI 10.1176/appi.ajp.158.1.29; Clause SL, 2002, ANN PHARMACOTHER, V36, P1505; Coon P, 2002, DIABETES CARE, V25, P2224, DOI 10.2337/diacare.25.12.2224; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; *CTR MED MED SERV, 2003 CLIN DIAGN LAB; *CTR MED MED SERV, 2000 MED PROV AN REV; *CTR MED MED SERV, 2003 NAT PHYS FRE; CUTLER DM, 2001, HEALTH AFFAIR, V20, P11; de Wit GA, 2002, NEPHROL DIAL TRANSPL, V17, P86, DOI 10.1093/ndt/17.1.86; Di Iorio D, 2000, ARCH FAM MED, V9, P1015, DOI 10.1001/archfami.9.10.1015; DiMatteo MR, 2002, MED CARE, V40, P794, DOI 10.1097/01.MLR.0000024612.61915.2D; Erlinger TP, 2000, J AM GERIATR SOC, V48, P1486, DOI 10.1111/jgs.2000.48.11.1486; Farber HJ, 2003, J ASTHMA, V40, P17, DOI 10.1081/JAS-120017203; Friedman RH, 1996, AM J HYPERTENS, V9, P285, DOI 10.1016/0895-7061(95)00353-3; Fuiano G, 2000, AM J KIDNEY DIS, V35, P448, DOI 10.1016/S0272-6386(00)70197-1; Gaede P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gall MA, 1997, BMJ-BRIT MED J, V314, P783, DOI 10.1136/bmj.314.7083.783; Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Golan L, 1999, ANN INTERN MED, V131, P660, DOI 10.7326/0003-4819-131-9-199911020-00005; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hirth RA, 2000, MED DECIS MAKING, V20, P332, DOI 10.1177/0272989X0002000310; Hyman DJ, 2000, ARCH INTERN MED, V160, P2281, DOI 10.1001/archinte.160.15.2281; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; *IMS HLTH, ANG ANT DAT IMPR; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; JAMES GP, 1978, CLIN CHEM, V24, P1934; JEE SH, 2003, 43 ANN C CARD DIS EP; Jones CA, 1998, AM J KIDNEY DIS, V32, P992, DOI 10.1016/S0272-6386(98)70074-5; Kiberd BA, 1995, BRIT MED J, V311, P1595, DOI 10.1136/bmj.311.7020.1595; Kinchen KS, 2002, ANN INTERN MED, V137, P479, DOI 10.7326/0003-4819-137-6-200209170-00007; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; KLEIN R, 1995, DIABETES, V44, P916, DOI 10.2337/diabetes.44.8.916; KUTNER NG, 1991, AM J NEPHROL, V11, P334, DOI 10.1159/000168333; LEBOVITZ HE, 1994, KIDNEY INT, V45, pS150; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; Lipscomb J., 1996, COST EFFECTIVENESS H, P214; Lonn E, 2002, J AM COLL CARDIOL, V40, P693, DOI 10.1016/S0735-1097(02)02035-1; Luce BR, 1996, COST EFFECTIVENESS H, P176; MADAIO MP, 1990, KIDNEY INT, V38, P529, DOI 10.1038/ki.1990.236; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Manninen D L, 1991, Clin Transpl, P193; Markell MS, 1997, AM J KIDNEY DIS, V29, P881, DOI 10.1016/S0272-6386(97)90462-5; MARTIN TL, 1995, DIABETES CARE, V18, P1124, DOI 10.2337/diacare.18.8.1124; Marwah DS, 1996, AM J KIDNEY DIS, V28, P47, DOI 10.1016/S0272-6386(96)90129-8; Mattock MB, 1998, DIABETES, V47, P1786, DOI 10.2337/diabetes.47.11.1786; *MED EC CO, 2001, 2001 DRUG TOP RED BO; Mehta SS, 1999, AM J HYPERTENS, V12, P333, DOI 10.1016/S0895-7061(00)86958-7; MENDELSSOHN DC, 1995, AM J KIDNEY DIS, V26, P580, DOI 10.1016/0272-6386(95)90592-8; Merkus MP, 1997, AM J KIDNEY DIS, V29, P584, DOI 10.1016/S0272-6386(97)90342-5; Molitch ME, 2003, DIABETES CARE, V26, pS94, DOI [10.2337/diacare.26.2007.s94, DOI 10.2337/DIACARE.26.2007.S94]; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Murray CJL, 2000, HEALTH ECON, V9, P235, DOI 10.1002/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-O; Nass K, 1999, AM J KIDNEY DIS, V34, P955, DOI 10.1016/S0272-6386(99)70058-2; *NAT KIDN FDN, 2000, NAT KIDN FDN CLIN PR; Nelson CR, 2000, HYPERTENSION, V36, P600, DOI 10.1161/01.HYP.36.4.600; Nelson RG, 1996, NEW ENGL J MED, V335, P1636, DOI 10.1056/NEJM199611283352203; Ni H, 2003, AM HEART J, V146, P121, DOI 10.1016/S0002-8703(02)94800-3; Nosadini R, 2000, DIABETES, V49, P476, DOI 10.2337/diabetes.49.3.476; *OFF AN EP NCHS, CDC WOND 1999 COMPR; Okosun IS, 2000, ANN EPIDEMIOL, V10, P263, DOI 10.1016/S1047-2797(00)00045-4; Palmer AJ, 2000, DIABETOLOGIA, V43, P13, DOI 10.1007/s001250050003; PARRISH AE, 1992, CLIN NEPHROL, V38, P135; Patel RP, 2002, ANN PHARMACOTHER, V36, P40, DOI 10.1345/aph.1A046; Rachmani R, 2000, DIABETES RES CLIN PR, V49, P187, DOI 10.1016/S0168-8227(00)00155-8; Raiz L, 1997, J Health Soc Policy, V8, P67, DOI 10.1300/J045v08n04_05; RALSTON SH, 1988, ANN RHEUM DIS, V47, P759, DOI 10.1136/ard.47.9.759; Ramsey SD, 2001, MED CARE, V39, P979, DOI 10.1097/00005650-200109000-00008; RASGON S, 1993, AM J KIDNEY DIS, V22, P403, DOI 10.1016/S0272-6386(12)70143-9; Renal Physicians Association, 2001, Clin Nephrol, V56, P179; Ruggenenti P, 1998, BRIT MED J, V316, P504, DOI 10.1136/bmj.316.7130.504; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Ruggenenti P, 2000, AM J KIDNEY DIS, V35, P1155, DOI 10.1016/S0272-6386(00)70054-0; Schoenfeld ER, 2001, OPHTHALMOLOGY, V108, P563, DOI 10.1016/S0161-6420(00)00600-X; SHAW ST, 1985, JAMA-J AM MED ASSOC, V253, P1596, DOI 10.1001/jama.253.11.1596; Speirs C, 1998, BRIT J CLIN PHARMACO, V46, P63, DOI 10.1046/j.1365-2125.1998.00031.x; Stratta P, 1996, AM J KIDNEY DIS, V27, P631, DOI 10.1016/S0272-6386(96)90096-7; Tengs TO, 2000, MED CARE, V38, P583, DOI 10.1097/00005650-200006000-00004; Thom DH, 2002, FAM PRACT, V19, P476, DOI 10.1093/fampra/19.5.476; *THOMPS MICR, 2003, MICR HLTH CAR SER, P116; Torffvit O, 2001, J DIABETES COMPLICAT, V15, P307, DOI 10.1016/S1056-8727(01)00176-3; *US DEP HHS, 2000, DET DIS PAT CHRON RE; *US DEP LAB, 2002, NAT COMP SURV 2001; *US REN DAT SYST, USRDS 2002 ANN DAT R; van Manen JG, 2001, PERITON DIALYSIS INT, V21, P595; Vargas CM, 2000, AM J EPIDEMIOL, V152, P272, DOI 10.1093/aje/152.3.272; Vijan S, 2000, JAMA-J AM MED ASSOC, V283, P889, DOI 10.1001/jama.283.7.889; Voyaki SM, 2001, J HYPERTENS, V19, P511, DOI 10.1097/00004872-200103000-00020; Wang PS, 2002, J GEN INTERN MED, V17, P504, DOI 10.1046/j.1525-1497.2002.00406.x; Warram JH, 1996, J AM SOC NEPHROL, V7, P930; WOOLHANDLER S, 1989, JAMA-J AM MED ASSOC, V262, P1214, DOI 10.1001/jama.262.9.1214; Wyatt RJ, 1998, J AM SOC NEPHROL, V9, P853; Yusuf HR, 1998, PREV MED, V27, P1, DOI 10.1006/pmed.1997.0268; Yusuf S, 2000, NEW ENGL J MED, V342, P145	107	279	295	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2003	290	23					3101	3114		10.1001/jama.290.23.3101	http://dx.doi.org/10.1001/jama.290.23.3101			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	753ZB	14679273				2022-12-24	WOS:000187277300029
J	Inoki, K; Zhu, TQ; Guan, KL				Inoki, K; Zhu, TQ; Guan, KL			TSC2 mediates cellular energy response to control cell growth and survival	CELL			English	Article							ACTIVATED PROTEIN-KINASE; P70 S6 KINASE; TUMOR-SUPPRESSOR GENE; TUBEROUS-SCLEROSIS; MAMMALIAN TARGET; RAPAMYCIN; MTOR; PHOSPHORYLATION; INSULIN; COMPLEX	Mutations in either the TSC1 or TSC2 tumor suppressor gene are responsible for Tuberous Sclerosis Complex. The gene products of TSC1 and TSC2 form a functional complex and inhibit the phosphorylation of S6K and 4EBP1, two key regulators of translation. Here, we describe that TSC2 is regulated by cellular energy levels and plays an essential role in the cellular energy response pathway. Under energy starvation conditions, the AMP-activated protein kinase (AMPK) phosphorylates TSC2 and enhances its activity. Phosphorylation of TSC2 by AMPK is required for translation regulation and cell size control in response to energy deprivation. Furthermore, TSC2 and its phosphorylation by AMPK protect cells from energy deprivation-induced apoptosis. These observations demonstrate a model where TSC2 functions as a key player in regulation of the common mTOR pathway of protein synthesis, cell growth, and viability in response to cellular energy levels.	Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guan, KL (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	kunliang@umich.edu	Guan, Kun-Liang/ADK-7088-2022; INOKI, KEN/A-1202-2007		NIDDK NIH HHS [R01 DK124709] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Au KS, 1998, AM J HUM GENET, V62, P286, DOI 10.1086/301705; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.tb20498.x; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Jaeschke A, 2002, J CELL BIOL, V159, P217, DOI 10.1083/jcb.jcb.200206108; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Kenerson HL, 2002, CANCER RES, V62, P5645; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Kobayashi T, 2001, P NATL ACAD SCI USA, V98, P8762, DOI 10.1073/pnas.151033798; Krause U, 2002, EUR J BIOCHEM, V269, P3751, DOI 10.1046/j.1432-1033.2002.03074.x; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Onda H, 2002, MOL CELL NEUROSCI, V21, P561, DOI 10.1006/mcne.2002.1184; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Potter CJ, 2001, CURR OPIN GENET DEV, V11, P279, DOI 10.1016/S0959-437X(00)00191-X; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE715, DOI 10.1152/ajpendo.2000.279.4.E715; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; Yoo LI, 2002, NAT REV CANCER, V2, P529, DOI 10.1038/nrc843; Young J, 1998, MOL MED TODAY, V4, P313, DOI 10.1016/S1357-4310(98)01245-3; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	51	2875	2995	11	222	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 26	2003	115	5					577	590		10.1016/S0092-8674(03)00929-2	http://dx.doi.org/10.1016/S0092-8674(03)00929-2			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651849	Bronze			2022-12-24	WOS:000186885600008
J	Imaizumi, T; Tran, HG; Swartz, TE; Briggs, WR; Kay, SA				Imaizumi, T; Tran, HG; Swartz, TE; Briggs, WR; Kay, SA			FKF1 is essential for photoperiodic-specific light signalling in Arabidopsis	NATURE			English	Article							CIRCADIAN CLOCK; PHOTORECEPTOR PHOTOTROPIN; PROTEIN; PLANTS; NPH1; PURIFICATION; TRANSDUCTION; RECEPTORS; MEDIATE; DOMAINS	Adaptation to seasonal change is a crucial component of an organism's survival strategy. To monitor seasonal variation, organisms have developed the capacity to measure day length ( photoperiodism). Day-length assessment involves the photoperiodic control of flowering in Arabidopsis thaliana, whereby the coincidence of light and high expression of CONSTANS ( CO) induces the expression of FLOWERING LOCUS T (FT), leading to flowering in long-day conditions(1). Although controlling CO expression is clearly a key step in day-length discrimination, the mechanism that generates day-length-dependent CO expression remains unknown. Here we show that the clock-controlled FLAVIN-BINDING, KELCH REPEAT, F-BOX (FKF1)(2) protein has an essential role in generating the diurnal CO peak and that this function is dependent on light. We show that a recombinant FKF1 LIGHT, OXYGEN OR VOLTAGE ( LOV)(3) domain binds the chromophore flavin mononucleotide and undergoes light-induced photochemistry, indicating that FKF1 may function as a photoperiodic blue-light receptor. It is likely that the circadian control of FKF1 expression and the light regulation of FKF1 function coincide to control the daytime CO waveform precisely, which in turn is crucial for day-length discrimination by Arabidopsis.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA	Scripps Research Institute; Carnegie Institution for Science	Kay, SA (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878				Alabadi D, 2002, CURR BIOL, V12, P757, DOI 10.1016/S0960-9822(02)00815-1; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Blazquez MA, 1999, PLANT PHYSIOL, V120, P1025, DOI 10.1104/pp.120.4.1025; CARRINGTON JC, 1991, PLANT CELL, V3, P953, DOI 10.1105/tpc.3.9.953; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Lin CT, 2002, PLANT CELL, V14, pS207, DOI 10.1105/tpc.000646; MILLAR AJ, 1992, PLANT CELL, V4, P1075, DOI 10.1105/tpc.4.9.1075; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Schultz TF, 2001, PLANT CELL, V13, P2659, DOI 10.1105/tpc.13.12.2659; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Yanovsky MJ, 2003, NAT REV MOL CELL BIO, V4, P265, DOI 10.1038/nrm1077; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Yanovsky MJ, 2001, J BIOL RHYTHM, V16, P523, DOI 10.1177/074873001129002213	28	414	461	4	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2003	426	6964					302	306		10.1038/nature02090	http://dx.doi.org/10.1038/nature02090			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628054				2022-12-24	WOS:000186660800047
J	Silk, JB; Alberts, SC; Altmann, J				Silk, JB; Alberts, SC; Altmann, J			Social bonds of female baboons enhance infant survival	SCIENCE			English	Article							NONHUMAN-PRIMATES; ENVIRONMENT; EVOLUTION; MONKEYS; STRESS	Among nonhuman primates, females often form strong bonds with kin and other group members. These relationships are thought to have adaptive value for females, but direct effects of sociality on fitness have never been demonstrated. We present 16 years of behavioral data from a well-studied population of wild baboons, which demonstrate that sociality of adult females is positively associated with infant survival, an important component of variation in female lifetime fitness. The effects of sociality on infant survival are independent of the effects of dominance rank, group membership, and environmental conditions. Our results are consistent with the evidence that social support has beneficial effects on human health and well-being across the life span. For humans and other primates, sociality has adaptive value.	Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90095 USA; Duke Univ, Dept Biol, Durham, NC 27708 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Natl Museums Kenya, Inst Primate Res, Nairobi, Kenya; Brookfield Zoo, Dept Conservat Biol, Brookfield, IL 60513 USA	University of California System; University of California Los Angeles; Duke University; Princeton University	Silk, JB (corresponding author), Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90095 USA.							ALBERTS SC, IN PRESS PRIMATE SEA; Altmann J, 2003, OFFSPRING, P140; AURELLI F, 2000, NATURAL CONFLICT RES, P193; Berntson, 2000, HDB PSYCHOPHYSIOLOGY, P643; Bronikowski AM, 1996, BEHAV ECOL SOCIOBIOL, V39, P11, DOI 10.1007/s002650050262; Buchan JC, 2003, NATURE, V425, P179, DOI 10.1038/nature01866; Cacioppo JT, 2000, INT J PSYCHOPHYSIOL, V35, P143, DOI 10.1016/S0167-8760(99)00049-5; CHENEY D, 1986, SCIENCE, V234, P1361, DOI 10.1126/science.3538419; Clutton-Brock T.H., 1988, REPROD SUCCESS STUDI; COHEN S, 1992, PSYCHOL SCI, V3, P301, DOI 10.1111/j.1467-9280.1992.tb00677.x; COLLINS NL, 1993, J PERS SOC PSYCHOL, V65, P1243, DOI 10.1037/0022-3514.65.6.1243; Cords M., 1997, MACHIAVELLIAN INTELL, P24; DUNBAR RIM, 1991, FOLIA PRIMATOL, V57, P121, DOI 10.1159/000156574; Henzi SP, 1999, PRIMATES, V40, P47, DOI 10.1007/BF02557701; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; LEFEVRE JA, 1992, PHYSIOL BEHAV, V52, P603, DOI 10.1016/0031-9384(92)90354-5; Melnick D.J., 1987, P121; Palombit RA, 1999, EVOL ANTHROPOL, V7, P117, DOI 10.1002/(SICI)1520-6505(1999)7:4<117::AID-EVAN2>3.0.CO;2-O; SALTZMAN W, 1991, PHYSIOL BEHAV, V50, P271, DOI 10.1016/0031-9384(91)90066-W; Sapolsky RM, 1997, ARCH GEN PSYCHIAT, V54, P1137; Seeman TE, 2002, PSYCHOSOM MED, V64, P395, DOI 10.1097/00006842-200205000-00004; Seeman TE, 1996, PSYCHOSOM MED, V58, P459, DOI 10.1097/00006842-199609000-00008; SHIVELY CA, 1989, ATHEROSCLEROSIS, V77, P69, DOI 10.1016/0021-9150(89)90011-7; Silk JB, 1999, BEHAVIOUR, V136, P679, DOI 10.1163/156853999501522; SILK JB, IN PRESS ANIM BEHAV; Smuts Barbara, 1985, SEX FRIENDSHIP BABOO; *STATA, 2003, STATA 8 0; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934	30	692	703	3	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2003	302	5648					1231	1234		10.1126/science.1088580	http://dx.doi.org/10.1126/science.1088580			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	742XW	14615543				2022-12-24	WOS:000186544300060
J	Navarro-Gonzalez, R; Rainey, FA; Molina, P; Bagaley, DR; Hollen, BJ; de la Rosa, J'; Small, AM; Quinn, RC; Grunthaner, FJ; Caceres, L; Gomez-Silva, B; McKay, CP				Navarro-Gonzalez, R; Rainey, FA; Molina, P; Bagaley, DR; Hollen, BJ; de la Rosa, J'; Small, AM; Quinn, RC; Grunthaner, FJ; Caceres, L; Gomez-Silva, B; McKay, CP			Mars-like soils in the Atacama Desert, Chile, and the dry limit of microbial life	SCIENCE			English	Article								The Viking missions showed the martian soil to be lifeless and depleted in organic material and indicated the presence of one or more reactive oxidants. Here we report the presence of Mars-like soils in the extreme arid region of the Atacama Desert. Samples from this region had organic species only at trace levels and extremely low levels of culturable bacteria. Two samples from the extreme arid region were tested for DNA and none was recovered. Incubation experiments, patterned after the Viking labeled-release experiment but with separate biological and nonbiological isomers, show active decomposition of organic species in these soils by nonbiological processes.	Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Lab Quim Plasmas & Estudios Planetarios, Mexico City 04510, DF, Mexico; Univ Paris 12, Lab Interuniv Syst Atmospher, CNRS, UMR 7583, F-94010 Creteil, France; Univ Paris 07, Lab Interuniv Syst Atmospher, CNRS, UMR 7583, F-94010 Creteil, France; Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; NASA, Div Space Sci, Ames Res Ctr, Moffett Field, CA 94035 USA; NASA, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Antofagasta, Fac Ingn, Inst Desierto, Antofagasta, Chile; Univ Antofagasta, Fac Ingn, Dept Ingn Quim, Antofagasta, Chile; Univ Antofagasta, Fac Ciencias Salud, Inst Desierto, Antofagasta, Chile; Univ Antofagasta, Fac Ciencias Salud, Dept Biomed, Unidad Bioquim, Antofagasta, Chile	Universidad Nacional Autonoma de Mexico; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Louisiana State University System; Louisiana State University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Universidad de Antofagasta; Universidad de Antofagasta; Universidad de Antofagasta; Universidad de Antofagasta	Navarro-Gonzalez, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Lab Quim Plasmas & Estudios Planetarios, Circuito Exterior,Ciudad Univ,Apartado Postal 70-, Mexico City 04510, DF, Mexico.		De la Rosa, José/A-3573-2010; GOMEZ-SILVA, BENITO/J-8324-2017; Navarro-González, Rafael/D-1748-2009; Rainey, Fred/AAG-7996-2019; Rainey, Fred A/C-8767-2013; Gómez-Silva, Benito/AAT-8215-2020	Navarro-González, Rafael/0000-0002-6078-7621; Rainey, Fred A/0000-0001-9129-6844; Gómez-Silva, Benito/0000-0002-7611-9943; Grunthaner, Frank/0000-0003-2397-6658; Caceres, Luis/0000-0001-7359-2148				ARROYO MTK, 1988, ANN MO BOT GARD, V75, P55, DOI 10.2307/2399466; Benner SA, 2000, P NATL ACAD SCI USA, V97, P2425, DOI 10.1073/pnas.040539497; Biemann K., 1977, Journal of Geophysical Research, V82, P4641, DOI 10.1029/JS082i028p04641; Levin G. V., 1977, Journal of Geophysical Research, V82, P4663, DOI 10.1029/JS082i028p04663; McKay CP, 1998, PLANET SPACE SCI, V46, P769, DOI 10.1016/S0032-0633(98)00011-7; MCKAY CP, 2003, ASTROBIOLOGY, V3, P293; Miller A, 1976, WORLD SURVEY CLIMATO, V12, P113; Oyama V. I., 1977, Journal of Geophysical Research, V82, P4669, DOI 10.1029/JS082i028p04669; PLUMB RC, 1989, NATURE, V338, P633, DOI 10.1038/338633a0	9	393	405	8	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2003	302	5647					1018	1021		10.1126/science.1089143	http://dx.doi.org/10.1126/science.1089143			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605363				2022-12-24	WOS:000186396300039
J	Busino, L; Donzelli, M; Chiesa, M; Guardavaccaro, D; Ganoth, D; Dorrello, NV; Hershko, A; Pagano, M; Draetta, GF				Busino, L; Donzelli, M; Chiesa, M; Guardavaccaro, D; Ganoth, D; Dorrello, NV; Hershko, A; Pagano, M; Draetta, GF			Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage	NATURE			English	Article							KAPPA-B-ALPHA; UBIQUITIN LIGASE; PHOSPHORYLATION; DESTRUCTION; CHECKPOINT; PROTEOLYSIS; COMPLEX; IDENTIFICATION; PROGRESSION; CATENIN	The Cdc25A phosphatase is essential for cell-cycle progression because of its function in dephosphorylating cyclin-dependent kinases. In response to DNA damage or stalled replication, the ATM and ATR protein kinases activate the checkpoint kinases Chk1 and Chk2, which leads to hyperphosphorylation of Cdc25A(1-3). These events stimulate the ubiquitin-mediated proteolysis of Cdc25A(1,4,5) and contribute to delaying cell-cycle progression, thereby preventing genomic instability(1-7). Here we report that beta-TrCP is the F-box protein that targets phosphorylated Cdc25A for degradation by the Skp1/Cul1/F-box protein complex. Downregulation of beta-TrCP1 and beta-TrCP2 expression by short interfering RNAs causes an accumulation of Cdc25A in cells progressing through S phase and prevents the degradation of Cdc25A induced by ionizing radiation, indicating that beta-TrCP may function in the intra-S-phase checkpoint. Consistent with this hypothesis, suppression of beta-TrCP expression results in radioresistant DNA synthesis in response to DNA damage - a phenotype indicative of a defect in the intra-S-phase checkpoint that is associated with an inability to regulate Cdc25A properly. Our results show that beta-TrCP has a crucial role in mediating the response to DNA damage through Cdc25A degradation.	European Inst Oncol, I-20141 Milan, Italy; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; NYU, Inst Canc, New York, NY 10016 USA; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Biochem Unit, IL-31096 Haifa, Israel	IRCCS European Institute of Oncology (IEO); New York University; New York University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Donzelli, M (corresponding author), European Inst Oncol, 435 Via Ripamonti, I-20141 Milan, Italy.	mdonzell@ieo.it	Donzelli, Maddalena/ABD-3774-2020	Guardavaccaro, Daniele/0000-0002-4517-1765; pagano, michele/0000-0003-3210-2442; DONZELLI, MADDALENA/0000-0002-4045-0802	Telethon [E.0865] Funding Source: Medline	Telethon(Fondazione Telethon)		Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Clucas C, 2002, EMBO J, V21, P665, DOI 10.1093/emboj/21.4.665; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Lang V, 2003, MOL CELL BIOL, V23, P402, DOI 10.1128/MCB.23.1.402-413.2003; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Spruck CH, 2002, CELL CYCLE, V1, P248, DOI 10.4161/cc.1.4.132; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299	28	351	370	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2003	426	6962					87	91		10.1038/nature02082	http://dx.doi.org/10.1038/nature02082			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603323				2022-12-24	WOS:000186370800047
J	Shattuck, TM; Valimaki, S; Obara, T; Gaz, RD; Clark, OH; Shoback, D; Wierman, ME; Tojo, K; Robbins, CM; Carpten, JD; Farnebo, LO; Larsson, C; Arnold, A				Shattuck, TM; Valimaki, S; Obara, T; Gaz, RD; Clark, OH; Shoback, D; Wierman, ME; Tojo, K; Robbins, CM; Carpten, JD; Farnebo, LO; Larsson, C; Arnold, A			Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							JAW TUMOR SYNDROME; HEREDITARY HYPERPARATHYROIDISM; SUPPRESSOR GENES; RETINOBLASTOMA; DIAGNOSIS; MANAGEMENT; HISTORY; CANCER; BRCA2	BACKGROUND: We looked for mutations of the HRPT2 gene, which encodes the parafibromin protein, in sporadic parathyroid carcinoma because germ-line inactivating HRPT2 mutations have been found in a type of familial hyperparathyroidism -- hyperparathyroidism-jaw tumor (HPT-JT) syndrome -- that carries an increased risk of parathyroid cancer. METHODS: We directly sequenced the full coding and flanking splice-junctional regions of the HRPT2 gene in 21 parathyroid carcinomas from 15 patients who had no known family history of primary hyperparathyroidism or the HPT-JT syndrome at presentation. We also sought to confirm the somatic nature of the identified mutations and tested the carcinomas for tumor-specific loss of heterozygosity at HRPT2. RESULTS: Parathyroid carcinomas from 10 of the 15 patients had HRPT2 mutations, all of which were predicted to inactivate the encoded parafibromin protein. Two distinct HRPT2 mutations were found in tumors from five patients, and biallelic inactivation as a result of a mutation and loss of heterozygosity was found in one tumor. At least one HRPT2 mutation was demonstrably somatic in carcinomas from six patients. Unexpectedly, HRPT2 mutations in the parathyroid carcinomas of three patients were identified as germ-line mutations. CONCLUSIONS: Sporadic parathyroid carcinomas frequently have HRPT2 mutations that are likely to be of pathogenetic importance. Certain patients with apparently sporadic parathyroid carcinoma carry germ-line mutations in HRPT2 and may have the HPT-JT syndrome or a phenotypic variant.	Univ Connecticut, Sch Med, Ctr Mol Med, Farmington, CT 06030 USA; Univ Connecticut, Sch Med, Div Endocrinol & Metab, Farmington, CT 06030 USA; Karolinska Hosp, Dept Mol Med, S-10401 Stockholm, Sweden; Karolinska Hosp, Dept Surg Sci, S-10401 Stockholm, Sweden; Tokyo Womens Med Univ, Dept Endocrine Surg, Sinjuku Ku, Tokyo, Japan; Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; Univ Calif San Francisco, Mt Zion Med Ctr, Dept Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Vet Affairs Med Ctr, Endocrine Res Unit, San Francisco, CA 94143 USA; Univ Colorado, Vet Affairs Med Ctr, Div Endocrinol, Denver, CO 80202 USA; Jikei Univ, Sch Med, Dept Internal Med, Div Diabet & Endocrinol, Tokyo, Japan; NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA	University of Connecticut; University of Connecticut; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Tokyo Women's Medical University; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Medical Center at Mount Zion; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Colorado System; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jikei University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Arnold, A (corresponding author), Univ Connecticut, Sch Med, Ctr Mol Med, 263 Farmington Ave, Farmington, CT 06030 USA.	catharina.larsson@cmm.ki.se; molecularmedicine@uchc.edu						Agarwal SK, 1998, CANCER GENET CYTOGEN, V106, P30, DOI 10.1016/S0165-4608(98)00049-1; ANDERSON BJ, 1983, SURGERY, V94, P906; Arnold A, 2002, J BONE MINER RES, V17, pN30; BONDESON L, 1993, AM J SURG PATHOL, V17, P820, DOI 10.1097/00000478-199308000-00007; Carpten JD, 2002, NAT GENET, V32, P676, DOI 10.1038/ng1048; COSTA J, 2003, J ENDOCR GENET, V3, P57; CRYNS VL, 1994, NEW ENGL J MED, V330, P757, DOI 10.1056/NEJM199403173301105; Dotzenrath C, 1996, J CLIN ENDOCR METAB, V81, P3194, DOI 10.1210/jc.81.9.3194; EVERSOLE LR, 1985, ORAL SURG ORAL MED O, V60, P505, DOI 10.1016/0030-4220(85)90239-7; FITKO R, 1990, HUM PATHOL, V21, P234, DOI 10.1016/0046-8177(90)90136-S; Haber D, 1997, NAT GENET, V16, P320, DOI 10.1038/ng0897-320; Haven CJ, 2000, J CLIN ENDOCR METAB, V85, P1449, DOI 10.1210/jc.85.4.1449; Imanishi Y, 1999, J BONE MINER RES, V14, pS421; JACKSON CE, 1990, SURGERY, V108, P1006; KENNETT S, 1971, ORAL SURG ORAL MED O, V31, P502, DOI 10.1016/0030-4220(71)90347-1; Kytola S, 2000, AM J PATHOL, V157, P579, DOI 10.1016/S0002-9440(10)64568-3; Marx SJ, 2000, NEW ENGL J MED, V343, P1863, DOI 10.1056/NEJM200012213432508; Marx SJ, 2002, J BONE MINER RES, V17, pN37; Marx SJ, 2001, NEW ENGL J MED, V344, P696; Marx SJ, 2001, NEW ENGL J MED, V344, P240; Pearce SHS, 1996, CLIN ENDOCRINOL, V45, P195, DOI 10.1046/j.1365-2265.1996.d01-1561.x; ROTH SI, 1962, ARCH PATHOL, V73, P495; SANDELIN K, 1991, SURGERY, V110, P978; SANDELIN K, 1992, WORLD J SURG, V16, P724, DOI 10.1007/BF02067369; SCHANTZ A, 1973, CANCER-AM CANCER SOC, V31, P600, DOI 10.1002/1097-0142(197303)31:3<600::AID-CNCR2820310316>3.0.CO;2-0; Shane E, 2001, J CLIN ENDOCR METAB, V86, P485, DOI 10.1210/jc.86.2.485; Shattuck TM, 2003, CLIN ENDOCRINOL, V59, P180, DOI 10.1046/j.1365-2265.2003.01814.x; Shattuck TM, 2002, J CLIN ENDOCR METAB, V87, P3911, DOI 10.1210/jc.87.8.3911; Simonds WF, 2002, MEDICINE, V81, P1, DOI 10.1097/00005792-200201000-00001; SZABO J, 1995, AM J HUM GENET, V56, P944; Teh BT, 1996, J CLIN ENDOCR METAB, V81, P4204, DOI 10.1210/jc.81.12.4204; VETTO JT, 1993, SURGERY, V114, P882; WANG CA, 1985, AM J SURG, V149, P522, DOI 10.1016/S0002-9610(85)80050-7; Wassif WS, 1999, CLIN ENDOCRINOL, V50, P191, DOI 10.1046/j.1365-2265.1999.00633.x	34	384	400	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2003	349	18					1722	1729		10.1056/NEJMoa031237	http://dx.doi.org/10.1056/NEJMoa031237			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	737FJ	14585940				2022-12-24	WOS:000186219500006
J	Rogers, GC; Rogers, SL; Schwimmer, TA; Ems-McClung, SC; Walczak, CE; Vale, RD; Scholey, JM; Sharp, DJ				Rogers, GC; Rogers, SL; Schwimmer, TA; Ems-McClung, SC; Walczak, CE; Vale, RD; Scholey, JM; Sharp, DJ			Two mitotic kinesins cooperate to drive sister chromatid separation during anaphase	NATURE			English	Article							CENTROMERE-ASSOCIATED KINESIN; MICROTUBULE FLUX; CHROMOSOME MOVEMENT; DYNAMICS; POLEWARD; SPINDLE; KINETOCHORE; PROTEIN; MITOSIS; XKCM1	During anaphase identical sister chromatids separate and move towards opposite poles of the mitotic spindle(1,2). In the spindle, kinetochore microtubules(3) have their plus ends embedded in the kinetochore and their minus ends at the spindle pole. Two models have been proposed to account for the movement of chromatids during anaphase. In the ' Pac- Man' model, kinetochores induce the depolymerization of kinetochore microtubules at their plus ends, which allows chromatids to move towards the pole by ' chewing up' microtubule tracks(4,5). In the 'poleward flux' model, kinetochores anchor kinetochore microtubules and chromatids are pulled towards the poles through the depolymerization of kinetochore microtubules at the minus ends(6). Here, we show that two functionally distinct microtubule- destabilizing KinI kinesin enzymes ( so named because they possess a kinesin- like ATPase domain positioned internally within the polypeptide) are responsible for normal chromatid- to- pole motion in Drosophila. One of them, KLP59C, is required to depolymerize kinetochore microtubules at their kinetochore- associated plus ends, thereby contributing to chromatid motility through a Pac- Man- based mechanism. The other, KLP10A, is required to depolymerize microtubules at their pole- associated minus ends, thereby moving chromatids by means of poleward flux.	Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Indiana Univ, Med Sci Program, Bloomington, IN 47405 USA; Univ Calif Davis, Ctr Genet & Dev, Davis, CA 95616 USA; Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA	Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Indiana University System; Indiana University Bloomington; University of California System; University of California Davis; University of California System; University of California Davis	Sharp, DJ (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA.	dsharp@aecom.yu.edu			NIGMS NIH HHS [R01 GM059618] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059618] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bousbaa H, 1997, J CELL SCI, V110, P1979; Brust-Mascher I, 2002, MOL BIOL CELL, V13, P3967, DOI 10.1091/mbc.02-05-0069; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Garcia MA, 2002, CURR BIOL, V12, P610, DOI 10.1016/S0960-9822(02)00761-3; Goldstein LSB, 2000, J CELL BIOL, V150, pF63, DOI 10.1083/jcb.150.2.F63; GORBSKY GJ, 1987, J CELL BIOL, V104, P9, DOI 10.1083/jcb.104.1.9; Hunter AW, 2000, J CELL SCI, V113, P4379; Kline-Smith SL, 2002, MOL BIOL CELL, V13, P2718, DOI 10.1091/mbc.E01-12-0143; Maddox P, 2002, CURR BIOL, V12, P1670, DOI 10.1016/S0960-9822(02)01183-1; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; McIntosh JR, 2002, ANNU REV CELL DEV BI, V18, P193, DOI 10.1146/annurev.cellbio.18.032002.132412; MITCHISON T, 1986, CELL, V45, P515, DOI 10.1016/0092-8674(86)90283-7; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Mitchison TJ, 2001, NAT CELL BIOL, V3, pE17, DOI 10.1038/35050656; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; Sharp DJ, 1999, NAT CELL BIOL, V1, P51, DOI 10.1038/9025; SULLIVAN W, 1995, CURR OPIN CELL BIOL, V7, P18, DOI 10.1016/0955-0674(95)80040-9; SULLIVAN W, 1993, DEVELOPMENT, V118, P1245; Troxell CL, 2001, MOL BIOL CELL, V12, P3476, DOI 10.1091/mbc.12.11.3476; VALDESPEREZ PE, 1995, J THEOR BIOL, V175, P525, DOI 10.1006/jtbi.1995.0160; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Walczak CE, 2002, CURR BIOL, V12, P1885, DOI 10.1016/S0960-9822(02)01227-7; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Waters JC, 1996, MOL BIOL CELL, V7, P1547, DOI 10.1091/mbc.7.10.1547; West RR, 2002, J CELL SCI, V115, P931; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95	30	262	268	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2004	427	6972					364	370		10.1038/nature02256	http://dx.doi.org/10.1038/nature02256			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765KE	14681690				2022-12-24	WOS:000188266200044
J	Sparen, P; Vagero, D; Shestov, DB; Plavinskaja, S; Parfenova, N; Hoptiar, V; Paturot, D; Galanti, MR				Sparen, P; Vagero, D; Shestov, DB; Plavinskaja, S; Parfenova, N; Hoptiar, V; Paturot, D; Galanti, MR			Long term mortality after severe starvation during the siege of Leningrad: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; WOMEN BORN 1915-29; ANOREXIA-NERVOSA; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; PRENATAL EXPOSURE; EATING-DISORDERS; DUTCH FAMINE; SWEDISH MEN; RISK	Objective To determine whether starvation during periods of increased growth after birth has long term health consequences. Design Analysis of cardiovascular risk factors and mortality in a longitudinal follow up after the 1941-4 siege of Leningrad. Mortality measured from 1975 to the end of 1999. Setting St Petersburg, Russia (formerly Leningrad). Participants 5000 men born 1916-35 who lived in Leningrad, randomly selected to take part in health examinations in 1975-7. Of the 3905 men who participated, a third had experienced the siege. Main outcome measures Relative risk of ischaemic heart disease and mortality from stroke by siege exposure. Odds ratios and means for several cardiovascular risk factors. Results Three to six decades after the siege, in men who experienced the siege around the age of puberty blood pressure was raised (mean difference in systolic 3.3 mm Hg, in diastolic 1.3 mm Hg) as was mortality from ischaemic heart disease (relative risk 1.39, 95% confidence interval 1.07 to 1.79) and stroke (1.67, 1.15 to 2.43), including haemorrhagic stroke (1.71, 0.90 to 3.22). The effect on mortality was partly mediated via blood pressure but not by any other measured biological, behavioural, or social factor. Conclusions Starvation, or accompanying chronic stress, particularly at the onset of or during puberty, may increase vulnerability to later cardiovascular disease.	Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; Stockholm Univ, Karolinska Inst, CHESS, Ctr Hlth Equity Studies, S-10691 Stockholm, Sweden; Russian Acad Med Sci, Inst Expt Med, St Petersburg, Russia; Univ Coll, Sodertorns Hgsk, Huddinge, Sweden; Karolinska Hosp, Dept Med, Clin Epidemiol Unit, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Stockholm University; Institute of Experimental Medicine; Russian Academy of Medical Sciences; Sodertorn University; Karolinska Institutet; Karolinska University Hospital	Sparen, P (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.		Parfenova, Nina/E-6672-2014	Parfenova, Nina/0000-0002-1236-3058; Sparen, Par/0000-0002-5184-8971				ABERNATHY JR, 1988, AM J CARDIOL, V61, P1071, DOI 10.1016/0002-9149(88)90128-2; Agresti A., 1990, CATEGORICAL DATA ANA, pXV; ANTONOV AN, 1947, J PEDIATR, V30, P250, DOI 10.1016/S0022-3476(47)80160-X; Beevor Anthony, 1998, STALINGRAD; Bohlooly-Y M, 2001, ENDOCRINOLOGY, V142, P3317, DOI 10.1210/en.142.8.3317; Breslow NE., 1987, STAT METHODS CANC RE, P81; BROZEK J, 1948, JAMA-J AM MED ASSOC, V137, P1569, DOI 10.1001/jama.1948.02890520001001; Bygren LO, 2000, AM J HUM BIOL, V12, P447, DOI 10.1002/1520-6300(200007/08)12:4&lt;447::AID-AJHB3&gt;3.0.CO;2-M; COOKE RA, 1995, BRIT J HOSP MED, V54, P313; DESIMONE GD, 1994, BRIT HEART J, V71, P287; FORSDAHL A, 1977, BRIT J PREV SOC MED, V31, P91; GARNETT ES, 1969, LANCET, V1, P914; Holdaway I M, 1999, Pituitary, V2, P29, DOI 10.1023/A:1009965803750; Hypponen E, 2001, BRIT MED J, V323, P1033, DOI 10.1136/bmj.323.7320.1033; Kannisto V, 1997, AM J EPIDEMIOL, V145, P987, DOI 10.1093/oxfordjournals.aje.a009067; Kermack WO, 1934, LANCET, V1, P698; Keys A, 1950, BIOL HUMAN STARVATIO; KREIPE RE, 1992, PEDIATR ANN, V21, P760; LEON D, 2001, FETAL ORIGINS CARDIO; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; MARSHALL WA, 1986, HUMAN GROWTH COMPREH, P171; Melamed S, 1999, J PSYCHOSOM RES, V46, P591, DOI 10.1016/S0022-3999(99)00007-0; NELSON MJ, 1992, AM J EPIDEMIOL, V136, P633, DOI 10.1093/oxfordjournals.aje.a116543; PAVLOV DV, 1965, LENINGRAD 1941 BLOCK; PECK AMN, 1989, J EPIDEMIOL COMMUN H, V43, P380, DOI 10.1136/jech.43.4.380; Roseboom TJ, 2000, HEART, V84, P595, DOI 10.1136/heart.84.6.595; Roseboom TJ, 2000, AM J CLIN NUTR, V72, P1101; Rosmond R, 2000, J INTERN MED, V247, P188, DOI 10.1046/j.1365-2796.2000.00603.x; Stanner SA, 1997, BMJ-BRIT MED J, V315, P1342, DOI 10.1136/bmj.315.7119.1342; Stein Z., 1975, FAMINE HUM DEV DUTCH; Stoving RK, 1999, J PSYCHIATR RES, V33, P139, DOI 10.1016/S0022-3956(98)00049-1; Swenne I, 2000, ACTA PAEDIATR, V89, P447, DOI 10.1080/080352500750028177; Zicha J, 1999, PHYSIOL REV, V79, P1227, DOI 10.1152/physrev.1999.79.4.1227	33	93	99	0	17	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 3	2004	328	7430					11	14A		10.1136/bmj.37942.603970.9A	http://dx.doi.org/10.1136/bmj.37942.603970.9A			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	761QG	14660443	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000187919000013
J	DeBusk, RF				DeBusk, RF			Sexual activity in patients with angina	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; ERECTILE DYSFUNCTION; SILDENAFIL CITRATE; PHYSICAL EXERTION; EFFICACY; RISK		Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA	Stanford University	DeBusk, RF (corresponding author), Stanford Univ, Sch Med, Dept Med, 780 Welch Rd,Suite 106, Palo Alto, CA 94304 USA.							*AHCPR, 1994, AHCPR PUBL; Albert CM, 2000, NEW ENGL J MED, V343, P1355, DOI 10.1056/NEJM200011093431902; *AM HEART ASS, 2000, EM CARD CAR ADV CARD; American Heart Association, 2003, HEART DIS STROK STAT; BOHLEN JG, 1984, ARCH INTERN MED, V144, P1745, DOI 10.1001/archinte.144.9.1745; Cheitlin MD, 1999, CIRCULATION, V99, P168, DOI 10.1161/01.CIR.99.1.168; Conti CR, 1999, AM J CARDIOL, V83, p29C; DeBusk R, 2000, AM J CARDIOL, V86, P175, DOI 10.1016/S0002-9149(00)00896-1; DEBUSK RF, 1986, NEW ENGL J MED, V314, P161, DOI 10.1056/NEJM198601163140307; DeBusk RF, 2002, JAMA-J AM MED ASSOC, V287, P2359, DOI 10.1001/jama.287.18.2359; DeBusk RF, 2000, AM J CARDIOL, V86, p51F; FROELICHER VF, 1980, CARDIOLOGY, V66, P223, DOI 10.1159/000170869; Kloner RA, 2003, AM J CARDIOL, V92, p37M, DOI 10.1016/S0002-9149(03)00074-2; LAUMANN EO, 1994, SOCIAL ORG SEXUALITY, P77; MITTLEMAN MA, 1995, CIRCULATION, V92, P1720, DOI 10.1161/01.CIR.92.7.1720; Muller JE, 1996, JAMA-J AM MED ASSOC, V275, P1405, DOI 10.1001/jama.275.18.1405; POLLOCK ML, 1995, HEART DIS REHABILITA; Porst H, 2001, INT J IMPOT RES, V13, P192, DOI 10.1038/sj.ijir.3900713; Webb DJ, 2000, J AM COLL CARDIOL, V36, P25, DOI 10.1016/S0735-1097(00)00705-1	19	26	27	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2003	290	23					3129	3132		10.1001/jama.290.23.3129	http://dx.doi.org/10.1001/jama.290.23.3129			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753ZB	14679276				2022-12-24	WOS:000187277300032
J	Houck, O				Houck, O			Tales from a troubled marriage: Science and law in environmental policy	SCIENCE			English	Article							CLEAN-AIR ACT	Early environmental policy depended on science, with mixed results. Newer approaches continue to rely on science to identify problems and solve them, but use other mechanisms to set standards and legal obligations. Given the important role that science continues to play, however, several cautionary tales are in order concerning "scientific management," "good science," the lure of money, and the tension between objectivity and involvement in important issues of our time.	Tulane Univ, Sch Law, New Orleans, LA 70118 USA	Tulane University	Houck, O (corresponding author), Tulane Univ, Sch Law, 6329 Freret St, New Orleans, LA 70118 USA.							Adler RW, 1999, HARVARD ENVIRON LAW, V23, P203; ADLER RW, 1993, CLEAN WATER ACT 20 Y; BABICH A, 2003, ENV FORUM        MAY, P36; BEAN MJ, 1999, ENV FORUM        JAN, P26; BEEMAN P, 1994, DES MOINES REGI 0307, P1; *BNA, 1990, BNA ENV REP CURR DEV, V21, P1485; *BNA, 1993, BNA ENV REP CURR DEV, V24, P878; Breyer S., 1993, BREAKING VICIOUS CIR; BRIDGES T, 1990, WASHINGTON POST 0624, pH2; COGLIANESE G, SHIFTING SANDS LIMIT; *EPA, 1989, WAT QUAL IMPR STUD; GREER L, 2002, ENV FORUM        JAN, P28; Harr J., 1995, CIVIL ACTION; HOUCK O, 2002, CLEAN WATER ACT TMDL, P173; Houck OA, 1994, MISS LJ, V63, P403; HOUCK OA, 1991, ENV LAW REGIST, V21, P10551; Houck Oliver, 1991, ENV L REP, V21, P10; Houck Oliver A., 1993, U COLO L REV, V64, P277; Houck OliverA., 2002, CLEAN WATER ACT TMDL; HOWARD P, 1990, HOUSTON POST    1024, pA2; JACKSON DZ, 2003, BOSTON GLOBE    0620, pA15; KURLANSKY M, 1997, COD, P122; Lambrecht Bill, 2003, ST LOUIS POST D 1106, pA1; LATIN H, 1991, ENV L, V21, P1647; Limbaugh Rush, 1992, WAY THINGS OUGGHT BE, V160; MILLER H, 2003, NY TIMES        0807; PERCIVAL R, 2003, ENV REGULATION LAW S, P333; REITZE A, 2001, ENVIRON LAW, V21, P1550; REUKIN AC, 2003, NY TIMES        0619, pA1; REVKIN AC, 2003, NY TIMES        0829, pA11; RODGERS WH, 1992, ENV LAW, V1; RODGERS WH, 1992, ENV LAW, V2; SCHOENBROD D, 1983, UCLA LAW REV, V30, P740; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; TYSON JL, 1994, CHRISTIAN SCI M 0314, P11; TYSON JL, 1979, BATON ROUGE MOR 0525, pB1; WAGAR WE, 1995, COLUMBIA LAW REV, V95, P1613; WILL G, 1998, TIMES PICAYUNE  0223, pB7; 2003, BNA DAILY ENV   1030, pA14; 1986, FED REG, V51, P40572	40	33	34	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1926	1929		10.1126/science.1093758	http://dx.doi.org/10.1126/science.1093758			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752NL	14671294				2022-12-24	WOS:000187174000049
J	Kawaguchi, Y; Kovacs, JJ; McLaurin, A; Vance, JM; Ito, A; Yao, TP				Kawaguchi, Y; Kovacs, JJ; McLaurin, A; Vance, JM; Ito, A; Yao, TP			The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress	CELL			English	Article							HISTONE DEACETYLASES; IN-VIVO; PROTEASOME; DISEASE; MICROTUBULES; DEGRADATION; INHIBITOR; TUBULIN; BODIES; DOMAIN	The efficient clearance of cytotoxic misfolded protein aggregates is critical for cell survival. Misfolded protein aggregates are transported and removed from the cytoplasm by dynein motors via the microtubule network to a novel organelle termed the aggresome where they are processed. However, the means by which dynein motors recognize misfolded protein cargo, and the cellular factors that regulate aggresome formation, remain unknown. We have discovered that HDAC6, a microtubule-associated deacetylase, is a component of the aggresome. We demonstrate that HDAC6 has the capacity to bind both polyubiquitinated misfolded proteins and dynein motors, thereby acting to recruit misfolded protein cargo to dynein motors for transport to aggresomes. Indeed, cells deficient in HDAC6 fail to clear misfolded protein aggregates from the cytoplasm, cannot form aggresomes properly, and are hypersensitive to the accumulation of misfolded proteins. These findings identify HDAC6 as a crucial player in the cellular management of misfolded protein-induced stress.	Duke Univ, Dept Pharmcol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Dept Med, Durham, NC 27710 USA; Duke Univ, Ctr Human Genet, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Yao, TP (corresponding author), Duke Univ, Dept Pharmcol & Canc Biol, Durham, NC 27710 USA.		Ito, Akihiro/A-6100-2015		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039764] Funding Source: NIH RePORTER; NINDS NIH HHS [NS39764] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hook SS, 2002, P NATL ACAD SCI USA, V99, P13425, DOI 10.1073/pnas.172511699; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Lam YA, 2000, P NATL ACAD SCI USA, V97, P9902, DOI 10.1073/pnas.170173897; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McNaught KSP, 2002, EUR J NEUROSCI, V16, P2136, DOI 10.1046/j.1460-9568.2002.02301.x; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; Tran PB, 1999, TRENDS NEUROSCI, V22, P194, DOI 10.1016/S0166-2236(99)01409-5; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wojcik C, 1996, EUR J CELL BIOL, V71, P311; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	26	1145	1197	1	72	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 12	2003	115	6					727	738		10.1016/S0092-8674(03)00939-5	http://dx.doi.org/10.1016/S0092-8674(03)00939-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675537	Bronze			2022-12-24	WOS:000187366100012
J	Salter, MG; Franklin, KA; Whitelam, GC				Salter, MG; Franklin, KA; Whitelam, GC			Gating of the rapid shade-avoidance response by the circadian clock in plants	NATURE			English	Article							APRR1/TOC1 QUINTET; PHYTOCHROME-A; ARABIDOPSIS; PERCEPTION; EXPRESSION; SIGNAL; PATTERNS; GENE	The phytochromes are a family of plant photoreceptor proteins that control several adaptive developmental strategies(1,2). For example, the phytochromes perceive far- red light ( wavelengths between 700 and 800 nm) reflected or scattered from the leaves of nearby vegetation. This provides an early warning of potential shading, and triggers a series of ' shade- avoidance' responses, such as a rapid increase in elongation(3), by which the plant attempts to overgrow its neighbours(3). Other, less immediate, responses include accelerated flowering and early production of seeds. However, little is known about the molecular events that connect light perception with increased growth in shade avoidance. Here we show that the circadian clock gates this rapid shade- avoidance response. It is most apparent around dusk and is accompanied by altered expression of several genes. One of these rapidly responsive genes encodes a basic helix - loop - helix protein, PIL1, previously shown to interact with the clock protein TOC1 ( ref. 4). Furthermore PIL1 and TOC1 are both required for the accelerated growth associated with the shade- avoidance response.	Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England	University of Leicester	Whitelam, GC (corresponding author), Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England.	gcw1@le.ac.uk						Botto JF, 2002, PLANT CELL ENVIRON, V25, P53, DOI 10.1046/j.0016-8025.2001.00812.x; Carabelli M, 1996, P NATL ACAD SCI USA, V93, P3530, DOI 10.1073/pnas.93.8.3530; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Franklin KA, 2003, PLANT PHYSIOL, V131, P1340, DOI 10.1104/pp.102.015487; Hall A, 2001, PLANT PHYSIOL, V127, P1808, DOI 10.1104/pp.010294; Halliday KJ, 2003, PLANT J, V33, P875, DOI 10.1046/j.1365-313X.2003.01674.x; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; JOHNSON E, 1994, PLANT PHYSIOL, V105, P141, DOI 10.1104/pp.105.1.141; KENDRICK RE, 1999, PHOTOMORPHOGENESIS P; Makino S, 2002, PLANT CELL PHYSIOL, V43, P58, DOI 10.1093/pcp/pcf005; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; MORGAN DC, 1980, PLANTA, V150, P95, DOI 10.1007/BF00582351; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; Sharrock RA, 2002, PLANT PHYSIOL, V130, P442, DOI 10.1104/pp.005389; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Smith H, 1997, PLANT CELL ENVIRON, V20, P840, DOI 10.1046/j.1365-3040.1997.d01-104.x; Tepperman JM, 2001, P NATL ACAD SCI USA, V98, P9437, DOI 10.1073/pnas.161300998; Toth R, 2001, PLANT PHYSIOL, V127, P1607, DOI 10.1104/pp.010467; Yamashino T, 2003, PLANT CELL PHYSIOL, V44, P619, DOI 10.1093/pcp/pcg078	20	236	258	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					680	683		10.1038/nature02174	http://dx.doi.org/10.1038/nature02174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668869				2022-12-24	WOS:000187132800046
J	Sesso, HD; Buring, JE; Rifai, N; Blake, GJ; Gaziano, JM; Ridker, PM				Sesso, HD; Buring, JE; Rifai, N; Blake, GJ; Gaziano, JM; Ridker, PM			C-reactive protein and the risk of developing hypertension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; INFLAMMATION; HEALTH; COHORT; ATHEROSCLEROSIS; INTERLEUKIN-6; ASSOCIATION; EXPRESSION; PREVENTION	Context Although it has been hypothesized that hypertension is in part an inflammatory disorder, clinical data linking inflammation with incident hypertension are scarce. Objective To examine whether C-reactive protein levels, a marker of systemic inflammation, are associated with incident hypertension. Design, Setting, and Participants A prospective cohort study that began in 1992 of 20525 female US health professionals aged 45 years or older who provided baseline blood samples with initially normal levels of blood pressure (BP) (systolic BP <140 mm Hg and diastolic BP <90 mm Hg, and no history of hypertension or antihypertensive medications) and then followed up for a median of 7.8 years for the development of incident hypertension. Plasma C-reactive protein levels were measured and baseline coronary risk factors were collected. Main Outcome Measure Incident hypertension, defined as either a new physician diagnosis, the initiation of anti hypertensive treatment, or self-reported systolic BP of at least 140 mm Hg or a diastolic BP of at least 90 mm Hg. Results During follow-up, 5365 women developed incident hypertension. In crude models, the relative risks (RRs) and 95% confidence intervals (Cis) of developing hypertension from the lowest (referent) to the highest levels of baseline C-reactive protein were 1.00, 1.25 (95% CI, 1.14-1.40)', 1.51 (95% Cl, 1.35-1.68), 1.90 (95% Cl, 1 ' 72-2.11), and 2.50 (95% Cl, 2.27-2.75) (linear trend P<.001). In fully adjusted models for coronary risk factors, the RRs and 95% Cis were 1.00, 1.07 (95% Cl, 0.95-1.20), 1.17 (95% Cl, 1.04-1.31), 1.30 (95% Cl, 1.17-1.45), and 1.52 (95% Cl, 1.36-1.69) (linear trend P<.001). C-reactive protein was significantly associated with an increased risk of developing hypertension in all prespecified subgroups evaluated, including those with very low levels of baseline BP, as well as those with no traditional coronary risk factors. Similar results were found when treating C-reactive protein as a continuous variable and controlling for baseline BP. Conclusion C- reactive protein levels are associated with future development of hypertension, which suggests that hypertension is in part an inflammatory disorder.	Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Dept Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Donald W Reynolds Ctr Cardiovasc Res, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital	Sesso, HD (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Dept Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	hsesso@hsph.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bautista LE, 2001, J HYPERTENS, V19, P857, DOI 10.1097/00004872-200105000-00004; Bermudez EA, 2002, ARTERIOSCL THROM VAS, V22, P1668, DOI 10.1161/01.ATV.0000029781.31325.66; Brasier AR, 2002, ARTERIOSCL THROM VAS, V22, P1257, DOI 10.1161/01.ATV.0000021412.56621.A2; Chae CU, 2001, HYPERTENSION, V38, P399, DOI 10.1161/01.HYP.38.3.399; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; DAWSON S, 1992, ATHEROSCLEROSIS, V95, P105, DOI 10.1016/0021-9150(92)90014-8; Devaraj S, 2003, CIRCULATION, V107, P398, DOI 10.1161/01.CIR.0000052617.91920.FD; Engstrom G, 2002, ARTERIOSCL THROM VAS, V22, P2054, DOI 10.1161/01.ATV.0000041842.43905.F3; Ford ES, 2000, J CLIN EPIDEMIOL, V53, P95, DOI 10.1016/S0895-4356(99)00143-2; GILES WH, 1995, AM J PREV MED, V11, P163, DOI 10.1016/S0749-3797(18)30468-9; Klag M J, 1993, Ann Epidemiol, V3, P442; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Liuzzo G, 2001, Rays, V26, P221; Meier-Ewert HK, 2001, CLIN CHEM, V47, P426; Ockene IS, 2001, CLIN CHEM, V47, P444; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Poli KA, 2000, CIRCULATION, V101, P264, DOI 10.1161/01.CIR.101.3.264; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 1999, CIRCULATION, V100, P713, DOI 10.1161/01.CIR.100.7.713; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rohde LEP, 1999, AM J CARDIOL, V84, P1018, DOI 10.1016/S0002-9149(99)00491-9; Sesso HD, 2000, HYPERTENSION, V36, P801, DOI 10.1161/01.HYP.36.5.801; Skoog T, 2002, EUR HEART J, V23, P376, DOI 10.1053/euhj.2001.2805; Srikumar N, 2002, AM J HYPERTENS, V15, P683, DOI 10.1016/S0895-7061(02)02952-7; TODD ME, 1992, CAN J PHYSIOL PHARM, V70, P536, DOI 10.1139/y92-069; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; Venugopal SK, 2002, CIRCULATION, V106, P1439, DOI 10.1161/01.CIR.0000033116.22237.F9; Verma S, 2001, Cardiol Rev, V9, P250, DOI 10.1097/00045415-200109000-00003; Verma S, 2002, CIRCULATION, V105, P1890, DOI 10.1161/01.CIR.0000015126.83143.B4; Verma S, 2002, CIRCULATION, V106, P913, DOI 10.1161/01.CIR.0000029802.88087.5E; Wang CH, 2003, CIRCULATION, V107, P1783, DOI 10.1161/01.CIR.0000061916.95736.E5; Yamada S, 2001, AM J EPIDEMIOL, V153, P1183, DOI 10.1093/aje/153.12.1183; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	37	753	797	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2003	290	22					2945	2951		10.1001/jama.290.22.2945	http://dx.doi.org/10.1001/jama.290.22.2945			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751WH	14665655	Bronze			2022-12-24	WOS:000187112700025
J	De Cock, KM; Marum, E; Mbori-Ngacha, D				De Cock, KM; Marum, E; Mbori-Ngacha, D			A serostatus-based approach to HIV/AIDS prevention and care in Africa	LANCET			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; PUBLIC-HEALTH; HIV EPIDEMIC; RURAL UGANDA; TRANSMISSION; TUBERCULOSIS; PREVALENCE; DISEASE; AIDS		Univ Kenya, Nairobi, Kenya; US Ctr Dis Control & Prevent Kenya, Nairobi, Kenya		De Cock, KM (corresponding author), POB 30137, Nairobi, Kenya.		Abrams, William R/A-5782-2008					Ammann AJ, 2003, BRIT MED J, V326, P1342, DOI 10.1136/bmj.326.7403.1342; BRATTEGAARD K, 1993, AIDS, V7, P883, DOI 10.1097/00002030-199306000-00019; Buve A, 2001, AIDS, V15, pS5, DOI 10.1097/00002030-200108004-00002; Cantwell MF, 1997, INT J TUBERC LUNG D, V1, P205; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Clinton WJ, 2003, NEW ENGL J MED, V348, P1800, DOI 10.1056/NEJMsb023052; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; De Cock KM, 2002, LANCET, V360, P67, DOI 10.1016/S0140-6736(02)09337-6; Frankish H, 2003, LANCET, V362, P297, DOI 10.1016/S0140-6736(03)14007-X; Gayle HD, 2003, NEW ENGL J MED, V348, P1802, DOI 10.1056/NEJMsb030352; Grant AD, 2001, AM J TROP MED HYG, V65, P810, DOI 10.4269/ajtmh.2001.65.810; Gruskin S, 2002, LANCET, V360, P1880, DOI 10.1016/S0140-6736(02)11780-6; *HLTH CAN, 2002, TRANSM HIV MOTH CHIL, P2; *I MED, 1999, RED ODDS PREV PER TR; Janssen RS, 2001, AM J PUBLIC HEALTH, V91, P1019, DOI 10.2105/AJPH.91.7.1019; Joesoef MR, 2003, INT J STD AIDS, V14, P193, DOI 10.1258/095646203762869214; Lewis DK, 2003, T ROY SOC TROP MED H, V97, P91, DOI 10.1016/S0035-9203(03)90035-6; Lucas SB, 1996, BRIT MED J, V312, P335, DOI 10.1136/bmj.312.7027.335; MARUM E, 2002, 14 INT AIDS C BARC S; Pisani E, 2003, BRIT MED J, V326, P1384, DOI 10.1136/bmj.326.7403.1384; Robinson NJ, 1999, INT J STD AIDS, V10, P718, DOI 10.1258/0956462991913394; Stetler HC, 1997, AIDS, V11, P369, DOI 10.1097/00002030-199703110-00015; Stringer EM, 2003, AIDS, V17, P1377, DOI 10.1097/00002030-200306130-00012; Stringer EM, 2001, OBSTET GYNECOL, V98, P1104, DOI 10.1016/S0029-7844(01)01631-3; Talbot EA, 2003, INT J TUBERC LUNG D, V7, P710; Temmerman M, 2003, AIDS, V17, P1239, DOI 10.1097/00002030-200305230-00016; *UNAIDS, 2003, FOLL UP 2001 UN SPEC; *US CDCP, 2002, MMWR-MORBID MORTAL W, V51, P1013; *US CDCP, 1998, MMWR-MORBID MORTAL W, V47, pRR12; Vetter KM, 1996, PEDIATR INFECT DIS J, V15, P438, DOI 10.1097/00006454-199605000-00011; World Health Organization (WHO), 2003, RIGHT KNOW NEW APPR; 2003, LANCET, V361, P539; 2003, NY TIMES        0809	33	100	102	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 29	2003	362	9398					1847	1849		10.1016/S0140-6736(03)14906-9	http://dx.doi.org/10.1016/S0140-6736(03)14906-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654325				2022-12-24	WOS:000186872900026
J	Liao, JC; Beal, DN; Lauder, GV; Triantafyllou, MS				Liao, JC; Beal, DN; Lauder, GV; Triantafyllou, MS			Fish exploiting vortices decrease muscle activity	SCIENCE			English	Article							HYDRODYNAMIC FUNCTION; ONCORHYNCHUS-MYKISS; SWIMMING SPEEDS; LOCOMOTION; SCHOOLS; TROUT; PROPULSION; SALMON; SLOW	Fishes moving through turbulent flows or in formation are regularly exposed to vortices. Although animals living in fluid environments commonly capture energy from vortices, experimental data on the hydrodynamics and neural control of interactions between fish and vortices are lacking. We used quantitative flow visualization and electromyography to show that trout will adopt a novel mode of locomotion to slalom in between experimentally generated vortices by activating only their anterior axial muscles. Reduced muscle activity during vortex exploitation compared with the activity of fishes engaged in undulatory swimming suggests a decrease in the cost of locomotion and provides a mechanism to understand the patterns of fish distributions in schools and riverine environments.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; MIT, Dept Ocean Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT)	Liao, JC (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.							ABRAHAMS MV, 1987, ENVIRON BIOL FISH, V20, P79, DOI 10.1007/BF00002028; ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; Anderson J.M, 1996, THESIS MIT; Belyayev V., 1969, PROBLEMS ICHTHYOLOGY, V9, P578; BOSE N, 1990, PROC R SOC SER B-BIO, V240, P591, DOI 10.1098/rspb.1990.0054; BREDER C. M., 1965, ZOOLOGICA NEW YORK, V50, P97; BREDER CM, 1976, FISH B-NOAA, V74, P471; Drucker EG, 1999, J EXP BIOL, V202, P2393; Drucker EG, 2002, INTEGR COMP BIOL, V42, P243, DOI 10.1093/icb/42.2.243; FAUSCH KD, 1993, CAN J FISH AQUAT SCI, V50, P1198, DOI 10.1139/f93-136; GOLPALKRISHNAN R, 1994, J FLUID MECH, V274, P1, DOI DOI 10.1017/S0022112094002016; Hammond L, 1998, J EXP BIOL, V201, P1659; HARTWELL SI, 1978, T AM FISH SOC, V107, P793, DOI 10.1577/1548-8659(1978)107<793:SPOJMB>2.0.CO;2; Herskin J, 1998, J FISH BIOL, V53, P366, DOI 10.1006/jfbi.1998.0708; Hinch SG, 2000, CAN J FISH AQUAT SCI, V57, P2470, DOI 10.1139/cjfas-57-12-2470; JAYNE BC, 1994, J COMP PHYSIOL A, V175, P123; Liao JC, 2003, J EXP BIOL, V206, P1059, DOI 10.1242/jeb.00209; McGlinchey SM, 2001, COMP BIOCHEM PHYS A, V129, P727, DOI 10.1016/S1095-6433(01)00334-8; Nauen JC, 2002, J EXP BIOL, V205, P1709; PARTRIDGE BL, 1979, NATURE, V279, P418, DOI 10.1038/279418a0; Pavlov D.S., 2000, Journal of Ichthyology, V40, pS232; PITCHER TJ, 1976, SCIENCE, V194, P963, DOI 10.1126/science.982056; Streitlien K, 1996, AIAA J, V34, P2315, DOI 10.2514/3.13396; Webb Paul W., 1998, P3; Webb PW, 1998, J EXP BIOL, V201, P2403; WEIHS D, 1973, NATURE, V241, P290, DOI 10.1038/241290a0; WU TY, 1975, SWIMMING FLYING NATU, V2; Zdravkovich M.M., 1997, FLOW CIRCULAR CYLIND, V1	28	545	571	5	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1566	1569		10.1126/science.1088295	http://dx.doi.org/10.1126/science.1088295			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645849				2022-12-24	WOS:000186802200044
J	Wang, LJ; Fan, C; Topol, SE; Topol, EJ; Wang, Q				Wang, LJ; Fan, C; Topol, SE; Topol, EJ; Wang, Q			Mutation of MEF2A in an inherited disorder with features of coronary artery disease	SCIENCE			English	Article							HEART-DISEASE; MOUSE EMBRYOGENESIS; LINKAGE ANALYSIS; EXPRESSION; CHROMOSOME-2; LINEAGES; SUGGESTS; LOCUS; DEATH	The early genetic pathway(s) triggering the pathogenesis of coronary artery disease (CAD) and myocardial infarction (MI) remain largely unknown. Here, we describe an autosomal dominant form of CAD/MI (adCAD1) that is caused by the deletion of seven amino acids in transcription factor MEF2A. The deletion disrupts nuclear localization of MEF2A, reduces MEF2A-mediated transcription activation, and abolishes synergistic activation by MEF2A and by the transcription factor GATA-1 through a dominant-negative mechanism. The MEF2A protein demonstrates strong expression in the endothelium of coronary arteries. These results identify a pathogenic gene for a familial vascular disease with features of CAD and implicate the MEF2A signaling pathway in the pathogenesis of CAD/MI.	Cleveland Clin Fdn, Ctr Cardiovasc Genet, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Lerner Res Inst, Ctr Mol Genet, Dept Mol Cardiol, Cleveland, OH 44195 USA; Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Dept Med, Cleveland, OH 44195 USA; Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Topol, EJ (corresponding author), Cleveland Clin Fdn, Ctr Cardiovasc Genet, Dept Cardiovasc Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.			Topol, Eric/0000-0002-1478-4729	NHLBI NIH HHS [R01 HL065630, R01 HL66251, R01 HL65630, R01 HL066251] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066251, R01HL065630] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; Borghi S, 2001, J CELL SCI, V114, P4477; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Firulli AB, 1996, CIRC RES, V78, P196, DOI 10.1161/01.RES.78.2.196; Francke S, 2001, HUM MOL GENET, V10, P2751, DOI 10.1093/hmg/10.24.2751; Harrap SB, 2002, ARTERIOSCL THROM VAS, V22, P874, DOI 10.1161/01.ATV.0000016258.40568.F1; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mao ZX, 1996, J BIOL CHEM, V271, P14371, DOI 10.1074/jbc.271.24.14371; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; Pajukanta P, 2000, AM J HUM GENET, V67, P1481, DOI 10.1086/316902; SCHILDKRAUT JM, 1989, AM J CARDIOL, V64, P555, DOI 10.1016/0002-9149(89)90477-3; Subramanian SV, 1996, MECH DEVELOP, V57, P103, DOI 10.1016/0925-4773(96)00542-4; WANG Q, 2000, TXB CARDIOVASCULAR M, V3, P1	18	265	308	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1578	1581		10.1126/science.1088477	http://dx.doi.org/10.1126/science.1088477			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645853	Green Accepted			2022-12-24	WOS:000186802200048
J	Relman, DA				Relman, DA			Shedding light on microbial detection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Med Ctr, Stanford, CA 94305 USA	Stanford University	Relman, DA (corresponding author), Stanford Univ, Med Ctr, Stanford, CA 94305 USA.			Relman, David A./0000-0001-8331-1354				Kovacs GTA, 2003, P IEEE, V91, P915, DOI 10.1109/JPROC.2003.813580; McFadden P, 2002, SCIENCE, V297, P2075, DOI 10.1126/science.297.5589.2075; Rider TH, 2003, SCIENCE, V301, P213, DOI 10.1126/science.1084920	3	14	18	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2003	349	22					2162	2163		10.1056/NEJMcibr035737	http://dx.doi.org/10.1056/NEJMcibr035737			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746ZV	14645646				2022-12-24	WOS:000186779700014
J	Nejentsev, S; Guja, C; McCormack, R; Cooper, J; Howson, JMM; Nutland, S; Rance, H; Walker, N; Undlien, D; Ronningen, KS; Tuomilehto-Wolf, E; Tuomilehto, J; Ionescu-Tirgoviste, C; Gale, EAM; Bingley, PJ; Gillespie, KM; Savage, DA; Carson, DJ; Patterson, CC; Maxwell, AP; Todd, JA				Nejentsev, S; Guja, C; McCormack, R; Cooper, J; Howson, JMM; Nutland, S; Rance, H; Walker, N; Undlien, D; Ronningen, KS; Tuomilehto-Wolf, E; Tuomilehto, J; Ionescu-Tirgoviste, C; Gale, EAM; Bingley, PJ; Gillespie, KM; Savage, DA; Carson, DJ; Patterson, CC; Maxwell, AP; Todd, JA			Association of intercellular adhesion molecule-1 gene with type 1 diabetes	LANCET			English	Article								Intercellular adhesion molecule-1 (ICAM-1) functions via its ligands, the leucocyte integrins, in adhesion of immune cells to endothelial cells and in T cell activation. The third immunoglobulin-like extracellular domain binds integrin Mac-1 and contains a common non-conservative aminoacid polymorphism, G241R. Phenotypically, ICAM-1 has been associated with type I diabetes, a T-cell-mediated autoimmune disease. We assessed two independent datasets, and noted that R241 was associated with lower risk of type I diabetes than is G241 (3695 families, relative risk 0.91, p=0-03; 446 families, 0.60, p=0.006). Our data indicate an aetiological role for ICAM-1 in type I diabetes, which needs to be confirmed In future genetic and functional experiments.	Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Juvenile Diabet Res Fdn,Wellcome Trust Diabet & I, Cambridge CB2 2XY, England; Inst Diabet Nutr & Metab Dis N Paulescu, Diabet Clin, Bucharest, Romania; Queens Univ Belfast, Dept Med Genet, Belfast, Antrim, North Ireland; Univ Oslo, Ulleval Univ Hosp, Inst Med Genet, Oslo, Norway; Norwegian Inst Publ Hlth, Div Epidemiol, Lab Mol Epidemiol, Oslo, Norway; Natl Publ Hlth Inst, Diabet & Genet Epidemiol Unit, Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; Univ Bristol, Div Med, Diabet & Metab Unit, Bristol, Avon, England; Queens Univ Belfast, Dept Child Hlth, Belfast BT7 1NN, Antrim, North Ireland; Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast, Antrim, North Ireland; Belfast City Hosp, Reg Nephrol Unit, Belfast BT9 7AD, Antrim, North Ireland	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Queens University Belfast; University of Oslo; Norwegian Institute of Public Health (NIPH); Finland National Institute for Health & Welfare; University of Helsinki; University of Bristol; Queens University Belfast; Queens University Belfast; Belfast City Hospital	Nejentsev, S (corresponding author), Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Juvenile Diabet Res Fdn,Wellcome Trust Diabet & I, Wellcome Trust MRC Bldg, Cambridge CB2 2XY, England.		Todd, John A/A-3542-2010; Guja, Cristian/K-2334-2019	Todd, John A/0000-0003-2740-8148; Howson, Joanna/0000-0001-7618-0050; Walker, Neil/0000-0001-9796-7688; Maxwell, Alexander P./0000-0002-6110-7253				Camacho SA, 2001, NAT IMMUNOL, V2, P523, DOI 10.1038/88720; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Cox NJ, 2001, AM J HUM GENET, V69, P820, DOI 10.1086/323501; Douek IF, 2002, DIABETOLOGIA, V45, P495, DOI 10.1007/s00125-002-0790-0; Kristiansen OP, 2000, IMMUNOGENETICS, V52, P107, DOI 10.1007/s002510000258; Weinberg CR, 2000, AM J EPIDEMIOL, V152, P197, DOI 10.1093/aje/152.3.197	6	31	32	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 22	2003	362	9397					1723	1724		10.1016/S0140-6736(03)14847-7	http://dx.doi.org/10.1016/S0140-6736(03)14847-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746VE	14643123				2022-12-24	WOS:000186767700013
J	Bergman, TJ; Beehner, JC; Cheney, DL; Seyfarth, RM				Bergman, TJ; Beehner, JC; Cheney, DL; Seyfarth, RM			Hierarchical classification by rank and kinship in baboons	SCIENCE			English	Article							FEMALE BABOONS; SOCIAL RELATIONSHIPS; DOMINANCE RELATIONS; PAPIO-CYNOCEPHALUS; JAPANESE MACAQUES; BONNET MACAQUES; KIN; RECOGNITION; INDIVIDUALS; MONKEYS	Humans routinely classify others according to both their individual attributes, such as social status or wealth, and membership in higher order groups, such as families or castes. They also recognize that people's individual attributes may be influenced and regulated by their group affiliations. It is not known whether such rule-governed, hierarchical classifications are specific to humans or might also occur in nonlinguistic species. Here we show that baboons recognize that a dominance hierarchy can be subdivided into family groups. In playback experiments, baboons respond more strongly to call sequences mimicking dominance rank reversals between families than within families, indicating that they classify others simultaneously according to both individual rank and kinship. The selective pressures imposed by complex societies may therefore have favored cognitive skills that constitute an evolutionary precursor to some components of human cognition.	Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Bergman, TJ (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.		Seyfarth, Robert/AAX-9474-2020; Beehner, Jacinta/E-8467-2012; Bergman, Thore J/B-8196-2008	Beehner, Jacinta/0000-0001-6566-6872; Bergman, Thore J/0000-0002-9615-5001	NIMH NIH HHS [MH62249] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062249] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AURELI F, 1992, ANIM BEHAV, V44, P283, DOI 10.1016/0003-3472(92)90034-7; BERGMAN TL, UNPUB; Bernstein I.S., 1991, P6; Chapais B, 2001, INT J PRIMATOL, V22, P203, DOI 10.1023/A:1005619430744; CHAPAIS B, 1988, BEHAVIOUR, V104, P41, DOI 10.1163/156853988X00593; Cheney D. L., 1990, MONKEYS SEE WORLD IN; Cheney DL, 1999, ANIM BEHAV, V58, P67, DOI 10.1006/anbe.1999.1131; CHENEY DL, 1995, J COMP PSYCHOL, V109, P134, DOI 10.1037/0735-7036.109.2.134; DASSER V, 1988, ANIM BEHAV, V36, P225, DOI 10.1016/S0003-3472(88)80265-3; EHARDT CL, 1986, INT J PRIMATOL, V7, P157, DOI 10.1007/BF02692316; Gouzoules S., 1987, P299; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; HAUSFATER G, 1982, SCIENCE, V217, P752, DOI 10.1126/science.217.4561.752; Jackendoff R., 2002, FDN LANGUAGE BRAIN M; MACUDA T, 1995, J EXP PSYCHOL ANIM B, V21, P20, DOI 10.1037/0097-7403.21.1.20; Pinker S, 1995, LANGUAGE INSTINCT; Rendall D, 1996, ANIM BEHAV, V51, P1007, DOI 10.1006/anbe.1996.0103; SAMUELS A, 1987, ANIM BEHAV, V35, P785, DOI 10.1016/S0003-3472(87)80115-X; Schusterman RJ, 1998, ANIM BEHAV, V55, P1087, DOI 10.1006/anbe.1997.0654; Seyfarth RM, 2003, ANNU REV PSYCHOL, V54, P145, DOI 10.1146/annurev.psych.54.101601.145121; Silk JB, 1999, ANIM BEHAV, V58, P45, DOI 10.1006/anbe.1999.1129; Silk JB, 1999, BEHAVIOUR, V136, P679, DOI 10.1163/156853999501522; SILK JB, IN PRESS ANIM BEHAV; SILK JB, 2002, INT J PRIMATOL, V17, P445; Sinha A, 1998, PHILOS T ROY SOC B, V353, P619, DOI 10.1098/rstb.1998.0230; Walters J.R., 1987, P306	26	267	271	0	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2003	302	5648					1234	1236		10.1126/science.1087513	http://dx.doi.org/10.1126/science.1087513			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14615544				2022-12-24	WOS:000186544300061
J	Kenet, T; Bibitchkov, D; Tsodyks, M; Grinvald, A; Arieli, A				Kenet, T; Bibitchkov, D; Tsodyks, M; Grinvald, A; Arieli, A			Spontaneously emerging cortical representations of visual attributes	NATURE			English	Article							OBLIQUE CONTOURS; ONGOING ACTIVITY; IN-VIVO; CORTEX; VARIABILITY; RESPONSES; DYNAMICS; CELLS; SYNCHRONIZATION; CIRCUITS	Spontaneous cortical activity - ongoing activity in the absence of intentional sensory input - has been studied extensively(1), using methods ranging from EEG (electroencephalography)(2-4), through voltage sensitive dye imaging(5-7), down to recordings from single neurons(8,9). Ongoing cortical activity has been shown to play a critical role in development(10-14), and must also be essential for processing sensory perception, because it modulates stimulus-evoked activity(5,15,16), and is correlated with behaviour(17). Yet its role in the processing of external information and its relationship to internal representations of sensory attributes remains unknown. Using voltage sensitive dye imaging, we previously established a close link between ongoing activity in the visual cortex of anaesthetized cats and the spontaneous firing of a single neuron(6). Here we report that such activity encompasses a set of dynamically switching cortical states, many of which correspond closely to orientation maps. When such an orientation state emerged spontaneously, it spanned several hypercolumns and was often followed by a state corresponding to a proximal orientation. We suggest that dynamically switching cortical states could represent the brain's internal context, and therefore reflect or influence memory, perception and behaviour.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Kenet, T (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, 513 Parnassus Ave,Box 0732, San Francisco, CA 94143 USA.		GRINVALD, AMIRAM/AAH-9919-2019; tsodyks, misha/J-4430-2013	Tsodyks, Misha/0000-0002-5661-4349				Adrian ED, 1934, BRAIN, V57, P355, DOI 10.1093/brain/57.4.355; ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Azouz R, 1999, J NEUROSCI, V19, P2209; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; Chapman B, 1998, P NATL ACAD SCI USA, V95, P2609, DOI 10.1073/pnas.95.5.2609; Chiu CY, 2002, NEURON, V35, P1123, DOI 10.1016/S0896-6273(02)00867-X; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P2621, DOI 10.1073/pnas.95.5.2621; CREUTZFELDT OD, 1966, ELECTROEN CLIN NEURO, V20, P19, DOI 10.1016/0013-4694(66)90137-4; Elul R, 1971, Int Rev Neurobiol, V15, P227; Ernst UA, 2001, NAT NEUROSCI, V4, P431, DOI 10.1038/86089; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Grinvald A, 1999, MODERN TECHNIQUES NE, P893, DOI 10.1007/978-3-642-58552-4_34; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kisley MA, 1999, J NEUROSCI, V19, P10451; Kohonen T., 2000, SELF ORG MAPS; Lestienne R, 2001, PROG NEUROBIOL, V65, P545, DOI 10.1016/S0301-0082(01)00019-3; Li BW, 2003, J NEUROPHYSIOL, V90, P204, DOI 10.1152/jn.00954.2002; McCormick DA, 1999, SCIENCE, V285, P541, DOI 10.1126/science.285.5427.541; NODA H, 1970, BRAIN RES, V18, P513, DOI 10.1016/0006-8993(70)90134-4; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Scherrer J, 1976, Prog Brain Res, V45, P309, DOI 10.1016/S0079-6123(08)60996-6; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; SOFTKY WR, 1993, J NEUROSCI, V13, P334; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Sur M, 1999, J NEUROBIOL, V41, P33, DOI 10.1002/(SICI)1097-4695(199910)41:1<33::AID-NEU6>3.0.CO;2-1; Thompson I, 1997, CURR BIOL, V7, pR324, DOI 10.1016/S0960-9822(06)00150-3; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Wang G, 2003, NEUROSCI LETT, V338, P77, DOI 10.1016/S0304-3940(02)01355-1	30	617	622	3	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2003	425	6961					954	956		10.1038/nature02078	http://dx.doi.org/10.1038/nature02078			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14586468				2022-12-24	WOS:000186230600040
J	Witmer, LM; Chatterjee, S; Franzosa, J; Rowe, T				Witmer, LM; Chatterjee, S; Franzosa, J; Rowe, T			Neuroanatomy of flying reptiles and implications for flight, posture and behaviour	NATURE			English	Article							PIGEONS	Comparison of birds and pterosaurs, the two archosaurian flyers, sheds light on adaptation to an aerial lifestyle. The neurological basis of control holds particular interest in that flight demands on sensory integration, equilibrium, and muscular coordination are acute(1-8). Here we compare the brain and vestibular apparatus in two pterosaurs based on high-resolution computed tomographic (CT) scans from which we constructed digital endocasts. Although general neural organization resembles birds, pterosaurs had smaller brains relative to body mass than do birds. This difference probably has more to do with phylogeny than flight, in that birds evolved from nonavian theropods that had already established trends for greater encephalization(5,9). Orientation of the osseous labyrinth relative to the long axis of the skull was different in these two pterosaur species, suggesting very different head postures and reflecting differing behaviours. Their enlarged semicircular canals reflect a highly refined organ of equilibrium, which is concordant with pterosaurs being visually based, aerial predators. Their enormous cerebellar floccular lobes may suggest neural integration of extensive sensory information from the wing, further enhancing eye- and neck-based reflex mechanisms for stabilizing gaze.	Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; Texas Tech Univ Museum, Lubbock, TX 79409 USA; Univ Texas, Jackson Sch Geosci, Austin, TX 78712 USA	University System of Ohio; Ohio University; Texas Tech University System; Texas Tech University; University of Texas System; University of Texas Austin	Witmer, LM (corresponding author), Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA.	witmerL@ohio.edu						Bennett S. Christopher, 2001, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V260, P1; BLANKS RHI, 1972, AM J PHYSIOL, V223, P55, DOI 10.1152/ajplegacy.1972.223.1.55; Brochu CA, 2001, J PALEONTOL, V75, P1185, DOI 10.1666/0022-3360(2001)075<1185:PAFDIA>2.0.CO;2; BUTLER AB, 1996, COMP VERTEBRATE NEUR, P514; CHATTERJEE S, IN PRESS GEOL SOC AM; de Beer G. R., 1947, Proceedings of the Linnean Society of London, V159, P125; Duijm M., 1951, Proceedings of the Koninklijke Nederlandse Akademie van Wetenschappen, V54C, P202; Duijm M., 1951, P KONINKL NEDERL A C, V54, P260; Edinger T, 1941, AM J SCI, V239, P665, DOI 10.2475/ajs.239.9.665; EDINGER T, 1927, Z ANAT ENTWICKLUNGS, V82, P105; ERICHSEN JT, 1989, BRAIN BEHAV EVOLUT, V33, P268, DOI 10.1159/000115935; Hopson J.A., 1979, P39; HURLBURT GR, 1996, THESIS U TORONTO, P250; Jerison H.J., 1973, EVOLUTION BRAIN INTE, P482; JONES GM, 1963, PROC R SOC SER B-BIO, V157, P403, DOI 10.1098/rspb.1963.0019; Kellner Alexander Wilhelm Armin, 1996, American Museum Novitates, V3175, P1; Kellner AWA, 2000, NATL SCI MUSEUM MONO, V17, P1, DOI 10.1159/000061634; Larsson HCE, 2000, J VERTEBR PALEONTOL, V20, P615, DOI 10.1671/0272-4634(2000)020[0615:FEANTD]2.0.CO;2; LEBEDKIN S, 1924, ANAT ANZEIGER, V58, P447; Newton E.T., 1888, PHILOS T R SOC B, V179, P503; Proctor N. S., 1993, MANUAL ORNITHOLOGY A, V340; Romer A.S, 1956, OSTEOLOGY REPTILES; Spoor F, 2002, NATURE, V417, P163, DOI 10.1038/417163a; Spoor F, 1998, YEARB PHYS ANTHROPOL, V41, P211; Tischlinger H., 2002, ARCHAEOPTERYX, V20, P1; TURKEWITSCH B. G., 1934, ZEITSCHR ANAT U ENTWICKLUNGSGESCH, V103, P551, DOI 10.1007/BF02118934; Unwin David M., 2000, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V3, P181; Wellnhofer P., 1975, PALAONTOGRAPHICA A, V148, P1; Wellnhofer P., 1991, ILLUSTRATED ENCY PTE, P192; WHARTON DS, 2002, THESIS U BRISTOL, P343; Winship IR, 2003, J COMP NEUROL, V456, P127, DOI 10.1002/cne.10507	31	197	204	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2003	425	6961					950	953		10.1038/nature02048	http://dx.doi.org/10.1038/nature02048			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14586467	Green Published			2022-12-24	WOS:000186230600039
J	Hinds, BJ; Chopra, N; Rantell, T; Andrews, R; Gavalas, V; Bachas, LG				Hinds, BJ; Chopra, N; Rantell, T; Andrews, R; Gavalas, V; Bachas, LG			Aligned multiwalled carbon nanotube membranes	SCIENCE			English	Article							ARRAYS	An array of aligned carbon nanotubes (CNTs) was incorporated across a polymer film to form a well-ordered nanoporous membrane structure. This membrane structure was confirmed by electron microscopy, anisotropic electrical conductivity, gas flow, and ionic transport studies. The measured nitrogen permeance was consistent with the flux calculated by Knudsen diffusion through nanometer-scale tubes of the observed microstructure. Data on Ru(NH3)(6)(3+) transport across the membrane in aqueous solution also indicated transport through aligned CNT cores of the observed microstructure. The lengths of the nanotubes within the polymer film were reduced by selective electrochemical oxidation, allowing for tunable pore lengths. Oxidative trimming processes resulted in carboxylate end groups that were readily functionalized at the entrance to each CNT inner core. Membranes with CNT tips that were functionalized with biotin showed a reduction in Ru(NH3)(6)(3+) flux by a factor of 15 when bound with streptavidin, thereby demonstrating the ability to gate molecular transport through CNT cores for potential applications in chemical separations and sensing.	Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA; Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; Univ Kentucky, Ctr Appl Energy Res, Lexington, KY 40511 USA	University of Kentucky; University of Kentucky; University of Kentucky	Hinds, BJ (corresponding author), Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA.		Bachas, Leonidas G/G-2479-2015; Nitin, Chopra/F-8236-2011	Bachas, Leonidas/0000-0002-3308-6264				Ago H, 2000, APPL PHYS LETT, V77, P79, DOI 10.1063/1.126883; Andrews R, 1999, CHEM PHYS LETT, V303, P467, DOI 10.1016/S0009-2614(99)00282-1; Asefa T, 1999, NATURE, V402, P867, DOI 10.1038/47229; Bahr JL, 2001, CHEM MATER, V13, P3823, DOI 10.1021/cm0109903; Casavant MJ, 2003, J APPL PHYS, V93, P2153, DOI 10.1063/1.1536732; Cheung CL, 2002, J PHYS CHEM B, V106, P2429, DOI 10.1021/jp0142278; Hamon MA, 2002, APPL PHYS A-MATER, V74, P333, DOI 10.1007/s003390201281; Huang SM, 2002, J PHYS CHEM B, V106, P3543, DOI 10.1021/jp014047y; Ito T, 2003, ELECTROCHEM SOLID ST, V6, pC4, DOI 10.1149/1.1526779; Jirage KB, 1997, SCIENCE, V278, P655, DOI 10.1126/science.278.5338.655; Kanzow H, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.125402; Klein E, 2000, J MEMBRANE SCI, V179, P1, DOI 10.1016/S0376-7388(00)00514-7; Lee SB, 2002, SCIENCE, V296, P2198, DOI 10.1126/science.1071396; Merkulov VI, 2002, APPL PHYS LETT, V80, P4816, DOI 10.1063/1.1487920; Miller SA, 2002, J ELECTROANAL CHEM, V522, P66, DOI 10.1016/S0022-0728(02)00648-4; Nguyen CV, 2002, NANO LETT, V2, P1079, DOI 10.1021/nl025689f; Pages X, 2001, SEP PURIF TECHNOL, V25, P399, DOI 10.1016/S1383-5866(01)00068-5; Qian D, 2000, APPL PHYS LETT, V76, P2868, DOI 10.1063/1.126500; Ren ZF, 1998, SCIENCE, V282, P1105, DOI 10.1126/science.282.5391.1105; Steinle ED, 2002, ANAL CHEM, V74, P2416, DOI 10.1021/ac020024j; Sun L, 2000, J AM CHEM SOC, V122, P12340, DOI 10.1021/ja002429w; Thurn-Albrecht T, 2000, ADV MATER, V12, P787, DOI 10.1002/(SICI)1521-4095(200006)12:11<787::AID-ADMA787>3.0.CO;2-1; WIPF DO, 1988, ANAL CHEM, V60, P306, DOI 10.1021/ac00155a006; Zhang ZJ, 2000, APPL PHYS LETT, V77, P3764, DOI 10.1063/1.1330751	24	1129	1186	18	836	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2004	303	5654					62	65		10.1126/science.1092048	http://dx.doi.org/10.1126/science.1092048			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YU	14645855				2022-12-24	WOS:000187710600031
J	Si, K; Giustetto, M; Etkin, A; Hsu, R; Janisiewicz, AM; Miniaci, MC; Kim, JH; Zhu, HX; Kandel, ER				Si, K; Giustetto, M; Etkin, A; Hsu, R; Janisiewicz, AM; Miniaci, MC; Kim, JH; Zhu, HX; Kandel, ER			A neuronal isoform of CPEB regulates local protein synthesis and stabilizes synapse-specific long-term facilitation in Aplysia	CELL			English	Article							XENOPUS OOCYTE MATURATION; ELEMENT-BINDING PROTEIN; CAMKII MESSENGER-RNA; DROSOPHILA ORB GENE; CYTOPLASMIC POLYADENYLATION; TRANSLATIONAL CONTROL; S6 KINASE; EXPRESSION; PHOSPHORYLATION; POTENTIATION	Synapse-specific facilitation requires rapamycin-dependent local protein synthesis at the activated synapse. In Aplysia, rapamycin-dependent local protein synthesis serves two functions: (1) it provides a component of the mark at the activated synapse and thereby confers synapse specificity and (2) it stabilizes the synaptic growth associated with long-term facilitation. Here we report that a neuron-specific isoform of cytoplasmic polyadenylation element binding protein (CPEB) regulates this synaptic protein synthesis in an activity-dependent manner. Aplysia CPEB protein is upregulated locally at activated synapses, and it is needed not for the initiation but for the stable maintenance of long-term facilitation. We suggest that Aplysia CPEB is one of the stabilizing components of the synaptic mark.	Columbia Univ, New York State Psychiat Inst, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, New York State Psychiat Inst, Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute	Si, K (corresponding author), Columbia Univ, New York State Psychiat Inst, Coll Phys & Surg, Howard Hughes Med Inst, 722 W 168th St, New York, NY 10032 USA.	ks560@columbia.edu; erk5@columbia.edu	Etkin, Amit/ABD-5761-2021; giustetto, maurizio/D-6606-2011	giustetto, maurizio/0000-0003-1323-4060; Miniaci, Maria/0000-0003-3844-0581				Bally-Cuif L, 1998, MECH DEVELOP, V77, P31, DOI 10.1016/S0925-4773(98)00109-9; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chang JS, 1999, DEV BIOL, V215, P91, DOI 10.1006/dbio.1999.9444; Chang JS, 2001, DEVELOPMENT, V128, P3169; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; DESGROSEILLERS L, 1994, BBA-GENE STRUCT EXPR, V1217, P322, DOI 10.1016/0167-4781(94)90293-3; FOX CA, 1989, GENE DEV, V3, P2151, DOI 10.1101/gad.3.12b.2151; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gebauer F, 1996, P NATL ACAD SCI USA, V93, P14602, DOI 10.1073/pnas.93.25.14602; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Khan A, 2001, J NEUROSCI, V21, P382, DOI 10.1523/JNEUROSCI.21-02-00382.2001; Kim CH, 1999, J NEUROSCI, V19, P4314; Kim JH, 2003, NEURON, V40, P151, DOI 10.1016/S0896-6273(03)00595-6; LANTZ V, 1992, DEVELOPMENT, V115, P75; Liu JM, 2003, BRAIN RES, V959, P68, DOI 10.1016/S0006-8993(02)03729-0; Liu QR, 1997, J NEUROSCI, V17, P755; Loreni F, 2000, EUR J BIOCHEM, V267, P6594, DOI 10.1046/j.1432-1327.2000.01753.x; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Moccia R, 2003, J NEUROSCI, V23, P9409; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Reverte CG, 2003, DEV BIOL, V255, P383, DOI 10.1016/S0012-1606(02)00089-1; Salles FJ, 1999, METH MOL B, V118, P441; Schroeder KE, 1999, DEV BIOL, V214, P288, DOI 10.1006/dbio.1999.9426; Schwarze SR, 2000, TRENDS PHARMACOL SCI, V21, P45, DOI 10.1016/S0165-6147(99)01429-7; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Tan LH, 2001, DEVELOPMENT, V128, P1159; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; [No title captured]	43	322	333	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2003	115	7					893	904		10.1016/S0092-8674(03)01021-3	http://dx.doi.org/10.1016/S0092-8674(03)01021-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	758RV	14697206	Bronze			2022-12-24	WOS:000187664700012
J	Holbrook, A; Goldsmith, C				Holbrook, A; Goldsmith, C			Innovation and placebos in research: a new design of clinical trial	LANCET			English	Editorial Material							DISORDERS; ETHICS		St Josephs Healthcare, Ctr Evaluat Med, Hamilton, ON L8N 1G6, Canada; McMaster Univ, Div Clin Pharmacol, Hamilton, ON, Canada; McMaster Univ, Dept Med, Hamilton, ON, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Holbrook, A (corresponding author), St Josephs Healthcare, Ctr Evaluat Med, Hamilton, ON L8N 1G6, Canada.		anand, amit/A-7222-2009					Amdur RJ, 2001, INT J CANCER, V96, P261, DOI 10.1002/ijc.1026; Charney DS, 2002, ARCH GEN PSYCHIAT, V59, P262, DOI 10.1001/archpsyc.59.3.262; Emanuel EJ, 2001, NEW ENGL J MED, V345, P915, DOI 10.1056/NEJM200109203451211; Fava M, 2003, PSYCHOTHER PSYCHOSOM, V72, P115, DOI 10.1159/000069738; Feinstein AR, 2002, J CLIN EPIDEMIOL, V55, P427, DOI 10.1016/S0895-4356(01)00495-4; GOLDSMITH CH, 2002, JOINT STAT M NEW YOR, P282; Huston P, 2001, NEW ENGL J MED, V345, P912, DOI 10.1056/NEJM200109203451210; ROTHMAN KJ, 1994, NEW ENGL J MED, V331, P394, DOI 10.1056/NEJM199408113310611; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; Weijer C, 2002, CAN MED ASSOC J, V166, P603	10	3	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 20	2003	362	9401					2036	2037		10.1016/S0140-6736(03)15147-1	http://dx.doi.org/10.1016/S0140-6736(03)15147-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UJ	14697799				2022-12-24	WOS:000187429600004
J	Miranda, JJ				Miranda, JJ			TB and you and me ... personal reflections	LANCET			English	Article									UCL, Int Hlth & Med Educ Ctr, London N19 5LW, England	University of London; University College London	Miranda, JJ (corresponding author), UCL, Int Hlth & Med Educ Ctr, London N19 5LW, England.		Miranda, J. Jaime/A-8482-2008	Miranda, J. Jaime/0000-0002-4738-5468					0	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 20	2003	362	9401					2081	2082		10.1016/S0140-6736(03)15106-9	http://dx.doi.org/10.1016/S0140-6736(03)15106-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UJ	14697811				2022-12-24	WOS:000187429600025
J	Wu, L; Hickson, ID				Wu, L; Hickson, ID			The Bloom's syndrome helicase suppresses crossing over during homologous recombination	NATURE			English	Article							SYNDROME GENE-PRODUCT; TOPOISOMERASE-III-ALPHA; STRAND-BREAK REPAIR; HOLLIDAY JUNCTION RESOLUTION; RECQ HELICASES; ESCHERICHIA-COLI; BRANCH MIGRATION; MAMMALIAN-CELLS; MEIOSIS; YEAST	Mutations in BLM, which encodes a RecQ helicase, give rise to Bloom's syndrome, a disorder associated with cancer predisposition and genomic instability(1). A defining feature of Bloom's syndrome is an elevated frequency of sister chromatid exchanges(2). These arise from crossing over of chromatid arms during homologous recombination, a ubiquitous process that exists to repair DNA double-stranded breaks and damaged replication forks. Whereas crossing over is required in meiosis, in mitotic cells it can be associated with detrimental loss of heterozygosity. BLM forms an evolutionarily conserved complex with human topoisomerase IIIalpha (hTOPO IIIalpha)(3,4), which can break and rejoin DNA to alter its topology. Inactivation of homologues of either protein leads to hyper-recombination in unicellular organisms(5). Here, we show that BLM and hTOPO IIIalpha together effect the resolution of a recombination intermediate containing a double Holliday junction. The mechanism, which we term double-junction dissolution, is distinct from classical Holliday junction resolution and prevents exchange of flanking sequences. Loss of such an activity explains many of the cellular phenotypes of Bloom's syndrome. These results have wider implications for our understanding of the process of homologous recombination and the mechanisms that exist to prevent tumorigenesis.	Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Canc Res UK, Oxford OX3 9DS, England	Cancer Research UK; University of Oxford	Hickson, ID (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Canc Res UK, Oxford OX3 9DS, England.		Hickson, Ian/AAJ-7548-2020					Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; BENSON FE, 1994, J BIOL CHEM, V269, P5195; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Constantinou A, 2001, CELL, V104, P259, DOI 10.1016/S0092-8674(01)00210-0; Constantinou A, 2002, EMBO J, V21, P5577, DOI 10.1093/emboj/cdf554; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; FU TJ, 1994, J MOL BIOL, V236, P91, DOI 10.1006/jmbi.1994.1121; Gangloff S, 1999, EMBO J, V18, P1701, DOI 10.1093/emboj/18.6.1701; Goulaouic H, 1999, NUCLEIC ACIDS RES, V27, P2443, DOI 10.1093/nar/27.12.2443; Harmon FG, 1999, MOL CELL, V3, P611, DOI 10.1016/S1097-2765(00)80354-8; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Johnson FB, 2000, CANCER RES, V60, P1162; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; LLOYD RG, 1993, NUCLEIC ACIDS RES, V21, P1719, DOI 10.1093/nar/21.8.1719; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; NASMYTH KA, 1982, ANNU REV GENET, V16, P439, DOI 10.1146/annurev.ge.16.120182.002255; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Wu L, 2002, NUCLEIC ACIDS RES, V30, P4823, DOI 10.1093/nar/gkf611; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Wu L, 2001, CELL MOL LIFE SCI, V58, P894, DOI 10.1007/PL00000909	28	848	863	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					870	874		10.1038/nature02253	http://dx.doi.org/10.1038/nature02253			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685245				2022-12-24	WOS:000187342000066
J	Lyuksyutova, AI; Lu, CC; Milanesio, N; King, LA; Guo, NN; Wang, YS; Nathans, J; Tessier-Lavigne, M; Zou, YM				Lyuksyutova, AI; Lu, CC; Milanesio, N; King, LA; Guo, NN; Wang, YS; Nathans, J; Tessier-Lavigne, M; Zou, YM			Anterior-posterior guidance of commissural Axons by Wnt-frizzled signaling	SCIENCE			English	Article							SONIC HEDGEHOG; SPINAL-CORD; FLOOR PLATE; CHEMOATTRACTANT; MECHANISMS; NETRIN-1; RECEPTOR	Commissural neurons in the mammalian dorsal spinal cord send axons ventrally toward the floor plate, where they cross the midline and turn anteriorly toward the brain; a gradient of chemoattractant(s) inside the spinal cord controls this turning. In rodents, several Wnt proteins stimulate the extension of commissural axons after midline crossing (postcrossing). We found that Wnt4 messenger RNA is expressed in a decreasing anterior-to-posterior gradient in the floor plate, and that a directed source of Wnt4 protein attracted postcrossing commissural axons. Commissural axons in mice lacking the Wnt receptor Frizzled3 displayed anterior-posterior guidance defects after midline crossing. Thus, Wnt-Frizzled signaling guides commissural axons along the anterior-posterior axis of the spinal cord.	Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Univ Chicago, Comm Dev Biol, Chicago, IL 60637 USA; Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Ophthalmol, Baltimore, MD 21205 USA; Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA	University of Chicago; University of Chicago; University of Chicago; Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Stanford University	Zou, YM (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.	yzou@bsd.uchicago.edu		Nathans, Jeremy/0000-0001-8106-5460	NINDS NIH HHS [R01 NS047484] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047484] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Liu AP, 2000, MECH DEVELOP, V91, P409, DOI 10.1016/S0925-4773(99)00308-1; LYUKSYUTOVA AI, UNPUB; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang YS, 2002, J NEUROSCI, V22, P8563; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	16	443	451	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1984	1988		10.1126/science.1089610	http://dx.doi.org/10.1126/science.1089610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671310				2022-12-24	WOS:000187174000067
J	Nef, S; Verma-Kurvari, S; Merenmies, J; Vassalli, JD; Efstratiadis, A; Accili, D; Parada, LF				Nef, S; Verma-Kurvari, S; Merenmies, J; Vassalli, JD; Efstratiadis, A; Accili, D; Parada, LF			Testis determination requires insulin receptor family function in mice	NATURE			English	Article							SEX DETERMINATION; SRY EXPRESSION; GENE; REVERSAL; PROLIFERATION; LACKING	In mice, gonads are formed shortly before embryonic day 10.5 by the thickening of the mesonephros and consist of somatic cells and migratory primordial germ cells(1). The male sex-determining process is set in motion by the sex-determining region of the Y chromosome (Sry), which triggers differentiation of the Sertoli cell lineage. In turn, Sertoli cells function as organizing centres and direct differentiation of the testis. In the absence of Sry expression, neither XX nor XY gonads develop testes(2), and alterations in Sry expression are often associated with abnormal sexual differentiation(3-8). The molecular signalling mechanisms by which Sry specifies the male pathway and models the undifferentiated gonad are unknown. Here we show that the insulin receptor tyrosine kinase family, comprising Ir, Igf1r and Irr, is required for the appearance of male gonads and thus for male sexual differentiation. XY mice that are mutant for all three receptors develop ovaries and show a completely female phenotype. Reduced expression of both Sry and the early testis-specific marker Sox9 indicates that the insulin signalling pathway is required for male sex determination.	Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Geneva, Dept Morphol, Ctr Med Univ, CH-1211 Geneva 4, Switzerland; Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Naomi Berrie Diabet Ctr, New York, NY 10032 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Geneva; Columbia University; Columbia University; Columbia University	Parada, LF (corresponding author), Univ Texas, SW Med Ctr, Ctr Dev Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	luis.parada@utsouthwestern.edu	Nef, Serge/AAV-6445-2020; Parada, luis F/B-9400-2014	Nef, Serge/0000-0001-5462-0676; 				Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Albrecht KH, 2003, GENETICS, V164, P277; Burgoyne PS, 1993, GONADAL DEV FUNCTION, P17; CAPEL B, 1993, NAT GENET, V5, P301, DOI 10.1038/ng1193-301; Capel B, 2000, MECH DEVELOP, V92, P89, DOI 10.1016/S0925-4773(99)00327-5; Clarkson MJ, 2002, TRENDS ENDOCRIN MET, V13, P106, DOI 10.1016/S1043-2760(01)00541-0; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; JESKE YWA, 1995, NAT GENET, V10, P480, DOI 10.1038/ng0895-480; Joshi RL, 1996, EMBO J, V15, P1542, DOI 10.1002/j.1460-2075.1996.tb00498.x; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kitamura T, 2001, MOL CELL BIOL, V21, P5624, DOI 10.1128/MCB.21.16.5624-5630.2001; LEE CH, 1994, DEV BIOL, V165, P442, DOI 10.1006/dbio.1994.1266; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Louvi A, 1997, DEV BIOL, V189, P33, DOI 10.1006/dbio.1997.8666; Nagamine CM, 1999, DEV BIOL, V216, P182, DOI 10.1006/dbio.1999.9436; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Parr BA, 1998, NATURE, V395, P707, DOI 10.1038/27221; Scherer G, 1999, CELL MOL LIFE SCI, V55, P821, DOI 10.1007/s000180050335; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schmahl J, 2003, DEV BIOL, V258, P264, DOI 10.1016/S0012-1606(03)00122-2; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Swain A, 1999, GENE DEV, V13, P755, DOI 10.1101/gad.13.7.755; Tevosian SG, 2002, DEVELOPMENT, V129, P4627; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Washburn LL, 2001, GENETICS, V158, P1675	27	202	210	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2003	426	6964					291	295		10.1038/nature02059	http://dx.doi.org/10.1038/nature02059			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628051				2022-12-24	WOS:000186660800044
J	Peggs, KS; Verfuerth, S; Pizzey, A; Khan, N; Guiver, M; Moss, PA; Mackinnon, S				Peggs, KS; Verfuerth, S; Pizzey, A; Khan, N; Guiver, M; Moss, PA; Mackinnon, S			Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines	LANCET			English	Article							DENDRITIC CELLS; RECONSTITUTION; ANTIGEN	Adoptive transfer of CMV-specific T cells offers the potential for reconstitution of viral immunity after allogeneic transplantation. However, the logistics of producing virus-specific T-cell clones has limited the application of cellular therapies. We treated 16 patients for CMV infection with polyclonal CMV-specific T-cell lines generated by short-term culture. Massive in-vivo expansions of CMV-specific cytotoxic T lymphocytes were observed, resulting in reconstitution of viral immunity. In eight cases antiviral drugs were not required, and subsequent episodes of reactivation occurred in only two patients. Our findings indicate that application of CMV-specific cell lines is both feasible and effective in a clinical environment.	UCL Royal Free & UCL Med Sch, Dept Haematol, London WC1E 6HX, England; Univ Birmingham, CR UK Inst Canc Studies, Birmingham, W Midlands, England; Publ Hlth Lab Serv, Dept Virol, Manchester, Lancs, England	University of London; University College London; University of Birmingham	Peggs, KS (corresponding author), UCL Royal Free & UCL Med Sch, Dept Haematol, London WC1E 6HX, England.	kpeggs@hotmail.com	Mackinnon, Stephen/C-5559-2008; Wilson, Matthew H/K-3193-2013; Moss, Paul/D-1728-2009; PEGGS, Karl/B-3869-2009; Pizzey, Arnold/E-6301-2015	Moss, Paul/0000-0002-6895-1967; Pizzey, Arnold/0000-0003-1850-1121				Chakrabarti S, 2002, BLOOD, V99, P4357, DOI 10.1182/blood.V99.12.4357; Cwynarski K, 2001, BLOOD, V97, P1232, DOI 10.1182/blood.V97.5.1232; Peggs K, 2002, BLOOD, V99, P213, DOI 10.1182/blood.V99.1.213; Peggs K, 2001, BLOOD, V97, P994, DOI 10.1182/blood.V97.4.994; RIDDELL SR, 1992, SCIENCE, V257, P238	5	377	388	2	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 25	2003	362	9393					1375	1377		10.1016/S0140-6736(03)14634-X	http://dx.doi.org/10.1016/S0140-6736(03)14634-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735YX	14585640				2022-12-24	WOS:000186143300012
J	Yu, XC; Chini, CCS; He, M; Mer, G; Chen, JJ				Yu, XC; Chini, CCS; He, M; Mer, G; Chen, JJ			The BRCT domain is a phospho-protein binding domain	SCIENCE			English	Article							DNA-DAMAGE; CHECKPOINT; REPAIR; FHA	The carboxyl-terminal domain (BRCT) of the Breast Cancer Gene 1 (BRCA1) protein is an evolutionarily conserved module that exists in a large number of proteins from prokaryotes to eukaryotes. Although most BRCT domain-containing proteins participate in DNA-damage checkpoint or DNA-repair pathways, or both, the function of the BRCT domain is not fully understood. We show that the BRCA1 BRCT domain directly interacts with phosphorylated BRCA1-Associated Carboxyl-terminal Helicase (BACH1). This specific interaction between BRCA1 and phosphorylated BACH1 is cell cycle regulated and is required for DNA damage-induced checkpoint control during the transition from G(2) to M phase of the cell cycle. Further, we show that two other BRCT domains interact with their respective physiological partners in a phosphorylation-dependent manner. Thirteen additional BRCT domains also preferentially bind phospho-peptides rather than nonphosphorylated control peptides. These data imply that the BRCT domain is a phospho-protein binding domain involved in cell cycle control.	Mayo Clin & Mayo Fdn, Dept Oncol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Med Genet, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Chen, JJ (corresponding author), Mayo Clin & Mayo Fdn, Dept Oncol, Rochester, MN 55905 USA.		Mer, Georges/AAT-4946-2021	Mer, Georges/0000-0002-1900-1578	NATIONAL CANCER INSTITUTE [R01CA089239, R01CA092312] Funding Source: NIH RePORTER; NCI NIH HHS [CA92312, CA89239] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chen YM, 1996, CANCER RES, V56, P3168; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; Ludwig T, 2001, GENE DEV, V15, P1188, DOI 10.1101/gad.879201; Taylor RM, 2000, MOL CELL BIOL, V20, P735, DOI 10.1128/MCB.20.2.735-740.2000; Tseng HM, 2002, J BIOL CHEM, V277, P45630, DOI 10.1074/jbc.M206861200; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yamane K, 2002, MOL CELL BIOL, V22, P555, DOI 10.1128/MCB.22.2.555-566.2002; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Zhao S, 2002, NUCLEIC ACIDS RES, V30, P4815, DOI 10.1093/nar/gkf612	15	658	669	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					639	642		10.1126/science.1088753	http://dx.doi.org/10.1126/science.1088753			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576433				2022-12-24	WOS:000186119900058
J	Loutfy, MR; Blatt, LM; Siminovitch, KA; Ward, S; Wolff, B; Lho, H; Pham, DH; Deif, H; LaMere, EA; Chang, M; Kain, KC; Farcas, GA; Ferguson, P; Latchford, M; Levy, G; Dennis, JW; Lai, EKY; Fish, EN				Loutfy, MR; Blatt, LM; Siminovitch, KA; Ward, S; Wolff, B; Lho, H; Pham, DH; Deif, H; LaMere, EA; Chang, M; Kain, KC; Farcas, GA; Ferguson, P; Latchford, M; Levy, G; Dennis, JW; Lai, EKY; Fish, EN			Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome - A preliminary study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SARS; OUTBREAK; ALPHA; MANAGEMENT; MECHANISMS; RIBAVIRIN; EFFICACY; OUTCOMES; THERAPY; TORONTO	Context Severe acute respiratory syndrome (SARS) is anew clinical entity for which no effective therapeutic strategy has been developed. Objective To provide preliminary results on the potential therapeutic benefit and tolerability of interferon alfacon-1 plus corticosteroids for SARS. Design, Setting, and Patients Open-label study of 22 patients diagnosed as having probable SARS at North York General Hospital, Toronto, Ontario, between April 11 and May 30, 2003. Interventions Thirteen patients were treated with corticosteroids alone and 9 patients were treated with corticosteroids plus subcutaneous interferon alfacon-1. Main Outcome Measures Clinical parameters, including oxygen saturation and requirement, laboratory measures, and serial chest radiography results. Results Resolution of fever and lymphopenia were similar between the 2 treatment groups. Of the 13 patients treated with corticosteroids alone, 5 (38.5%) were transferred to the intensive care unit, 3 (23.1 %) required intubation and mechanical ventilation, and 1 (7.7%) died. Of the 9 patients in the interferon alfacon-1 treatment group, 3 (33.3 %) were transferred to the intensive care unit, 1 (11.1 %) required intubation and mechanical ventilation, and none died. The interferon alfacon-1 treatment group had a shorter time to 50% resolution of lung radiographic abnormalities (median time, 4 days vs 9 days; P=.001), had, better oxygen saturation (P=.02), resolved their need for supplemental oxygen more rapidly (median, 10 days vs 16 days; P=.02), had less of an increase in creatine kinase levels (P=.03), and showed a trend toward more rapid resolution of lactate dehydrogenase levels compared with the group receiving corticosteroids alone. Conclusions In this preliminary, uncontrolled study of patients with SARS, Use of interferon alfacon-1 plus corticosteroids was associated with reduced disease-associated impaired oxygen saturation, more rapid resolution of radiographic lung abnormalities, and lower levels of creatine kinase. These findings suggest that further investigation may be warranted to determine the role of interferon alfacon-1 as a therapeutic agent for the treatment of SARS.	Toronto Gen Res Inst, Div Cell & Mol Biol, Toronto, ON M5G 2M1, Canada; N York Gen Hosp, Toronto, ON, Canada; Univ Toronto, Toronto, ON, Canada; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Intermune Corp, Brisbane, CA USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Fish, EN (corresponding author), Toronto Gen Res Inst, Div Cell & Mol Biol, Canadian Blood Serv Bldg,Room 424,67 Coll St, Toronto, ON M5G 2M1, Canada.	en.fish@utoronto.ca	Dennis, James/E-7268-2013; Siminovitch, Katherine/K-1475-2013	Kain, Kevin/0000-0001-6068-1272				Alton K., 1983, BIOL INTERFERON SYST, P119; Avendano M, 2003, CAN MED ASSOC J, V168, P1649; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Blatt LM, 1996, J INTERF CYTOK RES, V16, P489, DOI 10.1089/jir.1996.16.489; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Brierley MM, 2002, J INTERF CYTOK RES, V22, P835, DOI 10.1089/107999002760274845; *CDCP, UPD INT US CAS DEF S; Cinatl J, 2003, LANCET, V362, P293, DOI 10.1016/S0140-6736(03)13973-6; Cornberg M, 2001, Forum (Genova), V11, P154; Cotler SJ, 2003, J VIRAL HEPATITIS, V10, P43, DOI 10.1046/j.1365-2893.2003.00401.x; Friis RH, 1996, EPIDEMIOLOGY PUBLIC; Fujimori K, 2002, J GASTROENTEROL, V37, P40, DOI 10.1007/s535-002-8131-9; HIGGINS PG, 1983, ANTIMICROB AGENTS CH, V24, P713, DOI 10.1128/AAC.24.5.713; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Melian EB, 2001, DRUGS, V61, P1661, DOI 10.2165/00003495-200161110-00009; Nguyen MH, 2001, CURR OPIN INFECT DIS, V14, P593, DOI 10.1097/00001432-200110000-00014; Oba Y, 2003, NEW ENGL J MED, V348, P2034; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Pockros PJ, 2003, J VIRAL HEPATITIS, V10, P55, DOI 10.1046/j.1365-2893.2003.00402.x; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; So LKY, 2003, LANCET, V361, P1615, DOI 10.1016/S0140-6736(03)13265-5; Soza A, 2002, HEPATOLOGY, V36, P1273, DOI 10.1053/jhep.2002.36502; SPERBER SJ, 1989, J INTERFERON RES, V9, P285, DOI 10.1089/jir.1989.9.285; TURNER RB, 1986, J INFECT DIS, V154, P443, DOI 10.1093/infdis/154.3.443; TYRRELL DAJ, 1986, J ANTIMICROB CHEMOTH, V18, P153, DOI 10.1093/jac/18.Supplement_B.153; *WHO, REV CAS DEF SARS; World Health Organization, CUM NUMB REP PROB CA; Wu W, 2003, CHINESE MED J-PEKING, V116, P811	30	279	310	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2003	290	24					3222	3228		10.1001/jama.290.24.3222	http://dx.doi.org/10.1001/jama.290.24.3222			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	756TR	14693875				2022-12-24	WOS:000187499300026
J	Kruger, M; Meyerdierks, A; Glockner, FO; Amann, R; Widdel, F; Kube, M; Reinhardt, R; Kahnt, R; Bocher, R; Thauer, RK; Shima, S				Kruger, M; Meyerdierks, A; Glockner, FO; Amann, R; Widdel, F; Kube, M; Reinhardt, R; Kahnt, R; Bocher, R; Thauer, RK; Shima, S			A conspicuous nickel protein in microbial mats that oxidize methane anaerobically	NATURE			English	Article							CORAL-LIKE STRUCTURES; MARINE-SEDIMENTS; BLACK-SEA; SULFATE REDUCTION; MCRA GENES; OXIDATION; BACTERIA; SEEPS; CONSORTIUM; ARCHAEA	Anaerobic oxidation of methane (AOM) in marine sediments is an important microbial process in the global carbon cycle and in control of greenhouse gas emission. The responsible organisms supposedly reverse the reactions of methanogenesis(1-8), but cultures providing biochemical proof of this have not been isolated. Here we searched for AOM-associated cell components in microbial mats from anoxic methane seeps in the Black Sea(9-11). These mats catalyse AOM rather than carry out methanogenesis. We extracted a prominent nickel compound displaying the same absorption spectrum as the nickel cofactor F(430) of methyl-coenzyme M reductase, the terminal enzyme of methanogenesis(12); however, the nickel compound exhibited a higher molecular mass than F430. The apparent variant of F430 was part of an abundant protein that was purified from the mat and that consists of three different subunits. Determined amino-terminal amino acid sequences matched a gene locus cloned from the mat. Sequence analyses revealed similarities to methyl-coenzyme M reductase from methanogenic archaea. The abundance of the nickel protein (7% of extracted proteins) in the mat suggests an important role in AOM.	Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Widdel, F (corresponding author), Max Planck Inst Marine Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	fwiddel@mpi-bremen.de; thauer@mailer.uni-marburg.de	Amann, Rudolf I/C-6534-2014	Amann, Rudolf I/0000-0002-0846-7372; Reinhardt, Richard/0000-0001-9376-2132				BARNES RO, 1976, GEOLOGY, V4, P297, DOI 10.1130/0091-7613(1976)4<297:MPACIA>2.0.CO;2; Bian LQ, 2001, GEOCHEM GEOPHY GEOSY, V2, DOI 10.1029/2000GC000112; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Elvert M, 1999, NATURWISSENSCHAFTEN, V86, P295, DOI 10.1007/s001140050619; Hallam SJ, 2003, APPL ENVIRON MICROB, V69, P5483, DOI 10.1128/AEM.69.9.5483-5491.2003; Hansen LB, 1998, AQUAT MICROB ECOL, V14, P195, DOI 10.3354/ame014195; Harder J, 1997, MAR GEOL, V137, P13, DOI 10.1016/S0025-3227(96)00075-8; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; IVERSEN N, 1985, LIMNOL OCEANOGR, V30, P944, DOI 10.4319/lo.1985.30.5.0944; Lueders T, 2001, ENVIRON MICROBIOL, V3, P194, DOI 10.1046/j.1462-2920.2001.00179.x; Lynn DJ, 2002, NUCLEIC ACIDS RES, V30, P4272, DOI 10.1093/nar/gkf546; MARTENS CS, 1974, SCIENCE, V185, P1167, DOI 10.1126/science.185.4157.1167; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Michaelis W, 2002, SCIENCE, V297, P1013, DOI 10.1126/science.1072502; Nauhaus K, 2002, ENVIRON MICROBIOL, V4, P296, DOI 10.1046/j.1462-2920.2002.00299.x; Niewohner C, 1998, GEOCHIM COSMOCHIM AC, V62, P455, DOI 10.1016/S0016-7037(98)00055-6; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Pancost RD, 2001, GEOCHIM COSMOCHIM AC, V65, P1611, DOI 10.1016/S0016-7037(00)00562-7; Pimenov NV, 1997, MICROBIOLOGY+, V66, P354; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; REEBURGH W, 1976, EARTH PLANET SC LETT, V28, P345; Schbath S, 1997, J COMPUT BIOL, V4, P189, DOI 10.1089/cmb.1997.4.189; Sorensen KB, 2001, MICROBIAL ECOL, V42, P1; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Tourova TP, 2002, MICROBIOLOGY+, V71, P196, DOI 10.1023/A:1015102422144; Valentine DL, 2000, ENVIRON MICROBIOL, V2, P477, DOI 10.1046/j.1462-2920.2000.00135.x; ZEHNDER AJB, 1979, J BACTERIOL, V137, P420, DOI 10.1128/JB.137.1.420-432.1979; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	30	257	275	4	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					878	881		10.1038/nature02207	http://dx.doi.org/10.1038/nature02207			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685246				2022-12-24	WOS:000187342000068
J	Geisbert, TW; Hensley, LE; Jahrling, PB; Larsen, T; Geisbert, JB; Paragas, J; Young, HA; Fredeking, TM; Rote, WE; Vlasuk, GP				Geisbert, TW; Hensley, LE; Jahrling, PB; Larsen, T; Geisbert, JB; Paragas, J; Young, HA; Fredeking, TM; Rote, WE; Vlasuk, GP			Treatment of Ebola virus infection with a recombinant inhibitor of factor Vila/tissue factor: a study in rhesus monkeys	LANCET			English	Article							ANTICOAGULANT PROTEIN C2; DISSEMINATED INTRAVASCULAR COAGULATION; TISSUE FACTOR/FACTOR-VIIA; FACTOR VIIA/TISSUE FACTOR; FACTOR PATHWAY; IN-VITRO; ACTIVATION; MECHANISMS; RELEASE; COMPLEX	Background Infection with the Ebola virus induces overexpression of the procoagulant tissue factor in primate monocytes and macrophages, suggesting that inhibition of the tissue-factor pathway could ameliorate the effects of Ebola haemorrhagic fever. Here, we tested the notion that blockade of fVIIa/tissue factor is beneficial after infection with Ebola virus. Methods We used a rhesus macaque model of Ebola haemorrhagic fever, which produces near 100% mortality. We administered recombinant nematode anticoagulant protein c2 (rNAPc2), a potent inhibitor of tissue factor-initiated blood coagulation, to the macaques either 10 min (n=6) or 24 h (n=3) after a high-dose lethal injection of Ebola virus. Three animals served as untreated Ebola virus-positive controls. Historical controls were also used in some analyses. Findings Both treatment regimens prolonged survival time, with a 33% survival rate in each treatment group. Survivors are still alive and healthy after 9 months. All but one of the 17 controls died. The mean survival for the six rNAPc2-treated macaques that died was 11.7 days compared with 8.3 days for untreated controls (p=0.0184). rNAPc2 attenuated the coagulation response as evidenced by modulation of various important coagulation factors, including plasma D dimers, which were reduced in nearly all treated animals; less prominent fibrin deposits and intravascular thromboemboli were observed in tissues of some animals that succumbed to Ebola virus. Furthermore, rNAPc2 attenuated the proinflammatory response with lower plasma concentrations of interleukin 6 and monocyte chemoattractant protein-1 (MCP-1) noted in the treated than in the untreated macaques. Interpretation Post-exposure protection with rNAPc2 against Ebola virus in primates provides a new foundation for therapeutic regimens that target the disease process rather than viral replication.	USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; USA, Med Res Inst Infect Dis, Div Pathol, Ft Detrick, MD 21702 USA; NCI, Cellular & Mol Immunol Sect, Expt Immunol Lab, FCRDC, Frederick, MD USA; Antibody Syst, Hurst, TX USA; Corvas Int, San Diego, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Geisbert, TW (corresponding author), USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA.		; Young, Howard/A-6350-2008	Hensley, Lisa/0000-0003-1188-4342; Young, Howard/0000-0002-3118-5111; Larsen, Thomas/0000-0002-3609-9490				Arai A, 2000, THROMB RES, V97, P153, DOI 10.1016/S0049-3848(99)00147-4; Bick RL, 1998, SEMIN THROMB HEMOST, V24, P3, DOI 10.1055/s-2007-994971; Bray M, 2001, J COMP PATHOL, V125, P243, DOI 10.1053/jcpa.2001.0503; Bray M, 2000, ANTIVIR RES, V45, P135, DOI 10.1016/S0166-3542(00)00066-8; de Jonge E, 2003, CLIN DIAGN LAB IMMUN, V10, P495, DOI 10.1128/CDLI.10.3.495-497.2003; de Pont ACJM, 2002, BLOOD, V100, p487A; Funahara Y, 1983, Bibl Haematol, P201; Geisbert TW, 2003, J INFECT DIS, V188, P1618, DOI 10.1086/379724; Geisbert TW, 2002, EMERG INFECT DIS, V8, P503; Huggins J, 1999, J INFECT DIS, V179, pS240, DOI 10.1086/514316; Huggins J.W., 1995, ANTIVIR RES, V26, pA301; Iversen N, 2000, BLOOD COAGUL FIBRIN, V11, P591, DOI 10.1097/00001721-200010000-00002; Jahrling PB, 1999, J INFECT DIS, V179, pS224, DOI 10.1086/514310; Johnson K, 1998, J IMMUNOL, V160, P5130; Lee A, 2001, CIRCULATION, V104, P74, DOI 10.1161/hc2601.091386; McVey JH, 1999, BEST PRACT RES CL HA, V12, P361, DOI 10.1053/beha.1999.0030; Moons AHM, 2003, J AM COLL CARDIOL, V41, P2147, DOI 10.1016/S0735-1097(03)00478-9; ROBSON SC, 1994, BRIT J HAEMATOL, V86, P322, DOI 10.1111/j.1365-2141.1994.tb04733.x; Sanchez A, 2001, FIELDS VIROLOGY, P1279; Vlasuk GP, 2002, TRENDS CARDIOVAS MED, V12, P325, DOI 10.1016/S1050-1738(02)00185-8	20	283	330	0	38	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 13	2003	362	9400					1953	1958		10.1016/S0140-6736(03)15012-X	http://dx.doi.org/10.1016/S0140-6736(03)15012-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683653	Green Submitted			2022-12-24	WOS:000187210700006
J	Pretty, J				Pretty, J			Social capital and the collective management of resources	SCIENCE			English	Article								The proposition that natural resources need protection from the destructive actions of people is widely accepted. Yet communities have shown in the past and increasingly today that they can collaborate for long-term resource management. The term social capital captures the idea that social bonds and norms are critical for sustainability. Where social capital is high in formalized groups, people have the confidence to invest in collective activities, knowing that others will do so too. Some 0.4 to 0.5 million groups have been established since the early 1990s for watershed, forest, irrigation, pest, wildlife, fishery, and microfinance management. These offer a route to sustainable management and governance of common resources.	Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England	University of Essex	Pretty, J (corresponding author), Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England.	jpretty@essex.ac.uk	Pretty, Jules/D-4071-2012	Nedanov, Aleksandar/0000-0002-4238-9275; Pretty, Jules/0000-0002-3897-6581				[Anonymous], 1999, CULTURAL SPIRITUAL V; [Anonymous], 2002, DRAMA COMMONS; Beck T, 2001, WORLD DEV, V29, P119, DOI 10.1016/S0305-750X(00)00089-9; Callicott JB, 1998, GREAT NEW WILDERNESS; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; DONNELLYROARK P, 2002, GROWTH EQUITY SOCIAL; Dryzek J. S., 2000, DELIBERATIVE DEMOCRA; FLORA CB, 1993, ANN AM ACAD POLIT SS, V529, P48, DOI 10.1177/0002716293529001005; Gadgil Madhav, 2013, THIS FISSURED LAND E; Gardner G.T., 1996, ENV PROBLEMS HUMAN B; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Keohane R. O., 1993, I EARTH; Krishna A., 2002, ACTIVE SOCIAL CAPITA; Landolt P., 1996, AM PROSPECT; Murali K. S., 2002, Environmental Management and Health, V13, P512, DOI 10.1108/09566160210441807; Murali K. S., 2003, International Journal of Environment and Sustainable Development, V2, P19, DOI 10.1504/IJESD.2003.002361; Narayan D., 1997, 1796 WORLD BANK; Nash Roderick, 1973, WILDERNESS AM MIND; ORiordan T., 2002, BIODIVERSITY SUSTAIN; OSTROM E, 1990, GOVT COMMONS; Ostrom E., 2002, DRAMA COMMONS; PONTIUS J, 2001, FARMER FIELD SCH COM; Pretty J, 2001, WORLD DEV, V29, P209, DOI 10.1016/S0305-750X(00)00098-X; Pretty J., 2002, AGRICULTURE RECONNEC; Pretty JN, 2003, AGR ECOSYST ENVIRON, V95, P217, DOI 10.1016/S0167-8809(02)00087-7; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Putnam RD., 2000, BOWLING ALONE COLLAP; SINGLETON S, 1992, J THEORETICAL POLITI, V4, P309, DOI DOI 10.1177/0951692892004003004; Stern P.C., 2002, DRAMA COMMONS, P443; Taylor Michael, 1982, COMMUNITY ANARCHY LI; Uphoff N., 2002, AGROECOLOGICAL INNOV; Wade R., 1994, VILLAGE REPUBLICS; Wilkinson RG, 1999, ANN NY ACAD SCI, V896, P48, DOI 10.1111/j.1749-6632.1999.tb08104.x; WOOLCOCK M, 2001, ISUMA CANADIAN J POL, V0002	34	834	873	8	280	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1912	1914		10.1126/science.1090847	http://dx.doi.org/10.1126/science.1090847			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752NL	14671287	Green Submitted			2022-12-24	WOS:000187174000042
J	Boerma, JT; Ghys, PD; Walker, N				Boerma, JT; Ghys, PD; Walker, N			Estimates of HIV-1 prevalence from national population-based surveys as a new gold standard	LANCET			English	Editorial Material							GENERAL-POPULATION; INFECTION; RISK; SURVEILLANCE; MIGRATION; EPIDEMIC		WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; Joint UN Programme HIV AIDS, Geneva, Switzerland	World Health Organization	Boerma, JT (corresponding author), WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland.	boermat@who.int						Bloom SS, 2002, SEX TRANSM INFECT, V78, P261, DOI 10.1136/sti.78.4.261; Boerma JT, 2001, POPUL DEV REV, V27, P303, DOI 10.1111/j.1728-4457.2001.00303.x; *CDCP, 2001, ET INT PREV IST COMP; *CELL PLAN STAT MI, 2002, HIV TEST MAL FIND 20; Fylkesnes K, 1998, AIDS, V12, P1227, DOI 10.1097/00002030-199810000-00015; Glynn JR, 2001, AIDS, V15, P1717, DOI 10.1097/00002030-200109070-00016; Glynn JR, 2001, AIDS, V15, P2025, DOI 10.1097/00002030-200110190-00016; Gregson S, 2002, AIDS, V16, P643, DOI 10.1097/00002030-200203080-00017; Hodes R, 2002, AIDS, V16, P1, DOI 10.1097/00002030-200201040-00001; Kilian AHD, 1999, AIDS, V13, P391, DOI 10.1097/00002030-199902250-00012; Kwesigabo G, 2000, J ACQ IMMUN DEF SYND, V23, P410; NUNN AJ, 1995, AIDS, V9, P503, DOI 10.1097/00002030-199509050-00013; PISON G, 1993, J ACQ IMMUN DEF SYND, V6, P196; Schwartlander B, 1999, AIDS, V13, P2445, DOI 10.1097/00002030-199912030-00017; Shisana O, 2002, S AFRICAN NATL HIV P; *UNAIDS, 2002, REP GLOB HIV AIDS EP; *UNAIDS WHO, 2002, AIDS EP UPD; WALKER N, IN PRESS AIDS; Zaba B, 1998, AIDS, V12, pS41; [No title captured]	20	100	100	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2003	362	9399					1929	1931		10.1016/S0140-6736(03)14967-7	http://dx.doi.org/10.1016/S0140-6736(03)14967-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667753				2022-12-24	WOS:000187011600027
J	Venstrom, JM; McBride, MA; Rother, KI; Hirshberg, B; Orchard, TJ; Harlan, DM				Venstrom, JM; McBride, MA; Rother, KI; Hirshberg, B; Orchard, TJ; Harlan, DM			Survival after pancreas transplantation in patients with diabetes and preserved kidney function	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; COMPLICATIONS; MELLITUS; RECIPIENTS; REGISTRY; PROGNOSIS; MORTALITY; IMPACT; ONSET; ERA	Context Solitary pancreas transplantation (ie, pancreas alone or pancreas-after-kidney) for diabetes mellitus remains controversial due to procedure-associated morbidity/ mortality, toxicity of immunosuppression, expense, and unproven effects on the secondary complications of diabetes. Whether transplantation offers a survival advantage over conventional therapies for diabetes is unknown. Objective To determine the association between solitary pancreas transplantation and survival in patients with diabetes and preserved kidney function. Design, Setting, and Patients Retrospective observational cohort study conducted at 124 transplant centers in the United States, in 11572 patients with diabetes mellitus on the waiting list for pancreas transplantation (pancreas alone, pancreas-after-kidney, or simultaneous pancreas-kidney) at the United Network for Organ Sharing/ Organ Procurement and Transplantation Network between January 1, 1995, and December 31, 2000. All patients receiving a multiorgan (other than simultaneous pancreas-kidney) transplant were excluded, as were those listed for solitary pancreas transplantation who had a serum creatinine level greater than 2 mg/dL (176.8 mumol/L) at time of listing, or who ultimately received a simultaneous pancreas-kidney transplant. Main Outcome Measure All-cause mortality Within 4 years following transplantation (or within a comparable time on the waiting list for the group not undergoing transplantation). Results Overall relative risk of all-cause mortality for transplant recipients (compared with patients awaiting the same procedure) over 4 years of follow-up was 1.57 (95% confidence interval [CI], 0.98-2.53; P=.06) for pancreas transplant alone, 1.42 (95% Cl, 1.03-1.94; P=.03) for pancreas-after-kidney transplant, and 0.43 (95% Cl, 0.39-0.48) for simultaneous pancreas-kidney transplant. Transplant patient 1 - and 4-year survival rates were 96.5% and 85.2% for pancreas transplant alone, respectively, and 95.3% and 84.5% for pancreas-after-kidney transplant, while 1 - and 4-year survival rates for patients on the waiting list were 97.6% and 92.1% for pancreas transplant alone, respectively, and 97.1% and 88.1% for pancreas-after-kidney transplant. Conclusion From 1995-2000, survival for those with diabetes and preserved kidney function and receiving a solitary pancreas transplant was significantly worse compared with the survival of waiting-list patients receiving conventional therapy.	NIDDKD, Transplantat & Autoimmun Branch, NIH, US Dept HHS, Bethesda, MD 20892 USA; Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; United Network Organ Sharing, Richmond, VA USA; Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University; United Network for Organ Sharing; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Uniformed Services University of the Health Sciences - USA	Harlan, DM (corresponding author), NIDDKD, Transplantat & Autoimmun Branch, NIH, US Dept HHS, 10 Ctr Dr,Bldg 10,Room 8N307, Bethesda, MD 20892 USA.			orchard, trevor/0000-0001-9552-3215	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK062000] Funding Source: NIH RePORTER; PHS HHS [231-00-0115] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bunnapradist S, 2003, J AM SOC NEPHROL, V14, P208, DOI 10.1097/01.ASN.0000037678.54984.41; DECKERT T, 1978, DIABETOLOGIA, V14, P363, DOI 10.1007/BF01228130; DECKERT T, 1978, DIABETOLOGIA, V14, P371, DOI 10.1007/BF01228131; Fioretto P, 1998, NEW ENGL J MED, V339, P69, DOI 10.1056/NEJM199807093390202; GROSS CR, 1992, CLIN TRANSPLANT, V6, P165; Gross CR, 1998, CLIN TRANSPLANT, V12, P351; Gruessner AC, 2001, TRANSPLANT P, V33, P1643, DOI 10.1016/S0041-1345(00)02625-7; Gruessner RWG, 1997, TRANSPLANTATION, V64, P1572, DOI 10.1097/00007890-199712150-00011; Gruessner RWG, 1997, J AM COLL SURGEONS, V185, P128, DOI 10.1016/S1072-7515(01)00895-X; Hosenpud JD, 1998, LANCET, V351, P24, DOI 10.1016/S0140-6736(97)06405-2; Humar A, 2000, ANN SURG, V231, P269, DOI 10.1097/00000658-200002000-00017; KATZ H, 1991, NEW ENGL J MED, V325, P1278, DOI 10.1056/NEJM199110313251804; Landgraf R, 1996, DIABETOLOGIA, V39, P1415, DOI 10.1007/s001250050593; Luzi L, 1998, NEW ENGL J MED, V339, P115, DOI 10.1056/NEJM199807093390210; Nishimura R, 2001, DIABETES CARE, V24, P823, DOI 10.2337/diacare.24.5.823; Ojo AO, 2001, TRANSPLANTATION, V71, P82, DOI 10.1097/00007890-200101150-00014; Piehlmeier W, 1996, EUR J SURG, V162, P933; PIEHLMEIER W, 1991, DIABETOLOGIA S1, V34, P150; Reddy KS, 2003, AM J KIDNEY DIS, V41, P464, DOI 10.1053/ajkd.2003.50057; Robertson R Paul, 2003, Diabetes Care, V26 Suppl 1, pS120; Robertson RP, 1998, J CLIN ENDOCR METAB, V83, P1868, DOI 10.1210/jc.83.6.1868; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sutherland DER, 1999, TRANSPLANT P, V31, P597, DOI 10.1016/S0041-1345(98)01573-5; Sutherland DER, 2001, ANN SURG, V233, P463, DOI 10.1097/00000658-200104000-00003; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	25	217	225	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2003	290	21					2817	2823		10.1001/jama.290.21.2817	http://dx.doi.org/10.1001/jama.290.21.2817			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QP	14657065				2022-12-24	WOS:000186872800023
J	Lingel, A; Simon, B; Izaurralde, E; Sattler, M				Lingel, A; Simon, B; Izaurralde, E; Sattler, M			Structure and nucleic-acid binding of the Drosophila Argonaute 2 PAZ domain	NATURE			English	Article							RNA INTERFERENCE; PROTEIN STRUCTURES; GENE; NMR; ATP; RECOGNITION; CLEAVAGE; PROGRAM; HOMOLOG; SYSTEM	RNA interference is a conserved mechanism that regulates gene expression in response to the presence of double-stranded (ds) RNAs1,2. The RNase III-like enzyme Dicer first cleaves dsRNA into 21-23-nucleotide small interfering RNAs (siR-NAs)(3-6). In the effector step, the multimeric RNA-induced silencing complex ( RISC) identifies messenger RNAs homologous to the siRNAs and promotes their degradation(3,7). The Argonaute 2 protein (Ago2) is a critical component of RISC8,9. Both Argonaute and Dicer family proteins contain a common PAZ domain whose function is unknown(10). Here we present the three-dimensional nuclear magnetic resonance structure of the Drosophila melanogaster Ago2 PAZ domain. This domain adopts a nucleic-acid-binding fold that is stabilized by conserved hydrophobic residues. The nucleic-acid-binding patch is located in a cleft between the surface of a central beta-barrel and a conserved module comprising strands beta3, beta4 and helix alpha3. Because critical structural residues and the binding surface are conserved, we suggest that PAZ domains in all members of the Argonaute and Dicer families adopt a similar fold with nucleic-acid binding function, and that this plays an important part in gene silencing.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Izaurralde, E (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Sattler, Michael/A-2407-2012; Lingel, Andreas/AAP-5078-2021; Sattler, Michael/C-1169-2010; Izaurralde, Elisa/G-3239-2012	Sattler, Michael/0000-0002-1594-0527; Simon, Bernd/0000-0003-0164-5516; Izaurralde, Elisa/0000-0001-7365-2649				Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bogden CE, 1999, MOL CELL, V3, P487, DOI 10.1016/S1097-2765(00)80476-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denli AM, 2003, TRENDS BIOCHEM SCI, V28, P196, DOI 10.1016/S0968-0004(03)00058-6; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kataoka Y, 2001, GENES CELLS, V6, P313, DOI 10.1046/j.1365-2443.2001.00427.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; YAN KS, 2003, NATURE          1116; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	30	326	362	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2003	426	6965					465	469		10.1038/nature02123	http://dx.doi.org/10.1038/nature02123			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14615801				2022-12-24	WOS:000186800800043
J	Xiong, W; Ferrell, JE				Xiong, W; Ferrell, JE			A positive-feedback-based bistable 'memory module' that governs a cell fate decision	NATURE			English	Article							XENOPUS OOCYTE MATURATION; RANA PIPIENS OOCYTES; MAP KINASE; INHIBITORY KINASE; CYCLIN-B; ACTIVATION; PROTEIN; MOS; DIFFERENTIATION; INITIATION	The maturation of Xenopus oocytes can be thought of as a process of cell fate induction, with the immature oocyte representing the default fate and the mature oocyte representing the induced fate(1,2). Crucial mediators of Xenopus oocyte maturation, including the p42 mitogen-activated protein kinase (MAPK) and the cell-division cycle protein kinase Cdc2, are known to be organized into positive feedback loops(3). In principle, such positive feedback loops could produce an actively maintained 'memory' of a transient inductive stimulus and could explain the irreversibility of maturation(3-6). Here we show that the p42 MAPK and Cdc2 system normally generates an irreversible biochemical response from a transient stimulus, but the response becomes transient when positive feedback is blocked. Our results explain how a group of intrinsically reversible signal transducers can generate an irreversible response at a systems level, and show how a cell fate can be maintained by a self-sustaining pattern of protein kinase activation.	Stanford Univ, Dept Mol Pharmacol, Sch Med, Stanford, CA 94305 USA	Stanford University	Ferrell, JE (corresponding author), Stanford Univ, Dept Mol Pharmacol, Sch Med, Stanford, CA 94305 USA.							Abrieu A, 2001, J CELL SCI, V114, P257; Bagowski CP, 2001, CURR BIOL, V11, P1176, DOI 10.1016/S0960-9822(01)00330-X; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bosch E, 1997, ONCOGENE, V15, P1021, DOI 10.1038/sj.onc.1201270; DETTLAFF TA, 1966, J EMBRYOL EXP MORPH, V16, P183; Dupre A, 2002, EMBO J, V21, P4026, DOI 10.1093/emboj/cdf400; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GOTOH Y, 1995, J BIOL CHEM, V270, P25898, DOI 10.1074/jbc.270.43.25898; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Matten WT, 1996, DEV BIOL, V179, P485, DOI 10.1006/dbio.1996.0277; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; Nebreda AR, 2000, CURR OPIN CELL BIOL, V12, P666, DOI 10.1016/S0955-0674(00)00150-2; NEBREDA AR, 1995, EMBO J, V14, P5597, DOI 10.1002/j.1460-2075.1995.tb00247.x; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; ROY LM, 1991, J CELL BIOL, V113, P507, DOI 10.1083/jcb.113.3.507; Roy LM, 1996, ONCOGENE, V12, P2203; SCHUETZ AW, 1967, J EXP ZOOL, V166, P347, DOI 10.1002/jez.1401660307; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; SMITH LD, 1968, DEV BIOL, V17, P627, DOI 10.1016/0012-1606(68)90010-9; Sohaskey ML, 1999, MOL BIOL CELL, V10, P3729, DOI 10.1091/mbc.10.11.3729; Thomas R, 2001, CHAOS, V11, P170, DOI 10.1063/1.1350439; YEW N, 1992, NATURE, V355, P649, DOI 10.1038/355649a0	30	554	568	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2003	426	6965					460	465		10.1038/nature02089	http://dx.doi.org/10.1038/nature02089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647386				2022-12-24	WOS:000186800800042
J	Mootha, VK; Bunkenborg, J; Olsen, JV; Hjerrild, M; Wisniewski, JR; Stahl, E; Bolouri, MS; Ray, HN; Sihag, S; Kamal, M; Patterson, N; Lander, ES; Mann, M				Mootha, VK; Bunkenborg, J; Olsen, JV; Hjerrild, M; Wisniewski, JR; Stahl, E; Bolouri, MS; Ray, HN; Sihag, S; Kamal, M; Patterson, N; Lander, ES; Mann, M			Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria	CELL			English	Article							MASS-SPECTROMETRY; CYTOCHROME-C; SEQUENCE DATABASES; PROTEOMIC ANALYSIS; IDENTIFICATION; EXPRESSION; APOPTOSIS; SUBUNIT; COMPLEX; ORIGIN	Mitochondria are tailored to meet the metabolic and signaling needs of each cell. To explore its molecular composition, we performed a proteomic survey of mitochondria from mouse brain, heart, kidney, and liver and combined the results with existing gene annotations to produce a list of 591 mitochondrial proteins, including 163 proteins not previously associated with this organelle. The protein expression data were largely concordant with large-scale surveys of RNA abundance and both measures indicate tissue-specific differences in organelle composition. RNA expression profiles across tissues revealed networks of mitochondrial genes that share functional and regulatory mechanisms. We also determined a larger "neighborhood" of genes whose expression is closely correlated to the mitochondrial genes. The combined analysis identifies specific genes of biological interest, such as candidates for mtDNA repair enzymes, offers new insights into the biogenesis and ancestry of mammalian mitochondria, and provides a framework for understanding the organelle's contribution to human disease.	MIT, Ctr Genome Res, Whitehead Inst, Cambridge, MA 02139 USA; MDS Proteom, DK-5230 Odense, Denmark; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Univ So Denmark, Ctr Expt Bioinformat, DK-5230 Odense, Denmark; MIT, Dept Biol, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Southern Denmark; Massachusetts Institute of Technology (MIT)	Lander, ES (corresponding author), MIT, Ctr Genome Res, Whitehead Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lander@genome.wi.mit.edu; mann@bmb.sdu.dk	Olsen, Jesper/C-4738-2008; Mann, Matthias/A-3454-2013; Olsen, Jesper/ABH-4638-2020	Mann, Matthias/0000-0003-1292-4799; Olsen, Jesper/0000-0002-4747-4938; Bunkenborg, Jakob/0000-0002-2908-9323				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Brenner C, 1999, J CELL PHYSIOL, V181, P179, DOI 10.1002/(SICI)1097-4652(199911)181:2<179::AID-JCP1>3.0.CO;2-8; CHI NW, 1994, J BIOL CHEM, V269, P29984; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Endele S, 1999, GENOMICS, V60, P218, DOI 10.1006/geno.1999.5881; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; GHADIALLY FN, 1997, ULTRASTRUCTURAL PATH, V1; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hardman RA, 2001, CANCER RES, V61, P1392; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Karlberg O, 2000, YEAST, V17, P170, DOI 10.1002/1097-0061(20000930)17:3<170::AID-YEA25>3.0.CO;2-V; KLAUSNER RD, 1989, SCIENCE, V246, P870, DOI 10.1126/science.2683086; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lian Z, 2001, BLOOD, V98, P513, DOI 10.1182/blood.V98.3.513; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Lopez MF, 2000, ELECTROPHORESIS, V21, P3427, DOI 10.1002/1522-2683(20001001)21:16<3427::AID-ELPS3427>3.0.CO;2-L; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; Marc P, 2002, EMBO REP, V3, P159, DOI 10.1093/embo-reports/kvf025; Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Ozawa T, 2003, NAT BIOTECHNOL, V21, P287, DOI 10.1038/nbt791; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PULGSERVER P, 2003, ENDOCR REV, V24, P78; Rabilloud T, 1998, ELECTROPHORESIS, V19, P1006, DOI 10.1002/elps.1150190616; Samuel SJ, 1997, HEPATOLOGY, V25, P1213, DOI 10.1002/hep.510250525; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Scharfe C, 2000, NUCLEIC ACIDS RES, V28, P155, DOI 10.1093/nar/28.1.155; STREYER L, 1988, BIOCHEMISTRY; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122; Vijayasarathy C, 1998, BBA-BIOMEMBRANES, V1371, P71, DOI 10.1016/S0005-2736(97)00278-2; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Westermann B, 2003, NAT BIOTECHNOL, V21, P239, DOI 10.1038/nbt0303-239	49	683	728	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 26	2003	115	5					629	640		10.1016/S0092-8674(03)00926-7	http://dx.doi.org/10.1016/S0092-8674(03)00926-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651853	Bronze			2022-12-24	WOS:000186885600012
J	Rayapureddi, JP; Kattamuri, C; Steinmetz, BD; Frankfort, BJ; Ostrin, EJ; Mardon, G; Hegde, RS				Rayapureddi, JP; Kattamuri, C; Steinmetz, BD; Frankfort, BJ; Ostrin, EJ; Mardon, G; Hegde, RS			Eyes absent represents a class of protein tyrosine phosphatases	NATURE			English	Article							P-TYPE ATPASE; DROSOPHILA EYE; GENE; DEHALOGENASE; SUBSTRATE; MUTATIONS; EYA1; SUPERFAMILY; ACTIVATION; COMPLEX	The Eyes absent proteins are members of a conserved regulatory network implicated in the development of the eye, muscle, kidney and ear(1-7). Mutations in the Eyes absent genes have been associated with several congenital disorders including the multi-organ disease bronchio-oto-renal syndrome(8), congenital cataracts(9) and late-onset deafness(10). On the basis of previous analyses it has been shown that Eyes absent is a nuclear transcription factor, acting through interaction with homeodomain-containing Sine oculis (also known as Six) proteins(11). Here we show that Eyes absent is also a protein tyrosine phosphatase. It does not resemble the classical tyrosine phosphatases that use cysteine as a nucleophile and proceed by means of a thiol-phosphate intermediate(12). Rather, Eyes absent is the prototype for a class of protein tyrosine phosphatases that use a nucleophilic aspartic acid in a metal-dependent reaction. Furthermore, the phosphatase activity of Eyes absent contributes to its ability to induce eye formation in Drosophila.	Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Neurosci & Program Dev Biol, Houston, TX 77030 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Hegde, RS (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.				NEI NIH HHS [R01 EY014648] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011232, R01EY014648] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abdelhak S, 1997, HUM MOL GENET, V6, P2247, DOI 10.1093/hmg/6.13.2247; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Azuma N, 2000, HUM MOL GENET, V9, P363, DOI 10.1093/hmg/9.3.363; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Borsani G, 1999, HUM MOL GENET, V8, P11, DOI 10.1093/hmg/8.1.11; Bui QT, 2000, GENETICS, V155, P709; CHARBONNEAU H, 1992, ANNU REV CELL BIOL, V8, P463, DOI 10.1146/annurev.cellbio.8.1.463; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Collet JF, 1999, J BIOL CHEM, V274, P33985, DOI 10.1074/jbc.274.48.33985; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; DAUM G, 1993, ANAL BIOCHEM, V211, P50, DOI 10.1006/abio.1993.1231; DENU JM, 1995, J BIOL CHEM, V270, P3796, DOI 10.1074/jbc.270.8.3796; Desplan C, 1997, CELL, V91, P861, DOI 10.1016/S0092-8674(00)80475-4; Fan XM, 2000, J BIOL CHEM, V275, P32129, DOI 10.1074/jbc.M004577200; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Morais MC, 2000, BIOCHEMISTRY-US, V39, P10385, DOI 10.1021/bi001171j; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Pappu KS, 2003, DEVELOPMENT, V130, P3053, DOI 10.1242/dev.00534; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Ridder IS, 1999, BIOCHEM J, V339, P223, DOI 10.1042/0264-6021:3390223; Ridder IS, 1997, J BIOL CHEM, V272, P33015, DOI 10.1074/jbc.272.52.33015; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Wayne S, 2001, HUM MOL GENET, V10, P195, DOI 10.1093/hmg/10.3.195; Xu PX, 1997, P NATL ACAD SCI USA, V94, P11974, DOI 10.1073/pnas.94.22.11974; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Xu PX, 1997, DEVELOPMENT, V124, P219; Xu PX, 2002, DEVELOPMENT, V129, P3033; ZHANG ZY, 1993, P NATL ACAD SCI USA, V90, P4446, DOI 10.1073/pnas.90.10.4446	30	188	210	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2003	426	6964					295	298		10.1038/nature02093	http://dx.doi.org/10.1038/nature02093			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	744YQ	14628052				2022-12-24	WOS:000186660800045
J	Kodama, S; Kuhtreiber, W; Fujimura, S; Dale, EA; Faustman, DL				Kodama, S; Kuhtreiber, W; Fujimura, S; Dale, EA; Faustman, DL			Islet regeneration during the reversal of autoimmune diabetes in NOD mice	SCIENCE			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW CELLS; IN-VIVO; ADULT MICE; DIFFERENTIATE; FUSION; HEPATOCYTES; BRAIN; PROGENITORS; EXPRESSION	Nonobese diabetic (NOD) mice are a model for type 1 diabetes in humans. Treatment of NOD mice with end-stage disease by injection of donor splenocytes and complete Freund's adjuvant eliminates autoimmunity and permanently restores normoglycemia. The return of endogenous insulin secretion is accompanied by the reappearance of pancreatic beta cells. We now show that live donor male or labeled splenocytes administered to diabetic NOD females contain cells that rapidly differentiate into islet and ductal epithelial cells within the pancreas. Treatment with irradiated splenocytes is also followed by islet regeneration, but at a slower rate. The islets generated in both instances are persistent, functional, and apparent in all NOD hosts with permanent disease reversal.	Massachusetts Gen Hosp, Immunobiol Lab, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University	Faustman, DL (corresponding author), Massachusetts Gen Hosp, Immunobiol Lab, Bldg 149,13th St,Room 3602, Charlestown, MA 02129 USA.	faustman@helix.mgh.harvard.edu		Kuhtreiber, Willem/0000-0002-5717-5915	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK57521-02] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; FAUSTMAN D, 1991, SCIENCE, V254, P1756, DOI 10.1126/science.1763324; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hayashi T, 1999, MOL CELL BIOL, V19, P8646; Hayashi T, 2000, NAT MED, V6, P1065, DOI 10.1038/80353; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Orlic D, 2001, ANN NY ACAD SCI, V938, P221; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Ryu S, 2001, J CLIN INVEST, V108, P63, DOI 10.1172/JCI200112335; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Yang G, 1997, J IMMUNOL, V159, P3068; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	36	281	313	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2003	302	5648					1223	1227		10.1126/science.1088949	http://dx.doi.org/10.1126/science.1088949			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14615542				2022-12-24	WOS:000186544300058
J	Zhou, Y; Su, Y; Li, BL; Liu, F; Ryder, JW; Wu, X; Gonzalez-DeWhitt, PA; Gelfanova, V; Hale, JE; May, PC; Paul, SM; Ni, BH				Zhou, Y; Su, Y; Li, BL; Liu, F; Ryder, JW; Wu, X; Gonzalez-DeWhitt, PA; Gelfanova, V; Hale, JE; May, PC; Paul, SM; Ni, BH			Nonsteroidal anti-inflammatory drugs can lower amyloidogenic A beta(42) by inhibiting Rho	SCIENCE			English	Article							ALZHEIMERS-DISEASE; SULINDAC SULFIDE; RAS; PROTEIN	A subset of nonsteroidal anti-inflammatory drugs (NSAIDs) has been shown to preferentially reduce the secretion of the highly amyloidogenic, 42-residue amyloid-beta peptide Abeta(42). We found that Rho and its effector, Rho-associated kinase, preferentially regulated the amount of Abeta(42) produced in vitro and that only those NSAIDs effective as Rho inhibitors lowered Abeta(42). Administration of Y-27632, a selective Rock inhibitor, also preferentially lowered brain levels of Abeta(42) in a transgenic mouse model of Alzheimer's disease. Thus, the Rho-Rock pathway may regulate amyloid precursor protein processing, and a subset of NSAIDs can reduce Abeta(42) through inhibition of Rho activity.	Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery Res & Biores Technol & Prot, Indianapolis, IN 46285 USA	Eli Lilly	Zhou, Y (corresponding author), Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery Res & Biores Technol & Prot, Indianapolis, IN 46285 USA.	zhou_yan_yz@lilly.com; paul_steven_m@lilly.com	Paul, Steve/ABE-5400-2020					CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Gala M, 2002, CANCER LETT, V175, P89, DOI 10.1016/S0304-3835(01)00716-9; Gan XD, 2001, J BIOL CHEM, V276, P48702, DOI 10.1074/jbc.M109402200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herrmann C, 1998, ONCOGENE, V17, P1769, DOI 10.1038/sj.onc.1202085; Holstein SA, 2002, BIOCHEMISTRY-US, V41, P13698, DOI 10.1021/bi026251x; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Kuhn TB, 1998, J NEUROBIOL, V37, P524, DOI 10.1002/(SICI)1097-4695(199812)37:4<524::AID-NEU3>3.0.CO;2-H; MCGEER PL, 1990, LANCET, V335, P1037, DOI 10.1016/0140-6736(90)91101-F; Morihara T, 2002, J NEUROCHEM, V83, P1009, DOI 10.1046/j.1471-4159.2002.01195.x; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591	15	273	319	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2003	302	5648					1215	1217		10.1126/science.1090154	http://dx.doi.org/10.1126/science.1090154			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14615541				2022-12-24	WOS:000186544300056
J	di Fagagna, FD; Reaper, PM; Clay-Farrace, L; Fiegler, H; Carr, P; von Zglinicki, T; Saretzki, G; Carter, NP; Jackson, SP				di Fagagna, FD; Reaper, PM; Clay-Farrace, L; Fiegler, H; Carr, P; von Zglinicki, T; Saretzki, G; Carter, NP; Jackson, SP			A DNA damage checkpoint response in telomere-initiated senescence	NATURE			English	Article							IONIZING-RADIATION; S-CHECKPOINT; LIFE-SPAN; SENSITIVITY; GENOME; MDC1; ATM; APOPTOSIS; DISTINCT; KINASE	Most human somatic cells can undergo only a limited number of population doublings in vitro(1). This exhaustion of proliferative potential, called senescence, can be triggered when telomeres the ends of linear chromosomes-cannot fulfil their normal protective functions. Here we show that senescent human fibroblasts display molecular markers characteristic of cells bearing DNA double-strand breaks. These markers include nuclear foci of phosphorylated histone H2AX and their co-localization with DNA repair and DNA damage checkpoint factors such as 53BP1, MDC1 and NBS1. We also show that senescent cells contain activated forms of the DNA damage checkpoint kinases CHK1 and CHK2. Furthermore, by chromatin immunoprecipitation and whole-genome scanning approaches, we show that the chromosome ends of senescent cells directly contribute to the DNA damage response, and that uncapped telomeres directly associate with many, but not all, DNA damage response proteins. Finally, we show that inactivation of DNA damage checkpoint kinases in senescent cells can restore cell-cycle progression into S phase. Thus, we propose that telomere-initiated senescence reflects a DNA damage checkpoint response that is activated with a direct contribution from dysfunctional telomeres.	Univ Cambridge, Wellcome Trust Canc Res UK Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Newcastle Univ, Inst Ageing & Hlth, Henry Wellcome Lab Biogerontol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England	University of Cambridge; Wellcome Trust Sanger Institute; Newcastle University - UK	Jackson, SP (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Inst Canc & Dev Biol, Cambridge CB2 1QR, England.	dadda@ifom-firc.it; spj13@mole.bio.cam.ac.uk	d'Adda di Fagagna, Fabrizio/AAC-4683-2022; Jackson, Stephen Philip/R-4548-2019; Saretzki, Gabriele Christine/I-7175-2019; Dry, Kate/I-2328-2014	d'Adda di Fagagna, Fabrizio/0000-0002-9603-5966; Jackson, Stephen Philip/0000-0001-9317-7937; Saretzki, Gabriele Christine/0000-0003-2100-8223; von Zglinicki, Thomas/0000-0002-5939-0248; DADDADIFAGAGNA, FABRIZIO/0000-0002-1976-3185				Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)82148-6; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chehab NH, 2000, GENE DEV, V14, P278; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; di Fagagna FD, 2001, CURR BIOL, V11, P1192, DOI 10.1016/S0960-9822(01)00328-1; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Freire R, 1998, GENE DEV, V12, P2560, DOI 10.1101/gad.12.16.2560; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Goytisolo FA, 2000, J EXP MED, V192, P1625, DOI 10.1084/jem.192.11.1625; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Martens UM, 1998, NAT GENET, V18, P76, DOI 10.1038/ng0198-018; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/nrc1044; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stoeber K, 2001, J CELL SCI, V114, P2027; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299	30	1186	1218	10	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2003	426	6963					194	198		10.1038/nature02118	http://dx.doi.org/10.1038/nature02118			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14608368				2022-12-24	WOS:000186517200047
J	Wentworth, P; Nieva, J; Takeuchi, C; Galve, R; Wentworth, AD; Dilley, RB; DeLaria, GA; Saven, A; Babior, BM; Janda, KD; Eschenmoser, A; Lerner, RA				Wentworth, P; Nieva, J; Takeuchi, C; Galve, R; Wentworth, AD; Dilley, RB; DeLaria, GA; Saven, A; Babior, BM; Janda, KD; Eschenmoser, A; Lerner, RA			Evidence for ozone formation in human atherosclerotic arteries	SCIENCE			English	Article							LOW-DENSITY-LIPOPROTEIN; CHOLESTEROL; OZONIZATION; OXIDATION	Here, we report evidence for the production of ozone in human disease. Signature products unique to cholesterol ozonolysis are present within atherosclerotic tissue at the time of carotid endarterectomy, suggesting that ozone production occurred during lesion development. Furthermore, advanced atherosclerotic plaques generate ozone when the leukocytes within the diseased arteries are activated in vitro. The steroids produced by cholesterol ozonolysis cause effects that are thought to be critical to the pathogenesis of atherosclerosis, including cytotoxicity, lipid-loading in macrophages, and deformation of the apolipoprotein B-100 secondary structure. We propose the trivial designation "atheronals" for this previously unrecognized class of steroids.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Clin, Div Hematol & Oncol, La Jolla, CA 92037 USA; Scripps Clin, Div Cardiothorac & Vasc Surg, La Jolla, CA 92037 USA; ETH Honggerberg, Organ Chem Lab, CH-8093 Zurich, Switzerland; Univ Oxford, Oxford Glycobiol Inst, Dept Biochem, Oxford OX1 3QU, England	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oxford	Wentworth, P (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Galve, Roger/I-3443-2017	Galve, Roger/0000-0001-6189-5037	NCI NIH HHS [P01CA27489] Funding Source: Medline; NIAID NIH HHS [5T32AI07606] Funding Source: Medline; NIGMS NIH HHS [GM 43858] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA027489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043858, R29GM043858] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Babior BM, 2003, P NATL ACAD SCI USA, V100, P3031, DOI 10.1073/pnas.0530251100; CORNFORTH JW, 1953, BIOCHEM J, V54, P590, DOI 10.1042/bj0540590; GUMULKA J, 1983, J AM CHEM SOC, V105, P1972, DOI 10.1021/ja00345a052; GUMULKA J, 1982, LIPIDS, V17, P197, DOI 10.1007/BF02535103; Hansson GK, 2002, CIRC RES, V91, P281, DOI 10.1161/01.RES.0000029784.15893.10; HIETTER H, 1986, CANCER BIOCHEM BIOPH, V9, P75; JAWORSKI K, 1988, J ORG CHEM, V53, P545, DOI 10.1021/jo00238a014; LORENZO JL, 1987, FEBS LETT, V218, P77, DOI 10.1016/0014-5793(87)81022-0; LUND E, 1995, ACCOUNTS CHEM RES, V28, P241, DOI 10.1021/ar00054a001; PARYZEK Z, 1990, J CHEM SOC PERK T 1, P1222, DOI 10.1039/p19900001222; REYMOND JL, 1995, J ORG CHEM, V60, P6970, DOI 10.1021/jo00126a057; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SEVANIAN A, 1984, P NATL ACAD SCI-BIOL, V81, P4198, DOI 10.1073/pnas.81.13.4198; SMALL DM, 1988, ARTERIOSCLEROSIS, V8, P103, DOI 10.1161/01.ATV.8.2.103; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; STEINBRECHER UP, 1984, P NATL ACAD SCI-BIOL, V81, P3883, DOI 10.1073/pnas.81.12.3883; TAKEUCHI K, 1990, ANAL CHIM ACTA, V230, P183, DOI 10.1016/S0003-2670(00)82779-8; TAKEUCHI K, 1989, ANAL CHEM, V61, P619, DOI 10.1021/ac00181a025; WANG KY, 1993, STEROIDS, V58, P225, DOI 10.1016/0039-128X(93)90023-G; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wentworth P, 2001, SCIENCE, V293, P1806, DOI 10.1126/science.1062722; Wentworth P, 2002, SCIENCE, V298, P2195, DOI 10.1126/science.1077642; Wentworth P, 2003, P NATL ACAD SCI USA, V100, P1490, DOI 10.1073/pnas.0437831100	24	230	249	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2003	302	5647					1053	1056		10.1126/science.1089525	http://dx.doi.org/10.1126/science.1089525			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605372				2022-12-24	WOS:000186396300051
J	Changelian, PS; Flanagan, ME; Ball, DJ; Kent, CR; Magnuson, KS; Martin, WH; Rizzuti, BJ; Sawyer, PS; Perry, BD; Brissette, WH; McCurdy, SP; Kudlacz, EM; Conklyn, MJ; Elliott, EA; Koslov, ER; Fisher, MB; Strelevitz, TJ; Yoon, K; Whipple, DA; Sun, JM; Munchhof, MJ; Doty, JL; Casavant, JM; Blumenkopf, TA; Hines, M; Brown, MF; Lillie, BM; Subramanyam, C; Shang-Poa, C; Milici, AJ; Beckius, GE; Moyer, JD; Su, CY; Woodworth, TG; Gaweco, AS; Beals, CR; Littman, BH; Fisher, DA; Smith, JF; Zagouras, P; Magna, HA; Saltarelli, MJ; Johnson, KS; Nelms, LF; Des Etages, SG; Hayes, LS; Kawabata, TT; Finco-Kent, D; Baker, DL; Larson, M; Si, MS; Paniagua, R; Higgins, J; Holm, B; Reitz, B; Zhou, YJ; Morris, RE; O'Shea, JJ; Borie, DC				Changelian, PS; Flanagan, ME; Ball, DJ; Kent, CR; Magnuson, KS; Martin, WH; Rizzuti, BJ; Sawyer, PS; Perry, BD; Brissette, WH; McCurdy, SP; Kudlacz, EM; Conklyn, MJ; Elliott, EA; Koslov, ER; Fisher, MB; Strelevitz, TJ; Yoon, K; Whipple, DA; Sun, JM; Munchhof, MJ; Doty, JL; Casavant, JM; Blumenkopf, TA; Hines, M; Brown, MF; Lillie, BM; Subramanyam, C; Shang-Poa, C; Milici, AJ; Beckius, GE; Moyer, JD; Su, CY; Woodworth, TG; Gaweco, AS; Beals, CR; Littman, BH; Fisher, DA; Smith, JF; Zagouras, P; Magna, HA; Saltarelli, MJ; Johnson, KS; Nelms, LF; Des Etages, SG; Hayes, LS; Kawabata, TT; Finco-Kent, D; Baker, DL; Larson, M; Si, MS; Paniagua, R; Higgins, J; Holm, B; Reitz, B; Zhou, YJ; Morris, RE; O'Shea, JJ; Borie, DC			Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor	SCIENCE			English	Article							T-CELL HOMEOSTASIS; TRANSPLANTATION; LEUKEMIA; SURVIVAL; MICE; GENE; JAK3	Because of its requirement for signaling by multiple cytokines, Janus kinase 3 (JAK3) is an excellent target for clinical immunosuppression. We report the development of a specific, orally active inhibitor of JAK3, CP-690,550, that significantly prolonged survival in a murine model of heart transplantation and in cynomolgus monkeys receiving kidney transplants. CP-690,550 treatment was not associated with hypertension, hyperlipidemia, or lymphoproliferative disease. On the basis of these preclinical results, we believe JAK3 blockade by CP-690,550 has potential for therapeutically desirable immunosuppression in human organ transplantation and in other clinical settings.	Pfizer Global Res & Dev, Dept Antibacterials & Immunol, Immunol Grp, Groton, CT 06340 USA; Pfizer Global Res & Dev, Dept Drug Safety Evaluat, Groton, CT 06340 USA; Pfizer Global Res & Dev, Dept Pharmacokinet Dynam & Metab, Groton, CT 06340 USA; Pfizer Global Res & Dev, Dept Genom & Proteom Sci, Groton, CT 06340 USA; Stanford Univ, Sch Med, Transplantat Immunol Lab, Stanford, CA 94305 USA; NIH, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA	Pfizer; Pfizer; Pfizer; Pfizer; Stanford University; National Institutes of Health (NIH) - USA	Changelian, PS (corresponding author), Pfizer Global Res & Dev, Dept Antibacterials & Immunol, Immunol Grp, Groton, CT 06340 USA.			Si, Ming-Sing/0000-0002-1927-420X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041106, Z01AR041106] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Behbod F, 2001, J IMMUNOL, V166, P3724, DOI 10.4049/jimmunol.166.6.3724; Borie DC, 2002, J SURG RES, V107, P64, DOI 10.1006/jsre.2002.6499; CHANGELIAN PS, UNPUB; Christopher K, 2002, J IMMUNOL, V169, P522, DOI 10.4049/jimmunol.169.1.522; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; COPELAND RA, ENZYMES PRACTICAL IN; CORRY RJ, 1973, TRANSPLANT P, V5, P733; Druker BJ, 2000, J CLIN INVEST, V105, P3, DOI 10.1172/JCI9083; El-Sawy T, 2002, CURR OPIN IMMUNOL, V14, P562, DOI 10.1016/S0952-7915(02)00382-5; Gozalo-Sanmillan S, 2001, J IMMUNOL, V166, P727, DOI 10.4049/jimmunol.166.2.727; Hausen B, 2001, TRANSPLANTATION, V72, P1128, DOI 10.1097/00007890-200109270-00025; Hong JC, 2000, SEMIN NEPHROL, V20, P108; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Nurse P, 2002, CHEMBIOCHEM, V3, P596, DOI 10.1002/1439-7633(20020703)3:7<596::AID-CBIC596>3.0.CO;2-U; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Saemann MD, 2003, TRANSPLANTATION, V75, P1864, DOI 10.1097/01.TP.0000065738.58742.A9; Saiura A, 2001, TRANSPLANTATION, V72, P320, DOI 10.1097/00007890-200107270-00027; Singer AL, 2002, SCIENCE, V296, P1639, DOI 10.1126/science.1071551; Sohn SJ, 1998, J IMMUNOL, V160, P2130; Stock PG, 2003, AM J TRANSPLANT, V3, P373, DOI 10.1034/j.1600-6143.2003.00115.x; Uckun FM, 2002, BLOOD, V99, P4192, DOI 10.1182/blood.V99.11.4192	24	530	646	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2003	302	5646					875	878		10.1126/science.1087061	http://dx.doi.org/10.1126/science.1087061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14593182				2022-12-24	WOS:000186258000052
J	Yildiz, A; Tomishige, M; Vale, RD; Selvin, PR				Yildiz, A; Tomishige, M; Vale, RD; Selvin, PR			Kinesin walks hand-over-hand	SCIENCE			English	Article							MYOSIN-V; MOTOR; MOTILITY; MOVEMENT; BINDING	Kinesin is a processive motor that takes 8.3-nm center-of-mass steps along microtubules for each adenosine triphosphate hydrolyzed. Whether kinesin moves by a "hand-over-hand" or an "inchworm" model has been controversial. We have labeled a single head of the kinesin dimer with a Cy3 fluorophore and localized the position of the dye to within 2 nm before and after a step. We observed that single kinesin heads take steps of 17.3 +/- 3.3 nm. A kinetic analysis of the dwell times between steps shows that the 17-nm steps alternate with 0-nm steps. These results strongly support a hand-over-hand mechanism, and not an inchworm mechanism. In addition, our results suggest that kinesin is bound by both heads to the microtubule while it waits for adenosine triphosphate in between steps.	Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94107 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94107 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Selvin, PR (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.	selvin@uiuc.edu	Yildiz, Ahmet/E-6167-2015	Yildiz, Ahmet/0000-0003-4792-174X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044420, R29AR044420, P01AR042895] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR42895, AR44420] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ali MY, 2002, NAT STRUCT BIOL, V9, P464, DOI 10.1038/nsb803; Asenjo AB, 2003, NAT STRUCT BIOL, V10, P836, DOI 10.1038/nsb984; Bartko AP, 1999, J PHYS CHEM B, V103, P11237, DOI 10.1021/jp993364q; Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Hoenger A, 2000, J MOL BIOL, V297, P1087, DOI 10.1006/jmbi.2000.3627; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; Kawaguchi K, 2001, SCIENCE, V291, P667, DOI 10.1126/science.291.5504.667; Kawaguchi K, 2003, BIOPHYS J, V84, P1103, DOI 10.1016/S0006-3495(03)74926-1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	20	694	725	5	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2004	303	5658					676	678		10.1126/science.1093753	http://dx.doi.org/10.1126/science.1093753			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768EN	14684828				2022-12-24	WOS:000188530800042
J	Raxworthy, CJ; Martinez-Meyer, E; Horning, N; Nussbaum, RA; Schneider, GE; Ortega-Huerta, MA; Peterson, AT				Raxworthy, CJ; Martinez-Meyer, E; Horning, N; Nussbaum, RA; Schneider, GE; Ortega-Huerta, MA; Peterson, AT			Predicting distributions of known and unknown reptile species in Madagascar	NATURE			English	Article							BIODIVERSITY HOTSPOTS; FUTURE	Despite the importance of tropical biodiversity(1), informative species distributional data are seldom available for biogeographical study or setting conservation priorities(2,3). Modelling ecological niche distributions of species offers a potential soluion(4-7); however, the utility of old locality data from museums, and of more recent remotely sensed satellite data, remains poorly explored, especially for rapidly changing tropical landscapes. Using 29 modern data sets of environmental land coverage and 621 chameleon occurrence localities from Madagascar ( historical and recent), here we demonstrate a significant ability of our niche models in predicting species distribution. At 11 recently inventoried sites, highest predictive success (85.1%) was obtained for models based only on modern occurrence data (74.7% and 82.8% predictive success, respectively, for pre-1978 and all data combined). Notably, these models also identified three intersecting areas of over-prediction that recently yielded seven chameleon species new to science. We conclude that ecological niche modelling using recent locality records and readily available environmental coverage data provides informative biogeographical data for poorly known tropical landscapes, and offers innovative potential for the discovery of unknown distributional areas and unknown species.	Amer Museum Nat Hist, New York, NY 10024 USA; Univ Nacl Autonoma Mexico, Inst Biol, Mexico City 04510, DF, Mexico; Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA; Univ Kansas, Nat Hist Museum, Lawrence, KS 66045 USA; Univ Kansas, Biodivers Res Ctr, Lawrence, KS 66045 USA	American Museum of Natural History (AMNH); Universidad Nacional Autonoma de Mexico; University of Michigan System; University of Michigan; University of Kansas; University of Kansas	Raxworthy, CJ (corresponding author), Amer Museum Nat Hist, Cent Pk W & 79th St, New York, NY 10024 USA.	rax@amnh.org	Peterson, A. Townsend/I-5697-2013; Martinez-Meyer, Enrique/B-1464-2008	Peterson, A. Townsend/0000-0003-0243-2379; Martinez-Meyer, Enrique/0000-0003-1184-9264				Anderson RP, 2002, GLOBAL ECOL BIOGEOGR, V11, P131, DOI 10.1046/j.1466-822X.2002.00275.x; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Andreone F, 2001, ITAL J ZOOL, V68, P235, DOI 10.1080/11250000109356414; ANGAP (Association nationale pour la Gestion des Aires protegees), 2001, PLAN GEST RES NAT AI; Brygoo E. R., 1971, Faune de Madagascar, V33, P1; Brygoo E.-R., 1978, Faune de Madagascar, V47, P1; Crisci JV, 2001, J BIOGEOGR, V28, P157, DOI 10.1046/j.1365-2699.2001.00523.x; *ESRI, 1997, ARCATLAS; Goodman S.M., 1998, AKONNY ALA, V24, P19; GOODMAN S. M., 2002, AKONNY ALA, V28, P1; GREEN GM, 1990, SCIENCE, V248, P212, DOI 10.1126/science.248.4952.212; Martinez-Meyer E., 2002, THESIS U KANSAS; Mayaux P, 2000, INT J REMOTE SENS, V21, P3139, DOI 10.1080/01431160050145018; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NELSON R, 1993, INT J REMOTE SENS, V14, P1463, DOI 10.1080/01431169308953981; New M., 1997, 1961 1990 MEAN MONTH; Peterson AT, 1999, ECOL MODEL, V117, P159, DOI 10.1016/S0304-3800(99)00023-X; Peterson AT, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P617; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; RAKOTOMALALA D, 2001, RECH DEV SERIE SCI B, V17, P133; Rakotomalala Domoina, 2002, Boissiera, V59, P339; Raselimanana A.P., 1998, RECHERCHES DEV SB, V13, P43; RASELIMANANA AP, 1998, RECHERCHES DEV SB, V14, P183; Rasolonandrasana AP, 1999, RECHERCHES POUR LE D, V15; Raxworthy CJ, 2002, NATURE, V415, P784, DOI 10.1038/415784a; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2	30	381	418	5	121	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 18	2003	426	6968					837	841		10.1038/nature02205	http://dx.doi.org/10.1038/nature02205			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685238	Green Published			2022-12-24	WOS:000187342000058
J	Aungst, JL; Heyward, PM; Puche, AC; Karnup, SV; Hayar, A; Szabo, G; Shipley, MT				Aungst, JL; Heyward, PM; Puche, AC; Karnup, SV; Hayar, A; Szabo, G; Shipley, MT			Centre-surround inhibition among olfactory bulb glomeruli	NATURE			English	Article							MITRAL CELLS; PRESYNAPTIC INHIBITION; 2-DEOXYGLUCOSE UPTAKE; FUNCTIONAL MRI; RAT; LAYER; REPRESENTATIONS; DISCRIMINATION; LOCALIZATION; ORGANIZATION	Centre - surround inhibition - the suppression of activity of neighbouring cells by a central group of neurons - is a fundamental mechanism that increases contrast in patterned sensory processing. The initial stage of neural processing in olfaction occurs in olfactory bulb glomeruli, but evidence for functional interactions between glomeruli is fragmentary. Here we show that the so- called ' short axon' cells, contrary to their name, send interglomerular axons over long distances to form excitatory synapses with inhibitory periglomerular neurons up to 20 - 30 glomeruli away. Interglomerular excitation of these periglomerular cells potently inhibits mitral cells and forms an on- centre, off- surround circuit. This interglomerular centre - surround inhibitory network, along with the well- established mitral - granule - mitral inhibitory circuit, forms a serial, two- stage inhibitory circuit that could enhance spatiotemporal responses to odours.	Univ Maryland, Sch Med, Dept Anat & Neurobiol, Program Neurosci, Baltimore, MD 21201 USA; Hungarian Acad Sci, Inst Expt Med, Dept Gene Technol & Dev Neurobiol, Budapest, Hungary	University System of Maryland; University of Maryland Baltimore; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Shipley, MT (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Program Neurosci, Room 222,685 W Baltimore St, Baltimore, MD 21201 USA.		Szabo, Gabor/A-5087-2008	Szabo, Gabor/0000-0001-5438-5151				Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; AroniadouAnderjaska V, 1997, NEUROSCIENCE, V79, P425, DOI 10.1016/S0306-4522(96)00706-3; ASTIC L, 1982, BRAIN RES, V245, P17, DOI 10.1016/0006-8993(82)90335-3; BENSON TE, 1985, BRAIN RES, V339, P67, DOI 10.1016/0006-8993(85)90622-5; Carlson GC, 2000, J NEUROSCI, V20, P2011; Chen WR, 2002, J NEUROPHYSIOL, V88, P2755, DOI 10.1152/jn.00057.2002; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; CORNWALL J, 1988, J NEUROSCI METH, V24, P1, DOI 10.1016/0165-0270(88)90028-3; GOLGI C, 1875, FINA STRUTTURA BULBI; GREER CA, 1981, BRAIN RES, V217, P279, DOI 10.1016/0006-8993(81)90004-4; GROSSBERG S, 1976, BIOL CYBERN, V23, P121, DOI 10.1007/BF00344744; GROSSBERG S, 1970, J THEOR BIOL, V27, P291, DOI 10.1016/0022-5193(70)90143-8; GUTHRIE KM, 1995, CHEM SENSES, V20, P271, DOI 10.1093/chemse/20.2.271; HALASZ N, 1993, J COMP NEUROL, V337, P307, DOI 10.1002/cne.903370211; Heyward P, 2001, J NEUROSCI, V21, P5311, DOI 10.1523/JNEUROSCI.21-14-05311.2001; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; JASTREBOFF PJ, 1984, P NATL ACAD SCI-BIOL, V81, P5250, DOI 10.1073/pnas.81.16.5250; Johnson BA, 1996, J COMP NEUROL, V376, P557, DOI 10.1002/(SICI)1096-9861(19961223)376:4<557::AID-CNE5>3.0.CO;2-0; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; KAUER JS, 1988, NATURE, V331, P166, DOI 10.1038/331166a0; KAUER JS, 1987, BRAIN RES, V418, P255, DOI 10.1016/0006-8993(87)90093-X; KAWANO T, 1982, J NEUROCHEM, V39, P342, DOI 10.1111/j.1471-4159.1982.tb03953.x; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; MARTINEZ DP, 1984, BRAIN RES, V308, P223, DOI 10.1016/0006-8993(84)91061-8; Mombaerts P, 1996, COLD SPRING HARB SYM, V61, P135; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; MUGNAINI E, 1984, NEUROSCI LETT, V47, P221, DOI 10.1016/0304-3940(84)90517-2; ONODA N, 1992, NEUROSCI LETT, V137, P157, DOI 10.1016/0304-3940(92)90393-L; PINCHING AJ, 1971, J CELL SCI, V9, P305; PINCHING AJ, 1972, J CELL SCI, V10, P637; PINCHING AJ, 1971, J CELL SCI, V9, P379; PINCHING AJ, 1971, J CELL SCI, V9, P347; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Ramon y Cajal S, 1909, HISTOLOGIE SYSTEME N; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Rubin BD, 2001, NAT NEUROSCI, V4, P355, DOI 10.1038/85997; Sheikh SN, 1999, NEUROCHEM INT, V35, P73, DOI 10.1016/S0197-0186(99)00063-7; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, V3rd Edn, P133; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wachowiak M, 1999, J NEUROSCI, V19, P8808, DOI 10.1523/JNEUROSCI.19-20-08808.1999; Wachowiak M, 1998, J NEUROPHYSIOL, V80, P1011, DOI 10.1152/jn.1998.80.2.1011; Xu FQ, 2000, P NATL ACAD SCI USA, V97, P10601, DOI 10.1073/pnas.180321397; Yang XJ, 1998, P NATL ACAD SCI USA, V95, P7715, DOI 10.1073/pnas.95.13.7715; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	47	311	315	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					623	629		10.1038/nature02185	http://dx.doi.org/10.1038/nature02185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668854				2022-12-24	WOS:000187132800031
J	Zarrinpar, A; Park, SH; Lim, WA				Zarrinpar, A; Park, SH; Lim, WA			Optimization of specificity in a cellular protein interaction network by negative selection	NATURE			English	Article							SH3 DOMAIN; PEPTIDE RECOGNITION; CAENORHABDITIS-ELEGANS; PEX13P; SRC; LOCALIZATION; PREDICTION; STABILITY; PATHWAYS; MODULES	Most proteins that participate in cellular signalling networks contain modular protein- interaction domains. Multiple versions of such domains are present within a given organism(1): the yeast proteome, for example, contains 27 different Src homology 3 ( SH3) domains(2). This raises the potential problem of crossreaction. It is generally thought that isolated domain - ligand pairs lack sufficient information to encode biologically unique interactions, and that specificity is instead encoded by the context in which the interaction pairs are presented(3,4). Here we show that an isolated peptide ligand from the yeast protein Pbs2 recognizes its biological partner, the SH3 domain from Sho1, with near- absolute specificity - no other SH3 domain present in the yeast genome cross- reacts with the Pbs2 peptide, in vivo or in vitro. Such high specificity, however, is not observed in a set of non- yeast SH3 domains, and Pbs2 motif variants that cross- react with other SH3 domains confer a fitness defect, indicating that the Pbs2 motif might have been optimized to minimize interaction with competing domains specifically found in yeast. System- wide negative selection is a subtle but powerful evolutionary mechanism to optimize specificity within an interaction network composed of overlapping recognition elements.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, 600 16th St, San Francisco, CA 94143 USA.	wlim@itsa.ucsf.edu						Barnett P, 2000, EMBO J, V19, P6382, DOI 10.1093/emboj/19.23.6382; Bottger G, 2000, MOL BIOL CELL, V11, P3963, DOI 10.1091/mbc.11.11.3963; Cesareni G, 2002, FEBS LETT, V513, P38, DOI 10.1016/S0014-5793(01)03307-5; Fazi B, 2002, J BIOL CHEM, V277, P5290, DOI 10.1074/jbc.M109848200; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Kwok Pui-Yan, 2003, Methods Mol Biol, V212, P71; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; LIM WA, 1994, PROTEIN SCI, V3, P1261, DOI 10.1002/pro.5560030812; LIM WA, 1994, NAT STRUCT BIOL, V1, P221, DOI 10.1038/nsb0494-221; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Maxwell KL, 1998, BIOCHEMISTRY-US, V37, P16172, DOI 10.1021/bi981788p; Mayer BJ, 2001, J CELL SCI, V114, P1253; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Orr MR, 1998, TRENDS ECOL EVOL, V13, P502, DOI 10.1016/S0169-5347(98)01511-0; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Schneider TD, 2000, NUCLEIC ACIDS RES, V28, P2794, DOI 10.1093/nar/28.14.2794; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Sudol M, 1998, ONCOGENE, V17, P1469, DOI 10.1038/sj.onc.1202182; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; ZARRINPAR A, SCIENCE, DOI DOI 10.1126/STKE.2003.179.RE8	29	199	206	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					676	680		10.1038/nature02178	http://dx.doi.org/10.1038/nature02178			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668868				2022-12-24	WOS:000187132800045
J	Thomas, RK; Diehl, V				Thomas, RK; Diehl, V			Unhappy neighbourhood: spatial genome organisation and lymphomagenesis in B cells	LANCET			English	Editorial Material							SOMATIC HYPERMUTATION; GENE; LOCI; MUTATION		Univ Cologne, Dept Internal Med 1, D-50924 Cologne, Germany; Univ Cologne, Ctr Mol Med Cologne, D-50924 Cologne, Germany	University of Cologne; University of Cologne	Thomas, RK (corresponding author), Univ Cologne, Dept Internal Med 1, D-50924 Cologne, Germany.							JAEGER U, 1993, BLOOD, V81, P1833; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848	10	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1868	1870		10.1016/S0140-6736(03)14998-7	http://dx.doi.org/10.1016/S0140-6736(03)14998-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667739				2022-12-24	WOS:000187011600004
J	de Joussineau, C; Soule, J; Martin, M; Anguille, C; Montcourrier, P; Alexandre, D				de Joussineau, C; Soule, J; Martin, M; Anguille, C; Montcourrier, P; Alexandre, D			Delta-promoted filopodia mediate long-range lateral inhibition in Drosophila	NATURE			English	Article							CELL EXTENSION ACTIVITY; NOTCH; EXPRESSION; PROTEIN; EZRIN; MORPHOGENESIS; GENES; DETERMINANTS; EMERGENCE; ENHANCER	Drosophila thoracic mechanosensory bristles originate from cells that are singled out from 'proneural' groups of competent epithelial cells. Neural competence is restricted to individual sensory organ precursors (SOPs) by Delta/Notch-mediated 'lateral inhibition', whereas other cells in the proneural field adopt an epidermal fate. The precursors of the large macrochaetes differentiate separately from individual proneural clusters that comprise about 20 - 30 cells or as heterochronic pairs from groups of more than 100 cells(1), whereas the precursors of the small regularly spaced microchaetes emerge from even larger proneural fields(2). This indicates that lateral inhibition might act over several cell diameters; it was difficult to reconcile with the fact that the inhibitory ligand Delta is membrane-bound until the observation that SOPs frequently extend thin processes(3,4) offered an attractive hypothesis. Here we show that the extension of these planar filopodia - a common attribute of wing imaginal disc cells - is promoted by Delta and that their experimental suppression reduces Notch signalling in distant cells and increases bristle density in large proneural groups, showing that these membrane specializations mediate long- range lateral inhibition.	Univ Montpellier 2, UMR 5539, Lab Dynam Mol Interact Membranaires, F-34095 Montpellier 5, France	Universite de Montpellier	Alexandre, D (corresponding author), Univ Montpellier 2, UMR 5539, Lab Dynam Mol Interact Membranaires, CC 107,Pl Eugene Bataillon, F-34095 Montpellier 5, France.			MARTIN, Marianne/0000-0001-8932-3129				ANDREOLI C, 1994, J CELL SCI, V107, P2509; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; BENDER LB, 1993, GENETICS, V133, P967; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; HAENLIN M, 1994, MECH DEVELOP, V47, P99, DOI 10.1016/0925-4773(94)90099-X; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; HUANG F, 1991, DEVELOPMENT, V111, P1087; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; KOOH PJ, 1993, DEVELOPMENT, V117, P493; Lai EC, 2001, DEV BIOL, V231, P217, DOI 10.1006/dbio.2000.0124; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LOCKE M, 1981, NATURE, V293, P733, DOI 10.1038/293733a0; MARTIN M, 1995, J CELL BIOL, V128, P1081, DOI 10.1083/jcb.128.6.1081; Martin M, 1997, MOL BIOL CELL, V8, P1543, DOI 10.1091/mbc.8.8.1543; Meir E, 2002, CURR BIOL, V12, P778, DOI 10.1016/S0960-9822(02)00839-4; Milan M, 2001, CELL, V106, P785, DOI 10.1016/S0092-8674(01)00489-5; Mishra-Gorur K, 2002, J CELL BIOL, V159, P313, DOI 10.1083/jcb.200203117; PARKS AL, 1993, DEV BIOL, V157, P484, DOI 10.1006/dbio.1993.1151; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Renaud O, 2001, DEV BIOL, V240, P361, DOI 10.1006/dbio.2001.0482; Sanson B, 1999, CELL, V98, P207, DOI 10.1016/S0092-8674(00)81015-6; Seugnet L, 1997, DEVELOPMENT, V124, P2015; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; USUI K, 1993, ROUX ARCH DEV BIOL, V203, P151, DOI 10.1007/BF00365054; Wigglesworth VB, 1940, J EXP BIOL, V17, P180; Zeng CY, 1998, GENE DEV, V12, P1086, DOI 10.1101/gad.12.8.1086	30	143	144	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2003	426	6966					555	559		10.1038/nature02157	http://dx.doi.org/10.1038/nature02157			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654840				2022-12-24	WOS:000186944300038
J	Col, NF; Pauker, SG				Col, NF; Pauker, SG			The discrepancy between observational studies and randomized trials of menopausal hormone therapy: Did expectations shape experience?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNRECOGNIZED MYOCARDIAL-INFARCTION; ESTROGEN REPLACEMENT THERAPY; CORONARY-HEART-DISEASE; POSTMENOPAUSAL WOMEN; CARDIOVASCULAR-DISEASE; PLUS PROGESTIN; PRIMARY PREVENTION; SEX-DIFFERENCES; CASE-FATALITY; PREVALENCE	Differences between observational and randomized studies of the effects of menopausal hormone therapy (HT) on coronary heart disease (CHD) have been attributed to the fact that women who choose to use HT tend to be healthier than those who do not. Although this bias should affect all clinical outcomes with modifiable risk factors, estimates for stroke and pulmonary embolism were unaffected. The authors sought possible explanations for this isolated discrepancy in CHD findings. Unlike the randomized Women's Health Initiative (WHI) trial, the observational Nurses' Health Study (NHS) did not try to detect silent myocardial infarctions. Many women present with atypical ischemic symptoms. Hormone therapy users who believe that HT reduces CHD risks might not interpret ischemic symptoms as related to CHD, might not seek medical attention, and might present differently to their physicians, all of which could lead to more unrecognized myocardial infarctions among HT users in the NHS. In addition, persons completing death certificates and NHS physicians interpreting death certificates were not blinded to the use of HT. If persons assigning cause of death knew the patient had used HT and believed that HT prevented CHD, they might have been more likely to assign a condition other than CHD as the cause of death. If HT users were 20% less likely to have their infarctions recognized and their deaths attributed to CHID, a true increase in CHD due to HT use would appear to be a reduction in CHD. Combining these reporting biases with socioeconomic differences between users and nonusers could explain discrepancies. Beliefs held by patients, clinicians, and investigators might have affected the ascertainment of CHD outcomes in observational studies.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Womens Hlth, Boston, MA 02120 USA; Tufts Univ New England Med Ctr, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Tufts Medical Center	Col, NF (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Womens Hlth, 1620 Tremont St, Boston, MA 02120 USA.	ncol@partners.org	Col, Nananda/AAE-3445-2019	Col, Nananda/0000-0001-7106-662X	AHRQ HHS [R01 HS01332901] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ADLER NE, 1993, JAMA-J AM MED ASSOC, V269, P3140, DOI 10.1001/jama.269.24.3140; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; BARRETTCONNOR E, 1991, ANN INTERN MED, V115, P455, DOI 10.7326/0003-4819-115-6-455; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; BUTLER C, 1986, BRIT J CLIN PSYCHOL, V25, P173, DOI 10.1111/j.2044-8260.1986.tb00693.x; CAMPBELL S, 1977, CLIN OBSTET GYNAECOL, V4, P31; Campisi R, 2002, CIRCULATION, V105, P425, DOI 10.1161/hc0402.102860; CAULEY JA, 1990, AM J OBSTET GYNECOL, V163, P1438, DOI 10.1016/0002-9378(90)90602-4; Flaten MA, 1999, PSYCHOSOM MED, V61, P250, DOI 10.1097/00006842-199903000-00018; Girdler SS, 1999, J WOMEN HEALTH GEN-B, V8, P637, DOI 10.1089/jwh.1.1999.8.637; Goldberg RJ, 1998, AM HEART J, V136, P189, DOI 10.1053/hj.1998.v136.88874; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; GRIMM RH, 1987, CIRCULATION, V75, P6; Grodstein F, 1996, AM J EPIDEMIOL, V143, P979; GRODSTEIN F, 1995, PROG CARDIOVASC DIS, V38, P199, DOI 10.1016/S0033-0620(95)80012-3; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; HEALY B, 1991, NEW ENGL J MED, V325, P274, DOI 10.1056/NEJM199107253250408; HORWITZ RI, 1990, LANCET, V336, P542, DOI 10.1016/0140-6736(90)92095-Y; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Humphrey LL, 2002, ANN INTERN MED, V137, P273, DOI 10.7326/0003-4819-137-4-200208200-00012; Jonsdottir LS, 1998, EUR HEART J, V19, P1011, DOI 10.1053/euhj.1998.0980; KANNEL WB, 1979, AM J CARDIOL, V44, P53, DOI 10.1016/0002-9149(79)90250-9; KANNEL WB, 1990, ADV CARDIOL, V37, P202; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P817, DOI 10.7326/0003-4819-136-11-200206040-00011; Kessler KM, 2001, ANN INTERN MED, V135, P1092, DOI 10.7326/0003-4819-135-12-200112180-00023; LINDBERG HA, 1960, ARCH INTERN MED, V106, P628, DOI 10.1001/archinte.1960.03820050040008; LUPARELLO TJ, 1970, PSYCHOSOM MED, V32, P509, DOI 10.1097/00006842-197009000-00009; Matthews KA, 1996, AM J EPIDEMIOL, V143, P971; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; NADELMANN J, 1990, AM J CARDIOL, V66, P533, DOI 10.1016/0002-9149(90)90477-I; ORENTLICHER D, 1991, JAMA-J AM MED ASSOC, V266, P559; Peterson ED, 1998, AM HEART J, V136, P186, DOI 10.1053/hj.1998.v136.89736; Petitti DB, 1998, JAMA-J AM MED ASSOC, V280, P650, DOI 10.1001/jama.280.7.650; POSTHUMA WFM, 1994, BRIT MED J, V308, P1268; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; Qizilbash N, 1995, LANCET, V346, P1647; ROSENBERG L, 1993, AM J EPIDEMIOL, V137, P54, DOI 10.1093/oxfordjournals.aje.a116602; ROSENMAN RH, 1967, AM J CARDIOL, V19, P776, DOI 10.1016/0002-9149(67)90498-5; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sacco RL, 1999, NEUROLOGY, V53, pS15; SARTWELL PE, 1969, AM J EPIDEMIOL, V90, P365, DOI 10.1093/oxfordjournals.aje.a121082; SCHLESSELMAN JJ, 1992, J CLIN EPIDEMIOL, V45, P449, DOI 10.1016/0895-4356(92)90094-4; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sheifer SE, 2001, ANN INTERN MED, V135, P801, DOI 10.7326/0003-4819-135-9-200111060-00010; Sheifer SE, 2000, J AM COLL CARDIOL, V35, P119, DOI 10.1016/S0735-1097(99)00524-0; Sidney S, 1997, ANN INTERN MED, V127, P501, DOI 10.7326/0003-4819-127-7-199710010-00001; Simon J A, 2001, Climacteric, V4, P19, DOI 10.1080/713605032; Sourander L, 1998, LANCET, V352, P1965, DOI 10.1016/S0140-6736(98)05066-1; STAMPFER MJ, 1985, NEW ENGL J MED, V313, P1044, DOI 10.1056/NEJM198510243131703; STERNBACH RA, 1964, PSYCHOPHYSIOLOGY, V1, P67; STURGEON SR, 1995, EPIDEMIOLOGY, V6, P227, DOI 10.1097/00001648-199505000-00006; Tunstall-Pedoe H, 1998, HEART, V80, P112, DOI 10.1136/hrt.80.2.112; TunstallPedoe H, 1996, CIRCULATION, V93, P1981, DOI 10.1161/01.CIR.93.11.1981; TUNSTALLPEDOE H, 1978, BRIT HEART J, V40, P510; Wagner KR, 1996, J RHEUMATOL, V23, P2079; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; WENGER NK, 1990, ANN INTERN MED, V112, P557, DOI 10.7326/0003-4819-112-8-557; WILSON PWF, 1985, NEW ENGL J MED, V313, P1038, DOI 10.1056/NEJM198510243131702; YANO K, 1989, ARCH INTERN MED, V149, P1528, DOI 10.1001/archinte.149.7.1528; 1973, JAMA, V226, P652; 1973, CIRCULATION S, V47, pI1; 1980, N ENGL J MED, V303, P1083	64	36	36	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2003	139	11					923	929		10.7326/0003-4819-139-11-200312020-00011	http://dx.doi.org/10.7326/0003-4819-139-11-200312020-00011			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WW	14644895				2022-12-24	WOS:000186884800006
J	El-Serag, H; Davila, JA; Petersen, NJ; McGlynn, KA				El-Serag, H; Davila, JA; Petersen, NJ; McGlynn, KA			The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update	ANNALS OF INTERNAL MEDICINE			English	Article							HEPATITIS-C-VIRUS; PRIMARY LIVER-CANCER; DIABETES-MELLITUS; RISING INCIDENCE; RISK-FACTORS; PREVALENCE; INFECTION; JAPAN	Background: The incidence of hepatocellular carcinoma was reported to be increasing in the United States. However, alternate explanations were diagnostic or reclassification bias and changes in the demographic features of the general population. Objective: To examine the temporal trends in the incidence of hepatocellular carcinoma. Design: Retrospective cohort study. Setting: Information collected by population-based registries of the Surveillance, Epidemiology, and End Results (SEER) program. Patients: Persons given a diagnosis of hepatocellular carcinoma between 1975 and 1998. Measurements: Linear Poisson multivariate regression model, controlling for differences in age, sex, race or ethnicity, and geographic region among patients with hepatocellular carcinoma and in the underlying population. Results: The overall age-adjusted incidence rates of hepatocellular carcinoma increased from 1.4 per 100 000 in 1975 to 1977 to 3.0 per 100 000 in 1996 to 1998. There was a 25% increase during the last 3 years of the study compared with the preceding 3 years (1993 to 1995). The increase affected most age groups above 40 years, with the greatest increase in the 45- to 49-year-old age group. White men had the greatest increase (31%) in the last time period (1996 to 1998) compared with 1993 to 1995. The Poisson regression model confirmed an almost 2-fold increase in the incidence rate ratio for hepatocellular carcinoma between 1975 to 1978 and 1996 to 1998. Conclusions: The incidence of hepatocellular carcinoma continues to increase rapidly in the United States, with rates increasing the fastest in white men 45 to 54 years of age. These findings are consistent with a true increase and could be explained by consequences of hepatitis C virus acquired during the 1960s and 1970s.	Houston Vet Affairs Med Ctr, Houston, TX 77030 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center	El-Serag, H (corresponding author), Houston Vet Affairs Med Ctr, 2002 Holcombe Blvd 152, Houston, TX 77030 USA.	hasheme@bcm.tmc.edu			NATIONAL CANCER INSTITUTE [ZIACP010158, Z01CP010158] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adami HO, 1996, J NATL CANCER I, V88, P1472, DOI 10.1093/jnci/88.20.1472; Alter MJ, 1997, HEPATOLOGY, V26, pS62, DOI 10.1002/hep.510260711; Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332; COLOMBO M, 1989, LANCET, V2, P1006; Davila JA, 2003, J CLIN EPIDEMIOL, V56, P487, DOI 10.1016/S0895-4356(02)00605-4; El-Serag HB, 2000, ARCH INTERN MED, V160, P3227, DOI 10.1001/archinte.160.21.3227; El-Serag HB, 2001, AM J GASTROENTEROL, V96, P2462, DOI 10.1111/j.1572-0241.2001.04054.x; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Hassan MM, 2002, J CLIN GASTROENTEROL, V35, P266, DOI 10.1097/00004836-200209000-00013; Hassan MM, 2002, HEPATOLOGY, V36, P1206, DOI 10.1053/jhep.2002.36780; Kaczynski J, 1999, NEW ENGL J MED, V341, P451; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; McCarthy EP, 2000, MED CARE, V38, P868, DOI 10.1097/00005650-200008000-00010; MCQUILLAN GM, 1989, AM J MED, V87, pS5; *NAT CANC I, 2001, SURV EP END RES SEER; OKUDA K, 1987, CANCER RES, V47, P4967; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P15584, DOI 10.1073/pnas.242608099; Warren JL, 2002, MED CARE S, V40; World Health Organization, 1976, INT CLASS DIS ONC	19	764	790	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2003	139	10					817	823		10.7326/0003-4819-139-10-200311180-00009	http://dx.doi.org/10.7326/0003-4819-139-10-200311180-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744ZV	14623619				2022-12-24	WOS:000186663500005
J	Gupta, R; Sheikh, A; Strachan, D; Anderson, HR				Gupta, R; Sheikh, A; Strachan, D; Anderson, HR			Increasing hospital admissions for systemic allergic disorders in England: analysis of national admissions' data	BRITISH MEDICAL JOURNAL			English	Article									St George Hosp, Sch Med, Dept Community Hlth Sci, London SW17 0RE, England	St Georges University London	Gupta, R (corresponding author), St George Hosp, Sch Med, Dept Community Hlth Sci, Cranmer Terrace, London SW17 0RE, England.		Anderson, Hugh R/A-7417-2016; Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056				*DEP HLTH, PRESCR COST AN; *DEP HLTH, 1991, HOSP EP STAT, V1; Sheikh A, 2000, BRIT MED J, V320, P1441, DOI 10.1136/bmj.320.7247.1441; *UCB I ALL, 1997, EUR ALL WHIT PAP ALL; *WHO, 1977, INT CLASS DIS MAN IN	5	99	100	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 15	2003	327	7424					1142	1143		10.1136/bmj.327.7424.1142	http://dx.doi.org/10.1136/bmj.327.7424.1142			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744HL	14615340	Green Published, Bronze			2022-12-24	WOS:000186622100021
J	Robinson, BWS; Creaney, J; Lake, R; Nowak, A; Musk, AW; de Klerk, N; Winzell, P; Hellstrom, KE; Hellstrom, I				Robinson, BWS; Creaney, J; Lake, R; Nowak, A; Musk, AW; de Klerk, N; Winzell, P; Hellstrom, KE; Hellstrom, I			Mesothelin-family proteins and diagnosis of mesothelioma	LANCET			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; MOLECULAR-CLONING; OVARIAN-CARCINOMA; GENE-THERAPY; CELL-LINE; CANCER; EXPRESSION; ANTIBODY; SERUM; CDNA	Background Mesothelioma is a highly aggressive tumour for which there are no reliable serum tumour. markers. Identification of such a marker would be useful in diagnosis of mesothelioma and for monitoring responses to treatment and screening at-risk individuals. Methods We assayed serum concentrations of soluble mesothelin-related proteins (SMR) using a double determinant (sandwich) ELISA in a blinded study of serum samples from 44 patients with histologically proven mesothelioma; 68 matched healthy controls, 40 of whom had been exposed to asbestos; and 160 patients with other inflammatory or malignant lung and pleural diseases. Findings 37 (84%) of 44 patients with mesothelioma had raised concentrations of SMR at a serum dilution of 1/80, compared with three (2%) of 160 patients with other cancers or other inflammatory lung or pleural diseases, and with none of 28 controls who had not been exposed to asbestos. SMR concentrations correlated with tumour size and increased during tumour progression. Seven of the 40 asbestos-exposed individuals had increased serum concentrations of SMR; three of those seven developed mesothelioma and one developed lung carcinoma within 1-5 years. None of the 33 asbestos-exposed participants whose serum samples had normal concentrations of SMR and who were followed up over 8 years developed mesothelioma. Interpretation Determination of SMR in serum could be a useful marker for diagnosis of mesothelioma and to monitor disease progression. It might also prove helpful for screening asbestos-exposed individuals for early evidence of mesothelioma.	Univ Western Australia, Queen Elizabeth II Med Ctr, Dept Med, Perth, WA 6009, Australia; Western Australian Inst Med Res, Perth, WA, Australia; Sir Charles Gairdner Hosp, Dept Resp Med, Perth, WA, Australia; Telethon Inst Child Hlth Res, Subiaco, WA, Australia; UWA Ctr Child Hlth Res, Subiaco, WA, Australia; Pacific NW Res Inst, Seattle, WA USA	University of Western Australia; University of Western Australia; University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia	Robinson, BWS (corresponding author), Univ Western Australia, Queen Elizabeth II Med Ctr, Dept Med, 4th Floor,G Block, Perth, WA 6009, Australia.	bwsrobin@cyllene.uwa.edu.au	de Klerk, Nicholas H/D-8388-2016; Robinson, Bruce/N-1900-2014; Nowak, Anna K/B-2487-2013	de Klerk, Nicholas H/0000-0001-9223-0767; Nowak, Anna K/0000-0002-9317-9526	NATIONAL CANCER INSTITUTE [R01CA085780, R01CA079490, K22CA098008] Funding Source: NIH RePORTER; NCI NIH HHS [CA 98008, CA 85780, CA 79490] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANTMAN K, 1988, J CLIN ONCOL, V6, P147, DOI 10.1200/JCO.1988.6.1.147; Argani P, 2001, CLIN CANCER RES, V7, P3862; BATES SE, 1991, ANN INTERN MED, V115, P623, DOI 10.7326/0003-4819-115-8-623; Boutin C, 1998, EUR RESPIR J, V12, P972, DOI 10.1183/09031936.98.12040972; Byrne MJ, 1999, J CLIN ONCOL, V17, P25, DOI 10.1200/JCO.1999.17.1.25; Caminschi I, 1999, AM J RESP CELL MOL, V21, P347, DOI 10.1165/ajrcmb.21.3.3575; Carretta A, 2000, EUR J CARDIO-THORAC, V17, P377, DOI 10.1016/S1010-7940(00)00377-8; CHANG K, 1992, CANCER RES, V52, P181; CHANG K, 1994, INT J CANCER, V57, P90, DOI 10.1002/ijc.2910570117; Chowdhury PS, 1998, P NATL ACAD SCI USA, V95, P669, DOI 10.1073/pnas.95.2.669; CONAGHAN P, 1996, IMMUNOPATHOLOGY LUNG, P147; Henderson DW, 1998, AM J CLIN PATHOL, V110, P397, DOI 10.1093/ajcp/110.3.397; HILLERDAL G, 1991, CANCER, V67, P2410, DOI 10.1002/1097-0142(19910501)67:9<2410::AID-CNCR2820670933>3.0.CO;2-D; Ho L, 2001, Cancer Treat Res, V105, P327; Johnson P J, 2001, Clin Liver Dis, V5, P145, DOI 10.1016/S1089-3261(05)70158-6; Kagan E., 1996, IMMUNOPATHOLOGY LUNG, P421; KOJIMA T, 1995, J BIOL CHEM, V270, P21984, DOI 10.1074/jbc.270.37.21984; Marzo AL, 2000, J IMMUNOL, V165, P6047, DOI 10.4049/jimmunol.165.11.6047; McIntosh MW, 2002, CANCER EPIDEM BIOMAR, V11, P159; McLaren BR, 2000, CANCER CHEMOTH PHARM, V45, P502, DOI 10.1007/s002800051026; Musk AW, 1998, INT J CANCER, V75, P355, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt;355::AID-IJC5&gt;3.0.CO;2-1; Nowak AK, 2002, SEMIN ONCOL, V29, P82, DOI 10.1053/sonc.2002.30234; Olt G, 1990, Obstet Gynecol Surv, V45, P570, DOI 10.1097/00006254-199009000-00002; Poteat HT, 2000, AM J CLIN PATHOL, V113, P421, DOI 10.1309/E11X-491Y-GUJH-EGGF; Robinson B., 1996, IMMUNOPATHOLOGY LUNG, P165; ROBINSON BWS, 1993, LUNG CANCER, V9, P413; Rothman KJ., 1986, MODERN EPIDEMIOLOGY; Rusch VW, 1999, ANN THORAC SURG, V68, P1799, DOI 10.1016/S0003-4975(99)01038-3; Scholler N, 1999, P NATL ACAD SCI USA, V96, P11531, DOI 10.1073/pnas.96.20.11531; Scott B., 2000, TXB LUNG CANC, P273; Spurzem J., 1996, IMMUNOPATHOLOGY LUNG, P119; Urwin Debra, 2000, Molecular Cell Biology Research Communications, V3, P26, DOI 10.1006/mcbr.2000.0181; Vauthey JN, 1996, DIGEST DIS, V14, P5, DOI 10.1159/000171535; YAMAGUCHI N, 1994, J BIOL CHEM, V269, P805; Zellos LS, 2002, SEMIN ONCOL, V29, P41, DOI 10.1053/sonc.2002.30230	35	427	444	1	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 15	2003	362	9396					1612	1616		10.1016/S0140-6736(03)14794-0	http://dx.doi.org/10.1016/S0140-6736(03)14794-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744MZ	14630441				2022-12-24	WOS:000186637400009
J	Schumacher, MA; Lau, AOT; Johnson, PJ				Schumacher, MA; Lau, AOT; Johnson, PJ			Structural basis of core promoter recognition in a primitive eukaryote	CELL			English	Article							RNA-POLYMERASE-II; C-TERMINAL DOMAIN; PROTEIN-CODING GENES; LARGEST-SUBUNIT; DNA-BINDING; CRYSTAL-STRUCTURE; ETS-DOMAIN; INITIATOR ELEMENT; CAPPING ENZYME; TRANSCRIPTION	Transcription start site selection in eukaryotes is mediated through combinations of the TATA, initiator (lnr), and downstream promoter elements (DPE). In Trichomonas vaginalis, a parabasalian flagellate thought to represent an ancient eukaryote lineage, the lnr appears to be solely responsible for start site selection and is recognized by the initiator binding protein 39 kDa (IBP39). IBP39 contains an N-terminal lnr binding domain (IBD) connected via a flexible linker to a C-terminal domain (C domain). Here we present crystal structures of the apoIBD and IBD-lnr complexes and the C domain. The 11313 structures reveal a winged-helix motif with prokaryotic and eukaryotic features and a scaffold similar to that of ETS-family proteins. The C domain structure and biochemical studies indicate that it interacts with the T. vaginalis RNAP 11 large subunit C-terminal domain. These data suggest that binding of IBP39 to the lnr directly recruits RNAP 11 and in this way initiates transcription.	Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Sch Med, Los Angeles, CA 90095 USA	Oregon Health & Science University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Schumacher, MA (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.			Lau, Audrey/0000-0001-8212-0142	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI050359, R01AI030537] Funding Source: NIH RePORTER; NIAID NIH HHS [F32AI50359, AI30537] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARKHIPOVA IR, 1995, GENETICS, V139, P1359; BARRONCASELLA E, 1992, J MOL EVOL, V35, P405, DOI 10.1007/BF00171818; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; CHAPMAN AB, 1994, J BIOL CHEM, V269, P4754; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; CORDEN JL, 1985, P NATL ACAD SCI USA, V82, P7934, DOI 10.1073/pnas.82.23.7934; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Donaldson LW, 1996, EMBO J, V15, P125, DOI 10.1002/j.1460-2075.1996.tb00340.x; EVERS R, 1989, NUCLEIC ACIDS RES, V17, P3403, DOI 10.1093/nar/17.9.3403; EVERS R, 1989, CELL, V56, P585, DOI 10.1016/0092-8674(89)90581-3; Fabrega C, 2003, MOL CELL, V11, P1549, DOI 10.1016/S1097-2765(03)00187-4; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HANSEN SK, 1995, CELL, V82, P565, DOI 10.1016/0092-8674(95)90029-2; Heyduk T, 1996, METHOD ENZYMOL, V274, P492; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; Hirose Y, 1999, GENE DEV, V13, P1234, DOI 10.1101/gad.13.10.1234; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kadonaga JT, 2002, EXP MOL MED, V34, P259, DOI 10.1038/emm.2002.36; Kaufmann J, 1998, MOL CELL BIOL, V18, P233, DOI 10.1128/MCB.18.1.233; Keeling PJ, 2000, NATURE, V405, P635, DOI 10.1038/35015167; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; KOWESTRA D, 1991, NATURE, V349, P178; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Liston DR, 1999, MOL CELL BIOL, V19, P2380; Liston DR, 2001, MOL CELL BIOL, V21, P7872, DOI 10.1128/MCB.21.22.7872-7882.2001; Litingtung Y, 1999, MOL GEN GENET, V261, P100, DOI 10.1007/s004380050946; Lo K, 1996, GENE, V182, P13, DOI 10.1016/S0378-1119(96)00438-6; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6; Mo Y, 2000, NAT STRUCT BIOL, V7, P292; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Myers JK, 2001, BIOCHEMISTRY-US, V40, P8479, DOI 10.1021/bi0027884; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; QUON DVK, 1994, P NATL ACAD SCI USA, V91, P4579, DOI 10.1073/pnas.91.10.4579; Quon DVK, 1996, J MOL EVOL, V43, P253, DOI 10.1007/PL00006084; RAVISHANKER G, 1989, J BIOMOL STRUCT DYN, V6, P669, DOI 10.1080/07391102.1989.10507729; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smale ST, 1998, COLD SPRING HARB SYM, V63, P21, DOI 10.1101/sqb.1998.63.21; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Verger A, 2002, BIOESSAYS, V24, P362, DOI 10.1002/bies.10068; WEMER MH, 1997, J BIOMOL NMR, V10, P317; WEST ML, 1995, GENETICS, V140, P1223; Wintjens R, 1996, J MOL BIOL, V262, P294, DOI 10.1006/jmbi.1996.0514	56	50	51	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 14	2003	115	4					413	424		10.1016/S0092-8674(03)00887-0	http://dx.doi.org/10.1016/S0092-8674(03)00887-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	744KB	14622596	Bronze			2022-12-24	WOS:000186627100008
J	Huangfu, DW; Liu, AM; Rakeman, AS; Murcia, NS; Niswander, L; Anderson, KV				Huangfu, DW; Liu, AM; Rakeman, AS; Murcia, NS; Niswander, L; Anderson, KV			Hedgehog signalling in the mouse requires intraflagellar transport proteins	NATURE			English	Article							KINESIN-II; GENE; DISEASE; GLI3; MORPHOGENESIS; EXPRESSION; DELETION; PATHWAY; LACKING; MUTANTS	Intraflagellar transport (IFT) proteins were first identified as essential factors for the growth and maintenance of flagella in the single-celled alga Chlamydomonas reinhardtii(1). In a screen for embryonic patterning mutations induced by ethylnitrosourea, here we identify two mouse mutants, wimple (wim) and flexo (fxo), that lack ventral neural cell types and show other phenotypes characteristic of defects in Sonic hedgehog signalling. Both mutations disrupt IFT proteins: the wim mutation is an allele of the previously uncharacterized mouse homologue of IFT172; and fxo is a new hypomorphic allele of polaris, the mouse homologue of IFT88. Genetic analysis shows that Wim, Polaris and the IFT motor protein Kif3a are required for Hedgehog signalling at a step downstream of Patched1 ( the Hedgehog receptor) and upstream of direct targets of Hedgehog signalling. Our data show that IFT machinery has an essential and vertebrate-specific role in Hedgehog signal transduction.	Sloan Kettering Inst, Dev Biol Program, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Mol Cell & Dev Biol Program, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Neurosci Program, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Howard Hughes Med Inst, New York, NY 10021 USA; Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University; Howard Hughes Medical Institute; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Anderson, KV (corresponding author), Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10021 USA.	k-anderson@ski.mskcc.org	Niswander, Lee/D-3976-2013	Niswander, Lee/0000-0002-9959-0594; Huangfu, Danwei/0000-0002-1145-6199; Anderson, Kathryn/0000-0003-1657-2161				Bale AE, 2002, ANNU REV GENOM HUM G, V3, P47, DOI 10.1146/annurev.genom.3.022502.103031; Caspary T, 2002, CURR BIOL, V12, P1628, DOI 10.1016/S0960-9822(02)01147-8; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Eggenschwiler JT, 2000, DEV BIOL, V227, P648, DOI 10.1006/dbio.2000.9918; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; Farrelly D, 1999, P NATL ACAD SCI USA, V96, P14511, DOI 10.1073/pnas.96.25.14511; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; HAN Y, 1932, CURR BIOL, V13, P1679; Howard PW, 2000, J BIOL CHEM, V275, P13336, DOI 10.1074/jbc.275.18.13336; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Motoyama J, 2003, DEV BIOL, V259, P150, DOI 10.1016/S0012-1606(03)00159-3; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Ray K, 1999, J CELL BIOL, V147, P507, DOI 10.1083/jcb.147.3.507; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schimenti JC, 2000, GENOME RES, V10, P1043, DOI 10.1101/gr.10.7.1043; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Sloboda RD, 2002, CELL MOTIL CYTOSKEL, V52, P1, DOI 10.1002/cm.10035; SULIK K, 1994, DEV DYNAM, V201, P260, DOI 10.1002/aja.1002010309; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Vetter DE, 2002, NAT GENET, V31, P363, DOI 10.1038/ng914; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3; Wheatley DN, 1996, CELL BIOL INT, V20, P73, DOI 10.1006/cbir.1996.0011; Ying LT, 2000, DEV DYNAM, V219, P143, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1050>3.3.CO;2-H; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916	30	1002	1026	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2003	426	6962					83	87		10.1038/nature02061	http://dx.doi.org/10.1038/nature02061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739WY	14603322				2022-12-24	WOS:000186370800046
J	Kodama, A; Karakesisoglou, L; Wong, E; Vaezi, A; Fuchs, E				Kodama, A; Karakesisoglou, L; Wong, E; Vaezi, A; Fuchs, E			ACF7: An essential integrator of microtubule dynamics	CELL			English	Article							ADENOMATOUS POLYPOSIS-COLI; CELL POLARITY; MITOTIC SPINDLE; FISSION YEAST; MIGRATING CELLS; RHO-GTPASES; PLUS-END; F-ACTIN; CYTOSKELETON; PROTEINS	ACF7 is a member of the spectraplakin family of cytoskeletal crosslinking proteins possessing actin and microtubule binding domains. Here, we show that ACF7 is an essential integrator of MT-actin dynamics. In endodermal cells, ACF7 binds along microtubules but concentrates at their distal ends and at cell borders when polarized. In ACF7's absence, microtubules still bind EB1 and CLIP170, but they no longer grow along polarized actin bundles, nor do they pause and tether to actin-rich cortical sites. The consequences are less stable, long microtubules with skewed cytoplasmic trajectories and altered dynamic instability. In response to wounding, ACF7 null cultures activate polarizing signals, but fail to maintain them and coordinate migration. Rescue of these defects requires ACF7's actin and microtubule binding domains. Thus, spectraplakins are important for controlling microtubule dynamics and reinforcing links between microtubules and polarized F-actin, so that cellular polarization and coordinated cell movements can be sustained.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA.		Fuchs, Elaine/G-1565-2016	Karakesisoglou, Iakowos (Akis)/0000-0002-8549-0728	NIAMS NIH HHS [R01 AR027883-28] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abe K, 1996, EXP CELL RES, V229, P27, DOI 10.1006/excr.1996.0340; Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Andra K, 1998, GENE DEV, V12, P3442, DOI 10.1101/gad.12.21.3442; Barth AIM, 2002, J CELL SCI, V115, P1583; Behrens R, 2002, J CELL BIOL, V157, P783, DOI 10.1083/jcb.200112027; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Fuchs E, 2001, GENE DEV, V15, P1, DOI 10.1101/gad.861501; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Glynn JM, 2001, CURR BIOL, V11, P836, DOI 10.1016/S0960-9822(01)00235-4; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; GOTLIEB AI, 1981, J CELL BIOL, V91, P589, DOI 10.1083/jcb.91.2.589; GUNDERSEN GG, 1986, J CELL BIOL, V102, P1118, DOI 10.1083/jcb.102.3.1118; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Gupton SL, 2002, CURR BIOL, V12, P1891, DOI 10.1016/S0960-9822(02)01276-9; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Kaverina I, 2002, J CELL SCI, V115, P2283; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kofron M, 2002, J CELL BIOL, V158, P695, DOI 10.1083/jcb.200202123; Komarova YA, 2002, J CELL SCI, V115, P3527; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Lee S, 2002, DEVELOPMENT, V129, P1195; Leung CL, 2002, TRENDS CELL BIOL, V12, P37, DOI 10.1016/S0962-8924(01)02180-8; LIU JJ, 2003, IN PRESS J CELL BIOL; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Murray P, 2001, DIFFERENTIATION, V68, P227, DOI 10.1046/j.1432-0436.2001.680410.x; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Reuter JE, 2003, DEVELOPMENT, V130, P1203, DOI 10.1242/dev.00319; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Roper K, 2002, J CELL SCI, V115, P4215, DOI 10.1242/jcs.00157; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Subramanian A, 2003, CURR BIOL, V13, P1086, DOI 10.1016/S0960-9822(03)00416-0; Sun DM, 2001, J CELL SCI, V114, P161; Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991; TIMAUER JS, 2002, MOL BIOL CELL, V13, P3614; Tirnauer JS, 2002, MOL BIOL CELL, V13, P4308, DOI 10.1091/mbc.e02-04-0236; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Wittmann T, 2001, J CELL SCI, V114, P3795; Yang YM, 1999, CELL, V98, P229, DOI 10.1016/S0092-8674(00)81017-X; Yvon AMC, 2002, MOL BIOL CELL, V13, P1871, DOI 10.1091/mbc.01-11-0539; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	62	254	263	0	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 31	2003	115	3					343	354		10.1016/S0092-8674(03)00813-4	http://dx.doi.org/10.1016/S0092-8674(03)00813-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	740RH	14636561	Bronze			2022-12-24	WOS:000186415000013
J	Wang, L				Wang, L			Expanding the genetic code	SCIENCE			English	Editorial Material							UNNATURAL AMINO-ACID; ESCHERICHIA-COLI; TRANSFER-RNA; GENERATION; PROTEINS		Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Wang, L (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.		Wang, Lei/E-7912-2011	Wang, Lei/0000-0002-5859-2526				BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Knight RD, 2001, NAT REV GENET, V2, P49, DOI 10.1038/35047500; Liu HT, 2003, J AM CHEM SOC, V125, P1702, DOI 10.1021/ja029433n; Mehl RA, 2003, J AM CHEM SOC, V125, P935, DOI 10.1021/ja0284153; Sakamoto K, 2002, NUCLEIC ACIDS RES, V30, P4692, DOI 10.1093/nar/gkf589; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Walsh CT, 2001, CURR OPIN CHEM BIOL, V5, P525, DOI 10.1016/S1367-5931(00)00235-0; Wang L, 2001, CHEM BIOL, V8, P883, DOI 10.1016/S1074-5521(01)00063-1; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang L, 2003, P NATL ACAD SCI USA, V100, P56, DOI 10.1073/pnas.0234824100; Wang L, 2000, J AM CHEM SOC, V122, P5010, DOI 10.1021/ja000595y; Wang L, 2003, J ORG CHEM, V68, P174, DOI 10.1021/jo026570u; Wang L, 2002, J AM CHEM SOC, V124, P1836, DOI 10.1021/ja012307j; Wang L, 2002, THESIS U CALIFORNIA	15	7	8	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					584	585		10.1126/science.302.5645.584	http://dx.doi.org/10.1126/science.302.5645.584			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576413				2022-12-24	WOS:000186119900037
J	Kmietowicz, Z				Kmietowicz, Z			Information for patients: Getting professional help	BRITISH MEDICAL JOURNAL			English	Article									BMJ Publishing Grp, London WC1H 9JR, England	BMJ Publishing Group Ltd	Kmietowicz, Z (corresponding author), BMJ Publishing Grp, London WC1H 9JR, England.								0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1396	1396		10.1136/bmj.327.7428.1396	http://dx.doi.org/10.1136/bmj.327.7428.1396			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670891	Green Published			2022-12-24	WOS:000187417900029
J	Birnbaum, K; Shasha, DE; Wang, JY; Jung, JW; Lambert, GM; Galbraith, DW; Benfey, PN				Birnbaum, K; Shasha, DE; Wang, JY; Jung, JW; Lambert, GM; Galbraith, DW; Benfey, PN			A gene expression map of the Arabidopsis root	SCIENCE			English	Article							LASER CAPTURE MICRODISSECTION; COMPUTATIONAL ANALYSIS; CHROMOSOMAL DOMAINS; DIFFERENTIATION; REVEALS; PHLOEM; CELLS	A global map of gene expression within an organ can identify genes with coordinated expression in localized domains, thereby relating gene activity to cell fate and tissue specialization. Here, we present localization of expression of more than 22,000 genes in the Arabidopsis root. Gene expression was mapped to 15 different zones of the root that correspond to cell types and tissues at progressive developmental stages. Patterns of gene expression traverse traditional anatomical boundaries and show cassettes of hormonal response. Chromosomal clustering defined some coregulated genes. This expression map correlates groups of genes to specific cell fates and should serve to guide reverse genetics.	Duke Univ, Dept Biol, Durham, NC 27708 USA; NYU, Dept Biol, New York, NY 10003 USA; NYU, Courant Inst Math Sci, New York, NY 10003 USA; Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA	Duke University; New York University; New York University; University of Arizona	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Box 91000, Durham, NC 27708 USA.		Galbraith, David/AAG-8891-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020716] Funding Source: NIH RePORTER; NIGMS NIH HHS [5 F32 GM20716-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asano T, 2002, PLANT J, V32, P401, DOI 10.1046/j.1365-313X.2002.01423.x; BENFEY PN, 1994, TRENDS GENET, V10, P84, DOI 10.1016/0168-9525(94)90230-5; Berleth T, 2000, CURR OPIN PLANT BIOL, V3, P406, DOI 10.1016/S1369-5266(00)00104-7; BIRNBAUM K, UNPUB; BONKE M, IN PRESS NATURE; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Jasper H, 2002, DEV CELL, V3, P511, DOI 10.1016/S1534-5807(02)00297-6; Kerk NM, 2003, PLANT PHYSIOL, V132, P27, DOI 10.1104/pp.102.018127; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Lin Y, 2001, DEVELOPMENT, V128, P3697; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Milioni D, 2002, PLANT CELL, V14, P2813, DOI 10.1105/tpc.005231; Murdock LL, 2002, J AGR FOOD CHEM, V50, P6605, DOI 10.1021/jf020192c; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; TRUERNIT E, 1995, PLANTA, V196, P564, DOI 10.1007/BF00203657; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2; Wysocka-Diller JW, 2000, DEVELOPMENT, V127, P595	21	921	958	7	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1956	1960		10.1126/science.1090022	http://dx.doi.org/10.1126/science.1090022			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671301				2022-12-24	WOS:000187174000058
J	Gunjan, A; Verreault, A				Gunjan, A; Verreault, A			A Rad53 kinase-dependent surveillsnce mechanism 3that regulates histone protein levels6 in S. cerevisiae	CELL			English	Article							STALLED REPLICATION FORKS; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; CHECKPOINT PATHWAYS; PHASE CHECKPOINT; BUDDING YEAST; MESSENGER-RNA; CHROMATIN; DAMAGE; PROGRESSION	Rad53 and Mec1 are protein kinases required for DNA replication and recovery from DNA damage in Saccharomyces cerevisiae. Here, we show that rad53, but not mec1 mutants, are extremely sensitive to histone overexpression, as Rad53 is required for degradation of excess histones. Consequently, excess histones accumulate in rad53 mutants, resulting in slow growth, DNA damage sensitivity, and chromosome loss phenotypes that are significantly suppressed by a reduction in histone gene dosage. Rad53 monitors excess histones by associating with them in a dynamic complex that is modulated by its kinase activity. Our results argue that Rad53 contributes to genome stability independently of Mec1 by preventing the damaging effects of excess histones both during normal cell cycle progression and in response to DNA damage.	Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Verreault, A (corresponding author), Canc Res UK, London Res Inst, Clare Hall Labs, Blanche Lane, S Mimms EN6 3LD, Herts, England.			Gunjan, Akash/0000-0001-8478-3978				Berloco M, 2001, P NATL ACAD SCI USA, V98, P12126, DOI 10.1073/pnas.211428798; BONNER WM, 1988, BIOCHEMISTRY-US, V27, P6542, DOI 10.1021/bi00417a052; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; COMMERFORD SL, 1982, P NATL ACAD SCI-BIOL, V79, P1163, DOI 10.1073/pnas.79.4.1163; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; DILWORTH SM, 1987, CELL, V51, P1009, DOI 10.1016/0092-8674(87)90587-3; Dominski Z, 2003, MOL CELL, V12, P295, DOI 10.1016/S1097-2765(03)00278-8; Downs JA, 2003, MOL CELL, V11, P1685, DOI 10.1016/S1097-2765(03)00197-7; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; Fay DS, 1997, CURR GENET, V31, P97, DOI 10.1007/s002940050181; FRANCESCONI S, 1991, P NATL ACAD SCI USA, V88, P3877, DOI 10.1073/pnas.88.9.3877; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; HAAS A, 1990, J BIOL CHEM, V265, P21664; HAN M, 1987, CELL, V48, P589, DOI 10.1016/0092-8674(87)90237-6; Holmes SG, 2001, YEAST, V18, P291, DOI 10.1002/1097-0061(20010315)18:4<291::AID-YEA668>3.0.CO;2-V; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Klein HL, 2001, GENETICS, V159, P1501; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; Melo JA, 2001, GENE DEV, V15, P2809; Myung K, 2003, P NATL ACAD SCI USA, V100, P6640, DOI 10.1073/pnas.1232239100; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; PICKART CM, 1988, J BIOL CHEM, V263, P15076; Quivy JP, 2001, EMBO J, V20, P2015, DOI 10.1093/emboj/20.8.2015; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; Steger DJ, 1999, METHODS, V19, P410, DOI 10.1006/meth.1999.0877; Sullivan E, 2001, GENE DEV, V15, P173, DOI 10.1101/gad.862801; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Sutton A, 2001, GENETICS, V158, P587; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; van Beekvelt CA, 2001, NUCLEIC ACIDS RES, V29, P5001, DOI 10.1093/nar/29.24.5001; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; WOODLAND HR, 1977, DEV BIOL, V57, P118, DOI 10.1016/0012-1606(77)90359-1; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	47	237	242	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 26	2003	115	5					537	549		10.1016/S0092-8674(03)00896-1	http://dx.doi.org/10.1016/S0092-8674(03)00896-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651846	Bronze			2022-12-24	WOS:000186885600005
J	Wilcock, GK				Wilcock, GK			Dementia with Lewy bodies	LANCET			English	Editorial Material							INTERNATIONAL WORKSHOP; CONSENSUS CRITERIA; ALZHEIMERS-DISEASE; POPULATION; DIAGNOSIS; PREVALENCE; OLDER		Univ Bristol, Frenchay Hosp, Dept Care Elderly, Bristol BS16 1LE, Avon, England	University of Bristol	Wilcock, GK (corresponding author), Univ Bristol, Frenchay Hosp, Dept Care Elderly, Bristol BS16 1LE, Avon, England.							American Psychological Association, 1994, DIAGN STAT MAN MENT, V4th; HANSEN L, 1990, NEUROLOGY, V40, P1; McKeith IG, 2000, NEUROLOGY, V54, P1050, DOI 10.1212/WNL.54.5.1050; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; McKeith IG, 1999, NEUROLOGY, V53, P902, DOI 10.1212/WNL.53.5.902; Perry R H, 1989, Lancet, V1, P166; PERRY RH, 1990, J NEUROL SCI, V95, P119, DOI 10.1016/0022-510X(90)90236-G; Rahkonen T, 2003, J NEUROL NEUROSUR PS, V74, P720, DOI 10.1136/jnnp.74.6.720; Stevens T, 2002, BRIT J PSYCHIAT, V180, P270, DOI 10.1192/bjp.180.3.270; Yamada T, 2002, PSYCHIAT CLIN NEUROS, V56, P71, DOI 10.1046/j.1440-1819.2002.00931.x; Yamada T, 2001, PSYCHIAT CLIN NEUROS, V55, P21, DOI 10.1046/j.1440-1819.2001.00779.x	11	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 22	2003	362	9397					1689	1690		10.1016/S0140-6736(03)14883-0	http://dx.doi.org/10.1016/S0140-6736(03)14883-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746VE	14643115				2022-12-24	WOS:000186767700005
J	Matamala, R; Gonzalez-Meler, MA; Jastrow, JD; Norby, RJ; Schlesinger, WH				Matamala, R; Gonzalez-Meler, MA; Jastrow, JD; Norby, RJ; Schlesinger, WH			Impacts of fine root turnover on forest NPP and soil C sequestration potential	SCIENCE			English	Article							ELEVATED ATMOSPHERIC CO2; CARBON STORAGE; ECOSYSTEMS; BIOMASS; ENRICHMENT; MORTALITY; DYNAMICS; PATTERNS	Estimates of forest net primary production (NPP) demand accurate estimates of root production and turnover. We assessed root turnover with the use of an isotope tracer in two forest free-air carbon dioxide enrichment experiments. Growth at elevated carbon dioxide did not accelerate root turnover in either the pine or the hardwood forest. Turnover of fine root carbon varied from 1.2 to 9 years, depending on root diameter and dominant tree species. These long turnover times suggest that root production and turnover in forests have been overestimated and that sequestration of anthropogenic atmospheric carbon in forest soils may be lower than currently estimated.	Argonne Natl Lab, Div Environm Res, Argonne, IL 60439 USA; Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; United States Department of Energy (DOE); Oak Ridge National Laboratory; Duke University	Matamala, R (corresponding author), Argonne Natl Lab, Div Environm Res, Argonne, IL 60439 USA.		Jastrow, Julie D./AAX-1631-2020; Norby, Richard J/C-1773-2012	Jastrow, Julie D./0000-0001-7069-4560; Norby, Richard J/0000-0002-0238-9828; Gonzalez-Meler, Miquel/0000-0001-5388-7969				ABER JD, 1985, OECOLOGIA, V66, P317, DOI 10.1007/BF00378292; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; Eissenstat DM, 1997, ADV ECOL RES, V27, P1, DOI 10.1016/S0065-2504(08)60005-7; Ellsworth DS, 1999, PLANT CELL ENVIRON, V22, P461, DOI 10.1046/j.1365-3040.1999.00433.x; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Gaudinski JB, 2001, OECOLOGIA, V129, P420, DOI 10.1007/s004420100746; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; GRIER CC, 1981, CAN J FOREST RES, V11, P155, DOI 10.1139/x81-021; HENDRICK RL, 1993, NATURE, V361, P59, DOI 10.1038/361059a0; Hendricks JJ, 1997, OECOLOGIA, V112, P300, DOI 10.1007/s004420050312; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; JASTROW JD, UNPUB; Langley JA, 2002, OECOLOGIA, V131, P542, DOI 10.1007/s00442-002-0932-6; Luo YQ, 2003, GLOBAL CHANGE BIOL, V9, P1118, DOI 10.1046/j.1365-2486.2003.00642.x; Matamala R, 2000, GLOB CHANGE BIOL, V6, P967, DOI 10.1046/j.1365-2486.2000.00374.x; MILCHUNAS DG, 1992, ECOLOGY, V73, P593, DOI 10.2307/1940765; Norby RJ, 2002, ECOL APPL, V12, P1261, DOI 10.1890/1051-0761(2002)012[1261:NPPOAC]2.0.CO;2; NORBY RJ, UNPUB; Pataki DE, 2003, BIOSCIENCE, V53, P805, DOI 10.1641/0006-3568(2003)053[0805:TCIEFU]2.0.CO;2; Pritchard SG, 2001, GLOBAL CHANGE BIOL, V7, P829, DOI 10.1046/j.1354-1013.2001.00457.x; SANTANTONIO D, 1987, CAN J FOREST RES, V17, P900, DOI 10.1139/x87-141; Schlesinger WH, 2001, NATURE, V411, P466, DOI 10.1038/35078060; Schoettle A.W., 1994, ECOL BULL, V43, P136, DOI DOI 10.2307/20113137	23	360	409	14	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2003	302	5649					1385	1387		10.1126/science.1089543	http://dx.doi.org/10.1126/science.1089543			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631037				2022-12-24	WOS:000186683500049
J	Stocking, MA				Stocking, MA			Tropical soils and food security: The next 50 years	SCIENCE			English	Article							QUALITY; FERTILITY; SYSTEMS; EROSION; TOOL	An appreciation of the dynamism of the links between soil resources and society provides a platform for examining food security over the next 50 years. Interventions to reverse declining trends in food security must recognize the variable resilience and sensitivity of major tropical soil types. In most agroecosystems, declining crop yield is exponentially related to loss of soil quality. For the majority smallholder (subsistence) farmers, investments to reverse degradation are primarily driven by private benefit, socially or financially. "Tragedy of the commons" scenarios can be averted by pragmatic local solutions that help farmers to help themselves.	Univ E Anglia, Sch Dev Studies, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Stocking, MA (corresponding author), Univ E Anglia, Sch Dev Studies, Norwich NR4 7TJ, Norfolk, England.							Andrews SS, 2001, ECOL APPL, V11, P1573, DOI 10.1890/1051-0761(2001)011[1573:DASQAT]2.0.CO;2; [Anonymous], 1999, WORLD HLTH REPORT 19; Boardman J, 2003, ENVIRON SCI POLICY, V6, P1, DOI 10.1016/S1462-9011(02)00120-X; Brookfield H., 2001, EXPLORING AGRODIVERS; *CIMMYT, 2003, GLOB WARM THREAT FOO; CROSSON P, 1995, SOIL EROSION ITS ON; Doran J. W., 1996, SSSA SPECIAL PUBLICA, V49; Dorward P, 2003, AGR SYST, V75, P97, DOI 10.1016/S0308-521X(02)00034-3; *FAO COMM WORLD FO, 2001, IMP HIV AIDS FOOD SE; Food and Agriculture Organization of the United Nations (FAO), SPEC PROGR FOOD SEC; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; Gordon Prain, 1999, BIOL CULTURAL DIVERS; GYASI EA, 2002, CULTIVATING BIODIVER, P245; HHIEMSTRA W, 1992, LET FARMERS JUDGE EX; *INT FOOD POL RES, 2002, REACH SUST FOOD SEC; KAHLHURA F, 2003, AGR BIODIVERSITY SMA; Karlen DL, 2003, GEODERMA, V114, P145, DOI 10.1016/S0016-7061(03)00039-9; KIOME RM, 1995, GLOBAL ENVIRON CHANG, V5, P281, DOI 10.1016/0959-3780(95)00063-T; LAL R, 1994, SOIL EROSION RES MET; Lutz E., 1994, 8 WORLD BANK; Mausback M.J., 1998, SOIL QUALITY AGR SUS, P33; MAZZUCATO V, 2000, TROPICAL RESOURCE MA, V32; Pretty J, 2001, WORLD DEV, V29, P209, DOI 10.1016/S0305-750X(00)00098-X; Pretty Jules, 1995, REGENERATING AGR POL; Renwick A, 2002, PHILOS T ROY SOC A, V360, P1721, DOI 10.1098/rsta.2002.1028; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; Sanchez PA, 2003, GEODERMA, V114, P157, DOI 10.1016/S0016-7061(03)00040-5; Scherr S J, 1995, 14 INT FOOD POL RES; Seybold CA, 1998, ADV SOIL S, P387; Stocking M., 1988, Soil Technology, V1, P289, DOI 10.1016/0933-3630(88)90028-1; Stocking M., 2001, HDB FIELD ASSESSMENT; Stocking M., 2003, ENCY SOIL SCI; Stocking M., 2000, ENV SCI ENV MANAGEME, P287; STOCKING M, 1999, PUBLICATION AGL MISC, P91; STOCKING M, 2002, SUSTAINABLE USE MANA, V1, P178; Swift MJ, 1999, NATURE RESOUR, V35, P12; SWIFT MJ, 1998, CARBON NUTR DYNAMICS, P59; Tengberg A, 1998, ADV GEOECOL, V31, P355; Tengberg A, 2001, RESPONSE TO LAND DEGRADATION, P171; TENGBERG A, 1998, EXPT AGR, V34, P55; *UN DEV PROGR, 2001, ANN REP 2001; *UN DEV PROGR, 2003, MILL DEV GOALS; Versteeg MN, 1998, AGR SYST, V56, P269, DOI 10.1016/S0308-521X(97)00041-3; Whitbread AM, 2000, SOIL TILL RES, V54, P63, DOI 10.1016/S0167-1987(99)00112-9; *WORLD FOOD PROGR, WORLD FOOD PROGR GOA; 2003, DAILY NEWS      0617	46	155	170	3	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2003	302	5649					1356	1359		10.1126/science.1088579	http://dx.doi.org/10.1126/science.1088579			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745HP	14631030				2022-12-24	WOS:000186683500040
J	Svensson, M; Gustafsson, F; Galatius, S; Hildebrandt, PR; Atar, D				Svensson, M; Gustafsson, F; Galatius, S; Hildebrandt, PR; Atar, D			Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study	BRITISH MEDICAL JOURNAL			English	Article									Aker Univ Hosp, Div Cardiol, Oslo, Norway; Frederiksberg Univ Hosp, Dept Cardiol & Endocrinol, DK-2000 Copenhagen, Denmark	University of Oslo	Atar, D (corresponding author), Aker Univ Hosp, Div Cardiol, Oslo, Norway.			Gustafsson, Finn/0000-0003-2144-341X				GALATIUS S, 2002, AM HEART J S, V144, pS2; GREENBERG B, 2002, J CARDIOVASC PHARM, V38, P59; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Remme WJ, 2002, EUR J HEART FAIL, V4, P11, DOI 10.1016/S1388-9842(01)00231-8	5	53	58	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 15	2003	327	7424					1141	1142		10.1136/bmj.327.7424.1141	http://dx.doi.org/10.1136/bmj.327.7424.1141			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744HL	14615339	Green Published, Bronze			2022-12-24	WOS:000186622100020
J	Kaksonen, M; Sun, Y; Drubin, DG				Kaksonen, M; Sun, Y; Drubin, DG			A pathway for association of receptors, adaptors, and actin during endocytic internalization	CELL			English	Article							ALDRICH-SYNDROME PROTEIN; CLATHRIN-COATED PITS; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; IN-VIVO; MEDIATED ENDOCYTOSIS; FILAMENT TURNOVER; ARP2/3 COMPLEX; CYTOSKELETON; DYNAMICS	In budding yeast, many proteins involved in endocytic internalization, including adaptors and actin cytoskeletal proteins, are localized to cortical patches of differing protein composition. Using multicolor real-time fluorescence microscopy and particle tracking algorithms, we define an early endocytic pathway wherein an invariant sequence of changes in cortical patch protein composition correlates with changes in patch motility. Three Arp2/3 activators each showed a distinct behavior, suggesting distinct patch-related endocytic functions. Actin polymerization occurs late in the endocytic pathway and is required both for endocytic internalization and for patch disassembly. In cells lacking the highly conserved endocytic protein Sla2p, patch motility was arrested and actin comet tails associated with endocytic patch complexes. Fluorescence recovery after photobleaching of the actin comet tails revealed that endocytic complexes are nucleation sites for rapid actin polymerization. Attention is now focused on the mechanisms by which the order and timing of events in this endocytic pathway are achieved.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Drubin, DG (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 16 Barker Hall, Berkeley, CA 94720 USA.			Kaksonen, Marko/0000-0003-3645-7689; Sun, Yidi/0000-0002-2157-1983	NIGMS NIH HHS [GM42759, GM50399] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM042759, R01GM050399, R01GM042759] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Belmont LD, 1998, J CELL BIOL, V142, P1289, DOI 10.1083/jcb.142.5.1289; Carlsson AE, 2002, BIOPHYS J, V82, P2333, DOI 10.1016/S0006-3495(02)75579-3; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; Doyle T, 1996, P NATL ACAD SCI USA, V93, P3886, DOI 10.1073/pnas.93.9.3886; DRUBIN DG, 1988, J CELL BIOL, V107, P2551, DOI 10.1083/jcb.107.6.2551; Engqvist-Goldstein AEY, 1999, J CELL BIOL, V147, P1503, DOI 10.1083/jcb.147.7.1503; ENGQVISTGOLDSTE.AE, 2003, IN PRESS ANN REV CEL; Geli MI, 1998, J CELL SCI, V111, P1031; Goode BL, 2001, CURR OPIN MICROBIOL, V4, P703, DOI 10.1016/S1369-5274(01)00272-7; Gourlay CW, 2003, J CELL SCI, V116, P2551, DOI 10.1242/jcs.00454; Higgins MK, 2002, TRENDS BIOCHEM SCI, V27, P257, DOI 10.1016/S0968-0004(02)02089-3; HOLTZMAN DA, 1993, J CELL BIOL, V122, P635, DOI 10.1083/jcb.122.3.635; Howard JP, 2002, J CELL BIOL, V157, P315, DOI 10.1083/jcb.200110027; KARPOVA TS, 1995, J CELL BIOL, V131, P1483, DOI 10.1083/jcb.131.6.1483; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Li R, 1997, J CELL BIOL, V136, P649, DOI 10.1083/jcb.136.3.649; McCann RO, 1997, P NATL ACAD SCI USA, V94, P5679, DOI 10.1073/pnas.94.11.5679; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Moreau V, 1997, MOL BIOL CELL, V8, P1361, DOI 10.1091/mbc.8.7.1361; MULHOLLAND J, 1994, J CELL BIOL, V125, P381, DOI 10.1083/jcb.125.2.381; Mulholland J, 1999, MOL BIOL CELL, V10, P799, DOI 10.1091/mbc.10.3.799; Munn AL, 2001, BBA-MOL BASIS DIS, V1535, P236, DOI 10.1016/S0925-4439(01)00028-X; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Rodal AA, 2003, CURR BIOL, V13, P1000, DOI 10.1016/S0960-9822(03)00383-X; Sekiya-Kawasaki M, 2003, J CELL BIOL, V162, P765, DOI 10.1083/jcb.200305077; Smith MG, 2001, J CELL SCI, V114, P1505; Tang HY, 2000, MOL CELL BIOL, V20, P12, DOI 10.1128/MCB.20.1.12-25.2000; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; Uruno T, 2003, J BIOL CHEM, V278, P26086, DOI 10.1074/jbc.M301997200; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; Waddle JA, 1996, J CELL BIOL, V132, P861, DOI 10.1083/jcb.132.5.861; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Warren DT, 2002, J CELL SCI, V115, P1703; Wendland B, 1996, J CELL BIOL, V135, P1485, DOI 10.1083/jcb.135.6.1485; Wesp A, 1997, MOL BIOL CELL, V8, P2291, DOI 10.1091/mbc.8.11.2291; Winter D, 1997, CURR BIOL, V7, P519, DOI 10.1016/S0960-9822(06)00223-5; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Yang S, 1999, MOL BIOL CELL, V10, P2265, DOI 10.1091/mbc.10.7.2265; Zeng GH, 2001, MOL BIOL CELL, V12, P3759, DOI 10.1091/mbc.12.12.3759	44	516	523	4	44	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 14	2003	115	4					475	487		10.1016/S0092-8674(03)00883-3	http://dx.doi.org/10.1016/S0092-8674(03)00883-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	744KB	14622601	Bronze			2022-12-24	WOS:000186627100013
J	Bonke, M; Thitamadee, S; Mahonen, AP; Hauser, MT; Helariutta, Y				Bonke, M; Thitamadee, S; Mahonen, AP; Hauser, MT; Helariutta, Y			APL regulates vascular tissue identity in Arabidopsis	NATURE			English	Article							RADIAL ORGANIZATION; PATTERN-FORMATION; SIEVE ELEMENTS; ROOT; DIFFERENTIATION; CELL; MORPHOGENESIS; TRAFFICKING; MUTATIONS; PHLOEM	Vascular plants have a long-distance transport system consisting of two tissue types with elongated cell files, phloem and xylem(1). Phloem has two basic cell types, enucleate sieve elements and companion cells. Xylem has various lignified cell types, such as tracheary elements, the differentiation of which involves deposition of elaborate cell wall thickenings and programmed cell death(1-4). Until now, little has been known about the genetic control of phloem-xylem patterning. Here we identify the ALTERED PHLOEM DEVELOPMENT (APL) gene, which encodes a MYB coiled-coil-type transcription factor that is required for phloem identity in Arabidopsis. Phloem is established through asymmetric cell divisions and subsequent differentiation. We show that both processes are impaired by a recessive apl mutation. This is associated with the formation of cells that have xylem characteristics in the position of phloem. The APL expression profile is consistent with a key role in phloem development. Ectopic APL expression in the vascular bundle inhibits xylem development. Our studies suggest that APL has a dual role both in promoting phloem differentiation and in repressing xylem differentiation during vascular development.	Univ Helsinki, Inst Biotechnol, Plant Mol Biol Lab, FIN-00014 Helsinki, Finland; BOKU Univ Nat Resources & Appl Life Sci Vienna, Ctr Appl Genet, A-1190 Vienna, Austria	University of Helsinki; University of Natural Resources & Life Sciences, Vienna	Helariutta, Y (corresponding author), Univ Helsinki, Inst Biotechnol, Plant Mol Biol Lab, POB 56, FIN-00014 Helsinki, Finland.		Hauser, Marie-Theres/J-6029-2013; Mähönen, Ari Pekka/B-9764-2015; Helariutta, Yrjo/AAE-8149-2020	Hauser, Marie-Theres/0000-0001-8938-2460; Mähönen, Ari Pekka/0000-0001-6051-866X; Helariutta, Yrjo/0000-0002-7287-8459				ALONI R, 1987, ANNU REV PLANT PHYS, V38, P179, DOI 10.1146/annurev.pp.38.060187.001143; Baum SF, 2002, AM J BOT, V89, P908, DOI 10.3732/ajb.89.6.908; Carland FM, 1999, PLANT CELL, V11, P2123, DOI 10.1105/tpc.11.11.2123; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Imlau A, 1999, PLANT CELL, V11, P309, DOI 10.1105/tpc.11.3.309; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Kuhn C, 1997, SCIENCE, V275, P1298, DOI 10.1126/science.275.5304.1298; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Lin Y, 2001, DEVELOPMENT, V128, P3697; Liu YG, 1999, P NATL ACAD SCI USA, V96, P6535, DOI 10.1073/pnas.96.11.6535; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; McCann M, 1997, TRENDS PLANT SCI, V2, P333, DOI 10.1016/S1360-1385(97)84620-1; McConnell JR, 1998, DEVELOPMENT, V125, P2935; Oparka KJ, 1999, PLANT CELL, V11, P739, DOI 10.1105/tpc.11.4.739; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; SCHERES B, 1995, DEVELOPMENT, V121, P53; SCHERES B, 1994, DEVELOPMENT, V120, P2475; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; TORRESRUIZ RA, 1994, DEVELOPMENT, V120, P2967; WAITES R, 1995, DEVELOPMENT, V121, P2143; Wisman E, 1998, PLANT MOL BIOL, V37, P989, DOI 10.1023/A:1006082009151; Ye ZH, 2002, ANNU REV PLANT BIOL, V53, P183, DOI 10.1146/annurev.arplant.53.100301.135245; Yoshimura T, 1996, PLANT CELL PHYSIOL, V37, P1167, DOI 10.1093/oxfordjournals.pcp.a029068	25	322	352	7	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2003	426	6963					181	186		10.1038/nature02100	http://dx.doi.org/10.1038/nature02100			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614507				2022-12-24	WOS:000186517200044
J	Freckleton, RP; Sutherland, WJ; Watkinson, AR				Freckleton, RP; Sutherland, WJ; Watkinson, AR			Deciding the future of GM crops in Europe	SCIENCE			English	Editorial Material							HERBICIDE-TOLERANT CROPS; BIODIVERSITY		Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Tyndall Ctr Climate Change Res, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	University of Oxford; University of East Anglia; University of East Anglia; University of East Anglia	Freckleton, RP (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.		Freckleton, Rob P/B-6455-2013; Sutherland, William/B-1291-2013; Watkinson, Andrew R/N-1649-2013	Freckleton, Robert/0000-0002-8338-864X; Sutherland, William/0000-0002-6498-0437				Brooks DR, 2003, PHILOS T R SOC B, V358, P1847, DOI 10.1098/rstb.2003.1407; *CAB OFF, 2003, STRAT UN FIELD WORK; Campbell S, 2003, NATURE, V425, P559, DOI 10.1038/425559b; Champion GT, 2003, PHILOS T ROY SOC B, V358, P1801, DOI 10.1098/rstb.2003.1405; Dewar AM, 2003, P ROY SOC B-BIOL SCI, V270, P335, DOI 10.1098/rspb.2002.2248; Firbank LG, 2003, J APPL ECOL, V40, P2, DOI 10.1046/j.1365-2664.2003.00787.x; FRECKLETON RP, IN PRESS P R SOC B; *GM SCI REV PAN, 2003, 1 DEP TRAD IND GM SC; Hawes C, 2003, PHILOS T ROY SOC B, V358, P1899, DOI 10.1098/rstb.2003.1406; Heard MS, 2003, PHILOS T ROY SOC B, V358, P1833, DOI 10.1098/rstb.2003.1401; Heard MS, 2003, PHILOS T ROY SOC B, V358, P1819, DOI 10.1098/rstb.2003.1402; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Roy DB, 2003, PHILOS T ROY SOC B, V358, P1879, DOI 10.1098/rstb.2003.1404; Squire GR, 2003, PHILOS T R SOC B, V358, P1779, DOI 10.1098/rstb.2003.1403; Watkinson AR, 2000, SCIENCE, V289, P1554, DOI 10.1126/science.289.5484.1554; [No title captured]	17	19	20	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2003	302	5647					994	996		10.1126/science.1092671	http://dx.doi.org/10.1126/science.1092671			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605355				2022-12-24	WOS:000186396300030
J	Miller, AI; Foote, M				Miller, AI; Foote, M			Increased longevities of post-Paleozoic marine genera after mass extinctions	SCIENCE			English	Article							TAXONOMIC DIVERSITY; FOSSIL RECORD; END; RECOVERY; ORIGINATION; COMPONENTS; EVOLUTION	Cohorts of marine taxa that originated during recoveries from mass extinctions were commonly more widespread spatially than those originating at other times. Coupled with the recognition of a correlation between the geographic ranges and temporal longevities of marine taxa, this observation predicts that recovery taxa were unusually long-lived geologically. We analyzed this possibility by assessing the longevities of marine genus cohorts that originated in successive substages throughout the Phanerozoic. Results confirm that several mass extinction recovery cohorts were significantly longer lived than other cohorts, but this effect was limited to the post-Paleozoic, suggesting differences in the dynamics of Paleozoic versus post-Paleozoic diversification.	Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA; Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Cincinnati; University of Chicago	Miller, AI (corresponding author), Univ Cincinnati, Dept Geol, POB 210013, Cincinnati, OH 45221 USA.							Adrain JM, 2000, SCIENCE, V289, P110, DOI 10.1126/science.289.5476.110; Droser ML, 2000, GEOLOGY, V28, P675, DOI 10.1130/0091-7613(2000)028<0675:DOTAES>2.3.CO;2; Erwin DH, 1998, SCIENCE, V279, P1324, DOI 10.1126/science.279.5355.1324; Erwin DH, 2001, P NATL ACAD SCI USA, V98, P5399, DOI 10.1073/pnas.091092698; Erwin DH, 1998, TRENDS ECOL EVOL, V13, P344, DOI 10.1016/S0169-5347(98)01436-0; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Foote M, 2000, PALEOBIOLOGY, V26, P578, DOI 10.1666/0094-8373(2000)026<0578:OAECOT>2.0.CO;2; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; Jablonski D, 1998, SCIENCE, V279, P1327, DOI 10.1126/science.279.5355.1327; JABLONSKI D, 1991, SCIENCE, V253, P754, DOI 10.1126/science.253.5021.754; KENDALL DG, 1948, ANN MATH STAT, V19, P1, DOI 10.1214/aoms/1177730285; Kirchner JW, 2000, NATURE, V404, P177, DOI 10.1038/35004564; Kirchner JW, 2002, NATURE, V415, P65, DOI 10.1038/415065a; MARKOV AV, 2002, PALEONTOL J, V36, P121; Myers N, 2001, P NATL ACAD SCI USA, V98, P5389, DOI 10.1073/pnas.091092498; RAUP DM, 1985, PALEOBIOLOGY, V11, P42, DOI 10.1017/S0094837300011386; RAUP DM, 1986, SCIENCE, V231, P833, DOI 10.1126/science.11542060; RAUP DM, 1991, PALEOBIOLOGY, V17, P37, DOI 10.1017/S0094837300010332; Rodland DL, 2001, PALAIOS, V16, P95, DOI 10.2307/3515554; SCHUBERT JK, 1992, GEOLOGY, V20, P883, DOI 10.1130/0091-7613(1992)020<0883:ETSAPM>2.3.CO;2; Sepkoski J.J., 2002, B AM PALEONTOL, V363, P1; SHEEHAN P M, 1975, Paleobiology, V1, P205; Sheehan PM, 2001, ANNU REV EARTH PL SC, V29, P331, DOI 10.1146/annurev.earth.29.1.331; STANLEY SM, 1994, SCIENCE, V266, P1340, DOI 10.1126/science.266.5189.1340; Walker LJ, 2002, J GEOL, V110, P75, DOI 10.1086/324318	25	41	44	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2003	302	5647					1030	1032		10.1126/science.1089719	http://dx.doi.org/10.1126/science.1089719			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14605366				2022-12-24	WOS:000186396300043
J	Goldfine, AB; Kahn, CR				Goldfine, AB; Kahn, CR			Adiponectin: linking the fat cell to insulin sensitivity	LANCET			English	Editorial Material							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; RESISTANCE; OXIDATION; GENE		Joslin Diabet Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Kahn, CR (corresponding author), Joslin Diabet Ctr, Boston, MA 02215 USA.	C.Ronald.Kahn@joslin.harvard.edu	Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228; Goldfine, Allison/0000-0002-0345-1048				Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mora S, 2002, DIABETES-METAB RES, V18, P345, DOI 10.1002/dmrr.321; Musi N, 2003, BIOCHEM SOC T, V31, P191, DOI 10.1042/bst0310191; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Stefan N, 2002, DIABETES, V51, P1884, DOI 10.2337/diabetes.51.6.1884; Stumvoll M, 2002, DIABETES, V51, P37, DOI 10.2337/diabetes.51.1.37; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Ukkola O, 2003, METABOLISM, V52, P881, DOI 10.1016/S0026-0495(03)00074-X; Vasseur F, 2003, INT CONGR SER, V1253, P37, DOI 10.1007/s11892-003-0039-4; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	19	89	94	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2003	362	9394					1431	1432		10.1016/S0140-6736(03)14727-7	http://dx.doi.org/10.1016/S0140-6736(03)14727-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739PX	14602433				2022-12-24	WOS:000186356600005
J	Thompson, T; Barbour, R; Schwartz, L				Thompson, T; Barbour, R; Schwartz, L			Adherence to advance directives in critical care decision making: vignette study	BRITISH MEDICAL JOURNAL			English	Article							PROFESSIONALS; ATTITUDES; VIEWS	Objective To explore health professionals' decision making in a critical care scenario when there is an advance directive. Design Qualitative study. Setting Scotland. Participants Interviewees (n = 12) comprising general practitioners, hospital specialists, and nurses, and six focus groups (n = 34 participants) comprising general practitioners, geriatricians (consultants and specialist registrars), hospital nurses, and hospice nurses. Results When presented with an advance directive that applied to the same hypothetical scenario, health professionals came to divergent conclusions as to the "right thing to do' " Arguments opposing treatment centred on the supremacy of autonomy as an ethical principle. Other arguments were that the decision to treat was consistent with the terms of the advance directive, or that, notwithstanding the advance directive, the patients quality of life was sufficient to warrant treatment. Conclusion Advance directives are open to widely varying interpretation. Some of this variability is related to the ambiguity of the directive's terminology whereas some is related to the willingness of health professionals to make subjective value judgments concerning quality of life.	Univ Bristol, Div Primary Hlth Care, Bristol BS6 6JL, Avon, England; Univ Dundee, Sch Nursing & Midwifery, Dundee DD1 4HJ, Scotland; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; Univ Glasgow, Dept Gen Practice, Glasgow G12 8QQ, Lanark, Scotland	University of Bristol; University of Dundee; McMaster University; University of Glasgow	Thompson, T (corresponding author), Univ Bristol, Div Primary Hlth Care, Bristol BS6 6JL, Avon, England.			Schwartz, Lisa/0000-0002-4959-225X				Barbour RS, 2000, FAM PRACT, V17, P83, DOI 10.1093/fampra/17.1.83; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; *BRIT MED ASS, 1999, WITHH WITHDR LIF PRO; Charles C, 1999, BRIT MED J, V319, P780, DOI 10.1136/bmj.319.7212.780; Collins K, 1999, BRIT J GEN PRACT, V49, P641; DANIS M, 1991, NEW ENGL J MED, V324, P882, DOI 10.1056/NEJM199103283241304; DAVIDSON KW, 1989, JAMA-J AM MED ASSOC, V262, P2415, DOI 10.1001/jama.262.17.2415; Ditto PH, 2001, ARCH INTERN MED, V161, P421, DOI 10.1001/archinte.161.3.421; Docker C, 2000, BMJ-BRIT MED J, V320, P54; DOWNIE RS, 2000, CLIN JUDGEMENT; DOWNIE RS, 1994, HLTH RESPECT, P51; DOWNIE RS, 1994, HLTH RESPECT, P141; Hojat M, 2001, ACAD MED, V76, P669, DOI 10.1097/00001888-200107000-00001; *HOUS LORDS, 1994, REP SEL COMM MED ETH, V1, P54; Ikonomidis S, 1999, J MED ETHICS, V25, P522, DOI 10.1136/jme.25.6.522; KELNER M, 1993, CAN MED ASSOC J, V148, P1331; Mallik M, 1997, J ADV NURS, V25, P130, DOI 10.1046/j.1365-2648.1997.1997025130.x; MCLEAN S, 2000, ETHICS LAW INTENSIVE, P68; MUHR T, 1997, ATLAS SHORT USERS GU; NEUBERGER J, 1999, DYING WELL GUIDE ENA; Richie J, 1994, ANAL QUALITATIVE DAT, P173, DOI DOI 10.4324/9780203413081_CHAPTER_9; SOMMERVILLE A, 1995, BRIT MED J, V310, P1663; Swartz R, 1998, Adv Ren Replace Ther, V5, P109; Thompson TDB, 2003, PALLIATIVE MED, V17, P403, DOI 10.1191/0269216303pm784oa	24	60	60	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 1	2003	327	7422					1011	1014		10.1136/bmj.327.7422.1011	http://dx.doi.org/10.1136/bmj.327.7422.1011			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738NE	14593032	Bronze, Green Published			2022-12-24	WOS:000186294100016
J	Collins, NC; Thordal-Christensen, H; Lipka, V; Bau, S; Kombrink, E; Qiu, JL; Huckelhoven, R; Stein, M; Freialdenhoven, A; Somerville, SC; Schulze-Lefert, P				Collins, NC; Thordal-Christensen, H; Lipka, V; Bau, S; Kombrink, E; Qiu, JL; Huckelhoven, R; Stein, M; Freialdenhoven, A; Somerville, SC; Schulze-Lefert, P			SNARE-protein-mediated disease resistance at the plant cell wall	NATURE			English	Article							POWDERY MILDEW FUNGUS; PAPILLA FORMATION; BARLEY; COMPLEX; GENES; SPECIFICITY; IDENTIFICATION; SYNTAXIN; FUSION; HORDEI	Failure of pathogenic fungi to breach the plant cell wall constitutes a major component of immunity of non-host plant species species outside the pathogen host range - and accounts for a proportion of aborted infection attempts on 'susceptible' host plants (basal resistance)(1-4). Neither form of penetration resistance is understood at the molecular level. We developed a screen for penetration ( pen) mutants of Arabidopsis, which are disabled in non-host penetration resistance against barley powdery mildew, Blumeria graminis f. sp. hordei, and we isolated the PEN1 gene. We also isolated barley ROR2 (ref. 2), which is required for basal penetration resistance against B. g. hordei. The genes encode functionally homologous syntaxins, demonstrating a mechanistic link between non-host resistance and basal penetration resistance in monocotyledons and dicotyledons. We show that resistance in barley requires a SNAP-25 (synaptosome-associated protein, molecular mass 25 kDa) homologue capable of forming a binary SNAP receptor ( SNARE) complex with ROR2. Genetic control of vesicle behaviour at penetration sites, and plasma membrane location of PEN1/ROR2, is consistent with a proposed involvement of SNARE-complex-mediated exocytosis and/or homotypic vesicle fusion events in resistance. Functions associated with SNARE-dependent penetration resistance are dispensable for immunity mediated by race-specific resistance (R) genes, highlighting fundamental differences between these two resistance forms.	Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Riso Natl Lab, Plant Res Dept, DK-4000 Roskilde, Denmark; Univ Giessen, Inst Phytopathol & Appl Zool, D-35392 Giessen, Germany; Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA	Max Planck Society; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Technical University of Denmark; Justus Liebig University Giessen; Carnegie Institution for Science	Schulze-Lefert, P (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany.		Schulze-Lefert, Paul/A-7746-2008; Thordal-Christensen, Hans/F-6281-2014; Huckelhoven, Ralph/H-6676-2013; Lipka, Volker/C-5874-2009; Bruening, Stefan/B-8505-2011; Schulze-Lefert, Paul/B-6707-2011	Thordal-Christensen, Hans/0000-0001-8813-0157; Huckelhoven, Ralph/0000-0001-5632-5451; Stein, Monica/0000-0002-1926-4212; Qiu, Jin-Long/0000-0001-8054-2552				Adam L, 1996, PLANT J, V9, P341, DOI 10.1046/j.1365-313X.1996.09030341.x; Betz WJ, 2000, NAT NEUROSCI, V3, P636, DOI 10.1038/76579; Blatt MR, 2002, NEW PHYTOL, V153, P405, DOI 10.1046/j.0028-646X.2001.00341.x; Emans N, 2002, PLANT CELL, V14, P71, DOI 10.1105/tpc.010339; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Freialdenhoven A, 1996, PLANT CELL, V8, P5, DOI 10.1105/tpc.8.1.5; Hammond-Kosack KE, 2003, CURR OPIN BIOTECH, V14, P177, DOI 10.1016/S0958-1669(03)00035-1; Hoogkamp TJH, 1998, PHYTOPATHOLOGY, V88, P856, DOI 10.1094/PHYTO.1998.88.8.856; Huckelhoven R, 1999, PLANT PHYSIOL, V119, P1251, DOI 10.1104/pp.119.4.1251; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; JOHNSON LEB, 1982, CAN J BOT, V60, P1068, DOI 10.1139/b82-137; KOGA H, 1990, CAN J BOT, V68, P2344, DOI 10.1139/b90-299; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Lerman JC, 2000, BIOCHEMISTRY-US, V39, P8470, DOI 10.1021/bi0003994; Mellersh DG, 2002, PLANT J, V29, P257, DOI 10.1046/j.0960-7412.2001.01215.x; Misura KMS, 2001, J BIOL CHEM, V276, P13273, DOI 10.1074/jbc.M009636200; Munson M, 2000, NAT STRUCT BIOL, V7, P894; Peterhansel C, 1997, PLANT CELL, V9, P1397, DOI 10.1105/tpc.9.8.1397; Sanderfoot AA, 2000, PLANT PHYSIOL, V124, P1558, DOI 10.1104/pp.124.4.1558; Shen QH, 2003, PLANT CELL, V15, P732, DOI 10.1105/tpc.009258; SNYDER BA, 1990, SCIENCE, V248, P1637, DOI 10.1126/science.248.4963.1637; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Yu Y, 2000, THEOR APPL GENET, V101, P1093, DOI 10.1007/s001220051584	24	696	734	4	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2003	425	6961					973	977		10.1038/nature02076	http://dx.doi.org/10.1038/nature02076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737KY	14586469				2022-12-24	WOS:000186230600044
J	Horne-Badovinac, S; Rebagliati, M; Stainier, DYR				Horne-Badovinac, S; Rebagliati, M; Stainier, DYR			A cellular framework for gut-looping morphogenesis in zebrafish	SCIENCE			English	Article							LEFT-RIGHT ASYMMETRY; RIGHT AXIS FORMATION; ENDODERM FORMATION; HEART; PATHWAYS; PROTEIN; GENES; LIVER; ROLES; SOUL	Many vertebrate organs adopt asymmetric positions with respect to the midline, but little is known about the cellular changes and tissue movements that occur downstream of left-right gene expression to produce this asymmetry. Here, we provide evidence that the looping of the zebrafish gut results from the asymmetric migration of the neighboring lateral plate mesoderm (LPM). Mutations that disrupt the epithelial structure of the LPM perturb this asymmetric migration and inhibit gut looping. Asymmetric LPM migration still occurs when the endoderm is ablated from the gut-looping region, suggesting that the LPM can autonomously provide a motive force for gut displacement. Finally, reducing left-sided Nodal activity randomizes the pattern of LPM migration and gut looping. These results reveal a cellular framework for the regulation of organ laterality by asymmetrically expressed genes.	Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Program Human Genet, San Francisco, CA 94143 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Iowa	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94143 USA.			Stainier, Didier/0000-0002-0382-0026				Alexander J, 1999, DEV BIOL, V215, P343, DOI 10.1006/dbio.1999.9441; Bisgrove BW, 2000, DEVELOPMENT, V127, P3567; Burdine RD, 2000, GENE DEV, V14, P763; Campione M, 1999, DEVELOPMENT, V126, P1225; Chen JN, 1997, DEVELOPMENT, V124, P4373; Chin AJ, 2000, DEV BIOL, V227, P403, DOI 10.1006/dbio.2000.9924; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Kikuchi Y, 2000, GENE DEV, V14, P1279; Liang JO, 2000, DEVELOPMENT, V127, P5101; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Mercola M, 2001, ANNU REV CELL DEV BI, V17, P779, DOI 10.1146/annurev.cellbio.17.1.779; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Ober EA, 2003, MECH DEVELOP, V120, P5, DOI 10.1016/S0925-4773(02)00327-1; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Peterson RT, 2001, CURR BIOL, V11, P1481, DOI 10.1016/S0960-9822(01)00482-1; Tabin CJ, 2003, GENE DEV, V17, P1, DOI 10.1101/gad.1053803; Wei XY, 2002, NAT GENET, V31, P150, DOI 10.1038/ng883; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527	21	105	108	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					662	665		10.1126/science.1085397	http://dx.doi.org/10.1126/science.1085397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	14576439				2022-12-24	WOS:000186119900064
J	Yoshimura, T; Yasuo, S; Watanabe, M; Iigo, M; Yamamura, T; Hirunagi, K; Ebihara, S				Yoshimura, T; Yasuo, S; Watanabe, M; Iigo, M; Yamamura, T; Hirunagi, K; Ebihara, S			Light-induced hormone conversion of T-4 to T-3 regulates photoperiodic response of gonads in birds	NATURE			English	Article							CIRCADIAN CLOCK GENES; JAPANESE-QUAIL; ELECTRICAL-STIMULATION; GONADOTROPHIN RELEASE; TUBERAL HYPOTHALAMUS; TESTICULAR GROWTH; THYROIDECTOMY; EXPRESSION; THYROXINE; RHYTHMICITY	Reproduction of many temperate zone birds is under photoperiodic control. The Japanese quail is an excellent model for studying the mechanism of photoperiodic time measurement because of its distinct and marked response to changing photoperiods. Studies on this animal have suggested that the mediobasal hypothalamus (MBH) is an important centre controlling photoperiodic time measurement(1-8). Here we report that expression in the MBH of the gene encoding type 2 iodothyronine deiodinase (Dio2), which catalyses the intracellular deiodination of thyroxine (T-4) prohormone to the active 3,5,3'-triiodothyronine (T-3), is induced by light in Japanese quail. Intracerebroventricular administration of T-3 mimics the photoperiodic response, whereas the Dio2 inhibitor iopanoic acid prevents gonadal growth. These findings demonstrate that light-induced Dio2 expression in the MBH may be involved in the photoperiodic response of gonads in Japanese quail.	Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Chikusa Ku, Nagoya, Aichi 4648601, Japan; Nagoya Univ Museum, Chikusa Ku, Nagoya, Aichi 4648601, Japan; Utsunomiya Univ, Fac Agr, Dept Appl Biol Chem, Utsunomiya, Tochigi 3218505, Japan	Nagoya University; Nagoya University; Utsunomiya University	Yoshimura, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.		Yoshimura, Takashi/C-8306-2012; Iigo, Masayuki/I-7110-2013	Yoshimura, Takashi/0000-0001-7018-9652; Iigo, Masayuki/0000-0001-8251-4141				Bernal J, 2002, J ENDOCRINOL INVEST, V25, P268, DOI 10.1007/BF03344003; Chopra I J, 1978, Recent Prog Horm Res, V34, P521; DAVIES DT, 1975, PROC R SOC SER B-BIO, V191, P303, DOI 10.1098/rspb.1975.0130; DAWSON A, 1993, J ENDOCRINOL, V139, P51, DOI 10.1677/joe.0.1390051; Dawson A, 1998, GEN COMP ENDOCR, V110, P196, DOI 10.1006/gcen.1998.7065; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Dawson A., 2001, P141; FOLLETT BK, 1988, J COMP PHYSIOL B, V157, P829, DOI 10.1007/BF00691015; FOLLETT BK, 1988, J COMP PHYSIOL B, V157, P837, DOI 10.1007/BF00691016; FOLLETT BK, 1969, NATURE, V223, P968, DOI 10.1038/223968b0; FOLLETT BK, 1985, J ENDOCRINOL, V107, P211, DOI 10.1677/joe.0.1070211; FOLLETT BK, 1984, J EXP ZOOL, V232, P573, DOI 10.1002/jez.1402320325; IKUTA K, 1987, GEN COMP ENDOCR, V65, P99, DOI 10.1016/0016-6480(87)90228-0; JUSS TS, 1993, AVIAN ENDOCRINOLOGY, P47; KONISHI H, 1987, J COMP PHYSIOL A, V161, P315, DOI 10.1007/BF00615251; Kuenzel W.J., 1988, STEREOTAXIC ATLAS BR; Leonard JL, 1986, THYROID HORMONE META, P189; MEDDLE SL, 1995, J COMP PHYSIOL A, V176, P79; Meddle SL, 1997, J NEUROSCI, V17, P8909; NICHOLS DH, 1985, CLIN OBSTET GYNECOL, V28, P375, DOI 10.1097/00003081-198528020-00015; OHTA M, 1984, J COMP PHYSIOL, V154, P583, DOI 10.1007/BF00610171; OHTA M, 1987, GEN COMP ENDOCR, V68, P286, DOI 10.1016/0016-6480(87)90040-2; Prendergast BJ, 2002, P NATL ACAD SCI USA, V99, P16291, DOI 10.1073/pnas.232490799; SHARP PJ, 1969, NEUROENDOCRINOLOGY, V5, P205, DOI 10.1159/000121861; SILVER R, 1988, CELL TISSUE RES, V253, P189; TAGAWA M, 1987, GEN COMP ENDOCR, V68, P129, DOI 10.1016/0016-6480(87)90068-2; Yasuo S, 2003, ENDOCRINOLOGY, V144, P3742, DOI 10.1210/en.2003-0435; Yoshimura T, 2000, MOL BRAIN RES, V78, P207, DOI 10.1016/S0169-328X(00)00091-7	28	366	382	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2003	426	6963					178	181		10.1038/nature02117	http://dx.doi.org/10.1038/nature02117			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614506				2022-12-24	WOS:000186517200043
